Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
3658 10879 53 None 1 18 Human 9.5 pAC50 = 9.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
517 10879 53 None 1 18 Human 9.5 pAC50 = 9.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
5709 10879 53 None 1 18 Human 9.5 pAC50 = 9.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL312448 10879 53 None 1 18 Human 9.5 pAC50 = 9.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
DB06694 10879 53 None 1 18 Human 9.5 pAC50 = 9.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
11079 9510 63 None 5 7 Human 9.2 pAC50 = 9.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
3369 9510 63 None 5 7 Human 9.2 pAC50 = 9.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
4436 9510 63 None 5 7 Human 9.2 pAC50 = 9.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
5509 9510 63 None 5 7 Human 9.2 pAC50 = 9.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL761 9510 63 None 5 7 Human 9.2 pAC50 = 9.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
DB06711 9510 63 None 5 7 Human 9.2 pAC50 = 9.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
2142 9870 58 None -1 18 Human 9.1 pAC50 = 9.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
4920903 9870 58 None -1 18 Human 9.1 pAC50 = 9.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
502 9870 58 None -1 18 Human 9.1 pAC50 = 9.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
5775 9870 58 None -1 18 Human 9.1 pAC50 = 9.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL597 9870 58 None -1 18 Human 9.1 pAC50 = 9.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
DB00692 9870 58 None -1 18 Human 9.1 pAC50 = 9.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
1960 9632 67 None -2 19 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
439260 9632 67 None -2 19 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
505 9632 67 None -2 19 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL1437 9632 67 None -2 19 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00368 9632 67 None -2 19 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
11079 9510 63 None 5 7 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
3369 9510 63 None 5 7 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
4436 9510 63 None 5 7 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
5509 9510 63 None 5 7 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL761 9510 63 None 5 7 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
DB06711 9510 63 None 5 7 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
3036780 114308 20 None -7 15 Human 8.9 pAC50 = 8.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 10.1038/s41467-023-40064-9
46780481 114308 20 None -7 15 Human 8.9 pAC50 = 8.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 10.1038/s41467-023-40064-9
9903970 114308 20 None -7 15 Human 8.9 pAC50 = 8.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 10.1038/s41467-023-40064-9
CHEMBL3187365 114308 20 None -7 15 Human 8.9 pAC50 = 8.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 10.1038/s41467-023-40064-9
CHEMBL3544974 114308 20 None -7 15 Human 8.9 pAC50 = 8.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 10.1038/s41467-023-40064-9
CHEMBL504548 114308 20 None -7 15 Human 8.9 pAC50 = 8.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 10.1038/s41467-023-40064-9
DB06216 114308 20 None -7 15 Human 8.9 pAC50 = 8.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 10.1038/s41467-023-40064-9
2803 7742 58 None -3 14 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
516 7742 58 None -3 14 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
704 7742 58 None -3 14 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
CHEMBL134 7742 58 None -3 14 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
DB00575 7742 58 None -3 14 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
1960 9632 67 None -2 19 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
439260 9632 67 None -2 19 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
505 9632 67 None -2 19 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL1437 9632 67 None -2 19 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00368 9632 67 None -2 19 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
129211 10521 78 None -1 14 Human 8.8 pAC50 = 8.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
2562 10521 78 None -1 14 Human 8.8 pAC50 = 8.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
488 10521 78 None -1 14 Human 8.8 pAC50 = 8.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
CHEMBL836 10521 78 None -1 14 Human 8.8 pAC50 = 8.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
DB00706 10521 78 None -1 14 Human 8.8 pAC50 = 8.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
124 9755 47 None -8 25 Human 8.7 pAC50 = 8.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1038/s41467-023-40064-9
2032 9755 47 None -8 25 Human 8.7 pAC50 = 8.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1038/s41467-023-40064-9
4636 9755 47 None -8 25 Human 8.7 pAC50 = 8.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL762 9755 47 None -8 25 Human 8.7 pAC50 = 8.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1038/s41467-023-40064-9
DB00935 9755 47 None -8 25 Human 8.7 pAC50 = 8.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1038/s41467-023-40064-9
16351 109507 47 None -17 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 343 0 0 4 4.1 CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
CHEMBL304902 109507 47 None -17 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 343 0 0 4 4.1 CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
DB13256 109507 47 None -17 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 343 0 0 4 4.1 CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
9429 208912 58 None -5 18 Human 6.0 pAC50 = 6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
CHEMBL609109 208912 58 None -5 18 Human 6.0 pAC50 = 6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
DB01622 208912 58 None -5 18 Human 6.0 pAC50 = 6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
3599 23651 88 None 1 3 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 20 0 4 5.7 CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
CHEMBL125 23651 88 None 1 3 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 20 0 4 5.7 CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
3062316 40349 121 None -1 10 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 487 7 3 9 3.3 Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1 10.1038/s41467-023-40064-9
CHEMBL1421 40349 121 None -1 10 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 487 7 3 9 3.3 Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1 10.1038/s41467-023-40064-9
54676537 159633 72 None - 1 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 353 5 1 6 3.5 CC(=O)CC(c1ccc([N+](=O)[O-])cc1)c1c(O)c2ccccc2oc1=O 10.1038/s41467-023-40064-9
CHEMBL397420 159633 72 None - 1 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 353 5 1 6 3.5 CC(=O)CC(c1ccc([N+](=O)[O-])cc1)c1c(O)c2ccccc2oc1=O 10.1038/s41467-023-40064-9
2162 48288 100 None -5 22 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1491 48288 100 None -5 22 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
3783 20777 23 None -27 6 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 4 2.9 CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL1197051 20777 23 None -27 6 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 4 2.9 CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
6989215 8267 80 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 213 3 5 5 -0.5 OC(=O)[C@H]([C@@H](c1ccc(c(c1)O)O)O)N 10.1038/s41467-023-40064-9
7391 8267 80 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 213 3 5 5 -0.5 OC(=O)[C@H]([C@@H](c1ccc(c(c1)O)O)O)N 10.1038/s41467-023-40064-9
92974 8267 80 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 213 3 5 5 -0.5 OC(=O)[C@H]([C@@H](c1ccc(c(c1)O)O)O)N 10.1038/s41467-023-40064-9
971 8267 80 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 213 3 5 5 -0.5 OC(=O)[C@H]([C@@H](c1ccc(c(c1)O)O)O)N 10.1038/s41467-023-40064-9
CHEMBL2103827 8267 80 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 213 3 5 5 -0.5 OC(=O)[C@H]([C@@H](c1ccc(c(c1)O)O)O)N 10.1038/s41467-023-40064-9
DB06262 8267 80 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 213 3 5 5 -0.5 OC(=O)[C@H]([C@@H](c1ccc(c(c1)O)O)O)N 10.1038/s41467-023-40064-9
242 7258 124 None -120 32 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
34 7258 124 None -120 32 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
60795 7258 124 None -120 32 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL1112 7258 124 None -120 32 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB01238 7258 124 None -120 32 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
2683 109665 25 None -812 24 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
CHEMBL305906 109665 25 None -812 24 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
CHEMBL334255 109665 25 None -812 24 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
31101 7516 40 None -199 29 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
35 7516 40 None -199 29 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
403 7516 40 None -199 29 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
CHEMBL493 7516 40 None -199 29 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
DB01200 7516 40 None -199 29 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
9417 140290 54 None -33 15 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL1524185 140290 54 None -33 15 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL370753 140290 54 None -33 15 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
22530 62904 58 None -3 9 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 2 0 2 3.7 CN1CCc2c(c3ccccc3n2Cc2ccccc2)C1 10.1038/s41467-023-40064-9
CHEMBL1600878 62904 58 None -3 9 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 2 0 2 3.7 CN1CCc2c(c3ccccc3n2Cc2ccccc2)C1 10.1038/s41467-023-40064-9
CHEMBL1625607 62904 58 None -3 9 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 2 0 2 3.7 CN1CCc2c(c3ccccc3n2Cc2ccccc2)C1 10.1038/s41467-023-40064-9
60860 212418 30 None -21 6 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 275 2 3 1 1.3 N=C(N)NCc1cccc(I)c1 10.1038/s41467-023-40064-9
CHEMBL1615777 212418 30 None -21 6 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 275 2 3 1 1.3 N=C(N)NCc1cccc(I)c1 10.1038/s41467-023-40064-9
CHEMBL818 212418 30 None -21 6 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 275 2 3 1 1.3 N=C(N)NCc1cccc(I)c1 10.1038/s41467-023-40064-9
5354 162435 21 None -51 10 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 337 12 2 3 5.6 CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1 10.1038/s41467-023-40064-9
CHEMBL404849 162435 21 None -51 10 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 337 12 2 3 5.6 CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1 10.1038/s41467-023-40064-9
2441 105401 24 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 1 1 3 2.6 O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1 10.1038/s41467-023-40064-9
CHEMBL277062 105401 24 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 1 1 3 2.6 O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1 10.1038/s41467-023-40064-9
104850 10103 96 None -1071 28 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
4150 10103 96 None -1071 28 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
743 10103 96 None -1071 28 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
CHEMBL111 10103 96 None -1071 28 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
DB06155 10103 96 None -1071 28 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
1056 10144 116 None -19 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 6 2.5 O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C 10.1038/s41467-023-40064-9
2405 10144 116 None -19 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 6 2.5 O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C 10.1038/s41467-023-40064-9
77999 10144 116 None -19 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 6 2.5 O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C 10.1038/s41467-023-40064-9
CHEMBL121 10144 116 None -19 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 6 2.5 O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C 10.1038/s41467-023-40064-9
DB00412 10144 116 None -19 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 6 2.5 O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C 10.1038/s41467-023-40064-9
4499 66549 99 None -6 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 388 6 1 7 3.2 COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-] 10.1038/s41467-023-40064-9
CHEMBL1726 66549 99 None -6 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 388 6 1 7 3.2 COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-] 10.1038/s41467-023-40064-9
103 10925 61 None 1 22 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2875 10925 61 None 1 22 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
5736 10925 61 None 1 22 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL285802 10925 61 None 1 22 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB09225 10925 61 None 1 22 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
10184665 10763 51 None -645 10 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
4799 10763 51 None -645 10 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
7353 10763 51 None -645 10 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
CHEMBL1198857 10763 51 None -645 10 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
DB09082 10763 51 None -645 10 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
2267 7347 71 None -45 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
271 7347 71 None -45 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
7121 7347 71 None -45 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL639 7347 71 None -45 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
DB00972 7347 71 None -45 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
2274 9947 58 None -24 37 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
4917 9947 58 None -24 37 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
7279 9947 58 None -24 37 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL728 9947 58 None -24 37 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00433 9947 58 None -24 37 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
2601 10552 33 None -354 17 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
443951 10552 33 None -354 17 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
56 10552 33 None -354 17 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
CHEMBL73151 10552 33 None -354 17 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
DB13399 10552 33 None -354 17 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
11626560 207716 94 None -1 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 449 5 2 6 5.0 C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl 10.1038/s41467-023-40064-9
CHEMBL601719 207716 94 None -1 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 449 5 2 6 5.0 C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl 10.1038/s41467-023-40064-9
10071196 9898 79 None -831 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
5142 9898 79 None -831 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
8423 9898 79 None -831 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
CHEMBL2111101 9898 79 None -831 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
DB05316 9898 79 None -831 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
3675 14506 68 None -91 4 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 136 3 2 2 0.7 NNCCc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1089 14506 68 None -91 4 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 136 3 2 2 0.7 NNCCc1ccccc1 10.1038/s41467-023-40064-9
135409453 10545 41 None -363 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
226 10545 41 None -363 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
CHEMBL76370 10545 41 None -363 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
2470 10425 50 None -13803 23 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3300 10425 50 None -13803 23 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5265 10425 50 None -13803 23 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
99 10425 50 None -13803 23 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL267930 10425 50 None -13803 23 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
180 7189 56 None -63 38 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
200 7189 56 None -63 38 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
2160 7189 56 None -63 38 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL629 7189 56 None -63 38 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00321 7189 56 None -63 38 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
4822 51806 47 None -16 10 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 293 0 0 2 4.7 CN1CCC(=C2c3ccccc3Sc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL152408 51806 47 None -16 10 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 293 0 0 2 4.7 CN1CCC(=C2c3ccccc3Sc3ccccc32)CC1 10.1038/s41467-023-40064-9
16351 109507 47 None -17 17 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 343 0 0 4 4.1 CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
CHEMBL304902 109507 47 None -17 17 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 343 0 0 4 4.1 CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
DB13256 109507 47 None -17 17 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 343 0 0 4 4.1 CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
37264 196201 24 None 8 3 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 6 2 10 1.3 COc1cc2c(N)nc(N3CCN(C(=O)OCC(C)(C)O)CC3)nc2c(OC)c1OC 10.1038/s41467-023-40064-9
CHEMBL513301 196201 24 None 8 3 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 6 2 10 1.3 COc1cc2c(N)nc(N3CCN(C(=O)OCC(C)(C)O)CC3)nc2c(OC)c1OC 10.1038/s41467-023-40064-9
643976 21290 30 None -2 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 456 7 6 10 -1.6 Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O)c2cc1C 10.1038/s41467-023-40064-9
CHEMBL1201794 21290 30 None -2 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 456 7 6 10 -1.6 Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O)c2cc1C 10.1038/s41467-023-40064-9
72093 41835 9 None -10 28 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
CHEMBL1433361 41835 9 None -10 28 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
CHEMBL2103773 41835 9 None -10 28 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
65016 16981 86 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 505 11 3 7 2.4 CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1 10.1038/s41467-023-40064-9
CHEMBL116 16981 86 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 505 11 3 7 2.4 CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1 10.1038/s41467-023-40064-9
22323 22071 32 None -3 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
9571037 22071 32 None -3 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1213553 22071 32 None -3 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
47319 33237 35 None -4 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 929 24 0 12 8.1 COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC 10.1038/s41467-023-40064-9
CHEMBL1360 33237 35 None -4 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 929 24 0 12 8.1 COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC 10.1038/s41467-023-40064-9
3191 109635 97 None -660 33 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 10.1038/s41467-023-40064-9
CHEMBL305660 109635 97 None -660 33 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 10.1038/s41467-023-40064-9
DB11742 109635 97 None -660 33 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 10.1038/s41467-023-40064-9
2372 113245 40 None -144 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 345 10 2 5 2.6 COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC 10.1038/s41467-023-40064-9
CHEMBL314010 113245 40 None -144 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 345 10 2 5 2.6 COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC 10.1038/s41467-023-40064-9
216416 118358 48 None -141 23 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 413 6 1 3 5.7 Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
CHEMBL328190 118358 48 None -141 23 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 413 6 1 3 5.7 Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
23480 130868 23 None -15 7 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 5 1 1 5.0 CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL363295 130868 23 None -15 7 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 5 1 1 5.0 CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C 10.1038/s41467-023-40064-9
135412795 51525 23 None -7 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 1 1 3 3.4 O=C1CN=C(c2ccccc2)c2c(sc3c2CCCC3)N1 10.1038/s41467-023-40064-9
CHEMBL1521495 51525 23 None -7 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 1 1 3 3.4 O=C1CN=C(c2ccccc2)c2c(sc3c2CCCC3)N1 10.1038/s41467-023-40064-9
2805 168669 38 None -3 9 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 329 6 0 2 4.9 Clc1ccc(C(OCCN2CCCCC2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL415087 168669 38 None -3 9 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 329 6 0 2 4.9 Clc1ccc(C(OCCN2CCCCC2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
3053 211913 95 None 1 7 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 393 16 5 8 -2.7 O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O 10.1038/s41467-023-40064-9
CHEMBL780 211913 95 None 1 7 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 393 16 5 8 -2.7 O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O 10.1038/s41467-023-40064-9
1024 8352 27 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 165 3 2 2 1.3 CN[C@H]([C@@H](c1ccccc1)O)C 10.1038/s41467-023-40064-9
5359318 8352 27 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 165 3 2 2 1.3 CN[C@H]([C@@H](c1ccccc1)O)C 10.1038/s41467-023-40064-9
556 8352 27 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 165 3 2 2 1.3 CN[C@H]([C@@H](c1ccccc1)O)C 10.1038/s41467-023-40064-9
65326 8352 27 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 165 3 2 2 1.3 CN[C@H]([C@@H](c1ccccc1)O)C 10.1038/s41467-023-40064-9
9294 8352 27 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 165 3 2 2 1.3 CN[C@H]([C@@H](c1ccccc1)O)C 10.1038/s41467-023-40064-9
CHEMBL1523964 8352 27 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 165 3 2 2 1.3 CN[C@H]([C@@H](c1ccccc1)O)C 10.1038/s41467-023-40064-9
CHEMBL211456 8352 27 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 165 3 2 2 1.3 CN[C@H]([C@@H](c1ccccc1)O)C 10.1038/s41467-023-40064-9
CHEMBL2146102 8352 27 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 165 3 2 2 1.3 CN[C@H]([C@@H](c1ccccc1)O)C 10.1038/s41467-023-40064-9
DB01364 8352 27 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 165 3 2 2 1.3 CN[C@H]([C@@H](c1ccccc1)O)C 10.1038/s41467-023-40064-9
119570 9933 96 None -3890 10 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N 10.1038/s41467-023-40064-9
2233 9933 96 None -3890 10 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N 10.1038/s41467-023-40064-9
953 9933 96 None -3890 10 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N 10.1038/s41467-023-40064-9
CHEMBL301265 9933 96 None -3890 10 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N 10.1038/s41467-023-40064-9
DB00413 9933 96 None -3890 10 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N 10.1038/s41467-023-40064-9
2782 38774 67 None -3801 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 3 4.3 Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1 10.1038/s41467-023-40064-9
CHEMBL1407943 38774 67 None -3801 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 3 4.3 Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1 10.1038/s41467-023-40064-9
CHEMBL3216363 38774 67 None -3801 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 3 4.3 Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1 10.1038/s41467-023-40064-9
4528 104902 80 None -5 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 238 1 1 2 2.8 CN1Cc2c(N)cccc2C(c2ccccc2)C1 10.1038/s41467-023-40064-9
CHEMBL273575 104902 80 None -5 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 238 1 1 2 2.8 CN1Cc2c(N)cccc2C(c2ccccc2)C1 10.1038/s41467-023-40064-9
5311017 127382 11 None -13 5 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 239 5 0 1 3.8 C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL3545985 127382 11 None -13 5 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 239 5 0 1 3.8 C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1 10.1038/s41467-023-40064-9
DB00865 127382 11 None -13 5 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 239 5 0 1 3.8 C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1 10.1038/s41467-023-40064-9
26248 168318 102 None -1 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 3 1 7 2.0 CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O 10.1038/s41467-023-40064-9
CHEMBL41286 168318 102 None -1 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 3 1 7 2.0 CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O 10.1038/s41467-023-40064-9
CHEMBL1630575 63117 0 None -2 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 1093 23 16 18 -3.3 CC[C@H](C)C[C@H](C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CCN)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O 10.1038/s41467-023-40064-9
443869 84916 45 None 1 10 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 491 7 1 8 3.8 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)[C@H]1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
CHEMBL2103761 84916 45 None 1 10 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 491 7 1 8 3.8 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)[C@H]1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
68555 109889 21 None -3 7 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 307 7 1 5 2.6 CNCCc1ccc(OC(=O)C(C)C)c(OC(=O)C(C)C)c1 10.1038/s41467-023-40064-9
CHEMBL307739 109889 21 None -3 7 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 307 7 1 5 2.6 CNCCc1ccc(OC(=O)C(C)C)c(OC(=O)C(C)C)c1 10.1038/s41467-023-40064-9
15942715 84968 19 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 446 5 1 5 4.0 CCCCOC(=O)C(=O)[C@H]1[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL2105087 84968 19 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 446 5 1 5 4.0 CCCCOC(=O)C(=O)[C@H]1[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C 10.1038/s41467-023-40064-9
6918178 21217 44 None 1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 484 4 1 5 4.1 CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL1200908 21217 44 None 1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 484 4 1 5 4.1 CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C 10.1038/s41467-023-40064-9
667492 50679 43 None 1 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 234 1 2 3 0.2 CN1C(=O)/C(=N\NC(N)=S)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1512080 50679 43 None 1 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 234 1 2 3 0.2 CN1C(=O)/C(=N\NC(N)=S)c2ccccc21 10.1038/s41467-023-40064-9
3652 10869 79 None -2089 15 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 281 7 0 5 3.2 CCCCCCOc1nsnc1C1=CCCN(C1)C 10.1038/s41467-023-40064-9
57 10869 79 None -2089 15 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 281 7 0 5 3.2 CCCCCCOc1nsnc1C1=CCCN(C1)C 10.1038/s41467-023-40064-9
60809 10869 79 None -2089 15 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 281 7 0 5 3.2 CCCCCCOc1nsnc1C1=CCCN(C1)C 10.1038/s41467-023-40064-9
CHEMBL21536 10869 79 None -2089 15 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 281 7 0 5 3.2 CCCCCCOc1nsnc1C1=CCCN(C1)C 10.1038/s41467-023-40064-9
DB15357 10869 79 None -2089 15 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 281 7 0 5 3.2 CCCCCCOc1nsnc1C1=CCCN(C1)C 10.1038/s41467-023-40064-9
213046 9164 59 None -6 17 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
4168 9164 59 None -6 17 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
7461 9164 59 None -6 17 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
CHEMBL1237021 9164 59 None -6 17 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
DB08815 9164 59 None -6 17 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
3351 101777 52 None -2 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 388 5 0 5 2.8 O=C(COc1ccc(Cl)cc1)N1CCN(Cc2ccc3c(c2)OCO3)CC1 10.1038/s41467-023-40064-9
CHEMBL254857 101777 52 None -2 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 388 5 0 5 2.8 O=C(COc1ccc(Cl)cc1)N1CCN(Cc2ccc3c(c2)OCO3)CC1 10.1038/s41467-023-40064-9
6917906 74547 21 None -6 5 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 887 35 10 12 1.7 CCCCCCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL1908331 74547 21 None -6 5 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 887 35 10 12 1.7 CCCCCCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)C(=O)O 10.1038/s41467-023-40064-9
98941 53724 17 None -66 11 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 457 7 0 4 6.3 COc1ccc2c(c1)OC(C)(C)C(c1ccccc1)C2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
CHEMBL154126 53724 17 None -66 11 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 457 7 0 4 6.3 COc1ccc2c(c1)OC(C)(C)C(c1ccccc1)C2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
CHEMBL4743867 220812 14 None -4466 15 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL None None None OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1 10.1038/s41467-023-40064-9
3474 44875 57 None -4 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 6 3 6 3.1 O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12 10.1038/s41467-023-40064-9
CHEMBL146095 44875 57 None -4 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 6 3 6 3.1 O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12 10.1038/s41467-023-40064-9
49843517 85069 41 None -40 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 590 13 2 6 8.5 CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\C)C(=O)O)c(Cl)c3)n2)c1OC 10.1038/s41467-023-40064-9
CHEMBL2107831 85069 41 None -40 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 590 13 2 6 8.5 CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\C)C(=O)O)c(Cl)c3)n2)c1OC 10.1038/s41467-023-40064-9
3103 48432 49 None -138 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 0 2 3.9 CN1CCC(OC(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1492 48432 49 None -138 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 0 2 3.9 CN1CCC(OC(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
DB01146 48432 49 None -138 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 0 2 3.9 CN1CCC(OC(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
16222096 87258 67 None -50 7 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 531 4 3 4 3.8 O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1 10.1038/s41467-023-40064-9
CHEMBL2146883 87258 67 None -50 7 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 531 4 3 4 3.8 O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1 10.1038/s41467-023-40064-9
2580 85170 18 None -660 10 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 446 6 1 4 4.1 NC(=O)C1(N2CCCCC2)CCN(CCCN2c3ccccc3CCc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL2110775 85170 18 None -660 10 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 446 6 1 4 4.1 NC(=O)C1(N2CCCCC2)CCN(CCCN2c3ccccc3CCc3ccccc32)CC1 10.1038/s41467-023-40064-9
448537 167029 89 None -54 31 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL411 167029 89 None -54 31 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
16362 9899 71 None -14 35 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2172 9899 71 None -14 35 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
90 9899 71 None -14 35 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1423 9899 71 None -14 35 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01100 9899 71 None -14 35 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
3634 90883 51 None 1 9 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 7 2 5 3.7 CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12 10.1038/s41467-023-40064-9
CHEMBL22077 90883 51 None 1 9 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 7 2 5 3.7 CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12 10.1038/s41467-023-40064-9
3478 12198 103 None -758 4 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 445 7 3 6 2.1 Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1 10.1038/s41467-023-40064-9
CHEMBL1073 12198 103 None -758 4 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 445 7 3 6 2.1 Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1 10.1038/s41467-023-40064-9
72287 67835 38 None 1 9 Human 7.9 pAC50 = 7.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 328 5 0 4 4.5 COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1764 67835 38 None 1 9 Human 7.9 pAC50 = 7.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 328 5 0 4 4.5 COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
DB01403 67835 38 None 1 9 Human 7.9 pAC50 = 7.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 328 5 0 4 4.5 COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
19675 58444 43 None -12 15 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 7 1 5 5.0 CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1584 58444 43 None -12 15 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 7 1 5 5.0 CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
2284 9956 33 None -3 34 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
4926 9956 33 None -3 34 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
7281 9956 33 None -3 34 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL564 9956 33 None -3 34 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00420 9956 33 None -3 34 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
2398 7741 62 None -72 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2801 7741 62 None -72 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
701 7741 62 None -72 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL415 7741 62 None -72 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB01242 7741 62 None -72 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
55483 211876 40 None -8 11 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 13 4 4 3.6 Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O 10.1038/s41467-023-40064-9
CHEMBL77622 211876 40 None -8 11 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 13 4 4 3.6 Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O 10.1038/s41467-023-40064-9
2869 10924 89 None -5011 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 287 5 2 3 1.9 CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C 10.1038/s41467-023-40064-9
60 10924 89 None -5011 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 287 5 2 3 1.9 CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C 10.1038/s41467-023-40064-9
60857 10924 89 None -5011 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 287 5 2 3 1.9 CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C 10.1038/s41467-023-40064-9
CHEMBL1185 10924 89 None -5011 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 287 5 2 3 1.9 CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C 10.1038/s41467-023-40064-9
DB00315 10924 89 None -5011 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 287 5 2 3 1.9 CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C 10.1038/s41467-023-40064-9
4762 21241 27 None 1 2 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 177 1 1 2 1.7 CC1NCCOC1c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1201208 21241 27 None 1 2 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 177 1 1 2 1.7 CC1NCCOC1c1ccccc1 10.1038/s41467-023-40064-9
5556 210039 27 None -33 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 342 1 0 4 4.2 Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2 10.1038/s41467-023-40064-9
CHEMBL646 210039 27 None -33 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 342 1 0 4 4.2 Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2 10.1038/s41467-023-40064-9
2218 22055 23 None -5 12 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 322 8 0 2 4.4 CCN(CC)CCCN(c1ccccc1)C1Cc2ccccc2C1 10.1038/s41467-023-40064-9
CHEMBL1213033 22055 23 None -5 12 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 322 8 0 2 4.4 CCN(CC)CCCN(c1ccccc1)C1Cc2ccccc2C1 10.1038/s41467-023-40064-9
2780 117306 36 None -1479 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 5 2 4 3.3 COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL325109 117306 36 None -1479 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 5 2 4 3.3 COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
DB13511 117306 36 None -1479 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 5 2 4 3.3 COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
9417 140290 54 None -33 15 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL1524185 140290 54 None -33 15 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL370753 140290 54 None -33 15 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
5365247 145207 33 None -100 10 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 316 4 0 2 3.8 CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1 10.1038/s41467-023-40064-9
CHEMBL37744 145207 33 None -100 10 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 316 4 0 2 3.8 CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1 10.1038/s41467-023-40064-9
2318 161635 29 None -20 15 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 351 7 1 3 4.1 CC(Cc1cccc(C(F)(F)F)c1)NCCOC(=O)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL400599 161635 29 None -20 15 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 351 7 1 3 4.1 CC(Cc1cccc(C(F)(F)F)c1)NCCOC(=O)c1ccccc1 10.1038/s41467-023-40064-9
2771 201796 74 None -46 16 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL1200781 201796 74 None -46 16 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL549 201796 74 None -46 16 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
3950 196287 109 None -4 2 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 233 4 1 3 2.3 O=NN(CCCl)C(=O)NC1CCCCC1 10.1038/s41467-023-40064-9
CHEMBL514 196287 109 None -4 2 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 233 4 1 3 2.3 O=NN(CCCl)C(=O)NC1CCCCC1 10.1038/s41467-023-40064-9
37 7565 60 None -141 12 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
460 7565 60 None -141 12 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
54746 7565 60 None -141 12 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
CHEMBL1201087 7565 60 None -141 12 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
DB00248 7565 60 None -141 12 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
1599 9120 50 None -7585 21 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
3955 9120 50 None -7585 21 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
7215 9120 50 None -7585 21 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL841 9120 50 None -7585 21 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
DB00836 9120 50 None -7585 21 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
2723 160825 108 None -7 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 156 0 1 1 2.7 Cc1cc(O)cc(C)c1Cl 10.1038/s41467-023-40064-9
CHEMBL398440 160825 108 None -7 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 156 0 1 1 2.7 Cc1cc(O)cc(C)c1Cl 10.1038/s41467-023-40064-9
135398737 7745 93 None -17 43 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
38 7745 93 None -17 43 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
722 7745 93 None -17 43 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL42 7745 93 None -17 43 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
DB00363 7745 93 None -17 43 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
5351322 101566 38 None 1 9 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 398 4 4 8 1.8 C(=N/NC1=NCCN1)\c1c2ccccc2c(/C=N/NC2=NCCN2)c2ccccc12 10.1038/s41467-023-40064-9
CHEMBL25336 101566 38 None 1 9 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 398 4 4 8 1.8 C(=N/NC1=NCCN1)\c1c2ccccc2c(/C=N/NC2=NCCN2)c2ccccc12 10.1038/s41467-023-40064-9
3117 214620 103 None -20 24 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC 10.1038/s41467-023-40064-9
CHEMBL964 214620 103 None -20 24 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC 10.1038/s41467-023-40064-9
9818306 21191 15 None -2 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 1 1 3 3.8 CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12 10.1038/s41467-023-40064-9
CHEMBL1200430 21191 15 None -2 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 1 1 3 3.8 CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12 10.1038/s41467-023-40064-9
2398 7741 62 None -72 36 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2801 7741 62 None -72 36 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
701 7741 62 None -72 36 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL415 7741 62 None -72 36 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB01242 7741 62 None -72 36 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2337 10030 77 None -4 29 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
50 10030 77 None -4 29 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
5002 10030 77 None -4 29 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL716 10030 77 None -4 29 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
DB01224 10030 77 None -4 29 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
1530 8963 50 None -912 25 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
3827 8963 50 None -912 25 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
7206 8963 50 None -912 25 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
CHEMBL534 8963 50 None -912 25 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
DB00920 8963 50 None -912 25 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
243 9976 91 None -1288 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N 10.1038/s41467-023-40064-9
3052762 9976 91 None -1288 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N 10.1038/s41467-023-40064-9
3502 9976 91 None -1288 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N 10.1038/s41467-023-40064-9
CHEMBL117287 9976 91 None -1288 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N 10.1038/s41467-023-40064-9
DB06480 9976 91 None -1288 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N 10.1038/s41467-023-40064-9
2351 11072 49 None -3 22 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1008 11072 49 None -3 22 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1257078 11072 49 None -3 22 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
21772 85174 31 None -1000 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 293 4 0 1 4.5 CC(CC1c2ccccc2CCc2ccccc21)CN(C)C 10.1038/s41467-023-40064-9
CHEMBL2110816 85174 31 None -1000 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 293 4 0 1 4.5 CC(CC1c2ccccc2CCc2ccccc21)CN(C)C 10.1038/s41467-023-40064-9
4413 104849 57 None -4 15 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 347 4 5 4 2.6 N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1 10.1038/s41467-023-40064-9
CHEMBL273264 104849 57 None -4 15 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 347 4 5 4 2.6 N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1 10.1038/s41467-023-40064-9
60151560 174221 39 None -1 5 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 439 11 1 5 5.3 CCO[C@@H](Cc1ccc(OCCn2c(C)ccc2-c2ccc(SC)cc2)cc1)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL4297530 174221 39 None -1 5 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 439 11 1 5 5.3 CCO[C@@H](Cc1ccc(OCCn2c(C)ccc2-c2ccc(SC)cc2)cc1)C(=O)O 10.1038/s41467-023-40064-9
216239 30567 118 None -8 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
CHEMBL1200485 30567 118 None -8 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
CHEMBL1336 30567 118 None -8 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
1830 9368 44 None -416 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
207 9368 44 None -416 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
23897 9368 44 None -416 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
CHEMBL460 9368 44 None -416 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
DB01618 9368 44 None -416 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
196122 119365 55 None -1 4 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 478 13 1 6 4.5 CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O 10.1038/s41467-023-40064-9
CHEMBL3301681 119365 55 None -1 4 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 478 13 1 6 4.5 CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O 10.1038/s41467-023-40064-9
392622 63086 95 None -8 20 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
CHEMBL163 63086 95 None -8 20 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
1570 64073 97 None 2 3 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 127 0 1 3 1.5 On1ccccc1=S 10.1038/s41467-023-40064-9
CHEMBL1650619 64073 97 None 2 3 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 127 0 1 3 1.5 On1ccccc1=S 10.1038/s41467-023-40064-9
1548955 95356 20 None -43 11 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
2800 95356 20 None -43 11 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL2355051 95356 20 None -43 11 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
1155 8410 53 None -257 11 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
3343 8410 53 None -257 11 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
557 8410 53 None -257 11 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL32800 8410 53 None -257 11 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
DB01288 8410 53 None -257 11 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
9270 21202 66 None -5 3 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 384 2 0 4 4.4 C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL1200624 21202 66 None -5 3 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 384 2 0 4 4.4 C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
3158 63041 27 None -125 28 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1628227 63041 27 None -125 28 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
DB01142 63041 27 None -125 28 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
60663 182448 42 None -8 12 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL1421212 182448 42 None -8 12 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL1534525 182448 42 None -8 12 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL45816 182448 42 None -8 12 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
5994 11413 88 None -5 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 1 0 2 4.7 CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C 10.1038/s41467-023-40064-9
CHEMBL103 11413 88 None -5 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 1 0 2 4.7 CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C 10.1038/s41467-023-40064-9
4034 62596 55 None -12 18 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
CHEMBL1623 62596 55 None -12 18 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
DB00737 62596 55 None -12 18 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
441383 27105 57 None -165 20 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1306 27105 57 None -165 20 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 10.1038/s41467-023-40064-9
2470 10425 50 None -13803 23 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3300 10425 50 None -13803 23 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5265 10425 50 None -13803 23 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
99 10425 50 None -13803 23 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL267930 10425 50 None -13803 23 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5440 35497 37 None -1995 16 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1378 35497 37 None -1995 16 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
DB00372 35497 37 None -1995 16 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
3926 214020 40 None -2 18 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 491 9 1 3 5.8 Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL92870 214020 40 None -2 18 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 491 9 1 3 5.8 Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1038/s41467-023-40064-9
31703 201496 63 None -25 9 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL359744 201496 63 None -25 9 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL53463 201496 63 None -25 9 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
24826799 17570 104 None -50 20 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 532 4 1 6 4.5 Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12 10.1038/s41467-023-40064-9
CHEMBL1171837 17570 104 None -50 20 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 532 4 1 6 4.5 Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12 10.1038/s41467-023-40064-9
2162 48288 100 None -5 22 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1491 48288 100 None -5 22 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
5584 209990 44 None -9 9 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 294 4 0 2 4.1 CC(CN(C)C)CN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL644 209990 44 None -9 9 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 294 4 0 2 4.1 CC(CN(C)C)CN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
DB00726 209990 44 None -9 9 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 294 4 0 2 4.1 CC(CN(C)C)CN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
4735 201894 96 None -199 14 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL361506 201894 96 None -199 14 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL55 201894 96 None -199 14 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL508338 195745 0 None -181 15 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL None None None None 10.1038/s41467-023-40064-9
1712 9270 43 None 1 8 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 4 0 4 4.9 CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C 10.1038/s41467-023-40064-9
4078 9270 43 None 1 8 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 4 0 4 4.9 CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C 10.1038/s41467-023-40064-9
7227 9270 43 None 1 8 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 4 0 4 4.9 CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C 10.1038/s41467-023-40064-9
CHEMBL1088 9270 43 None 1 8 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 4 0 4 4.9 CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C 10.1038/s41467-023-40064-9
DB00933 9270 43 None 1 8 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 4 0 4 4.9 CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C 10.1038/s41467-023-40064-9
2865 10915 73 None -23 20 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
59 10915 73 None -23 20 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
60854 10915 73 None -23 20 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL708 10915 73 None -23 20 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
DB00246 10915 73 None -23 20 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
10531 8202 21 None -301 26 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
121 8202 21 None -301 26 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
888 8202 21 None -301 26 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
CHEMBL1732 8202 21 None -301 26 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
DB00320 8202 21 None -301 26 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
2286 9957 51 None -37 28 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
4927 9957 51 None -37 28 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
7282 9957 51 None -37 28 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
CHEMBL643 9957 51 None -37 28 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
DB01069 9957 51 None -37 28 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
56959 38330 103 None -3 9 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
CHEMBL1404 38330 103 None -3 9 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
CHEMBL1526084 38330 103 None -3 9 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
213 10625 55 None -18 22 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
2717 10625 55 None -18 22 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
5533 10625 55 None -18 22 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL621 10625 55 None -18 22 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
DB00656 10625 55 None -18 22 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
6231 36543 33 None -6 4 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 0 1 2 3.6 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL1387 36543 33 None -6 4 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 0 1 2 3.6 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
2247 7293 81 None -26 42 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
249 7293 81 None -26 42 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2603 7293 81 None -26 42 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL296419 7293 81 None -26 42 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
DB00637 7293 81 None -26 42 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
10180 105645 47 None -33 11 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 340 6 1 4 4.5 CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12 10.1038/s41467-023-40064-9
CHEMBL279014 105645 47 None -33 11 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 340 6 1 4 4.5 CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12 10.1038/s41467-023-40064-9
9324 16010 60 None -3 6 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 2 0 4 4.8 CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL110691 16010 60 None -3 6 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 2 0 4 4.8 CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
1662 195484 80 None -1 3 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 162 4 3 3 -0.3 CC(O)(CC(=O)O)CC(=O)O 10.1038/s41467-023-40064-9
CHEMBL50444 195484 80 None -1 3 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 162 4 3 3 -0.3 CC(O)(CC(=O)O)CC(=O)O 10.1038/s41467-023-40064-9
25151352 147384 67 None -4 11 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 417 5 2 4 5.2 FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1 10.1038/s41467-023-40064-9
CHEMBL3813873 147384 67 None -4 11 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 417 5 2 4 5.2 FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1 10.1038/s41467-023-40064-9
4046 9261 33 None -35 17 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
4252 9261 33 None -35 17 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
CHEMBL416956 9261 33 None -35 17 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
DB00358 9261 33 None -35 17 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
54454 12030 88 None -7 14 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 418 6 1 5 4.6 CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 10.1038/s41467-023-40064-9
CHEMBL1064 12030 88 None -7 14 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 418 6 1 5 4.6 CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 10.1038/s41467-023-40064-9
9822750 85184 65 None -4 8 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL2111097 85184 65 None -4 8 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1c1ccccc1Cl 10.1038/s41467-023-40064-9
119369 9384 74 None -602 7 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
2197 9384 74 None -602 7 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
4004 9384 74 None -602 7 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
CHEMBL420762 9384 74 None -602 7 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
2005 85005 91 None - 1 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 173 6 2 2 0.8 CC(=O)NCCCCCC(=O)O 10.1038/s41467-023-40064-9
CHEMBL2105922 85005 91 None - 1 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 173 6 2 2 0.8 CC(=O)NCCCCCC(=O)O 10.1038/s41467-023-40064-9
2162 48288 100 None -5 22 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1491 48288 100 None -5 22 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
12555 24733 53 None -38 9 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 7 0 4 3.4 CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12 10.1038/s41467-023-40064-9
CHEMBL12610 24733 53 None -38 9 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 7 0 4 3.4 CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12 10.1038/s41467-023-40064-9
10133 7697 78 None -6 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C 10.1038/s41467-023-40064-9
145714624 7697 78 None -6 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C 10.1038/s41467-023-40064-9
4361 7697 78 None -6 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C 10.1038/s41467-023-40064-9
608 7697 78 None -6 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C 10.1038/s41467-023-40064-9
CHEMBL240597 7697 78 None -6 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C 10.1038/s41467-023-40064-9
DB06777 7697 78 None -6 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C 10.1038/s41467-023-40064-9
657202 19302 6 None -524 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 282 6 0 2 3.5 CCCC(CCC)C(=O)O[C@H]1C[C@H]2CC[C@@H](C1)[N+]2(C)C 10.1038/s41467-023-40064-9
CHEMBL1186610 19302 6 None -524 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 282 6 0 2 3.5 CCCC(CCC)C(=O)O[C@H]1C[C@H]2CC[C@@H](C1)[N+]2(C)C 10.1038/s41467-023-40064-9
9911830 25920 100 None 1 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 454 6 2 7 5.6 COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC 10.1038/s41467-023-40064-9
CHEMBL1289494 25920 100 None 1 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 454 6 2 7 5.6 COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC 10.1038/s41467-023-40064-9
5281718 41024 84 None - 1 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 5 6 8 0.4 OC[C@H]1O[C@@H](Oc2cc(O)cc(/C=C/c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O 10.1038/s41467-023-40064-9
CHEMBL142652 41024 84 None - 1 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 5 6 8 0.4 OC[C@H]1O[C@@H](Oc2cc(O)cc(/C=C/c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O 10.1038/s41467-023-40064-9
4041 106287 18 None -19 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 270 1 0 2 3.6 CN1CCN=C(c2ccccc2)c2cc(Cl)ccc21 10.1038/s41467-023-40064-9
CHEMBL28333 106287 18 None -19 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 270 1 0 2 3.6 CN1CCN=C(c2ccccc2)c2cc(Cl)ccc21 10.1038/s41467-023-40064-9
2695 10613 81 None -2 6 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 10.1038/s41467-023-40064-9
5504 10613 81 None -2 6 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 10.1038/s41467-023-40064-9
7310 10613 81 None -2 6 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL770 10613 81 None -2 6 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 10.1038/s41467-023-40064-9
DB00797 10613 81 None -2 6 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 10.1038/s41467-023-40064-9
45138674 23418 50 None 1 6 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 572 6 1 7 5.7 COc1cccc(N2CCN(C3=Nc4c(F)cccc4[C@H](CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1 10.1038/s41467-023-40064-9
CHEMBL1241951 23418 50 None 1 6 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 572 6 1 7 5.7 COc1cccc(N2CCN(C3=Nc4c(F)cccc4[C@H](CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1 10.1038/s41467-023-40064-9
8569 29415 91 None -1 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 244 3 2 4 2.3 COc1ccc(C(=O)c2ccccc2O)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL1326877 29415 91 None -1 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 244 3 2 4 2.3 COc1ccc(C(=O)c2ccccc2O)c(O)c1 10.1038/s41467-023-40064-9
24821094 73868 93 None -6 8 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
CHEMBL1873475 73868 93 None -6 8 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
3658 10879 53 None 1 18 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
517 10879 53 None 1 18 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
5709 10879 53 None 1 18 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL312448 10879 53 None 1 18 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
DB06694 10879 53 None 1 18 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
1028 7079 71 None 1 19 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
139148732 7079 71 None 1 19 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
479 7079 71 None 1 19 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
5816 7079 71 None 1 19 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL679 7079 71 None 1 19 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00668 7079 71 None 1 19 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
2146 9874 67 None -20 15 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
485 9874 67 None -20 15 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
6041 9874 67 None -20 15 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL1215 9874 67 None -20 15 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
DB00388 9874 67 None -20 15 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
4151 10379 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
493 10379 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
5312125 10379 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
CHEMBL24778 10379 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
DB06207 10379 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
150 9287 21 None -194 17 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
1764 9287 21 None -194 17 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
8226 9287 21 None -194 17 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
CHEMBL1201356 9287 21 None -194 17 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
DB00353 9287 21 None -194 17 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
135398737 7745 93 None -17 43 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
38 7745 93 None -17 43 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
722 7745 93 None -17 43 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL42 7745 93 None -17 43 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
DB00363 7745 93 None -17 43 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
31729 212563 10 None -131 7 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL83063 212563 10 None -131 7 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
202 8290 77 None -3 17 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
60835 8290 77 None -3 17 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
972 8290 77 None -3 17 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1175 8290 77 None -3 17 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
DB00476 8290 77 None -3 17 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
448537 167029 89 None -54 31 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL411 167029 89 None -54 31 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
3035016 19366 50 None -1 3 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 483 3 5 10 0.6 CC(=O)[C@]1(N)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C1)C(=O)c1ccccc1C3=O 10.1038/s41467-023-40064-9
CHEMBL1186894 19366 50 None -1 3 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 483 3 5 10 0.6 CC(=O)[C@]1(N)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C1)C(=O)c1ccccc1C3=O 10.1038/s41467-023-40064-9
89683805 161212 67 None -6760 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 473 6 3 8 4.3 CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1 10.1038/s41467-023-40064-9
CHEMBL3989908 161212 67 None -6760 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 473 6 3 8 4.3 CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1 10.1038/s41467-023-40064-9
44439 172466 19 None -63 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 377 9 3 5 2.8 COc1ccc(CCC(C)NCC(O)c2ccc(O)c([S+](C)[O-])c2)cc1 10.1038/s41467-023-40064-9
CHEMBL424518 172466 19 None -63 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 377 9 3 5 2.8 COc1ccc(CCC(C)NCC(O)c2ccc(O)c([S+](C)[O-])c2)cc1 10.1038/s41467-023-40064-9
444795 146777 105 None -57 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 300 5 1 1 5.6 CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1 10.1038/s41467-023-40064-9
CHEMBL38 146777 105 None -57 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 300 5 1 1 5.6 CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1 10.1038/s41467-023-40064-9
5489013 64179 32 None -21 6 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 8 2 4 3.0 COc1cccc(C(=O)CCN[C@@H](C)[C@H](O)c2ccccc2)c1 10.1038/s41467-023-40064-9
CHEMBL1651913 64179 32 None -21 6 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 8 2 4 3.0 COc1cccc(C(=O)CCN[C@@H](C)[C@H](O)c2ccccc2)c1 10.1038/s41467-023-40064-9
1923 111501 136 None -3 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 145 0 1 2 1.9 Oc1cccc2cccnc12 10.1038/s41467-023-40064-9
CHEMBL310555 111501 136 None -3 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 145 0 1 2 1.9 Oc1cccc2cccnc12 10.1038/s41467-023-40064-9
1753 9282 28 None 2 4 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1038/s41467-023-40064-9
483 9282 28 None 2 4 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1038/s41467-023-40064-9
6082 9282 28 None 2 4 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1038/s41467-023-40064-9
CHEMBL524 9282 28 None 2 4 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1038/s41467-023-40064-9
DB00723 9282 28 None 2 4 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1038/s41467-023-40064-9
2726 7706 68 None -29 42 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
621 7706 68 None -29 42 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
83 7706 68 None -29 42 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL71 7706 68 None -29 42 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB00477 7706 68 None -29 42 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
135409453 10545 41 None -363 36 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
226 10545 41 None -363 36 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
CHEMBL76370 10545 41 None -363 36 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
214 10632 58 None -22 28 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
2740 10632 58 None -22 28 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
5566 10632 58 None -22 28 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
66064 10632 58 None -22 28 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL422 10632 58 None -22 28 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
DB00831 10632 58 None -22 28 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
26248 168318 102 None -1 11 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 368 3 1 7 2.0 CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O 10.1038/s41467-023-40064-9
CHEMBL41286 168318 102 None -1 11 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 368 3 1 7 2.0 CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O 10.1038/s41467-023-40064-9
11289 21210 67 None -2 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 380 6 0 3 5.9 COc1ccc(C(Cl)=C(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1200761 21210 67 None -2 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 380 6 0 3 5.9 COc1ccc(C(Cl)=C(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1 10.1038/s41467-023-40064-9
2880 104784 49 None -13 9 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 5 0 3 4.6 C=C(c1ccccc1OCc1cccc(Cl)c1)n1ccnc1 10.1038/s41467-023-40064-9
CHEMBL27289 104784 49 None -13 9 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 5 0 3 4.6 C=C(c1ccccc1OCc1cccc(Cl)c1)n1ccnc1 10.1038/s41467-023-40064-9
3356 210147 81 None -33 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 414 7 2 4 3.4 O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL1200822 210147 81 None -33 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 414 7 2 4 3.4 O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL652 210147 81 None -33 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 414 7 2 4 3.4 O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F 10.1038/s41467-023-40064-9
54684141 214779 82 None 1 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 270 2 2 3 3.0 C/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL973 214779 82 None 1 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 270 2 2 3 3.0 C/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
1499 8872 47 None -44668 38 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
3779 8872 47 None -44668 38 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
536 8872 47 None -44668 38 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
CHEMBL434 8872 47 None -44668 38 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
DB01064 8872 47 None -44668 38 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
16564 211774 32 None -144 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 207 2 3 3 0.3 N=C(N)NCC1COc2ccccc2O1 10.1038/s41467-023-40064-9
CHEMBL76725 211774 32 None -144 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 207 2 3 3 0.3 N=C(N)NCC1COc2ccccc2O1 10.1038/s41467-023-40064-9
2028 9753 80 None -10715 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
359 9753 80 None -10715 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
4634 9753 80 None -10715 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
CHEMBL1231 9753 80 None -10715 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
DB01062 9753 80 None -10715 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
34040 34858 72 None -7244 11 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 483 4 0 6 3.9 CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13 10.1038/s41467-023-40064-9
CHEMBL1372950 34858 72 None -7244 11 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 483 4 0 6 3.9 CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13 10.1038/s41467-023-40064-9
DB00699 34858 72 None -7244 11 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 483 4 0 6 3.9 CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13 10.1038/s41467-023-40064-9
3081361 100709 123 None -35 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 474 5 1 5 4.4 COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1 10.1038/s41467-023-40064-9
CHEMBL24828 100709 123 None -35 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 474 5 1 5 4.4 COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1 10.1038/s41467-023-40064-9
5344 180252 101 None -3981 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 267 3 2 5 1.7 Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C 10.1038/s41467-023-40064-9
CHEMBL453 180252 101 None -3981 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 267 3 2 5 1.7 Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C 10.1038/s41467-023-40064-9
3157 8252 71 None -38 22 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
7170 8252 71 None -38 22 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
954 8252 71 None -38 22 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
CHEMBL707 8252 71 None -38 22 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
DB00590 8252 71 None -38 22 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
2142 9870 58 None -1 18 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
4920903 9870 58 None -1 18 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
502 9870 58 None -1 18 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
5775 9870 58 None -1 18 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL597 9870 58 None -1 18 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
DB00692 9870 58 None -1 18 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
1890 9535 49 None -4 24 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
4449 9535 49 None -4 24 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
7247 9535 49 None -4 24 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
CHEMBL623 9535 49 None -4 24 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
DB01149 9535 49 None -4 24 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
10453870 80437 62 None -1 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 4 4 6 2.1 OC[C@H]1O[C@@H](c2ccc(F)c(Cc3cc4ccccc4s3)c2)[C@H](O)[C@@H](O)[C@@H]1O 10.1038/s41467-023-40064-9
CHEMBL2018096 80437 62 None -1 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 4 4 6 2.1 OC[C@H]1O[C@@H](c2ccc(F)c(Cc3cc4ccccc4s3)c2)[C@H](O)[C@@H](O)[C@@H]1O 10.1038/s41467-023-40064-9
9419 42696 35 None -72 7 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 295 3 0 3 3.0 CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1442422 42696 35 None -72 7 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 295 3 0 3 3.0 CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21 10.1038/s41467-023-40064-9
DB13225 42696 35 None -72 7 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 295 3 0 3 3.0 CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21 10.1038/s41467-023-40064-9
4601 213526 35 None -1148 19 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1201023 213526 35 None -1148 19 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL900 213526 35 None -1148 19 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 10.1038/s41467-023-40064-9
DB01173 213526 35 None -1148 19 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 10.1038/s41467-023-40064-9
8609 21216 66 None -1 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 229 2 2 4 2.2 Nc1ccc(C(=O)Oc2ccccc2)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL1200868 21216 66 None -1 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 229 2 2 4 2.2 Nc1ccc(C(=O)Oc2ccccc2)c(O)c1 10.1038/s41467-023-40064-9
5205 84962 58 None -2 8 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 261 0 0 1 3.8 CN1CCC2=C(C1)c1ccccc1Cc1ccccc12 10.1038/s41467-023-40064-9
CHEMBL2104895 84962 58 None -2 8 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 261 0 0 1 3.8 CN1CCC2=C(C1)c1ccccc1Cc1ccccc12 10.1038/s41467-023-40064-9
1209 8439 75 None -91 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
203 8439 75 None -91 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
3386 8439 75 None -91 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL41 8439 75 None -91 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
DB00472 8439 75 None -91 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
2202 9906 96 None -389 10 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 10.1038/s41467-023-40064-9
4850 9906 96 None -389 10 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 10.1038/s41467-023-40064-9
49 9906 96 None -389 10 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 10.1038/s41467-023-40064-9
CHEMBL1371770 9906 96 None -389 10 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 10.1038/s41467-023-40064-9
DB12478 9906 96 None -389 10 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 10.1038/s41467-023-40064-9
39941 125084 54 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 3 1 3 4.3 CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1 10.1038/s41467-023-40064-9
CHEMBL340978 125084 54 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 3 1 3 4.3 CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1 10.1038/s41467-023-40064-9
5280453 212750 74 None -5 8 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 6 3 3 5.7 C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O 10.1038/s41467-023-40064-9
CHEMBL846 212750 74 None -5 8 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 6 3 3 5.7 C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O 10.1038/s41467-023-40064-9
2749 39417 101 None 1 3 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 207 1 1 3 2.4 Cc1cc(C2CCCCC2)n(O)c(=O)c1 10.1038/s41467-023-40064-9
CHEMBL1413 39417 101 None 1 3 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 207 1 1 3 2.4 Cc1cc(C2CCCCC2)n(O)c(=O)c1 10.1038/s41467-023-40064-9
9846332 58833 37 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 444 2 3 5 2.4 C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C(Cl)=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO 10.1038/s41467-023-40064-9
CHEMBL1587228 58833 37 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 444 2 3 5 2.4 C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C(Cl)=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO 10.1038/s41467-023-40064-9
3157 8252 71 None -38 22 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
7170 8252 71 None -38 22 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
954 8252 71 None -38 22 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
CHEMBL707 8252 71 None -38 22 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
DB00590 8252 71 None -38 22 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
27901 84982 22 None -33 8 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 286 4 0 3 3.8 CN1CCC(N(Cc2cccs2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL2105458 84982 22 None -33 8 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 286 4 0 3 3.8 CN1CCC(N(Cc2cccs2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
2993 121470 24 None -177 13 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 456 11 2 2 6.2 Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL121663 121470 24 None -177 13 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 456 11 2 2 6.2 Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL333826 121470 24 None -177 13 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 456 11 2 2 6.2 Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21 10.1038/s41467-023-40064-9
1343 8670 62 None -9 12 Human 7.6 pAC50 = 7.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
3519 8670 62 None -9 12 Human 7.6 pAC50 = 7.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
522 8670 62 None -9 12 Human 7.6 pAC50 = 7.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
CHEMBL862 8670 62 None -9 12 Human 7.6 pAC50 = 7.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
DB01018 8670 62 None -9 12 Human 7.6 pAC50 = 7.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
2169 51621 35 None -4 12 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
CHEMBL152231 51621 35 None -4 12 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
9853053 127297 74 None -1 9 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 693 10 2 3 8.4 O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL354541 127297 74 None -1 9 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 693 10 2 3 8.4 O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
93154 12208 29 None -316 8 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 1 0 2 4.0 c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2 10.1038/s41467-023-40064-9
CHEMBL107360 12208 29 None -316 8 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 1 0 2 4.0 c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2 10.1038/s41467-023-40064-9
3735 213010 76 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 571 4 2 2 3.7 CCC(Cc1c(I)cc(I)c(N)c1I)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL867 213010 76 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 571 4 2 2 3.7 CCC(Cc1c(I)cc(I)c(N)c1I)C(=O)O 10.1038/s41467-023-40064-9
65863 21237 57 None -14 11 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 436 6 0 4 7.0 Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1201196 21237 57 None -14 11 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 436 6 0 4 7.0 Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1 10.1038/s41467-023-40064-9
7547 12276 94 None -3 4 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 2 2 1 5.3 O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1076347 12276 94 None -3 4 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 2 2 1 5.3 O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
65646 128079 26 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 6 2 9 0.8 Cc1oc(=O)oc1COC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C 10.1038/s41467-023-40064-9
CHEMBL3580454 128079 26 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 6 2 9 0.8 Cc1oc(=O)oc1COC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C 10.1038/s41467-023-40064-9
71743 85042 62 None -1 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 353 3 0 4 3.6 O=C(Oc1ccc2c(c1)CCCN2C(=O)C(Cl)Cl)c1ccco1 10.1038/s41467-023-40064-9
CHEMBL2107014 85042 62 None -1 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 353 3 0 4 3.6 O=C(Oc1ccc2c(c1)CCCN2C(=O)C(Cl)Cl)c1ccco1 10.1038/s41467-023-40064-9
5440 35497 37 None -1995 16 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1378 35497 37 None -1995 16 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
DB00372 35497 37 None -1995 16 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
2705 10614 64 None -1288 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
360 10614 64 None -1288 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
443879 10614 64 None -1288 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
CHEMBL1382 10614 64 None -1288 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
DB01036 10614 64 None -1288 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
104870 105656 47 None -8 10 Human 5.6 pAC50 = 5.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 10.1038/s41467-023-40064-9
5374 105656 47 None -8 10 Human 5.6 pAC50 = 5.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 10.1038/s41467-023-40064-9
CHEMBL279085 105656 47 None -8 10 Human 5.6 pAC50 = 5.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 10.1038/s41467-023-40064-9
21722 24764 31 None -16 21 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 2 4.3 CN(C)CCCn1c2c(c3ccccc31)CCCCCC2 10.1038/s41467-023-40064-9
CHEMBL126224 24764 31 None -16 21 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 2 4.3 CN(C)CCCn1c2c(c3ccccc31)CCCCCC2 10.1038/s41467-023-40064-9
5282219 42643 63 None -4 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 450 12 1 5 5.7 CC(C)=CCOc1ccc(/C=C/C(=O)c2ccc(OCC=C(C)C)cc2OCC(=O)O)cc1 10.1038/s41467-023-40064-9
CHEMBL1441961 42643 63 None -4 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 450 12 1 5 5.7 CC(C)=CCOc1ccc(/C=C/C(=O)c2ccc(OCC=C(C)C)cc2OCC(=O)O)cc1 10.1038/s41467-023-40064-9
16678941 84928 109 None -1 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 452 5 2 5 4.7 Cc1ccc(NC(=O)C2(c3ccc4c(c3)OC(F)(F)O4)CC2)nc1-c1cccc(C(=O)O)c1 10.1038/s41467-023-40064-9
CHEMBL2103870 84928 109 None -1 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 452 5 2 5 4.7 Cc1ccc(NC(=O)C2(c3ccc4c(c3)OC(F)(F)O4)CC2)nc1-c1cccc(C(=O)O)c1 10.1038/s41467-023-40064-9
71927 85178 18 None -2 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 202 2 1 3 0.9 COc1cc(N)cn[n+]1-c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL2106667 85178 18 None -2 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 202 2 1 3 0.9 COc1cc(N)cn[n+]1-c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL2110922 85178 18 None -2 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 202 2 1 3 0.9 COc1cc(N)cn[n+]1-c1ccccc1 10.1038/s41467-023-40064-9
1549120 203265 85 None -16 19 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL56337 203265 85 None -16 19 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
24821094 73868 93 None -6 8 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
CHEMBL1873475 73868 93 None -6 8 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
446156 46599 29 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 459 11 3 5 4.9 COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1 10.1038/s41467-023-40064-9
CHEMBL1477 46599 29 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 459 11 3 5 4.9 COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1 10.1038/s41467-023-40064-9
1027 8357 73 None -676 7 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 0 2 1 2.7 N=C1NCC2N1c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
3241 8357 73 None -676 7 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 0 2 1 2.7 N=C1NCC2N1c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
7176 8357 73 None -676 7 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 0 2 1 2.7 N=C1NCC2N1c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL1106 8357 73 None -676 7 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 0 2 1 2.7 N=C1NCC2N1c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
DB00751 8357 73 None -676 7 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 0 2 1 2.7 N=C1NCC2N1c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
37464 25993 26 None -707 8 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 291 6 2 3 3.5 CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1290 25993 26 None -707 8 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 291 6 2 3 3.5 CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1 10.1038/s41467-023-40064-9
DB01359 25993 26 None -707 8 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 291 6 2 3 3.5 CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1 10.1038/s41467-023-40064-9
37907 42172 88 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 292 4 0 4 3.7 CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1ccnc1 10.1038/s41467-023-40064-9
CHEMBL1437764 42172 88 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 292 4 0 4 3.7 CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1ccnc1 10.1038/s41467-023-40064-9
3336 101776 30 None -5248 14 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 315 7 1 1 5.6 CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1405922 101776 30 None -5248 14 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 315 7 1 1 5.6 CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL254832 101776 30 None -5248 14 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 315 7 1 1 5.6 CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
6989 107729 115 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 150 1 1 1 2.8 Cc1ccc(C(C)C)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL29411 107729 115 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 150 1 1 1 2.8 Cc1ccc(C(C)C)c(O)c1 10.1038/s41467-023-40064-9
60663 182448 42 None -8 12 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL1421212 182448 42 None -8 12 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL1534525 182448 42 None -8 12 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL45816 182448 42 None -8 12 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
3606 210267 60 None -3 8 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 270 5 2 2 4.8 CCC(c1ccc(O)cc1)C(CC)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL6615 210267 60 None -3 8 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 270 5 2 2 4.8 CCC(c1ccc(O)cc1)C(CC)c1ccc(O)cc1 10.1038/s41467-023-40064-9
65948 25328 109 None -12 6 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 582 9 2 9 4.7 CC1=C(C(=O)OC(C)C)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1 10.1038/s41467-023-40064-9
CHEMBL1275868 25328 109 None -12 6 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 582 9 2 9 4.7 CC1=C(C(=O)OC(C)C)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1 10.1038/s41467-023-40064-9
54679224 66677 113 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 145 0 2 3 1.1 Oc1cc(O)c(Cl)cn1 10.1038/s41467-023-40064-9
CHEMBL1730601 66677 113 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 145 0 2 3 1.1 Oc1cc(O)c(Cl)cn1 10.1038/s41467-023-40064-9
180 7189 56 None -63 38 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
200 7189 56 None -63 38 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
2160 7189 56 None -63 38 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL629 7189 56 None -63 38 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00321 7189 56 None -63 38 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
2389 10104 118 None -13 29 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
5073 10104 118 None -13 29 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
96 10104 118 None -13 29 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
CHEMBL85 10104 118 None -13 29 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
DB00734 10104 118 None -13 29 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
2337 10030 77 None -4 29 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
50 10030 77 None -4 29 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
5002 10030 77 None -4 29 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL716 10030 77 None -4 29 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
DB01224 10030 77 None -4 29 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
135 9310 43 None -72 33 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
1796 9310 43 None -72 33 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
4184 9310 43 None -72 33 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL6437 9310 43 None -72 33 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
DB06148 9310 43 None -72 33 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
2333 149113 97 None -2 14 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 422 3 1 3 5.5 CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1 10.1038/s41467-023-40064-9
CHEMBL388590 149113 97 None -2 14 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 422 3 1 3 5.5 CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1 10.1038/s41467-023-40064-9
135 9310 43 None -72 33 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
1796 9310 43 None -72 33 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
4184 9310 43 None -72 33 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL6437 9310 43 None -72 33 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
DB06148 9310 43 None -72 33 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
135400189 51349 73 None -26 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 488 8 1 8 2.1 CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12 10.1038/s41467-023-40064-9
CHEMBL1520 51349 73 None -26 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 488 8 1 8 2.1 CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12 10.1038/s41467-023-40064-9
1155 8410 53 None -257 11 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
3343 8410 53 None -257 11 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
557 8410 53 None -257 11 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL32800 8410 53 None -257 11 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
DB01288 8410 53 None -257 11 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
65981 25226 102 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 452 10 2 4 5.2 CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O 10.1038/s41467-023-40064-9
CHEMBL1272 25226 102 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 452 10 2 4 5.2 CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O 10.1038/s41467-023-40064-9
6010 37471 44 None -1 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 302 0 1 2 4.3 C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O 10.1038/s41467-023-40064-9
CHEMBL1395 37471 44 None -1 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 302 0 1 2 4.3 C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O 10.1038/s41467-023-40064-9
5328940 106992 107 None -3 23 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 529 9 1 8 5.2 COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl 10.1038/s41467-023-40064-9
CHEMBL288441 106992 107 None -3 23 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 529 9 1 8 5.2 COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl 10.1038/s41467-023-40064-9
1960 9632 67 None -2 19 Human 6.6 pAC50 = 6.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
439260 9632 67 None -2 19 Human 6.6 pAC50 = 6.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
505 9632 67 None -2 19 Human 6.6 pAC50 = 6.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL1437 9632 67 None -2 19 Human 6.6 pAC50 = 6.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00368 9632 67 None -2 19 Human 6.6 pAC50 = 6.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
2448 106099 70 None -12 15 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 419 6 1 3 4.5 O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1 10.1038/s41467-023-40064-9
CHEMBL28218 106099 70 None -12 15 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 419 6 1 3 4.5 O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1 10.1038/s41467-023-40064-9
DB12401 106099 70 None -12 15 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 419 6 1 3 4.5 O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1 10.1038/s41467-023-40064-9
3151 8244 97 None -151 23 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
945 8244 97 None -151 23 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
965 8244 97 None -151 23 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL219916 8244 97 None -151 23 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01184 8244 97 None -151 23 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
6256 16443 86 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 2 3 6 -0.8 O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL1129 16443 86 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 2 3 6 -0.8 O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F 10.1038/s41467-023-40064-9
4006 65883 94 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 288 4 0 6 3.1 CC(C)OC(=O)C(C(=O)OC(C)C)=C1SC=CS1 10.1038/s41467-023-40064-9
CHEMBL1697754 65883 94 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 288 4 0 6 3.1 CC(C)OC(=O)C(C(=O)OC(C)C)=C1SC=CS1 10.1038/s41467-023-40064-9
14052 179357 51 None -5495 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 204 9 4 4 -0.3 CC[C@@H](CO)NCCN[C@@H](CC)CO 10.1038/s41467-023-40064-9
CHEMBL44884 179357 51 None -5495 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 204 9 4 4 -0.3 CC[C@@H](CO)NCCN[C@@H](CC)CO 10.1038/s41467-023-40064-9
1046 209431 116 None -1412 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 123 1 1 3 -0.4 NC(=O)c1cnccn1 10.1038/s41467-023-40064-9
CHEMBL614 209431 116 None -1412 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 123 1 1 3 -0.4 NC(=O)c1cnccn1 10.1038/s41467-023-40064-9
43082 67057 37 None -72 10 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 357 6 0 2 5.5 CC(OCCN1CCCCCC1)(c1ccccc1)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL1742452 67057 37 None -72 10 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 357 6 0 2 5.5 CC(OCCN1CCCCCC1)(c1ccccc1)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
219024 10073 65 None -6456 5 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC 10.1038/s41467-023-40064-9
2362 10073 65 None -6456 5 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC 10.1038/s41467-023-40064-9
5596 10073 65 None -6456 5 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC 10.1038/s41467-023-40064-9
CHEMBL317052 10073 65 None -6456 5 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC 10.1038/s41467-023-40064-9
DB06213 10073 65 None -6456 5 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC 10.1038/s41467-023-40064-9
2520 210787 70 None -50 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL1280 210787 70 None -50 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL6966 210787 70 None -50 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
11154555 7587 62 None -1096 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
5037 7587 62 None -1096 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
7671 7587 62 None -1096 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL2028019 7587 62 None -1096 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL3085826 7587 62 None -1096 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB06016 7587 62 None -1096 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
2406 107180 89 None -16 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O 10.1038/s41467-023-40064-9
CHEMBL290106 107180 89 None -16 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O 10.1038/s41467-023-40064-9
3627 50903 18 None -39 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 3 0 2 4.1 CN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1515447 50903 18 None -39 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 3 0 2 4.1 CN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
2247 7293 81 None -26 42 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
249 7293 81 None -26 42 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2603 7293 81 None -26 42 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL296419 7293 81 None -26 42 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
DB00637 7293 81 None -26 42 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2749 7132 40 None -1 10 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
5574 7132 40 None -1 10 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
7237 7132 40 None -1 10 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
CHEMBL829 7132 40 None -1 10 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
DB01246 7132 40 None -1 10 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
2142 9870 58 None -1 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
4920903 9870 58 None -1 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
502 9870 58 None -1 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
5775 9870 58 None -1 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL597 9870 58 None -1 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
DB00692 9870 58 None -1 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
6337614 19768 54 None -26 6 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 1 0 2 2.7 O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2 10.1038/s41467-023-40064-9
CHEMBL1189679 19768 54 None -26 6 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 1 0 2 2.7 O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2 10.1038/s41467-023-40064-9
242 7258 124 None -120 32 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
34 7258 124 None -120 32 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
60795 7258 124 None -120 32 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL1112 7258 124 None -120 32 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB01238 7258 124 None -120 32 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
9051 21214 67 None -5 3 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 0 2 4.5 CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C 10.1038/s41467-023-40064-9
CHEMBL1200853 21214 67 None -5 3 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 0 2 4.5 CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C 10.1038/s41467-023-40064-9
4121 57609 62 None -1 2 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 359 2 2 5 0.6 CN1C(CCl)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O 10.1038/s41467-023-40064-9
CHEMBL1577 57609 62 None -1 2 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 359 2 2 5 0.6 CN1C(CCl)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O 10.1038/s41467-023-40064-9
24765256 180076 23 None -2 4 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 757 6 3 9 3.9 CC[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1 10.1038/s41467-023-40064-9
CHEMBL4525964 180076 23 None -2 4 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 757 6 3 9 3.9 CC[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1 10.1038/s41467-023-40064-9
15387 52596 55 None 1 8 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 5 0 2 3.5 CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1531134 52596 55 None 1 8 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 5 0 2 3.5 CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1 10.1038/s41467-023-40064-9
5748845 85006 12 None - 1 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 522 9 4 13 -3.2 CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccc(N)n3CCO)CS[C@H]12)c1csc(N)n1 10.1038/s41467-023-40064-9
CHEMBL2105940 85006 12 None - 1 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 522 9 4 13 -3.2 CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccc(N)n3CCO)CS[C@H]12)c1csc(N)n1 10.1038/s41467-023-40064-9
68818 85043 28 None 3 3 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 217 1 2 3 2.2 c1ccc2c(SC3=NCCN3)c[nH]c2c1 10.1038/s41467-023-40064-9
CHEMBL2107015 85043 28 None 3 3 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 217 1 2 3 2.2 c1ccc2c(SC3=NCCN3)c[nH]c2c1 10.1038/s41467-023-40064-9
3294 8787 111 None -3 23 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
71360 8787 111 None -3 23 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
87 8787 111 None -3 23 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
CHEMBL14376 8787 111 None -3 23 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
DB04946 8787 111 None -3 23 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
115368 9830 47 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
2112 9830 47 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
7556 9830 47 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
CHEMBL1472975 9830 47 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
DB08922 9830 47 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
4151 10379 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
493 10379 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
5312125 10379 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
CHEMBL24778 10379 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
DB06207 10379 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
6077 157477 31 None 3 11 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 5 0 4 4.4 CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL39560 157477 31 None 3 11 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 5 0 4 4.4 CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
2107 9829 50 None 2 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
4747 9829 50 None 2 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
9216 9829 50 None 2 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
CHEMBL251940 9829 50 None 2 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
DB01608 9829 50 None 2 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
62867 9903 35 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 475 8 1 6 4.0 OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
7557 9903 35 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 475 8 1 6 4.0 OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
CHEMBL398880 9903 35 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 475 8 1 6 4.0 OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
DB01621 9903 35 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 475 8 1 6 4.0 OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
2407 10145 76 None 1 17 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 6 1 3 4.3 CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1 10.1038/s41467-023-40064-9
59227 10145 76 None 1 17 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 6 1 3 4.3 CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1 10.1038/s41467-023-40064-9
941 10145 76 None 1 17 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 6 1 3 4.3 CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1 10.1038/s41467-023-40064-9
CHEMBL1303 10145 76 None 1 17 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 6 1 3 4.3 CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1 10.1038/s41467-023-40064-9
DB05271 10145 76 None 1 17 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 6 1 3 4.3 CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1 10.1038/s41467-023-40064-9
5568 204279 29 None -1 13 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
66069 204279 29 None -1 13 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
CHEMBL1201102 204279 29 None -1 13 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
CHEMBL570 204279 29 None -1 13 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
DB00508 204279 29 None -1 13 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
11976 7707 59 None -1 16 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
667467 7707 59 None -1 16 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
CHEMBL908 7707 59 None -1 16 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
DB01239 7707 59 None -1 16 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
2585 7590 103 None -50 34 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
522 7590 103 None -50 34 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
551 7590 103 None -50 34 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
CHEMBL723 7590 103 None -50 34 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
DB01136 7590 103 None -50 34 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
1524 8962 96 None -23 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
197 8962 96 None -23 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
3822 8962 96 None -23 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
88 8962 96 None -23 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL51 8962 96 None -23 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
DB12465 8962 96 None -23 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
2583 10548 118 None -3019 16 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
592 10548 118 None -3019 16 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
65999 10548 118 None -3019 16 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
CHEMBL1017 10548 118 None -3019 16 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
DB00966 10548 118 None -3019 16 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
3601 21275 9 None -45 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 502 9 0 0 8.2 C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2-c2ccccc21)C1c2ccccc2-c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1201349 21275 9 None -45 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 502 9 0 0 8.2 C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2-c2ccccc21)C1c2ccccc2-c2ccccc21 10.1038/s41467-023-40064-9
212 10578 47 None -28 22 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
2639 10578 47 None -28 22 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
941651 10578 47 None -28 22 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
CHEMBL1201 10578 47 None -28 22 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
DB01623 10578 47 None -28 22 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
1043 8363 14 None -15488 23 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
149 8363 14 None -15488 23 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
3251 8363 14 None -15488 23 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
8223 8363 14 None -15488 23 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
CHEMBL1982133 8363 14 None -15488 23 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
CHEMBL442 8363 14 None -15488 23 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
DB00696 8363 14 None -15488 23 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
118422671 9533 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
1887 9533 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
189562 9533 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
71301 9533 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
7246 9533 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
9844194 9533 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
CHEMBL2365658 9533 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
CHEMBL3526436 9533 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
CHEMBL434394 9533 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
DB04861 9533 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
4452 9538 19 None -10232 21 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1038/s41467-023-40064-9
983 9538 19 None -10232 21 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1038/s41467-023-40064-9
CHEMBL20734 9538 19 None -10232 21 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1038/s41467-023-40064-9
1720 9731 38 None - 1 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 4 4 1.1 OC(c1cc(O)cc(c1)O)CNC(C)C 10.1038/s41467-023-40064-9
4086 9731 38 None - 1 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 4 4 1.1 OC(c1cc(O)cc(c1)O)CNC(C)C 10.1038/s41467-023-40064-9
7250 9731 38 None - 1 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 4 4 1.1 OC(c1cc(O)cc(c1)O)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL776 9731 38 None - 1 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 4 4 1.1 OC(c1cc(O)cc(c1)O)CNC(C)C 10.1038/s41467-023-40064-9
DB00816 9731 38 None - 1 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 4 4 1.1 OC(c1cc(O)cc(c1)O)CNC(C)C 10.1038/s41467-023-40064-9
2389 10104 118 None -13 29 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
5073 10104 118 None -13 29 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
96 10104 118 None -13 29 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
CHEMBL85 10104 118 None -13 29 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
DB00734 10104 118 None -13 29 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
228 7233 28 None -75 19 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 10.1038/s41467-023-40064-9
33 7233 28 None -75 19 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 10.1038/s41467-023-40064-9
6005 7233 28 None -75 19 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 10.1038/s41467-023-40064-9
CHEMBL53 7233 28 None -75 19 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 10.1038/s41467-023-40064-9
DB00714 7233 28 None -75 19 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 10.1038/s41467-023-40064-9
2169 51621 35 None -4 12 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
CHEMBL152231 51621 35 None -4 12 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
3584 10549 64 None -69 11 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
5401 10549 64 None -69 11 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
7302 10549 64 None -69 11 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
CHEMBL611 10549 64 None -69 11 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
DB01162 10549 64 None -69 11 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
5482 21192 80 None -3 13 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1200438 21192 80 None -3 13 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
2993 121470 24 None -177 13 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 456 11 2 2 6.2 Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL121663 121470 24 None -177 13 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 456 11 2 2 6.2 Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL333826 121470 24 None -177 13 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 456 11 2 2 6.2 Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21 10.1038/s41467-023-40064-9
681 8247 72 None -162 14 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
940 8247 72 None -162 14 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
947 8247 72 None -162 14 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL59 8247 72 None -162 14 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
DB00988 8247 72 None -162 14 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
2105 9828 37 None -114 24 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
47811 9828 37 None -114 24 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
48 9828 37 None -114 24 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
CHEMBL531 9828 37 None -114 24 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
DB01186 9828 37 None -114 24 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
2220 9908 82 None -269 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
27400 9908 82 None -269 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
93 9908 82 None -269 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
CHEMBL294951 9908 82 None -269 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
DB06153 9908 82 None -269 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
1086 8371 27 None -91 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 5 0 3 5.0 CCN(C(CN1c2ccccc2Sc2c1cccc2)C)CC 10.1038/s41467-023-40064-9
3290 8371 27 None -91 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 5 0 3 5.0 CCN(C(CN1c2ccccc2Sc2c1cccc2)C)CC 10.1038/s41467-023-40064-9
7181 8371 27 None -91 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 5 0 3 5.0 CCN(C(CN1c2ccccc2Sc2c1cccc2)C)CC 10.1038/s41467-023-40064-9
CHEMBL1206 8371 27 None -91 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 5 0 3 5.0 CCN(C(CN1c2ccccc2Sc2c1cccc2)C)CC 10.1038/s41467-023-40064-9
DB00392 8371 27 None -91 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 5 0 3 5.0 CCN(C(CN1c2ccccc2Sc2c1cccc2)C)CC 10.1038/s41467-023-40064-9
2200 26975 61 None 1 12 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1256819 26975 61 None 1 12 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1305 26975 61 None 1 12 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
DB08799 26975 61 None 1 12 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
2136 9869 30 None 1 21 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 10.1038/s41467-023-40064-9
4768 9869 30 None 1 21 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 10.1038/s41467-023-40064-9
7268 9869 30 None 1 21 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL753 9869 30 None 1 21 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 10.1038/s41467-023-40064-9
DB00925 9869 30 None 1 21 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 10.1038/s41467-023-40064-9
68712 107114 60 None -4 7 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1038/s41467-023-40064-9
CHEMBL289480 107114 60 None -4 7 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1038/s41467-023-40064-9
65700 85035 28 None -10 8 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 238 1 1 2 3.3 CNC1Cc2ccccc2N(C)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL2106919 85035 28 None -10 8 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 238 1 1 2 3.3 CNC1Cc2ccccc2N(C)c2ccccc21 10.1038/s41467-023-40064-9
4066 211405 78 None -21 16 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 322 2 0 3 4.6 c1ccc2c(c1)Sc1ccccc1N2CC1CN2CCC1CC2 10.1038/s41467-023-40064-9
CHEMBL73451 211405 78 None -21 16 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 322 2 0 3 4.6 c1ccc2c(c1)Sc1ccccc1N2CC1CN2CCC1CC2 10.1038/s41467-023-40064-9
DB01071 211405 78 None -21 16 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 322 2 0 3 4.6 c1ccc2c(c1)Sc1ccccc1N2CC1CN2CCC1CC2 10.1038/s41467-023-40064-9
3108 214066 116 None -1 7 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 504 12 4 12 -0.0 OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1 10.1038/s41467-023-40064-9
CHEMBL932 214066 116 None -1 7 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 504 12 4 12 -0.0 OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1 10.1038/s41467-023-40064-9
47936 200201 88 None -74 6 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 2 3 7 1.5 C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(C)=O)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C 10.1038/s41467-023-40064-9
CHEMBL52606 200201 88 None -74 6 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 2 3 7 1.5 C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(C)=O)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C 10.1038/s41467-023-40064-9
3158 63041 27 None -125 28 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1628227 63041 27 None -125 28 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
DB01142 63041 27 None -125 28 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
1971 9641 38 None -89 32 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
2404 9641 38 None -89 32 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
4543 9641 38 None -89 32 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL445 9641 38 None -89 32 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
DB00540 9641 38 None -89 32 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
3584 10549 64 None -69 11 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
5401 10549 64 None -69 11 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
7302 10549 64 None -69 11 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
CHEMBL611 10549 64 None -69 11 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
DB01162 10549 64 None -69 11 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
124087 8171 114 None -112 27 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
7157 8171 114 None -112 27 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
814 8171 114 None -112 27 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
CHEMBL1172 8171 114 None -112 27 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
DB00967 8171 114 None -112 27 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
441074 26186 82 None -1 11 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 4 1 4 3.2 C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12 10.1038/s41467-023-40064-9
CHEMBL1294 26186 82 None -1 11 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 4 1 4 3.2 C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12 10.1038/s41467-023-40064-9
115 7131 71 None 14 5 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
2092 7131 71 None 14 5 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
7109 7131 71 None 14 5 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
CHEMBL709 7131 71 None 14 5 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
DB00346 7131 71 None 14 5 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
4260 59332 31 None -3 9 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 6 0 4 3.0 CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C 10.1038/s41467-023-40064-9
CHEMBL159226 59332 31 None -3 9 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 6 0 4 3.0 CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C 10.1038/s41467-023-40064-9
DB09205 59332 31 None -3 9 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 6 0 4 3.0 CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C 10.1038/s41467-023-40064-9
1353 8692 93 None -22 39 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
3559 8692 93 None -22 39 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
86 8692 93 None -22 39 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
CHEMBL54 8692 93 None -22 39 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
DB00502 8692 93 None -22 39 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
5022 8432 76 None -8 9 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
6918248 8432 76 None -8 9 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
8182 8432 76 None -8 9 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL231068 8432 76 None -8 9 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
DB04908 8432 76 None -8 9 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
6075 156887 42 None -14 20 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 10.1038/s41467-023-40064-9
CHEMBL395110 156887 42 None -14 20 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 10.1038/s41467-023-40064-9
5591 164310 90 None -4 17 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
CHEMBL408 164310 90 None -4 17 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
2181 9902 46 None -1 7 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N 10.1038/s41467-023-40064-9
4830 9902 46 None -1 7 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N 10.1038/s41467-023-40064-9
92 9902 46 None -1 7 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N 10.1038/s41467-023-40064-9
CHEMBL440294 9902 46 None -1 7 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N 10.1038/s41467-023-40064-9
DB09286 9902 46 None -1 7 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N 10.1038/s41467-023-40064-9
2146 9874 67 None -20 15 Human 8.4 pAC50 = 8.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
485 9874 67 None -20 15 Human 8.4 pAC50 = 8.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
6041 9874 67 None -20 15 Human 8.4 pAC50 = 8.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL1215 9874 67 None -20 15 Human 8.4 pAC50 = 8.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
DB00388 9874 67 None -20 15 Human 8.4 pAC50 = 8.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
17676 13844 29 None -1 13 Human 8.4 pAC50 = 8.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 411 7 1 6 3.5 CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
5281082 13844 29 None -1 13 Human 8.4 pAC50 = 8.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 411 7 1 6 3.5 CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1085 13844 29 None -1 13 Human 8.4 pAC50 = 8.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 411 7 1 6 3.5 CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
DB01063 13844 29 None -1 13 Human 8.4 pAC50 = 8.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 411 7 1 6 3.5 CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
1427 8794 54 None -112 30 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
357 8794 54 None -112 30 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
3696 8794 54 None -112 30 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL11 8794 54 None -112 30 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00458 8794 54 None -112 30 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
1385580 36049 76 None -478 19 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 7 1 4 4.1 O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
4615 36049 76 None -478 19 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 7 1 4 4.1 O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL13828 36049 76 None -478 19 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 7 1 4 4.1 O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
DB12877 36049 76 None -478 19 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 7 1 4 4.1 O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
3952 8669 38 None -4 21 Human 7.4 pAC50 = 7.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
5353646 8669 38 None -4 21 Human 7.4 pAC50 = 7.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
5443 8669 38 None -4 21 Human 7.4 pAC50 = 7.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
5702063 8669 38 None -4 21 Human 7.4 pAC50 = 7.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
CHEMBL1331786 8669 38 None -4 21 Human 7.4 pAC50 = 7.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
CHEMBL420 8669 38 None -4 21 Human 7.4 pAC50 = 7.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
DB00629 8669 38 None -4 21 Human 7.4 pAC50 = 7.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
4209 9937 75 None -24 17 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
4893 9937 75 None -24 17 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
503 9937 75 None -24 17 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
5385 9937 75 None -24 17 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
CHEMBL2 9937 75 None -24 17 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
DB00457 9937 75 None -24 17 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
5329102 201505 86 None -3 37 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
CHEMBL535 201505 86 None -3 37 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
5803 169006 84 None 1 8 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 622 4 2 3 4.6 O=C(O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 10.1038/s41467-023-40064-9
CHEMBL41632 169006 84 None 1 8 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 622 4 2 3 4.6 O=C(O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 10.1038/s41467-023-40064-9
71897 85023 19 None -141 7 Human 6.4 pAC50 = 6.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 304 4 1 3 2.7 Cc1cc(CCN2CCN(c3cccc(Cl)c3)CC2)n[nH]1 10.1038/s41467-023-40064-9
CHEMBL2106537 85023 19 None -141 7 Human 6.4 pAC50 = 6.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 304 4 1 3 2.7 Cc1cc(CCN2CCN(c3cccc(Cl)c3)CC2)n[nH]1 10.1038/s41467-023-40064-9
44591583 191315 96 None 3 2 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 251 2 1 4 1.6 N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1 10.1038/s41467-023-40064-9
CHEMBL484785 191315 96 None 3 2 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 251 2 1 4 1.6 N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1 10.1038/s41467-023-40064-9
5453 210398 102 None 1 14 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 189 3 0 1 0.2 S=P(N1CC1)(N1CC1)N1CC1 10.1038/s41467-023-40064-9
CHEMBL671 210398 102 None 1 14 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 189 3 0 1 0.2 S=P(N1CC1)(N1CC1)N1CC1 10.1038/s41467-023-40064-9
1613 9127 53 None -16 34 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
205 9127 53 None -16 34 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3964 9127 53 None -16 34 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL831 9127 53 None -16 34 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00408 9127 53 None -16 34 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3947 213174 53 None -6 16 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 418 7 0 3 5.8 CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL87708 213174 53 None -6 16 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 418 7 0 3 5.8 CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
3152 195190 103 None -9 10 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 379 6 0 4 4.4 COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2 10.1038/s41467-023-40064-9
CHEMBL502 195190 103 None -9 10 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 379 6 0 4 4.4 COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2 10.1038/s41467-023-40064-9
55645 91145 8 None -1258 11 Human 6.4 pAC50 = 6.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 7 2 4 2.1 CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21 10.1038/s41467-023-40064-9
CHEMBL2218861 91145 8 None -1258 11 Human 6.4 pAC50 = 6.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 7 2 4 2.1 CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21 10.1038/s41467-023-40064-9
nan 91145 8 None -1258 11 Human 6.4 pAC50 = 6.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 7 2 4 2.1 CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21 10.1038/s41467-023-40064-9
3689 109548 55 None -64 16 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1372983 109548 55 None -64 16 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL305187 109548 55 None -64 16 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
60065 91144 6 None -2 11 Human 5.4 pAC50 = 5.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 505 7 1 8 4.2 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@@H]2CCCN(Cc3ccccc3)C2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
CHEMBL2218858 91144 6 None -2 11 Human 5.4 pAC50 = 5.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 505 7 1 8 4.2 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@@H]2CCCN(Cc3ccccc3)C2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
4418 40996 85 None -4 18 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
CHEMBL142635 40996 85 None -4 18 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
DB12092 40996 85 None -4 18 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
100 10577 58 None -8 38 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
2637 10577 58 None -8 38 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
5452 10577 58 None -8 38 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
CHEMBL479 10577 58 None -8 38 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
DB00679 10577 58 None -8 38 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
2335 18620 22 None -38 34 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
8478 18620 22 None -38 34 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1182210 18620 22 None -38 34 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL221753 18620 22 None -38 34 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
2895 210371 41 None -16 15 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 275 3 0 1 4.6 CN(C)CCC=C1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL669 210371 41 None -16 15 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 275 3 0 1 4.6 CN(C)CCC=C1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
DB00924 210371 41 None -16 15 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 275 3 0 1 4.6 CN(C)CCC=C1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
54682461 91461 62 None 1 12 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 602 11 2 6 7.3 CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1 10.1038/s41467-023-40064-9
CHEMBL222559 91461 62 None 1 12 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 602 11 2 6 7.3 CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1 10.1038/s41467-023-40064-9
82153 50675 45 None 11 3 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 434 2 2 6 2.3 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1 10.1038/s41467-023-40064-9
CHEMBL1512 50675 45 None 11 3 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 434 2 2 6 2.3 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1 10.1038/s41467-023-40064-9
4011 89183 49 None -8 26 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 10.1038/s41467-023-40064-9
CHEMBL21731 89183 49 None -8 26 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 10.1038/s41467-023-40064-9
2710 91083 31 None -10 9 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 300 3 0 2 3.7 CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL22150 91083 31 None -10 9 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 300 3 0 2 3.7 CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
DB08936 91083 31 None -10 9 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 300 3 0 2 3.7 CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
54758501 145845 58 None -1621 11 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 486 7 2 8 5.1 C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1 10.1038/s41467-023-40064-9
CHEMBL3786343 145845 58 None -1621 11 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 486 7 2 8 5.1 C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1 10.1038/s41467-023-40064-9
6719 39442 39 None -6 4 Human 5.3 pAC50 = 5.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 340 4 0 3 4.1 O=C1c2ccccc2C(=O)C1C(=O)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1413199 39442 39 None -6 4 Human 5.3 pAC50 = 5.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 340 4 0 3 4.1 O=C1c2ccccc2C(=O)C1C(=O)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
4195 21243 44 None 2 2 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 254 6 3 5 -0.2 COc1ccc(OC)c(C(O)CNC(=O)CN)c1 10.1038/s41467-023-40064-9
CHEMBL1201212 21243 44 None 2 2 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 254 6 3 5 -0.2 COc1ccc(OC)c(C(O)CNC(=O)CN)c1 10.1038/s41467-023-40064-9
DB00211 21243 44 None 2 2 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 254 6 3 5 -0.2 COc1ccc(OC)c(C(O)CNC(=O)CN)c1 10.1038/s41467-023-40064-9
36811 8236 37 None -1 17 Human 8.3 pAC50 = 8.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
535 8236 37 None -1 17 Human 8.3 pAC50 = 8.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
937 8236 37 None -1 17 Human 8.3 pAC50 = 8.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL926 8236 37 None -1 17 Human 8.3 pAC50 = 8.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
DB00841 8236 37 None -1 17 Human 8.3 pAC50 = 8.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
3083544 33582 51 None -407 6 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1200811 33582 51 None -407 6 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1363 33582 51 None -407 6 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1951071 33582 51 None -407 6 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL605993 33582 51 None -407 6 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
DB00983 33582 51 None -407 6 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
DB01274 33582 51 None -407 6 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
643976 21290 30 None -2 3 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 456 7 6 10 -1.6 Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O)c2cc1C 10.1038/s41467-023-40064-9
CHEMBL1201794 21290 30 None -2 3 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 456 7 6 10 -1.6 Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O)c2cc1C 10.1038/s41467-023-40064-9
133 9274 52 None -131 28 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
1723 9274 52 None -131 28 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
28693 9274 52 None -131 28 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
CHEMBL19215 9274 52 None -131 28 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
DB13520 9274 52 None -131 28 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
3033538 8101 39 None -63 13 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 10.1038/s41467-023-40064-9
7155 8101 39 None -63 13 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 10.1038/s41467-023-40064-9
781 8101 39 None -63 13 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 10.1038/s41467-023-40064-9
CHEMBL1201216 8101 39 None -63 13 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 10.1038/s41467-023-40064-9
DB00298 8101 39 None -63 13 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 10.1038/s41467-023-40064-9
2771 201796 74 None -46 16 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL1200781 201796 74 None -46 16 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL549 201796 74 None -46 16 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
191 7191 98 None -67 36 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
201 7191 98 None -67 36 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
2170 7191 98 None -67 36 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
CHEMBL1113 7191 98 None -67 36 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
DB00543 7191 98 None -67 36 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
107641 67917 78 None -2 2 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 4 1 2 3.4 CCC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1 10.1038/s41467-023-40064-9
CHEMBL1765292 67917 78 None -2 2 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 4 1 2 3.4 CCC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1 10.1038/s41467-023-40064-9
2540 11173 111 None -1047 28 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
CHEMBL1014 11173 111 None -1047 28 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
11504295 9697 47 None -416 8 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
4814 9697 47 None -416 8 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
7543 9697 47 None -416 8 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
CHEMBL605846 9697 47 None -416 8 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
DB09080 9697 47 None -416 8 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
1547484 7727 74 None -50 26 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
654 7727 74 None -50 26 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
9072 7727 74 None -50 26 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL43064 7727 74 None -50 26 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
DB00568 7727 74 None -50 26 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
5639 105671 75 None 7 13 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1038/s41467-023-40064-9
CHEMBL279229 105671 75 None 7 13 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1038/s41467-023-40064-9
2995 211184 53 None -213 18 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1696 211184 53 None -213 18 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL72 211184 53 None -213 18 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
DB01151 211184 53 None -213 18 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
114948 67071 14 None -457 6 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 577 5 3 6 2.5 CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 10.1038/s41467-023-40064-9
CHEMBL1743263 67071 14 None -457 6 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 577 5 3 6 2.5 CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 10.1038/s41467-023-40064-9
DB11274 67071 14 None -457 6 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 577 5 3 6 2.5 CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 10.1038/s41467-023-40064-9
146570 50228 67 None -1 7 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL1508 50228 67 None -1 7 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
4167 21272 43 None -109 10 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 2 0 2 5.0 CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1 10.1038/s41467-023-40064-9
CHEMBL1201342 21272 43 None -109 10 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 2 0 2 5.0 CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1 10.1038/s41467-023-40064-9
DB00340 21272 43 None -109 10 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 2 0 2 5.0 CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1 10.1038/s41467-023-40064-9
2855 10904 104 None -2951 12 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C 10.1038/s41467-023-40064-9
3322 10904 104 None -2951 12 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C 10.1038/s41467-023-40064-9
5717 10904 104 None -2951 12 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C 10.1038/s41467-023-40064-9
CHEMBL603 10904 104 None -2951 12 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C 10.1038/s41467-023-40064-9
DB00549 10904 104 None -2951 12 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C 10.1038/s41467-023-40064-9
2335 18620 22 None -38 34 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
8478 18620 22 None -38 34 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1182210 18620 22 None -38 34 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL221753 18620 22 None -38 34 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
5832 21232 54 None -7 5 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 1 0 3 4.1 C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL1201146 21232 54 None -7 5 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 1 0 3 4.1 C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
208898 72973 78 None -9 11 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 556 18 1 6 7.0 CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1 10.1038/s41467-023-40064-9
CHEMBL184412 72973 78 None -9 11 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 556 18 1 6 7.0 CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1 10.1038/s41467-023-40064-9
DB04855 72973 78 None -9 11 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 556 18 1 6 7.0 CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1 10.1038/s41467-023-40064-9
37 7565 60 None -141 12 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
460 7565 60 None -141 12 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
54746 7565 60 None -141 12 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
CHEMBL1201087 7565 60 None -141 12 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
DB00248 7565 60 None -141 12 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
5419 24832 57 None 10 5 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 200 1 1 2 2.1 c1ccc2c(c1)CCCC2C1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL1200413 24832 57 None 10 5 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 200 1 1 2 2.1 c1ccc2c(c1)CCCC2C1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL1266 24832 57 None 10 5 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 200 1 1 2 2.1 c1ccc2c(c1)CCCC2C1=NCCN1 10.1038/s41467-023-40064-9
DB06764 24832 57 None 10 5 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 200 1 1 2 2.1 c1ccc2c(c1)CCCC2C1=NCCN1 10.1038/s41467-023-40064-9
1028 7079 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
139148732 7079 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
479 7079 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
5816 7079 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL679 7079 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00668 7079 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
1028 7079 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
139148732 7079 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
479 7079 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
5816 7079 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL679 7079 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00668 7079 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
1524 8962 96 None -23 18 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
197 8962 96 None -23 18 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
3822 8962 96 None -23 18 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
88 8962 96 None -23 18 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL51 8962 96 None -23 18 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
DB12465 8962 96 None -23 18 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
2713 212050 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5353524 212050 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5360566 212050 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
88536661 212050 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
9552079 212050 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL1330113 212050 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL790 212050 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5324346 212361 59 None 2 3 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 9 1 4 3.2 COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL1409 212361 59 None 2 3 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 9 1 4 3.2 COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL814 212361 59 None 2 3 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 9 1 4 3.2 COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
1353 8692 93 None -22 39 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
3559 8692 93 None -22 39 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
86 8692 93 None -22 39 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
CHEMBL54 8692 93 None -22 39 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
DB00502 8692 93 None -22 39 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
102 10899 48 None -380 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
3659 10899 48 None -380 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
8969 10899 48 None -380 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL15245 10899 48 None -380 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
DB01392 10899 48 None -380 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
392622 63086 95 None -8 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
CHEMBL163 63086 95 None -8 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
3354 48558 50 None -7 9 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 391 5 0 5 4.4 Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O 10.1038/s41467-023-40064-9
CHEMBL1493 48558 50 None -7 9 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 391 5 0 5 4.4 Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O 10.1038/s41467-023-40064-9
DB01148 48558 50 None -7 9 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 391 5 0 5 4.4 Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O 10.1038/s41467-023-40064-9
447715 203706 68 None -10 7 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 420 5 3 3 5.1 CC[C@@H]1[C@@H]2C[C@H](O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@H]3[C@H](C)CCC(=O)O)[C@@H]2[C@@H]1O 10.1038/s41467-023-40064-9
CHEMBL566315 203706 68 None -10 7 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 420 5 3 3 5.1 CC[C@@H]1[C@@H]2C[C@H](O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@H]3[C@H](C)CCC(=O)O)[C@@H]2[C@@H]1O 10.1038/s41467-023-40064-9
25382 15929 37 None -16 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 291 3 0 1 4.7 CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL110094 15929 37 None -16 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 291 3 0 1 4.7 CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21 10.1038/s41467-023-40064-9
2435 10362 83 None -25 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
60149 10362 83 None -25 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
98 10362 83 None -25 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
CHEMBL12713 10362 83 None -25 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
DB06144 10362 83 None -25 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
2683 109665 25 None -812 24 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
CHEMBL305906 109665 25 None -812 24 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
CHEMBL334255 109665 25 None -812 24 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
2435 7509 100 None -199 10 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
395 7509 100 None -199 10 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
520 7509 100 None -199 10 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
5386 7509 100 None -199 10 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL844 7509 100 None -199 10 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
DB00484 7509 100 None -199 10 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
25295 20392 37 None -4 8 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 289 6 0 3 3.3 CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1 10.1038/s41467-023-40064-9
CHEMBL1194287 20392 37 None -4 8 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 289 6 0 3 3.3 CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1 10.1038/s41467-023-40064-9
10607 209026 100 None - 1 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 414 4 1 8 2.4 COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC 10.1038/s41467-023-40064-9
CHEMBL61 209026 100 None - 1 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 414 4 1 8 2.4 COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC 10.1038/s41467-023-40064-9
73417116 161210 0 None -11 5 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 266 2 2 2 3.0 N[C@@H]1C[C@H]1c1ccccc1.N[C@H]1C[C@@H]1c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL3989843 161210 0 None -11 5 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 266 2 2 2 3.0 N[C@@H]1C[C@H]1c1ccccc1.N[C@H]1C[C@@H]1c1ccccc1 10.1038/s41467-023-40064-9
5314 210887 23 None 25 2 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 290 9 0 4 0.3 C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
CHEMBL703 210887 23 None 25 2 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 290 9 0 4 0.3 C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
20628 103323 28 None -17 13 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 6 1 5 3.7 CN(C)CCCNc1c2ccccc2nc2cccc([N+](=O)[O-])c12 10.1038/s41467-023-40064-9
CHEMBL26291 103323 28 None -17 13 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 6 1 5 3.7 CN(C)CCCNc1c2ccccc2nc2cccc([N+](=O)[O-])c12 10.1038/s41467-023-40064-9
2865 10915 73 None -23 20 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
59 10915 73 None -23 20 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
60854 10915 73 None -23 20 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL708 10915 73 None -23 20 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
DB00246 10915 73 None -23 20 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
5353853 24758 47 None -39 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
9556529 24758 47 None -39 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1262 24758 47 None -39 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
2402 10143 62 None -354 16 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O 10.1038/s41467-023-40064-9
5095 10143 62 None -354 16 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O 10.1038/s41467-023-40064-9
7295 10143 62 None -354 16 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O 10.1038/s41467-023-40064-9
CHEMBL589 10143 62 None -354 16 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O 10.1038/s41467-023-40064-9
DB00268 10143 62 None -354 16 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O 10.1038/s41467-023-40064-9
1593 9119 66 None -3 6 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
30668 9119 66 None -3 6 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
9868 9119 66 None -3 6 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
CHEMBL17860 9119 66 None -3 6 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
DB04948 9119 66 None -3 6 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
4567 16720 34 None 2 12 Human 7.2 pAC50 = 7.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL114655 16720 34 None 2 12 Human 7.2 pAC50 = 7.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
16363 7383 53 None -13 21 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
312 7383 53 None -13 21 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
9215 7383 53 None -13 21 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL297302 7383 53 None -13 21 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB12867 7383 53 None -13 21 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
168871 95905 14 None -53 13 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 563 4 3 6 2.1 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 10.1038/s41467-023-40064-9
CHEMBL2365712 95905 14 None -53 13 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 563 4 3 6 2.1 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 10.1038/s41467-023-40064-9
3598 194600 76 None 1 17 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl 10.1038/s41467-023-40064-9
CHEMBL496 194600 76 None 1 17 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl 10.1038/s41467-023-40064-9
2247 7293 81 None -26 42 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
249 7293 81 None -26 42 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2603 7293 81 None -26 42 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL296419 7293 81 None -26 42 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
DB00637 7293 81 None -26 42 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
40466858 22927 67 None -20 4 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 348 6 1 3 4.0 Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1 10.1038/s41467-023-40064-9
5284514 22927 67 None -20 4 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 348 6 1 3 4.0 Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1 10.1038/s41467-023-40064-9
CHEMBL1224 22927 67 None -20 4 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 348 6 1 3 4.0 Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1 10.1038/s41467-023-40064-9
DB09488 22927 67 None -20 4 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 348 6 1 3 4.0 Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1 10.1038/s41467-023-40064-9
5077 10351 79 None -275 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
7552 10351 79 None -275 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
9913767 10351 79 None -275 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
CHEMBL238804 10351 79 None -275 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
DB11362 10351 79 None -275 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
1613 9127 53 None -16 34 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
205 9127 53 None -16 34 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3964 9127 53 None -16 34 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL831 9127 53 None -16 34 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00408 9127 53 None -16 34 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
4195 21243 44 None 2 2 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 254 6 3 5 -0.2 COc1ccc(OC)c(C(O)CNC(=O)CN)c1 10.1038/s41467-023-40064-9
CHEMBL1201212 21243 44 None 2 2 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 254 6 3 5 -0.2 COc1ccc(OC)c(C(O)CNC(=O)CN)c1 10.1038/s41467-023-40064-9
DB00211 21243 44 None 2 2 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 254 6 3 5 -0.2 COc1ccc(OC)c(C(O)CNC(=O)CN)c1 10.1038/s41467-023-40064-9
12488 8438 56 None -19 28 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F 10.1038/s41467-023-40064-9
941361 8438 56 None -19 28 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F 10.1038/s41467-023-40064-9
CHEMBL30008 8438 56 None -19 28 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F 10.1038/s41467-023-40064-9
DB04841 8438 56 None -19 28 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F 10.1038/s41467-023-40064-9
1909 9598 64 None -1 11 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
2559 9598 64 None -1 11 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
4474 9598 64 None -1 11 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
CHEMBL1484 9598 64 None -1 11 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
CHEMBL3302409 9598 64 None -1 11 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
DB00622 9598 64 None -1 11 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
82146 11302 113 None 1 8 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 348 3 1 1 6.1 C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C 10.1038/s41467-023-40064-9
CHEMBL1023 11302 113 None 1 8 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 348 3 1 1 6.1 C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C 10.1038/s41467-023-40064-9
213046 9164 59 None -6 17 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
4168 9164 59 None -6 17 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
7461 9164 59 None -6 17 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
CHEMBL1237021 9164 59 None -6 17 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
DB08815 9164 59 None -6 17 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
137 7158 52 None -3467 8 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
2119 7158 52 None -3467 8 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
563 7158 52 None -3467 8 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
66368 7158 52 None -3467 8 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
CHEMBL266195 7158 52 None -3467 8 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
DB00866 7158 52 None -3467 8 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
68617 212306 62 None -14 30 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1709 212306 62 None -14 30 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL809 212306 62 None -14 30 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
11823027 199395 37 None -436 3 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 10.1038/s41467-023-40064-9
4411 199395 37 None -436 3 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 10.1038/s41467-023-40064-9
CHEMBL3246778 199395 37 None -436 3 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 10.1038/s41467-023-40064-9
CHEMBL521606 199395 37 None -436 3 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 10.1038/s41467-023-40064-9
DB01203 199395 37 None -436 3 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 10.1038/s41467-023-40064-9
1690 9832 19 None -2 4 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
4058 9832 19 None -2 4 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
5750 9832 19 None -2 4 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
7221 9832 19 None -2 4 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL607 9832 19 None -2 4 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
DB00454 9832 19 None -2 4 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
2291 9958 58 None -147 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
2561 9958 58 None -147 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
4932 9958 58 None -147 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL631 9958 58 None -147 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
DB01182 9958 58 None -147 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
1588 9105 27 None -467 23 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
28864 9105 27 None -467 23 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
43 9105 27 None -467 23 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
CHEMBL157138 9105 27 None -467 23 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
DB00589 9105 27 None -467 23 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
82146 11302 113 None 1 8 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 348 3 1 1 6.1 C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C 10.1038/s41467-023-40064-9
CHEMBL1023 11302 113 None 1 8 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 348 3 1 1 6.1 C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C 10.1038/s41467-023-40064-9
2803 7742 58 None -3 14 Human 8.1 pAC50 = 8.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
516 7742 58 None -3 14 Human 8.1 pAC50 = 8.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
704 7742 58 None -3 14 Human 8.1 pAC50 = 8.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
CHEMBL134 7742 58 None -3 14 Human 8.1 pAC50 = 8.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
DB00575 7742 58 None -3 14 Human 8.1 pAC50 = 8.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
2470 10425 50 None -13803 23 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3300 10425 50 None -13803 23 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5265 10425 50 None -13803 23 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
99 10425 50 None -13803 23 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL267930 10425 50 None -13803 23 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
154257 185398 67 None -13 19 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 470 7 2 5 6.3 Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12 10.1038/s41467-023-40064-9
CHEMBL46740 185398 67 None -13 19 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 470 7 2 5 6.3 Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12 10.1038/s41467-023-40064-9
6324616 175603 25 None 1 3 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 697 2 6 12 4.8 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL437765 175603 25 None 1 3 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 697 2 6 12 4.8 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
3949 107390 50 None -8 16 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 468 8 0 5 4.9 COc1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(OC)c1OC 10.1038/s41467-023-40064-9
CHEMBL29188 107390 50 None -8 16 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 468 8 0 5 4.9 COc1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(OC)c1OC 10.1038/s41467-023-40064-9
444029 174536 10 None -1 2 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 509 6 2 9 2.0 C=C[C@@]1(C)CC(=O)[C@]2(O)[C@@]3(C)[C@@H](O)CCC(C)(C)[C@@H]3[C@H](OC(=O)CCN(C)C)[C@H](OC(C)=O)[C@@]2(C)O1 10.1038/s41467-023-40064-9
CHEMBL4303178 174536 10 None -1 2 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 509 6 2 9 2.0 C=C[C@@]1(C)CC(=O)[C@]2(O)[C@@]3(C)[C@@H](O)CCC(C)(C)[C@@H]3[C@H](OC(=O)CCN(C)C)[C@H](OC(C)=O)[C@@]2(C)O1 10.1038/s41467-023-40064-9
4631 201751 29 None -1071 5 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL546 201751 29 None -1071 5 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C 10.1038/s41467-023-40064-9
DB01580 201751 29 None -1071 5 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C 10.1038/s41467-023-40064-9
71398 113216 44 None -1174 14 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 302 5 4 4 3.6 C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL313972 113216 44 None -1174 14 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 302 5 4 4 3.6 C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1 10.1038/s41467-023-40064-9
31101 7516 40 None -199 29 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
35 7516 40 None -199 29 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
403 7516 40 None -199 29 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
CHEMBL493 7516 40 None -199 29 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
DB01200 7516 40 None -199 29 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
11057 182928 23 None -1 25 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 10.1038/s41467-023-40064-9
3468 182928 23 None -1 25 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL459265 182928 23 None -1 25 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL64894 182928 23 None -1 25 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 10.1038/s41467-023-40064-9
636403 195047 22 None -3 7 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 570 5 2 5 6.8 CC1(C)[C@@H](OC(=O)CCC(=O)O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12 10.1038/s41467-023-40064-9
CHEMBL499915 195047 22 None -3 7 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 570 5 2 5 6.8 CC1(C)[C@@H](OC(=O)CCC(=O)O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12 10.1038/s41467-023-40064-9
124087 8171 114 None -112 27 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
7157 8171 114 None -112 27 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
814 8171 114 None -112 27 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
CHEMBL1172 8171 114 None -112 27 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
DB00967 8171 114 None -112 27 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
41684 37995 105 None -19 32 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
CHEMBL1401 37995 105 None -19 32 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
5284550 48495 15 None -87 16 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1492500 48495 15 None -87 16 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 10.1038/s41467-023-40064-9
21855 91021 42 None -112 9 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 292 5 0 2 4.1 CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1 10.1038/s41467-023-40064-9
CHEMBL22108 91021 42 None -112 9 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 292 5 0 2 4.1 CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1 10.1038/s41467-023-40064-9
DB08801 91021 42 None -112 9 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 292 5 0 2 4.1 CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1 10.1038/s41467-023-40064-9
134 9292 24 None -457 18 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
1775 9292 24 None -457 18 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
9681 9292 24 None -457 18 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
CHEMBL1065 9292 24 None -457 18 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
DB00247 9292 24 None -457 18 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
2391 214232 92 None -9 5 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 361 5 0 5 4.1 CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1 10.1038/s41467-023-40064-9
CHEMBL942 214232 92 None -9 5 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 361 5 0 5 4.1 CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1 10.1038/s41467-023-40064-9
151537 169443 49 None -1 5 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
41867 169443 49 None -1 5 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL417 169443 49 None -1 5 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
3294 8787 111 None -3 23 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
71360 8787 111 None -3 23 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
87 8787 111 None -3 23 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
CHEMBL14376 8787 111 None -3 23 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
DB04946 8787 111 None -3 23 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
1343 8670 62 None -9 12 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
3519 8670 62 None -9 12 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
522 8670 62 None -9 12 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
CHEMBL862 8670 62 None -9 12 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
DB01018 8670 62 None -9 12 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
2683 10606 60 None -10 6 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
5487 10606 60 None -10 6 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
7308 10606 60 None -10 6 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
CHEMBL1079 10606 60 None -10 6 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
DB00697 10606 60 None -10 6 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
4209 9937 75 None -24 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
4893 9937 75 None -24 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
503 9937 75 None -24 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
5385 9937 75 None -24 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
CHEMBL2 9937 75 None -24 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
DB00457 9937 75 None -24 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
12574 9383 88 None -1 8 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1038/s41467-023-40064-9
4810 9383 88 None -1 8 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1038/s41467-023-40064-9
CHEMBL19236 9383 88 None -1 8 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1038/s41467-023-40064-9
DB09242 9383 88 None -1 8 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1038/s41467-023-40064-9
2419 10236 84 None -3019 14 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
5152 10236 84 None -3019 14 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
559 10236 84 None -3019 14 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL1263 10236 84 None -3019 14 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
DB00938 10236 84 None -3019 14 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
25102847 84996 93 None -7 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 501 8 2 6 5.5 COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC 10.1038/s41467-023-40064-9
CHEMBL2105717 84996 93 None -7 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 501 8 2 6 5.5 COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC 10.1038/s41467-023-40064-9
3397 212267 112 None -1 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 3.2 CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1 10.1038/s41467-023-40064-9
CHEMBL806 212267 112 None -1 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 3.2 CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1 10.1038/s41467-023-40064-9
135398745 9688 112 None -14 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
47 9688 112 None -14 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
CHEMBL715 9688 112 None -14 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
DB00334 9688 112 None -14 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
277 8083 62 None -954 29 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
2913 8083 62 None -954 29 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
765 8083 62 None -954 29 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
CHEMBL516 8083 62 None -954 29 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
DB00434 8083 62 None -954 29 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
610479 22272 90 None 1 5 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 261 3 2 2 4.1 Cc1c(Cl)cccc1Nc1ccccc1C(=O)O 10.1038/s41467-023-40064-9
CHEMBL121626 22272 90 None 1 5 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 261 3 2 2 4.1 Cc1c(Cl)cccc1Nc1ccccc1C(=O)O 10.1038/s41467-023-40064-9
3280 55223 28 None -5 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 10 0 5 5.4 CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC 10.1038/s41467-023-40064-9
CHEMBL1555736 55223 28 None -5 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 10 0 5 5.4 CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC 10.1038/s41467-023-40064-9
3166 176199 23 None -1230 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 317 8 0 3 4.2 CCN(CC)CCOC(=O)C(c1ccccc1)C1CCCCC1 10.1038/s41467-023-40064-9
CHEMBL442444 176199 23 None -1230 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 317 8 0 3 4.2 CCN(CC)CCOC(=O)C(c1ccccc1)C1CCCCC1 10.1038/s41467-023-40064-9
2583 10548 118 None -3019 16 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
592 10548 118 None -3019 16 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
65999 10548 118 None -3019 16 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
CHEMBL1017 10548 118 None -3019 16 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
DB00966 10548 118 None -3019 16 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
1201549 7384 24 None -138 26 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
333 7384 24 None -138 26 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
7601 7384 24 None -138 26 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1201203 7384 24 None -138 26 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL438151 7384 24 None -138 26 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
DB00245 7384 24 None -138 26 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
2600 10551 74 None -151 32 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
2608 10551 74 None -151 32 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
5405 10551 74 None -151 32 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL17157 10551 74 None -151 32 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
DB00342 10551 74 None -151 32 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
1400 8738 70 None -15 16 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
3658 8738 70 None -15 16 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
7199 8738 70 None -15 16 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
91513 8738 70 None -15 16 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL896 8738 70 None -15 16 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
DB00557 8738 70 None -15 16 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
3678 101567 57 None -33 8 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 9 0 1 4.6 CCN(CCCc1ccccc1)CCCc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL253371 101567 57 None -33 8 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 9 0 1 4.6 CCN(CCCc1ccccc1)CCCc1ccccc1 10.1038/s41467-023-40064-9
DB01616 101567 57 None -33 8 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 9 0 1 4.6 CCN(CCCc1ccccc1)CCCc1ccccc1 10.1038/s41467-023-40064-9
7019 174755 106 None -2 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 194 0 1 2 3.0 Nc1c2ccccc2nc2ccccc12 10.1038/s41467-023-40064-9
CHEMBL1308088 174755 106 None -2 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 194 0 1 2 3.0 Nc1c2ccccc2nc2ccccc12 10.1038/s41467-023-40064-9
CHEMBL43184 174755 106 None -2 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 194 0 1 2 3.0 Nc1c2ccccc2nc2ccccc12 10.1038/s41467-023-40064-9
150311 16584 102 None -2 7 Human 5.0 pAC50 = 5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 409 6 2 3 4.9 O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1 10.1038/s41467-023-40064-9
CHEMBL1138 16584 102 None -2 7 Human 5.0 pAC50 = 5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 409 6 2 3 4.9 O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1 10.1038/s41467-023-40064-9
10934575 211265 0 None 3 5 Human 10.0 pEC50 = 10.0 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72441 211265 0 None 3 5 Human 10.0 pEC50 = 10.0 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
44362146 171713 1 None 50 3 Human 9.6 pEC50 = 9.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 258 4 1 4 2.8 c1ccc(-c2ccsc2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL422477 171713 1 None 50 3 Human 9.6 pEC50 = 9.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 258 4 1 4 2.8 c1ccc(-c2ccsc2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
44574074 196248 0 None 977 2 Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 262 2 0 4 2.7 c1ccc([C@@H]2Cc3nccn3C2)c(-c2cncnc2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL513691 196248 0 None 977 2 Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 262 2 0 4 2.7 c1ccc([C@@H]2Cc3nccn3C2)c(-c2cncnc2)c1 10.1016/j.bmcl.2009.03.166
11109088 210959 0 None 1 5 Human 9.4 pEC50 = 9.4 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70751 210959 0 None 1 5 Human 9.4 pEC50 = 9.4 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
22493318 51531 0 None 13 3 Human 9.3 pEC50 = 9.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 241 4 2 4 2.4 c1coc(-c2ccccc2NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL152155 51531 0 None 13 3 Human 9.3 pEC50 = 9.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 241 4 2 4 2.4 c1coc(-c2ccccc2NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
44362194 41156 1 None 10 3 Human 9.3 pEC50 = 9.3 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 1 4 2.3 c1ccc(-c2ccoc2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL142784 41156 1 None 10 3 Human 9.3 pEC50 = 9.3 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 1 4 2.3 c1ccc(-c2ccoc2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
22493352 55048 0 None 2 3 Human 9.2 pEC50 = 9.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ncco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL155326 55048 0 None 2 3 Human 9.2 pEC50 = 9.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ncco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
22493236 67170 0 None 5 3 Human 9.1 pEC50 = 9.1 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 242 4 3 5 0.9 c1ccc(-c2nc[nH]n2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
CHEMBL17491 67170 0 None 5 3 Human 9.1 pEC50 = 9.1 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 242 4 3 5 0.9 c1ccc(-c2nc[nH]n2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
44271661 168575 0 None -1 3 Human 9.1 pEC50 = 9.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 233 4 2 5 0.9 COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL414185 168575 0 None -1 3 Human 9.1 pEC50 = 9.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 233 4 2 5 0.9 COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44271661 168575 0 None -1 3 Human 9.1 pEC50 = 9.1 Functional
Effective concentration showing agonistic activity towards Human alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells was determinedEffective concentration showing agonistic activity towards Human alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells was determined
ChEMBL 233 4 2 5 0.9 COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL414185 168575 0 None -1 3 Human 9.1 pEC50 = 9.1 Functional
Effective concentration showing agonistic activity towards Human alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells was determinedEffective concentration showing agonistic activity towards Human alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells was determined
ChEMBL 233 4 2 5 0.9 COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
22493280 55049 0 None 1 3 Human 9.1 pEC50 = 9.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ccno2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL155327 55049 0 None 1 3 Human 9.1 pEC50 = 9.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ccno2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
44271661 168575 0 None -1 3 Human 9.1 pEC50 = 9.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 233 4 2 5 0.9 COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL414185 168575 0 None -1 3 Human 9.1 pEC50 = 9.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 233 4 2 5 0.9 COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
44369431 52129 0 None 57 3 Human 9.1 pEC50 = 9.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 271 4 2 4 3.1 Cc1ccsc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL152693 52129 0 None 57 3 Human 9.1 pEC50 = 9.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 271 4 2 4 3.1 Cc1ccsc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
44362208 42207 1 None 3 3 Human 9.0 pEC50 = 9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 258 4 1 4 2.8 c1csc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL143801 42207 1 None 3 3 Human 9.0 pEC50 = 9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 258 4 1 4 2.8 c1csc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
22493258 105440 0 None 5 3 Human 9.0 pEC50 = 9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 241 4 3 4 1.5 c1ccc(-c2cc[nH]n2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
CHEMBL277375 105440 0 None 5 3 Human 9.0 pEC50 = 9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 241 4 3 4 1.5 c1ccc(-c2cc[nH]n2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
44574078 185540 0 None 120 3 Human 9.0 pEC50 = 9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 0 3 3.3 c1cncc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL468711 185540 0 None 120 3 Human 9.0 pEC50 = 9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 0 3 3.3 c1cncc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
44219718 195625 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 280 2 0 4 2.8 Fc1ccc(-c2cncnc2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL506744 195625 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 280 2 0 4 2.8 Fc1ccc(-c2cncnc2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
44362286 105662 1 None 7 2 Human 8.9 pEC50 = 8.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 1 4 2.3 c1coc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL279136 105662 1 None 7 2 Human 8.9 pEC50 = 8.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 1 4 2.3 c1coc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
44362195 127867 0 None 2 3 Human 8.9 pEC50 = 8.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 241 4 2 3 2.1 c1c[nH]c(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL357129 127867 0 None 2 3 Human 8.9 pEC50 = 8.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 241 4 2 3 2.1 c1c[nH]c(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
22493263 104860 0 None 50 3 Human 8.9 pEC50 = 8.9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 270 5 2 6 1.4 CCn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL273316 104860 0 None 50 3 Human 8.9 pEC50 = 8.9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 270 5 2 6 1.4 CCn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
22493365 105240 0 None 15 3 Human 8.9 pEC50 = 8.9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 241 4 3 4 1.5 c1ccc(-c2cn[nH]c2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
CHEMBL275844 105240 0 None 15 3 Human 8.9 pEC50 = 8.9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 241 4 3 4 1.5 c1ccc(-c2cn[nH]c2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
44329788 214881 0 None - 1 Human 8.9 pEC50 = 8.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 6 2 5 2.1 CCC(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL97859 214881 0 None - 1 Human 8.9 pEC50 = 8.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 6 2 5 2.1 CCC(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
11098175 210949 0 None 2 4 Human 8.8 pEC50 = 8.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL70691 210949 0 None 2 4 Human 8.8 pEC50 = 8.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
10221005 211101 0 None 72 3 Human 8.7 pEC50 = 8.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 267 4 2 5 0.8 Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL71479 211101 0 None 72 3 Human 8.7 pEC50 = 8.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 267 4 2 5 0.8 Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
44362185 127807 0 None 19 3 Human 8.7 pEC50 = 8.7 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 253 4 1 4 2.1 c1cncc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL356605 127807 0 None 19 3 Human 8.7 pEC50 = 8.7 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 253 4 1 4 2.1 c1cncc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
22493343 70745 0 None 19 3 Human 8.7 pEC50 = 8.7 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 256 4 2 6 0.9 Cn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL18069 70745 0 None 19 3 Human 8.7 pEC50 = 8.7 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 256 4 2 6 0.9 Cn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
44343410 18327 2 None -1 3 Human 8.0 pEC50 = 8 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 219 4 2 3 2.7 CSc1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
CHEMBL118055 18327 2 None -1 3 Human 8.0 pEC50 = 8 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 219 4 2 3 2.7 CSc1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
9837963 69745 0 None 8 3 Human 8.0 pEC50 = 8 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17851 69745 0 None 8 3 Human 8.0 pEC50 = 8 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
44329796 215158 0 None 1 3 Human 8.0 pEC50 = 8 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 7 2 5 2.1 CCCCOC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL99559 215158 0 None 1 3 Human 8.0 pEC50 = 8 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 7 2 5 2.1 CCCCOC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
22493289 56462 0 None 4 3 Human 8.0 pEC50 = 8 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 253 4 2 5 1.6 c1cnc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
CHEMBL156661 56462 0 None 4 3 Human 8.0 pEC50 = 8 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 253 4 2 5 1.6 c1cnc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
11034737 211307 0 None -1 4 Human 8.0 pEC50 = 8.0 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 289 4 2 4 2.8 CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72724 211307 0 None -1 4 Human 8.0 pEC50 = 8.0 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 289 4 2 4 2.8 CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
44362145 41257 3 None - 1 Human 7.0 pEC50 = 7 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 2 4 1.5 c1ccc(-c2ncc[nH]2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL142864 41257 3 None - 1 Human 7.0 pEC50 = 7 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 2 4 1.5 c1ccc(-c2ncc[nH]2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
22493401 215028 0 None - 1 Human 7.0 pEC50 = 7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 288 7 2 4 2.0 CCCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL98769 215028 0 None - 1 Human 7.0 pEC50 = 7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 288 7 2 4 2.0 CCCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
22493225 69286 0 None - 1 Human 6.0 pEC50 = 6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 270 4 2 6 1.2 Cc1nc(-c2ccccc2NCC2=NCCN2)n(C)n1 10.1016/s0960-894x(03)00050-7
CHEMBL17819 69286 0 None - 1 Human 6.0 pEC50 = 6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 270 4 2 6 1.2 Cc1nc(-c2ccccc2NCC2=NCCN2)n(C)n1 10.1016/s0960-894x(03)00050-7
44574878 185326 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 2 1 2 2.7 COc1cccc(C2CCc3nc[nH]c3C2)c1 10.1016/j.bmcl.2009.03.162
CHEMBL466916 185326 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 2 1 2 2.7 COc1cccc(C2CCc3nc[nH]c3C2)c1 10.1016/j.bmcl.2009.03.162
22493372 127016 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1ncc(-c2ccccc2NCC2=NCCN2)o1 10.1016/s0960-894x(01)00822-8
CHEMBL352225 127016 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1ncc(-c2ccccc2NCC2=NCCN2)o1 10.1016/s0960-894x(01)00822-8
11059195 108949 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 321 4 2 5 1.5 CS(=O)(=O)c1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL302698 108949 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 321 4 2 5 1.5 CS(=O)(=O)c1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
44574987 185456 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 3 0 3 2.8 FC(F)Oc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL467915 185456 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 3 0 3 2.8 FC(F)Oc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
76632 106826 51 None -5 2 Human 5.0 pEC50 = 5.0 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 181 4 1 3 1.2 COc1ccc(OC)c(CCN)c1 10.1021/jm00144a012
CHEMBL287047 106826 51 None -5 2 Human 5.0 pEC50 = 5.0 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 181 4 1 3 1.2 COc1ccc(OC)c(CCN)c1 10.1021/jm00144a012
44449657 102841 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 265 2 1 3 3.5 Cc1oncc1-c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL260009 102841 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 265 2 1 3 3.5 Cc1oncc1-c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44571891 176795 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 280 3 1 4 2.8 Cc1noc(Cc2cccc3c2CC[C@H]3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
CHEMBL444252 176795 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 280 3 1 4 2.8 Cc1noc(Cc2cccc3c2CC[C@H]3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
2435 7509 100 None -25 10 Bovine 6.0 pEC50 = 6.0 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
395 7509 100 None -25 10 Bovine 6.0 pEC50 = 6.0 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
520 7509 100 None -25 10 Bovine 6.0 pEC50 = 6.0 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
5386 7509 100 None -25 10 Bovine 6.0 pEC50 = 6.0 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
CHEMBL844 7509 100 None -25 10 Bovine 6.0 pEC50 = 6.0 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
DB00484 7509 100 None -25 10 Bovine 6.0 pEC50 = 6.0 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
44449690 102936 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 1 2 3.6 c1ccc(-c2cccc3c2CCC3c2ncc[nH]2)nc1 10.1016/j.bmcl.2008.03.070
CHEMBL260575 102936 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 1 2 3.6 c1ccc(-c2cccc3c2CCC3c2ncc[nH]2)nc1 10.1016/j.bmcl.2008.03.070
1960 9632 67 None -97 19 Rat 5.9 pEC50 = 5.9 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
439260 9632 67 None -97 19 Rat 5.9 pEC50 = 5.9 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
505 9632 67 None -97 19 Rat 5.9 pEC50 = 5.9 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
CHEMBL1437 9632 67 None -97 19 Rat 5.9 pEC50 = 5.9 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
DB00368 9632 67 None -97 19 Rat 5.9 pEC50 = 5.9 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
44574105 185587 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 305 5 1 4 1.3 CNS(=O)(=O)CCc1ccccc1[C@@H]1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
CHEMBL469127 185587 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 305 5 1 4 1.3 CNS(=O)(=O)CCc1ccccc1[C@@H]1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
44574045 196065 0 None 60 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 260 2 0 2 3.9 c1ccc(-c2ccccc2[C@@H]2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.166
CHEMBL512062 196065 0 None 60 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 260 2 0 2 3.9 c1ccc(-c2ccccc2[C@@H]2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.166
2765 7730 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(02)00753-9
515 7730 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(02)00753-9
CHEMBL13852 7730 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(02)00753-9
DB09202 7730 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(02)00753-9
22493274 17810 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 258 4 2 4 2.1 c1ccc(N2CCCCC2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL117581 17810 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 258 4 2 4 2.1 c1ccc(N2CCCCC2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
10015132 170648 1 None 29 3 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 253 4 1 4 2.1 c1ccc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(02)00753-9
CHEMBL420683 170648 1 None 29 3 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 253 4 1 4 2.1 c1ccc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(02)00753-9
9817256 211017 0 None 251 2 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL71001 211017 0 None 251 2 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
2765 7730 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00764-8
515 7730 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00764-8
CHEMBL13852 7730 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00764-8
DB09202 7730 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00764-8
10038958 125503 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 273 4 1 5 2.5 Cc1cnsc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
CHEMBL341747 125503 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 273 4 1 5 2.5 Cc1cnsc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
10015132 170648 1 None 29 3 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 253 4 1 4 2.1 c1ccc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(01)00764-8
CHEMBL420683 170648 1 None 29 3 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 253 4 1 4 2.1 c1ccc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(01)00764-8
22493265 68908 0 None 19 3 Human 7.9 pEC50 = 7.9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 284 6 2 6 1.8 CCCn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17776 68908 0 None 19 3 Human 7.9 pEC50 = 7.9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 284 6 2 6 1.8 CCCn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
2765 7730 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00569-8
515 7730 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00569-8
CHEMBL13852 7730 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00569-8
DB09202 7730 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00569-8
44329790 119323 0 None 5 3 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 247 5 2 5 1.3 CCOC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL329928 119323 0 None 5 3 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 247 5 2 5 1.3 CCOC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
22493224 215124 4 None 6 3 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 246 5 3 4 0.9 CCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL99362 215124 4 None 6 3 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 246 5 3 4 0.9 CCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
2765 7730 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00822-8
515 7730 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00822-8
CHEMBL13852 7730 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00822-8
DB09202 7730 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00822-8
12924821 109674 7 None - 1 Human 6.9 pEC50 = 6.9 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 207 2 1 3 1.5 COc1ccc(OC)c2c1CCC(N)C2 10.1021/jm00144a012
CHEMBL30596 109674 7 None - 1 Human 6.9 pEC50 = 6.9 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 207 2 1 3 1.5 COc1ccc(OC)c2c1CCC(N)C2 10.1021/jm00144a012
44593577 185243 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.7 c1ccc(C2CCc3nc[nH]c3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL466296 185243 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.7 c1ccc(C2CCc3nc[nH]c3C2)cc1 10.1016/j.bmcl.2009.03.162
44343251 17292 2 None - 1 Human 6.9 pEC50 = 6.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 251 4 2 4 1.4 CS(=O)(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
CHEMBL116843 17292 2 None - 1 Human 6.9 pEC50 = 6.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 251 4 2 4 1.4 CS(=O)(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
44362510 125711 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 267 4 1 4 2.4 Cc1cccc(-c2ccccc2OCC2=NCCN2)n1 10.1016/s0960-894x(01)00764-8
CHEMBL342324 125711 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 267 4 1 4 2.4 Cc1cccc(-c2ccccc2OCC2=NCCN2)n1 10.1016/s0960-894x(01)00764-8
22493257 214425 3 None 2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 272 4 2 4 1.3 O=C(c1ccccc1NCC1=NCCN1)N1CCCC1 10.1016/s0960-894x(01)00569-8
CHEMBL95245 214425 3 None 2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 272 4 2 4 1.3 O=C(c1ccccc1NCC1=NCCN1)N1CCCC1 10.1016/s0960-894x(01)00569-8
44362289 128475 1 None - 1 Human 5.9 pEC50 = 5.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 254 4 1 5 1.5 c1cnc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(01)00764-8
CHEMBL358802 128475 1 None - 1 Human 5.9 pEC50 = 5.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 254 4 1 5 1.5 c1cnc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(01)00764-8
44449306 102381 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 305 5 2 3 2.6 CCCS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257801 102381 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 305 5 2 3 2.6 CCCS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44449730 162887 0 None 22 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 2 2 2 2.9 c1cc(-c2cn[nH]c2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
CHEMBL406316 162887 0 None 22 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 2 2 2 2.9 c1cc(-c2cn[nH]c2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
9817256 211017 0 None 251 2 Human 7.9 pEC50 = 7.9 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL71001 211017 0 None 251 2 Human 7.9 pEC50 = 7.9 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
44449278 102427 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257977 102427 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44574877 185320 0 None 23 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 2 1 2 2.7 COc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
CHEMBL466869 185320 0 None 23 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 2 1 2 2.7 COc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
44574135 195957 0 None 18 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 1 3 2.8 Fc1ccc(C2Cc3nccn3C2)c(-c2ccn[nH]2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL511211 195957 0 None 18 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 1 3 2.8 Fc1ccc(C2Cc3nccn3C2)c(-c2ccn[nH]2)c1 10.1016/j.bmcl.2009.03.166
22493269 53600 0 None 6 3 Human 7.8 pEC50 = 7.8 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1ncoc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL154023 53600 0 None 6 3 Human 7.8 pEC50 = 7.8 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1ncoc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
44343257 17272 0 None 13 3 Human 7.8 pEC50 = 7.8 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 250 4 1 2 3.7 c1ccc(-c2ccccc2OCc2c[nH]cn2)cc1 10.1016/s0960-894x(02)00753-9
CHEMBL116700 17272 0 None 13 3 Human 7.8 pEC50 = 7.8 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 250 4 1 2 3.7 c1ccc(-c2ccccc2OCc2c[nH]cn2)cc1 10.1016/s0960-894x(02)00753-9
10199052 214733 0 None 5 3 Human 7.8 pEC50 = 7.8 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 258 5 3 4 1.0 O=C(NC1CC1)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL97044 214733 0 None 5 3 Human 7.8 pEC50 = 7.8 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 258 5 3 4 1.0 O=C(NC1CC1)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
619552 109475 3 None - 1 Rat 5.8 pEC50 = 5.8 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 250 2 0 3 2.5 Cn1nc(Cc2ccccc2)c2ccccc2c1=O 10.1016/j.bmcl.2006.02.003
CHEMBL304747 109475 3 None - 1 Rat 5.8 pEC50 = 5.8 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 250 2 0 3 2.5 Cn1nc(Cc2ccccc2)c2ccccc2c1=O 10.1016/j.bmcl.2006.02.003
45280075 129141 0 None -91 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 430 10 4 6 2.5 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(C4CC4)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
CHEMBL3600395 129141 0 None -91 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 430 10 4 6 2.5 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(C4CC4)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
44343235 16969 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 241 4 1 4 2.6 c1ccc(-c2ccno2)c(OCc2c[nH]cn2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL115977 16969 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 241 4 1 4 2.6 c1ccc(-c2ccno2)c(OCc2c[nH]cn2)c1 10.1016/s0960-894x(02)00753-9
44362013 42157 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 273 4 1 5 2.5 Cc1cc(-c2ccccc2OCC2=NCCN2)sn1 10.1016/s0960-894x(01)00764-8
CHEMBL143766 42157 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 273 4 1 5 2.5 Cc1cc(-c2ccccc2OCC2=NCCN2)sn1 10.1016/s0960-894x(01)00764-8
481 9667 7 None 8 2 Human 6.8 pEC50 = 6.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1021/jm000542r
9838763 9667 7 None 8 2 Human 6.8 pEC50 = 6.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1021/jm000542r
CHEMBL72958 9667 7 None 8 2 Human 6.8 pEC50 = 6.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1021/jm000542r
10199335 211526 0 None 120 2 Human 7.8 pEC50 = 7.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74467 211526 0 None 120 2 Human 7.8 pEC50 = 7.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
44574834 179400 1 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 1 1 2.3 c1ccc2c(c1)CC(c1ncc[nH]1)C2 10.1016/j.bmcl.2009.03.162
CHEMBL449279 179400 1 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 1 1 2.3 c1ccc2c(c1)CC(c1ncc[nH]1)C2 10.1016/j.bmcl.2009.03.162
2146 9874 67 None -186 15 Rat 5.8 pEC50 = 5.8 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
485 9874 67 None -186 15 Rat 5.8 pEC50 = 5.8 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
6041 9874 67 None -186 15 Rat 5.8 pEC50 = 5.8 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
CHEMBL1215 9874 67 None -186 15 Rat 5.8 pEC50 = 5.8 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
DB00388 9874 67 None -186 15 Rat 5.8 pEC50 = 5.8 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
44449247 102189 0 None 1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 2 1 2 2.8 COc1c(C)ccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL256984 102189 0 None 1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 2 1 2 2.8 COc1c(C)ccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44571843 186100 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 242 4 1 2 2.7 COCCc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL473425 186100 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 242 4 1 2 2.7 COCCc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
44571937 196329 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 282 3 1 3 2.9 Fc1ccn(Cc2cccc3c2CCC3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
CHEMBL514333 196329 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 282 3 1 3 2.9 Fc1ccn(Cc2cccc3c2CCC3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
9794803 17778 2 None 4 3 Human 7.8 pEC50 = 7.8 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL117381 17778 2 None 4 3 Human 7.8 pEC50 = 7.8 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
44449692 163764 0 None 8 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 251 2 1 3 3.1 c1cc(-c2ncco2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
CHEMBL407308 163764 0 None 8 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 251 2 1 3 3.1 c1cc(-c2ncco2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
44281493 106772 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 247 2 1 3 2.5 COc1ccc(OC)c2c1CC[C@H]1NCCCC21 10.1021/jm00144a012
CHEMBL286702 106772 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 247 2 1 3 2.5 COc1ccc(OC)c2c1CC[C@H]1NCCCC21 10.1021/jm00144a012
44574106 185205 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 317 3 1 3 3.3 CNC(=O)c1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL466012 185205 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 317 3 1 3 3.3 CNC(=O)c1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
44574107 195539 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 280 2 0 4 2.8 Fc1ccc(C2Cc3nccn3C2)c(-c2cncnc2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL505414 195539 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 280 2 0 4 2.8 Fc1ccc(C2Cc3nccn3C2)c(-c2cncnc2)c1 10.1016/j.bmcl.2009.03.166
44574935 179401 0 None 19 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 218 1 0 2 2.9 Clc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL449284 179401 0 None 19 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 218 1 0 2 2.9 Clc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
9794803 17778 2 None 4 3 Human 7.7 pEC50 = 7.7 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL117381 17778 2 None 4 3 Human 7.7 pEC50 = 7.7 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
9859855 67171 0 None 12 2 Human 7.7 pEC50 = 7.7 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 254 4 2 4 2.1 Cn1cccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17492 67171 0 None 12 2 Human 7.7 pEC50 = 7.7 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 254 4 2 4 2.1 Cn1cccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
124 9755 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00569-8
2032 9755 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00569-8
4636 9755 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00569-8
CHEMBL762 9755 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00569-8
DB00935 9755 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00569-8
22493320 10976 0 None 3 3 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 246 4 2 4 0.8 CN(C)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL100198 10976 0 None 3 3 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 246 4 2 4 0.8 CN(C)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44329481 11004 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 289 7 2 5 2.4 CCC(CC)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL100383 11004 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 289 7 2 5 2.4 CCC(CC)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
10378649 115370 0 None 15 3 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 7 3 4 1.6 CCCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL320419 115370 0 None 15 3 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 7 3 4 1.6 CCCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
124 9755 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00822-8
2032 9755 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00822-8
4636 9755 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00822-8
CHEMBL762 9755 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00822-8
DB00935 9755 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00822-8
11811395 211480 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 281 5 2 5 1.3 CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74071 211480 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 281 5 2 5 1.3 CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
44571844 179334 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 295 4 2 2 3.1 FC(F)(F)CNCc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL448510 179334 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 295 4 2 2 3.1 FC(F)(F)CNCc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
22493367 72959 0 None 1 3 Human 6.7 pEC50 = 6.7 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 298 7 2 6 2.2 CCCCn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL18436 72959 0 None 1 3 Human 6.7 pEC50 = 6.7 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 298 7 2 6 2.2 CCCCn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
44574075 179355 0 None 72 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 251 2 0 4 2.9 c1ccc([C@@H]2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL448802 179355 0 None 72 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 251 2 0 4 2.9 c1ccc([C@@H]2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
44369351 126380 0 None 2 3 Human 8.7 pEC50 = 8.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 257 4 2 4 2.8 c1csc(-c2ccccc2NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL346380 126380 0 None 2 3 Human 8.7 pEC50 = 8.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 257 4 2 4 2.8 c1csc(-c2ccccc2NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
11140347 211312 1 None -1 5 Human 8.6 pEC50 = 8.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72768 211312 1 None -1 5 Human 8.6 pEC50 = 8.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
44362196 41262 1 None 7 3 Human 8.6 pEC50 = 8.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 259 4 1 5 2.2 c1ccc(-c2nccs2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL142871 41262 1 None 7 3 Human 8.6 pEC50 = 8.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 259 4 1 5 2.2 c1ccc(-c2nccs2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
44362288 42403 1 None 251 2 Human 8.6 pEC50 = 8.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 254 4 1 5 1.5 c1ccc(-c2cnccn2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL143973 42403 1 None 251 2 Human 8.6 pEC50 = 8.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 254 4 1 5 1.5 c1ccc(-c2cnccn2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
9881853 105250 0 None - 1 Human 8.6 pEC50 = 8.6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 268 5 2 4 2.6 CCn1cccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL275902 105250 0 None - 1 Human 8.6 pEC50 = 8.6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 268 5 2 4 2.6 CCn1cccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
10198532 214475 0 None 1 3 Human 8.6 pEC50 = 8.6 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 232 4 3 4 0.5 CNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL95523 214475 0 None 1 3 Human 8.6 pEC50 = 8.6 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 232 4 3 4 0.5 CNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44369434 52155 0 None 17 2 Human 8.6 pEC50 = 8.6 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 255 4 2 4 2.7 Cc1ccc(-c2ccccc2NCC2=NCCN2)o1 10.1016/s0960-894x(01)00822-8
CHEMBL152725 52155 0 None 17 2 Human 8.6 pEC50 = 8.6 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 255 4 2 4 2.7 Cc1ccc(-c2ccccc2NCC2=NCCN2)o1 10.1016/s0960-894x(01)00822-8
9947861 210941 0 None 21 3 Human 8.6 pEC50 = 8.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70634 210941 0 None 21 3 Human 8.6 pEC50 = 8.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
124 9755 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
2032 9755 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
4636 9755 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
CHEMBL762 9755 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
DB00935 9755 47 None -8 25 Human 7.7 pEC50 = 7.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
10422033 127753 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 246 5 2 5 1.5 CO/N=C(\C)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL356195 127753 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 246 5 2 5 1.5 CO/N=C(\C)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
44281250 121584 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 247 2 1 3 2.5 COc1ccc(OC)c2c1CC[C@@H]1NCCCC21 10.1021/jm00144a012
CHEMBL33405 121584 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 247 2 1 3 2.5 COc1ccc(OC)c2c1CC[C@@H]1NCCCC21 10.1021/jm00144a012
44449691 102937 0 None 2 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 1 2 3.6 c1cncc(-c2cccc3c2CCC3c2ncc[nH]2)c1 10.1016/j.bmcl.2008.03.070
CHEMBL260576 102937 0 None 2 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 1 2 3.6 c1cncc(-c2cccc3c2CCC3c2ncc[nH]2)c1 10.1016/j.bmcl.2008.03.070
4038180 6992 14 None -1 6 Human 7.7 pEC50 = 7.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
480 6992 14 None -1 6 Human 7.7 pEC50 = 7.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
CHEMBL109783 6992 14 None -1 6 Human 7.7 pEC50 = 7.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
44449278 102427 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257977 102427 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
1960 9632 67 None -2 19 Human 5.7 pEC50 = 5.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
439260 9632 67 None -2 19 Human 5.7 pEC50 = 5.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
505 9632 67 None -2 19 Human 5.7 pEC50 = 5.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
CHEMBL1437 9632 67 None -2 19 Human 5.7 pEC50 = 5.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
DB00368 9632 67 None -2 19 Human 5.7 pEC50 = 5.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
10135864 129296 0 None -10 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 404 9 4 6 1.9 Cc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
CHEMBL3601200 129296 0 None -10 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 404 9 4 6 1.9 Cc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
44574937 185440 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 0 3 2.2 COc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL467688 185440 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 0 3 2.2 COc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
44449276 102426 0 None 1 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 241 2 2 2 1.8 CNC(=O)c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257976 102426 0 None 1 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 241 2 2 2 1.8 CNC(=O)c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
11090351 170170 0 None 20 2 Human 7.6 pEC50 = 7.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL419448 170170 0 None 20 2 Human 7.6 pEC50 = 7.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
44449278 102427 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257977 102427 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44593577 185243 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.7 c1ccc(C2CCc3nc[nH]c3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL466296 185243 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.7 c1ccc(C2CCc3nc[nH]c3C2)cc1 10.1016/j.bmcl.2009.03.162
10221004 211010 0 None 20 2 Human 6.6 pEC50 = 6.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 267 5 2 5 0.9 CCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70973 211010 0 None 20 2 Human 6.6 pEC50 = 6.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 267 5 2 5 0.9 CCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
22493356 53785 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 266 4 2 4 2.5 Cc1cccnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL154170 53785 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 266 4 2 4 2.5 Cc1cccnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
10804826 30387 2 None 1 2 Human 4.6 pEC50 = 4.6 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL133451 30387 2 None 1 2 Human 4.6 pEC50 = 4.6 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
216249 8087 51 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 317 5 2 5 1.4 Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1 10.1016/j.bmcl.2008.03.070
3469 8087 51 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 317 5 2 5 1.4 Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1 10.1016/j.bmcl.2008.03.070
CHEMBL257978 8087 51 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 317 5 2 5 1.4 Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1 10.1016/j.bmcl.2008.03.070
10423384 41370 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 272 4 1 4 3.1 Cc1ccc(-c2ccccc2OCC2=NCCN2)s1 10.1016/s0960-894x(01)00764-8
CHEMBL142958 41370 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 272 4 1 4 3.1 Cc1ccc(-c2ccccc2OCC2=NCCN2)s1 10.1016/s0960-894x(01)00764-8
10084685 126214 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 273 4 1 5 2.5 Cc1csc(-c2ccccc2OCC2=NCCN2)n1 10.1016/s0960-894x(01)00764-8
CHEMBL344957 126214 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 273 4 1 5 2.5 Cc1csc(-c2ccccc2OCC2=NCCN2)n1 10.1016/s0960-894x(01)00764-8
10221066 169941 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 269 5 2 5 2.0 CCn1ccc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(03)00050-7
CHEMBL417999 169941 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 269 5 2 5 2.0 CCn1ccc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(03)00050-7
44271931 105169 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 283 6 2 5 2.4 CCCn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL275386 105169 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 283 6 2 5 2.4 CCCn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
10180440 129297 0 None -6 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 420 10 4 7 1.6 COc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
CHEMBL3601201 129297 0 None -6 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 420 10 4 7 1.6 COc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
2683 10606 60 None 1 6 Bovine 6.6 pEC50 = 6.6 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
5487 10606 60 None 1 6 Bovine 6.6 pEC50 = 6.6 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
7308 10606 60 None 1 6 Bovine 6.6 pEC50 = 6.6 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
CHEMBL1079 10606 60 None 1 6 Bovine 6.6 pEC50 = 6.6 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
DB00697 10606 60 None 1 6 Bovine 6.6 pEC50 = 6.6 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
44574138 185284 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 0 4 2.5 Fc1ccc(C2Cc3nccn3C2)c(-n2cccn2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL466635 185284 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 0 4 2.5 Fc1ccc(C2Cc3nccn3C2)c(-n2cccn2)c1 10.1016/j.bmcl.2009.03.166
44593557 190697 11 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2009.03.162
CHEMBL481322 190697 11 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2009.03.162
44574874 185172 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 232 1 1 1 3.3 Clc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
CHEMBL465599 185172 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 232 1 1 1 3.3 Clc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
122184771 129298 0 None -3 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 434 11 4 7 2.0 CCOc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
CHEMBL3601202 129298 0 None -3 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 434 11 4 7 2.0 CCOc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
44449723 162913 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 264 2 1 3 2.9 Cn1nccc1-c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL406348 162913 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 264 2 1 3 2.9 Cn1nccc1-c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
124 9755 47 None -52 25 Rat 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
2032 9755 47 None -52 25 Rat 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
4636 9755 47 None -52 25 Rat 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
CHEMBL762 9755 47 None -52 25 Rat 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
DB00935 9755 47 None -52 25 Rat 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
2146 9874 67 None -20 15 Human 5.5 pEC50 = 5.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
485 9874 67 None -20 15 Human 5.5 pEC50 = 5.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
6041 9874 67 None -20 15 Human 5.5 pEC50 = 5.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
CHEMBL1215 9874 67 None -20 15 Human 5.5 pEC50 = 5.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
DB00388 9874 67 None -20 15 Human 5.5 pEC50 = 5.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
44574134 185283 0 None 91 3 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 269 2 0 4 3.0 Fc1ccc(-c2ncco2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL466634 185283 0 None 91 3 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 269 2 0 4 3.0 Fc1ccc(-c2ncco2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
44574077 185539 0 None - 1 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 267 2 0 4 3.3 c1ccc([C@@H]2Cc3nccn3C2)c(-c2nccs2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL468710 185539 0 None - 1 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 267 2 0 4 3.3 c1ccc([C@@H]2Cc3nccn3C2)c(-c2nccs2)c1 10.1016/j.bmcl.2009.03.166
44574136 195820 0 None - 1 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 1 3 2.8 Fc1ccc(-c2ccn[nH]2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL509350 195820 0 None - 1 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 1 3 2.8 Fc1ccc(-c2ccn[nH]2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
44449725 102965 0 None 208 3 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 264 2 2 2 3.2 Cc1n[nH]cc1-c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL260720 102965 0 None 208 3 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 264 2 2 2 3.2 Cc1n[nH]cc1-c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44269124 35591 1 None 23 3 Human 8.5 pEC50 = 8.5 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(02)00753-9
CHEMBL13789 35591 1 None 23 3 Human 8.5 pEC50 = 8.5 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(02)00753-9
44269124 35591 1 None 23 3 Human 8.5 pEC50 = 8.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(01)00764-8
CHEMBL13789 35591 1 None 23 3 Human 8.5 pEC50 = 8.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(01)00764-8
10060965 42008 1 None 39 3 Human 8.5 pEC50 = 8.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 256 4 1 4 2.6 Cc1ccoc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
CHEMBL143562 42008 1 None 39 3 Human 8.5 pEC50 = 8.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 256 4 1 4 2.6 Cc1ccoc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
9816515 69752 0 None 5 3 Human 8.5 pEC50 = 8.5 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1ccc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(03)00050-7
CHEMBL17856 69752 0 None 5 3 Human 8.5 pEC50 = 8.5 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1ccc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(03)00050-7
44329797 114883 0 None 67 3 Human 8.5 pEC50 = 8.5 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 261 5 2 5 1.7 CC(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL319553 114883 0 None 67 3 Human 8.5 pEC50 = 8.5 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 261 5 2 5 1.7 CC(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
10244367 56817 0 None - 1 Human 8.5 pEC50 = 8.5 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 6 2 5 1.9 CC/C(=N\OC)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL156950 56817 0 None - 1 Human 8.5 pEC50 = 8.5 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 6 2 5 1.9 CC/C(=N\OC)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
11000184 19824 0 None 4 5 Human 8.5 pEC50 = 8.5 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1190038 19824 0 None 4 5 Human 8.5 pEC50 = 8.5 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540035 19824 0 None 4 5 Human 8.5 pEC50 = 8.5 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
44343247 117412 0 None 15 3 Human 8.4 pEC50 = 8.4 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 258 6 3 3 2.2 CCCNC(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
CHEMBL325745 117412 0 None 15 3 Human 8.4 pEC50 = 8.4 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 258 6 3 3 2.2 CCCNC(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
15959112 210311 0 None -1 2 Rat 5.5 pEC50 = 5.5 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 280 2 1 5 2.7 Oc1nnc(Cc2ccc3c(c2)OCO3)c2ccccc12 10.1016/j.bmcl.2006.02.003
CHEMBL66433 210311 0 None -1 2 Rat 5.5 pEC50 = 5.5 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 280 2 1 5 2.7 Oc1nnc(Cc2ccc3c(c2)OCO3)c2ccccc12 10.1016/j.bmcl.2006.02.003
11264016 106422 2 None - 1 Human 4.5 pEC50 = 4.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 193 2 1 3 1.1 COc1ccc(OC)c2c1CC(N)C2 10.1021/jm00144a012
CHEMBL284307 106422 2 None - 1 Human 4.5 pEC50 = 4.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 193 2 1 3 1.1 COc1ccc(OC)c2c1CC(N)C2 10.1021/jm00144a012
44281507 106703 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 233 2 1 3 2.4 COc1ccc(OC)c2c1C1CCC2[C@@H](N)C1 10.1021/jm00144a012
CHEMBL286226 106703 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 233 2 1 3 2.4 COc1ccc(OC)c2c1C1CCC2[C@@H](N)C1 10.1021/jm00144a012
44280965 106759 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 233 2 1 3 2.4 COc1ccc(OC)c2c1C1CCC2[C@H](N)C1 10.1021/jm00144a012
CHEMBL286609 106759 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 233 2 1 3 2.4 COc1ccc(OC)c2c1C1CCC2[C@H](N)C1 10.1021/jm00144a012
10804826 30387 2 None -1 2 Rat 4.5 pEC50 = 4.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL133451 30387 2 None -1 2 Rat 4.5 pEC50 = 4.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
44593557 190697 11 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2009.03.166
CHEMBL481322 190697 11 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2009.03.166
44593557 190697 11 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL481322 190697 11 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
9816986 170918 0 None 21 3 Human 7.5 pEC50 = 7.5 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL421011 170918 0 None 21 3 Human 7.5 pEC50 = 7.5 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
9816986 170918 0 None 21 3 Human 7.5 pEC50 = 7.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00764-8
CHEMBL421011 170918 0 None 21 3 Human 7.5 pEC50 = 7.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00764-8
9816986 170918 0 None 21 3 Human 7.5 pEC50 = 7.5 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL421011 170918 0 None 21 3 Human 7.5 pEC50 = 7.5 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44593577 185243 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.7 c1ccc(C2CCc3nc[nH]c3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL466296 185243 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.7 c1ccc(C2CCc3nc[nH]c3C2)cc1 10.1016/j.bmcl.2009.03.162
481 9667 7 None 8 2 Human 6.5 pEC50 = 6.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1016/s0960-894x(01)00764-8
9838763 9667 7 None 8 2 Human 6.5 pEC50 = 6.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1016/s0960-894x(01)00764-8
CHEMBL72958 9667 7 None 8 2 Human 6.5 pEC50 = 6.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1016/s0960-894x(01)00764-8
22493344 105438 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 323 5 2 5 2.5 FC(F)(F)Cn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL277361 105438 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 323 5 2 5 2.5 FC(F)(F)Cn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
44449277 161962 2 None -1 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 1 2 2.5 COc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL402388 161962 2 None -1 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 1 2 2.5 COc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44449305 162389 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL404566 162389 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44571889 190808 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 264 3 1 3 2.7 c1cc(Cn2cccn2)c2c(c1)[C@H](c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.10.066
CHEMBL482148 190808 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 264 3 1 3 2.7 c1cc(Cn2cccn2)c2c(c1)[C@H](c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.10.066
44449337 161895 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 284 2 2 2 3.5 Clc1ccc2c(c1-c1ccn[nH]1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL402003 161895 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 284 2 2 2 3.5 Clc1ccc2c(c1-c1ccn[nH]1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
22493272 51529 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1nc(-c2ccccc2NCC2=NCCN2)co1 10.1016/s0960-894x(01)00822-8
CHEMBL152154 51529 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1nc(-c2ccccc2NCC2=NCCN2)co1 10.1016/s0960-894x(01)00822-8
44574133 195155 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 269 2 0 4 3.0 Fc1ccc(C2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL501404 195155 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 269 2 0 4 3.0 Fc1ccc(C2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
122184835 129319 0 None 3 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 420 10 5 7 1.1 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(CO)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
CHEMBL3601310 129319 0 None 3 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 420 10 5 7 1.1 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(CO)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
44449249 101973 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 Cc1ccc2c(c1NS(C)(=O)=O)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL255938 101973 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 Cc1ccc2c(c1NS(C)(=O)=O)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
10420352 175519 10 None -83 2 Human 5.5 pEC50 = 5.5 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
CHEMBL43711 175519 10 None -83 2 Human 5.5 pEC50 = 5.5 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
44280982 106540 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 205 2 1 3 1.3 COc1ccc(OC)c2c1CC1C2[C@@H]1N 10.1021/jm00144a012
CHEMBL285082 106540 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 205 2 1 3 1.3 COc1ccc(OC)c2c1CC1C2[C@@H]1N 10.1021/jm00144a012
124 9755 47 None -8 25 Human 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
2032 9755 47 None -8 25 Human 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
4636 9755 47 None -8 25 Human 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
CHEMBL762 9755 47 None -8 25 Human 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
DB00935 9755 47 None -8 25 Human 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
44574936 185409 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 218 1 0 2 2.9 Clc1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL467495 185409 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 218 1 0 2 2.9 Clc1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
44369646 126941 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 271 4 2 4 3.1 Cc1ccc(-c2ccccc2NCC2=NCCN2)s1 10.1016/s0960-894x(01)00822-8
CHEMBL351543 126941 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 271 4 2 4 3.1 Cc1ccc(-c2ccccc2NCC2=NCCN2)s1 10.1016/s0960-894x(01)00822-8
44571841 186099 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 228 3 1 2 2.6 COCc1cccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL473424 186099 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 228 3 1 2 2.6 COCc1cccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
44574988 196008 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 227 2 1 3 1.3 NC(=O)c1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL511576 196008 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 227 2 1 3 1.3 NC(=O)c1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
521 8186 69 None -501 5 Bovine 6.4 pEC50 = 6.4 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
5311068 8186 69 None -501 5 Bovine 6.4 pEC50 = 6.4 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
835 8186 69 None -501 5 Bovine 6.4 pEC50 = 6.4 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
CHEMBL778 8186 69 None -501 5 Bovine 6.4 pEC50 = 6.4 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
DB00633 8186 69 None -501 5 Bovine 6.4 pEC50 = 6.4 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
22493349 126465 0 None 2 2 Human 7.4 pEC50 = 7.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1cc(-c2ccccc2NCC2=NCCN2)on1 10.1016/s0960-894x(01)00822-8
CHEMBL347268 126465 0 None 2 2 Human 7.4 pEC50 = 7.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1cc(-c2ccccc2NCC2=NCCN2)on1 10.1016/s0960-894x(01)00822-8
17804479 102435 19 None -1 4 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.9 c1ccc2c(c1)CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL258007 102435 19 None -1 4 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.9 c1ccc2c(c1)CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
10083742 41380 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 256 4 1 5 1.5 Cn1nccc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
CHEMBL142967 41380 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 256 4 1 5 1.5 Cn1nccc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
44329739 119101 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 287 5 2 5 2.2 O=C(OC1CCCC1)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL329272 119101 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 287 5 2 5 2.2 O=C(OC1CCCC1)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
104452 209880 73 None -4 2 Rat 5.4 pEC50 = 5.4 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 270 2 1 3 3.6 Oc1nnc(Cc2ccc(Cl)cc2)c2ccccc12 10.1016/j.bmcl.2006.02.003
CHEMBL63976 209880 73 None -4 2 Rat 5.4 pEC50 = 5.4 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 270 2 1 3 3.6 Oc1nnc(Cc2ccc(Cl)cc2)c2ccccc12 10.1016/j.bmcl.2006.02.003
22493381 104858 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1cc(-c2ccccc2NCC2=NCCN2)cn1 10.1016/s0960-894x(03)00050-7
CHEMBL273312 104858 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1cc(-c2ccccc2NCC2=NCCN2)cn1 10.1016/s0960-894x(03)00050-7
22493231 214444 0 None -5 3 Human 6.4 pEC50 = 6.4 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 286 4 2 4 1.7 O=C(c1ccccc1NCC1=NCCN1)N1CCCCC1 10.1016/s0960-894x(01)00569-8
CHEMBL95333 214444 0 None -5 3 Human 6.4 pEC50 = 6.4 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 286 4 2 4 1.7 O=C(c1ccccc1NCC1=NCCN1)N1CCCCC1 10.1016/s0960-894x(01)00569-8
44574104 196268 0 None - 1 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 353 4 1 4 3.3 CS(=O)(=O)Nc1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL513871 196268 0 None - 1 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 353 4 1 4 3.3 CS(=O)(=O)Nc1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
9838376 175079 0 None 15 2 Human 8.4 pEC50 = 8.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 272 4 2 5 2.5 Cc1nc(-c2ccccc2NCC2=NCCN2)cs1 10.1016/s0960-894x(01)00822-8
CHEMBL434074 175079 0 None 15 2 Human 8.4 pEC50 = 8.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 272 4 2 5 2.5 Cc1nc(-c2ccccc2NCC2=NCCN2)cs1 10.1016/s0960-894x(01)00822-8
11108001 17644 2 None -2 5 Human 8.3 pEC50 = 8.3 Functional
Agonist potency at Alpha-1A adrenoceptors assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1A adrenoceptors assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL117248 17644 2 None -2 5 Human 8.3 pEC50 = 8.3 Functional
Agonist potency at Alpha-1A adrenoceptors assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1A adrenoceptors assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540542 17644 2 None -2 5 Human 8.3 pEC50 = 8.3 Functional
Agonist potency at Alpha-1A adrenoceptors assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1A adrenoceptors assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
9816460 126671 0 None 39 3 Human 8.3 pEC50 = 8.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 253 4 2 5 1.6 c1ccc(-c2cnccn2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL349082 126671 0 None 39 3 Human 8.3 pEC50 = 8.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 253 4 2 5 1.6 c1ccc(-c2cnccn2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
1028 7079 71 None 1 19 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
139148732 7079 71 None 1 19 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
479 7079 71 None 1 19 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
5816 7079 71 None 1 19 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
CHEMBL679 7079 71 None 1 19 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
DB00668 7079 71 None 1 19 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
11058166 211484 0 None 10 2 Human 7.4 pEC50 = 7.4 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74114 211484 0 None 10 2 Human 7.4 pEC50 = 7.4 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1 10.1021/jm000542r
44574986 195989 0 None 7 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 202 1 0 2 2.4 Fc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL511411 195989 0 None 7 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 202 1 0 2 2.4 Fc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
22493415 56747 0 None -1 2 Human 7.4 pEC50 = 7.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 268 4 3 6 1.1 Nc1nccc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(01)00822-8
CHEMBL156893 56747 0 None -1 2 Human 7.4 pEC50 = 7.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 268 4 3 6 1.1 Nc1nccc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(01)00822-8
44449686 102859 0 None 7 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 267 2 1 3 3.6 c1cc(-c2nccs2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
CHEMBL260116 102859 0 None 7 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 267 2 1 3 3.6 c1cc(-c2nccs2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
25066019 102187 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1c(Cl)ccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL256982 102187 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1c(Cl)ccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
25066019 102187 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1c(Cl)ccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2009.03.162
CHEMBL256982 102187 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1c(Cl)ccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2009.03.162
25066019 102187 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1c(Cl)ccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL256982 102187 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1c(Cl)ccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
11079593 210894 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70326 210894 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
15959119 83831 0 None -1 2 Rat 5.4 pEC50 = 5.4 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 310 4 0 3 3.8 C=CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmcl.2006.02.003
CHEMBL207277 83831 0 None -1 2 Rat 5.4 pEC50 = 5.4 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 310 4 0 3 3.8 C=CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmcl.2006.02.003
44369647 53981 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnoc2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL154346 53981 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnoc2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
44449248 101972 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 248 2 1 2 3.2 COc1c(Cl)ccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL255937 101972 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 248 2 1 2 3.2 COc1c(Cl)ccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44449338 102466 1 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 1 1 2.5 c1ccc2c(c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL258178 102466 1 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 1 1 2.5 c1ccc2c(c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44449338 102466 1 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 1 1 2.5 c1ccc2c(c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2009.03.162
CHEMBL258178 102466 1 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 1 1 2.5 c1ccc2c(c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2009.03.162
44593580 185321 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 242 3 1 2 2.8 COCc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
CHEMBL466876 185321 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 242 3 1 2 2.8 COCc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
11747739 20007 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1191324 20007 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL542402 20007 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
44574103 179367 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 2 0 4 2.4 c1ccc(-n2cccn2)c([C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL448908 179367 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 2 0 4 2.4 c1ccc(-n2cccn2)c([C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
44574137 195869 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 0 4 2.5 Fc1ccc(-n2cccn2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL510023 195869 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 0 4 2.5 Fc1ccc(-n2cccn2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
11108001 17644 2 None -2 5 Human 8.3 pEC50 = 8.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL117248 17644 2 None -2 5 Human 8.3 pEC50 = 8.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL540542 17644 2 None -2 5 Human 8.3 pEC50 = 8.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
44362149 40706 0 None 2 3 Human 8.3 pEC50 = 8.3 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 259 4 1 5 2.2 c1ccc(-c2ccns2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL142387 40706 0 None 2 3 Human 8.3 pEC50 = 8.3 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 259 4 1 5 2.2 c1ccc(-c2ccns2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
44362150 126168 0 None 15 2 Human 8.3 pEC50 = 8.3 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 2 4 1.5 c1ccc(-c2cc[nH]n2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL344551 126168 0 None 15 2 Human 8.3 pEC50 = 8.3 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 2 4 1.5 c1ccc(-c2cc[nH]n2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
10859076 20454 0 None 5 4 Human 8.3 pEC50 = 8.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1194763 20454 0 None 5 4 Human 8.3 pEC50 = 8.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL553276 20454 0 None 5 4 Human 8.3 pEC50 = 8.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
6604803 123296 2 None 1 4 Rat 8.3 pEC50 = 8.3 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL336161 123296 2 None 1 4 Rat 8.3 pEC50 = 8.3 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
6604803 123296 2 None -1 4 Human 8.3 pEC50 = 8.3 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL336161 123296 2 None -1 4 Human 8.3 pEC50 = 8.3 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
4038180 6992 14 None 1 6 Rat 8.2 pEC50 = 8.2 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
480 6992 14 None 1 6 Rat 8.2 pEC50 = 8.2 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
CHEMBL109783 6992 14 None 1 6 Rat 8.2 pEC50 = 8.2 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
9816461 17491 7 None 60 2 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL117094 17491 7 None 60 2 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL544290 17491 7 None 60 2 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
44343245 117392 2 None - 1 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 256 4 2 3 3.0 c1ccc(N2CCCCC2)c(NCc2c[nH]cn2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL325648 117392 2 None - 1 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 256 4 2 3 3.0 c1ccc(N2CCCCC2)c(NCc2c[nH]cn2)c1 10.1016/s0960-894x(02)00753-9
44343275 117551 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 240 4 2 4 2.7 c1ccc(-c2cnco2)c(NCc2c[nH]cn2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL326067 117551 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 240 4 2 4 2.7 c1ccc(-c2cnco2)c(NCc2c[nH]cn2)c1 10.1016/s0960-894x(02)00753-9
22493233 176066 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 268 4 2 4 2.4 Cc1ccc(-c2ccccc2NCC2=NCCN2)n1C 10.1016/s0960-894x(03)00050-7
CHEMBL441412 176066 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 268 4 2 4 2.4 Cc1ccc(-c2ccccc2NCC2=NCCN2)n1C 10.1016/s0960-894x(03)00050-7
9903313 179457 0 None 5 3 Human 7.3 pEC50 = 7.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 5 2 4 1.2 CCN(C)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL450018 179457 0 None 5 3 Human 7.3 pEC50 = 7.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 5 2 4 1.2 CCN(C)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
22493379 214905 0 None 2 3 Human 7.3 pEC50 = 7.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 5 3 4 1.2 CC(C)NC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL98016 214905 0 None 2 3 Human 7.3 pEC50 = 7.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 5 3 4 1.2 CC(C)NC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
22493411 174809 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 6 3 4 1.6 CCC(C)NC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL432192 174809 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 6 3 4 1.6 CCC(C)NC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44329701 214457 0 None -6 3 Human 6.3 pEC50 = 6.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 6 2 5 1.9 CC(C)COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL95398 214457 0 None -6 3 Human 6.3 pEC50 = 6.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 6 2 5 1.9 CC(C)COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44574044 185210 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 209 1 0 3 2.1 N#Cc1ccccc1[C@@H]1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
CHEMBL466046 185210 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 209 1 0 3 2.1 N#Cc1ccccc1[C@@H]1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
44219719 185457 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 209 1 0 3 2.1 N#Cc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL467916 185457 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 209 1 0 3 2.1 N#Cc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
10399043 126940 0 None -2 3 Human 7.3 pEC50 = 7.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 232 5 2 5 1.1 CO/N=C/c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL351542 126940 0 None -2 3 Human 7.3 pEC50 = 7.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 232 5 2 5 1.1 CO/N=C/c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
10916464 210932 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70563 210932 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1 10.1021/jm000542r
44574875 195422 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 232 1 1 1 3.3 Clc1cccc(C2CCc3nc[nH]c3C2)c1 10.1016/j.bmcl.2009.03.162
CHEMBL503269 195422 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 232 1 1 1 3.3 Clc1cccc(C2CCc3nc[nH]c3C2)c1 10.1016/j.bmcl.2009.03.162
44449245 102188 0 None 6 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 2 2 2 2.9 c1cc(-c2ccn[nH]2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
CHEMBL256983 102188 0 None 6 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 2 2 2 2.9 c1cc(-c2ccn[nH]2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
22493347 126390 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 6 2 5 1.9 CCO/N=C(\C)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL346465 126390 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 6 2 5 1.9 CCO/N=C(\C)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
44281057 106451 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 221 2 1 3 1.9 COc1ccc(OC)c2c1CCCC(N)C2 10.1021/jm00144a012
CHEMBL284486 106451 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 221 2 1 3 1.9 COc1ccc(OC)c2c1CCCC(N)C2 10.1021/jm00144a012
9816461 17491 7 None 60 2 Human 7.3 pEC50 = 7.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL117094 17491 7 None 60 2 Human 7.3 pEC50 = 7.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL544290 17491 7 None 60 2 Human 7.3 pEC50 = 7.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
44574938 195693 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 0 3 2.2 COc1cccc(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.162
CHEMBL507755 195693 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 0 3 2.2 COc1cccc(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.162
44571888 190696 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 246 3 1 2 2.8 COCc1cc(F)cc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL481321 190696 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 246 3 1 2 2.8 COCc1cc(F)cc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
44343244 16724 0 None 5 2 Human 8.2 pEC50 = 8.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 241 3 3 4 2.0 Oc1ccc2cccc(NCC3=NCCN3)c2c1 10.1016/s0960-894x(02)00753-9
CHEMBL114669 16724 0 None 5 2 Human 8.2 pEC50 = 8.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 241 3 3 4 2.0 Oc1ccc2cccc(NCC3=NCCN3)c2c1 10.1016/s0960-894x(02)00753-9
44343236 118141 0 None 15 3 Human 8.2 pEC50 = 8.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 243 4 1 5 1.7 c1ccc(-c2ccno2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL327005 118141 0 None 15 3 Human 8.2 pEC50 = 8.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 243 4 1 5 1.7 c1ccc(-c2ccno2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
9903932 66284 0 None 501 2 Human 8.2 pEC50 = 8.2 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 284 5 2 6 1.9 CC(C)n1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17151 66284 0 None 501 2 Human 8.2 pEC50 = 8.2 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 284 5 2 6 1.9 CC(C)n1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
44271932 71985 0 None 6 3 Human 8.2 pEC50 = 8.2 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1ccnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL18256 71985 0 None 6 3 Human 8.2 pEC50 = 8.2 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1ccnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
22493392 53929 0 None 3 3 Human 8.2 pEC50 = 8.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 252 4 2 4 2.2 c1ccc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
CHEMBL154298 53929 0 None 3 3 Human 8.2 pEC50 = 8.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 252 4 2 4 2.2 c1ccc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
9838192 118089 18 None -2 3 Rabbit 7.2 pEC50 = 7.2 Functional
Agonist activity at rabbit urethra adrenergic alpha1A receptorAgonist activity at rabbit urethra adrenergic alpha1A receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1016/j.bmc.2008.02.091
CHEMBL326702 118089 18 None -2 3 Rabbit 7.2 pEC50 = 7.2 Functional
Agonist activity at rabbit urethra adrenergic alpha1A receptorAgonist activity at rabbit urethra adrenergic alpha1A receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1016/j.bmc.2008.02.091
122184772 129299 0 None -1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 424 9 4 6 2.3 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(Cl)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
CHEMBL3601203 129299 0 None -1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 424 9 4 6 2.3 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(Cl)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
44574132 185368 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 280 2 0 4 2.8 Fc1cccc(-c2cncnc2)c1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
CHEMBL467259 185368 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 280 2 0 4 2.8 Fc1cccc(-c2cncnc2)c1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
44571842 186051 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 242 4 1 2 3.0 CCOCc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL473043 186051 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 242 4 1 2 3.0 CCOCc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
44571887 195195 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 246 3 1 2 2.8 COCc1c(F)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL502078 195195 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 246 3 1 2 2.8 COCc1c(F)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
44343243 16617 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 239 3 3 3 2.9 Oc1ccc2cccc(NCc3c[nH]cn3)c2c1 10.1016/s0960-894x(02)00753-9
CHEMBL114054 16617 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 239 3 3 3 2.9 Oc1ccc2cccc(NCc3c[nH]cn3)c2c1 10.1016/s0960-894x(02)00753-9
44343173 17793 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 272 6 2 3 2.5 CCN(CC)C(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
CHEMBL117482 17793 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 272 6 2 3 2.5 CCN(CC)C(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
9838294 66447 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 269 5 2 5 2.0 CCn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17221 66447 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 269 5 2 5 2.0 CCn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
11079 9510 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00569-8
3369 9510 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00569-8
4436 9510 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00569-8
5509 9510 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00569-8
CHEMBL761 9510 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00569-8
DB06711 9510 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00569-8
11079 9510 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00822-8
3369 9510 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00822-8
4436 9510 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00822-8
5509 9510 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00822-8
CHEMBL761 9510 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00822-8
DB06711 9510 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00822-8
25154770 190431 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 246 3 1 2 2.8 COCc1ccc(F)c2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL480272 190431 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 246 3 1 2 2.8 COCc1ccc(F)c2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
22493325 126540 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 257 4 2 6 1.5 Cc1noc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(01)00822-8
CHEMBL347920 126540 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 257 4 2 6 1.5 Cc1noc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(01)00822-8
22493287 126871 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 320 4 2 4 3.2 FC(F)(F)c1cccnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL350906 126871 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 320 4 2 4 3.2 FC(F)(F)c1cccnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
11097789 109775 1 None -1 5 Human 8.1 pEC50 = 8.1 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL306792 109775 1 None -1 5 Human 8.1 pEC50 = 8.1 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
11140345 210950 0 None 2 5 Human 8.1 pEC50 = 8.1 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70692 210950 0 None 2 5 Human 8.1 pEC50 = 8.1 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
9795167 114271 0 None 6 3 Human 8.1 pEC50 = 8.1 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 260 6 3 4 1.2 CCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL318544 114271 0 None 6 3 Human 8.1 pEC50 = 8.1 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 260 6 3 4 1.2 CCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
44352155 123586 0 None 7 5 Human 8.1 pEC50 = 8.1 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 251 4 2 3 2.8 c1ccc(-c2ccccc2NCC2=NCCN2)cc1 10.1016/s0960-894x(01)00764-8
CHEMBL337862 123586 0 None 7 5 Human 8.1 pEC50 = 8.1 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 251 4 2 3 2.8 c1ccc(-c2ccccc2NCC2=NCCN2)cc1 10.1016/s0960-894x(01)00764-8
9795167 114271 0 None 6 3 Human 8.1 pEC50 = 8.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 6 3 4 1.2 CCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL318544 114271 0 None 6 3 Human 8.1 pEC50 = 8.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 6 3 4 1.2 CCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44329703 214941 0 None 7 2 Human 8.1 pEC50 = 8.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 4 2 5 2.1 CC(C)(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL98243 214941 0 None 7 2 Human 8.1 pEC50 = 8.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 4 2 5 2.1 CC(C)(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44449304 102380 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 277 3 2 3 1.9 CS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257800 102380 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 277 3 2 3 1.9 CS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
12764879 185202 0 None 100 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 0 2 2.2 c1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL465963 185202 0 None 100 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 0 2 2.2 c1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
172745 106899 7 None -234 2 Human 4.2 pEC50 = 4.2 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
CHEMBL287587 106899 7 None -234 2 Human 4.2 pEC50 = 4.2 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
1753 9282 28 None 2 4 Human 6.1 pEC50 = 6.1 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1021/jm00144a012
483 9282 28 None 2 4 Human 6.1 pEC50 = 6.1 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1021/jm00144a012
6082 9282 28 None 2 4 Human 6.1 pEC50 = 6.1 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1021/jm00144a012
CHEMBL524 9282 28 None 2 4 Human 6.1 pEC50 = 6.1 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1021/jm00144a012
DB00723 9282 28 None 2 4 Human 6.1 pEC50 = 6.1 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1021/jm00144a012
12764880 185325 1 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 0 2 2.6 c1ccc(C2CCc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL466914 185325 1 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 0 2 2.6 c1ccc(C2CCc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
22493359 128466 0 None -1 2 Human 6.1 pEC50 = 6.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 257 4 2 6 1.5 Cc1nc(-c2ccccc2NCC2=NCCN2)no1 10.1016/s0960-894x(01)00822-8
CHEMBL358685 128466 0 None -1 2 Human 6.1 pEC50 = 6.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 257 4 2 6 1.5 Cc1nc(-c2ccccc2NCC2=NCCN2)no1 10.1016/s0960-894x(01)00822-8
12764879 185202 0 None 100 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 0 2 2.2 c1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL465963 185202 0 None 100 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 0 2 2.2 c1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
44593580 185321 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 242 3 1 2 2.8 COCc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
CHEMBL466876 185321 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 242 3 1 2 2.8 COCc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
44449303 102379 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 284 2 2 2 3.5 Clc1ccc2c(c1-c1cn[nH]c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257799 102379 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 284 2 2 2 3.5 Clc1ccc2c(c1-c1cn[nH]c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44449303 102379 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 284 2 2 2 3.5 Clc1ccc2c(c1-c1cn[nH]c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL257799 102379 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 284 2 2 2 3.5 Clc1ccc2c(c1-c1cn[nH]c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
9840212 68895 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 324 5 2 6 1.9 FC(F)(F)Cn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17764 68895 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 324 5 2 6 1.9 FC(F)(F)Cn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
44329133 214480 0 None -6 3 Human 7.1 pEC50 = 7.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 6 3 4 1.5 CC(C)CNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL95565 214480 0 None -6 3 Human 7.1 pEC50 = 7.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 6 3 4 1.5 CC(C)CNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
22493408 67973 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 256 4 3 5 1.2 Cc1n[nH]c(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(03)00050-7
CHEMBL17657 67973 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 256 4 3 5 1.2 Cc1n[nH]c(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(03)00050-7
541604 172118 10 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 201 3 4 4 0.5 CNCC(O)c1cc(O)c(O)cc1F 10.1021/jm00118a019
CHEMBL42359 172118 10 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 201 3 4 4 0.5 CNCC(O)c1cc(O)c(O)cc1F 10.1021/jm00118a019
44574079 196088 0 None 8 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 0 3 3.3 c1ccc([C@@H]2Cc3nccn3C2)c(-c2ccncc2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL512289 196088 0 None 8 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 0 3 3.3 c1ccc([C@@H]2Cc3nccn3C2)c(-c2ccncc2)c1 10.1016/j.bmcl.2009.03.166
11522042 210458 1 None -1 2 Rat 6.1 pEC50 = 6.1 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 284 2 0 3 3.2 Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmcl.2006.02.003
CHEMBL67457 210458 1 None -1 2 Rat 6.1 pEC50 = 6.1 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 284 2 0 3 3.2 Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmcl.2006.02.003
45381933 129317 0 None -12 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 458 9 4 6 2.7 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(C(F)(F)F)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
CHEMBL3601308 129317 0 None -12 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 458 9 4 6 2.7 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(C(F)(F)F)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
44574989 196009 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 3 0 3 2.4 COCc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL511577 196009 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 3 0 3 2.4 COCc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
12764879 185202 0 None 100 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 0 2 2.2 c1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL465963 185202 0 None 100 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 0 2 2.2 c1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
44571840 194993 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 276 3 1 3 2.0 CS(=O)(=O)Cc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL499180 194993 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 276 3 1 3 2.0 CS(=O)(=O)Cc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
45381852 129300 0 None -60 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 418 10 4 6 2.2 CCc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
CHEMBL3601204 129300 0 None -60 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 418 10 4 6 2.2 CCc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
22493254 175867 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 6 2 5 1.9 CC/C(=N/OC)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL439822 175867 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 6 2 5 1.9 CC/C(=N/OC)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
44571845 195913 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 289 3 1 2 2.9 FC1(F)CN(Cc2cccc3c2CCC3c2ncc[nH]2)C1 10.1016/j.bmcl.2008.10.066
CHEMBL510613 195913 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 289 3 1 2 2.9 FC1(F)CN(Cc2cccc3c2CCC3c2ncc[nH]2)C1 10.1016/j.bmcl.2008.10.066
2803 7742 58 None -6 14 Bovine 7.1 pEC50 = 7.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
516 7742 58 None -6 14 Bovine 7.1 pEC50 = 7.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
704 7742 58 None -6 14 Bovine 7.1 pEC50 = 7.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
CHEMBL134 7742 58 None -6 14 Bovine 7.1 pEC50 = 7.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
DB00575 7742 58 None -6 14 Bovine 7.1 pEC50 = 7.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
2146 9874 67 None 1 15 Bovine 8.1 pEC50 = 8.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
485 9874 67 None 1 15 Bovine 8.1 pEC50 = 8.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
6041 9874 67 None 1 15 Bovine 8.1 pEC50 = 8.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
CHEMBL1215 9874 67 None 1 15 Bovine 8.1 pEC50 = 8.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
DB00388 9874 67 None 1 15 Bovine 8.1 pEC50 = 8.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
44574080 195725 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 264 2 0 4 2.6 Cn1cc(-c2ccccc2[C@@H]2Cc3nccn3C2)cn1 10.1016/j.bmcl.2009.03.166
CHEMBL508084 195725 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 264 2 0 4 2.6 Cn1cc(-c2ccccc2[C@@H]2Cc3nccn3C2)cn1 10.1016/j.bmcl.2009.03.166
9838192 118089 18 None 2 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1016/j.bmcl.2008.03.070
CHEMBL326702 118089 18 None 2 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1016/j.bmcl.2008.03.070
44571938 186852 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 300 3 1 3 3.0 Fc1ccn(Cc2c(F)ccc3c2CC[C@H]3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
CHEMBL474796 186852 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 300 3 1 3 3.0 Fc1ccn(Cc2c(F)ccc3c2CC[C@H]3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
1960 9632 67 None -2 19 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jmedchem.5b00638
439260 9632 67 None -2 19 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jmedchem.5b00638
505 9632 67 None -2 19 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jmedchem.5b00638
CHEMBL1437 9632 67 None -2 19 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jmedchem.5b00638
DB00368 9632 67 None -2 19 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jmedchem.5b00638
44571890 198755 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 265 3 1 4 2.1 c1cc(Cn2ccnn2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.10.066
CHEMBL520117 198755 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 265 3 1 4 2.1 c1cc(Cn2ccnn2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.10.066
44574076 179240 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 251 2 0 4 2.9 c1ccc([C@H]2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL448147 179240 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 251 2 0 4 2.9 c1ccc([C@H]2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
44574985 195186 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 0 3 2.2 COc1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL501920 195186 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 0 3 2.2 COc1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
123562321 147289 0 None 1 3 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 443 12 3 6 2.9 COc1ccc(F)cc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3810110 147289 0 None 1 3 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 443 12 3 6 2.9 COc1ccc(F)cc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
129211 10521 78 None -1 14 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2020.112616
2562 10521 78 None -1 14 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2020.112616
488 10521 78 None -1 14 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2020.112616
CHEMBL836 10521 78 None -1 14 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2020.112616
DB00706 10521 78 None -1 14 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2020.112616
499 10849 18 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity against human recombinant alpha1 receptor expressed in CHOK1 cells assessed as reduction in epinephrine-induced increase in intracellular Ca2+ levelsAntagonist activity against human recombinant alpha1 receptor expressed in CHOK1 cells assessed as reduction in epinephrine-induced increase in intracellular Ca2+ levels
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.ejmech.2014.12.045
5685 10849 18 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity against human recombinant alpha1 receptor expressed in CHOK1 cells assessed as reduction in epinephrine-induced increase in intracellular Ca2+ levelsAntagonist activity against human recombinant alpha1 receptor expressed in CHOK1 cells assessed as reduction in epinephrine-induced increase in intracellular Ca2+ levels
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.ejmech.2014.12.045
CHEMBL25554 10849 18 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity against human recombinant alpha1 receptor expressed in CHOK1 cells assessed as reduction in epinephrine-induced increase in intracellular Ca2+ levelsAntagonist activity against human recombinant alpha1 receptor expressed in CHOK1 cells assessed as reduction in epinephrine-induced increase in intracellular Ca2+ levels
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.ejmech.2014.12.045
499 10849 18 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human recombinant alpha1A adrenoceptor assessed as inhibition of epinephrine-induced intracellular Ca2+ releaseAntagonist activity at human recombinant alpha1A adrenoceptor assessed as inhibition of epinephrine-induced intracellular Ca2+ release
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm401895u
5685 10849 18 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human recombinant alpha1A adrenoceptor assessed as inhibition of epinephrine-induced intracellular Ca2+ releaseAntagonist activity at human recombinant alpha1A adrenoceptor assessed as inhibition of epinephrine-induced intracellular Ca2+ release
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm401895u
CHEMBL25554 10849 18 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human recombinant alpha1A adrenoceptor assessed as inhibition of epinephrine-induced intracellular Ca2+ releaseAntagonist activity at human recombinant alpha1A adrenoceptor assessed as inhibition of epinephrine-induced intracellular Ca2+ release
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm401895u
123854385 147294 0 None 72 3 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 527 13 3 6 4.3 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3810145 147294 0 None 72 3 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 527 13 3 6 4.3 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
4151 10379 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
493 10379 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
5312125 10379 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
CHEMBL24778 10379 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
DB06207 10379 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
4151 10379 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.5b02023
493 10379 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.5b02023
5312125 10379 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.5b02023
CHEMBL24778 10379 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.5b02023
DB06207 10379 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.5b02023
9913616 147161 6 None 8 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 493 13 3 6 3.7 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3808572 147161 6 None 8 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 493 13 3 6 3.7 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
10160408 147218 0 None 1 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 439 13 3 6 3.1 CCOc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809248 147218 0 None 1 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 439 13 3 6 3.1 CCOc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
86344174 147246 0 None 251 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 507 13 3 6 4.0 Cc1ccc(OCC(F)(F)F)c(OCCN[C@H](C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809490 147246 0 None 251 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 507 13 3 6 4.0 Cc1ccc(OCC(F)(F)F)c(OCCN[C@H](C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
2389 10104 118 None -13 29 Human 8.0 pIC50 = 8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2018.01.038
5073 10104 118 None -13 29 Human 8.0 pIC50 = 8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2018.01.038
96 10104 118 None -13 29 Human 8.0 pIC50 = 8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2018.01.038
CHEMBL85 10104 118 None -13 29 Human 8.0 pIC50 = 8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2018.01.038
DB00734 10104 118 None -13 29 Human 8.0 pIC50 = 8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2018.01.038
2389 10104 118 None -13 29 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.ejmech.2017.12.099
5073 10104 118 None -13 29 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.ejmech.2017.12.099
96 10104 118 None -13 29 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.ejmech.2017.12.099
CHEMBL85 10104 118 None -13 29 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.ejmech.2017.12.099
DB00734 10104 118 None -13 29 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.ejmech.2017.12.099
145946682 174353 0 None -10 3 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 444 7 0 3 5.6 Fc1ccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
CHEMBL4225239 174353 0 None -10 3 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 444 7 0 3 5.6 Fc1ccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
CHEMBL4300633 174353 0 None -10 3 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 444 7 0 3 5.6 Fc1ccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
145964299 170911 0 None -1 6 Human 8.0 pIC50 = 8.0 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 426 8 1 6 3.8 CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccn1 10.1016/j.bmcl.2018.01.038
CHEMBL4210030 170911 0 None -1 6 Human 8.0 pIC50 = 8.0 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 426 8 1 6 3.8 CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccn1 10.1016/j.bmcl.2018.01.038
76071739 149575 0 None -25 3 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)C[C@H]1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3892879 149575 0 None -25 3 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)C[C@H]1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
145946986 174384 0 None -4 3 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 460 7 0 3 6.2 Clc1cccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)c1 10.1016/j.bmcl.2018.03.070
CHEMBL4227241 174384 0 None -4 3 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 460 7 0 3 6.2 Clc1cccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)c1 10.1016/j.bmcl.2018.03.070
CHEMBL4300995 174384 0 None -4 3 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 460 7 0 3 6.2 Clc1cccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)c1 10.1016/j.bmcl.2018.03.070
145990794 173579 0 None -19 6 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 437 6 0 5 3.8 O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1 10.1016/j.ejmech.2017.12.099
CHEMBL4284346 173579 0 None -19 6 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 437 6 0 5 3.8 O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1 10.1016/j.ejmech.2017.12.099
131978695 157640 0 None 5 3 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 440 5 1 4 5.4 COc1ccc2[nH]c3c(c2c1)CC1c2cc(OCc4ccccc4)c(OC)cc2CCN1C3 10.1021/acs.jmedchem.6b01217
CHEMBL3957222 157640 0 None 5 3 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 440 5 1 4 5.4 COc1ccc2[nH]c3c(c2c1)CC1c2cc(OCc4ccccc4)c(OC)cc2CCN1C3 10.1021/acs.jmedchem.6b01217
134138882 154506 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 318 0 1 3 3.6 c1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2C1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3932187 154506 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 318 0 1 3 3.6 c1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2C1C3)OCO4 10.1021/acs.jmedchem.6b01217
44575544 180777 0 None -3 4 Human 7.9 pIC50 = 7.9 Functional
Inhibition of adrenergic receptor 1a expressed in HEK293 cells assessed as inhibition of calcium influx after 10 mins by Fluo-4-AM based fluorimetryInhibition of adrenergic receptor 1a expressed in HEK293 cells assessed as inhibition of calcium influx after 10 mins by Fluo-4-AM based fluorimetry
ChEMBL 794 5 5 13 3.0 CC(C)CC(=O)O[C@H]1/C=C/C=C/C(=O)O[C@H]2[C@@H](C)C[C@@H]3[C@]2(O)[C@H](O)[C@@]2(CO)O[C@H]2[C@H]2[C@H]4OC5(c6ccccc6)O[C@@H]([C@@H](C)[C@@]23O5)[C@@]4(O)[C@](C)(O)C[C@H]2CC[C@H]1[C@H]2C 10.1021/np3000359
CHEMBL454246 180777 0 None -3 4 Human 7.9 pIC50 = 7.9 Functional
Inhibition of adrenergic receptor 1a expressed in HEK293 cells assessed as inhibition of calcium influx after 10 mins by Fluo-4-AM based fluorimetryInhibition of adrenergic receptor 1a expressed in HEK293 cells assessed as inhibition of calcium influx after 10 mins by Fluo-4-AM based fluorimetry
ChEMBL 794 5 5 13 3.0 CC(C)CC(=O)O[C@H]1/C=C/C=C/C(=O)O[C@H]2[C@@H](C)C[C@@H]3[C@]2(O)[C@H](O)[C@@]2(CO)O[C@H]2[C@H]2[C@H]4OC5(c6ccccc6)O[C@@H]([C@@H](C)[C@@]23O5)[C@@]4(O)[C@](C)(O)C[C@H]2CC[C@H]1[C@H]2C 10.1021/np3000359
127044893 147186 0 None 2 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 411 11 3 5 2.4 Cc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3808878 147186 0 None 2 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 411 11 3 5 2.4 Cc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
134157118 160981 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 332 0 0 4 3.6 Cn1c2c(c3ccccc31)CC1c3cc4c(cc3CCN1C2)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3985901 160981 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 332 0 0 4 3.6 Cn1c2c(c3ccccc31)CC1c3cc4c(cc3CCN1C2)OCO4 10.1021/acs.jmedchem.6b01217
123141715 147313 0 None 2 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 459 12 3 6 3.4 COc1cc(Cl)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3810401 147313 0 None 2 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 459 12 3 6 3.4 COc1cc(Cl)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
44347716 23080 0 None -3 3 Rat 4.8 pIC50 = 4.8 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 590 27 4 8 6.3 COc1cccc(CNCCCCCCNCCSSCCNCCCCCCNCc2ccccc2OC)c1 10.1021/jm000995w
CHEMBL122621 23080 0 None -3 3 Rat 4.8 pIC50 = 4.8 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 590 27 4 8 6.3 COc1cccc(CNCCCCCCNCCSSCCNCCCCCCNCc2ccccc2OC)c1 10.1021/jm000995w
145966333 170839 0 None -134 6 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 424 8 1 6 3.6 CNC(=O)c1cc(OCCCCN2CCN(c3cccc4sccc34)CC2)ccn1 10.1016/j.bmcl.2018.01.038
CHEMBL4209188 170839 0 None -134 6 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 424 8 1 6 3.6 CNC(=O)c1cc(OCCCCN2CCN(c3cccc4sccc34)CC2)ccn1 10.1016/j.bmcl.2018.01.038
123986550 147176 0 None 223 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 521 14 3 6 4.2 CCc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3808717 147176 0 None 223 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 521 14 3 6 4.2 CCc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
134142282 152468 0 None 2 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3916182 152468 0 None 2 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
242 7258 124 None -120 32 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.ejmech.2017.12.099
34 7258 124 None -120 32 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.ejmech.2017.12.099
60795 7258 124 None -120 32 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.ejmech.2017.12.099
CHEMBL1112 7258 124 None -120 32 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.ejmech.2017.12.099
DB01238 7258 124 None -120 32 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.ejmech.2017.12.099
242 7258 124 None -120 32 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2018.01.038
34 7258 124 None -120 32 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2018.01.038
60795 7258 124 None -120 32 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2018.01.038
CHEMBL1112 7258 124 None -120 32 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2018.01.038
DB01238 7258 124 None -120 32 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2018.01.038
145983928 173191 0 None -48 6 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 435 6 0 5 3.6 O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1 10.1016/j.ejmech.2017.12.099
CHEMBL4277101 173191 0 None -48 6 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 435 6 0 5 3.6 O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1 10.1016/j.ejmech.2017.12.099
10820251 103397 0 None -208 3 Rat 5.7 pIC50 = 5.7 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CNCCCCCCNCCSSCCNCCCCCCNCc3ccccc3C(=O)N(C)CCCCCCN(C)c3nc(N)c4cc(OC)c(OC)cc4n3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL1203233 103397 0 None -208 3 Rat 5.7 pIC50 = 5.7 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CNCCCCCCNCCSSCCNCCCCCCNCc3ccccc3C(=O)N(C)CCCCCCN(C)c3nc(N)c4cc(OC)c(OC)cc4n3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL263434 103397 0 None -208 3 Rat 5.7 pIC50 = 5.7 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CNCCCCCCNCCSSCCNCCCCCCNCc3ccccc3C(=O)N(C)CCCCCCN(C)c3nc(N)c4cc(OC)c(OC)cc4n3)nc(N)c2cc1OC 10.1021/jm000995w
10606263 148329 0 None -81 3 Rat 5.7 pIC50 = 5.7 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1161 33 6 20 7.3 COc1cc2nc(N3CCN(C(=O)c4ccc(CNCCCCCCNCCSSCCNCCCCCCNCc5ccc(C(=O)N6CCN(c7nc(N)c8cc(OC)c(OC)cc8n7)CC6)cc5)cc4)CC3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL384790 148329 0 None -81 3 Rat 5.7 pIC50 = 5.7 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1161 33 6 20 7.3 COc1cc2nc(N3CCN(C(=O)c4ccc(CNCCCCCCNCCSSCCNCCCCCCNCc5ccc(C(=O)N6CCN(c7nc(N)c8cc(OC)c(OC)cc8n7)CC6)cc5)cc4)CC3)nc(N)c2cc1OC 10.1021/jm000995w
123472560 147272 0 None 616 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 507 13 3 6 4.0 Cc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809840 147272 0 None 616 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 507 13 3 6 4.0 Cc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
129211 10521 78 None -1 14 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/acs.jmedchem.6b01217
2562 10521 78 None -1 14 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/acs.jmedchem.6b01217
488 10521 78 None -1 14 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/acs.jmedchem.6b01217
CHEMBL836 10521 78 None -1 14 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/acs.jmedchem.6b01217
DB00706 10521 78 None -1 14 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/acs.jmedchem.6b01217
123415538 147155 0 None 8 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 491 11 3 5 3.6 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccc(F)cc1Br 10.1021/acs.jmedchem.5b02023
CHEMBL3808511 147155 0 None 8 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 491 11 3 5 3.6 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccc(F)cc1Br 10.1021/acs.jmedchem.5b02023
123667086 147177 0 None -8 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 573 13 3 6 3.8 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Br)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3808726 147177 0 None -8 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 573 13 3 6 3.8 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Br)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
127044912 147206 0 None -26 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 501 14 3 6 4.3 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccccc1OCc1ccccc1 10.1021/acs.jmedchem.5b02023
CHEMBL3809093 147206 0 None -26 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 501 14 3 6 4.3 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccccc1OCc1ccccc1 10.1021/acs.jmedchem.5b02023
117839022 147309 0 None 407 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 529 13 3 6 3.7 C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3810346 147309 0 None 407 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 529 13 3 6 3.7 C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
124018870 147189 0 None -7 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 445 12 3 6 2.3 COc1ccc(F)cc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3808896 147189 0 None -7 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 445 12 3 6 2.3 COc1ccc(F)cc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
123368349 147211 0 None 95 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 505 12 3 6 2.9 COc1cc(Br)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3809175 147211 0 None 95 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 505 12 3 6 2.9 COc1cc(Br)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
123387804 147199 0 None -52 3 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 423 12 3 5 3.3 CCc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3808999 147199 0 None -52 3 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 423 12 3 5 3.3 CCc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
156767236 189736 0 None 9 2 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 449 11 1 5 4.7 COc1ccccc1N1CCN(CCCCn2cc(CCCC(=O)O)c3ccccc32)CC1 10.1016/j.ejmech.2020.112616
CHEMBL4792905 189736 0 None 9 2 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 449 11 1 5 4.7 COc1ccccc1N1CCN(CCCCn2cc(CCCC(=O)O)c3ccccc32)CC1 10.1016/j.ejmech.2020.112616
134157566 160805 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1cccc2[nH]c3c(c12)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3984249 160805 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1cccc2[nH]c3c(c12)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
134137522 149876 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 336 0 1 3 3.7 Fc1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2C1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3895460 149876 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 336 0 1 3 3.7 Fc1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2C1C3)OCO4 10.1021/acs.jmedchem.6b01217
123204312 147250 0 None 74 3 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 425 11 3 5 2.7 Cc1cccc(C)c1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3809532 147250 0 None 74 3 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 425 11 3 5 2.7 Cc1cccc(C)c1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
134150827 158946 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 392 5 1 4 4.6 CCCOc1cc2c(cc1OC)CCN1Cc3[nH]c4ccc(OC)cc4c3CC21 10.1021/acs.jmedchem.6b01217
CHEMBL3968227 158946 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 392 5 1 4 4.6 CCCOc1cc2c(cc1OC)CCN1Cc3[nH]c4ccc(OC)cc4c3CC21 10.1021/acs.jmedchem.6b01217
134155537 157764 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 406 6 1 4 5.0 CCCCOc1cc2c(cc1OC)CCN1Cc3[nH]c4ccc(OC)cc4c3CC21 10.1021/acs.jmedchem.6b01217
CHEMBL3958316 157764 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 406 6 1 4 5.0 CCCCOc1cc2c(cc1OC)CCN1Cc3[nH]c4ccc(OC)cc4c3CC21 10.1021/acs.jmedchem.6b01217
123322716 147301 0 None 17 3 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 425 12 3 5 2.7 CCc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3810198 147301 0 None 17 3 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 425 12 3 5 2.7 CCc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
134149598 155256 0 None 33 2 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 336 0 1 3 3.7 Fc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3938121 155256 0 None 33 2 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 336 0 1 3 3.7 Fc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
123801568 147267 0 None 100 3 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 441 11 3 7 1.9 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc2c(c1)OCO2 10.1021/acs.jmedchem.5b02023
CHEMBL3809781 147267 0 None 100 3 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 441 11 3 7 1.9 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc2c(c1)OCO2 10.1021/acs.jmedchem.5b02023
134150128 158879 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 424 3 1 4 5.1 c1ccc(COc2ccc3[nH]c4c(c3c2)CC2c3cc5c(cc3CCN2C4)OCO5)cc1 10.1021/acs.jmedchem.6b01217
CHEMBL3967696 158879 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 424 3 1 4 5.1 c1ccc(COc2ccc3[nH]c4c(c3c2)CC2c3cc5c(cc3CCN2C4)OCO5)cc1 10.1021/acs.jmedchem.6b01217
9891967 114302 34 None 4 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3187195 114302 34 None 4 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
123644751 147281 0 None 125 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 529 13 3 6 3.7 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3810005 147281 0 None 125 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 529 13 3 6 3.7 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
123475619 147269 0 None 43 3 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 503 12 3 6 3.5 COc1cc(Br)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809794 147269 0 None 43 3 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 503 12 3 6 3.5 COc1cc(Br)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
76071859 157132 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)C[C@@H]1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3953156 157132 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)C[C@@H]1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
156767234 189375 0 None 10 2 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 467 11 1 4 5.7 O=C(O)CCCc1cn(CCCCCN2CCN(c3ccccc3Cl)CC2)c2ccccc12 10.1016/j.ejmech.2020.112616
CHEMBL4788144 189375 0 None 10 2 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 467 11 1 4 5.7 O=C(O)CCCc1cn(CCCCCN2CCN(c3ccccc3Cl)CC2)c2ccccc12 10.1016/j.ejmech.2020.112616
123393714 147252 0 None 3 3 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 439 11 3 5 3.1 Cc1ccc(C)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c1C 10.1021/acs.jmedchem.5b02023
CHEMBL3809543 147252 0 None 3 3 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 439 11 3 5 3.1 Cc1ccc(C)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c1C 10.1021/acs.jmedchem.5b02023
145993493 174136 0 None -47 6 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 439 6 0 5 4.5 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1 10.1016/j.ejmech.2017.12.099
CHEMBL4294617 174136 0 None -47 6 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 439 6 0 5 4.5 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1 10.1016/j.ejmech.2017.12.099
145993117 173700 0 None -309 6 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 427 7 0 5 4.4 CCC1(C)CC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)C(=O)C1 10.1016/j.ejmech.2017.12.099
CHEMBL4286717 173700 0 None -309 6 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 427 7 0 5 4.4 CCC1(C)CC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)C(=O)C1 10.1016/j.ejmech.2017.12.099
123311113 147299 0 None 91 3 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 523 14 3 6 3.6 CCc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3810187 147299 0 None 91 3 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 523 14 3 6 3.6 CCc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c1 10.1021/acs.jmedchem.5b02023
10582125 88609 0 None -47 3 Rat 5.4 pIC50 = 5.4 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1161 33 6 20 7.3 COc1cc2nc(N3CCN(C(=O)c4cccc(CNCCCCCCNCCSSCCNCCCCCCNCc5cccc(C(=O)N6CCN(c7nc(N)c8cc(OC)c(OC)cc8n7)CC6)c5)c4)CC3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL216443 88609 0 None -47 3 Rat 5.4 pIC50 = 5.4 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1161 33 6 20 7.3 COc1cc2nc(N3CCN(C(=O)c4cccc(CNCCCCCCNCCSSCCNCCCCCCNCc5cccc(C(=O)N6CCN(c7nc(N)c8cc(OC)c(OC)cc8n7)CC6)c5)c4)CC3)nc(N)c2cc1OC 10.1021/jm000995w
123688273 147259 0 None 36 3 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 513 13 3 6 3.2 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc(F)cc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3809630 147259 0 None 36 3 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 513 13 3 6 3.2 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc(F)cc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
127044911 147226 0 None -10 3 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 425 12 3 6 2.7 COc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809319 147226 0 None -10 3 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 425 12 3 6 2.7 COc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
123183757 147255 0 None 10 3 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 445 12 3 6 2.3 COc1cc(F)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3809600 147255 0 None 10 3 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 445 12 3 6 2.3 COc1cc(F)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
127044894 147145 0 None 3 3 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 427 12 3 6 2.1 COc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3808408 147145 0 None 3 3 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 427 12 3 6 2.1 COc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
134147190 156577 0 None 3 3 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 334 0 2 4 3.3 Oc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3948551 156577 0 None 3 3 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 334 0 2 4 3.3 Oc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
10034370 163771 0 None -10 3 Rat 7.3 pIC50 = 7.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CNCCCCCCNCCSSCCNCCCCCCNCc4cccc(C(=O)N(C)CCCCCCN(C)c5nc(N)c6cc(OC)c(OC)cc6n5)c4)c3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL1203232 163771 0 None -10 3 Rat 7.3 pIC50 = 7.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CNCCCCCCNCCSSCCNCCCCCCNCc4cccc(C(=O)N(C)CCCCCCN(C)c5nc(N)c6cc(OC)c(OC)cc6n5)c4)c3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL407315 163771 0 None -10 3 Rat 7.3 pIC50 = 7.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CNCCCCCCNCCSSCCNCCCCCCNCc4cccc(C(=O)N(C)CCCCCCN(C)c5nc(N)c6cc(OC)c(OC)cc6n5)c4)c3)nc(N)c2cc1OC 10.1021/jm000995w
127043026 147225 0 None 8 2 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 507 13 3 6 4.0 Cc1ccc(OCC(F)(F)F)c(OCCN[C@@H](C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809314 147225 0 None 8 2 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 507 13 3 6 4.0 Cc1ccc(OCC(F)(F)F)c(OCCN[C@@H](C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
16638286 156379 1 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 323 0 0 5 2.8 c1c2c(cc3c1OCO3)CN1CCc3cc4c(cc3C1C2)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3946997 156379 1 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 323 0 0 5 2.8 c1c2c(cc3c1OCO3)CN1CCc3cc4c(cc3C1C2)OCO4 10.1021/acs.jmedchem.6b01217
10034371 172759 0 None -1479 3 Rat 5.3 pIC50 = 5.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CNCCCCCCNCCSSCCNCCCCCCNCc4ccc(C(=O)N(C)CCCCCCN(C)c5nc(N)c6cc(OC)c(OC)cc6n5)cc4)cc3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL1203235 172759 0 None -1479 3 Rat 5.3 pIC50 = 5.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CNCCCCCCNCCSSCCNCCCCCCNCc4ccc(C(=O)N(C)CCCCCCN(C)c5nc(N)c6cc(OC)c(OC)cc6n5)cc4)cc3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL425267 172759 0 None -1479 3 Rat 5.3 pIC50 = 5.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CNCCCCCCNCCSSCCNCCCCCCNCc4ccc(C(=O)N(C)CCCCCCN(C)c5nc(N)c6cc(OC)c(OC)cc6n5)cc4)cc3)nc(N)c2cc1OC 10.1021/jm000995w
10630100 103376 0 None -186 3 Rat 5.3 pIC50 = 5.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1161 33 6 20 7.3 COc1cc2nc(N3CCN(C(=O)c4ccccc4CNCCCCCCNCCSSCCNCCCCCCNCc4ccccc4C(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)CC3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL263289 103376 0 None -186 3 Rat 5.3 pIC50 = 5.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1161 33 6 20 7.3 COc1cc2nc(N3CCN(C(=O)c4ccccc4CNCCCCCCNCCSSCCNCCCCCCNCc4ccccc4C(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)CC3)nc(N)c2cc1OC 10.1021/jm000995w
145947950 174512 0 None 1 3 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 440 7 0 3 5.8 Cc1cccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)c1 10.1016/j.bmcl.2018.03.070
CHEMBL4224703 174512 0 None 1 3 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 440 7 0 3 5.8 Cc1cccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)c1 10.1016/j.bmcl.2018.03.070
CHEMBL4302771 174512 0 None 1 3 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 440 7 0 3 5.8 Cc1cccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)c1 10.1016/j.bmcl.2018.03.070
21171 193755 33 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 339 2 0 5 3.1 COc1ccc2c(c1OC)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL490533 193755 33 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 339 2 0 5 3.1 COc1ccc2c(c1OC)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4 10.1021/acs.jmedchem.6b01217
21823379 151504 2 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 304 1 1 2 3.8 COc1ccc2c(c1)CCN1Cc3[nH]c4ccccc4c3CC21 10.1021/acs.jmedchem.6b01217
CHEMBL3908813 151504 2 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 304 1 1 2 3.8 COc1ccc2c(c1)CCN1Cc3[nH]c4ccccc4c3CC21 10.1021/acs.jmedchem.6b01217
4418 40996 85 None -4 18 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.03.070
CHEMBL142635 40996 85 None -4 18 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.03.070
DB12092 40996 85 None -4 18 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.03.070
145947047 174414 0 None -1 3 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 425 7 0 2 6.6 c1ccc(C2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
CHEMBL4227513 174414 0 None -1 3 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 425 7 0 2 6.6 c1ccc(C2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
CHEMBL4301557 174414 0 None -1 3 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 425 7 0 2 6.6 c1ccc(C2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
123576734 147202 0 None 15 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 455 13 3 6 2.7 CCc1ccc(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c(OC)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809032 147202 0 None 15 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 455 13 3 6 2.7 CCc1ccc(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c(OC)c1 10.1021/acs.jmedchem.5b02023
76071738 155108 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 318 0 1 3 3.6 c1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2[C@@H]1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3937032 155108 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 318 0 1 3 3.6 c1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2[C@@H]1C3)OCO4 10.1021/acs.jmedchem.6b01217
145946630 174352 0 None 12 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 456 8 0 4 5.5 COc1ccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
CHEMBL4224794 174352 0 None 12 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 456 8 0 4 5.5 COc1ccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
CHEMBL4300618 174352 0 None 12 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 456 8 0 4 5.5 COc1ccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
123752717 147248 0 None 26 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 439 11 3 5 3.1 Cc1cc(C)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c(C)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809500 147248 0 None 26 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 439 11 3 5 3.1 Cc1cc(C)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c(C)c1 10.1021/acs.jmedchem.5b02023
134145079 157001 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2C1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3952204 157001 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2C1C3)OCO4 10.1021/acs.jmedchem.6b01217
127044906 147196 0 None 7 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 529 13 3 6 3.7 C[C@@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3808981 147196 0 None 7 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 529 13 3 6 3.7 C[C@@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
123183788 147304 0 None 7 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 441 12 3 6 2.4 COc1cc(C)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3810220 147304 0 None 7 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 441 12 3 6 2.4 COc1cc(C)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
123378354 147165 0 None 6 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 493 11 3 5 3.0 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc(F)cc1Br 10.1021/acs.jmedchem.5b02023
CHEMBL3808595 147165 0 None 6 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 493 11 3 5 3.0 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc(F)cc1Br 10.1021/acs.jmedchem.5b02023
145963961 171182 0 None -32 6 Human 7.2 pIC50 = 7.2 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 425 8 1 7 3.0 CNC(=O)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccn1 10.1016/j.bmcl.2018.01.038
CHEMBL4213342 171182 0 None -32 6 Human 7.2 pIC50 = 7.2 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 425 8 1 7 3.0 CNC(=O)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccn1 10.1016/j.bmcl.2018.01.038
134157568 161238 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 352 4 0 4 3.1 COc1cc2cc[n+]3c(c2cc1OC)Cc1ccc(OC)c(OC)c1C3 10.1021/acs.jmedchem.6b01217
CHEMBL3984336 161238 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 352 4 0 4 3.1 COc1cc2cc[n+]3c(c2cc1OC)Cc1ccc(OC)c(OC)c1C3 10.1021/acs.jmedchem.6b01217
CHEMBL3990197 161238 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 352 4 0 4 3.1 COc1cc2cc[n+]3c(c2cc1OC)Cc1ccc(OC)c(OC)c1C3 10.1021/acs.jmedchem.6b01217
127044916 147260 0 None 1 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 443 12 3 6 2.9 COc1cc(F)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809676 147260 0 None 1 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 443 12 3 6 2.9 COc1cc(F)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
123437117 147147 0 None 23 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 461 12 3 6 2.8 COc1cc(Cl)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3808417 147147 0 None 23 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 461 12 3 6 2.8 COc1cc(Cl)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
127045050 147171 0 None -5 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 503 14 3 6 3.7 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCc1ccccc1 10.1021/acs.jmedchem.5b02023
CHEMBL3808632 147171 0 None -5 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 503 14 3 6 3.7 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCc1ccccc1 10.1021/acs.jmedchem.5b02023
118167692 170988 10 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at alpha1A adrenergic receptor (unknown origin)Antagonist activity at alpha1A adrenergic receptor (unknown origin)
ChEMBL 521 7 1 7 3.0 Cn1cnc(-c2cnc(O[C@H]3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)C[C@H]3F)c(C(N)=O)c2)c1 10.1021/acs.jmedchem.8b00633
CHEMBL4210892 170988 10 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at alpha1A adrenergic receptor (unknown origin)Antagonist activity at alpha1A adrenergic receptor (unknown origin)
ChEMBL 521 7 1 7 3.0 Cn1cnc(-c2cnc(O[C@H]3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)C[C@H]3F)c(C(N)=O)c2)c1 10.1021/acs.jmedchem.8b00633
134134752 150987 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 318 1 1 2 4.4 COc1ccc2c(c1)CCN1C(C)c3[nH]c4ccccc4c3CC21 10.1021/acs.jmedchem.6b01217
CHEMBL3904395 150987 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 318 1 1 2 4.4 COc1ccc2c(c1)CCN1C(C)c3[nH]c4ccccc4c3CC21 10.1021/acs.jmedchem.6b01217
10813278 113717 0 None - 0 Rabbit 10.7 pKd = 10.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 446 8 1 6 3.5 Cc1ccc(N2CCN(CCCNc3ncccc3C(=O)N(C)C)CC2)c(-n2cccc2)c1 10.1021/jm970166j
CHEMBL314880 113717 0 None - 0 Rabbit 10.7 pKd = 10.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 446 8 1 6 3.5 Cc1ccc(N2CCN(CCCNc3ncccc3C(=O)N(C)C)CC2)c(-n2cccc2)c1 10.1021/jm970166j
10697270 112955 0 None - 0 Rabbit 10.0 pKd = 10 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 519 9 2 8 3.2 CNC(=O)c1cnc2c(c(C)nn2C)c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL313775 112955 0 None - 0 Rabbit 10.0 pKd = 10 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 519 9 2 8 3.2 CNC(=O)c1cnc2c(c(C)nn2C)c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
10552132 119565 0 None - 0 Rabbit 10.0 pKd = 10 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 465 9 1 6 3.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL330579 119565 0 None - 0 Rabbit 10.0 pKd = 10 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 465 9 1 6 3.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
13305910 18608 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182155 18608 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL215421 18608 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3741808 18608 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
13305910 18608 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL1182155 18608 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL215421 18608 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL3741808 18608 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
10506159 118177 0 None - 0 Rabbit 9.9 pKd = 9.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 520 8 1 9 3.4 Cc1nn(C)c2ncc(C(=O)N(C)C)c(NCCCN3CCN(c4ccc(F)cc4-c4ncco4)CC3)c12 10.1021/jm970166j
CHEMBL327231 118177 0 None - 0 Rabbit 9.9 pKd = 9.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 520 8 1 9 3.4 Cc1nn(C)c2ncc(C(=O)N(C)C)c(NCCCN3CCN(c4ccc(F)cc4-c4ncco4)CC3)c12 10.1021/jm970166j
10693231 209541 0 None - 0 Human 9.8 pKd = 9.8 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 416 4 1 6 2.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C#N)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL62033 209541 0 None - 0 Human 9.8 pKd = 9.8 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 416 4 1 6 2.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C#N)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
129211 10521 78 None - 14 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
2562 10521 78 None - 14 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
488 10521 78 None - 14 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
CHEMBL836 10521 78 None - 14 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
DB00706 10521 78 None - 14 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
10526964 213744 0 None - 0 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 437 10 1 6 3.2 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC2CC2)CC1 10.1021/jm970166j
CHEMBL91278 213744 0 None - 0 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 437 10 1 6 3.2 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC2CC2)CC1 10.1021/jm970166j
10764021 213770 0 None - 0 Rabbit 9.7 pKd = 9.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 409 9 1 5 3.4 CCCc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL91400 213770 0 None - 0 Rabbit 9.7 pKd = 9.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 409 9 1 5 3.4 CCCc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
24897950 63126 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Antagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 mins
ChEMBL 462 11 2 6 2.9 COc1ccc(C[C@@H](C)NCCOc2ccccc2OCC(F)(F)F)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630940 63126 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Antagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 mins
ChEMBL 462 11 2 6 2.9 COc1ccc(C[C@@H](C)NCCOc2ccccc2OCC(F)(F)F)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
71462043 91343 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153555 91343 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220895 91343 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
129211 10521 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
2562 10521 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
488 10521 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
CHEMBL836 10521 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
DB00706 10521 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
129211 10521 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
2562 10521 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
488 10521 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
CHEMBL836 10521 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
DB00706 10521 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
499 10849 18 None - 1 Rat 9.5 pKd = 9.5 Functional
Antagonistic activity at ADRA1A in isolated rat prostatic vas deferensAntagonistic activity at ADRA1A in isolated rat prostatic vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.bmcl.2005.09.027
5685 10849 18 None - 1 Rat 9.5 pKd = 9.5 Functional
Antagonistic activity at ADRA1A in isolated rat prostatic vas deferensAntagonistic activity at ADRA1A in isolated rat prostatic vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.bmcl.2005.09.027
CHEMBL25554 10849 18 None - 1 Rat 9.5 pKd = 9.5 Functional
Antagonistic activity at ADRA1A in isolated rat prostatic vas deferensAntagonistic activity at ADRA1A in isolated rat prostatic vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.bmcl.2005.09.027
499 10849 18 None - 1 Rat 9.5 pKd = 9.5 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
5685 10849 18 None - 1 Rat 9.5 pKd = 9.5 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
CHEMBL25554 10849 18 None - 1 Rat 9.5 pKd = 9.5 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
10526831 118166 0 None - 0 Rabbit 9.5 pKd = 9.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 434 8 1 7 3.1 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2-c2ncco2)CC1 10.1021/jm970166j
CHEMBL327168 118166 0 None - 0 Rabbit 9.5 pKd = 9.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 434 8 1 7 3.1 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2-c2ncco2)CC1 10.1021/jm970166j
13305910 18608 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182155 18608 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL215421 18608 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3741808 18608 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
13305910 18608 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL1182155 18608 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL215421 18608 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL3741808 18608 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
129211 10521 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
2562 10521 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
488 10521 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
CHEMBL836 10521 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
DB00706 10521 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
129211 10521 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
2562 10521 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
488 10521 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
CHEMBL836 10521 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
DB00706 10521 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
44289437 176642 0 None - 0 Rat 9.5 pKd = 9.5 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 431 9 1 5 4.7 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2C1=O 10.1021/jm011066n
CHEMBL44403 176642 0 None - 0 Rat 9.5 pKd = 9.5 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 431 9 1 5 4.7 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2C1=O 10.1021/jm011066n
10789770 107662 0 None - 0 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 6 1 7 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)c(OC)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL293695 107662 0 None - 0 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 6 1 7 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)c(OC)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
10645210 213258 0 None - 0 Rabbit 9.4 pKd = 9.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 409 8 1 5 3.5 CC(C)c1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL88211 213258 0 None - 0 Rabbit 9.4 pKd = 9.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 409 8 1 5 3.5 CC(C)c1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
499 10849 18 None - 1 Rat 9.4 pKd = 9.4 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
5685 10849 18 None - 1 Rat 9.4 pKd = 9.4 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
CHEMBL25554 10849 18 None - 1 Rat 9.4 pKd = 9.4 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
499 10849 18 None - 1 Rat 9.4 pKd = 9.4 Functional
Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (Alpha-1A adrenergic receptor )Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (Alpha-1A adrenergic receptor )
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm021078o
5685 10849 18 None - 1 Rat 9.4 pKd = 9.4 Functional
Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (Alpha-1A adrenergic receptor )Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (Alpha-1A adrenergic receptor )
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm021078o
CHEMBL25554 10849 18 None - 1 Rat 9.4 pKd = 9.4 Functional
Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (Alpha-1A adrenergic receptor )Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (Alpha-1A adrenergic receptor )
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm021078o
44289437 176642 0 None - 0 Rat 9.4 pKd = 9.4 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 431 9 1 5 4.7 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2C1=O 10.1021/jm011066n
CHEMBL44403 176642 0 None - 0 Rat 9.4 pKd = 9.4 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 431 9 1 5 4.7 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2C1=O 10.1021/jm011066n
10787790 112767 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 411 9 1 6 2.8 CCOc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL313157 112767 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 411 9 1 6 2.8 CCOc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10744240 113811 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 508 9 2 7 2.8 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c(C(N)=O)cccc23)CC1 10.1021/jm970166j
CHEMBL315496 113811 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 508 9 2 7 2.8 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c(C(N)=O)cccc23)CC1 10.1021/jm970166j
10763212 174975 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 394 9 1 6 3.3 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)C2CC2)CC1 10.1021/jm970166j
CHEMBL433348 174975 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 394 9 1 6 3.3 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)C2CC2)CC1 10.1021/jm970166j
9893282 213248 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 533 9 1 8 3.5 Cc1nn(C)c2ncc(C(=O)N(C)C)c(NCCCN3CCN(c4ccccc4OCC(F)(F)F)CC3)c12 10.1021/jm970166j
CHEMBL88160 213248 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 533 9 1 8 3.5 Cc1nn(C)c2ncc(C(=O)N(C)C)c(NCCCN3CCN(c4ccccc4OCC(F)(F)F)CC3)c12 10.1021/jm970166j
44323795 213387 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 410 8 1 5 3.3 COc1ccccc1N1CCN(CCCNc2cc(C)ccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL89030 213387 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 410 8 1 5 3.3 COc1ccccc1N1CCN(CCCNc2cc(C)ccc2C(=O)N(C)C)CC1 10.1021/jm970166j
499 10849 18 None - 1 Rat 9.3 pKd = 9.3 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
5685 10849 18 None - 1 Rat 9.3 pKd = 9.3 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
CHEMBL25554 10849 18 None - 1 Rat 9.3 pKd = 9.3 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
9824384 125565 1 None - 0 Rat 9.2 pKd = 9.2 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL342062 125565 1 None - 0 Rat 9.2 pKd = 9.2 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
10478121 177581 0 None - 0 Human 9.2 pKd = 9.2 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 435 6 0 7 3.1 COc1cc2ncn(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
CHEMBL445325 177581 0 None - 0 Human 9.2 pKd = 9.2 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 435 6 0 7 3.1 COc1cc2ncn(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
10743446 113848 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 483 8 1 8 2.8 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c2nc(C)n3C)CC1 10.1021/jm970166j
CHEMBL315785 113848 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 483 8 1 8 2.8 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c2nc(C)n3C)CC1 10.1021/jm970166j
10549680 119161 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 1 6 3.1 CSc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL329601 119161 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 1 6 3.1 CSc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10647512 213804 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 456 8 2 6 1.6 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)c[nH]c3ccn[n+]2-3)CC1 10.1021/jm970166j
CHEMBL91547 213804 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 456 8 2 6 1.6 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)c[nH]c3ccn[n+]2-3)CC1 10.1021/jm970166j
10621397 213871 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 407 8 1 5 3.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2C2CC2)CC1 10.1021/jm970166j
CHEMBL91951 213871 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 407 8 1 5 3.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2C2CC2)CC1 10.1021/jm970166j
499 10849 18 None - 1 Rat 9.2 pKd = 9.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
5685 10849 18 None - 1 Rat 9.2 pKd = 9.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
CHEMBL25554 10849 18 None - 1 Rat 9.2 pKd = 9.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
10574245 118299 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 422 8 1 7 2.3 COc1ccccc1N1CCN(CCCNc2ncc(C#N)cc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL327872 118299 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 422 8 1 7 2.3 COc1ccccc1N1CCN(CCCNc2ncc(C#N)cc2C(=O)N(C)C)CC1 10.1021/jm970166j
10577066 119189 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 490 8 2 6 2.3 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)c[nH]c3c(Cl)cn[n+]2-3)CC1 10.1021/jm970166j
CHEMBL329773 119189 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 490 8 2 6 2.3 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)c[nH]c3c(Cl)cn[n+]2-3)CC1 10.1021/jm970166j
10530686 213682 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 549 9 1 6 5.2 CN(C)C(=O)c1cnc2c(Cl)cccc2c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL90878 213682 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 549 9 1 6 5.2 CN(C)C(=O)c1cnc2c(Cl)cccc2c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
11795906 213845 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 411 8 1 6 2.7 COc1cc(C)ccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL91785 213845 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 411 8 1 6 2.7 COc1cc(C)ccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
14423371 104230 1 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 441 11 1 8 3.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL27013 104230 1 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 441 11 1 8 3.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
71462043 91343 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153555 91343 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220895 91343 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
14423371 104230 1 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 441 11 1 8 3.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1016/s0960-894x(98)00217-0
CHEMBL27013 104230 1 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 441 11 1 8 3.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1016/s0960-894x(98)00217-0
10456471 107309 0 None - 0 Human 9.0 pKd = 9.0 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 6 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
CHEMBL291303 107309 0 None - 0 Human 9.0 pKd = 9.0 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 6 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
10572854 119343 0 None - 0 Rabbit 9.0 pKd = 9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 396 8 1 5 3.0 COc1ccccc1N1CCN(CCCNc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL330060 119343 0 None - 0 Rabbit 9.0 pKd = 9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 396 8 1 5 3.0 COc1ccccc1N1CCN(CCCNc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10786203 214048 0 None - 0 Rabbit 9.0 pKd = 9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 8 2 6 2.1 CNC(=O)c1cccnc1NCCCN1CCN(c2ccccc2OC)CC1 10.1021/jm970166j
CHEMBL93054 214048 0 None - 0 Rabbit 9.0 pKd = 9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 8 2 6 2.1 CNC(=O)c1cccnc1NCCCN1CCN(c2ccccc2OC)CC1 10.1021/jm970166j
11430491 69775 0 None - 0 Rat 9.0 pKd = 9 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 435 5 1 9 2.4 COc1cc2nc(N3CCN(C(=O)CC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL178673 69775 0 None - 0 Rat 9.0 pKd = 9 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 435 5 1 9 2.4 COc1cc2nc(N3CCN(C(=O)CC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
10527469 163044 3 None - 0 Human 9.0 pKd = 9 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
CHEMBL40650 163044 3 None - 0 Human 9.0 pKd = 9 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
4209 9937 75 None -1 17 Rat 9.0 pKd = 9.0 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
4893 9937 75 None -1 17 Rat 9.0 pKd = 9.0 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
503 9937 75 None -1 17 Rat 9.0 pKd = 9.0 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
5385 9937 75 None -1 17 Rat 9.0 pKd = 9.0 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
CHEMBL2 9937 75 None -1 17 Rat 9.0 pKd = 9.0 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
DB00457 9937 75 None -1 17 Rat 9.0 pKd = 9.0 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
10478121 177581 0 None - 0 Rat 9.0 pKd = 9.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 435 6 0 7 3.1 COc1cc2ncn(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
CHEMBL445325 177581 0 None - 0 Rat 9.0 pKd = 9.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 435 6 0 7 3.1 COc1cc2ncn(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
16121006 18613 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182182 18613 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL217469 18613 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
11742834 172549 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 419 9 1 5 4.7 COc1cccc(OC)c1OCCNC[C@@H]1C[C@H](c2ccccc2)c2ccccc2O1 10.1021/jm011066n
CHEMBL42472 172549 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 419 9 1 5 4.7 COc1cccc(OC)c1OCCNC[C@@H]1C[C@H](c2ccccc2)c2ccccc2O1 10.1021/jm011066n
10527469 163044 3 None - 0 Rat 8.9 pKd = 8.9 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
CHEMBL40650 163044 3 None - 0 Rat 8.9 pKd = 8.9 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
10834793 91354 0 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153557 91354 0 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220925 91354 0 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
132266 8061 12 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm8016046
486 8061 12 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm8016046
CHEMBL423294 8061 12 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm8016046
10505222 213444 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 490 8 1 7 3.6 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c(C#N)cccc23)CC1 10.1021/jm970166j
CHEMBL89397 213444 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 490 8 1 7 3.6 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c(C#N)cccc23)CC1 10.1021/jm970166j
10575254 213662 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 443 8 1 5 4.1 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2-c2ccccc2)CC1 10.1021/jm970166j
CHEMBL90746 213662 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 443 8 1 5 4.1 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2-c2ccccc2)CC1 10.1021/jm970166j
10814587 213671 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 480 8 1 7 3.4 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3nc(C)ccc23)CC1 10.1021/jm970166j
CHEMBL90810 213671 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 480 8 1 7 3.4 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3nc(C)ccc23)CC1 10.1021/jm970166j
10646065 213681 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 425 8 2 6 3.2 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)NC(C)(C)C)CC1 10.1021/jm970166j
CHEMBL90874 213681 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 425 8 2 6 3.2 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)NC(C)(C)C)CC1 10.1021/jm970166j
10624682 213817 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 483 8 1 8 2.8 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c2c(C)nn3C)CC1 10.1021/jm970166j
CHEMBL91605 213817 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 483 8 1 8 2.8 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c2c(C)nn3C)CC1 10.1021/jm970166j
10789770 107662 0 None - 0 Rat 8.9 pKd = 8.9 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 6 1 7 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)c(OC)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL293695 107662 0 None - 0 Rat 8.9 pKd = 8.9 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 6 1 7 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)c(OC)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
11742834 172549 0 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 419 9 1 5 4.7 COc1cccc(OC)c1OCCNC[C@@H]1C[C@H](c2ccccc2)c2ccccc2O1 10.1021/jm011066n
CHEMBL42472 172549 0 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 419 9 1 5 4.7 COc1cccc(OC)c1OCCNC[C@@H]1C[C@H](c2ccccc2)c2ccccc2O1 10.1021/jm011066n
10693231 209541 0 None - 0 Rat 8.8 pKd = 8.8 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 416 4 1 6 2.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C#N)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL62033 209541 0 None - 0 Rat 8.8 pKd = 8.8 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 416 4 1 6 2.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C#N)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
9865577 119086 2 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL329160 119086 2 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10621790 170595 0 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 415 8 1 6 2.6 COc1cc(F)ccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL420620 170595 0 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 415 8 1 6 2.6 COc1cc(F)ccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10839699 213530 0 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 520 9 1 8 3.8 Cc1noc2ncc(C(=O)N(C)C)c(NCCCN3CCN(c4ccccc4OCC(F)(F)F)CC3)c12 10.1021/jm970166j
CHEMBL90022 213530 0 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 520 9 1 8 3.8 Cc1noc2ncc(C(=O)N(C)C)c(NCCCN3CCN(c4ccccc4OCC(F)(F)F)CC3)c12 10.1021/jm970166j
10552164 213679 0 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 466 9 1 6 3.4 CN(C)C(=O)c1cccnc1N1CCC(NCCOc2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL90869 213679 0 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 466 9 1 6 3.4 CN(C)C(=O)c1cccnc1N1CCC(NCCOc2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
10549596 91380 1 None - 0 Rat 8.8 pKd = 8.8 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153553 91380 1 None - 0 Rat 8.8 pKd = 8.8 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221147 91380 1 None - 0 Rat 8.8 pKd = 8.8 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
10501886 118178 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 2 7 2.1 COc1ccccc1N1CCN(CCCNc2ncc(O)cc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL327232 118178 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 2 7 2.1 COc1ccccc1N1CCN(CCCNc2ncc(O)cc2C(=O)N(C)C)CC1 10.1021/jm970166j
10693071 213253 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 0 5 3.7 COc1ccccc1N1CCN(CCCSc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL88181 213253 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 0 5 3.7 COc1ccccc1N1CCN(CCCSc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10833725 213290 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 381 7 1 5 2.7 Cc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL88435 213290 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 381 7 1 5 2.7 Cc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10500734 213358 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 392 7 1 6 2.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2C#N)CC1 10.1021/jm970166j
CHEMBL88856 213358 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 392 7 1 6 2.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2C#N)CC1 10.1021/jm970166j
44324012 214028 0 None - 0 Rabbit 8.0 pKd = 8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 2 6 2.4 COc1ccccc1N1CCN(CCCNc2nc(C)cc(C)c2C(N)=O)CC1 10.1021/jm970166j
CHEMBL92901 214028 0 None - 0 Rabbit 8.0 pKd = 8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 2 6 2.4 COc1ccccc1N1CCN(CCCNc2nc(C)cc(C)c2C(N)=O)CC1 10.1021/jm970166j
11994673 19088 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL1185036 19088 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL385371 19088 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
10745791 43283 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 579 19 3 9 4.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CNCCCCCCN)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL144776 43283 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 579 19 3 9 4.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CNCCCCCCN)nc(N)c2cc1OC 10.1021/jm9810654
10394346 23735 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 638 11 2 10 3.0 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C(N)=O)CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL125365 23735 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 638 11 2 10 3.0 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C(N)=O)CC3)cccc2c1=O 10.1021/jm030825u
52945071 24415 0 None - 0 Rat 6.0 pKd = 6.0 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 470 7 2 5 2.7 O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1CC(O)CN1CCN(c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL1258344 24415 0 None - 0 Rat 6.0 pKd = 6.0 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 470 7 2 5 2.7 O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1CC(O)CN1CCN(c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
11133868 162121 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNC[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1021/jm011066n
CHEMBL40325 162121 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNC[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1021/jm011066n
2419 7482 28 None - 3 Rat 6.9 pKd = 6.9 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm9810654
9 7482 28 None - 3 Rat 6.9 pKd = 6.9 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm9810654
CHEMBL13647 7482 28 None - 3 Rat 6.9 pKd = 6.9 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm9810654
2419 7482 28 None - 3 Rat 6.9 pKd = 6.9 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(98)00217-0
9 7482 28 None - 3 Rat 6.9 pKd = 6.9 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(98)00217-0
CHEMBL13647 7482 28 None - 3 Rat 6.9 pKd = 6.9 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(98)00217-0
3584 10549 64 None -25 11 Rat 7.9 pKd = 7.9 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
5401 10549 64 None -25 11 Rat 7.9 pKd = 7.9 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
7302 10549 64 None -25 11 Rat 7.9 pKd = 7.9 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
CHEMBL611 10549 64 None -25 11 Rat 7.9 pKd = 7.9 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
DB01162 10549 64 None -25 11 Rat 7.9 pKd = 7.9 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
10574889 113323 0 None - 0 Rabbit 7.9 pKd = 7.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 435 7 1 5 3.4 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2C(F)(F)F)CC1 10.1021/jm970166j
CHEMBL314114 113323 0 None - 0 Rabbit 7.9 pKd = 7.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 435 7 1 5 3.4 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2C(F)(F)F)CC1 10.1021/jm970166j
10787895 118197 0 None - 0 Rabbit 7.9 pKd = 7.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 2 7 2.1 COc1cc(O)ccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL327351 118197 0 None - 0 Rabbit 7.9 pKd = 7.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 2 7 2.1 COc1cc(O)ccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10524875 214151 0 None - 0 Rabbit 7.9 pKd = 7.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ccncc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL93736 214151 0 None - 0 Rabbit 7.9 pKd = 7.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ccncc2C(=O)N(C)C)CC1 10.1021/jm970166j
52942664 24416 0 None - 0 Rat 6.9 pKd = 6.9 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 500 8 2 6 2.7 COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL1258345 24416 0 None - 0 Rat 6.9 pKd = 6.9 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 500 8 2 6 2.7 COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
52942591 24384 0 None - 0 Rat 5.9 pKd = 5.9 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 542 9 1 7 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL1258228 24384 0 None - 0 Rat 5.9 pKd = 5.9 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 542 9 1 7 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
44428846 98964 0 None - 0 Rat 6.9 pKd = 6.9 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@@H]3CCCC[C@@H]32)o1 10.1016/j.bmc.2007.01.028
CHEMBL242508 98964 0 None - 0 Rat 6.9 pKd = 6.9 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@@H]3CCCC[C@@H]32)o1 10.1016/j.bmc.2007.01.028
145971621 171384 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 414 9 1 7 2.0 COC(=O)Cc1ccc(OCC(O)CN2CCN(c3ccccc3OC)CC2)cc1 10.1016/j.bmcl.2018.01.068
CHEMBL4215889 171384 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 414 9 1 7 2.0 COC(=O)Cc1ccc(OCC(O)CN2CCN(c3ccccc3OC)CC2)cc1 10.1016/j.bmcl.2018.01.068
10506915 47013 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 552 13 1 9 4.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN4CCSC4)c3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL148061 47013 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 552 13 1 9 4.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN4CCSC4)c3)nc(N)c2cc1OC 10.1021/jm9810654
69782867 168362 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 549 8 1 9 4.4 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4C(C)C)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4129291 168362 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 549 8 1 9 4.4 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4C(C)C)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
25022505 195070 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 586 10 1 8 2.9 COC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL500266 195070 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 586 10 1 8 2.9 COC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
44586483 179246 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 600 11 1 8 3.3 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C(C)C(=O)OC)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL448198 179246 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 600 11 1 8 3.3 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C(C)C(=O)OC)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
44586429 191076 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 514 8 1 6 3.0 COc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL484102 191076 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 514 8 1 6 3.0 COc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
6603808 134300 3 None - 2 Rat 7.8 pKd = 7.8 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214986 134300 3 None - 2 Rat 7.8 pKd = 7.8 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL36622 134300 3 None - 2 Rat 7.8 pKd = 7.8 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3740374 134300 3 None - 2 Rat 7.8 pKd = 7.8 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
9891213 168281 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4128084 168281 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
50905589 63128 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 mins
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@@H]2Oc3ccccc3O[C@@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630942 63128 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 mins
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@@H]2Oc3ccccc3O[C@@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
10530133 43790 1 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 525 12 1 10 4.2 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccc(CCl)o3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL145181 43790 1 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 525 12 1 10 4.2 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccc(CCl)o3)nc(N)c2cc1OC 10.1021/jm9810654
132266 8061 12 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2007.01.028
486 8061 12 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2007.01.028
CHEMBL423294 8061 12 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2007.01.028
132266 8061 12 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2018.05.023
486 8061 12 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2018.05.023
CHEMBL423294 8061 12 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2018.05.023
71454865 91378 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153551 91378 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221145 91378 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
44289261 171691 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 417 9 1 4 5.1 COc1cccc(OC)c1OCCNCC1Cc2ccccc2C(c2ccccc2)C1 10.1021/jm011066n
CHEMBL42231 171691 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 417 9 1 4 5.1 COc1cccc(OC)c1OCCNCC1Cc2ccccc2C(c2ccccc2)C1 10.1021/jm011066n
44277158 108422 0 None - 0 Rat 5.8 pKd = 5.8 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 449 11 3 10 3.0 COc1cc2nc(NCCSSCCNC(=O)c3ccco3)nc(N)c2cc1OC 10.1016/s0960-894x(98)00217-0
CHEMBL29907 108422 0 None - 0 Rat 5.8 pKd = 5.8 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 449 11 3 10 3.0 COc1cc2nc(NCCSSCCNC(=O)c3ccco3)nc(N)c2cc1OC 10.1016/s0960-894x(98)00217-0
11430126 67337 0 None - 0 Rat 7.7 pKd = 7.7 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 421 4 1 9 2.0 COc1cc2nc(N3CCN(C(=O)C4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL175934 67337 0 None - 0 Rat 7.7 pKd = 7.7 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 421 4 1 9 2.0 COc1cc2nc(N3CCN(C(=O)C4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
6603808 134300 3 None - 2 Rat 7.7 pKd = 7.7 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214986 134300 3 None - 2 Rat 7.7 pKd = 7.7 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL36622 134300 3 None - 2 Rat 7.7 pKd = 7.7 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3740374 134300 3 None - 2 Rat 7.7 pKd = 7.7 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
3584 10549 64 None - 11 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
5401 10549 64 None - 11 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
7302 10549 64 None - 11 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
CHEMBL611 10549 64 None - 11 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
DB01162 10549 64 None - 11 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
44323554 213238 0 None - 0 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 446 8 1 7 2.9 CN(C)C(=O)c1cccnc1N1CCC(NCCOc2ccccc2-c2cncnc2)CC1 10.1021/jm970166j
CHEMBL88109 213238 0 None - 0 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 446 8 1 7 2.9 CN(C)C(=O)c1cccnc1N1CCC(NCCOc2ccccc2-c2cncnc2)CC1 10.1021/jm970166j
10651334 36524 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 607 20 2 9 5.2 CNCCCCCCN(C)Cc1ccc(C(=O)N(C)CCCCCCN(C)c2nc(N)c3cc(OC)c(OC)cc3n2)cc1 10.1021/jm9810654
CHEMBL138681 36524 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 607 20 2 9 5.2 CNCCCCCCN(C)Cc1ccc(C(=O)N(C)CCCCCCN(C)c2nc(N)c3cc(OC)c(OC)cc3n2)cc1 10.1021/jm9810654
10673882 45499 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 534 13 1 11 3.5 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccc(CN(C)C)o3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL146601 45499 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 534 13 1 11 3.5 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccc(CN(C)C)o3)nc(N)c2cc1OC 10.1021/jm9810654
45268939 203439 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL564481 203439 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
10786159 213419 1 None - 0 Rabbit 6.7 pKd = 6.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 382 7 1 6 2.1 Cc1cnccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL89222 213419 1 None - 0 Rabbit 6.7 pKd = 6.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 382 7 1 6 2.1 Cc1cnccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
3157 8252 71 None -2 22 Rat 8.7 pKd = 8.7 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
7170 8252 71 None -2 22 Rat 8.7 pKd = 8.7 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
954 8252 71 None -2 22 Rat 8.7 pKd = 8.7 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
CHEMBL707 8252 71 None -2 22 Rat 8.7 pKd = 8.7 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
DB00590 8252 71 None -2 22 Rat 8.7 pKd = 8.7 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
3157 8252 71 None -2 22 Rat 8.7 pKd = 8.7 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
7170 8252 71 None -2 22 Rat 8.7 pKd = 8.7 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
954 8252 71 None -2 22 Rat 8.7 pKd = 8.7 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
CHEMBL707 8252 71 None -2 22 Rat 8.7 pKd = 8.7 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
DB00590 8252 71 None -2 22 Rat 8.7 pKd = 8.7 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
11039289 123618 0 None - 0 Rat 8.6 pKd = 8.6 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 600 13 1 9 4.7 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCCCO[N+](=O)[O-])CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL338029 123618 0 None - 0 Rat 8.6 pKd = 8.6 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 600 13 1 9 4.7 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCCCO[N+](=O)[O-])CC3)cccc2c1=O 10.1021/jm030825u
4209 9937 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
4893 9937 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
503 9937 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
5385 9937 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
CHEMBL2 9937 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
DB00457 9937 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
10555166 213497 0 None - 0 Rabbit 8.6 pKd = 8.6 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 575 9 1 8 4.5 CN(C)C(=O)c1cnc2c(c(C(C)(C)C)nn2C)c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL89822 213497 0 None - 0 Rabbit 8.6 pKd = 8.6 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 575 9 1 8 4.5 CN(C)C(=O)c1cnc2c(c(C(C)(C)C)nn2C)c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
4209 9937 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
4893 9937 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
503 9937 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
5385 9937 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
CHEMBL2 9937 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
DB00457 9937 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
10549596 91380 1 None - 0 Rat 8.6 pKd = 8.6 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153553 91380 1 None - 0 Rat 8.6 pKd = 8.6 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221147 91380 1 None - 0 Rat 8.6 pKd = 8.6 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
10456471 107309 0 None - 0 Rat 8.5 pKd = 8.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 6 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
CHEMBL291303 107309 0 None - 0 Rat 8.5 pKd = 8.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 6 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
11133868 162121 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNC[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1021/jm011066n
CHEMBL40325 162121 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNC[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1021/jm011066n
115 7131 71 None 14 5 Human 6.7 pKd = 6.7 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
2092 7131 71 None 14 5 Human 6.7 pKd = 6.7 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
7109 7131 71 None 14 5 Human 6.7 pKd = 6.7 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
CHEMBL709 7131 71 None 14 5 Human 6.7 pKd = 6.7 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
DB00346 7131 71 None 14 5 Human 6.7 pKd = 6.7 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
11751173 70200 0 None - 0 Rat 7.6 pKd = 7.6 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 445 4 1 9 2.3 COc1cc2nc(N3CCN(C4=CC(=O)c5ccccc5C4=O)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL179743 70200 0 None - 0 Rat 7.6 pKd = 7.6 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 445 4 1 9 2.3 COc1cc2nc(N3CCN(C4=CC(=O)c5ccccc5C4=O)CC3)nc(N)c2cc1OC 10.1021/jm049153d
44586479 195406 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 572 10 1 8 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL503007 195406 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 572 10 1 8 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
115 7131 71 None - 5 Rat 7.6 pKd = 7.6 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
2092 7131 71 None - 5 Rat 7.6 pKd = 7.6 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
7109 7131 71 None - 5 Rat 7.6 pKd = 7.6 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
CHEMBL709 7131 71 None - 5 Rat 7.6 pKd = 7.6 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
DB00346 7131 71 None - 5 Rat 7.6 pKd = 7.6 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
10620831 213666 0 None - 0 Rabbit 7.6 pKd = 7.6 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ccc(C(=O)N(C)C)cn2)CC1 10.1021/jm970166j
CHEMBL90778 213666 0 None - 0 Rabbit 7.6 pKd = 7.6 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ccc(C(=O)N(C)C)cn2)CC1 10.1021/jm970166j
44586430 193809 0 None - 0 Rat 7.6 pKd = 7.6 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 528 9 1 6 3.4 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL490865 193809 0 None - 0 Rat 7.6 pKd = 7.6 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 528 9 1 6 3.4 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
3157 8252 71 None -38 22 Human 7.6 pKd = 7.6 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
7170 8252 71 None -38 22 Human 7.6 pKd = 7.6 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
954 8252 71 None -38 22 Human 7.6 pKd = 7.6 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
CHEMBL707 8252 71 None -38 22 Human 7.6 pKd = 7.6 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
DB00590 8252 71 None -38 22 Human 7.6 pKd = 7.6 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
135 9310 43 None -72 33 Human 6.6 pKd = 6.6 Functional
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00370a011
1796 9310 43 None -72 33 Human 6.6 pKd = 6.6 Functional
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00370a011
4184 9310 43 None -72 33 Human 6.6 pKd = 6.6 Functional
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00370a011
CHEMBL6437 9310 43 None -72 33 Human 6.6 pKd = 6.6 Functional
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00370a011
DB06148 9310 43 None -72 33 Human 6.6 pKd = 6.6 Functional
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00370a011
11273296 177075 0 None - 0 Rat 6.6 pKd = 6.6 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 586 11 1 8 2.9 CCOC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL444648 177075 0 None - 0 Rat 6.6 pKd = 6.6 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 586 11 1 8 2.9 CCOC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
10834793 91354 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153557 91354 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220925 91354 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
44289261 171691 0 None - 0 Rat 6.5 pKd = 6.5 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 417 9 1 4 5.1 COc1cccc(OC)c1OCCNCC1Cc2ccccc2C(c2ccccc2)C1 10.1021/jm011066n
CHEMBL42231 171691 0 None - 0 Rat 6.5 pKd = 6.5 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 417 9 1 4 5.1 COc1cccc(OC)c1OCCNCC1Cc2ccccc2C(c2ccccc2)C1 10.1021/jm011066n
10344976 107992 2 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 477 11 1 10 3.4 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL29591 107992 2 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 477 11 1 10 3.4 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
10363912 13310 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (alpha1A receptor)Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (alpha1A receptor)
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL1082862 13310 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (alpha1A receptor)Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (alpha1A receptor)
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL286003 13310 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (alpha1A receptor)Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (alpha1A receptor)
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
10344976 107992 2 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 477 11 1 10 3.4 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1016/s0960-894x(98)00217-0
CHEMBL29591 107992 2 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 477 11 1 10 3.4 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1016/s0960-894x(98)00217-0
10671310 213704 0 None - 0 Rabbit 8.5 pKd = 8.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 451 8 1 6 3.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL91036 213704 0 None - 0 Rabbit 8.5 pKd = 8.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 451 8 1 6 3.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OC(F)(F)F)CC1 10.1021/jm970166j
21473427 213756 0 None - 0 Rabbit 8.5 pKd = 8.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 410 8 1 5 3.3 COc1ccccc1N1CCN(CCCNc2c(C)cccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL91326 213756 0 None - 0 Rabbit 8.5 pKd = 8.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 410 8 1 5 3.3 COc1ccccc1N1CCN(CCCNc2c(C)cccc2C(=O)N(C)C)CC1 10.1021/jm970166j
148842 10718 27 None 12 2 Rat 8.4 pKd = 8.4 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm030825u
496 10718 27 None 12 2 Rat 8.4 pKd = 8.4 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm030825u
CHEMBL278865 10718 27 None 12 2 Rat 8.4 pKd = 8.4 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm030825u
489 6933 28 None - 1 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm970166j
5640 6933 28 None - 1 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm970166j
CHEMBL420060 6933 28 None - 1 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm970166j
44323803 213326 0 None - 0 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 398 8 1 7 1.8 COc1ccccc1N1CCN(CCCNc2cncnc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL88633 213326 0 None - 0 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 398 8 1 7 1.8 COc1ccccc1N1CCN(CCCNc2cncnc2C(=O)N(C)C)CC1 10.1021/jm970166j
10596968 213757 0 None - 0 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 0 5 3.0 COc1ccccc1N1CCN(CCCOc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL91338 213757 0 None - 0 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 0 5 3.0 COc1ccccc1N1CCN(CCCOc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10815708 213877 0 None - 0 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 515 9 1 6 4.5 CN(C)C(=O)c1cnc2ccccc2c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL91989 213877 0 None - 0 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 515 9 1 6 4.5 CN(C)C(=O)c1cnc2ccccc2c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
50905588 63127 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 mins
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@H]2Oc3ccccc3O[C@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630941 63127 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 mins
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@H]2Oc3ccccc3O[C@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
145971816 171311 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 412 8 1 6 2.6 COC(=O)Cc1ccc(OC[C@@H](O)CN2CCN(c3cc(C)ccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
CHEMBL4214992 171311 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 412 8 1 6 2.6 COC(=O)Cc1ccc(OC[C@@H](O)CN2CCN(c3cc(C)ccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
44428851 99093 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 447 4 1 7 3.5 COc1cc2nc(N3CCN(C(=O)c4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242934 99093 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 447 4 1 7 3.5 COc1cc2nc(N3CCN(C(=O)c4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
145962817 168298 0 None - 0 Rat 5.5 pKd = 5.5 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4128311 168298 0 None - 0 Rat 5.5 pKd = 5.5 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
10788615 213795 0 None - 0 Rabbit 7.5 pKd = 7.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 427 9 1 7 2.4 COc1ccc(N2CCN(CCCNc3ncccc3C(=O)N(C)C)CC2)c(OC)c1 10.1021/jm970166j
CHEMBL91480 213795 0 None - 0 Rabbit 7.5 pKd = 7.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 427 9 1 7 2.4 COc1ccc(N2CCN(CCCNc3ncccc3C(=O)N(C)C)CC2)c(OC)c1 10.1021/jm970166j
10598692 213923 0 None - 0 Rabbit 7.5 pKd = 7.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 429 9 1 5 4.6 COc1ccccc1N1CCN(CCCNc2ccccc2C(=O)c2ccccc2)CC1 10.1021/jm970166j
CHEMBL92259 213923 0 None - 0 Rabbit 7.5 pKd = 7.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 429 9 1 5 4.6 COc1ccccc1N1CCN(CCCNc2ccccc2C(=O)c2ccccc2)CC1 10.1021/jm970166j
4418 40996 85 None - 18 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.01.068
CHEMBL142635 40996 85 None - 18 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.01.068
DB12092 40996 85 None - 18 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.01.068
132266 8061 12 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
486 8061 12 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
CHEMBL423294 8061 12 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
11133288 172812 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 407 12 1 5 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1Cc1ccccc1 10.1021/jm011066n
CHEMBL42558 172812 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 407 12 1 5 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1Cc1ccccc1 10.1021/jm011066n
16721032 98963 0 None - 0 Rat 6.5 pKd = 6.5 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242507 98963 0 None - 0 Rat 6.5 pKd = 6.5 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
10348924 24717 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 620 10 1 10 3.8 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C#N)CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL125989 24717 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 620 10 1 10 3.8 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C#N)CC3)cccc2c1=O 10.1021/jm030825u
44417706 18607 0 None - 0 Rat 5.5 pKd = 5.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
CHEMBL1182152 18607 0 None - 0 Rat 5.5 pKd = 5.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
CHEMBL215188 18607 0 None - 0 Rat 5.5 pKd = 5.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
3584 10549 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
5401 10549 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
7302 10549 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
CHEMBL611 10549 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
DB01162 10549 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
3584 10549 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
5401 10549 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
7302 10549 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
CHEMBL611 10549 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
DB01162 10549 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
10072518 42679 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 451 11 1 7 4.0 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL144224 42679 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 451 11 1 7 4.0 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3)nc(N)c2cc1OC 10.1021/jm9810654
10553385 125943 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 498 13 1 9 3.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN(C)C)o3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL342997 125943 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 498 13 1 9 3.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN(C)C)o3)nc(N)c2cc1OC 10.1021/jm9810654
145964162 171115 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 412 8 1 6 2.6 COC(=O)Cc1ccc(OCC(O)CN2CCN(c3cc(C)ccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
CHEMBL4212528 171115 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 412 8 1 6 2.6 COC(=O)Cc1ccc(OCC(O)CN2CCN(c3cc(C)ccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
10621592 91346 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153559 91346 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220898 91346 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
9838192 118089 18 None - 3 Rat 5.4 pKd = 5.4 Functional
Antagonist activity at rat spleen adrenergic alpha1A receptorAntagonist activity at rat spleen adrenergic alpha1A receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1016/j.bmc.2008.02.091
CHEMBL326702 118089 18 None - 3 Rat 5.4 pKd = 5.4 Functional
Antagonist activity at rat spleen adrenergic alpha1A receptorAntagonist activity at rat spleen adrenergic alpha1A receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1016/j.bmc.2008.02.091
44289248 175755 0 None - 0 Rat 8.3 pKd = 8.3 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2S1 10.1021/jm011066n
CHEMBL43905 175755 0 None - 0 Rat 8.3 pKd = 8.3 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2S1 10.1021/jm011066n
10767688 43159 0 None - 0 Rat 6.4 pKd = 6.4 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 499 12 1 7 4.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CCl)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL144677 43159 0 None - 0 Rat 6.4 pKd = 6.4 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 499 12 1 7 4.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CCl)nc(N)c2cc1OC 10.1021/jm9810654
11994673 19088 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL1185036 19088 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL385371 19088 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
10430193 168377 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4129461 168377 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
10719536 127921 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 480 12 2 8 3.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN)c3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL357669 127921 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 480 12 2 8 3.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN)c3)nc(N)c2cc1OC 10.1021/jm9810654
145978803 170617 0 None - 0 Rat 6.3 pKd = 6.3 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 398 8 1 6 2.3 COC(=O)Cc1ccc(OCC(O)CN2CCN(c3ccccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
CHEMBL4206435 170617 0 None - 0 Rat 6.3 pKd = 6.3 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 398 8 1 6 2.3 COC(=O)Cc1ccc(OCC(O)CN2CCN(c3ccccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
4209 9937 75 None - 17 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
4893 9937 75 None - 17 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
503 9937 75 None - 17 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
5385 9937 75 None - 17 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
CHEMBL2 9937 75 None - 17 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
DB00457 9937 75 None - 17 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
10643699 213330 0 None - 0 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 7 2 6 2.1 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2O)CC1 10.1021/jm970166j
CHEMBL88664 213330 0 None - 0 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 7 2 6 2.1 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2O)CC1 10.1021/jm970166j
44289262 108151 2 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 421 9 1 6 4.3 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccccc1 10.1021/jm011066n
CHEMBL297106 108151 2 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 421 9 1 6 4.3 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccccc1 10.1021/jm011066n
44289262 108151 2 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 421 9 1 6 4.3 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccccc1 10.1021/jm011066n
CHEMBL297106 108151 2 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 421 9 1 6 4.3 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccccc1 10.1021/jm011066n
71454865 91378 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153551 91378 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221145 91378 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
3894573 10166 6 None - 0 Rabbit 7.3 pKd = 7.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm970166j
495 10166 6 None - 0 Rabbit 7.3 pKd = 7.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm970166j
CHEMBL88272 10166 6 None - 0 Rabbit 7.3 pKd = 7.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm970166j
10621592 91346 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153559 91346 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220898 91346 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
10097792 125367 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN(C)C)c3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL341665 125367 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN(C)C)c3)nc(N)c2cc1OC 10.1021/jm9810654
44417713 19194 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1185884 19194 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL439346 19194 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
10602797 43274 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 552 13 1 9 4.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN4CCSC4)cc3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL144768 43274 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 552 13 1 9 4.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN4CCSC4)cc3)nc(N)c2cc1OC 10.1021/jm9810654
11133288 172812 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 407 12 1 5 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1Cc1ccccc1 10.1021/jm011066n
CHEMBL42558 172812 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 407 12 1 5 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1Cc1ccccc1 10.1021/jm011066n
11994665 18606 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182151 18606 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL215151 18606 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
44289248 175755 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2S1 10.1021/jm011066n
CHEMBL43905 175755 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2S1 10.1021/jm011066n
10974101 123731 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 609 10 1 9 4.2 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C)CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL338608 123731 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 609 10 1 9 4.2 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C)CC3)cccc2c1=O 10.1021/jm030825u
2142 9870 58 None - 18 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
4920903 9870 58 None - 18 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
502 9870 58 None - 18 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
5775 9870 58 None - 18 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
CHEMBL597 9870 58 None - 18 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
DB00692 9870 58 None - 18 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
10766280 118416 0 None - 0 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 457 9 1 5 4.0 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2Cc2ccccc2)CC1 10.1021/jm970166j
CHEMBL328545 118416 0 None - 0 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 457 9 1 5 4.0 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2Cc2ccccc2)CC1 10.1021/jm970166j
10642742 213574 0 None - 0 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 367 7 1 5 2.4 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2)CC1 10.1021/jm970166j
CHEMBL90287 213574 0 None - 0 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 367 7 1 5 2.4 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2)CC1 10.1021/jm970166j
10814913 42692 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 489 12 1 8 4.3 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CCl)o3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL144238 42692 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 489 12 1 8 4.3 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CCl)o3)nc(N)c2cc1OC 10.1021/jm9810654
145975903 170600 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 412 8 1 6 2.6 COC(=O)Cc1ccc(OC[C@H](O)CN2CCN(c3cc(C)ccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
CHEMBL4206260 170600 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 412 8 1 6 2.6 COC(=O)Cc1ccc(OC[C@H](O)CN2CCN(c3cc(C)ccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
11169638 23966 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 600 11 1 8 3.3 CCOC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL1256344 23966 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 600 11 1 8 3.3 CCOC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
11454386 69881 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 477 8 1 9 3.6 COc1cc2nc(N3CCN(C(=O)CCCCC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL178923 69881 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 477 8 1 9 3.6 COc1cc2nc(N3CCN(C(=O)CCCCC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
10552704 170228 0 None - 0 Rabbit 8.1 pKd = 8.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 479 8 1 6 4.0 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c(C)cccc23)CC1 10.1021/jm970166j
CHEMBL419867 170228 0 None - 0 Rabbit 8.1 pKd = 8.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 479 8 1 6 4.0 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c(C)cccc23)CC1 10.1021/jm970166j
10767948 42723 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN(C)C)cc3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL144263 42723 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN(C)C)cc3)nc(N)c2cc1OC 10.1021/jm9810654
11994915 18604 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182145 18604 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214762 18604 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
10743978 128081 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 499 12 1 7 4.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CCl)cc3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL358060 128081 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 499 12 1 7 4.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CCl)cc3)nc(N)c2cc1OC 10.1021/jm9810654
69781970 168130 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4125981 168130 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
10815228 44042 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 499 12 1 7 4.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CCl)c3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL145384 44042 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 499 12 1 7 4.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CCl)c3)nc(N)c2cc1OC 10.1021/jm9810654
10531768 42426 0 None - 0 Rat 8.1 pKd = 8.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 607 20 2 9 5.2 CNCCCCCCN(C)Cc1cccc(C(=O)N(C)CCCCCCN(C)c2nc(N)c3cc(OC)c(OC)cc3n2)c1 10.1021/jm9810654
CHEMBL144000 42426 0 None - 0 Rat 8.1 pKd = 8.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 607 20 2 9 5.2 CNCCCCCCN(C)Cc1cccc(C(=O)N(C)CCCCCCN(C)c2nc(N)c3cc(OC)c(OC)cc3n2)c1 10.1021/jm9810654
52941981 24288 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 502 7 1 5 3.1 CN1C(=O)N(CC(O)CN2CCN(c3ccccc3F)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL1257883 24288 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 502 7 1 5 3.1 CN1C(=O)N(CC(O)CN2CCN(c3ccccc3F)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
3584 10549 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
5401 10549 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
7302 10549 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
CHEMBL611 10549 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
DB01162 10549 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
3584 10549 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
5401 10549 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
7302 10549 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
CHEMBL611 10549 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
DB01162 10549 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
3584 10549 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
5401 10549 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
7302 10549 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
CHEMBL611 10549 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
DB01162 10549 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
11994797 19086 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
CHEMBL1185017 19086 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
CHEMBL383938 19086 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
10553687 45655 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CN(C)C)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL146724 45655 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CN(C)C)nc(N)c2cc1OC 10.1021/jm9810654
49800167 24453 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 514 9 2 6 3.1 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL1258457 24453 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 514 9 2 6 3.1 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
2419 7482 28 None - 3 Rat 7.0 pKd = 7.0 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm011066n
9 7482 28 None - 3 Rat 7.0 pKd = 7.0 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm011066n
CHEMBL13647 7482 28 None - 3 Rat 7.0 pKd = 7.0 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm011066n
9827677 175201 0 None - 0 Human 9.7 pKi = 9.7 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 510 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL43491 175201 0 None - 0 Human 9.7 pKi = 9.7 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 510 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
44288945 175694 0 None - 0 Human 9.4 pKi = 9.4 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 485 7 2 3 4.4 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL43860 175694 0 None - 0 Human 9.4 pKi = 9.4 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 485 7 2 3 4.4 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
499 10849 18 None - 1 Human 9.4 pKi = 9.4 Functional
Antagonistic affinity tested against isolated Human recombinant Thoracic Aorta Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Human recombinant Thoracic Aorta Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
5685 10849 18 None - 1 Human 9.4 pKi = 9.4 Functional
Antagonistic affinity tested against isolated Human recombinant Thoracic Aorta Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Human recombinant Thoracic Aorta Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
CHEMBL25554 10849 18 None - 1 Human 9.4 pKi = 9.4 Functional
Antagonistic affinity tested against isolated Human recombinant Thoracic Aorta Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Human recombinant Thoracic Aorta Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
44289100 106925 0 None - 0 Human 9.2 pKi = 9.2 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 499 7 1 3 4.7 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL287791 106925 0 None - 0 Human 9.2 pKi = 9.2 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 499 7 1 3 4.7 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
10436842 107032 0 None - 0 Human 9.1 pKi = 9.1 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 524 7 1 4 4.6 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL288772 107032 0 None - 0 Human 9.1 pKi = 9.1 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 524 7 1 4 4.6 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
44288874 107872 0 None - 0 Human 9.0 pKi = 9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 528 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL295001 107872 0 None - 0 Human 9.0 pKi = 9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 528 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
44289107 172959 0 None - 0 Human 9.0 pKi = 9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 492 7 2 4 4.1 CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL42640 172959 0 None - 0 Human 9.0 pKi = 9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 492 7 2 4 4.1 CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
44288769 107925 0 None - 0 Human 9.0 pKi = 9.0 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 542 7 1 4 4.5 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL295395 107925 0 None - 0 Human 9.0 pKi = 9.0 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 542 7 1 4 4.5 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
44288847 172088 0 None - 0 Human 8.9 pKi = 8.9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 535 7 2 5 3.9 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL42335 172088 0 None - 0 Human 8.9 pKi = 8.9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 535 7 2 5 3.9 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
44288917 107031 0 None - 0 Human 8.7 pKi = 8.7 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 510 7 2 4 4.0 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL288768 107031 0 None - 0 Human 8.7 pKi = 8.7 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 510 7 2 4 4.0 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
44289035 107290 0 None - 0 Human 8.7 pKi = 8.7 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 524 7 1 4 4.4 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL291166 107290 0 None - 0 Human 8.7 pKi = 8.7 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 524 7 1 4 4.4 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
53327992 70179 0 None - 0 Human 8.0 pKi = 8 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation countingAntagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting
ChEMBL 461 7 0 5 3.6 COc1ccccc1N1CCN(CCCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796050 70179 0 None - 0 Human 8.0 pKi = 8 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation countingAntagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting
ChEMBL 461 7 0 5 3.6 COc1ccccc1N1CCN(CCCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
71451044 87249 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 410 7 0 5 4.3 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146807 87249 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 410 7 0 5 4.3 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O 10.1016/j.bmc.2012.08.032
25071930 25852 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 366 2 1 4 3.7 O=C1OC2(CCN(c3nc4cc(F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289039 25852 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 366 2 1 4 3.7 O=C1OC2(CCN(c3nc4cc(F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
25072242 26110 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 416 2 1 4 4.6 O=C1OC2(CCN(c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1290706 26110 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 416 2 1 4 4.6 O=C1OC2(CCN(c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
25022356 26111 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 348 2 1 4 3.6 O=C1OC2(CCN(c3nc4ccccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1290707 26111 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 348 2 1 4 3.6 O=C1OC2(CCN(c3nc4ccccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
71452871 87243 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 412 7 0 6 3.1 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146801 87243 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 412 7 0 6 3.1 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O 10.1016/j.bmc.2012.08.032
71458203 87247 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146805 87247 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O 10.1016/j.bmc.2012.08.032
25071310 25886 0 None - 0 Human 5.9 pKi = 5.9 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 431 3 1 4 5.5 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289267 25886 0 None - 0 Human 5.9 pKi = 5.9 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 431 3 1 4 5.5 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
25072876 25984 0 None - 0 Human 5.9 pKi = 5.9 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 416 2 1 4 5.0 O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.09.064
CHEMBL1289936 25984 0 None - 0 Human 5.9 pKi = 5.9 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 416 2 1 4 5.0 O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.09.064
44288843 175457 0 None - 0 Human 7.9 pKi = 7.9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 531 7 1 5 4.1 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL43651 175457 0 None - 0 Human 7.9 pKi = 7.9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 531 7 1 5 4.1 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
71461781 87244 0 None - 0 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 409 7 0 4 4.9 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146802 87244 0 None - 0 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 409 7 0 4 4.9 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmc.2012.08.032
71458205 87253 0 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 412 7 0 6 3.1 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146811 87253 0 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 412 7 0 6 3.1 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O 10.1016/j.bmc.2012.08.032
25072875 25939 0 None - 0 Human 5.8 pKi = 5.8 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 446 3 1 5 5.2 Cc1cccc(N2C[C@]3(CC[C@@H](c4nc5cc(OC(F)(F)F)ccc5[nH]4)CC3)OC2=O)n1 10.1016/j.bmcl.2010.09.064
CHEMBL1289609 25939 0 None - 0 Human 5.8 pKi = 5.8 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 446 3 1 5 5.2 Cc1cccc(N2C[C@]3(CC[C@@H](c4nc5cc(OC(F)(F)F)ccc5[nH]4)CC3)OC2=O)n1 10.1016/j.bmcl.2010.09.064
71456359 87245 0 None - 0 Human 7.7 pKi = 7.7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 411 7 0 5 3.8 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146803 87245 0 None - 0 Human 7.7 pKi = 7.7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 411 7 0 5 3.8 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmc.2012.08.032
71449250 87246 0 None - 0 Human 7.7 pKi = 7.7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccncc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146804 87246 0 None - 0 Human 7.7 pKi = 7.7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccncc2c1=O 10.1016/j.bmc.2012.08.032
71458204 87251 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146809 87251 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O 10.1016/j.bmc.2012.08.032
25071621 25872 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 432 3 1 5 4.5 O=C1OC2(CCN(c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289154 25872 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 432 3 1 5 4.5 O=C1OC2(CCN(c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
25073191 25923 0 None - 0 Human 5.7 pKi = 5.7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 432 3 1 5 4.9 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.09.064
CHEMBL1289503 25923 0 None - 0 Human 5.7 pKi = 5.7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 432 3 1 5 4.9 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.09.064
25071931 25973 0 None - 0 Human 5.7 pKi = 5.7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 415 2 1 3 5.6 O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289820 25973 0 None - 0 Human 5.7 pKi = 5.7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 415 2 1 3 5.6 O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
53327748 70162 0 None - 0 Human 8.6 pKi = 8.6 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation countingAntagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting
ChEMBL 435 8 0 5 3.5 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796033 70162 0 None - 0 Human 8.6 pKi = 8.6 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation countingAntagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting
ChEMBL 435 8 0 5 3.5 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
44288864 170241 0 None - 0 Human 6.6 pKi = 6.6 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 507 7 1 5 3.6 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL41996 170241 0 None - 0 Human 6.6 pKi = 6.6 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 507 7 1 5 3.6 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
44289103 162403 0 None - 0 Human 8.5 pKi = 8.5 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 506 7 1 4 4.4 CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL40464 162403 0 None - 0 Human 8.5 pKi = 8.5 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 506 7 1 4 4.4 CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
44288858 175934 0 None - 0 Human 8.5 pKi = 8.5 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 517 7 2 5 3.8 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL44042 175934 0 None - 0 Human 8.5 pKi = 8.5 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 517 7 2 5 3.8 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
49864841 22503 0 None - 0 Human 8.4 pKi = 8.4 Functional
Antagonist activity at human adrenergic alpha1A receptor assessed as intracellular calcium luminescence by cell based aequorin assayAntagonist activity at human adrenergic alpha1A receptor assessed as intracellular calcium luminescence by cell based aequorin assay
ChEMBL 266 1 1 4 1.6 C1=C(N2CCNCC2)c2nccn2Cc2ccccc21 10.1016/j.bmcl.2010.07.029
CHEMBL1222552 22503 0 None - 0 Human 8.4 pKi = 8.4 Functional
Antagonist activity at human adrenergic alpha1A receptor assessed as intracellular calcium luminescence by cell based aequorin assayAntagonist activity at human adrenergic alpha1A receptor assessed as intracellular calcium luminescence by cell based aequorin assay
ChEMBL 266 1 1 4 1.6 C1=C(N2CCNCC2)c2nccn2Cc2ccccc21 10.1016/j.bmcl.2010.07.029
53327991 70175 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation countingAntagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting
ChEMBL 449 8 0 5 3.7 COc1ccccc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796046 70175 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation countingAntagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting
ChEMBL 449 8 0 5 3.7 COc1ccccc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
15254720 68075 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 367 4 0 4 3.7 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL1767136 68075 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 367 4 0 4 3.7 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmc.2012.08.032
24804150 87255 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 641 14 0 7 7.2 O=c1c2ccncc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1016/j.bmc.2012.08.032
CHEMBL2146813 87255 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 641 14 0 7 7.2 O=c1c2ccncc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1016/j.bmc.2012.08.032
71456360 87250 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 412 7 0 6 3.1 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146808 87250 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 412 7 0 6 3.1 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O 10.1016/j.bmc.2012.08.032
2419 7482 28 None - 3 Human 6.4 pKi = 6.4 Functional
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm021078o
9 7482 28 None - 3 Human 6.4 pKi = 6.4 Functional
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm021078o
CHEMBL13647 7482 28 None - 3 Human 6.4 pKi = 6.4 Functional
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm021078o
17747460 68103 12 None - 2 Human 7.4 pKi = 7.4 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 640 14 0 6 7.8 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1016/j.bmc.2012.08.032
CHEMBL1767164 68103 12 None - 2 Human 7.4 pKi = 7.4 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 640 14 0 6 7.8 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1016/j.bmc.2012.08.032
25071929 25851 0 None - 0 Human 7.4 pKi = 7.4 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 426 2 1 4 4.3 O=C1OC2(CCN(c3nc4cc(Br)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289038 25851 0 None - 0 Human 7.4 pKi = 7.4 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 426 2 1 4 4.3 O=C1OC2(CCN(c3nc4cc(Br)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
71456361 87254 0 None - 0 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 369 4 0 6 2.5 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2nccnc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146812 87254 0 None - 0 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 369 4 0 6 2.5 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2nccnc2c1=O 10.1016/j.bmc.2012.08.032
44288729 170518 0 None - 0 Human 7.4 pKi = 7.4 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 507 7 2 5 3.5 CC1=C(C(=O)NCC(C)CN2CCC(C#N)(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL42053 170518 0 None - 0 Human 7.4 pKi = 7.4 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 507 7 2 5 3.5 CC1=C(C(=O)NCC(C)CN2CCC(C#N)(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
2267 7347 71 None -45 14 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmc.2012.08.032
271 7347 71 None -45 14 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmc.2012.08.032
7121 7347 71 None -45 14 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmc.2012.08.032
CHEMBL639 7347 71 None -45 14 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmc.2012.08.032
DB00972 7347 71 None -45 14 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmc.2012.08.032
71454639 87252 0 None - 0 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 410 7 0 5 4.3 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146810 87252 0 None - 0 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 410 7 0 5 4.3 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O 10.1016/j.bmc.2012.08.032
25073801 25956 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 450 3 1 5 5.0 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1cccc(F)n1 10.1016/j.bmcl.2010.09.064
CHEMBL1289714 25956 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 450 3 1 5 5.0 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1cccc(F)n1 10.1016/j.bmcl.2010.09.064
71461782 87248 0 None - 0 Human 8.2 pKi = 8.2 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 410 7 0 5 4.3 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146806 87248 0 None - 0 Human 8.2 pKi = 8.2 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 410 7 0 5 4.3 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O 10.1016/j.bmc.2012.08.032
71452872 87209 0 None - 0 Human 6.2 pKi = 6.2 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146484 87209 0 None - 0 Human 6.2 pKi = 6.2 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O 10.1016/j.bmc.2012.08.032
44288877 175378 0 None - 0 Human 8.2 pKi = 8.2 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 549 7 1 5 4.3 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL43594 175378 0 None - 0 Human 8.2 pKi = 8.2 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 549 7 1 5 4.3 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
25073189 25887 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 449 3 1 4 5.7 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1F 10.1016/j.bmcl.2010.09.064
CHEMBL1289268 25887 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 449 3 1 4 5.7 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1F 10.1016/j.bmcl.2010.09.064
25072880 25906 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 449 3 1 4 5.7 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccc(F)cc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289386 25906 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 449 3 1 4 5.7 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccc(F)cc1 10.1016/j.bmcl.2010.09.064
135398745 9688 112 None -2 33 Rat 7.4 pA2 = 7.4 Functional
Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.
Guide to Pharmacology 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 18542932
47 9688 112 None -2 33 Rat 7.4 pA2 = 7.4 Functional
Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.
Guide to Pharmacology 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 18542932
CHEMBL715 9688 112 None -2 33 Rat 7.4 pA2 = 7.4 Functional
Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.
Guide to Pharmacology 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 18542932
DB00334 9688 112 None -2 33 Rat 7.4 pA2 = 7.4 Functional
Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.
Guide to Pharmacology 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 18542932
41835 224494 0 None -54 2 Human 6.1 pA2 = 6.1 Functional
NoneNone
Drug Central 372 8 4 6 1.9 CC(CCC1=CC2=C(OCO2)C=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1 None
1753 9282 28 None 2 4 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC None
483 9282 28 None 2 4 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC None
6082 9282 28 None 2 4 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC None
CHEMBL524 9282 28 None 2 4 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC None
DB00723 9282 28 None 2 4 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC None
2435 7509 100 None -25 10 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
395 7509 100 None -25 10 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
520 7509 100 None -25 10 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
5386 7509 100 None -25 10 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
CHEMBL844 7509 100 None -25 10 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
DB00484 7509 100 None -25 10 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
521 8186 69 None -501 5 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
5311068 8186 69 None -501 5 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
835 8186 69 None -501 5 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
CHEMBL778 8186 69 None -501 5 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
DB00633 8186 69 None -501 5 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
2683 10606 60 None 1 6 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
5487 10606 60 None 1 6 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
7308 10606 60 None 1 6 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
CHEMBL1079 10606 60 None 1 6 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
DB00697 10606 60 None 1 6 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
2803 7742 58 None -6 14 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 7742 58 None -6 14 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 7742 58 None -6 14 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 7742 58 None -6 14 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 7742 58 None -6 14 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
1753 9282 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
1753 9282 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
1753 9282 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
483 9282 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
483 9282 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
483 9282 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
6082 9282 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
6082 9282 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
6082 9282 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
CHEMBL524 9282 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
CHEMBL524 9282 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
CHEMBL524 9282 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
DB00723 9282 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
DB00723 9282 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
DB00723 9282 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
2146 9874 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
2146 9874 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
2146 9874 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
485 9874 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
485 9874 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
485 9874 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
6041 9874 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
6041 9874 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
6041 9874 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
CHEMBL1215 9874 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
CHEMBL1215 9874 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
CHEMBL1215 9874 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
DB00388 9874 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
DB00388 9874 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
DB00388 9874 67 None -20 15 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
1960 9632 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
1960 9632 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
1960 9632 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
439260 9632 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
439260 9632 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
439260 9632 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
505 9632 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
505 9632 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
505 9632 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
CHEMBL1437 9632 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
CHEMBL1437 9632 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
CHEMBL1437 9632 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
DB00368 9632 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
DB00368 9632 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
DB00368 9632 67 None -2 19 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
1028 7079 71 None 1 19 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
139148732 7079 71 None 1 19 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
479 7079 71 None 1 19 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
5816 7079 71 None 1 19 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
CHEMBL679 7079 71 None 1 19 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
DB00668 7079 71 None 1 19 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
11079 9510 63 None 5 7 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
3369 9510 63 None 5 7 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
4436 9510 63 None 5 7 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
5509 9510 63 None 5 7 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
CHEMBL761 9510 63 None 5 7 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
DB06711 9510 63 None 5 7 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
2765 7730 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
2765 7730 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
515 7730 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
515 7730 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
CHEMBL13852 7730 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
CHEMBL13852 7730 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
DB09202 7730 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
DB09202 7730 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
124 9755 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
124 9755 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
124 9755 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
2032 9755 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
2032 9755 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
2032 9755 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
4636 9755 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
4636 9755 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
4636 9755 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
CHEMBL762 9755 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
CHEMBL762 9755 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
CHEMBL762 9755 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
DB00935 9755 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
DB00935 9755 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
DB00935 9755 47 None -8 25 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
4038180 6992 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 20978120
4038180 6992 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 28444738
4038180 6992 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 34355529
4038180 6992 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 7616455
480 6992 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 20978120
480 6992 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 28444738
480 6992 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 34355529
480 6992 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 7616455
CHEMBL109783 6992 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 20978120
CHEMBL109783 6992 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 28444738
CHEMBL109783 6992 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 34355529
CHEMBL109783 6992 14 None -1 6 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 7616455
135 9310 43 None -2 33 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 9310 43 None -2 33 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 9310 43 None -2 33 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 9310 43 None -2 33 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 9310 43 None -2 33 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
2398 7741 62 None -2 36 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
2801 7741 62 None -2 36 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
701 7741 62 None -2 36 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
CHEMBL415 7741 62 None -2 36 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
DB01242 7741 62 None -2 36 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
1971 9641 38 None -6 32 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
2404 9641 38 None -6 32 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
4543 9641 38 None -6 32 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
CHEMBL445 9641 38 None -6 32 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
DB00540 9641 38 None -6 32 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
180 7189 56 None -3 38 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
200 7189 56 None -3 38 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
2160 7189 56 None -3 38 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
CHEMBL629 7189 56 None -3 38 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
DB00321 7189 56 None -3 38 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
1225 8253 26 None -5 11 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
3958 8253 26 None -5 11 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
667468 8253 26 None -5 11 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
667477 8253 26 None -5 11 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
CHEMBL101740 8253 26 None -5 11 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
CHEMBL860 8253 26 None -5 11 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
DB01142 8253 26 None -5 11 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
3823 56995 42 None 5 16 Rat 8.4 pIC50 = 8.4 Functional
NoneNone
Drug Central 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
76973198 56995 42 None 5 16 Rat 8.4 pIC50 = 8.4 Functional
NoneNone
Drug Central 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
CHEMBL157101 56995 42 None 5 16 Rat 8.4 pIC50 = 8.4 Functional
NoneNone
Drug Central 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
2812 11551 101 None -3 44 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 None
CHEMBL104 11551 101 None -3 44 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 None
1016 10519 78 None -41 40 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
2561 10519 78 None -41 40 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
2733526 10519 78 None -41 40 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
5384 10519 78 None -41 40 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
CHEMBL83 10519 78 None -41 40 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
DB00675 10519 78 None -41 40 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
3198 212292 76 None -1 37 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL1201049 212292 76 None -1 37 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL808 212292 76 None -1 37 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
448537 167029 89 None 8 31 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
CHEMBL411 167029 89 None 8 31 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
441383 27105 57 None -2 20 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
CHEMBL1306 27105 57 None -2 20 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
10219 195575 37 None -1 10 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 None
CHEMBL493439 195575 37 None -1 10 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 None
CHEMBL50588 195575 37 None -1 10 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 None
1599 9120 50 None -97 21 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 None
3955 9120 50 None -97 21 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 None
7215 9120 50 None -97 21 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 None
CHEMBL841 9120 50 None -97 21 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 None
DB00836 9120 50 None -97 21 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 None
2291 9958 58 None -3 13 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
2561 9958 58 None -3 13 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
4932 9958 58 None -3 13 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
CHEMBL631 9958 58 None -3 13 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
DB01182 9958 58 None -3 13 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
1935 10506 97 None -1 12 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 None
2551 10506 97 None -1 12 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 None
6687 10506 97 None -1 12 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 None
CHEMBL95 10506 97 None -1 12 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 None
DB00382 10506 97 None -1 12 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 None
3191 109635 97 None -6 33 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 None
CHEMBL305660 109635 97 None -6 33 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 None
DB11742 109635 97 None -6 33 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 None
2351 10059 64 None -16 27 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
2820 10059 64 None -16 27 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
5035 10059 64 None -16 27 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
CHEMBL81 10059 64 None -16 27 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
DB00481 10059 64 None -16 27 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
2520 210787 70 None 1 20 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC None
CHEMBL1280 210787 70 None 1 20 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC None
CHEMBL6966 210787 70 None 1 20 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC None
2105 9828 37 None -16 24 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
47811 9828 37 None -16 24 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
48 9828 37 None -16 24 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
CHEMBL531 9828 37 None -16 24 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
DB01186 9828 37 None -16 24 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
1547484 7727 74 None -1 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
654 7727 74 None -1 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
9072 7727 74 None -1 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
CHEMBL43064 7727 74 None -1 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
DB00568 7727 74 None -1 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
2771 201796 74 None 3 16 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
CHEMBL1200781 201796 74 None 3 16 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
CHEMBL549 201796 74 None 3 16 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
1343 8670 62 None -7 12 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
3519 8670 62 None -7 12 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
522 8670 62 None -7 12 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
CHEMBL862 8670 62 None -7 12 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
DB01018 8670 62 None -7 12 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
102 10899 48 None -12 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 10899 48 None -12 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 10899 48 None -12 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 10899 48 None -12 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 10899 48 None -12 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
4735 201894 96 None 7 14 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 None
CHEMBL361506 201894 96 None 7 14 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 None
CHEMBL55 201894 96 None 7 14 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 None
12488 8438 56 None -2 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
941361 8438 56 None -2 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
CHEMBL30008 8438 56 None -2 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
DB04841 8438 56 None -2 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
1028 7079 71 None -3 19 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 7079 71 None -3 19 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 7079 71 None -3 19 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 7079 71 None -3 19 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 7079 71 None -3 19 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 7079 71 None -3 19 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
4011 89183 49 None -7 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 None
CHEMBL21731 89183 49 None -7 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 None
3952 8669 38 None -5 21 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5353646 8669 38 None -5 21 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5443 8669 38 None -5 21 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5702063 8669 38 None -5 21 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL1331786 8669 38 None -5 21 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL420 8669 38 None -5 21 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
DB00629 8669 38 None -5 21 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
191 7191 98 None -7 36 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
201 7191 98 None -7 36 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
2170 7191 98 None -7 36 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
CHEMBL1113 7191 98 None -7 36 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
DB00543 7191 98 None -7 36 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
3151 8244 97 None -10 23 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
945 8244 97 None -10 23 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
965 8244 97 None -10 23 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
CHEMBL219916 8244 97 None -10 23 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
DB01184 8244 97 None -10 23 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
277 8083 62 None -40 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
2913 8083 62 None -40 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
765 8083 62 None -40 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
CHEMBL516 8083 62 None -40 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
DB00434 8083 62 None -40 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
6075 156887 42 None -1 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 None
CHEMBL395110 156887 42 None -1 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 None
1201549 7384 24 None -15 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
333 7384 24 None -15 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
7601 7384 24 None -15 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
CHEMBL1201203 7384 24 None -15 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
CHEMBL438151 7384 24 None -15 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
DB00245 7384 24 None -15 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
213 10625 55 None -3 22 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
2717 10625 55 None -3 22 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
5533 10625 55 None -3 22 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
CHEMBL621 10625 55 None -3 22 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
DB00656 10625 55 None -3 22 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
36811 8236 37 None 1 17 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
535 8236 37 None 1 17 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
937 8236 37 None 1 17 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
CHEMBL926 8236 37 None 1 17 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
DB00841 8236 37 None 1 17 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
3033538 8101 39 None -3 13 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 None
7155 8101 39 None -3 13 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 None
781 8101 39 None -3 13 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 None
CHEMBL1201216 8101 39 None -3 13 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 None
DB00298 8101 39 None -3 13 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 None
133 9274 52 None -66 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
1723 9274 52 None -66 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
28693 9274 52 None -66 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
CHEMBL19215 9274 52 None -66 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
DB13520 9274 52 None -66 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
2337 10030 77 None -4 29 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 10030 77 None -4 29 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 10030 77 None -4 29 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 10030 77 None -4 29 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 10030 77 None -4 29 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
2337 10030 77 None -1 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 10030 77 None -1 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 10030 77 None -1 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 10030 77 None -1 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 10030 77 None -1 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
2286 9957 51 None -5 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
4927 9957 51 None -5 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
7282 9957 51 None -5 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
CHEMBL643 9957 51 None -5 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
DB01069 9957 51 None -5 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
135398745 9688 112 None -2 33 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 9688 112 None -2 33 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 9688 112 None -2 33 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 9688 112 None -2 33 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
1531 9046 69 None -2 12 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
3869 9046 69 None -2 12 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
7207 9046 69 None -2 12 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
CHEMBL429 9046 69 None -2 12 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
DB00598 9046 69 None -2 12 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
2136 9869 30 None 1 21 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
4768 9869 30 None 1 21 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
7268 9869 30 None 1 21 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
CHEMBL753 9869 30 None 1 21 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
DB00925 9869 30 None 1 21 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
26987 7736 33 None -16 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
6063 7736 33 None -16 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
671 7736 33 None -16 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
CHEMBL1626 7736 33 None -16 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
DB00283 7736 33 None -16 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
2274 9947 58 None 1 37 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
4917 9947 58 None 1 37 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
7279 9947 58 None 1 37 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
CHEMBL728 9947 58 None 1 37 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
DB00433 9947 58 None 1 37 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
1427 8794 54 None -112 30 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
357 8794 54 None -112 30 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
3696 8794 54 None -112 30 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
CHEMBL11 8794 54 None -112 30 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
DB00458 8794 54 None -112 30 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
2247 7293 81 None 4 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
249 7293 81 None 4 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
2603 7293 81 None 4 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
CHEMBL296419 7293 81 None 4 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
DB00637 7293 81 None 4 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
1212 8443 50 None -6 35 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
204 8443 50 None -6 35 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3372 8443 50 None -6 35 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL726 8443 50 None -6 35 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00623 8443 50 None -6 35 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
1588 9105 27 None -77 23 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
28864 9105 27 None -77 23 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
43 9105 27 None -77 23 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL157138 9105 27 None -77 23 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
DB00589 9105 27 None -77 23 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
180 7189 56 None -63 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
200 7189 56 None -63 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
2160 7189 56 None -63 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
CHEMBL629 7189 56 None -63 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
DB00321 7189 56 None -63 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
100 10577 58 None -8 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 10577 58 None -8 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 10577 58 None -8 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 10577 58 None -8 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 10577 58 None -8 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
134551 7146 27 None -15 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
271 7146 27 None -15 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
885 7146 27 None -15 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
CHEMBL1403281 7146 27 None -15 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
2142 9870 58 None 1 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 9870 58 None 1 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 9870 58 None 1 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 9870 58 None 1 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 9870 58 None 1 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 9870 58 None 1 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
2284 9956 33 None -1 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
4926 9956 33 None -1 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
7281 9956 33 None -1 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
CHEMBL564 9956 33 None -1 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
DB00420 9956 33 None -1 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
2726 7706 68 None -3 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 7706 68 None -3 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 7706 68 None -3 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 7706 68 None -3 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 7706 68 None -3 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
11954224 222732 0 None -1 5 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 581 4 3 6 2.0 CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C None
2585 7590 103 None -10 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
522 7590 103 None -10 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
551 7590 103 None -10 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
CHEMBL723 7590 103 None -10 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
DB01136 7590 103 None -10 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
31101 7516 40 None -2 29 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
35 7516 40 None -2 29 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
403 7516 40 None -2 29 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
CHEMBL493 7516 40 None -2 29 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
DB01200 7516 40 None -2 29 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
100 10577 58 None -1 38 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 10577 58 None -1 38 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 10577 58 None -1 38 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 10577 58 None -1 38 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 10577 58 None -1 38 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
6761 74574 19 None -3 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 None
CHEMBL1909072 74574 19 None -3 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 None
10531 8202 21 None -7 26 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
121 8202 21 None -7 26 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
888 8202 21 None -7 26 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
CHEMBL1732 8202 21 None -7 26 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
DB00320 8202 21 None -7 26 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
3168 16034 92 None -1 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 None
CHEMBL1108 16034 92 None -1 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 None
DB00450 16034 92 None -1 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 None
107715 207724 22 None -2 19 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O None
CHEMBL1255837 207724 22 None -2 19 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O None
CHEMBL601773 207724 22 None -2 19 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O None
3157 8252 71 None -2 22 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
7170 8252 71 None -2 22 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
954 8252 71 None -2 22 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
CHEMBL707 8252 71 None -2 22 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
DB00590 8252 71 None -2 22 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
4151 10379 89 None -1 10 Rat 8.0 pIC50 = 8.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
493 10379 89 None -1 10 Rat 8.0 pIC50 = 8.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
5312125 10379 89 None -1 10 Rat 8.0 pIC50 = 8.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
CHEMBL24778 10379 89 None -1 10 Rat 8.0 pIC50 = 8.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
DB06207 10379 89 None -1 10 Rat 8.0 pIC50 = 8.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
213 10625 55 None -18 22 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
2717 10625 55 None -18 22 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
5533 10625 55 None -18 22 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
CHEMBL621 10625 55 None -18 22 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
DB00656 10625 55 None -18 22 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
2995 211184 53 None -2 18 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
CHEMBL1696 211184 53 None -2 18 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
CHEMBL72 211184 53 None -2 18 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
DB01151 211184 53 None -2 18 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
4011 89183 49 None -8 26 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 None
CHEMBL21731 89183 49 None -8 26 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 None
1531 9046 69 None -1 12 Human 7.7 pIC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
3869 9046 69 None -1 12 Human 7.7 pIC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
7207 9046 69 None -1 12 Human 7.7 pIC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
CHEMBL429 9046 69 None -1 12 Human 7.7 pIC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
DB00598 9046 69 None -1 12 Human 7.7 pIC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
3294 8787 111 None -10 44 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
71360 8787 111 None -10 44 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
87 8787 111 None -10 44 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
CHEMBL14376 8787 111 None -10 44 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
DB04946 8787 111 None -10 44 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
3584 10549 64 None -2 14 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
5401 10549 64 None -2 14 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
7302 10549 64 None -2 14 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
CHEMBL611 10549 64 None -2 14 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
DB01162 10549 64 None -2 14 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
31729 212563 10 None - 0 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL83063 212563 10 None - 0 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
1193 8437 108 None - 0 Human 6.0 pAC50 = 6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 3 2 2 4.1 OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
2447 8437 108 None - 0 Human 6.0 pAC50 = 6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 3 2 2 4.1 OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
3371 8437 108 None - 0 Human 6.0 pAC50 = 6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 3 2 2 4.1 OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL23588 8437 108 None - 0 Human 6.0 pAC50 = 6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 3 2 2 4.1 OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
DB02266 8437 108 None - 0 Human 6.0 pAC50 = 6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 3 2 2 4.1 OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
5468 134006 85 None - 0 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 260 4 1 3 3.2 CC(C(=O)O)c1ccc(C(=O)c2ccccc2)s1 10.1038/s41467-023-40064-9
CHEMBL365795 134006 85 None - 0 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 260 4 1 3 3.2 CC(C(=O)O)c1ccc(C(=O)c2ccccc2)s1 10.1038/s41467-023-40064-9
5833 37257 74 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 416 1 0 5 4.9 CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12 10.1038/s41467-023-40064-9
CHEMBL1393 37257 74 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 416 1 0 5 4.9 CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12 10.1038/s41467-023-40064-9
1530 8963 50 None - 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
3827 8963 50 None - 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
7206 8963 50 None - 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
CHEMBL534 8963 50 None - 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
DB00920 8963 50 None - 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
202 8290 77 None - 33 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
60835 8290 77 None - 33 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
972 8290 77 None - 33 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1175 8290 77 None - 33 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
DB00476 8290 77 None - 33 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
3339 210420 117 None - 5 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 360 6 0 4 4.7 CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL672 210420 117 None - 5 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 360 6 0 4 4.7 CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1 10.1038/s41467-023-40064-9
4679 49535 89 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 7 1 6 2.9 COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC 10.1038/s41467-023-40064-9
CHEMBL1502 49535 89 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 7 1 6 2.9 COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC 10.1038/s41467-023-40064-9
2762 10635 31 None - 2 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 3 2.7 CN(CCN(c1ccccn1)Cc1ccccc1)C 10.1038/s41467-023-40064-9
5587 10635 31 None - 2 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 3 2.7 CN(CCN(c1ccccn1)Cc1ccccc1)C 10.1038/s41467-023-40064-9
7318 10635 31 None - 2 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 3 2.7 CN(CCN(c1ccccn1)Cc1ccccc1)C 10.1038/s41467-023-40064-9
CHEMBL1241 10635 31 None - 2 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 3 2.7 CN(CCN(c1ccccn1)Cc1ccccc1)C 10.1038/s41467-023-40064-9
DB00792 10635 31 None - 2 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 3 2.7 CN(CCN(c1ccccn1)Cc1ccccc1)C 10.1038/s41467-023-40064-9
154257 185398 67 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 470 7 2 5 6.3 Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12 10.1038/s41467-023-40064-9
CHEMBL46740 185398 67 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 470 7 2 5 6.3 Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12 10.1038/s41467-023-40064-9
2303 9961 68 None - 26 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
4946 9961 68 None - 26 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
564 9961 68 None - 26 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
63 9961 68 None - 26 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
91536 9961 68 None - 26 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL27 9961 68 None - 26 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL452861 9961 68 None - 26 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
DB00571 9961 68 None - 26 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
3121 14657 104 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 144 5 1 1 2.3 CCCC(CCC)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL109 14657 104 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 144 5 1 1 2.3 CCCC(CCC)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL433 14657 104 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 144 5 1 1 2.3 CCCC(CCC)C(=O)O 10.1038/s41467-023-40064-9
1212 8443 50 None -16 65 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
204 8443 50 None -16 65 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
3372 8443 50 None -16 65 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL726 8443 50 None -16 65 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
DB00623 8443 50 None -16 65 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
5311507 201594 41 None - 1 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 400 5 1 4 4.2 OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
CHEMBL53904 201594 41 None - 1 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 400 5 1 4 4.2 OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
DB01624 201594 41 None - 1 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 400 5 1 4 4.2 OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
68602 211905 80 None - 8 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C 10.1038/s41467-023-40064-9
CHEMBL77921 211905 80 None - 8 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C 10.1038/s41467-023-40064-9
2771 201796 74 None - 27 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL1200781 201796 74 None - 27 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL549 201796 74 None - 27 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
3878 211482 122 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 1 2 5 2.0 Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1 10.1038/s41467-023-40064-9
CHEMBL741 211482 122 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 1 2 5 2.0 Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1 10.1038/s41467-023-40064-9
5666 109769 35 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 237 5 1 4 1.5 CCOc1ccccc1OCC1CNCCO1 10.1038/s41467-023-40064-9
CHEMBL306700 109769 35 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 237 5 1 4 1.5 CCOc1ccccc1OCC1CNCCO1 10.1038/s41467-023-40064-9
54477 91428 36 None - 22 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 6 1 4 2.7 CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC 10.1038/s41467-023-40064-9
CHEMBL22242 91428 36 None - 22 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 6 1 4 2.7 CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC 10.1038/s41467-023-40064-9
1971 9641 38 None -1 30 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
2404 9641 38 None -1 30 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
4543 9641 38 None -1 30 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL445 9641 38 None -1 30 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
DB00540 9641 38 None -1 30 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
1155 8410 53 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
3343 8410 53 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
557 8410 53 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL32800 8410 53 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
DB01288 8410 53 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
3324 213217 115 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 321 7 1 9 0.5 CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O 10.1038/s41467-023-40064-9
CHEMBL880 213217 115 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 321 7 1 9 0.5 CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O 10.1038/s41467-023-40064-9
2795 21266 37 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 289 5 1 2 3.5 CN(C)CCC(O)(c1ccccc1)c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1201313 21266 37 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 289 5 1 2 3.5 CN(C)CCC(O)(c1ccccc1)c1ccccc1Cl 10.1038/s41467-023-40064-9
2802 179868 36 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 315 2 1 4 3.0 O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1 10.1038/s41467-023-40064-9
CHEMBL452 179868 36 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 315 2 1 4 3.0 O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1 10.1038/s41467-023-40064-9
2372 113245 40 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 345 10 2 5 2.6 COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC 10.1038/s41467-023-40064-9
CHEMBL314010 113245 40 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 345 10 2 5 2.6 COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC 10.1038/s41467-023-40064-9
150 9287 21 None - 16 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
1764 9287 21 None - 16 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
8226 9287 21 None - 16 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
CHEMBL1201356 9287 21 None - 16 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
DB00353 9287 21 None - 16 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
5770 211837 82 None - 7 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 608 8 1 10 4.2 COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC 10.1038/s41467-023-40064-9
CHEMBL772 211837 82 None - 7 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 608 8 1 10 4.2 COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC 10.1038/s41467-023-40064-9
2200 26975 61 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1256819 26975 61 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1305 26975 61 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
DB08799 26975 61 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
102 10899 48 None -346 49 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
3659 10899 48 None -346 49 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
8969 10899 48 None -346 49 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL15245 10899 48 None -346 49 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
DB01392 10899 48 None -346 49 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
9931954 17706 76 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 323 3 3 2 3.0 CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1 10.1038/s41467-023-40064-9
CHEMBL1173055 17706 76 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 323 3 3 2 3.0 CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1 10.1038/s41467-023-40064-9
5591 164310 90 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
CHEMBL408 164310 90 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
2274 9947 58 None -3 31 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
4917 9947 58 None -3 31 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
7279 9947 58 None -3 31 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL728 9947 58 None -3 31 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00433 9947 58 None -3 31 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
26757 214757 31 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL972 214757 31 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 10.1038/s41467-023-40064-9
3658 10879 53 None -9 8 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
517 10879 53 None -9 8 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
5709 10879 53 None -9 8 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL312448 10879 53 None -9 8 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
DB06694 10879 53 None -9 8 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
3151 8244 97 None -8 26 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
945 8244 97 None -8 26 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
965 8244 97 None -8 26 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL219916 8244 97 None -8 26 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01184 8244 97 None -8 26 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
3333 46942 111 None - 1 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 5 4.0 CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl 10.1038/s41467-023-40064-9
CHEMBL1480 46942 111 None - 1 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 5 4.0 CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl 10.1038/s41467-023-40064-9
12582 7737 45 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
2783 7737 45 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
CHEMBL49080 7737 45 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
DB01407 7737 45 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
56959 38330 103 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
CHEMBL1404 38330 103 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
CHEMBL1526084 38330 103 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
135398737 7745 93 None -5 90 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
38 7745 93 None -5 90 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
722 7745 93 None -5 90 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL42 7745 93 None -5 90 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
DB00363 7745 93 None -5 90 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
2284 9956 33 None -3 29 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
4926 9956 33 None -3 29 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
7281 9956 33 None -3 29 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL564 9956 33 None -3 29 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00420 9956 33 None -3 29 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
2337 10030 77 None -5 62 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
50 10030 77 None -5 62 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
5002 10030 77 None -5 62 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL716 10030 77 None -5 62 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
DB01224 10030 77 None -5 62 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
1890 9535 49 None -1 16 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
4449 9535 49 None -1 16 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
7247 9535 49 None -1 16 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
CHEMBL623 9535 49 None -1 16 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
DB01149 9535 49 None -1 16 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
2218 22055 23 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 322 8 0 2 4.4 CCN(CC)CCCN(c1ccccc1)C1Cc2ccccc2C1 10.1038/s41467-023-40064-9
CHEMBL1213033 22055 23 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 322 8 0 2 4.4 CCN(CC)CCCN(c1ccccc1)C1Cc2ccccc2C1 10.1038/s41467-023-40064-9
25151352 147384 67 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 417 5 2 4 5.2 FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1 10.1038/s41467-023-40064-9
CHEMBL3813873 147384 67 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 417 5 2 4 5.2 FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1 10.1038/s41467-023-40064-9
2576 23215 62 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 260 7 2 4 2.0 CCCC(C)(COC(N)=O)COC(=O)NC(C)C 10.1038/s41467-023-40064-9
CHEMBL1233 23215 62 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 260 7 2 4 2.0 CCCC(C)(COC(N)=O)COC(=O)NC(C)C 10.1038/s41467-023-40064-9
5280343 195054 124 None - 31 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1038/s41467-023-40064-9
CHEMBL1520590 195054 124 None - 31 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1038/s41467-023-40064-9
CHEMBL50 195054 124 None - 31 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1038/s41467-023-40064-9
2237 9936 79 None - 3 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
3634 9936 79 None - 3 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
4887 9936 79 None - 3 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
CHEMBL21333 9936 79 None - 3 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
DB01411 9936 79 None - 3 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
2520 210787 70 None - 12 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL1280 210787 70 None - 12 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL6966 210787 70 None - 12 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
135 9310 43 None -40 56 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
1796 9310 43 None -40 56 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
4184 9310 43 None -40 56 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL6437 9310 43 None -40 56 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
DB06148 9310 43 None -40 56 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
5482 21192 80 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1200438 21192 80 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
1224 8214 83 None - 13 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
3100 8214 83 None - 13 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
8980 8214 83 None - 13 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
916 8214 83 None - 13 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
CHEMBL657 8214 83 None - 13 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
DB01075 8214 83 None - 13 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
5329 176255 119 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 3 2 5 1.4 Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1 10.1038/s41467-023-40064-9
CHEMBL443 176255 119 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 3 2 5 1.4 Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1 10.1038/s41467-023-40064-9
104850 10103 96 None - 6 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
4150 10103 96 None - 6 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
743 10103 96 None - 6 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
CHEMBL111 10103 96 None - 6 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
DB06155 10103 96 None - 6 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
3463 181925 107 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 250 6 1 2 3.6 Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 10.1038/s41467-023-40064-9
CHEMBL457 181925 107 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 250 6 1 2 3.6 Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 10.1038/s41467-023-40064-9
2351 10059 64 None - 21 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O 10.1038/s41467-023-40064-9
2820 10059 64 None - 21 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O 10.1038/s41467-023-40064-9
5035 10059 64 None - 21 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O 10.1038/s41467-023-40064-9
CHEMBL81 10059 64 None - 21 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O 10.1038/s41467-023-40064-9
DB00481 10059 64 None - 21 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O 10.1038/s41467-023-40064-9
4775 45870 132 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 164 4 1 1 2.1 O=C(O)CCCc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1469 45870 132 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 164 4 1 1 2.1 O=C(O)CCCc1ccccc1 10.1038/s41467-023-40064-9
9417 140290 54 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL1524185 140290 54 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL370753 140290 54 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
4659569 29103 101 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1324 29103 101 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1038/s41467-023-40064-9
1786 9298 85 None - 11 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
4171 9298 85 None - 11 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
553 9298 85 None - 11 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
CHEMBL13 9298 85 None - 11 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
DB00264 9298 85 None - 11 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
1830 9368 44 None 1 28 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
207 9368 44 None 1 28 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
23897 9368 44 None 1 28 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
CHEMBL460 9368 44 None 1 28 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
DB01618 9368 44 None 1 28 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
8249 66179 65 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 205 3 5 2 0.2 N=C(N)NC(=N)NCCc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1528839 66179 65 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 205 3 5 2 0.2 N=C(N)NC(=N)NCCc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL170988 66179 65 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 205 3 5 2 0.2 N=C(N)NC(=N)NCCc1ccccc1 10.1038/s41467-023-40064-9
2200 26975 61 None - 2 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1256819 26975 61 None - 2 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1305 26975 61 None - 2 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
DB08799 26975 61 None - 2 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
31729 212563 10 None - 0 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL83063 212563 10 None - 0 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
5284616 168406 55 None - 0 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 914 6 3 13 6.2 CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C 10.1038/s41467-023-40064-9
CHEMBL413 168406 55 None - 0 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 914 6 3 13 6.2 CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C 10.1038/s41467-023-40064-9
191 7191 98 None - 29 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
201 7191 98 None - 29 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
2170 7191 98 None - 29 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
CHEMBL1113 7191 98 None - 29 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
DB00543 7191 98 None - 29 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
100 10577 58 None - 54 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
2637 10577 58 None - 54 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
5452 10577 58 None - 54 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
CHEMBL479 10577 58 None - 54 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
DB00679 10577 58 None - 54 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
4499 66549 99 None - 2 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 388 6 1 7 3.2 COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-] 10.1038/s41467-023-40064-9
CHEMBL1726 66549 99 None - 2 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 388 6 1 7 3.2 COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-] 10.1038/s41467-023-40064-9
5280453 212750 74 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 416 6 3 3 5.7 C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O 10.1038/s41467-023-40064-9
CHEMBL846 212750 74 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 416 6 3 3 5.7 C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O 10.1038/s41467-023-40064-9
1577 10475 110 None - 20 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
2537 10475 110 None - 20 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
5355 10475 110 None - 20 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
5501 10475 110 None - 20 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
643497 10475 110 None - 20 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
688272 10475 110 None - 20 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
958 10475 110 None - 20 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
960 10475 110 None - 20 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
CHEMBL196677 10475 110 None - 20 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
CHEMBL26 10475 110 None - 20 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
CHEMBL267044 10475 110 None - 20 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
DB00391 10475 110 None - 20 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
DB16021 10475 110 None - 20 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
nan 10475 110 None - 20 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
2286 9957 51 None - 30 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
4927 9957 51 None - 30 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
7282 9957 51 None - 30 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
CHEMBL643 9957 51 None - 30 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
DB01069 9957 51 None - 30 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
2220 9908 82 None - 14 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
27400 9908 82 None - 14 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
93 9908 82 None - 14 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
CHEMBL294951 9908 82 None - 14 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
DB06153 9908 82 None - 14 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
1400 8738 70 None - 3 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
3658 8738 70 None - 3 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
7199 8738 70 None - 3 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
91513 8738 70 None - 3 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL896 8738 70 None - 3 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
DB00557 8738 70 None - 3 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
1613 9127 53 None -2 44 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
205 9127 53 None -2 44 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3964 9127 53 None -2 44 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL831 9127 53 None -2 44 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00408 9127 53 None -2 44 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
176 7186 66 None - 31 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
2157 7186 66 None - 31 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
2566 7186 66 None - 31 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
CHEMBL633 7186 66 None - 31 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
DB01118 7186 66 None - 31 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
1222 8445 49 None - 32 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3396 8445 49 None - 32 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
85 8445 49 None - 32 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL46516 8445 49 None - 32 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
DB04842 8445 49 None - 32 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
2435 10362 83 None -16 48 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
60149 10362 83 None -16 48 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
98 10362 83 None -16 48 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
CHEMBL12713 10362 83 None -16 48 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
DB06144 10362 83 None -16 48 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
2284 9956 33 None -3 29 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
4926 9956 33 None -3 29 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
7281 9956 33 None -3 29 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL564 9956 33 None -3 29 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00420 9956 33 None -3 29 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
2105 9828 37 None -2 32 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
47811 9828 37 None -2 32 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
48 9828 37 None -2 32 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
CHEMBL531 9828 37 None -2 32 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
DB01186 9828 37 None -2 32 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
37264 196201 24 None - 0 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 435 6 2 10 1.3 COc1cc2c(N)nc(N3CCN(C(=O)OCC(C)(C)O)CC3)nc2c(OC)c1OC 10.1038/s41467-023-40064-9
CHEMBL513301 196201 24 None - 0 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 435 6 2 10 1.3 COc1cc2c(N)nc(N3CCN(C(=O)OCC(C)(C)O)CC3)nc2c(OC)c1OC 10.1038/s41467-023-40064-9
5282230 168700 87 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 6 2 4 3.1 COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC 10.1038/s41467-023-40064-9
CHEMBL415324 168700 87 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 6 2 4 3.1 COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC 10.1038/s41467-023-40064-9
3584 10549 64 None -2 14 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
5401 10549 64 None -2 14 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
7302 10549 64 None -2 14 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
CHEMBL611 10549 64 None -2 14 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
DB01162 10549 64 None -2 14 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
2389 10104 118 None -11 66 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
5073 10104 118 None -11 66 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
96 10104 118 None -11 66 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
CHEMBL85 10104 118 None -11 66 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
DB00734 10104 118 None -11 66 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
19675 58444 43 None - 0 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 7 1 5 5.0 CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1584 58444 43 None - 0 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 7 1 5 5.0 CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
213 10625 55 None - 43 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
2717 10625 55 None - 43 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
5533 10625 55 None - 43 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL621 10625 55 None - 43 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
DB00656 10625 55 None - 43 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
5329102 201505 86 None - 0 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
CHEMBL535 201505 86 None - 0 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
43815 193699 64 None - 25 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 329 4 1 4 3.3 Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1 10.1038/s41467-023-40064-9
CHEMBL1708 193699 64 None - 25 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 329 4 1 4 3.3 Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1 10.1038/s41467-023-40064-9
CHEMBL490 193699 64 None - 25 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 329 4 1 4 3.3 Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1 10.1038/s41467-023-40064-9
5039 69957 17 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 314 10 2 7 1.5 CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1 10.1038/s41467-023-40064-9
CHEMBL1790041 69957 17 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 314 10 2 7 1.5 CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1 10.1038/s41467-023-40064-9
DB00863 69957 17 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 314 10 2 7 1.5 CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1 10.1038/s41467-023-40064-9
2585 7590 103 None -9 22 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
522 7590 103 None -9 22 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
551 7590 103 None -9 22 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
CHEMBL723 7590 103 None -9 22 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
DB01136 7590 103 None -9 22 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
2726 7706 68 None -5 72 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
621 7706 68 None -5 72 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
83 7706 68 None -5 72 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL71 7706 68 None -5 72 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB00477 7706 68 None -5 72 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2683 10606 60 None - 4 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
5487 10606 60 None - 4 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
7308 10606 60 None - 4 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
CHEMBL1079 10606 60 None - 4 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
DB00697 10606 60 None - 4 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
1353 8692 93 None -6 85 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
3559 8692 93 None -6 85 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
86 8692 93 None -6 85 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
CHEMBL54 8692 93 None -6 85 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
DB00502 8692 93 None -6 85 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
31101 7516 40 None -12 35 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
35 7516 40 None -12 35 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
403 7516 40 None -12 35 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
CHEMBL493 7516 40 None -12 35 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
DB01200 7516 40 None -12 35 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
9915743 70316 93 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 556 11 2 8 5.9 CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C 10.1038/s41467-023-40064-9
CHEMBL180022 70316 93 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 556 11 2 8 5.9 CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C 10.1038/s41467-023-40064-9
4209 9937 75 None -1 33 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
4893 9937 75 None -1 33 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
503 9937 75 None -1 33 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
5385 9937 75 None -1 33 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
CHEMBL2 9937 75 None -1 33 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
DB00457 9937 75 None -1 33 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
4418 40996 85 None -1 7 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
CHEMBL142635 40996 85 None -1 7 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
DB12092 40996 85 None -1 7 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
4046 9261 33 None - 2 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
4252 9261 33 None - 2 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
CHEMBL416956 9261 33 None - 2 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
DB00358 9261 33 None - 2 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
3052776 213335 90 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 171 2 1 1 1.9 C#CCN[C@@H]1CCc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL887 213335 90 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 171 2 1 1 1.9 C#CCN[C@@H]1CCc2ccccc21 10.1038/s41467-023-40064-9
135409453 10545 41 None - 2 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
226 10545 41 None - 2 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
CHEMBL76370 10545 41 None - 2 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
4034 62596 55 None - 1 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
CHEMBL1623 62596 55 None - 1 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
DB00737 62596 55 None - 1 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
16362 9899 71 None -35 29 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2172 9899 71 None -35 29 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
90 9899 71 None -35 29 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1423 9899 71 None -35 29 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01100 9899 71 None -35 29 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2536 206144 40 None - 0 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 398 7 3 6 1.4 CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(=N)N)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL590799 206144 40 None - 0 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 398 7 3 6 1.4 CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(=N)N)cc2)cc1 10.1038/s41467-023-40064-9
3158 63041 27 None - 20 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1628227 63041 27 None - 20 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
DB01142 63041 27 None - 20 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
2803 7742 58 None -8 19 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
516 7742 58 None -8 19 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
704 7742 58 None -8 19 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
CHEMBL134 7742 58 None -8 19 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
DB00575 7742 58 None -8 19 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
47641 209650 32 None - 0 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 287 5 0 1 5.0 CN(C/C=C/c1ccccc1)Cc1cccc2ccccc12 10.1038/s41467-023-40064-9
CHEMBL626 209650 32 None - 0 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 287 5 0 1 5.0 CN(C/C=C/c1ccccc1)Cc1cccc2ccccc12 10.1038/s41467-023-40064-9
2419 10236 84 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
5152 10236 84 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
559 10236 84 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL1263 10236 84 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
DB00938 10236 84 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
21722 24764 31 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 2 4.3 CN(C)CCCn1c2c(c3ccccc31)CCCCCC2 10.1038/s41467-023-40064-9
CHEMBL126224 24764 31 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 2 4.3 CN(C)CCCn1c2c(c3ccccc31)CCCCCC2 10.1038/s41467-023-40064-9
4567 16720 34 None - 0 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL114655 16720 34 None - 0 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
4046 9261 33 None - 2 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
4252 9261 33 None - 2 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
CHEMBL416956 9261 33 None - 2 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
DB00358 9261 33 None - 2 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
2161 15505 121 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 10.1038/s41467-023-40064-9
CHEMBL1096 15505 121 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 10.1038/s41467-023-40064-9
135398735 143746 32 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
136262914 143746 32 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL374478 143746 32 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
4756 23421 50 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
CHEMBL1201022 23421 50 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
CHEMBL1242 23421 50 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
1427 8794 54 None - 27 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
357 8794 54 None - 27 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
3696 8794 54 None - 27 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL11 8794 54 None - 27 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00458 8794 54 None - 27 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
154417 29953 60 None - 5 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 289 4 1 4 1.9 CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)[C@H](CO)c1ccccc1)C2 10.1038/s41467-023-40064-9
CHEMBL1331216 29953 60 None - 5 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 289 4 1 4 1.9 CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)[C@H](CO)c1ccccc1)C2 10.1038/s41467-023-40064-9
DB00424 29953 60 None - 5 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 289 4 1 4 1.9 CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)[C@H](CO)c1ccccc1)C2 10.1038/s41467-023-40064-9
212 10578 47 None -7 25 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
2639 10578 47 None -7 25 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
941651 10578 47 None -7 25 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
CHEMBL1201 10578 47 None -7 25 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
DB01623 10578 47 None -7 25 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
3083544 33582 51 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1200811 33582 51 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1363 33582 51 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1951071 33582 51 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL605993 33582 51 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
DB00983 33582 51 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
DB01274 33582 51 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
5280793 53111 65 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 396 5 1 1 7.6 C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12 10.1038/s41467-023-40064-9
CHEMBL1536 53111 65 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 396 5 1 1 7.6 C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12 10.1038/s41467-023-40064-9
209 9831 97 None -11 23 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
2113 9831 97 None -11 23 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
4748 9831 97 None -11 23 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL567 9831 97 None -11 23 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00850 9831 97 None -11 23 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
10219 195575 37 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.1038/s41467-023-40064-9
CHEMBL493439 195575 37 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.1038/s41467-023-40064-9
CHEMBL50588 195575 37 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.1038/s41467-023-40064-9
1228 10638 34 None - 4 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 278 4 0 2 3.9 Cc1ccc(cc1)/C(=C\CN1CCCC1)/c1ccccn1 10.1038/s41467-023-40064-9
2763 10638 34 None - 4 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 278 4 0 2 3.9 Cc1ccc(cc1)/C(=C\CN1CCCC1)/c1ccccn1 10.1038/s41467-023-40064-9
5282443 10638 34 None - 4 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 278 4 0 2 3.9 Cc1ccc(cc1)/C(=C\CN1CCCC1)/c1ccccn1 10.1038/s41467-023-40064-9
CHEMBL855 10638 34 None - 4 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 278 4 0 2 3.9 Cc1ccc(cc1)/C(=C\CN1CCCC1)/c1ccccn1 10.1038/s41467-023-40064-9
DB00427 10638 34 None - 4 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 278 4 0 2 3.9 Cc1ccc(cc1)/C(=C\CN1CCCC1)/c1ccccn1 10.1038/s41467-023-40064-9
5324346 212361 59 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 9 1 4 3.2 COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL1409 212361 59 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 9 1 4 3.2 COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL814 212361 59 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 9 1 4 3.2 COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
36811 8236 37 None - 7 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
535 8236 37 None - 7 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
937 8236 37 None - 7 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL926 8236 37 None - 7 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
DB00841 8236 37 None - 7 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
1690 9832 19 None - 3 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
4058 9832 19 None - 3 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
5750 9832 19 None - 3 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
7221 9832 19 None - 3 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL607 9832 19 None - 3 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
DB00454 9832 19 None - 3 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
2895 210371 41 None - 8 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 275 3 0 1 4.6 CN(C)CCC=C1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL669 210371 41 None - 8 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 275 3 0 1 4.6 CN(C)CCC=C1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
DB00924 210371 41 None - 8 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 275 3 0 1 4.6 CN(C)CCC=C1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
102 10899 48 None -346 49 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
3659 10899 48 None -346 49 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
8969 10899 48 None -346 49 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL15245 10899 48 None -346 49 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
DB01392 10899 48 None -346 49 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
135409453 10545 41 None - 2 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
226 10545 41 None - 2 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
CHEMBL76370 10545 41 None - 2 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
16231 214288 57 None - 17 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 5 6 -1.1 N=C(N)NC(=O)c1nc(Cl)c(N)nc1N 10.1038/s41467-023-40064-9
CHEMBL945 214288 57 None - 17 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 5 6 -1.1 N=C(N)NC(=O)c1nc(Cl)c(N)nc1N 10.1038/s41467-023-40064-9
2600 10551 74 None - 13 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
2608 10551 74 None - 13 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
5405 10551 74 None - 13 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL17157 10551 74 None - 13 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
DB00342 10551 74 None - 13 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
2865 10915 73 None -14 53 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
59 10915 73 None -14 53 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
60854 10915 73 None -14 53 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL708 10915 73 None -14 53 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
DB00246 10915 73 None -14 53 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
22323 22071 32 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
9571037 22071 32 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1213553 22071 32 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
2705 10614 64 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
360 10614 64 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
443879 10614 64 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
CHEMBL1382 10614 64 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
DB01036 10614 64 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
2247 7293 81 None - 42 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
249 7293 81 None - 42 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2603 7293 81 None - 42 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL296419 7293 81 None - 42 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
DB00637 7293 81 None - 42 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
1024 8072 71 None - 1 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
162639143 8072 71 None - 1 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
5284373 8072 71 None - 1 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
760 8072 71 None - 1 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
CHEMBL160 8072 71 None - 1 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
DB00091 8072 71 None - 1 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
367 10596 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
5487427 10596 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
8592 10596 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
CHEMBL1900528 10596 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
CHEMBL3305968 10596 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
CHEMBL4650755 10596 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
DB01409 10596 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
135401907 45632 136 None - 1 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 136 0 2 3 -0.4 O=c1ncnc2[nH][nH]cc1-2 10.1038/s41467-023-40064-9
CHEMBL1467 45632 136 None - 1 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 136 0 2 3 -0.4 O=c1ncnc2[nH][nH]cc1-2 10.1038/s41467-023-40064-9
4940 21242 35 None - 0 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 340 5 0 4 4.8 CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1201210 21242 35 None - 0 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 340 5 0 4 4.8 CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
180 7189 56 None -12 40 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
200 7189 56 None -12 40 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
2160 7189 56 None -12 40 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL629 7189 56 None -12 40 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00321 7189 56 None -12 40 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
1547484 7727 74 None - 20 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
654 7727 74 None - 20 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
9072 7727 74 None - 20 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL43064 7727 74 None - 20 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
DB00568 7727 74 None - 20 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
5288783 21205 50 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 5 3 3 5.1 C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@@H](O)C4CC4)CC[C@@H]23)C[C@@H](O)C[C@@H]1O 10.1038/s41467-023-40064-9
CHEMBL1200666 21205 50 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 5 3 3 5.1 C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@@H](O)C4CC4)CC[C@@H]23)C[C@@H](O)C[C@@H]1O 10.1038/s41467-023-40064-9
119182 67181 92 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 2 3 8 -0.3 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F 10.1038/s41467-023-40064-9
CHEMBL1750 67181 92 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 2 3 8 -0.3 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F 10.1038/s41467-023-40064-9
55645 91145 8 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 7 2 4 2.1 CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21 10.1038/s41467-023-40064-9
CHEMBL2218861 91145 8 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 7 2 4 2.1 CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21 10.1038/s41467-023-40064-9
nan 91145 8 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 7 2 4 2.1 CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21 10.1038/s41467-023-40064-9
24958200 15346 76 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 320 3 2 4 2.6 NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12 10.1038/s41467-023-40064-9
CHEMBL1094636 15346 76 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 320 3 2 4 2.6 NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12 10.1038/s41467-023-40064-9
18283 215091 96 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 224 2 2 5 -0.7 Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O 10.1038/s41467-023-40064-9
CHEMBL991 215091 96 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 224 2 2 5 -0.7 Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O 10.1038/s41467-023-40064-9
4631 201751 29 None - 7 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL546 201751 29 None - 7 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C 10.1038/s41467-023-40064-9
DB01580 201751 29 None - 7 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C 10.1038/s41467-023-40064-9
5906 21267 23 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 2 3 3 0.8 C[C@H](N)[C@H](O)c1cccc(O)c1 10.1038/s41467-023-40064-9
CHEMBL1201319 21267 23 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 2 3 3 0.8 C[C@H](N)[C@H](O)c1cccc(O)c1 10.1038/s41467-023-40064-9
DB00610 21267 23 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 2 3 3 0.8 C[C@H](N)[C@H](O)c1cccc(O)c1 10.1038/s41467-023-40064-9
103 10925 61 None -6 53 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2875 10925 61 None -6 53 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
5736 10925 61 None -6 53 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL285802 10925 61 None -6 53 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB09225 10925 61 None -6 53 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
9429 208912 58 None - 4 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
CHEMBL609109 208912 58 None - 4 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
DB01622 208912 58 None - 4 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
4209 9937 75 None -1 33 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
4893 9937 75 None -1 33 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
503 9937 75 None -1 33 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
5385 9937 75 None -1 33 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
CHEMBL2 9937 75 None -1 33 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
DB00457 9937 75 None -1 33 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
2389 10104 118 None -11 66 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
5073 10104 118 None -11 66 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
96 10104 118 None -11 66 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
CHEMBL85 10104 118 None -11 66 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
DB00734 10104 118 None -11 66 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
3157 8252 71 None -2 12 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
7170 8252 71 None -2 12 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
954 8252 71 None -2 12 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
CHEMBL707 8252 71 None -2 12 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
DB00590 8252 71 None -2 12 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
2286 9957 51 None - 30 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
4927 9957 51 None - 30 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
7282 9957 51 None - 30 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
CHEMBL643 9957 51 None - 30 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
DB01069 9957 51 None - 30 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
2169 51621 35 None - 0 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
CHEMBL152231 51621 35 None - 0 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
60065 91144 6 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 505 7 1 8 4.2 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@@H]2CCCN(Cc3ccccc3)C2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
CHEMBL2218858 91144 6 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 505 7 1 8 4.2 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@@H]2CCCN(Cc3ccccc3)C2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
5328940 106992 107 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 529 9 1 8 5.2 COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl 10.1038/s41467-023-40064-9
CHEMBL288441 106992 107 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 529 9 1 8 5.2 COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl 10.1038/s41467-023-40064-9
2865 10915 73 None -14 53 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
59 10915 73 None -14 53 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
60854 10915 73 None -14 53 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL708 10915 73 None -14 53 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
DB00246 10915 73 None -14 53 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
2470 10425 50 None -208 58 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3300 10425 50 None -208 58 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5265 10425 50 None -208 58 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
99 10425 50 None -208 58 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL267930 10425 50 None -208 58 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5284550 48495 15 None 1 9 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1492500 48495 15 None 1 9 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 10.1038/s41467-023-40064-9
3152 195190 103 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 379 6 0 4 4.4 COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2 10.1038/s41467-023-40064-9
CHEMBL502 195190 103 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 379 6 0 4 4.4 COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2 10.1038/s41467-023-40064-9
54671203 41784 53 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 444 2 6 9 -0.3 C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21 10.1038/s41467-023-40064-9
CHEMBL1433 41784 53 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 444 2 6 9 -0.3 C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21 10.1038/s41467-023-40064-9
1231 7724 116 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 252 5 3 4 0.6 N#CNC(=NC)NCCSCc1nc[nH]c1C 10.1038/s41467-023-40064-9
2756 7724 116 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 252 5 3 4 0.6 N#CNC(=NC)NCCSCc1nc[nH]c1C 10.1038/s41467-023-40064-9
645 7724 116 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 252 5 3 4 0.6 N#CNC(=NC)NCCSCc1nc[nH]c1C 10.1038/s41467-023-40064-9
CHEMBL30 7724 116 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 252 5 3 4 0.6 N#CNC(=NC)NCCSCc1nc[nH]c1C 10.1038/s41467-023-40064-9
DB00501 7724 116 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 252 5 3 4 0.6 N#CNC(=NC)NCCSCc1nc[nH]c1C 10.1038/s41467-023-40064-9
446598 67229 50 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 424 7 4 7 0.4 CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1 10.1038/s41467-023-40064-9
CHEMBL1753 67229 50 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 424 7 4 7 0.4 CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1 10.1038/s41467-023-40064-9
68617 212306 62 None 3 26 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1709 212306 62 None 3 26 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL809 212306 62 None 3 26 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
73348210 217728 0 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O 10.1038/s41467-023-40064-9
CHEMBL3039583 217728 0 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O 10.1038/s41467-023-40064-9
nan 217728 0 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O 10.1038/s41467-023-40064-9
5280954 64373 32 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 634 9 1 10 4.6 COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC 10.1038/s41467-023-40064-9
CHEMBL1668 64373 32 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 634 9 1 10 4.6 COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC 10.1038/s41467-023-40064-9
1155 8410 53 None - 5 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
3343 8410 53 None - 5 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
557 8410 53 None - 5 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL32800 8410 53 None - 5 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
DB01288 8410 53 None - 5 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
5360696 8188 30 None - 3 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
6953 8188 30 None - 3 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
842 8188 30 None - 3 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
CHEMBL52440 8188 30 None - 3 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
DB00514 8188 30 None - 3 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
37 7565 60 None -18 17 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
460 7565 60 None -18 17 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
54746 7565 60 None -18 17 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
CHEMBL1201087 7565 60 None -18 17 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
DB00248 7565 60 None -18 17 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
25271887 11932 84 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 159 5 2 2 1.1 CC(C)C[C@H](CN)CC(=O)O 10.1038/s41467-023-40064-9
5486971 11932 84 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 159 5 2 2 1.1 CC(C)C[C@H](CN)CC(=O)O 10.1038/s41467-023-40064-9
CHEMBL1059 11932 84 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 159 5 2 2 1.1 CC(C)C[C@H](CN)CC(=O)O 10.1038/s41467-023-40064-9
10531 8202 21 None - 24 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
121 8202 21 None - 24 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
888 8202 21 None - 24 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
CHEMBL1732 8202 21 None - 24 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
DB00320 8202 21 None - 24 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
3152 195190 103 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 379 6 0 4 4.4 COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2 10.1038/s41467-023-40064-9
CHEMBL502 195190 103 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 379 6 0 4 4.4 COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2 10.1038/s41467-023-40064-9
242 7258 124 None -14 51 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
34 7258 124 None -14 51 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
60795 7258 124 None -14 51 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL1112 7258 124 None -14 51 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB01238 7258 124 None -14 51 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
71109 84981 10 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 272 4 1 4 2.9 OC(CN1CCCCC1)c1cc(-c2ccccc2)on1 10.1038/s41467-023-40064-9
CHEMBL2105453 84981 10 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 272 4 1 4 2.9 OC(CN1CCCCC1)c1cc(-c2ccccc2)on1 10.1038/s41467-023-40064-9
124087 8171 114 None - 15 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
7157 8171 114 None - 15 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
814 8171 114 None - 15 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
CHEMBL1172 8171 114 None - 15 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
DB00967 8171 114 None - 15 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
2683 10606 60 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
5487 10606 60 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
7308 10606 60 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
CHEMBL1079 10606 60 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
DB00697 10606 60 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
2176 9901 68 None - 27 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
4828 9901 68 None - 27 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
91 9901 68 None - 27 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL500 9901 68 None - 27 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
DB00960 9901 68 None - 27 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
5639 105671 75 None -1 5 Human 8.4 pAC50 = 8.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1038/s41467-023-40064-9
CHEMBL279229 105671 75 None -1 5 Human 8.4 pAC50 = 8.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1038/s41467-023-40064-9
4993 129135 110 None - 1 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 2 2 4 2.5 CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL36 129135 110 None - 1 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 2 2 4 2.5 CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
2099 16079 55 None - 1 Human 4.4 pAC50 = 4.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 294 2 1 3 2.4 Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O 10.1038/s41467-023-40064-9
CHEMBL1110 16079 55 None - 1 Human 4.4 pAC50 = 4.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 294 2 1 3 2.4 Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O 10.1038/s41467-023-40064-9
2351 11072 49 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1008 11072 49 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1257078 11072 49 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
135398744 75437 86 None - 3 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 474 7 1 8 1.6 CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12 10.1038/s41467-023-40064-9
CHEMBL192 75437 86 None - 3 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 474 7 1 8 1.6 CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12 10.1038/s41467-023-40064-9
2142 9870 58 None -2 37 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
4920903 9870 58 None -2 37 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
502 9870 58 None -2 37 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
5775 9870 58 None -2 37 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL597 9870 58 None -2 37 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
DB00692 9870 58 None -2 37 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
2378 105463 103 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 4 0 2 5.2 c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL277535 105463 103 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 4 0 2 5.2 c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1 10.1038/s41467-023-40064-9
1353 8692 93 None -6 85 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
3559 8692 93 None -6 85 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
86 8692 93 None -6 85 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
CHEMBL54 8692 93 None -6 85 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
DB00502 8692 93 None -6 85 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
2520 210787 70 None - 12 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL1280 210787 70 None - 12 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL6966 210787 70 None - 12 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
68712 107114 60 None -8 5 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1038/s41467-023-40064-9
CHEMBL289480 107114 60 None -8 5 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1038/s41467-023-40064-9
2398 7741 62 None 1 29 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2801 7741 62 None 1 29 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
701 7741 62 None 1 29 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL415 7741 62 None 1 29 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB01242 7741 62 None 1 29 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
4034 62596 55 None - 1 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
CHEMBL1623 62596 55 None - 1 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
DB00737 62596 55 None - 1 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
3157 8252 71 None -2 12 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
7170 8252 71 None -2 12 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
954 8252 71 None -2 12 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
CHEMBL707 8252 71 None -2 12 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
DB00590 8252 71 None -2 12 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
4976 210358 29 None - 12 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 4 1 1 4.3 CNCCCC1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL668 210358 29 None - 12 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 4 1 1 4.3 CNCCCC1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
135 9310 43 None -40 56 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
1796 9310 43 None -40 56 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
4184 9310 43 None -40 56 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL6437 9310 43 None -40 56 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
DB06148 9310 43 None -40 56 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
21722 24764 31 None - 6 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 2 4.3 CN(C)CCCn1c2c(c3ccccc31)CCCCCC2 10.1038/s41467-023-40064-9
CHEMBL126224 24764 31 None - 6 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 2 4.3 CN(C)CCCn1c2c(c3ccccc31)CCCCCC2 10.1038/s41467-023-40064-9
3365 11950 126 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 306 5 1 7 0.7 OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F 10.1038/s41467-023-40064-9
CHEMBL106 11950 126 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 306 5 1 7 0.7 OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F 10.1038/s41467-023-40064-9
135398737 7745 93 None -5 90 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
38 7745 93 None -5 90 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
722 7745 93 None -5 90 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL42 7745 93 None -5 90 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
DB00363 7745 93 None -5 90 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
135398745 9688 112 None -39 65 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
47 9688 112 None -39 65 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
CHEMBL715 9688 112 None -39 65 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
DB00334 9688 112 None -39 65 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
5029 22317 92 None - 4 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 359 8 1 5 3.0 COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C 10.1038/s41467-023-40064-9
CHEMBL1219 22317 92 None - 4 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 359 8 1 5 3.0 COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C 10.1038/s41467-023-40064-9
3033 36925 102 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 4 2 2 4.4 O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1034 36925 102 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 4 2 2 4.4 O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
CHEMBL139 36925 102 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 4 2 2 4.4 O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
11434515 7049 6 None - 5 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 484 9 1 6 4.7 O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2 10.1038/s41467-023-40064-9
11519741 7049 6 None - 5 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 484 9 1 6 4.7 O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2 10.1038/s41467-023-40064-9
4484 7049 6 None - 5 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 484 9 1 6 4.7 O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2 10.1038/s41467-023-40064-9
7449 7049 6 None - 5 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 484 9 1 6 4.7 O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2 10.1038/s41467-023-40064-9
CHEMBL1194325 7049 6 None - 5 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 484 9 1 6 4.7 O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2 10.1038/s41467-023-40064-9
DB08897 7049 6 None - 5 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 484 9 1 6 4.7 O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2 10.1038/s41467-023-40064-9
5340 175509 106 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 3 2 5 1.5 Nc1ccc(S(=O)(=O)Nc2nccs2)cc1 10.1038/s41467-023-40064-9
CHEMBL437 175509 106 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 3 2 5 1.5 Nc1ccc(S(=O)(=O)Nc2nccs2)cc1 10.1038/s41467-023-40064-9
1613 9127 53 None -2 44 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
205 9127 53 None -2 44 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3964 9127 53 None -2 44 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL831 9127 53 None -2 44 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00408 9127 53 None -2 44 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
1209 8439 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
203 8439 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
3386 8439 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL41 8439 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
DB00472 8439 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
5360696 8188 30 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
6953 8188 30 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
842 8188 30 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
CHEMBL52440 8188 30 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
DB00514 8188 30 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
1209 8439 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
203 8439 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
3386 8439 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL41 8439 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
DB00472 8439 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
3337 213146 27 None 13 40 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
65801 213146 27 None 13 40 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
66264 213146 27 None 13 40 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
91452 213146 27 None 13 40 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
CHEMBL87493 213146 27 None 13 40 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
DB00574 213146 27 None 13 40 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
214 10632 58 None -9 30 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
2740 10632 58 None -9 30 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
5566 10632 58 None -9 30 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
66064 10632 58 None -9 30 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL422 10632 58 None -9 30 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
DB00831 10632 58 None -9 30 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
4418 40996 85 None -1 7 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
CHEMBL142635 40996 85 None -1 7 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
DB12092 40996 85 None -1 7 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
242 7258 124 None -14 51 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
34 7258 124 None -14 51 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
60795 7258 124 None -14 51 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL1112 7258 124 None -14 51 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB01238 7258 124 None -14 51 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
1400 8738 70 None - 3 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
3658 8738 70 None - 3 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
7199 8738 70 None - 3 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
91513 8738 70 None - 3 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL896 8738 70 None - 3 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
DB00557 8738 70 None - 3 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
155906370 41564 70 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 129 0 4 2 -1.0 CN(C)C(=N)NC(=N)N 10.1038/s41467-023-40064-9
4091 41564 70 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 129 0 4 2 -1.0 CN(C)C(=N)NC(=N)N 10.1038/s41467-023-40064-9
CHEMBL1431 41564 70 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 129 0 4 2 -1.0 CN(C)C(=N)NC(=N)N 10.1038/s41467-023-40064-9
57469 25638 125 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 240 2 1 4 2.8 CC(C)Cn1cnc2c(N)nc3ccccc3c21 10.1038/s41467-023-40064-9
CHEMBL1282 25638 125 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 240 2 1 4 2.8 CC(C)Cn1cnc2c(N)nc3ccccc3c21 10.1038/s41467-023-40064-9
2727 194869 95 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 4 2 3 1.7 CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL498 194869 95 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 4 2 3 1.7 CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
65866 101039 73 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 611 12 1 8 6.5 COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
CHEMBL250270 101039 73 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 611 12 1 8 6.5 COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
2162 48288 100 None -3 6 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1491 48288 100 None -3 6 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
27447 66577 63 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 347 4 3 5 0.4 CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1 10.1038/s41467-023-40064-9
6560168 66577 63 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 347 4 3 5 0.4 CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1 10.1038/s41467-023-40064-9
CHEMBL1727 66577 63 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 347 4 3 5 0.4 CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1 10.1038/s41467-023-40064-9
92727 211331 77 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 628 15 4 5 4.3 Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O 10.1038/s41467-023-40064-9
CHEMBL729 211331 77 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 628 15 4 5 4.3 Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O 10.1038/s41467-023-40064-9
1524 8962 96 None -5 51 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
197 8962 96 None -5 51 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
3822 8962 96 None -5 51 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
88 8962 96 None -5 51 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL51 8962 96 None -5 51 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
DB12465 8962 96 None -5 51 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
240 7731 43 None - 25 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
2769 7731 43 None - 25 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
44279790 7731 43 None - 25 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
660 7731 43 None - 25 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
CHEMBL1729 7731 43 None - 25 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
CHEMBL560739 7731 43 None - 25 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
DB00604 7731 43 None - 25 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
2337 10030 77 None -5 62 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
50 10030 77 None -5 62 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
5002 10030 77 None -5 62 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL716 10030 77 None -5 62 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
DB01224 10030 77 None -5 62 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
10219 195575 37 None - 5 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.1038/s41467-023-40064-9
CHEMBL493439 195575 37 None - 5 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.1038/s41467-023-40064-9
CHEMBL50588 195575 37 None - 5 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.1038/s41467-023-40064-9
2713 212050 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5353524 212050 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5360566 212050 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
88536661 212050 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
9552079 212050 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL1330113 212050 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL790 212050 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
2771 201796 74 None - 27 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL1200781 201796 74 None - 27 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL549 201796 74 None - 27 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
2146 9874 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
485 9874 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
6041 9874 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL1215 9874 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
DB00388 9874 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
212 10578 47 None -7 25 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
2639 10578 47 None -7 25 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
941651 10578 47 None -7 25 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
CHEMBL1201 10578 47 None -7 25 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
DB01623 10578 47 None -7 25 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
1224 8214 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
3100 8214 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
8980 8214 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
916 8214 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
CHEMBL657 8214 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
DB01075 8214 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
39186 92710 54 None - 2 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 414 6 0 6 3.4 COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1 10.1038/s41467-023-40064-9
CHEMBL23 92710 54 None - 2 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 414 6 0 6 3.4 COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1 10.1038/s41467-023-40064-9
2247 7293 81 None - 42 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
249 7293 81 None - 42 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2603 7293 81 None - 42 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL296419 7293 81 None - 42 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
DB00637 7293 81 None - 42 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
5732 213714 59 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 3 0 3 3.2 Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1 10.1038/s41467-023-40064-9
CHEMBL911 213714 59 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 3 0 3 3.2 Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1 10.1038/s41467-023-40064-9
3158 63041 27 None - 20 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1628227 63041 27 None - 20 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
DB01142 63041 27 None - 20 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
5311017 127382 11 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 239 5 0 1 3.8 C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL3545985 127382 11 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 239 5 0 1 3.8 C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1 10.1038/s41467-023-40064-9
DB00865 127382 11 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 239 5 0 1 3.8 C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1 10.1038/s41467-023-40064-9
2146 9874 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
485 9874 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
6041 9874 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL1215 9874 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
DB00388 9874 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
26987 7736 33 None - 21 Human 8.1 pAC50 = 8.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
6063 7736 33 None - 21 Human 8.1 pAC50 = 8.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
671 7736 33 None - 21 Human 8.1 pAC50 = 8.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
CHEMBL1626 7736 33 None - 21 Human 8.1 pAC50 = 8.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
DB00283 7736 33 None - 21 Human 8.1 pAC50 = 8.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
36811 8236 37 None - 7 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
535 8236 37 None - 7 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
937 8236 37 None - 7 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL926 8236 37 None - 7 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
DB00841 8236 37 None - 7 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
1210 7705 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
1213 7705 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
2725 7705 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
33036 7705 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
4411 7705 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
616 7705 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
6976 7705 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
716121 7705 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
CHEMBL1201353 7705 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
CHEMBL1554789 7705 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
CHEMBL505 7705 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
DB01114 7705 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
DB13679 7705 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
5353627 91316 8 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 411 8 3 4 4.6 CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL2220442 91316 8 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 411 8 3 4 4.6 CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21 10.1038/s41467-023-40064-9
135398745 9688 112 None -39 65 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
47 9688 112 None -39 65 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
CHEMBL715 9688 112 None -39 65 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
DB00334 9688 112 None -39 65 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
38853 182801 79 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 3 4 4 0.4 C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O 10.1038/s41467-023-40064-9
6919173 182801 79 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 3 4 4 0.4 C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL459 182801 79 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 3 4 4 0.4 C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O 10.1038/s41467-023-40064-9
DB00968 182801 79 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 3 4 4 0.4 C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O 10.1038/s41467-023-40064-9
4212 205458 82 None - 4 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 444 12 8 10 -0.1 O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21 10.1038/s41467-023-40064-9
CHEMBL1417019 205458 82 None - 4 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 444 12 8 10 -0.1 O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21 10.1038/s41467-023-40064-9
CHEMBL58 205458 82 None - 4 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 444 12 8 10 -0.1 O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21 10.1038/s41467-023-40064-9
11626560 207716 94 None - 0 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 449 5 2 6 5.0 C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl 10.1038/s41467-023-40064-9
CHEMBL601719 207716 94 None - 0 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 449 5 2 6 5.0 C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl 10.1038/s41467-023-40064-9
16129706 215810 40 None - 5 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O 10.1038/s41467-023-40064-9
CHEMBL1823872 215810 40 None - 5 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O 10.1038/s41467-023-40064-9
26987 7736 33 None - 21 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
6063 7736 33 None - 21 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
671 7736 33 None - 21 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
CHEMBL1626 7736 33 None - 21 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
DB00283 7736 33 None - 21 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
1343 8670 62 None - 9 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
3519 8670 62 None - 9 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
522 8670 62 None - 9 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
CHEMBL862 8670 62 None - 9 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
DB01018 8670 62 None - 9 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
5472 212597 75 None - 3 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 10.1038/s41467-023-40064-9
CHEMBL1717 212597 75 None - 3 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 10.1038/s41467-023-40064-9
CHEMBL833 212597 75 None - 3 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 10.1038/s41467-023-40064-9
DB00208 212597 75 None - 3 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 10.1038/s41467-023-40064-9
1201549 7384 24 None - 20 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
333 7384 24 None - 20 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
7601 7384 24 None - 20 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1201203 7384 24 None - 20 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL438151 7384 24 None - 20 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
DB00245 7384 24 None - 20 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
16362 9899 71 None -35 29 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2172 9899 71 None -35 29 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
90 9899 71 None -35 29 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1423 9899 71 None -35 29 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01100 9899 71 None -35 29 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
115 7131 71 None -3 7 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
2092 7131 71 None -3 7 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
7109 7131 71 None -3 7 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
CHEMBL709 7131 71 None -3 7 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
DB00346 7131 71 None -3 7 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
1427 8794 54 None - 27 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
357 8794 54 None - 27 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
3696 8794 54 None - 27 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL11 8794 54 None - 27 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00458 8794 54 None - 27 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
1593 9119 66 None - 4 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
30668 9119 66 None - 4 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
9868 9119 66 None - 4 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
CHEMBL17860 9119 66 None - 4 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
DB04948 9119 66 None - 4 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
10100 22066 12 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 8 0 3 4.3 CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C 10.1038/s41467-023-40064-9
CHEMBL1213351 22066 12 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 8 0 3 4.3 CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C 10.1038/s41467-023-40064-9
191 7191 98 None - 29 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
201 7191 98 None - 29 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
2170 7191 98 None - 29 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
CHEMBL1113 7191 98 None - 29 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
DB00543 7191 98 None - 29 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
1890 9535 49 None -1 16 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
4449 9535 49 None -1 16 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
7247 9535 49 None -1 16 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
CHEMBL623 9535 49 None -1 16 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
DB01149 9535 49 None -1 16 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
71398 113216 44 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 302 5 4 4 3.6 C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL313972 113216 44 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 302 5 4 4 3.6 C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1 10.1038/s41467-023-40064-9
19861 214302 50 None - 1 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 290 0 0 2 3.7 CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1 10.1038/s41467-023-40064-9
CHEMBL946 214302 50 None - 1 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 290 0 0 2 3.7 CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1 10.1038/s41467-023-40064-9
DB00719 214302 50 None - 1 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 290 0 0 2 3.7 CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1 10.1038/s41467-023-40064-9
9801 98360 35 None - 0 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 329 8 1 1 5.4 CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL24072 98360 35 None - 0 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 329 8 1 1 5.4 CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
65709 66655 39 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 365 8 0 5 3.3 CCN(CC)CCn1c(=O)c(Cc2ccc(OC)cc2)nc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1729803 66655 39 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 365 8 0 5 3.3 CCN(CC)CCn1c(=O)c(Cc2ccc(OC)cc2)nc2ccccc21 10.1038/s41467-023-40064-9
2585 7590 103 None -9 22 Human 8.0 pAC50 = 8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
522 7590 103 None -9 22 Human 8.0 pAC50 = 8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
551 7590 103 None -9 22 Human 8.0 pAC50 = 8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
CHEMBL723 7590 103 None -9 22 Human 8.0 pAC50 = 8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
DB01136 7590 103 None -9 22 Human 8.0 pAC50 = 8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
319 8106 44 None - 9 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
321 8106 44 None - 9 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
444031 8106 44 None - 9 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
72054 8106 44 None - 9 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
784 8106 44 None - 9 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
CHEMBL1346 8106 44 None - 9 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
DB00496 8106 44 None - 9 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
3337 213146 27 None 13 40 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
65801 213146 27 None 13 40 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
66264 213146 27 None 13 40 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
91452 213146 27 None 13 40 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
CHEMBL87493 213146 27 None 13 40 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
DB00574 213146 27 None 13 40 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
4614 12163 103 None - 0 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 293 5 1 3 4.0 O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1 10.1038/s41467-023-40064-9
CHEMBL1071 12163 103 None - 0 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 293 5 1 3 4.0 O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1 10.1038/s41467-023-40064-9
5329102 201505 86 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
CHEMBL535 201505 86 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
441074 26186 82 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 4 1 4 3.2 C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12 10.1038/s41467-023-40064-9
CHEMBL1294 26186 82 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 4 1 4 3.2 C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12 10.1038/s41467-023-40064-9
2880 104784 49 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 5 0 3 4.6 C=C(c1ccccc1OCc1cccc(Cl)c1)n1ccnc1 10.1038/s41467-023-40064-9
CHEMBL27289 104784 49 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 5 0 3 4.6 C=C(c1ccccc1OCc1cccc(Cl)c1)n1ccnc1 10.1038/s41467-023-40064-9
1499 8872 47 None - 17 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
3779 8872 47 None - 17 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
536 8872 47 None - 17 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
CHEMBL434 8872 47 None - 17 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
DB01064 8872 47 None - 17 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
2540 11173 111 None - 4 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
CHEMBL1014 11173 111 None - 4 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
3180 21245 41 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 289 8 0 3 3.9 CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1 10.1038/s41467-023-40064-9
CHEMBL1201217 21245 41 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 289 8 0 3 3.9 CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1 10.1038/s41467-023-40064-9
4567 16720 34 None - 0 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL114655 16720 34 None - 0 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
2286 9957 51 None - 30 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
4927 9957 51 None - 30 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
7282 9957 51 None - 30 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
CHEMBL643 9957 51 None - 30 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
DB01069 9957 51 None - 30 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
129211 10521 78 None -1 16 Human 10.2 pEC50 = 10.2 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmc.2016.09.017
2562 10521 78 None -1 16 Human 10.2 pEC50 = 10.2 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmc.2016.09.017
488 10521 78 None -1 16 Human 10.2 pEC50 = 10.2 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmc.2016.09.017
CHEMBL836 10521 78 None -1 16 Human 10.2 pEC50 = 10.2 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmc.2016.09.017
DB00706 10521 78 None -1 16 Human 10.2 pEC50 = 10.2 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmc.2016.09.017
132578519 156488 0 None - 0 Human 8.0 pEC50 = 8.0 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 484 10 1 5 4.3 CC(C)Oc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2F)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3947830 156488 0 None - 0 Human 8.0 pEC50 = 8.0 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 484 10 1 5 4.3 CC(C)Oc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2F)CC1 10.1016/j.bmc.2016.09.017
134154987 157611 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 438 9 1 5 3.4 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3956998 157611 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 438 9 1 5 3.4 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2)CC1 10.1016/j.bmc.2016.09.017
9813756 15788 0 None - 3 Rabbit 5.9 pEC50 = 5.9 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL109848 15788 0 None - 3 Rabbit 5.9 pEC50 = 5.9 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
118727916 127472 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 335 6 0 3 2.9 O=C1CCCN1CCCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.bmc.2015.03.009
CHEMBL3400597 127472 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 335 6 0 3 2.9 O=C1CCCN1CCCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.bmc.2015.03.009
CHEMBL3547118 127472 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 335 6 0 3 2.9 O=C1CCCN1CCCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.bmc.2015.03.009
134156323 161036 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 455 9 1 6 3.3 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cncc3ccccc23)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3986337 161036 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 455 9 1 6 3.3 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cncc3ccccc23)CC1 10.1016/j.bmc.2016.09.017
134148920 155228 0 None - 0 Human 6.8 pEC50 = 6.8 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 456 9 1 5 3.6 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cc(Cl)ccc2F)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3937911 155228 0 None - 0 Human 6.8 pEC50 = 6.8 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 456 9 1 5 3.6 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cc(Cl)ccc2F)CC1 10.1016/j.bmc.2016.09.017
9944409 14385 0 None - 5 Rabbit 7.8 pEC50 = 7.8 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL108804 14385 0 None - 5 Rabbit 7.8 pEC50 = 7.8 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
134151231 158990 0 None - 0 Human 6.8 pEC50 = 6.8 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 464 11 1 7 2.8 COc1ccc(S(=O)(=O)NCC2CCN(CCOc3ccccc3OC)CC2)cc1OC 10.1016/j.bmc.2016.09.017
CHEMBL3968662 158990 0 None - 0 Human 6.8 pEC50 = 6.8 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 464 11 1 7 2.8 COc1ccc(S(=O)(=O)NCC2CCN(CCOc3ccccc3OC)CC2)cc1OC 10.1016/j.bmc.2016.09.017
76326541 92116 0 None - 4 Rabbit 6.8 pEC50 = 6.8 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCC[C@H]2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL2261355 92116 0 None - 4 Rabbit 6.8 pEC50 = 6.8 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCC[C@H]2c1c[nH]cn1 10.1007/s00044-004-0020-z
168290235 199747 0 None -16 20 Human 5.7 pEC50 = 5.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5201074 199747 0 None -16 20 Human 5.7 pEC50 = 5.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5222491 199747 0 None -16 20 Human 5.7 pEC50 = 5.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
9815005 116438 0 None - 3 Rabbit 4.7 pEC50 = 4.7 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 3 2 3 2.6 CS(=O)(=O)Nc1cccc2c1CCCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL322492 116438 0 None - 3 Rabbit 4.7 pEC50 = 4.7 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 3 2 3 2.6 CS(=O)(=O)Nc1cccc2c1CCCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
134148037 156551 0 None - 0 Human 6.7 pEC50 = 6.7 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 450 10 1 7 2.5 COc1ccc(S(=O)(=O)NC2CCN(CCOc3ccccc3OC)CC2)cc1OC 10.1016/j.bmc.2016.09.017
CHEMBL3948333 156551 0 None - 0 Human 6.7 pEC50 = 6.7 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 450 10 1 7 2.5 COc1ccc(S(=O)(=O)NC2CCN(CCOc3ccccc3OC)CC2)cc1OC 10.1016/j.bmc.2016.09.017
164612037 192156 0 None -4 20 Human 5.7 pEC50 = 5.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
CHEMBL4860528 192156 0 None -4 20 Human 5.7 pEC50 = 5.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
146762 20082 6 None - 0 Human 7.6 pEC50 = 7.6 Binding
Effective concentration (EC50) against alpha-1-adrenoceptor in the isolated rabbit ear arteryEffective concentration (EC50) against alpha-1-adrenoceptor in the isolated rabbit ear artery
ChEMBL 244 5 3 4 0.5 CNCCc1ccc(O)c(NS(C)(=O)=O)c1 10.1021/jm00380a017
CHEMBL1191956 20082 6 None - 0 Human 7.6 pEC50 = 7.6 Binding
Effective concentration (EC50) against alpha-1-adrenoceptor in the isolated rabbit ear arteryEffective concentration (EC50) against alpha-1-adrenoceptor in the isolated rabbit ear artery
ChEMBL 244 5 3 4 0.5 CNCCc1ccc(O)c(NS(C)(=O)=O)c1 10.1021/jm00380a017
CHEMBL543126 20082 6 None - 0 Human 7.6 pEC50 = 7.6 Binding
Effective concentration (EC50) against alpha-1-adrenoceptor in the isolated rabbit ear arteryEffective concentration (EC50) against alpha-1-adrenoceptor in the isolated rabbit ear artery
ChEMBL 244 5 3 4 0.5 CNCCc1ccc(O)c(NS(C)(=O)=O)c1 10.1021/jm00380a017
9903797 16211 5 None - 4 Rabbit 5.6 pEC50 = 5.6 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 279 5 2 3 2.1 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1C 10.1007/s00044-004-0020-z
CHEMBL111734 16211 5 None - 4 Rabbit 5.6 pEC50 = 5.6 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 279 5 2 3 2.1 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1C 10.1007/s00044-004-0020-z
11183468 116649 2 None - 6 Rabbit 6.6 pEC50 = 6.6 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL323402 116649 2 None - 6 Rabbit 6.6 pEC50 = 6.6 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
9950711 115983 0 None - 4 Rabbit 5.6 pEC50 = 5.6 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL321644 115983 0 None - 4 Rabbit 5.6 pEC50 = 5.6 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
118727910 127460 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 427 8 0 3 4.1 O=C1CCCN1CCCCN1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmc.2015.03.009
CHEMBL3400594 127460 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 427 8 0 3 4.1 O=C1CCCN1CCCCN1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmc.2015.03.009
CHEMBL3547015 127460 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 427 8 0 3 4.1 O=C1CCCN1CCCCN1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmc.2015.03.009
134136412 149732 0 None - 0 Human 7.5 pEC50 = 7.5 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 483 10 1 6 4.1 CC(C)Oc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc3cccnc23)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3894175 149732 0 None - 0 Human 7.5 pEC50 = 7.5 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 483 10 1 6 4.1 CC(C)Oc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc3cccnc23)CC1 10.1016/j.bmc.2016.09.017
168294767 199798 0 None -4 20 Human 5.5 pEC50 = 5.5 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5207281 199798 0 None -4 20 Human 5.5 pEC50 = 5.5 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222802 199798 0 None -4 20 Human 5.5 pEC50 = 5.5 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
9904117 16174 3 None - 5 Rabbit 6.4 pEC50 = 6.4 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111554 16174 3 None - 5 Rabbit 6.4 pEC50 = 6.4 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
3584 10549 64 None -2 14 Human 7.3 pEC50 = 7.3 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2015.03.009
5401 10549 64 None -2 14 Human 7.3 pEC50 = 7.3 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2015.03.009
7302 10549 64 None -2 14 Human 7.3 pEC50 = 7.3 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2015.03.009
CHEMBL611 10549 64 None -2 14 Human 7.3 pEC50 = 7.3 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2015.03.009
DB01162 10549 64 None -2 14 Human 7.3 pEC50 = 7.3 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2015.03.009
3584 10549 64 None -2 14 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2016.09.017
5401 10549 64 None -2 14 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2016.09.017
7302 10549 64 None -2 14 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2016.09.017
CHEMBL611 10549 64 None -2 14 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2016.09.017
DB01162 10549 64 None -2 14 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2016.09.017
9796525 16179 0 None - 3 Rabbit 5.3 pEC50 = 5.3 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 3 1 4 2.3 Cn1cnc(C2CCCc3c(NS(C)(=O)=O)cccc32)c1 10.1007/s00044-004-0020-z
CHEMBL111584 16179 0 None - 3 Rabbit 5.3 pEC50 = 5.3 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 3 1 4 2.3 Cn1cnc(C2CCCc3c(NS(C)(=O)=O)cccc32)c1 10.1007/s00044-004-0020-z
2146 9874 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assayAgonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2015.03.009
485 9874 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assayAgonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2015.03.009
6041 9874 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assayAgonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2015.03.009
CHEMBL1215 9874 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assayAgonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2015.03.009
DB00388 9874 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assayAgonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2015.03.009
2146 9874 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2016.09.017
485 9874 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2016.09.017
6041 9874 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2016.09.017
CHEMBL1215 9874 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2016.09.017
DB00388 9874 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2016.09.017
10267873 117437 0 None - 2 Rabbit 5.3 pEC50 = 5.3 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 317 4 2 3 2.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)C1CC1 10.1007/s00044-004-0020-z
CHEMBL325897 117437 0 None - 2 Rabbit 5.3 pEC50 = 5.3 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 317 4 2 3 2.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)C1CC1 10.1007/s00044-004-0020-z
9838192 118089 18 None - 6 Human 6.2 pEC50 = 6.2 Binding
Effective concentration in vitro against rabbit urethra Alpha-1A adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1A adrenergic receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm025550h
CHEMBL326702 118089 18 None - 6 Human 6.2 pEC50 = 6.2 Binding
Effective concentration in vitro against rabbit urethra Alpha-1A adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1A adrenergic receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm025550h
9838192 118089 18 None - 6 Rabbit 6.2 pEC50 = 6.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1007/s00044-004-0020-z
CHEMBL326702 118089 18 None - 6 Rabbit 6.2 pEC50 = 6.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1007/s00044-004-0020-z
9926529 16161 2 None - 5 Rabbit 6.2 pEC50 = 6.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111496 16161 2 None - 5 Rabbit 6.2 pEC50 = 6.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
9879119 16218 0 None - 5 Rabbit 7.2 pEC50 = 7.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111771 16218 0 None - 5 Rabbit 7.2 pEC50 = 7.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
11301627 16170 0 None - 2 Rabbit 5.2 pEC50 = 5.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 319 4 2 3 3.0 CC(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111537 16170 0 None - 2 Rabbit 5.2 pEC50 = 5.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 319 4 2 3 3.0 CC(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
43260 12254 65 None - 5 Rabbit 5.2 pEC50 = 5.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1007/s00044-004-0020-z
CHEMBL1076 12254 65 None - 5 Rabbit 5.2 pEC50 = 5.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1007/s00044-004-0020-z
43260 12254 65 None - 5 Human 5.2 pEC50 = 5.2 Binding
Effective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptor
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm025550h
CHEMBL1076 12254 65 None - 5 Human 5.2 pEC50 = 5.2 Binding
Effective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptor
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm025550h
134136428 149920 0 None - 0 Human 7.1 pEC50 = 7.1 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 456 9 1 5 3.6 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2F)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3895815 149920 0 None - 0 Human 7.1 pEC50 = 7.1 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 456 9 1 5 3.6 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2F)CC1 10.1016/j.bmc.2016.09.017
168295528 199810 0 None -4 20 Human 6.1 pEC50 = 6.1 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5206565 199810 0 None -4 20 Human 6.1 pEC50 = 6.1 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222872 199810 0 None -4 20 Human 6.1 pEC50 = 6.1 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
4038180 6992 14 None -6 8 Human 8.0 pEC50 = 8.0 Binding
Effective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm025550h
480 6992 14 None -6 8 Human 8.0 pEC50 = 8.0 Binding
Effective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm025550h
CHEMBL109783 6992 14 None -6 8 Human 8.0 pEC50 = 8.0 Binding
Effective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm025550h
4038180 6992 14 None - 8 Rabbit 8.0 pEC50 = 8.0 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
480 6992 14 None - 8 Rabbit 8.0 pEC50 = 8.0 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL109783 6992 14 None - 8 Rabbit 8.0 pEC50 = 8.0 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
132578518 155431 0 None - 0 Human 7.0 pEC50 = 7 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 441 8 1 6 3.1 COc1ccccc1OCCN1CCC(NS(=O)(=O)c2cncc3ccccc23)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3939560 155431 0 None - 0 Human 7.0 pEC50 = 7 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 441 8 1 6 3.1 COc1ccccc1OCCN1CCC(NS(=O)(=O)c2cncc3ccccc23)CC1 10.1016/j.bmc.2016.09.017
3158 63041 27 None -295 20 Rat 11.0 pIC50 = 11 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1021/jm9910369
CHEMBL1628227 63041 27 None -295 20 Rat 11.0 pIC50 = 11 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1021/jm9910369
DB01142 63041 27 None -295 20 Rat 11.0 pIC50 = 11 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1021/jm9910369
180 7189 56 None -10 40 Rat 10.7 pIC50 = 10.7 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1021/jm9910369
200 7189 56 None -10 40 Rat 10.7 pIC50 = 10.7 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1021/jm9910369
2160 7189 56 None -10 40 Rat 10.7 pIC50 = 10.7 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1021/jm9910369
CHEMBL629 7189 56 None -10 40 Rat 10.7 pIC50 = 10.7 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1021/jm9910369
DB00321 7189 56 None -10 40 Rat 10.7 pIC50 = 10.7 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1021/jm9910369
2398 7741 62 None -4 29 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1021/jm9910369
2801 7741 62 None -4 29 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1021/jm9910369
701 7741 62 None -4 29 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1021/jm9910369
CHEMBL415 7741 62 None -4 29 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1021/jm9910369
DB01242 7741 62 None -4 29 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1021/jm9910369
1971 9641 38 None -24 30 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1021/jm9910369
2404 9641 38 None -24 30 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1021/jm9910369
4543 9641 38 None -24 30 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1021/jm9910369
CHEMBL445 9641 38 None -24 30 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1021/jm9910369
DB00540 9641 38 None -24 30 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1021/jm9910369
135 9310 43 None -46 56 Rat 10.2 pIC50 = 10.2 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm9910369
1796 9310 43 None -46 56 Rat 10.2 pIC50 = 10.2 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm9910369
4184 9310 43 None -46 56 Rat 10.2 pIC50 = 10.2 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm9910369
CHEMBL6437 9310 43 None -46 56 Rat 10.2 pIC50 = 10.2 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm9910369
DB06148 9310 43 None -46 56 Rat 10.2 pIC50 = 10.2 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm9910369
4209 9937 75 None -1 33 Rat 9.7 pIC50 = 9.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
4893 9937 75 None -1 33 Rat 9.7 pIC50 = 9.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
503 9937 75 None -1 33 Rat 9.7 pIC50 = 9.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
5385 9937 75 None -1 33 Rat 9.7 pIC50 = 9.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
CHEMBL2 9937 75 None -1 33 Rat 9.7 pIC50 = 9.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
DB00457 9937 75 None -1 33 Rat 9.7 pIC50 = 9.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
2995 211184 53 None - 23 Rat 9.6 pIC50 = 9.6 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1021/jm9910369
CHEMBL1696 211184 53 None - 23 Rat 9.6 pIC50 = 9.6 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1021/jm9910369
CHEMBL72 211184 53 None - 23 Rat 9.6 pIC50 = 9.6 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1021/jm9910369
DB01151 211184 53 None - 23 Rat 9.6 pIC50 = 9.6 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1021/jm9910369
4209 9937 75 None -1 33 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm900458r
4893 9937 75 None -1 33 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm900458r
503 9937 75 None -1 33 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm900458r
5385 9937 75 None -1 33 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm900458r
CHEMBL2 9937 75 None -1 33 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm900458r
DB00457 9937 75 None -1 33 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm900458r
11638677 91364 0 None -5 6 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2011.04.032
CHEMBL2153423 91364 0 None -5 6 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2011.04.032
CHEMBL2220978 91364 0 None -5 6 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2011.04.032
10809876 109430 0 None - 0 Bovine 9.3 pIC50 = 9.3 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 381 5 0 5 2.4 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCC(=O)N3C)CC1 10.1021/jm970298c
CHEMBL304438 109430 0 None - 0 Bovine 9.3 pIC50 = 9.3 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 381 5 0 5 2.4 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCC(=O)N3C)CC1 10.1021/jm970298c
76071739 149575 0 None - 0 Rat 9.3 pIC50 = 9.3 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)C[C@H]1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3892879 149575 0 None - 0 Rat 9.3 pIC50 = 9.3 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)C[C@H]1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
10547091 208877 0 None - 0 Bovine 9.2 pIC50 = 9.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 369 5 1 6 3.4 COc1ccccc1N1CCN(CCc2ccc3nc(O)sc3c2)CC1 10.1021/jm970298c
CHEMBL60885 208877 0 None - 0 Bovine 9.2 pIC50 = 9.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 369 5 1 6 3.4 COc1ccccc1N1CCN(CCc2ccc3nc(O)sc3c2)CC1 10.1021/jm970298c
122179430 128219 0 None -3 3 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 599 8 1 13 2.7 CCN(CC)c1ccc2cc(-n3cc(C(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
CHEMBL3582270 128219 0 None -3 3 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 599 8 1 13 2.7 CCN(CC)c1ccc2cc(-n3cc(C(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
4209 9937 75 None -1 33 Rat 9.2 pIC50 = 9.2 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
4893 9937 75 None -1 33 Rat 9.2 pIC50 = 9.2 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
503 9937 75 None -1 33 Rat 9.2 pIC50 = 9.2 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
5385 9937 75 None -1 33 Rat 9.2 pIC50 = 9.2 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
CHEMBL2 9937 75 None -1 33 Rat 9.2 pIC50 = 9.2 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
DB00457 9937 75 None -1 33 Rat 9.2 pIC50 = 9.2 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
3157 8252 71 None -1 12 Rat 9.1 pIC50 = 9.1 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.10.026
7170 8252 71 None -1 12 Rat 9.1 pIC50 = 9.1 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.10.026
954 8252 71 None -1 12 Rat 9.1 pIC50 = 9.1 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.10.026
CHEMBL707 8252 71 None -1 12 Rat 9.1 pIC50 = 9.1 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.10.026
DB00590 8252 71 None -1 12 Rat 9.1 pIC50 = 9.1 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.10.026
4151 10379 89 None - 3 Rat 9.1 pIC50 = 9.1 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
493 10379 89 None - 3 Rat 9.1 pIC50 = 9.1 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
5312125 10379 89 None - 3 Rat 9.1 pIC50 = 9.1 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
CHEMBL24778 10379 89 None - 3 Rat 9.1 pIC50 = 9.1 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
DB06207 10379 89 None - 3 Rat 9.1 pIC50 = 9.1 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
10524876 210104 0 None - 0 Bovine 9.1 pIC50 = 9.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 397 7 1 6 4.2 COc1ccccc1N1CCN(CCCCc2ccc3nc(O)sc3c2)CC1 10.1021/jm970298c
CHEMBL64878 210104 0 None - 0 Bovine 9.1 pIC50 = 9.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 397 7 1 6 4.2 COc1ccccc1N1CCN(CCCCc2ccc3nc(O)sc3c2)CC1 10.1021/jm970298c
2389 10104 118 None -6 66 Rat 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
5073 10104 118 None -6 66 Rat 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
96 10104 118 None -6 66 Rat 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
CHEMBL85 10104 118 None -6 66 Rat 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
DB00734 10104 118 None -6 66 Rat 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
10691383 107552 0 None - 0 Bovine 9.0 pIC50 = 9 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 383 6 1 6 3.8 COc1ccccc1N1CCN(CCCc2ccc3nc(O)sc3c2)CC1 10.1021/jm970298c
CHEMBL292935 107552 0 None - 0 Bovine 9.0 pIC50 = 9 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 383 6 1 6 3.8 COc1ccccc1N1CCN(CCCc2ccc3nc(O)sc3c2)CC1 10.1021/jm970298c
19972363 101181 0 None - 0 Rat 9.0 pIC50 = 9 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 539 9 1 6 5.5 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OC(C)C)CC3)cccc2c1=O 10.1021/jm960697s
CHEMBL25098 101181 0 None - 0 Rat 9.0 pIC50 = 9 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 539 9 1 6 5.5 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OC(C)C)CC3)cccc2c1=O 10.1021/jm960697s
44275384 105586 0 None - 0 Rat 9.0 pIC50 = 9 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 529 7 1 5 5.7 Cc1ccc(Cl)cc1N1CCN(CCCNC(=O)c2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
CHEMBL278518 105586 0 None - 0 Rat 9.0 pIC50 = 9 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 529 7 1 5 5.7 Cc1ccc(Cl)cc1N1CCN(CCCNC(=O)c2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
2142 9870 58 None -2 37 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
4920903 9870 58 None -2 37 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
502 9870 58 None -2 37 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
5775 9870 58 None -2 37 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
CHEMBL597 9870 58 None -2 37 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
DB00692 9870 58 None -2 37 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
19972428 104872 0 None - 0 Rat 8.8 pIC50 = 8.8 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 496 8 0 6 5.6 COc1ccccc1N1CCN(CCCC(=O)c2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
CHEMBL27341 104872 0 None - 0 Rat 8.8 pIC50 = 8.8 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 496 8 0 6 5.6 COc1ccccc1N1CCN(CCCC(=O)c2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
3157 8252 71 None -1 12 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
7170 8252 71 None -1 12 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
954 8252 71 None -1 12 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
CHEMBL707 8252 71 None -1 12 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
DB00590 8252 71 None -1 12 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
107715 207724 22 None -1 20 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL1255837 207724 22 None -1 20 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL601773 207724 22 None -1 20 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
3168 16034 92 None 1 22 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
CHEMBL1108 16034 92 None 1 22 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
DB00450 16034 92 None 1 22 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
1427 8794 54 None - 27 Rat 8.8 pIC50 = 8.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1021/jm00172a035
357 8794 54 None - 27 Rat 8.8 pIC50 = 8.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1021/jm00172a035
3696 8794 54 None - 27 Rat 8.8 pIC50 = 8.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1021/jm00172a035
CHEMBL11 8794 54 None - 27 Rat 8.8 pIC50 = 8.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1021/jm00172a035
DB00458 8794 54 None - 27 Rat 8.8 pIC50 = 8.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1021/jm00172a035
9821397 107698 21 None - 0 Bovine 8.0 pIC50 = 8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 383 5 0 6 3.0 COc1ccccc1N1CCN(CCc2ccc3c(c2)sc(=O)n3C)CC1 10.1021/jm970298c
CHEMBL293923 107698 21 None - 0 Bovine 8.0 pIC50 = 8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 383 5 0 6 3.0 COc1ccccc1N1CCN(CCc2ccc3c(c2)sc(=O)n3C)CC1 10.1021/jm970298c
2389 10104 118 None -11 66 Human 8.0 pIC50 = 8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2016.04.087
5073 10104 118 None -11 66 Human 8.0 pIC50 = 8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2016.04.087
96 10104 118 None -11 66 Human 8.0 pIC50 = 8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2016.04.087
CHEMBL85 10104 118 None -11 66 Human 8.0 pIC50 = 8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2016.04.087
DB00734 10104 118 None -11 66 Human 8.0 pIC50 = 8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2016.04.087
19972481 100284 0 None - 0 Rat 8.0 pIC50 = 8 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 498 9 0 6 5.8 COc1ccccc1N1CCN(CCCCOc2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
CHEMBL24629 100284 0 None - 0 Rat 8.0 pIC50 = 8 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 498 9 0 6 5.8 COc1ccccc1N1CCN(CCCCOc2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
119146 103926 18 None - 4 Rat 8.0 pIC50 = 8 Binding
Displacement of [3H]prazosin from rat cerebral cortex alpha1 adrenergic receptorDisplacement of [3H]prazosin from rat cerebral cortex alpha1 adrenergic receptor
ChEMBL 409 6 0 4 3.6 CN1CN(c2ccccc2)C2(CCN(CCCC(=O)c3ccc(F)cc3)CC2)C1=O 10.1021/acs.jmedchem.2c00633
CHEMBL267932 103926 18 None - 4 Rat 8.0 pIC50 = 8 Binding
Displacement of [3H]prazosin from rat cerebral cortex alpha1 adrenergic receptorDisplacement of [3H]prazosin from rat cerebral cortex alpha1 adrenergic receptor
ChEMBL 409 6 0 4 3.6 CN1CN(c2ccccc2)C2(CCN(CCCC(=O)c3ccc(F)cc3)CC2)C1=O 10.1021/acs.jmedchem.2c00633
10409553 25680 0 None - 0 Bovine 7.0 pIC50 = 7 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 414 5 1 5 3.1 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccccc3)CC1)O2 10.1021/jm00099a028
CHEMBL1203299 25680 0 None - 0 Bovine 7.0 pIC50 = 7 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 414 5 1 5 3.1 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccccc3)CC1)O2 10.1021/jm00099a028
CHEMBL128451 25680 0 None - 0 Bovine 7.0 pIC50 = 7 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 414 5 1 5 3.1 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccccc3)CC1)O2 10.1021/jm00099a028
11198145 16587 2 None 1 5 Human 7.0 pIC50 = 7 Binding
Inhibition of Alpha-1 adrenergic receptorInhibition of Alpha-1 adrenergic receptor
ChEMBL 325 5 2 3 3.8 C[C@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/jm990199u
CHEMBL113830 16587 2 None 1 5 Human 7.0 pIC50 = 7 Binding
Inhibition of Alpha-1 adrenergic receptorInhibition of Alpha-1 adrenergic receptor
ChEMBL 325 5 2 3 3.8 C[C@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/jm990199u
13520310 170618 0 None - 0 Rat 7.0 pIC50 = 7 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 281 4 1 2 3.7 CN(C)CC(c1ccc(Cl)cc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL420644 170618 0 None - 0 Rat 7.0 pIC50 = 7 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 281 4 1 2 3.7 CN(C)CC(c1ccc(Cl)cc1)C1(O)CCCCC1 10.1021/jm00172a035
10072866 204254 0 None - 0 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 458 9 0 6 3.3 CCCN(CCCCN1C(=O)c2ccccc2S1(=O)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL51561 204254 0 None - 0 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 458 9 0 6 3.3 CCCN(CCCCN1C(=O)c2ccccc2S1(=O)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL56990 204254 0 None - 0 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 458 9 0 6 3.3 CCCN(CCCCN1C(=O)c2ccccc2S1(=O)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10478362 26872 0 None - 0 Bovine 6.0 pIC50 = 6 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 439 5 1 6 3.0 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc(C#N)cc3)CC1)O2 10.1021/jm00099a028
CHEMBL1203297 26872 0 None - 0 Bovine 6.0 pIC50 = 6 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 439 5 1 6 3.0 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc(C#N)cc3)CC1)O2 10.1021/jm00099a028
CHEMBL130410 26872 0 None - 0 Bovine 6.0 pIC50 = 6 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 439 5 1 6 3.0 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc(C#N)cc3)CC1)O2 10.1021/jm00099a028
10048445 42051 4 None - 0 Rat 6.0 pIC50 = 6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 432 5 1 3 4.6 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1=CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
CHEMBL143617 42051 4 None - 0 Rat 6.0 pIC50 = 6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 432 5 1 3 4.6 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1=CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
10391177 196033 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 497 7 0 4 4.0 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)N1CCCC1=O 10.1016/j.bmcl.2009.04.016
CHEMBL511747 196033 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 497 7 0 4 4.0 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)N1CCCC1=O 10.1016/j.bmcl.2009.04.016
9978353 18025 0 None - 0 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 400 7 1 5 3.1 COc1cccc2c1CC(NCCCCN1C(=O)CC3(CCCC3)CC1=O)CO2 10.1021/jm00038a007
CHEMBL1178987 18025 0 None - 0 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 400 7 1 5 3.1 COc1cccc2c1CC(NCCCCN1C(=O)CC3(CCCC3)CC1=O)CO2 10.1021/jm00038a007
CHEMBL52785 18025 0 None - 0 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 400 7 1 5 3.1 COc1cccc2c1CC(NCCCCN1C(=O)CC3(CCCC3)CC1=O)CO2 10.1021/jm00038a007
11743327 105478 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 1 5 3.9 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(O)c2C1 10.1021/jm00038a007
CHEMBL27763 105478 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 1 5 3.9 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(O)c2C1 10.1021/jm00038a007
9975915 106512 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 362 9 0 5 2.8 CCCN(CCCCN1CCOCC1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL284912 106512 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 362 9 0 5 2.8 CCCN(CCCCN1CCOCC1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
11524225 195778 0 None - 1 Human 5.0 pIC50 = 5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 403 4 0 5 4.3 Cc1cccc2c(=O)n(C)c(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)nc12 10.1016/j.bmcl.2008.10.034
CHEMBL508712 195778 0 None - 1 Human 5.0 pIC50 = 5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 403 4 0 5 4.3 Cc1cccc2c(=O)n(C)c(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)nc12 10.1016/j.bmcl.2008.10.034
131001 105769 7 None - 1 Bovine 4.0 pIC50 = 4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 249 5 1 3 2.8 CCCN(CCC)C1COc2cccc(O)c2C1 10.1021/jm00038a007
CHEMBL27995 105769 7 None - 1 Bovine 4.0 pIC50 = 4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 249 5 1 3 2.8 CCCN(CCC)C1COc2cccc(O)c2C1 10.1021/jm00038a007
10364722 105861 0 None - 1 Bovine 4.0 pIC50 = 4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL280608 105861 0 None - 1 Bovine 4.0 pIC50 = 4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL51888 105861 0 None - 1 Bovine 4.0 pIC50 = 4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10199052 214733 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 258 5 3 4 1.0 O=C(NC1CC1)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL97044 214733 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 258 5 3 4 1.0 O=C(NC1CC1)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
3158 63041 27 None -295 20 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
CHEMBL1628227 63041 27 None -295 20 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
DB01142 63041 27 None -295 20 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
11108001 17644 2 None -3 6 Human 7.0 pIC50 = 7.0 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL117248 17644 2 None -3 6 Human 7.0 pIC50 = 7.0 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL540542 17644 2 None -3 6 Human 7.0 pIC50 = 7.0 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
12488 8438 56 None -77 23 Rat 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
941361 8438 56 None -77 23 Rat 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
CHEMBL30008 8438 56 None -77 23 Rat 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
DB04841 8438 56 None -77 23 Rat 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
5656 209845 87 None - 43 Rat 7.0 pIC50 = 7.0 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
CHEMBL637 209845 87 None - 43 Rat 7.0 pIC50 = 7.0 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
134551 7146 27 None -3 21 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
271 7146 27 None -3 21 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
885 7146 27 None -3 21 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
CHEMBL1403281 7146 27 None -3 21 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
2142 9870 58 None -2 37 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
4920903 9870 58 None -2 37 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
502 9870 58 None -2 37 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
5775 9870 58 None -2 37 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
CHEMBL597 9870 58 None -2 37 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
DB00692 9870 58 None -2 37 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
73453 36389 24 None -6 17 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
CHEMBL1385840 36389 24 None -6 17 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
10094822 171667 4 None - 0 Rat 8.0 pIC50 = 8.0 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.8 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3ccc(Cl)cc32)CC1 10.1021/jm00104a007
CHEMBL422130 171667 4 None - 0 Rat 8.0 pIC50 = 8.0 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.8 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3ccc(Cl)cc32)CC1 10.1021/jm00104a007
10595604 120914 0 None - 0 Rat 7.0 pIC50 = 7.0 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 374 5 0 4 4.1 Fc1ccc(-n2cc(OCCN3CCOCC3)c3cc(Cl)ccc32)cc1 10.1021/jm960159f
CHEMBL332913 120914 0 None - 0 Rat 7.0 pIC50 = 7.0 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 374 5 0 4 4.1 Fc1ccc(-n2cc(OCCN3CCOCC3)c3cc(Cl)ccc32)cc1 10.1021/jm960159f
36811 8236 37 None -2 7 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
535 8236 37 None -2 7 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
937 8236 37 None -2 7 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
CHEMBL926 8236 37 None -2 7 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
DB00841 8236 37 None -2 7 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
11668594 193453 0 None - 1 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 405 7 0 5 4.9 CC(C)n1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL488251 193453 0 None - 1 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 405 7 0 5 4.9 CC(C)n1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
44376958 64253 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
CHEMBL165796 64253 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
22120332 62819 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 389 4 0 6 3.4 COc1cccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc12 10.1016/s0960-894x(99)00591-0
CHEMBL162490 62819 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 389 4 0 6 3.4 COc1cccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc12 10.1016/s0960-894x(99)00591-0
10015132 170648 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 253 4 1 4 2.1 c1ccc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(01)00764-8
CHEMBL420683 170648 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 253 4 1 4 2.1 c1ccc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(01)00764-8
44573964 185433 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 483 7 0 4 4.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)N1CCCC1 10.1016/j.bmcl.2009.04.016
CHEMBL467668 185433 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 483 7 0 4 4.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)N1CCCC1 10.1016/j.bmcl.2009.04.016
213 10625 55 None -4 43 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
2717 10625 55 None -4 43 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
5533 10625 55 None -4 43 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
CHEMBL621 10625 55 None -4 43 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
DB00656 10625 55 None -4 43 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
10503470 171102 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 444 9 1 4 4.1 CCN(CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL421239 171102 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 444 9 1 4 4.1 CCN(CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
127049863 147030 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 443 8 1 5 4.5 CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccc1F 10.1016/j.bmcl.2016.04.087
CHEMBL3805518 147030 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 443 8 1 5 4.5 CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccc1F 10.1016/j.bmcl.2016.04.087
240 7731 43 None -4 25 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
2769 7731 43 None -4 25 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
44279790 7731 43 None -4 25 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
660 7731 43 None -4 25 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL1729 7731 43 None -4 25 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL560739 7731 43 None -4 25 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
DB00604 7731 43 None -4 25 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
85469808 143408 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 439 7 0 4 3.8 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(Cc3ccccc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3739900 143408 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 439 7 0 4 3.8 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(Cc3ccccc3)CC2)cc1 10.1016/j.bmc.2015.11.020
42 8844 57 None - 18 Bovine 5.9 pIC50 = 5.9 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
56971 8844 57 None - 18 Bovine 5.9 pIC50 = 5.9 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
CHEMBL8412 8844 57 None - 18 Bovine 5.9 pIC50 = 5.9 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
4735 201894 96 None -77 10 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
CHEMBL361506 201894 96 None -77 10 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
CHEMBL55 201894 96 None -77 10 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
102 10899 48 None -1258 49 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
3659 10899 48 None -1258 49 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
8969 10899 48 None -1258 49 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
CHEMBL15245 10899 48 None -1258 49 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
DB01392 10899 48 None -1258 49 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
13520332 11066 0 None - 0 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 1 3 2.6 COc1ccc(C(CN(C)C)C2(O)CCCC2)cc1 10.1021/jm00172a035
CHEMBL100774 11066 0 None - 0 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 1 3 2.6 COc1ccc(C(CN(C)C)C2(O)CCCC2)cc1 10.1021/jm00172a035
85469757 143517 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 468 6 0 5 3.9 N#Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)c(F)c1 10.1016/j.bmc.2015.11.020
CHEMBL3740874 143517 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 468 6 0 5 3.9 N#Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)c(F)c1 10.1016/j.bmc.2015.11.020
44362511 126126 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 267 4 1 4 2.4 Cc1ccnc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL344294 126126 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 267 4 1 4 2.4 Cc1ccnc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
10829244 23280 0 None - 0 Rat 6.9 pIC50 = 6.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 316 4 0 2 4.5 CN(C)CCc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12 10.1021/jm960159f
CHEMBL123640 23280 0 None - 0 Rat 6.9 pIC50 = 6.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 316 4 0 2 4.5 CN(C)CCc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12 10.1021/jm960159f
10265758 11250 4 None - 0 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 281 4 1 2 3.7 CN(C)CC(c1cccc(Cl)c1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL101899 11250 4 None - 0 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 281 4 1 2 3.7 CN(C)CC(c1cccc(Cl)c1)C1(O)CCCCC1 10.1021/jm00172a035
2995 211184 53 None - 23 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1021/jm00172a035
CHEMBL1696 211184 53 None - 23 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1021/jm00172a035
CHEMBL72 211184 53 None - 23 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1021/jm00172a035
DB01151 211184 53 None - 23 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1021/jm00172a035
11689687 198058 0 None - 1 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 391 7 0 5 4.3 CCn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL519067 198058 0 None - 1 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 391 7 0 5 4.3 CCn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
45485061 205533 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 489 5 2 5 5.0 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)n1 10.1016/j.bmcl.2009.09.003
CHEMBL583014 205533 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 489 5 2 5 5.0 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)n1 10.1016/j.bmcl.2009.09.003
441383 27105 57 None -257 17 Rat 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL1306 27105 57 None -257 17 Rat 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
1343 8670 62 None -87 9 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
3519 8670 62 None -87 9 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
522 8670 62 None -87 9 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
CHEMBL862 8670 62 None -87 9 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
DB01018 8670 62 None -87 9 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
72197484 109271 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 330 4 2 4 3.5 c1ccc(Cc2nc3c(c(Nc4ccccc4)n2)CCNCC3)cc1 10.1016/j.ejmech.2013.02.020
CHEMBL2393243 109271 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 330 4 2 4 3.5 c1ccc(Cc2nc3c(c(Nc4ccccc4)n2)CCNCC3)cc1 10.1016/j.ejmech.2013.02.020
CHEMBL3040324 109271 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 330 4 2 4 3.5 c1ccc(Cc2nc3c(c(Nc4ccccc4)n2)CCNCC3)cc1 10.1016/j.ejmech.2013.02.020
10645487 22529 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 414 7 1 3 3.9 CN(CCc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL122269 22529 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 414 7 1 3 3.9 CN(CCc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12)CCN1CCNC1=O 10.1021/jm960159f
10788685 125238 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 428 8 1 3 4.3 CN(CCCN1CCNC1=O)CCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL341229 125238 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 428 8 1 3 4.3 CN(CCCN1CCNC1=O)CCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
19972519 101023 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 497 7 1 6 4.3 COc1ccccc1N1CCN(CCNC(=O)c2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
CHEMBL25012 101023 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 497 7 1 6 4.3 COc1ccccc1N1CCN(CCNC(=O)c2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
180 7189 56 None -10 40 Rat 7.9 pIC50 = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
200 7189 56 None -10 40 Rat 7.9 pIC50 = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
2160 7189 56 None -10 40 Rat 7.9 pIC50 = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
CHEMBL629 7189 56 None -10 40 Rat 7.9 pIC50 = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
DB00321 7189 56 None -10 40 Rat 7.9 pIC50 = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
85469809 143479 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 467 7 0 5 4.1 CC(=O)c1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3740558 143479 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 467 7 0 5 4.1 CC(=O)c1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
10381889 113846 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 328 2 0 3 4.1 CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1 10.1016/s0960-894x(02)00796-5
CHEMBL315772 113846 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 328 2 0 3 4.1 CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1 10.1016/s0960-894x(02)00796-5
10381889 113846 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 328 2 0 3 4.1 CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL315772 113846 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 328 2 0 3 4.1 CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1 10.1016/s0960-894x(01)00721-1
5656 209845 87 None - 43 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
CHEMBL637 209845 87 None - 43 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
1201549 7384 24 None -51 20 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
333 7384 24 None -51 20 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
7601 7384 24 None -51 20 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL1201203 7384 24 None -51 20 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL438151 7384 24 None -51 20 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
DB00245 7384 24 None -51 20 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
6075 156887 42 None -11 16 Rat 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
CHEMBL395110 156887 42 None -11 16 Rat 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
11796106 22352 0 None - 0 Rat 7.8 pIC50 = 7.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 414 7 1 3 3.9 CN(CCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL122113 22352 0 None - 0 Rat 7.8 pIC50 = 7.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 414 7 1 3 3.9 CN(CCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
85469811 143662 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 459 6 0 4 4.5 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3Cl)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3742198 143662 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 459 6 0 4 4.5 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3Cl)CC2)cc1 10.1016/j.bmc.2015.11.020
9886555 23267 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 387 5 0 4 4.0 CN1CCN(CCOc2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1 10.1021/jm960159f
CHEMBL123584 23267 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 387 5 0 4 4.0 CN1CCN(CCOc2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1 10.1021/jm960159f
13520317 11122 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1cccc(C(CN(C)C)C2(O)CCCCC2)c1 10.1021/jm00172a035
CHEMBL101055 11122 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1cccc(C(CN(C)C)C2(O)CCCCC2)c1 10.1021/jm00172a035
160023 26220 7 None - 0 Bovine 5.8 pIC50 = 5.8 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 456 5 1 8 2.6 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
CHEMBL1204345 26220 7 None - 0 Bovine 5.8 pIC50 = 5.8 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 456 5 1 8 2.6 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
CHEMBL129583 26220 7 None - 0 Bovine 5.8 pIC50 = 5.8 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 456 5 1 8 2.6 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
10255678 124149 0 None - 0 Bovine 4.8 pIC50 = 4.8 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 507 7 2 7 2.5 CS(=O)(=O)Nc1ccc(CCN2CCC3(CC2)CC(=O)c2cc(NS(C)(=O)=O)ccc2O3)cc1 10.1021/jm00099a028
CHEMBL1203296 124149 0 None - 0 Bovine 4.8 pIC50 = 4.8 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 507 7 2 7 2.5 CS(=O)(=O)Nc1ccc(CCN2CCC3(CC2)CC(=O)c2cc(NS(C)(=O)=O)ccc2O3)cc1 10.1021/jm00099a028
CHEMBL339769 124149 0 None - 0 Bovine 4.8 pIC50 = 4.8 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 507 7 2 7 2.5 CS(=O)(=O)Nc1ccc(CCN2CCC3(CC2)CC(=O)c2cc(NS(C)(=O)=O)ccc2O3)cc1 10.1021/jm00099a028
85469698 143604 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 425 6 0 4 3.8 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3741658 143604 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 425 6 0 4 3.8 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3)CC2)cc1 10.1016/j.bmc.2015.11.020
5282322 85019 21 None - 1 Rat 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 785 11 4 15 2.4 CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O nan
CHEMBL2106399 85019 21 None - 1 Rat 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 785 11 4 15 2.4 CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O nan
135398737 7745 93 None - 90 Bovine 6.8 pIC50 = 6.8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm970298c
38 7745 93 None - 90 Bovine 6.8 pIC50 = 6.8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm970298c
722 7745 93 None - 90 Bovine 6.8 pIC50 = 6.8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm970298c
CHEMBL42 7745 93 None - 90 Bovine 6.8 pIC50 = 6.8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm970298c
DB00363 7745 93 None - 90 Bovine 6.8 pIC50 = 6.8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm970298c
2477 7532 59 None - 29 Bovine 4.8 pIC50 = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
36 7532 59 None - 29 Bovine 4.8 pIC50 = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
437 7532 59 None - 29 Bovine 4.8 pIC50 = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
CHEMBL49 7532 59 None - 29 Bovine 4.8 pIC50 = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
DB00490 7532 59 None - 29 Bovine 4.8 pIC50 = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
10246054 113321 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 330 2 0 3 3.7 CN(C)CC1CC2c3cc(F)ccc3Cc3ccc(F)cc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL314107 113321 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 330 2 0 3 3.7 CN(C)CC1CC2c3cc(F)ccc3Cc3ccc(F)cc3N2O1 10.1016/s0960-894x(01)00721-1
44343410 18327 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 219 4 2 3 2.7 CSc1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
CHEMBL118055 18327 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 219 4 2 3 2.7 CSc1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
10592734 23853 0 None - 0 Rat 7.8 pIC50 = 7.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 332 5 0 3 4.4 CN(C)CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL125483 23853 0 None - 0 Rat 7.8 pIC50 = 7.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 332 5 0 3 4.4 CN(C)CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
8459 10071 4 None - 3 Bovine 7.8 pIC50 = 7.8 Binding
Binding affinity was tested on cloned bovine Alpha-1A adrenergic receptorBinding affinity was tested on cloned bovine Alpha-1A adrenergic receptor
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm960697s
9891980 10071 4 None - 3 Bovine 7.8 pIC50 = 7.8 Binding
Binding affinity was tested on cloned bovine Alpha-1A adrenergic receptorBinding affinity was tested on cloned bovine Alpha-1A adrenergic receptor
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm960697s
CHEMBL430717 10071 4 None - 3 Bovine 7.8 pIC50 = 7.8 Binding
Binding affinity was tested on cloned bovine Alpha-1A adrenergic receptorBinding affinity was tested on cloned bovine Alpha-1A adrenergic receptor
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm960697s
242 7258 124 None -14 51 Human 6.8 pIC50 = 6.8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2016.04.087
34 7258 124 None -14 51 Human 6.8 pIC50 = 6.8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2016.04.087
60795 7258 124 None -14 51 Human 6.8 pIC50 = 6.8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2016.04.087
CHEMBL1112 7258 124 None -14 51 Human 6.8 pIC50 = 6.8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2016.04.087
DB01238 7258 124 None -14 51 Human 6.8 pIC50 = 6.8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2016.04.087
10544602 124247 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 332 5 0 3 4.4 CN(C)CCOc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12 10.1021/jm960159f
CHEMBL339919 124247 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 332 5 0 3 4.4 CN(C)CCOc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12 10.1021/jm960159f
10739024 76608 0 None -33 6 Human 5.8 pIC50 = 5.8 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype.Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype.
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19376 76608 0 None -33 6 Human 5.8 pIC50 = 5.8 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype.Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype.
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
2771 201796 74 None -8 27 Rat 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 nan
CHEMBL1200781 201796 74 None -8 27 Rat 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 nan
CHEMBL549 201796 74 None -8 27 Rat 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 nan
10518508 108829 1 None - 0 Rat 7.8 pIC50 = 7.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 302 3 0 2 4.5 CN(C)Cc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL301956 108829 1 None - 0 Rat 7.8 pIC50 = 7.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 302 3 0 2 4.5 CN(C)Cc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
11502343 192929 0 None - 1 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 405 8 0 5 4.7 CCCn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL487230 192929 0 None - 1 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 405 8 0 5 4.7 CCCn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
10477439 42780 4 None - 0 Rat 7.7 pIC50 = 7.7 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 424 5 1 3 4.2 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(F)ccc32)CC1 10.1021/jm00104a007
CHEMBL144318 42780 4 None - 0 Rat 7.7 pIC50 = 7.7 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 424 5 1 3 4.2 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(F)ccc32)CC1 10.1021/jm00104a007
10426286 126131 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 322 2 0 2 5.0 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(C)CC1 10.1021/jm00104a007
CHEMBL344335 126131 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 322 2 0 2 5.0 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(C)CC1 10.1021/jm00104a007
10254306 127653 4 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 474 5 1 3 5.1 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(C(F)(F)F)ccc32)CC1 10.1021/jm00104a007
CHEMBL355917 127653 4 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 474 5 1 3 5.1 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(C(F)(F)F)ccc32)CC1 10.1021/jm00104a007
13520327 215144 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 355 5 1 3 3.8 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1Br 10.1021/jm00172a035
CHEMBL99503 215144 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 355 5 1 3 3.8 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1Br 10.1021/jm00172a035
19426635 212372 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 280 2 1 3 3.1 CNCC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL81485 212372 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 280 2 1 3 3.1 CNCC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
22493269 53600 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 256 4 2 5 2.1 Cc1ncoc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL154023 53600 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 256 4 2 5 2.1 Cc1ncoc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
22493289 56462 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 253 4 2 5 1.6 c1cnc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
CHEMBL156661 56462 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 253 4 2 5 1.6 c1cnc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
9934955 79051 0 None -489 6 Human 5.7 pIC50 = 5.7 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19826 79051 0 None -489 6 Human 5.7 pIC50 = 5.7 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
25014630 90314 1 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of alpha1A adrenergic receptorInhibition of alpha1A adrenergic receptor
ChEMBL 326 3 3 4 3.3 N=C(Nc1ccc2c(c1)CCN2C1CCNCC1)c1cccs1 10.1016/j.ejmech.2012.07.006
CHEMBL2203713 90314 1 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of alpha1A adrenergic receptorInhibition of alpha1A adrenergic receptor
ChEMBL 326 3 3 4 3.3 N=C(Nc1ccc2c(c1)CCN2C1CCNCC1)c1cccs1 10.1016/j.ejmech.2012.07.006
44461606 112772 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 308 3 0 3 3.8 CN(C)CCC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL313189 112772 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 308 3 0 3 3.8 CN(C)CCC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
10073934 194269 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 481 7 0 6 3.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1cncn1 10.1016/j.bmcl.2009.04.016
CHEMBL494155 194269 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 481 7 0 6 3.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1cncn1 10.1016/j.bmcl.2009.04.016
44573932 194270 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 482 7 0 7 2.9 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1cnnn1 10.1016/j.bmcl.2009.04.016
CHEMBL494156 194270 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 482 7 0 7 2.9 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1cnnn1 10.1016/j.bmcl.2009.04.016
1547484 7727 74 None -125 20 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
654 7727 74 None -125 20 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
9072 7727 74 None -125 20 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
CHEMBL43064 7727 74 None -125 20 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
DB00568 7727 74 None -125 20 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
10345121 194232 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 481 7 0 6 3.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1ccnn1 10.1016/j.bmcl.2009.04.016
CHEMBL493967 194232 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 481 7 0 6 3.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1ccnn1 10.1016/j.bmcl.2009.04.016
2105 9828 37 None -288 32 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
47811 9828 37 None -288 32 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
48 9828 37 None -288 32 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
CHEMBL531 9828 37 None -288 32 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
DB01186 9828 37 None -288 32 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
448537 167029 89 None -1584 25 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL411 167029 89 None -1584 25 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
9837963 69745 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cellsInhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17851 69745 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cellsInhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
148842 10718 27 None -8 5 Rat 8.7 pIC50 = 8.7 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm960697s
496 10718 27 None -8 5 Rat 8.7 pIC50 = 8.7 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm960697s
CHEMBL278865 10718 27 None -8 5 Rat 8.7 pIC50 = 8.7 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm960697s
85469933 143426 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 439 6 0 4 4.2 Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3740019 143426 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 439 6 0 4 4.2 Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
56961506 128217 0 None - 1 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 544 5 2 13 1.6 COc1cc2nc(N3CCN(C(=O)c4cn(-c5cc6ccc(O)cc6oc5=O)nn4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
CHEMBL3582269 128217 0 None - 1 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 544 5 2 13 1.6 COc1cc2nc(N3CCN(C(=O)c4cn(-c5cc6ccc(O)cc6oc5=O)nn4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
137380627 169445 3 None - 0 Rat 8.6 pIC50 = 8.6 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 772 17 2 14 4.7 COc1cc2nc(N3CCN(C(=O)CCCCCCCCCCC(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)CC3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.10.026
CHEMBL4170029 169445 3 None - 0 Rat 8.6 pIC50 = 8.6 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 772 17 2 14 4.7 COc1cc2nc(N3CCN(C(=O)CCCCCCCCCCC(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)CC3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.10.026
1353 8692 93 None - 85 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1021/jm970298c
3559 8692 93 None - 85 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1021/jm970298c
86 8692 93 None - 85 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1021/jm970298c
CHEMBL54 8692 93 None - 85 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1021/jm970298c
DB00502 8692 93 None - 85 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1021/jm970298c
10573576 207211 0 None - 0 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 409 7 0 5 3.2 COc1ccccc1N1CCN(CCCCc2ccc3c(c2)OCC(=O)N3C)CC1 10.1021/jm970298c
CHEMBL59823 207211 0 None - 0 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 409 7 0 5 3.2 COc1ccccc1N1CCN(CCCCc2ccc3c(c2)OCC(=O)N3C)CC1 10.1021/jm970298c
10671211 209506 0 None - 0 Bovine 6.7 pIC50 = 6.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 449 6 0 5 4.8 Cn1c(=O)sc2cc(CCCCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
CHEMBL61818 209506 0 None - 0 Bovine 6.7 pIC50 = 6.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 449 6 0 5 4.8 Cn1c(=O)sc2cc(CCCCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
10319624 105763 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 10 1 4 4.1 CCCN(CCCCNC(=O)c1ccc(F)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL27991 105763 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 10 1 4 4.1 CCCN(CCCCNC(=O)c1ccc(F)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL298534 105763 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 10 1 4 4.1 CCCN(CCCCNC(=O)c1ccc(F)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10265863 200103 0 None - 0 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 283 5 0 2 4.3 CCCN(CCC)C1COc2ccc3ccccc3c2C1 10.1021/jm00038a007
CHEMBL52438 200103 0 None - 0 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 283 5 0 2 4.3 CCCN(CCC)C1COc2ccc3ccccc3c2C1 10.1021/jm00038a007
9934955 79051 0 None -165 6 Rat 5.7 pIC50 = 5.7 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19826 79051 0 None -165 6 Rat 5.7 pIC50 = 5.7 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
121852 16938 7 None - 1 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL11592 16938 7 None - 1 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL301060 16938 7 None - 1 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
44376975 62760 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 435 5 0 5 4.6 O=c1c(CCN2CCc3oc4ccccc4c3C2)c(Cc2ccccc2)nc2ccccn12 10.1016/s0960-894x(99)00591-0
CHEMBL162436 62760 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 435 5 0 5 4.6 O=c1c(CCN2CCc3oc4ccccc4c3C2)c(Cc2ccccc2)nc2ccccn12 10.1016/s0960-894x(99)00591-0
9903313 179457 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 260 5 2 4 1.2 CCN(C)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL450018 179457 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 260 5 2 4 1.2 CCN(C)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
14739944 215179 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 261 4 1 2 3.3 Cc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
CHEMBL99670 215179 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 261 4 1 2 3.3 Cc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
2520 210787 70 None -147 12 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
CHEMBL1280 210787 70 None -147 12 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
CHEMBL6966 210787 70 None -147 12 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
3198 212292 76 None -1698 34 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1201049 212292 76 None -1698 34 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL808 212292 76 None -1698 34 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
9951544 64150 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 375 3 0 5 3.8 Cc1nc2ccccn2c(=O)c1CCN1CCc2sc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165181 64150 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 375 3 0 5 3.8 Cc1nc2ccccn2c(=O)c1CCN1CCc2sc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
10198532 214475 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 232 4 3 4 0.5 CNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL95523 214475 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 232 4 3 4 0.5 CNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
11581337 193451 0 None - 3 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 363 6 0 5 3.5 Cn1c(-c2ccc(OCCCN3CCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL488248 193451 0 None - 3 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 363 6 0 5 3.5 Cn1c(-c2ccc(OCCCN3CCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL557214 193451 0 None - 3 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 363 6 0 5 3.5 Cn1c(-c2ccc(OCCCN3CCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
2351 10059 64 None -138 21 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
2820 10059 64 None -138 21 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
5035 10059 64 None -138 21 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
CHEMBL81 10059 64 None -138 21 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
DB00481 10059 64 None -138 21 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
1016 10519 78 None -1737 35 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2561 10519 78 None -1737 35 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2733526 10519 78 None -1737 35 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
5384 10519 78 None -1737 35 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
CHEMBL83 10519 78 None -1737 35 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
DB00675 10519 78 None -1737 35 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
44329797 114883 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 261 5 2 5 1.7 CC(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL319553 114883 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 261 5 2 5 1.7 CC(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
135 9310 43 None -46 56 Rat 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
1796 9310 43 None -46 56 Rat 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
4184 9310 43 None -46 56 Rat 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
CHEMBL6437 9310 43 None -46 56 Rat 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
DB06148 9310 43 None -46 56 Rat 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
85469870 143428 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 439 6 0 4 4.2 Cc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
CHEMBL3740042 143428 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 439 6 0 4 4.2 Cc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
85469934 143513 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 443 6 0 4 4.0 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(F)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3740847 143513 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 443 6 0 4 4.0 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(F)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
10834872 22337 0 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 400 6 1 3 3.9 CN(CCN1CCNC1=O)Cc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL122018 22337 0 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 400 6 1 3 3.9 CN(CCN1CCNC1=O)Cc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
1588 9105 27 None -26 44 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
28864 9105 27 None -26 44 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
43 9105 27 None -26 44 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
CHEMBL157138 9105 27 None -26 44 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
DB00589 9105 27 None -26 44 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
10047772 43445 0 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 420 5 1 3 4.4 Cc1cccc2c(-c3ccc(F)cc3)cn(C3CCN(CCN4CCNC4=O)CC3)c12 10.1021/jm00104a007
CHEMBL144901 43445 0 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 420 5 1 3 4.4 Cc1cccc2c(-c3ccc(F)cc3)cn(C3CCN(CCN4CCNC4=O)CC3)c12 10.1021/jm00104a007
44573821 199512 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 503 6 0 2 6.8 Cc1ccc(N(C(=O)N(C)CCCN2CCC3(CCc4ccccc43)CC2)c2ccc(F)c(F)c2)cc1 10.1016/j.bmcl.2009.04.016
CHEMBL522037 199512 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 503 6 0 2 6.8 Cc1ccc(N(C(=O)N(C)CCCN2CCC3(CCc4ccccc43)CC2)c2ccc(F)c(F)c2)cc1 10.1016/j.bmcl.2009.04.016
3082597 106335 8 None - 1 Bovine 5.6 pIC50 = 5.6 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL283606 106335 8 None - 1 Bovine 5.6 pIC50 = 5.6 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
11753909 25740 0 None - 0 Bovine 5.6 pIC50 = 5.6 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 458 5 2 8 2.5 CS(=O)(=O)Nc1ccc2c(c1)C(O)CC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
CHEMBL1203301 25740 0 None - 0 Bovine 5.6 pIC50 = 5.6 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 458 5 2 8 2.5 CS(=O)(=O)Nc1ccc2c(c1)C(O)CC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
CHEMBL128745 25740 0 None - 0 Bovine 5.6 pIC50 = 5.6 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 458 5 2 8 2.5 CS(=O)(=O)Nc1ccc2c(c1)C(O)CC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
9845791 126009 4 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 434 5 1 3 4.7 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
CHEMBL343444 126009 4 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 434 5 1 3 4.7 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
44376954 62514 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 387 3 0 5 4.0 Cc1cc(C)n2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
CHEMBL162232 62514 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 387 3 0 5 4.0 Cc1cc(C)n2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
2247 7293 81 None -5 42 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
249 7293 81 None -5 42 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
2603 7293 81 None -5 42 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
CHEMBL296419 7293 81 None -5 42 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
DB00637 7293 81 None -5 42 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
1212 8443 50 None -19 65 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
204 8443 50 None -19 65 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
3372 8443 50 None -19 65 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
CHEMBL726 8443 50 None -19 65 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
DB00623 8443 50 None -19 65 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
3584 10549 64 None -2 14 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
5401 10549 64 None -2 14 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
7302 10549 64 None -2 14 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
CHEMBL611 10549 64 None -2 14 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
DB01162 10549 64 None -2 14 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
9931837 125951 4 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 418 5 1 3 4.3 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1=CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
CHEMBL343034 125951 4 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 418 5 1 3 4.3 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1=CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
44563063 192804 0 None - 1 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 439 7 0 5 5.3 O=c1c2ccccc2nc(-c2ccc(OCCCN3CCCCC3)cc2)n1-c1ccccc1 10.1016/j.bmcl.2008.10.034
CHEMBL487060 192804 0 None - 1 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 439 7 0 5 5.3 O=c1c2ccccc2nc(-c2ccc(OCCCN3CCCCC3)cc2)n1-c1ccccc1 10.1016/j.bmcl.2008.10.034
277 8083 62 None -117 50 Rat 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
2913 8083 62 None -117 50 Rat 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
765 8083 62 None -117 50 Rat 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
CHEMBL516 8083 62 None -117 50 Rat 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
DB00434 8083 62 None -117 50 Rat 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
44376900 63042 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 375 3 1 6 3.1 Cc1nc2c(O)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162826 63042 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 375 3 1 6 3.1 Cc1nc2c(O)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
11292933 63168 45 None - 9 Rat 7.6 pIC50 = 7.6 Binding
Inhibition of rat adrenergic alpha1A receptorInhibition of rat adrenergic alpha1A receptor
ChEMBL 415 5 1 4 3.4 Cc1ccc2c(N3CCN(CCc4cccc(N5CCNC5=O)c4)CC3)cccc2n1 10.1021/jm100714c
CHEMBL1631540 63168 45 None - 9 Rat 7.6 pIC50 = 7.6 Binding
Inhibition of rat adrenergic alpha1A receptorInhibition of rat adrenergic alpha1A receptor
ChEMBL 415 5 1 4 3.4 Cc1ccc2c(N3CCN(CCc4cccc(N5CCNC5=O)c4)CC3)cccc2n1 10.1021/jm100714c
22493258 105440 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cellsInhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells
ChEMBL 241 4 3 4 1.5 c1ccc(-c2cc[nH]n2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
CHEMBL277375 105440 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cellsInhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells
ChEMBL 241 4 3 4 1.5 c1ccc(-c2cc[nH]n2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
73603034 132730 29 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at alpha 1a adrenergic receptor (unknown origin)Antagonist activity at alpha 1a adrenergic receptor (unknown origin)
ChEMBL 465 4 3 8 2.9 Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CC[C@@H](N)[C@H](F)CC1 10.1021/acs.jmedchem.8b01857
CHEMBL3648680 132730 29 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at alpha 1a adrenergic receptor (unknown origin)Antagonist activity at alpha 1a adrenergic receptor (unknown origin)
ChEMBL 465 4 3 8 2.9 Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CC[C@@H](N)[C@H](F)CC1 10.1021/acs.jmedchem.8b01857
44376993 63258 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 427 3 0 5 4.7 Cc1nc2c(Cl)cc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL163247 63258 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 427 3 0 5 4.7 Cc1nc2c(Cl)cc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
14739954 115887 0 None - 0 Rat 6.6 pIC50 = 6.6 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 325 4 1 2 3.8 CN(C)CC(c1ccccc1Br)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL321364 115887 0 None - 0 Rat 6.6 pIC50 = 6.6 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 325 4 1 2 3.8 CN(C)CC(c1ccccc1Br)C1(O)CCCCC1 10.1021/jm00172a035
3191 109635 97 None -204 25 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
CHEMBL305660 109635 97 None -204 25 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
DB11742 109635 97 None -204 25 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
2812 11551 101 None -2238 34 Rat 4.6 pIC50 = 4.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
CHEMBL104 11551 101 None -2238 34 Rat 4.6 pIC50 = 4.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
10341964 39844 0 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 418 5 1 3 4.3 Cc1cccc2c(-c3ccc(F)cc3)cn(C3=CCN(CCN4CCNC4=O)CC3)c12 10.1021/jm00104a007
CHEMBL141667 39844 0 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 418 5 1 3 4.3 Cc1cccc2c(-c3ccc(F)cc3)cn(C3=CCN(CCN4CCNC4=O)CC3)c12 10.1021/jm00104a007
44269124 35591 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(01)00764-8
CHEMBL13789 35591 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(01)00764-8
10427137 42824 4 None -1 2 Rat 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 336 2 0 2 5.3 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1CCN(C)CC1 10.1021/jm00104a007
CHEMBL144362 42824 4 None -1 2 Rat 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 336 2 0 2 5.3 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1CCN(C)CC1 10.1021/jm00104a007
127046693 146445 0 None -2 2 Human 5.6 pIC50 = 5.6 Binding
Selectivity interaction (Binding assay) EUB0000341aCl ADRA1ASelectivity interaction (Binding assay) EUB0000341aCl ADRA1A
ChEMBL 300 3 2 4 2.2 C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N 10.6019/CHEMBL5212743
CHEMBL3797887 146445 0 None -2 2 Human 5.6 pIC50 = 5.6 Binding
Selectivity interaction (Binding assay) EUB0000341aCl ADRA1ASelectivity interaction (Binding assay) EUB0000341aCl ADRA1A
ChEMBL 300 3 2 4 2.2 C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N 10.6019/CHEMBL5212743
CHEMBL4762646 146445 0 None -2 2 Human 5.6 pIC50 = 5.6 Binding
Selectivity interaction (Binding assay) EUB0000341aCl ADRA1ASelectivity interaction (Binding assay) EUB0000341aCl ADRA1A
ChEMBL 300 3 2 4 2.2 C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N 10.6019/CHEMBL5212743
1935 10506 97 None -190 6 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
2551 10506 97 None -190 6 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
6687 10506 97 None -190 6 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
CHEMBL95 10506 97 None -190 6 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
DB00382 10506 97 None -190 6 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
45485062 203947 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 367 5 2 5 3.3 Cc1cccc(C(=O)N[C@H]2CC[C@@H](Nc3ncc(C)c(N(C)C)n3)CC2)c1 10.1016/j.bmcl.2009.09.003
CHEMBL567993 203947 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 367 5 2 5 3.3 Cc1cccc(C(=O)N[C@H]2CC[C@@H](Nc3ncc(C)c(N(C)C)n3)CC2)c1 10.1016/j.bmcl.2009.09.003
9956013 44411 4 None - 0 Rat 6.6 pIC50 = 6.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 462 6 0 3 5.5 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(CCN2CCN(C(C)C)C2=O)CC1 10.1021/jm00104a007
CHEMBL145712 44411 4 None - 0 Rat 6.6 pIC50 = 6.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 462 6 0 3 5.5 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(CCN2CCN(C(C)C)C2=O)CC1 10.1021/jm00104a007
44377007 63922 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3c(Cl)cccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL164612 63922 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3c(Cl)cccc3c2C1 10.1016/s0960-894x(99)00591-0
9795167 114271 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 260 6 3 4 1.2 CCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL318544 114271 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 260 6 3 4 1.2 CCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
10399043 126940 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 232 5 2 5 1.1 CO/N=C/c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL351542 126940 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 232 5 2 5 1.1 CO/N=C/c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
3151 8244 97 None -147 26 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
945 8244 97 None -147 26 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
965 8244 97 None -147 26 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
CHEMBL219916 8244 97 None -147 26 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
DB01184 8244 97 None -147 26 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
22120322 62695 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2c1 10.1016/s0960-894x(99)00591-0
CHEMBL162370 62695 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2c1 10.1016/s0960-894x(99)00591-0
12575 8769 30 None - 17 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/s0960-894x(99)00591-0
54459 8769 30 None - 17 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/s0960-894x(99)00591-0
CHEMBL10316 8769 30 None - 17 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/s0960-894x(99)00591-0
DB12551 8769 30 None - 17 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/s0960-894x(99)00591-0
11516386 192810 0 None - 1 Human 5.5 pIC50 = 5.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 377 6 0 5 3.9 Cn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL487064 192810 0 None - 1 Human 5.5 pIC50 = 5.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 377 6 0 5 3.9 Cn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
2435 10362 83 None - 48 Rat 8.5 pIC50 = 8.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm960159f
60149 10362 83 None - 48 Rat 8.5 pIC50 = 8.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm960159f
98 10362 83 None - 48 Rat 8.5 pIC50 = 8.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL12713 10362 83 None - 48 Rat 8.5 pIC50 = 8.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm960159f
DB06144 10362 83 None - 48 Rat 8.5 pIC50 = 8.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm960159f
2435 10362 83 None - 48 Rat 8.5 pIC50 = 8.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm00104a007
60149 10362 83 None - 48 Rat 8.5 pIC50 = 8.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm00104a007
98 10362 83 None - 48 Rat 8.5 pIC50 = 8.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm00104a007
CHEMBL12713 10362 83 None - 48 Rat 8.5 pIC50 = 8.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm00104a007
DB06144 10362 83 None - 48 Rat 8.5 pIC50 = 8.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm00104a007
56961460 128216 0 None - 1 Human 8.4 pIC50 = 8.4 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 477 4 2 10 2.0 COc1cc2nc(N3CCN(C(=O)c4cc5ccc(O)cc5oc4=O)CC3)nc(N)c2cc1OC 10.1021/ml5004298
CHEMBL3582268 128216 0 None - 1 Human 8.4 pIC50 = 8.4 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 477 4 2 10 2.0 COc1cc2nc(N3CCN(C(=O)c4cc5ccc(O)cc5oc4=O)CC3)nc(N)c2cc1OC 10.1021/ml5004298
10809238 207920 0 None - 0 Bovine 7.5 pIC50 = 7.5 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 371 4 0 5 3.1 Cn1c(=O)sc2cc(CCN3CCN(c4ccc(F)cc4)CC3)ccc21 10.1021/jm970298c
CHEMBL60318 207920 0 None - 0 Bovine 7.5 pIC50 = 7.5 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 371 4 0 5 3.1 Cn1c(=O)sc2cc(CCN3CCN(c4ccc(F)cc4)CC3)ccc21 10.1021/jm970298c
10501785 209507 0 None - 0 Bovine 7.5 pIC50 = 7.5 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 411 7 0 6 3.8 COc1ccccc1N1CCN(CCCCc2ccc3c(c2)sc(=O)n3C)CC1 10.1021/jm970298c
CHEMBL61819 209507 0 None - 0 Bovine 7.5 pIC50 = 7.5 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 411 7 0 6 3.8 COc1ccccc1N1CCN(CCCCc2ccc3c(c2)sc(=O)n3C)CC1 10.1021/jm970298c
10718277 210041 0 None - 0 Bovine 7.5 pIC50 = 7.5 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 447 6 0 4 4.2 CN1C(=O)COc2cc(CCCCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
CHEMBL64610 210041 0 None - 0 Bovine 7.5 pIC50 = 7.5 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 447 6 0 4 4.2 CN1C(=O)COc2cc(CCCCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
85469932 143564 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 455 7 0 5 3.9 COc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
CHEMBL3741318 143564 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 455 7 0 5 3.9 COc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
1305 7299 14 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2009.09.003
9934033 7299 14 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL182150 7299 14 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2009.09.003
138753277 184074 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of adrenergic receptor alpha1a (unknown origin)Inhibition of adrenergic receptor alpha1a (unknown origin)
ChEMBL 303 1 2 3 3.3 Cc1cc(Br)c(NC2=NCCN2)c2ccccc12 10.1021/acs.jmedchem.9b01870
CHEMBL4636550 184074 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of adrenergic receptor alpha1a (unknown origin)Inhibition of adrenergic receptor alpha1a (unknown origin)
ChEMBL 303 1 2 3 3.3 Cc1cc(Br)c(NC2=NCCN2)c2ccccc12 10.1021/acs.jmedchem.9b01870
13520336 11123 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 291 5 1 3 3.4 COc1ccc(C(CN(C)C)C2(O)CCCCCC2)cc1 10.1021/jm00172a035
CHEMBL101056 11123 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 291 5 1 3 3.4 COc1ccc(C(CN(C)C)C2(O)CCCCCC2)cc1 10.1021/jm00172a035
3501942 16237 55 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 2 3 2.7 CNCC(c1ccc(OC)cc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL1119 16237 55 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 2 3 2.7 CNCC(c1ccc(OC)cc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL1628258 16237 55 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 2 3 2.7 CNCC(c1ccc(OC)cc1)C1(O)CCCCC1 10.1021/jm00172a035
13520306 215014 12 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 247 4 1 2 3.0 CN(C)CC(c1ccccc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL98660 215014 12 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 247 4 1 2 3.0 CN(C)CC(c1ccccc1)C1(O)CCCCC1 10.1021/jm00172a035
10251234 18017 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1178932 18017 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50530 18017 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10476735 20503 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 411 9 0 7 3.5 CCCN(CCCCn1c(=O)oc2cccnc21)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1195096 20503 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 411 9 0 7 3.5 CCCN(CCCCn1c(=O)oc2cccnc21)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL553833 20503 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 411 9 0 7 3.5 CCCN(CCCCn1c(=O)oc2cccnc21)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
9981024 102872 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL26018 102872 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL300735 102872 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
9980269 105859 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 432 10 1 5 3.4 CCCN(CCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL280586 105859 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 432 10 1 5 3.4 CCCN(CCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL54266 105859 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 432 10 1 5 3.4 CCCN(CCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10342423 106245 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 426 11 1 5 3.9 CCCN(CCCCNC(=O)c1ccccc1OC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL28312 106245 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 426 11 1 5 3.9 CCCN(CCCCNC(=O)c1ccccc1OC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL48925 106245 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 426 11 1 5 3.9 CCCN(CCCCNC(=O)c1ccccc1OC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10366072 123675 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 442 5 1 7 3.0 CS(=O)(=O)Nc1ccc2c(c1)CCC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
CHEMBL1203300 123675 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 442 5 1 7 3.0 CS(=O)(=O)Nc1ccc2c(c1)CCC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
CHEMBL338361 123675 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 442 5 1 7 3.0 CS(=O)(=O)Nc1ccc2c(c1)CCC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
23027245 203907 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 387 5 2 5 3.7 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)cc3)CC2)n1 10.1016/j.bmcl.2009.09.003
CHEMBL567791 203907 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 387 5 2 5 3.7 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)cc3)CC2)n1 10.1016/j.bmcl.2009.09.003
1220 6975 55 None - 44 Bovine 4.5 pIC50 = 4.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm00038a007
31 6975 55 None - 44 Bovine 4.5 pIC50 = 4.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm00038a007
7 6975 55 None - 44 Bovine 4.5 pIC50 = 4.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm00038a007
CHEMBL56 6975 55 None - 44 Bovine 4.5 pIC50 = 4.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm00038a007
44343257 17272 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 250 4 1 2 3.7 c1ccc(-c2ccccc2OCc2c[nH]cn2)cc1 10.1016/s0960-894x(02)00753-9
CHEMBL116700 17272 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 250 4 1 2 3.7 c1ccc(-c2ccccc2OCc2c[nH]cn2)cc1 10.1016/s0960-894x(02)00753-9
1971 9641 38 None -24 30 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
2404 9641 38 None -24 30 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
4543 9641 38 None -24 30 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
CHEMBL445 9641 38 None -24 30 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
DB00540 9641 38 None -24 30 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
10497675 22869 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 344 6 0 2 5.3 CN(C)CCCCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL122384 22869 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 344 6 0 2 5.3 CN(C)CCCCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
1816 9318 102 None - 18 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
4205 9318 102 None - 18 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
7241 9318 102 None - 18 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
CHEMBL654 9318 102 None - 18 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
DB00370 9318 102 None - 18 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
10499570 23704 0 None - 0 Rat 7.5 pIC50 = 7.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 372 5 0 3 5.3 Fc1ccc(-n2cc(OCCN3CCCCC3)c3cc(Cl)ccc32)cc1 10.1021/jm960159f
CHEMBL125291 23704 0 None - 0 Rat 7.5 pIC50 = 7.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 372 5 0 3 5.3 Fc1ccc(-n2cc(OCCN3CCCCC3)c3cc(Cl)ccc32)cc1 10.1021/jm960159f
2274 9947 58 None -6 31 Rat 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
4917 9947 58 None -6 31 Rat 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
7279 9947 58 None -6 31 Rat 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
CHEMBL728 9947 58 None -6 31 Rat 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
DB00433 9947 58 None -6 31 Rat 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
44362195 127867 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 241 4 2 3 2.1 c1c[nH]c(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL357129 127867 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 241 4 2 3 2.1 c1c[nH]c(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
85469812 143464 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 469 8 0 5 4.2 CCOc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
CHEMBL3740351 143464 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 469 8 0 5 4.2 CCOc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
15987265 203666 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 503 6 2 5 5.3 Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL566075 203666 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 503 6 2 5 5.3 Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
196129 74573 17 None -1698 15 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
CHEMBL1909065 74573 17 None -1698 15 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
10409893 125894 0 None - 0 Rat 7.5 pIC50 = 7.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 420 5 1 3 4.4 Cc1cccc2c1c(-c1ccc(F)cc1)cn2C1CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
CHEMBL342730 125894 0 None - 0 Rat 7.5 pIC50 = 7.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 420 5 1 3 4.4 Cc1cccc2c1c(-c1ccc(F)cc1)cn2C1CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
85469930 143652 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 473 6 0 4 4.8 Cc1ccc(Cl)cc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
CHEMBL3742103 143652 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 473 6 0 4 4.8 Cc1ccc(Cl)cc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
10060965 42008 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 256 4 1 4 2.6 Cc1ccoc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
CHEMBL143562 42008 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 256 4 1 4 2.6 Cc1ccoc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
506 9032 39 None -97 6 Rat 6.5 pIC50 = 6.5 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype.Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype.
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
6603904 9032 39 None -97 6 Rat 6.5 pIC50 = 6.5 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype.Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype.
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
CHEMBL19476 9032 39 None -97 6 Rat 6.5 pIC50 = 6.5 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype.Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype.
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
44574357 185486 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 471 6 1 2 6.4 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2ccc(F)cc2)cc1 10.1016/j.bmcl.2009.04.016
CHEMBL468298 185486 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 471 6 1 2 6.4 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2ccc(F)cc2)cc1 10.1016/j.bmcl.2009.04.016
85469753 143539 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 503 6 0 4 4.6 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(Br)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3741079 143539 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 503 6 0 4 4.6 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(Br)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
3045401 62833 32 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 359 3 0 5 3.4 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162501 62833 32 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 359 3 0 5 3.4 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
2477 7532 59 None -218 29 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
36 7532 59 None -218 29 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
437 7532 59 None -218 29 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
CHEMBL49 7532 59 None -218 29 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
DB00490 7532 59 None -218 29 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
127049862 147035 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 425 8 1 5 4.4 CNC(=O)c1cccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1 10.1016/j.bmcl.2016.04.087
CHEMBL3805559 147035 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 425 8 1 5 4.4 CNC(=O)c1cccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1 10.1016/j.bmcl.2016.04.087
22493280 55049 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ccno2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL155327 55049 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ccno2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
44573820 200047 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 489 6 1 2 6.5 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2ccc(F)c(F)c2)cc1 10.1016/j.bmcl.2009.04.016
CHEMBL523882 200047 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 489 6 1 2 6.5 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2ccc(F)c(F)c2)cc1 10.1016/j.bmcl.2009.04.016
3082597 106335 8 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL283606 106335 8 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
191 7191 98 None -107 29 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
201 7191 98 None -107 29 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
2170 7191 98 None -107 29 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
CHEMBL1113 7191 98 None -107 29 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
DB00543 7191 98 None -107 29 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
3823 56995 42 None -3019 11 Rat 4.5 pIC50 = 4.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
76973198 56995 42 None -3019 11 Rat 4.5 pIC50 = 4.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL157101 56995 42 None -3019 11 Rat 4.5 pIC50 = 4.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
127041710 143394 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 450 6 0 4 4.4 [C-]#[N+]c1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
CHEMBL3739762 143394 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 450 6 0 4 4.4 [C-]#[N+]c1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
10403428 215176 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 315 4 1 2 4.0 CN(C)CC(c1cccc(C(F)(F)F)c1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL99653 215176 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 315 4 1 2 4.0 CN(C)CC(c1cccc(C(F)(F)F)c1)C1(O)CCCCC1 10.1021/jm00172a035
45484995 205298 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 403 6 2 5 3.5 Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3ccc(F)c(F)c3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL577904 205298 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 403 6 2 5 3.5 Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3ccc(F)c(F)c3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
44573931 194231 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 479 7 0 4 5.6 CN(CCCC1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1cccn1 10.1016/j.bmcl.2009.04.016
CHEMBL493962 194231 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 479 7 0 4 5.6 CN(CCCC1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1cccn1 10.1016/j.bmcl.2009.04.016
146431 215055 1 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 315 4 1 2 4.3 CN(C)CC(c1ccc(Cl)c(Cl)c1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL98894 215055 1 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 315 4 1 2 4.3 CN(C)CC(c1ccc(Cl)c(Cl)c1)C1(O)CCCCC1 10.1021/jm00172a035
2803 7742 58 None -3 19 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
516 7742 58 None -3 19 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
704 7742 58 None -3 19 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
CHEMBL134 7742 58 None -3 19 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
DB00575 7742 58 None -3 19 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
135398737 7745 93 None -5 90 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
38 7745 93 None -5 90 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
722 7745 93 None -5 90 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
CHEMBL42 7745 93 None -5 90 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
DB00363 7745 93 None -5 90 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
124 9755 47 None -13 32 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
2032 9755 47 None -13 32 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
4636 9755 47 None -13 32 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
CHEMBL762 9755 47 None -13 32 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
DB00935 9755 47 None -13 32 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
85469873 143370 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 493 6 0 4 4.9 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3C(F)(F)F)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3739542 143370 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 493 6 0 4 4.9 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3C(F)(F)F)CC2)cc1 10.1016/j.bmc.2015.11.020
3952 8669 38 None -26 12 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5353646 8669 38 None -26 12 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5443 8669 38 None -26 12 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5702063 8669 38 None -26 12 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL1331786 8669 38 None -26 12 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL420 8669 38 None -26 12 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
DB00629 8669 38 None -26 12 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
10108561 119721 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 295 2 0 4 2.8 CN(C)CC1CC2c3ccccc3Cc3ccncc3N2O1 10.1016/s0960-894x(02)00796-5
CHEMBL331077 119721 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 295 2 0 4 2.8 CN(C)CC1CC2c3ccccc3Cc3ccncc3N2O1 10.1016/s0960-894x(02)00796-5
44376923 63201 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2cccc(C)n2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL163190 63201 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2cccc(C)n2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
137399257 169229 0 None - 0 Rat 8.4 pIC50 = 8.4 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 513 8 1 8 3.7 COc1cc2nc(N3CCN(C(=O)Cc4ccc(OCc5ccccc5)cc4)CC3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.10.026
CHEMBL4166644 169229 0 None - 0 Rat 8.4 pIC50 = 8.4 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 513 8 1 8 3.7 COc1cc2nc(N3CCN(C(=O)Cc4ccc(OCc5ccccc5)cc4)CC3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.10.026
10734233 120521 0 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 316 4 0 2 4.5 CN(C)CCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL332365 120521 0 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 316 4 0 2 4.5 CN(C)CCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
10717072 170022 0 None - 0 Bovine 6.4 pIC50 = 6.4 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 421 4 0 5 4.0 Cn1c(=O)sc2cc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
CHEMBL418499 170022 0 None - 0 Bovine 6.4 pIC50 = 6.4 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 421 4 0 5 4.0 Cn1c(=O)sc2cc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
10527817 119845 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 456 8 0 3 5.0 CC(C)N1CCN(CCN(C)CCc2cn(-c3ccc(F)cc3)c3cc(Cl)ccc23)C1=O 10.1021/jm960159f
CHEMBL331193 119845 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 456 8 0 3 5.0 CC(C)N1CCN(CCN(C)CCc2cn(-c3ccc(F)cc3)c3cc(Cl)ccc23)C1=O 10.1021/jm960159f
10070029 172196 0 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 408 8 0 5 3.4 CCCN(CCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL423841 172196 0 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 408 8 0 5 3.4 CCCN(CCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL54089 172196 0 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 408 8 0 5 3.4 CCCN(CCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
121852 16938 7 None - 1 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL11592 16938 7 None - 1 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL301060 16938 7 None - 1 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10014217 106524 0 None - 1 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 233 2 0 3 2.1 COc1cccc2c1CC(N1CCCC1)CO2 10.1021/jm00038a007
CHEMBL285010 106524 0 None - 1 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 233 2 0 3 2.1 COc1cccc2c1CC(N1CCCC1)CO2 10.1021/jm00038a007
135 9310 43 None -40 56 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
1796 9310 43 None -40 56 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
4184 9310 43 None -40 56 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
CHEMBL6437 9310 43 None -40 56 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
DB06148 9310 43 None -40 56 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
10550615 121364 0 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 430 8 1 4 3.8 CN(CCOc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL333774 121364 0 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 430 8 1 4 3.8 CN(CCOc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12)CCN1CCNC1=O 10.1021/jm960159f
44318842 212887 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 308 2 0 3 3.7 Cc1ccc2c(c1)N1OC(CN(C)C)CC1c1ccccc1C2 10.1016/s0960-894x(01)00721-1
CHEMBL85735 212887 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 308 2 0 3 3.7 Cc1ccc2c(c1)N1OC(CN(C)C)CC1c1ccccc1C2 10.1016/s0960-894x(01)00721-1
11517341 180518 0 None - 1 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 419 5 0 6 4.0 COc1cccc2nc(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)n(C)c(=O)c12 10.1016/j.bmcl.2008.10.034
CHEMBL453653 180518 0 None - 1 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 419 5 0 6 4.0 COc1cccc2nc(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)n(C)c(=O)c12 10.1016/j.bmcl.2008.10.034
10812487 22343 0 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 428 8 1 3 4.3 CN(CCCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL122042 22343 0 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 428 8 1 3 4.3 CN(CCCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
10361439 116410 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Inhibition of alpha 1A adrenergic receptor (unknown origin)Inhibition of alpha 1A adrenergic receptor (unknown origin)
ChEMBL 364 6 0 3 4.7 COc1cccc2c1CCCC2CCCN1CCN(c2ccccc2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL322275 116410 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Inhibition of alpha 1A adrenergic receptor (unknown origin)Inhibition of alpha 1A adrenergic receptor (unknown origin)
ChEMBL 364 6 0 3 4.7 COc1cccc2c1CCCC2CCCN1CCN(c2ccccc2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL5206987 116410 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Inhibition of alpha 1A adrenergic receptor (unknown origin)Inhibition of alpha 1A adrenergic receptor (unknown origin)
ChEMBL 364 6 0 3 4.7 COc1cccc2c1CCCC2CCCN1CCN(c2ccccc2)CC1 10.1021/acs.jmedchem.2c00633
13520334 119322 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 297 4 1 2 3.0 CN(C)CC(c1ccc(Br)cc1)C1(O)CCC1 10.1021/jm00172a035
CHEMBL329923 119322 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 297 4 1 2 3.0 CN(C)CC(c1ccc(Br)cc1)C1(O)CCC1 10.1021/jm00172a035
44318454 212788 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 312 2 0 3 3.5 CN(C)CC1CC2c3ccccc3Cc3ccc(F)cc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL84931 212788 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 312 2 0 3 3.5 CN(C)CC1CC2c3ccccc3Cc3ccc(F)cc3N2O1 10.1016/s0960-894x(01)00721-1
78243717 144128 53 None - 0 Human 6.4 pIC50 = 6.4 Binding
Selectivity interaction (CEREP panel (cellular receptors and 30 other enzymes)) EUB0000199c ADRA1ASelectivity interaction (CEREP panel (cellular receptors and 30 other enzymes)) EUB0000199c ADRA1A
ChEMBL 321 4 1 5 2.4 O=C(/C=C/N1C[C@H]2C[C@@H]1CN2c1ccccn1)c1ccccc1O 10.6019/CHEMBL5212743
CHEMBL3752911 144128 53 None - 0 Human 6.4 pIC50 = 6.4 Binding
Selectivity interaction (CEREP panel (cellular receptors and 30 other enzymes)) EUB0000199c ADRA1ASelectivity interaction (CEREP panel (cellular receptors and 30 other enzymes)) EUB0000199c ADRA1A
ChEMBL 321 4 1 5 2.4 O=C(/C=C/N1C[C@H]2C[C@@H]1CN2c1ccccn1)c1ccccc1O 10.6019/CHEMBL5212743
10789000 210097 0 None - 0 Bovine 7.4 pIC50 = 7.4 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 435 6 1 5 5.2 Oc1nc2ccc(CCCCN3CCN(c4cccc(C(F)(F)F)c4)CC3)cc2s1 10.1021/jm970298c
CHEMBL64845 210097 0 None - 0 Bovine 7.4 pIC50 = 7.4 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 435 6 1 5 5.2 Oc1nc2ccc(CCCCN3CCN(c4cccc(C(F)(F)F)c4)CC3)cc2s1 10.1021/jm970298c
134142282 152468 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3916182 152468 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
22493352 55048 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ncco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL155326 55048 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ncco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
11502381 180923 0 None - 1 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 407 4 0 5 4.1 Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2c(F)cccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL454642 180923 0 None - 1 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 407 4 0 5 4.1 Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2c(F)cccc2c1=O 10.1016/j.bmcl.2008.10.034
9794803 17778 2 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL117381 17778 2 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
85469754 143673 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 503 7 0 6 3.3 CS(=O)(=O)c1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
CHEMBL3742276 143673 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 503 7 0 6 3.3 CS(=O)(=O)c1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
10378649 115370 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 274 7 3 4 1.6 CCCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL320419 115370 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 274 7 3 4 1.6 CCCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
5074 10105 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm960159f
97 10105 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm960159f
CHEMBL267777 10105 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm960159f
DB12693 10105 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm960159f
5074 10105 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptorCompound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptor
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a007
97 10105 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptorCompound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptor
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a007
CHEMBL267777 10105 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptorCompound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptor
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a007
DB12693 10105 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptorCompound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptor
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a007
5074 10105 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranesCompound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a006
97 10105 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranesCompound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a006
CHEMBL267777 10105 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranesCompound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a006
DB12693 10105 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranesCompound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a006
44573822 194244 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 505 6 0 3 6.4 Cc1ccc(N(C(=O)N(C)CCCN2CCC3(CC2)OCc2ccccc23)c2ccc(F)c(F)c2)cc1 10.1016/j.bmcl.2009.04.016
CHEMBL494009 194244 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 505 6 0 3 6.4 Cc1ccc(N(C(=O)N(C)CCCN2CCC3(CC2)OCc2ccccc23)c2ccc(F)c(F)c2)cc1 10.1016/j.bmcl.2009.04.016
44376984 62997 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 485 3 0 5 4.0 Cc1nc2ccc(I)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162682 62997 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 485 3 0 5 4.0 Cc1nc2ccc(I)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
85469869 143369 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 426 6 0 5 3.2 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccn3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3739533 143369 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 426 6 0 5 3.2 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccn3)CC2)cc1 10.1016/j.bmc.2015.11.020
44574359 185514 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 471 6 1 2 6.4 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2cccc(F)c2)cc1 10.1016/j.bmcl.2009.04.016
CHEMBL468509 185514 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 471 6 1 2 6.4 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2cccc(F)c2)cc1 10.1016/j.bmcl.2009.04.016
10531 8202 21 None -5 24 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
121 8202 21 None -5 24 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
888 8202 21 None -5 24 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL1732 8202 21 None -5 24 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00320 8202 21 None -5 24 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
100 10577 58 None 1 54 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
2637 10577 58 None 1 54 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
5452 10577 58 None 1 54 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
CHEMBL479 10577 58 None 1 54 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
DB00679 10577 58 None 1 54 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
6761 74574 19 None 1 18 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
CHEMBL1909072 74574 19 None 1 18 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
9802796 171109 0 None - 0 Rat 8.2 pIC50 = 8.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 430 8 1 4 3.8 CN(CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL421244 171109 0 None - 0 Rat 8.2 pIC50 = 8.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 430 8 1 4 3.8 CN(CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
44362185 127807 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 253 4 1 4 2.1 c1cncc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL356605 127807 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 253 4 1 4 2.1 c1cncc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
10364538 11158 0 None - 1 Bovine 6.3 pIC50 = 6.3 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 415 5 1 6 2.5 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccccn3)CC1)O2 10.1021/jm00099a028
CHEMBL101322 11158 0 None - 1 Bovine 6.3 pIC50 = 6.3 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 415 5 1 6 2.5 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccccn3)CC1)O2 10.1021/jm00099a028
CHEMBL1204312 11158 0 None - 1 Bovine 6.3 pIC50 = 6.3 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 415 5 1 6 2.5 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccccn3)CC1)O2 10.1021/jm00099a028
10245637 39908 2 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 323 2 0 3 3.6 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2N1CCN(C)CC1 10.1021/jm00104a007
CHEMBL141721 39908 2 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 323 2 0 3 3.6 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2N1CCN(C)CC1 10.1021/jm00104a007
9885114 126382 5 None -47 12 Rat 6.3 pIC50 = 6.3 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
CHEMBL346389 126382 5 None -47 12 Rat 6.3 pIC50 = 6.3 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
59271992 124826 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of alpha-adrenoceptor 1A (unknown origin)Inhibition of alpha-adrenoceptor 1A (unknown origin)
ChEMBL 513 13 2 7 3.5 COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2OC(=O)NCc2ccccc2)C(C)C)ccc1OC 10.1016/j.bmcl.2015.02.040
CHEMBL3403995 124826 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of alpha-adrenoceptor 1A (unknown origin)Inhibition of alpha-adrenoceptor 1A (unknown origin)
ChEMBL 513 13 2 7 3.5 COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2OC(=O)NCc2ccccc2)C(C)C)ccc1OC 10.1016/j.bmcl.2015.02.040
10092409 18818 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 400 9 0 4 3.7 CCCN(CCCCN1CC2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1183479 18818 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 400 9 0 4 3.7 CCCN(CCCCN1CC2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL299561 18818 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 400 9 0 4 3.7 CCCN(CCCCN1CC2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10095594 19140 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 456 10 0 5 4.6 CCCN(CCCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1185501 19140 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 456 10 0 5 4.6 CCCN(CCCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL417550 19140 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 456 10 0 5 4.6 CCCN(CCCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10251673 106266 0 None - 1 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 422 9 0 5 3.8 CCCN(CCCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL283207 106266 0 None - 1 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 422 9 0 5 3.8 CCCN(CCCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL52396 106266 0 None - 1 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 422 9 0 5 3.8 CCCN(CCCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10338595 169278 0 None - 1 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 360 9 0 4 4.0 CCCN(CCCCN1CCCCC1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL416747 169278 0 None - 1 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 360 9 0 4 4.0 CCCN(CCCCN1CCCCC1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
13520313 114528 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 325 4 1 2 3.8 CN(C)CC(c1cccc(Br)c1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL319142 114528 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 325 4 1 2 3.8 CN(C)CC(c1cccc(Br)c1)C1(O)CCCCC1 10.1021/jm00172a035
122179431 128221 0 None -1 3 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 585 9 1 13 3.1 CCN(CC)c1ccc2cc(-n3cc(CN4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
CHEMBL3582272 128221 0 None -1 3 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 585 9 1 13 3.1 CCN(CC)c1ccc2cc(-n3cc(CN4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
132499 114021 8 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 281 4 1 2 3.7 CN(C)CC(c1ccccc1Cl)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL316862 114021 8 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 281 4 1 2 3.7 CN(C)CC(c1ccccc1Cl)C1(O)CCCCC1 10.1021/jm00172a035
44376845 62319 1 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 419 5 0 7 3.4 COc1cc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2cc1OC 10.1016/s0960-894x(99)00591-0
CHEMBL162058 62319 1 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 419 5 0 7 3.4 COc1cc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2cc1OC 10.1016/s0960-894x(99)00591-0
26987 7736 33 None -75 21 Rat 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
6063 7736 33 None -75 21 Rat 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
671 7736 33 None -75 21 Rat 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
CHEMBL1626 7736 33 None -75 21 Rat 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
DB00283 7736 33 None -75 21 Rat 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
9904205 212629 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 294 2 0 3 3.4 CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(02)00796-5
CHEMBL83658 212629 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 294 2 0 3 3.4 CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(02)00796-5
9904205 212629 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 294 2 0 3 3.4 CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL83658 212629 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 294 2 0 3 3.4 CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
10432755 120573 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 428 8 1 3 4.3 CN(CCCN1CCNC1=O)CCc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12 10.1021/jm960159f
CHEMBL332425 120573 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 428 8 1 3 4.3 CN(CCCN1CCNC1=O)CCc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12 10.1021/jm960159f
10047887 127827 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 422 5 1 3 4.7 CNC(=O)N(C)CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(C)ccc32)CC1 10.1021/jm00104a007
CHEMBL356799 127827 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 422 5 1 3 4.7 CNC(=O)N(C)CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(C)ccc32)CC1 10.1021/jm00104a007
4452 9538 19 None - 18 Rat 6.3 pIC50 = 6.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1021/jm960159f
983 9538 19 None - 18 Rat 6.3 pIC50 = 6.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1021/jm960159f
CHEMBL20734 9538 19 None - 18 Rat 6.3 pIC50 = 6.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1021/jm960159f
44574358 185487 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 467 6 1 2 6.5 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2ccc(C)cc2)cc1 10.1016/j.bmcl.2009.04.016
CHEMBL468299 185487 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 467 6 1 2 6.5 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2ccc(C)cc2)cc1 10.1016/j.bmcl.2009.04.016
85469872 143583 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 459 6 0 4 4.5 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(Cl)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3741483 143583 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 459 6 0 4 4.5 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(Cl)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
4418 40996 85 None -1 7 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmc.2015.11.020
CHEMBL142635 40996 85 None -1 7 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmc.2015.11.020
DB12092 40996 85 None -1 7 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmc.2015.11.020
44596863 205706 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 367 6 1 6 2.3 C=Cc1c(C)nn(CCCN2CCN(c3ccc(C)cc3)CC2)c(=O)c1N 10.1021/jm900458r
CHEMBL584606 205706 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 367 6 1 6 2.3 C=Cc1c(C)nn(CCCN2CCN(c3ccc(C)cc3)CC2)c(=O)c1N 10.1021/jm900458r
4011 89183 49 None -125 24 Rat 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
CHEMBL21731 89183 49 None -125 24 Rat 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
1531 9046 69 None -3 16 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
3869 9046 69 None -3 16 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
7207 9046 69 None -3 16 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
CHEMBL429 9046 69 None -3 16 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
DB00598 9046 69 None -3 16 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
44376927 62411 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 461 3 0 5 5.0 Cc1nc2c(Cl)cc(C(F)(F)F)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162147 62411 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 461 3 0 5 5.0 Cc1nc2c(Cl)cc(C(F)(F)F)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
506 9032 39 None -81 6 Human 6.2 pIC50 = 6.2 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
6603904 9032 39 None -81 6 Human 6.2 pIC50 = 6.2 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
CHEMBL19476 9032 39 None -81 6 Human 6.2 pIC50 = 6.2 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
11502638 180522 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 419 5 0 6 4.0 COc1ccc2nc(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2008.10.034
CHEMBL453654 180522 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 419 5 0 6 4.0 COc1ccc2nc(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2008.10.034
10644514 107834 0 None - 0 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 397 6 0 6 3.4 COc1ccccc1N1CCN(CCCc2ccc3c(c2)sc(=O)n3C)CC1 10.1021/jm970298c
CHEMBL294730 107834 0 None - 0 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 397 6 0 6 3.4 COc1ccccc1N1CCN(CCCc2ccc3c(c2)sc(=O)n3C)CC1 10.1021/jm970298c
10409070 128702 4 None - 0 Rat 8.2 pIC50 = 8.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 406 5 1 3 4.1 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3ccccc32)CC1 10.1021/jm00104a007
CHEMBL359031 128702 4 None - 0 Rat 8.2 pIC50 = 8.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 406 5 1 3 4.1 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3ccccc32)CC1 10.1021/jm00104a007
31101 7516 40 None -4 35 Rat 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
35 7516 40 None -4 35 Rat 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
403 7516 40 None -4 35 Rat 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
CHEMBL493 7516 40 None -4 35 Rat 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
DB01200 7516 40 None -4 35 Rat 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
125017 16223 99 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 4 2 3 2.7 CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL1118 16223 99 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 4 2 3 2.7 CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1 10.1021/jm00172a035
10528455 22344 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 472 9 0 4 4.9 CC(C)N1CCN(CCN(C)CCOc2cn(-c3ccc(F)cc3)c3cc(Cl)ccc23)C1=O 10.1021/jm960159f
CHEMBL122047 22344 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 472 9 0 4 4.9 CC(C)N1CCN(CCN(C)CCOc2cn(-c3ccc(F)cc3)c3cc(Cl)ccc23)C1=O 10.1021/jm960159f
10413283 194247 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 490 7 0 3 5.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccccc1)c1ccc(F)c(F)c1 10.1016/j.bmcl.2009.04.016
CHEMBL494016 194247 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 490 7 0 3 5.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccccc1)c1ccc(F)c(F)c1 10.1016/j.bmcl.2009.04.016
121852 16938 7 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL11592 16938 7 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL301060 16938 7 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10024943 104165 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 416 9 0 5 3.7 CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL26975 104165 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 416 9 0 5 3.7 CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL52485 104165 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 416 9 0 5 3.7 CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
2291 9958 58 None -446 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
2561 9958 58 None -446 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
4932 9958 58 None -446 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
CHEMBL631 9958 58 None -446 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
DB01182 9958 58 None -446 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
14183742 215101 0 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 325 4 1 2 3.8 CN(C)CC(c1ccc(Br)cc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL99175 215101 0 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 325 4 1 2 3.8 CN(C)CC(c1ccc(Br)cc1)C1(O)CCCCC1 10.1021/jm00172a035
119081417 158438 38 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]prazosin from recombinant human adrenergic A1a receptor after 60 mins by scintillation counting methodDisplacement of [3H]prazosin from recombinant human adrenergic A1a receptor after 60 mins by scintillation counting method
ChEMBL 488 10 0 7 5.2 CCCOc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2CCN2CCOCC2)cc1 10.1021/acs.jmedchem.6b01839
CHEMBL3963965 158438 38 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]prazosin from recombinant human adrenergic A1a receptor after 60 mins by scintillation counting methodDisplacement of [3H]prazosin from recombinant human adrenergic A1a receptor after 60 mins by scintillation counting method
ChEMBL 488 10 0 7 5.2 CCCOc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2CCN2CCOCC2)cc1 10.1021/acs.jmedchem.6b01839
11567596 181361 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 403 4 0 5 4.4 Cn1c(-c2ccc(OC3CCN(C4CCCC4)CC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL455681 181361 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 403 4 0 5 4.4 Cn1c(-c2ccc(OC3CCN(C4CCCC4)CC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
1599 9120 50 None -3019 16 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
3955 9120 50 None -3019 16 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
7215 9120 50 None -3019 16 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
CHEMBL841 9120 50 None -3019 16 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
DB00836 9120 50 None -3019 16 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
1028 7079 71 None -47 30 Rat 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
139148732 7079 71 None -47 30 Rat 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
479 7079 71 None -47 30 Rat 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
5816 7079 71 None -47 30 Rat 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
CHEMBL679 7079 71 None -47 30 Rat 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
DB00668 7079 71 None -47 30 Rat 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
11618024 193452 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 389 4 0 5 4.0 Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL488249 193452 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 389 4 0 5 4.0 Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
2435 7509 100 None -436 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
395 7509 100 None -436 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
520 7509 100 None -436 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
5386 7509 100 None -436 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
CHEMBL844 7509 100 None -436 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
DB00484 7509 100 None -436 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
135398745 9688 112 None -13 65 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
47 9688 112 None -13 65 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
CHEMBL715 9688 112 None -13 65 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
DB00334 9688 112 None -13 65 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
10647075 23667 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 446 8 1 4 4.5 CN(CCSc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL125072 23667 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 446 8 1 4 4.5 CN(CCSc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
11618702 180623 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 423 4 0 5 4.7 Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2c(Cl)cccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL453893 180623 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 423 4 0 5 4.7 Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2c(Cl)cccc2c1=O 10.1016/j.bmcl.2008.10.034
23151199 192807 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 377 6 0 5 3.9 Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCCCC2)cc1 10.1016/j.bmcl.2008.10.034
CHEMBL487063 192807 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 377 6 0 5 3.9 Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCCCC2)cc1 10.1016/j.bmcl.2008.10.034
10219 195575 37 None -467 5 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL493439 195575 37 None -467 5 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL50588 195575 37 None -467 5 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
44269124 35591 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(02)00753-9
CHEMBL13789 35591 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(02)00753-9
85469931 143670 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 493 6 0 4 4.9 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3742253 143670 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 493 6 0 4 4.9 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
10003405 127853 4 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.8 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(Cl)ccc32)CC1 10.1021/jm00104a007
CHEMBL357019 127853 4 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.8 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(Cl)ccc32)CC1 10.1021/jm00104a007
1353 8692 93 None -10 85 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
3559 8692 93 None -10 85 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
86 8692 93 None -10 85 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
CHEMBL54 8692 93 None -10 85 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
DB00502 8692 93 None -10 85 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
44377035 126908 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2c(C)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL351200 126908 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2c(C)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
2585 7590 103 None -5 22 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
522 7590 103 None -5 22 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
551 7590 103 None -5 22 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
CHEMBL723 7590 103 None -5 22 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
DB01136 7590 103 None -5 22 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
9826570 120089 0 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 482 6 0 3 5.7 CC(C)N1CCN(CCN2CCC(c3cn(-c4ccc(F)cc4)c4cc(Cl)ccc34)CC2)C1=O 10.1021/jm960159f
CHEMBL331545 120089 0 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 482 6 0 3 5.7 CC(C)N1CCN(CCN2CCC(c3cn(-c4ccc(F)cc4)c4cc(Cl)ccc34)CC2)C1=O 10.1021/jm960159f
9826570 120089 0 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 482 6 0 3 5.7 CC(C)N1CCN(CCN2CCC(c3cn(-c4ccc(F)cc4)c4cc(Cl)ccc34)CC2)C1=O 10.1021/jm00104a007
CHEMBL331545 120089 0 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 482 6 0 3 5.7 CC(C)N1CCN(CCN2CCC(c3cn(-c4ccc(F)cc4)c4cc(Cl)ccc34)CC2)C1=O 10.1021/jm00104a007
14739952 11246 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 307 6 1 4 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1OC 10.1021/jm00172a035
CHEMBL101819 11246 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 307 6 1 4 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1OC 10.1021/jm00172a035
10251234 18017 0 None - 0 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1178932 18017 0 None - 0 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50530 18017 0 None - 0 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
9981024 102872 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL26018 102872 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL300735 102872 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10047322 103915 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 412 8 0 4 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2ccccc2C1 10.1021/jm00038a007
CHEMBL26783 103915 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 412 8 0 4 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2ccccc2C1 10.1021/jm00038a007
CHEMBL50993 103915 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 412 8 0 4 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2ccccc2C1 10.1021/jm00038a007
10008463 18021 0 None - 0 Bovine 4.2 pIC50 = 4.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 457 9 0 4 4.3 CCC[N+](C)(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1178971 18021 0 None - 0 Bovine 4.2 pIC50 = 4.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 457 9 0 4 4.3 CCC[N+](C)(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL51985 18021 0 None - 0 Bovine 4.2 pIC50 = 4.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 457 9 0 4 4.3 CCC[N+](C)(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10364835 43271 4 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 420 5 1 3 4.4 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
CHEMBL144767 43271 4 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 420 5 1 3 4.4 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
11641036 192802 0 None - 1 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 453 8 0 5 5.4 O=c1c2ccccc2nc(-c2ccc(OCCCN3CCCCC3)cc2)n1Cc1ccccc1 10.1016/j.bmcl.2008.10.034
CHEMBL487059 192802 0 None - 1 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 453 8 0 5 5.4 O=c1c2ccccc2nc(-c2ccc(OCCCN3CCCCC3)cc2)n1Cc1ccccc1 10.1016/j.bmcl.2008.10.034
44377036 126934 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL351483 126934 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
10544460 23182 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 330 5 0 2 4.9 CN(C)CCCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL123094 23182 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 330 5 0 2 4.9 CN(C)CCCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
42636941 185728 0 None - 1 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]prazosin form human recombinant alpha1A adrenergic receptorDisplacement of [3H]prazosin form human recombinant alpha1A adrenergic receptor
ChEMBL 343 5 0 5 4.4 CCCN1CCC(COc2nc3scc(C)c3n3cccc23)CC1 10.1016/j.bmc.2008.11.045
CHEMBL470432 185728 0 None - 1 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]prazosin form human recombinant alpha1A adrenergic receptorDisplacement of [3H]prazosin form human recombinant alpha1A adrenergic receptor
ChEMBL 343 5 0 5 4.4 CCCN1CCC(COc2nc3scc(C)c3n3cccc23)CC1 10.1016/j.bmc.2008.11.045
23027527 203571 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 371 5 2 5 3.1 Cc1cnc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)cc3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL565551 203571 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 371 5 2 5 3.1 Cc1cnc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)cc3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
44343247 117412 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 258 6 3 3 2.2 CCCNC(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
CHEMBL325745 117412 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 258 6 3 3 2.2 CCCNC(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
2286 9957 51 None -10 30 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
4927 9957 51 None -10 30 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
7282 9957 51 None -10 30 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
CHEMBL643 9957 51 None -10 30 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
DB01069 9957 51 None -10 30 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
1043 8363 14 None -35 29 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
149 8363 14 None -35 29 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
3251 8363 14 None -35 29 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
8223 8363 14 None -35 29 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL1982133 8363 14 None -35 29 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL442 8363 14 None -35 29 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00696 8363 14 None -35 29 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
2726 7706 68 None -2 72 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
621 7706 68 None -2 72 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
83 7706 68 None -2 72 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
CHEMBL71 7706 68 None -2 72 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
DB00477 7706 68 None -2 72 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
56961507 128220 0 None 1 3 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 678 6 4 11 5.0 COc1cc2nc(N3CCN(C(=S)Nc4ccc(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c(C(=O)O)c4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
CHEMBL3582271 128220 0 None 1 3 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 678 6 4 11 5.0 COc1cc2nc(N3CCN(C(=S)Nc4ccc(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c(C(=O)O)c4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
10251234 18017 0 None - 0 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1178932 18017 0 None - 0 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50530 18017 0 None - 0 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10252000 105323 0 None - 1 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 0 5 3.8 CCCN(CCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL27650 105323 0 None - 1 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 0 5 3.8 CCCN(CCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50188 105323 0 None - 1 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 0 5 3.8 CCCN(CCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
3082597 106335 8 None - 1 Bovine 4.1 pIC50 = 4.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL283606 106335 8 None - 1 Bovine 4.1 pIC50 = 4.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
22493392 53929 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 252 4 2 4 2.2 c1ccc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
CHEMBL154298 53929 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 252 4 2 4 2.2 c1ccc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
44376936 64248 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 4 0 5 3.7 Cc1nc2ccccn2c(=O)c1CCCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165776 64248 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 4 0 5 3.7 Cc1nc2ccccn2c(=O)c1CCCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
46182745 64101 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibition of radioligand binding to human adrenergic alpha1a receptorInhibition of radioligand binding to human adrenergic alpha1a receptor
ChEMBL 461 6 1 3 6.2 O=C(O)c1cc(-c2cccc(COc3ccc4c(c3)CN(C3CCCC3)C4=O)c2)ccc1Cl 10.1021/jm3005306
CHEMBL1651208 64101 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibition of radioligand binding to human adrenergic alpha1a receptorInhibition of radioligand binding to human adrenergic alpha1a receptor
ChEMBL 461 6 1 3 6.2 O=C(O)c1cc(-c2cccc(COc3ccc4c(c3)CN(C3CCCC3)C4=O)c2)ccc1Cl 10.1021/jm3005306
10736518 23165 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 348 5 0 3 5.1 CN(C)CCSc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL123027 23165 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 348 5 0 3 5.1 CN(C)CCSc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
10788207 207546 0 None - 0 Bovine 7.1 pIC50 = 7.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 419 4 0 4 3.4 CN1C(=O)COc2cc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
CHEMBL60047 207546 0 None - 0 Bovine 7.1 pIC50 = 7.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 419 4 0 4 3.4 CN1C(=O)COc2cc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
9816986 170918 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL421011 170918 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
2337 10030 77 None -3 62 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
50 10030 77 None -3 62 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
5002 10030 77 None -3 62 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
CHEMBL716 10030 77 None -3 62 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
DB01224 10030 77 None -3 62 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
10551704 123616 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 454 9 1 4 3.8 C#CCN(CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL338022 123616 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 454 9 1 4 3.8 C#CCN(CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
13520319 170184 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 315 4 1 2 4.0 CN(C)CC(c1ccc(C(F)(F)F)cc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL419533 170184 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 315 4 1 2 4.0 CN(C)CC(c1ccc(C(F)(F)F)cc1)C1(O)CCCCC1 10.1021/jm00172a035
85469756 143365 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 455 7 0 5 3.9 COc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3739513 143365 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 455 7 0 5 3.9 COc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
10093723 43210 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 422 5 1 3 4.7 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(CCNC(=O)N(C)C)CC1 10.1021/jm00104a007
CHEMBL144710 43210 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 422 5 1 3 4.7 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(CCNC(=O)N(C)C)CC1 10.1021/jm00104a007
85469868 143558 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 450 6 0 5 3.7 N#Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3741260 143558 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 450 6 0 5 3.7 N#Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
85469755 143547 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 461 6 0 4 4.1 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(F)cc3F)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3741161 143547 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 461 6 0 4 4.1 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(F)cc3F)CC2)cc1 10.1016/j.bmc.2015.11.020
44377200 64194 1 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 437 3 0 5 4.1 Cc1nc2ccc(Br)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165350 64194 1 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 437 3 0 5 4.1 Cc1nc2ccc(Br)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
2284 9956 33 None -1 29 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
4926 9956 33 None -1 29 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
7281 9956 33 None -1 29 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
CHEMBL564 9956 33 None -1 29 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
DB00420 9956 33 None -1 29 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
10645076 207089 0 None - 0 Bovine 7.1 pIC50 = 7.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 407 4 1 5 4.4 Oc1nc2ccc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)cc2s1 10.1021/jm970298c
CHEMBL59741 207089 0 None - 0 Bovine 7.1 pIC50 = 7.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 407 4 1 5 4.4 Oc1nc2ccc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)cc2s1 10.1021/jm970298c
5656 209845 87 None - 43 Rat 7.1 pIC50 = 7.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
CHEMBL637 209845 87 None - 43 Rat 7.1 pIC50 = 7.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
10321964 25623 0 None - 0 Bovine 6.1 pIC50 = 6.1 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor determined in a filtration-based assay using [3H]prazosin as the radioligand.Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor determined in a filtration-based assay using [3H]prazosin as the radioligand.
ChEMBL 459 6 1 7 3.0 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc([N+](=O)[O-])cc3)CC1)O2 10.1021/jm00099a028
CHEMBL1203302 25623 0 None - 0 Bovine 6.1 pIC50 = 6.1 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor determined in a filtration-based assay using [3H]prazosin as the radioligand.Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor determined in a filtration-based assay using [3H]prazosin as the radioligand.
ChEMBL 459 6 1 7 3.0 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc([N+](=O)[O-])cc3)CC1)O2 10.1021/jm00099a028
CHEMBL128132 25623 0 None - 0 Bovine 6.1 pIC50 = 6.1 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor determined in a filtration-based assay using [3H]prazosin as the radioligand.Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor determined in a filtration-based assay using [3H]prazosin as the radioligand.
ChEMBL 459 6 1 7 3.0 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc([N+](=O)[O-])cc3)CC1)O2 10.1021/jm00099a028
9795857 214927 59 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 249 4 2 3 2.4 COc1ccc(C(CN)C2(O)CCCCC2)cc1 10.1021/jm00172a035
CHEMBL98158 214927 59 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 249 4 2 3 2.4 COc1ccc(C(CN)C2(O)CCCCC2)cc1 10.1021/jm00172a035
10321248 106202 0 None - 1 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 444 9 0 6 3.7 CCCN(CCCON1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL28287 106202 0 None - 1 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 444 9 0 6 3.7 CCCN(CCCON1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50722 106202 0 None - 1 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 444 9 0 6 3.7 CCCN(CCCON1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
53246941 76197 42 None - 0 Human 6.0 pIC50 = 6.0 Binding
Selectivity interaction (Enzyme panel (receptors, ion channels, other enzymes)) EUB0000679a ADRA1ASelectivity interaction (Enzyme panel (receptors, ion channels, other enzymes)) EUB0000679a ADRA1A
ChEMBL 458 6 2 6 3.9 C[C@@H]1CCNC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)cc3n21 10.6019/CHEMBL5212743
CHEMBL1933288 76197 42 None - 0 Human 6.0 pIC50 = 6.0 Binding
Selectivity interaction (Enzyme panel (receptors, ion channels, other enzymes)) EUB0000679a ADRA1ASelectivity interaction (Enzyme panel (receptors, ion channels, other enzymes)) EUB0000679a ADRA1A
ChEMBL 458 6 2 6 3.9 C[C@@H]1CCNC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)cc3n21 10.6019/CHEMBL5212743
44573823 200013 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 491 6 0 3 6.1 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)N(c1ccccc1)c1ccc(F)c(F)c1 10.1016/j.bmcl.2009.04.016
CHEMBL523697 200013 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 491 6 0 3 6.1 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)N(c1ccccc1)c1ccc(F)c(F)c1 10.1016/j.bmcl.2009.04.016
3033538 8101 39 None -7 9 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
7155 8101 39 None -7 9 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
781 8101 39 None -7 9 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
CHEMBL1201216 8101 39 None -7 9 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
DB00298 8101 39 None -7 9 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
133 9274 52 None -70 43 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
1723 9274 52 None -70 43 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
28693 9274 52 None -70 43 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
CHEMBL19215 9274 52 None -70 43 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
DB13520 9274 52 None -70 43 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
14739950 215045 0 None - 0 Rat 7.0 pIC50 = 7.0 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 1 3 2.6 COc1cccc(C(CN(C)C)C2(O)CCCC2)c1 10.1021/jm00172a035
CHEMBL98842 215045 0 None - 0 Rat 7.0 pIC50 = 7.0 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 1 3 2.6 COc1cccc(C(CN(C)C)C2(O)CCCC2)c1 10.1021/jm00172a035
19063108 100259 0 None - 0 Bovine 6.0 pIC50 = 6.0 Binding
Binding affinity was tested on cloned bovine Alpha-1A adrenergic receptorBinding affinity was tested on cloned bovine Alpha-1A adrenergic receptor
ChEMBL 546 9 1 10 4.6 COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2c2nc(N)c3cc(OC)c(OC)cc3n2)cc1OC 10.1021/jm960697s
CHEMBL24619 100259 0 None - 0 Bovine 6.0 pIC50 = 6.0 Binding
Binding affinity was tested on cloned bovine Alpha-1A adrenergic receptorBinding affinity was tested on cloned bovine Alpha-1A adrenergic receptor
ChEMBL 546 9 1 10 4.6 COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2c2nc(N)c3cc(OC)c(OC)cc3n2)cc1OC 10.1021/jm960697s
85469871 143362 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 443 6 0 4 4.0 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3F)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3739505 143362 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 443 6 0 4 4.0 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3F)CC2)cc1 10.1016/j.bmc.2015.11.020
2398 7741 62 None -4 29 Rat 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
2801 7741 62 None -4 29 Rat 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
701 7741 62 None -4 29 Rat 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
CHEMBL415 7741 62 None -4 29 Rat 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
DB01242 7741 62 None -4 29 Rat 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
4209 9937 75 None -1 33 Rat 9.8 pKd = 9.8 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00025a012
4893 9937 75 None -1 33 Rat 9.8 pKd = 9.8 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00025a012
503 9937 75 None -1 33 Rat 9.8 pKd = 9.8 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00025a012
5385 9937 75 None -1 33 Rat 9.8 pKd = 9.8 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00025a012
CHEMBL2 9937 75 None -1 33 Rat 9.8 pKd = 9.8 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00025a012
DB00457 9937 75 None -1 33 Rat 9.8 pKd = 9.8 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00025a012
164612037 192156 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
CHEMBL4860528 192156 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
168290235 199747 0 None -16 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5201074 199747 0 None -16 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5222491 199747 0 None -16 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
168294767 199798 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5207281 199798 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222802 199798 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
168295528 199810 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5206565 199810 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222872 199810 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
44363762 46924 0 None - 1 Rat 9.2 pKd = 9.2 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 497 6 1 11 1.8 COc1cc2nc(N3CCN(S(=O)(=O)c4nonc4-c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
CHEMBL147984 46924 0 None - 1 Rat 9.2 pKd = 9.2 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 497 6 1 11 1.8 COc1cc2nc(N3CCN(S(=O)(=O)c4nonc4-c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
10250895 197121 0 None 1 5 Human 9.1 pKd = 9.1 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin)Binding affinity to alpha-1A adrenergic receptor (unknown origin)
ChEMBL 408 7 0 6 3.7 COc1ccccc1N1CCN(CCCOc2ccc3c(C)cc(=O)oc3c2)CC1 10.1021/jm400408r
CHEMBL51767 197121 0 None 1 5 Human 9.1 pKd = 9.1 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin)Binding affinity to alpha-1A adrenergic receptor (unknown origin)
ChEMBL 408 7 0 6 3.7 COc1ccccc1N1CCN(CCCOc2ccc3c(C)cc(=O)oc3c2)CC1 10.1021/jm400408r
10250895 197121 0 None -1 5 Rat 9.1 pKd = 9.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 408 7 0 6 3.7 COc1ccccc1N1CCN(CCCOc2ccc3c(C)cc(=O)oc3c2)CC1 10.1016/s0960-894x(02)00933-2
CHEMBL51767 197121 0 None -1 5 Rat 9.1 pKd = 9.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 408 7 0 6 3.7 COc1ccccc1N1CCN(CCCOc2ccc3c(C)cc(=O)oc3c2)CC1 10.1016/s0960-894x(02)00933-2
44364207 44571 0 None - 1 Rat 9.0 pKd = 9.0 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 513 6 1 11 1.0 COc1cc2nc(N3CCN(S(=O)(=O)c4no[n+]([O-])c4-c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
CHEMBL145838 44571 0 None - 1 Rat 9.0 pKd = 9.0 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 513 6 1 11 1.0 COc1cc2nc(N3CCN(S(=O)(=O)c4no[n+]([O-])c4-c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
71817386 109363 0 None -6 7 Rat 8.7 pKd = 8.7 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419769 109363 0 None -6 7 Rat 8.7 pKd = 8.7 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL3040851 109363 0 None -6 7 Rat 8.7 pKd = 8.7 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
2419 7482 28 None -288 11 Rat 6.0 pKd = 6.0 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
9 7482 28 None -288 11 Rat 6.0 pKd = 6.0 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
CHEMBL13647 7482 28 None -288 11 Rat 6.0 pKd = 6.0 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
10317514 199308 0 None -14 6 Rat 7.9 pKd = 7.9 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 378 6 0 5 3.7 Cc1cc(=O)oc2cc(OCCCN3CCN(c4ccccc4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
CHEMBL52096 199308 0 None -14 6 Rat 7.9 pKd = 7.9 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 378 6 0 5 3.7 Cc1cc(=O)oc2cc(OCCCN3CCN(c4ccccc4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
2419 7482 28 None -288 11 Rat 6.9 pKd = 6.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm400867d
9 7482 28 None -288 11 Rat 6.9 pKd = 6.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm400867d
CHEMBL13647 7482 28 None -288 11 Rat 6.9 pKd = 6.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm400867d
3584 10549 64 None -2 14 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.ejmech.2015.04.005
5401 10549 64 None -2 14 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.ejmech.2015.04.005
7302 10549 64 None -2 14 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.ejmech.2015.04.005
CHEMBL611 10549 64 None -2 14 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.ejmech.2015.04.005
DB01162 10549 64 None -2 14 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.ejmech.2015.04.005
73437674 125309 0 None -2 3 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 434 10 2 4 3.8 COc1ccccc1N1CCN(CCCNC(=O)CCCc2c[nH]c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415014 125309 0 None -2 3 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 434 10 2 4 3.8 COc1ccccc1N1CCN(CCCNC(=O)CCCc2c[nH]c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
14348818 116551 0 None 5 3 Rat 4.9 pKd = 4.9 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL323176 116551 0 None 5 3 Rat 4.9 pKd = 4.9 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
71817545 98899 0 None -2 7 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419765 98899 0 None -2 7 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
71817547 109355 0 None -81 7 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL2419771 109355 0 None -81 7 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL3040800 109355 0 None -81 7 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
76308474 113011 0 None -162 5 Rat 6.9 pKd = 6.9 Binding
Competitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contractionCompetitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contraction
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@H]3CCCC[C@@H]32)o1 10.1007/s00044-004-0024-8
CHEMBL2261607 113011 0 None -162 5 Rat 6.9 pKd = 6.9 Binding
Competitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contractionCompetitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contraction
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@H]3CCCC[C@@H]32)o1 10.1007/s00044-004-0024-8
CHEMBL3138856 113011 0 None -162 5 Rat 6.9 pKd = 6.9 Binding
Competitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contractionCompetitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contraction
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@H]3CCCC[C@@H]32)o1 10.1007/s00044-004-0024-8
10252540 92132 1 None -83 6 Rat 7.8 pKd = 7.8 Binding
Antagonist activity at alpha1A adrenoreceptor in Rattus norvegicus (rat) small mesenteric arteryAntagonist activity at alpha1A adrenoreceptor in Rattus norvegicus (rat) small mesenteric artery
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261604 92132 1 None -83 6 Rat 7.8 pKd = 7.8 Binding
Antagonist activity at alpha1A adrenoreceptor in Rattus norvegicus (rat) small mesenteric arteryAntagonist activity at alpha1A adrenoreceptor in Rattus norvegicus (rat) small mesenteric artery
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
10252540 92132 1 None -83 6 Rat 7.8 pKd = 7.8 Binding
Competitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contractionCompetitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contraction
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261604 92132 1 None -83 6 Rat 7.8 pKd = 7.8 Binding
Competitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contractionCompetitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contraction
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
1353 8692 93 None -10 85 Rat 7.8 pKd = 7.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1016/s0960-894x(02)00933-2
3559 8692 93 None -10 85 Rat 7.8 pKd = 7.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1016/s0960-894x(02)00933-2
86 8692 93 None -10 85 Rat 7.8 pKd = 7.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1016/s0960-894x(02)00933-2
CHEMBL54 8692 93 None -10 85 Rat 7.8 pKd = 7.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1016/s0960-894x(02)00933-2
DB00502 8692 93 None -10 85 Rat 7.8 pKd = 7.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1016/s0960-894x(02)00933-2
155559152 181559 0 None -21 3 Rat 5.7 pKd = 5.7 Binding
Antagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysisAntagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysis
ChEMBL 431 7 2 5 3.9 COc1ccc(N2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)cc1 10.1016/j.bmc.2016.09.010
CHEMBL4561614 181559 0 None -21 3 Rat 5.7 pKd = 5.7 Binding
Antagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysisAntagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysis
ChEMBL 431 7 2 5 3.9 COc1ccc(N2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)cc1 10.1016/j.bmc.2016.09.010
44294972 190797 0 None -1 2 Rat 6.7 pKd = 6.7 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 395 7 0 7 2.8 COc1cc(=O)oc2cc(OCCCN3CCN(c4ccccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
CHEMBL48205 190797 0 None -1 2 Rat 6.7 pKd = 6.7 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 395 7 0 7 2.8 COc1cc(=O)oc2cc(OCCCN3CCN(c4ccccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
73437673 125308 0 None -5 3 Rat 6.7 pKd = 6.7 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 420 9 2 4 3.4 COc1ccccc1N1CCN(CCCNC(=O)CCc2c[nH]c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415013 125308 0 None -5 3 Rat 6.7 pKd = 6.7 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 420 9 2 4 3.4 COc1ccccc1N1CCN(CCCNC(=O)CCc2c[nH]c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
10527913 128302 0 None - 1 Rat 8.6 pKd = 8.6 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 459 5 1 12 -0.4 COC(=O)c1c(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)CC2)no[n+]1[O-] 10.1021/jm00025a012
CHEMBL358498 128302 0 None - 1 Rat 8.6 pKd = 8.6 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 459 5 1 12 -0.4 COC(=O)c1c(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)CC2)no[n+]1[O-] 10.1021/jm00025a012
155567902 182773 0 None -6 3 Rat 6.7 pKd = 6.7 Binding
Antagonist activity at alpha-1a adrenergic receptor in SPF rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionsAntagonist activity at alpha-1a adrenergic receptor in SPF rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions
ChEMBL 448 7 1 8 0.9 COc1cc2c(cc1OCC(O)CN1CCN(C(=O)C3CCCO3)CC1)C(=O)C(C)OC2 10.1016/j.bmc.2019.05.004
CHEMBL4589115 182773 0 None -6 3 Rat 6.7 pKd = 6.7 Binding
Antagonist activity at alpha-1a adrenergic receptor in SPF rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionsAntagonist activity at alpha-1a adrenergic receptor in SPF rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions
ChEMBL 448 7 1 8 0.9 COc1cc2c(cc1OCC(O)CN1CCN(C(=O)C3CCCO3)CC1)C(=O)C(C)OC2 10.1016/j.bmc.2019.05.004
92766 113319 35 None 1 6 Human 6.6 pKd = 6.6 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00370a011
CHEMBL31410 113319 35 None 1 6 Human 6.6 pKd = 6.6 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00370a011
2803 7742 58 None -3 19 Rat 6.6 pKd = 6.6 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
516 7742 58 None -3 19 Rat 6.6 pKd = 6.6 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
704 7742 58 None -3 19 Rat 6.6 pKd = 6.6 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
CHEMBL134 7742 58 None -3 19 Rat 6.6 pKd = 6.6 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
DB00575 7742 58 None -3 19 Rat 6.6 pKd = 6.6 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
73438500 125306 0 None -2 3 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 392 7 2 4 3.1 COc1ccccc1N1CCN(CCCNC(=O)c2ccc3[nH]ccc3c2)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415011 125306 0 None -2 3 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 392 7 2 4 3.1 COc1ccccc1N1CCN(CCCNC(=O)c2ccc3[nH]ccc3c2)CC1 10.1016/j.ejmech.2015.04.005
44294683 196646 0 None -3 2 Rat 6.6 pKd = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 379 6 0 6 3.1 Cc1cc(=O)oc2cc(OCCCN3CCN(c4ccccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
CHEMBL51681 196646 0 None -3 2 Rat 6.6 pKd = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 379 6 0 6 3.1 Cc1cc(=O)oc2cc(OCCCN3CCN(c4ccccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
44364190 46539 0 None - 1 Rat 8.5 pKd = 8.5 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 539 6 1 11 1.4 COc1cc2nc(N3CCN(S(=O)(=O)c4no[n+]([O-])c4C4=C/C=C\C=C/C=C\4)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
CHEMBL147624 46539 0 None - 1 Rat 8.5 pKd = 8.5 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 539 6 1 11 1.4 COc1cc2nc(N3CCN(S(=O)(=O)c4no[n+]([O-])c4C4=C/C=C\C=C/C=C\4)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
71817549 109357 0 None -7 7 Rat 8.4 pKd = 8.4 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3040803 109357 0 None -7 7 Rat 8.4 pKd = 8.4 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3216590 109357 0 None -7 7 Rat 8.4 pKd = 8.4 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
2142 9870 58 None -2 37 Human 7.5 pKd = 7.5 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00370a011
4920903 9870 58 None -2 37 Human 7.5 pKd = 7.5 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00370a011
502 9870 58 None -2 37 Human 7.5 pKd = 7.5 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00370a011
5775 9870 58 None -2 37 Human 7.5 pKd = 7.5 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00370a011
CHEMBL597 9870 58 None -2 37 Human 7.5 pKd = 7.5 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00370a011
DB00692 9870 58 None -2 37 Human 7.5 pKd = 7.5 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00370a011
4418 40996 85 None -10 7 Rat 7.5 pKd = 7.5 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL142635 40996 85 None -10 7 Rat 7.5 pKd = 7.5 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
DB12092 40996 85 None -10 7 Rat 7.5 pKd = 7.5 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
71817547 109355 0 None -81 7 Rat 7.5 pKd = 7.5 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL2419771 109355 0 None -81 7 Rat 7.5 pKd = 7.5 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL3040800 109355 0 None -81 7 Rat 7.5 pKd = 7.5 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
44294973 190780 0 None 1 2 Rat 6.5 pKd = 6.5 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 394 7 0 6 3.4 COc1cc(=O)oc2cc(OCCCN3CCN(c4ccccc4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
CHEMBL48194 190780 0 None 1 2 Rat 6.5 pKd = 6.5 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 394 7 0 6 3.4 COc1cc(=O)oc2cc(OCCCN3CCN(c4ccccc4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
135398737 7745 93 None -5 90 Human 7.4 pKd = 7.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm00370a011
38 7745 93 None -5 90 Human 7.4 pKd = 7.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm00370a011
722 7745 93 None -5 90 Human 7.4 pKd = 7.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm00370a011
CHEMBL42 7745 93 None -5 90 Human 7.4 pKd = 7.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm00370a011
DB00363 7745 93 None -5 90 Human 7.4 pKd = 7.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm00370a011
86288949 119402 0 None -5 5 Rat 7.4 pKd = 7.4 Binding
Antagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 mins
ChEMBL 434 8 0 4 3.8 CN1C(=O)N(CCCCCN2CCN(c3ccccc3)CC2)C(C)(c2ccccc2)C1=O 10.1016/j.ejmech.2014.01.065
CHEMBL3233665 119402 0 None -5 5 Rat 7.4 pKd = 7.4 Binding
Antagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 mins
ChEMBL 434 8 0 4 3.8 CN1C(=O)N(CCCCCN2CCN(c3ccccc3)CC2)C(C)(c2ccccc2)C1=O 10.1016/j.ejmech.2014.01.065
CHEMBL3302599 119402 0 None -5 5 Rat 7.4 pKd = 7.4 Binding
Antagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 mins
ChEMBL 434 8 0 4 3.8 CN1C(=O)N(CCCCCN2CCN(c3ccccc3)CC2)C(C)(c2ccccc2)C1=O 10.1016/j.ejmech.2014.01.065
2419 7482 28 None -288 11 Human 6.4 pKd = 6.4 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm011066n
9 7482 28 None -288 11 Human 6.4 pKd = 6.4 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm011066n
CHEMBL13647 7482 28 None -288 11 Human 6.4 pKd = 6.4 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm011066n
102 10899 48 None -346 49 Human 6.4 pKd = 6.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00370a011
3659 10899 48 None -346 49 Human 6.4 pKd = 6.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00370a011
8969 10899 48 None -346 49 Human 6.4 pKd = 6.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00370a011
CHEMBL15245 10899 48 None -346 49 Human 6.4 pKd = 6.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00370a011
DB01392 10899 48 None -346 49 Human 6.4 pKd = 6.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00370a011
15112598 16093 0 None -2 3 Rat 5.4 pKd = 5.4 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 444 9 3 7 3.3 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(OC(C)C2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL111090 16093 0 None -2 3 Rat 5.4 pKd = 5.4 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 444 9 3 7 3.3 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(OC(C)C2=NCCN2)c(Cl)c1 10.1021/jm00115a008
134149596 155244 0 None -10 4 Rat 8.4 pKd = 8.4 Binding
Competitive antagonist activity at alpha1A-adrenoceptor in Wistar rat prostatic vas deference assessed as inhibition of (-)-NE-induced contractions preincubated for 60 mins before (-)-NE challenge measured after 45 mins by Schild plot analysisCompetitive antagonist activity at alpha1A-adrenoceptor in Wistar rat prostatic vas deference assessed as inhibition of (-)-NE-induced contractions preincubated for 60 mins before (-)-NE challenge measured after 45 mins by Schild plot analysis
ChEMBL 368 6 0 5 3.6 CC(C)Oc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3938038 155244 0 None -10 4 Rat 8.4 pKd = 8.4 Binding
Competitive antagonist activity at alpha1A-adrenoceptor in Wistar rat prostatic vas deference assessed as inhibition of (-)-NE-induced contractions preincubated for 60 mins before (-)-NE challenge measured after 45 mins by Schild plot analysisCompetitive antagonist activity at alpha1A-adrenoceptor in Wistar rat prostatic vas deference assessed as inhibition of (-)-NE-induced contractions preincubated for 60 mins before (-)-NE challenge measured after 45 mins by Schild plot analysis
ChEMBL 368 6 0 5 3.6 CC(C)Oc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
491 6980 9 None -44 12 Rat 8.4 pKd = 8.4 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
9891167 6980 9 None -44 12 Rat 8.4 pKd = 8.4 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
CHEMBL13856 6980 9 None -44 12 Rat 8.4 pKd = 8.4 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
71817545 98899 0 None -2 7 Rat 8.3 pKd = 8.3 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419765 98899 0 None -2 7 Rat 8.3 pKd = 8.3 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
14348818 116551 0 None 5 3 Rat 5.4 pKd = 5.4 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL323176 116551 0 None 5 3 Rat 5.4 pKd = 5.4 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
44294687 103682 0 None 7 2 Rat 7.4 pKd = 7.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 380 6 0 7 2.5 Cc1cc(=O)oc2cc(OCCCN3CCN(c4ncccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
CHEMBL265805 103682 0 None 7 2 Rat 7.4 pKd = 7.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 380 6 0 7 2.5 Cc1cc(=O)oc2cc(OCCCN3CCN(c4ncccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
155534921 178766 0 None -5 3 Rat 6.4 pKd = 6.4 Binding
Antagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysisAntagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysis
ChEMBL 461 8 2 6 3.9 COc1ccc(OC)c(N2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)c1 10.1016/j.bmc.2016.09.010
CHEMBL4471070 178766 0 None -5 3 Rat 6.4 pKd = 6.4 Binding
Antagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysisAntagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysis
ChEMBL 461 8 2 6 3.9 COc1ccc(OC)c(N2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)c1 10.1016/j.bmc.2016.09.010
44294988 200039 0 None 1 2 Rat 7.4 pKd = 7.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 396 7 0 8 2.2 COc1cc(=O)oc2cc(OCCCN3CCN(c4ncccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
CHEMBL52384 200039 0 None 1 2 Rat 7.4 pKd = 7.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 396 7 0 8 2.2 COc1cc(=O)oc2cc(OCCCN3CCN(c4ncccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
73437729 125313 0 None -2 3 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 426 7 2 4 3.8 COc1ccccc1N1CCN(CCCNC(=O)c2cc3cc(Cl)ccc3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415018 125313 0 None -2 3 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 426 7 2 4 3.8 COc1ccccc1N1CCN(CCCNC(=O)c2cc3cc(Cl)ccc3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
86288950 119420 0 None -15 6 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 mins
ChEMBL 452 8 0 4 3.9 CN1C(=O)N(CCCCCN2CCN(c3ccccc3F)CC2)C(C)(c2ccccc2)C1=O 10.1016/j.ejmech.2014.01.065
CHEMBL3233666 119420 0 None -15 6 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 mins
ChEMBL 452 8 0 4 3.9 CN1C(=O)N(CCCCCN2CCN(c3ccccc3F)CC2)C(C)(c2ccccc2)C1=O 10.1016/j.ejmech.2014.01.065
CHEMBL3302931 119420 0 None -15 6 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 mins
ChEMBL 452 8 0 4 3.9 CN1C(=O)N(CCCCCN2CCN(c3ccccc3F)CC2)C(C)(c2ccccc2)C1=O 10.1016/j.ejmech.2014.01.065
71817386 109363 0 None -6 7 Rat 8.3 pKd = 8.3 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419769 109363 0 None -6 7 Rat 8.3 pKd = 8.3 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL3040851 109363 0 None -6 7 Rat 8.3 pKd = 8.3 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
10694582 45341 0 None - 1 Rat 8.3 pKd = 8.3 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 444 5 2 11 -1.1 COc1cc2nc(N3CCN(C(=O)c4no[n+]([O-])c4C(N)=O)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
CHEMBL146481 45341 0 None - 1 Rat 8.3 pKd = 8.3 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 444 5 2 11 -1.1 COc1cc2nc(N3CCN(C(=O)c4no[n+]([O-])c4C(N)=O)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
73437677 125314 0 None -9 3 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 406 7 1 5 3.1 COc1ccccc1N1CCN(CCCNC(=O)c2cn(C)c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415019 125314 0 None -9 3 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 406 7 1 5 3.1 COc1ccccc1N1CCN(CCCNC(=O)c2cn(C)c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
73437675 125310 0 None -2 3 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 408 7 3 5 2.8 COc1ccccc1N1CCN(CCCNC(=O)c2cc3cc(O)ccc3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415015 125310 0 None -2 3 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 408 7 3 5 2.8 COc1ccccc1N1CCN(CCCNC(=O)c2cc3cc(O)ccc3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
73437730 125311 0 None -2 3 Rat 7.2 pKd = 7.2 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 437 8 2 6 3.0 COc1ccccc1N1CCN(CCCNC(=O)c2cc3cccc([N+](=O)[O-])c3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415016 125311 0 None -2 3 Rat 7.2 pKd = 7.2 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 437 8 2 6 3.0 COc1ccccc1N1CCN(CCCNC(=O)c2cc3cccc([N+](=O)[O-])c3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
73437678 125312 0 None -4 3 Rat 7.2 pKd = 7.2 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 470 7 2 4 3.9 COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccc(Br)cc3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415017 125312 0 None -4 3 Rat 7.2 pKd = 7.2 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 470 7 2 4 3.9 COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccc(Br)cc3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
9871544 20988 3 None -141 11 Human 6.2 pKd = 6.2 Binding
Binding affinity to Alpha-1A adrenergic receptorBinding affinity to Alpha-1A adrenergic receptor
ChEMBL 526 7 0 5 4.6 COc1ccc(C[C@H](C)CN2C[C@@H](C(=O)N3CCN(c4ccc(F)c(F)c4)CC3)[C@H]3CCCC[C@H]3C2)cn1 10.1016/j.bmcl.2010.01.063
CHEMBL1076624 20988 3 None -141 11 Human 6.2 pKd = 6.2 Binding
Binding affinity to Alpha-1A adrenergic receptorBinding affinity to Alpha-1A adrenergic receptor
ChEMBL 526 7 0 5 4.6 COc1ccc(C[C@H](C)CN2C[C@@H](C(=O)N3CCN(c4ccc(F)c(F)c4)CC3)[C@H]3CCCC[C@H]3C2)cn1 10.1016/j.bmcl.2010.01.063
CHEMBL1198948 20988 3 None -141 11 Human 6.2 pKd = 6.2 Binding
Binding affinity to Alpha-1A adrenergic receptorBinding affinity to Alpha-1A adrenergic receptor
ChEMBL 526 7 0 5 4.6 COc1ccc(C[C@H](C)CN2C[C@@H](C(=O)N3CCN(c4ccc(F)c(F)c4)CC3)[C@H]3CCCC[C@H]3C2)cn1 10.1016/j.bmcl.2010.01.063
118733023 125315 0 None -2 3 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 482 9 1 5 4.6 COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccccc3n2Cc2ccccc2)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415020 125315 0 None -2 3 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 482 9 1 5 4.6 COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccccc3n2Cc2ccccc2)CC1 10.1016/j.ejmech.2015.04.005
73438501 125307 0 None -1 3 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 406 8 2 4 3.0 COc1ccccc1N1CCN(CCCNC(=O)Cc2c[nH]c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415012 125307 0 None -1 3 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 406 8 2 4 3.0 COc1ccccc1N1CCN(CCCNC(=O)Cc2c[nH]c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
44294991 108300 0 None 2 2 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 424 8 0 7 3.4 COc1ccccc1N1CCN(CCCOc2ccc3c(OC)cc(=O)oc3c2)CC1 10.1016/s0960-894x(02)00933-2
CHEMBL298108 108300 0 None 2 2 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 424 8 0 7 3.4 COc1ccccc1N1CCN(CCCOc2ccc3c(OC)cc(=O)oc3c2)CC1 10.1016/s0960-894x(02)00933-2
73437676 125274 0 None -1 3 Rat 7.1 pKd = 7.1 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 422 8 2 5 3.1 COc1ccc2[nH]c(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)cc2c1 10.1016/j.ejmech.2015.04.005
CHEMBL3414578 125274 0 None -1 3 Rat 7.1 pKd = 7.1 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 422 8 2 5 3.1 COc1ccc2[nH]c(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)cc2c1 10.1016/j.ejmech.2015.04.005
14348818 116551 0 None 5 3 Rat 5.1 pKd = 5.1 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL323176 116551 0 None 5 3 Rat 5.1 pKd = 5.1 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
490 6979 8 None -36 12 Rat 8.1 pKd = 8.1 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
9890547 6979 8 None -36 12 Rat 8.1 pKd = 8.1 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
CHEMBL268758 6979 8 None -36 12 Rat 8.1 pKd = 8.1 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
10550345 125972 0 None - 1 Rat 8.0 pKd = 8.0 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 426 4 1 11 -0.3 COc1cc2nc(N3CCN(C(=O)c4no[n+]([O-])c4C#N)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
CHEMBL343188 125972 0 None - 1 Rat 8.0 pKd = 8.0 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 426 4 1 11 -0.3 COc1cc2nc(N3CCN(C(=O)c4no[n+]([O-])c4C#N)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
71817549 109357 0 None -7 7 Rat 8.0 pKd = 8.0 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3040803 109357 0 None -7 7 Rat 8.0 pKd = 8.0 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3216590 109357 0 None -7 7 Rat 8.0 pKd = 8.0 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
10531157 44576 0 None 2290 3 Human 11.0 pKi = 11 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 572 8 2 8 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145843 44576 0 None 2290 3 Human 11.0 pKi = 11 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 572 8 2 8 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
60820 11080 14 None 1 12 Human 10.7 pKi = 10.7 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 421 6 0 4 4.4 CC(C)Oc1ccccc1N1CCN(Cc2cccc(C(=O)N3CCCCC3)c2)CC1 10.1016/j.bmc.2008.02.091
CHEMBL10085 11080 14 None 1 12 Human 10.7 pKi = 10.7 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 421 6 0 4 4.4 CC(C)Oc1ccccc1N1CCN(Cc2cccc(C(=O)N3CCCCC3)c2)CC1 10.1016/j.bmc.2008.02.091
10745901 44238 0 None 1698 3 Human 10.7 pKi = 10.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 586 8 2 8 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])C[C@@H]2C)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145547 44238 0 None 1698 3 Human 10.7 pKi = 10.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 586 8 2 8 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])C[C@@H]2C)C1c1ccc(F)c(F)c1 10.1021/jm990202+
129211 10521 78 None -1 16 Human 10.5 pKi = 10.5 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
2562 10521 78 None -1 16 Human 10.5 pKi = 10.5 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
488 10521 78 None -1 16 Human 10.5 pKi = 10.5 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
CHEMBL836 10521 78 None -1 16 Human 10.5 pKi = 10.5 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
DB00706 10521 78 None -1 16 Human 10.5 pKi = 10.5 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
164089 117130 24 None -1 5 Bovine 10.5 pKi = 10.5 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 395 5 1 7 3.4 COc1cc2c(cc1OC)CN(c1cc(N)c3cc(OC)c(OC)cc3n1)CC2 10.1021/jm00018a001
CHEMBL324090 117130 24 None -1 5 Bovine 10.5 pKi = 10.5 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 395 5 1 7 3.4 COc1cc2c(cc1OC)CN(c1cc(N)c3cc(OC)c(OC)cc3n1)CC2 10.1021/jm00018a001
129211 10521 78 None -2 16 Rat 10.5 pKi = 10.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm990567u
2562 10521 78 None -2 16 Rat 10.5 pKi = 10.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm990567u
488 10521 78 None -2 16 Rat 10.5 pKi = 10.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm990567u
CHEMBL836 10521 78 None -2 16 Rat 10.5 pKi = 10.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm990567u
DB00706 10521 78 None -2 16 Rat 10.5 pKi = 10.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm990567u
4151 10379 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1016/j.bmcl.2004.11.032
493 10379 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1016/j.bmcl.2004.11.032
5312125 10379 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1016/j.bmcl.2004.11.032
CHEMBL24778 10379 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1016/j.bmcl.2004.11.032
DB06207 10379 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1016/j.bmcl.2004.11.032
4151 10379 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/jm960697s
493 10379 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/jm960697s
5312125 10379 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/jm960697s
CHEMBL24778 10379 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/jm960697s
DB06207 10379 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/jm960697s
44298611 107429 0 None 125 3 Human 10.4 pKi = 10.4 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 440 7 1 6 2.3 Cc1[nH]c(=O)n(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c(=O)c1C 10.1016/s0960-894x(03)00305-6
CHEMBL292189 107429 0 None 125 3 Human 10.4 pKi = 10.4 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 440 7 1 6 2.3 Cc1[nH]c(=O)n(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c(=O)c1C 10.1016/s0960-894x(03)00305-6
164089 117130 24 None -1 5 Human 10.4 pKi = 10.4 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 395 5 1 7 3.4 COc1cc2c(cc1OC)CN(c1cc(N)c3cc(OC)c(OC)cc3n1)CC2 10.1021/jm00018a001
CHEMBL324090 117130 24 None -1 5 Human 10.4 pKi = 10.4 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 395 5 1 7 3.4 COc1cc2c(cc1OC)CN(c1cc(N)c3cc(OC)c(OC)cc3n1)CC2 10.1021/jm00018a001
10789770 107662 0 None 1 5 Rat 10.4 pKi = 10.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 451 6 1 7 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)c(OC)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL293695 107662 0 None 1 5 Rat 10.4 pKi = 10.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 451 6 1 7 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)c(OC)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
10622402 209539 0 None 6 3 Rat 10.4 pKi = 10.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 427 5 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2s1 10.1021/jm000541z
CHEMBL62028 209539 0 None 6 3 Rat 10.4 pKi = 10.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 427 5 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2s1 10.1021/jm000541z
4209 9937 75 None -1 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2014.12.045
4893 9937 75 None -1 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2014.12.045
503 9937 75 None -1 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2014.12.045
5385 9937 75 None -1 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2014.12.045
CHEMBL2 9937 75 None -1 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2014.12.045
DB00457 9937 75 None -1 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2014.12.045
4209 9937 75 None -1 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm401895u
4893 9937 75 None -1 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm401895u
503 9937 75 None -1 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm401895u
5385 9937 75 None -1 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm401895u
CHEMBL2 9937 75 None -1 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm401895u
DB00457 9937 75 None -1 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm401895u
76333279 91591 0 None - 1 Human 10.3 pKi = 10.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 8 1 5 4.6 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2O1 10.1007/s00044-010-9379-1
CHEMBL2234441 91591 0 None - 1 Human 10.3 pKi = 10.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 8 1 5 4.6 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2O1 10.1007/s00044-010-9379-1
10698570 125536 0 None 257 3 Human 10.3 pKi = 10.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 586 8 2 8 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])C[C@H]2C)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL341849 125536 0 None 257 3 Human 10.3 pKi = 10.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 586 8 2 8 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])C[C@H]2C)C1c1ccc(F)c(F)c1 10.1021/jm990202+
11742834 172549 0 None -1 7 Human 10.3 pKi = 10.3 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 419 9 1 5 4.7 COc1cccc(OC)c1OCCNC[C@@H]1C[C@H](c2ccccc2)c2ccccc2O1 10.1021/jm011066n
CHEMBL42472 172549 0 None -1 7 Human 10.3 pKi = 10.3 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 419 9 1 5 4.7 COc1cccc(OC)c1OCCNC[C@@H]1C[C@H](c2ccccc2)c2ccccc2O1 10.1021/jm011066n
76333279 91591 0 None - 1 Human 10.3 pKi = 10.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 8 1 5 4.6 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2O1 10.1007/s00044-010-9379-1
CHEMBL2234441 91591 0 None - 1 Human 10.3 pKi = 10.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 8 1 5 4.6 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2O1 10.1007/s00044-010-9379-1
129211 10521 78 None -1 16 Human 10.3 pKi = 10.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2010.09.042
2562 10521 78 None -1 16 Human 10.3 pKi = 10.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2010.09.042
488 10521 78 None -1 16 Human 10.3 pKi = 10.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2010.09.042
CHEMBL836 10521 78 None -1 16 Human 10.3 pKi = 10.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2010.09.042
DB00706 10521 78 None -1 16 Human 10.3 pKi = 10.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2010.09.042
19085858 110929 0 None 173 3 Human 10.2 pKi = 10.2 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cells
ChEMBL 501 7 0 8 3.6 CSc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O 10.1016/s0960-894x(98)00446-6
CHEMBL309518 110929 0 None 173 3 Human 10.2 pKi = 10.2 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cells
ChEMBL 501 7 0 8 3.6 CSc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O 10.1016/s0960-894x(98)00446-6
10817365 43487 0 None 501 3 Human 10.2 pKi = 10.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 599 9 2 7 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL144933 43487 0 None 501 3 Human 10.2 pKi = 10.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 599 9 2 7 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)C(=O)N1 10.1021/jm990201h
10651636 44635 0 None 1318 3 Human 10.2 pKi = 10.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 630 8 2 5 6.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(C)cc3)(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL145894 44635 0 None 1318 3 Human 10.2 pKi = 10.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 630 8 2 5 6.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(C)cc3)(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
44298664 204065 0 None 31 3 Human 10.2 pKi = 10.2 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 462 7 1 6 2.8 O=c1[nH]c2ccccc2c(=O)n1CCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL56863 204065 0 None 31 3 Human 10.2 pKi = 10.2 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 462 7 1 6 2.8 O=c1[nH]c2ccccc2c(=O)n1CCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
19085914 212604 0 None 234 3 Human 10.2 pKi = 10.2 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 485 7 0 8 2.9 COc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O 10.1016/s0960-894x(98)00446-6
CHEMBL83340 212604 0 None 234 3 Human 10.2 pKi = 10.2 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 485 7 0 8 2.9 COc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O 10.1016/s0960-894x(98)00446-6
49781233 24697 0 None 5 3 Bovine 10.2 pKi = 10.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 392 2 0 7 2.9 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4nnnn4C)cc32)CC1 10.1021/jm100652h
CHEMBL1259217 24697 0 None 5 3 Bovine 10.2 pKi = 10.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 392 2 0 7 2.9 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4nnnn4C)cc32)CC1 10.1021/jm100652h
44324405 213540 0 None 117 3 Human 10.2 pKi = 10.2 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 2 4 3.9 CN1C=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
CHEMBL90086 213540 0 None 117 3 Human 10.2 pKi = 10.2 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 2 4 3.9 CN1C=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
10767606 214230 0 None 371 3 Human 10.2 pKi = 10.2 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 497 7 3 4 3.6 N#Cc1cc(F)ccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1016/j.ejmech.2017.03.025
CHEMBL94188 214230 0 None 371 3 Human 10.2 pKi = 10.2 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 497 7 3 4 3.6 N#Cc1cc(F)ccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1016/j.ejmech.2017.03.025
10767606 214230 0 None 371 3 Human 10.2 pKi = 10.2 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 497 7 3 4 3.6 N#Cc1cc(F)ccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
CHEMBL94188 214230 0 None 371 3 Human 10.2 pKi = 10.2 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 497 7 3 4 3.6 N#Cc1cc(F)ccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
4209 9937 75 None -1 33 Rat 10.2 pKi = 10.2 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990277d
4893 9937 75 None -1 33 Rat 10.2 pKi = 10.2 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990277d
503 9937 75 None -1 33 Rat 10.2 pKi = 10.2 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990277d
5385 9937 75 None -1 33 Rat 10.2 pKi = 10.2 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990277d
CHEMBL2 9937 75 None -1 33 Rat 10.2 pKi = 10.2 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990277d
DB00457 9937 75 None -1 33 Rat 10.2 pKi = 10.2 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990277d
9913449 113229 1 None 13 3 Human 10.1 pKi = 10.1 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL313990 113229 1 None 13 3 Human 10.1 pKi = 10.1 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
10526964 213744 0 None 1 3 Bovine 10.1 pKi = 10.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 437 10 1 6 3.2 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC2CC2)CC1 10.1021/jm970166j
CHEMBL91278 213744 0 None 1 3 Bovine 10.1 pKi = 10.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 437 10 1 6 3.2 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC2CC2)CC1 10.1021/jm970166j
76315111 91593 0 None - 1 Human 10.1 pKi = 10.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
CHEMBL2234443 91593 0 None - 1 Human 10.1 pKi = 10.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
10699164 43802 0 None 151 3 Human 10.1 pKi = 10.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 552 7 2 7 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C#N)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145190 43802 0 None 151 3 Human 10.1 pKi = 10.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 552 7 2 7 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C#N)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
499 10849 18 None -1 14 Rat 10.1 pKi = 10.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
5685 10849 18 None -1 14 Rat 10.1 pKi = 10.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
CHEMBL25554 10849 18 None -1 14 Rat 10.1 pKi = 10.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
52942381 24664 0 None -2 4 Bovine 10.1 pKi = 10.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 339 2 1 4 3.1 CN1CCN(C2Cc3ccccc3Sc3ccc(CN)cc32)CC1 10.1021/jm100652h
CHEMBL1259113 24664 0 None -2 4 Bovine 10.1 pKi = 10.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 339 2 1 4 3.1 CN1CCN(C2Cc3ccccc3Sc3ccc(CN)cc32)CC1 10.1021/jm100652h
19085876 212593 0 None 87 3 Human 10.1 pKi = 10.1 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 473 6 0 7 3.0 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3cc(F)ccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL83272 212593 0 None 87 3 Human 10.1 pKi = 10.1 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 473 6 0 7 3.0 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3cc(F)ccc32)CC1 10.1016/s0960-894x(98)00446-6
49781447 24616 0 None 3 4 Bovine 10.1 pKi = 10.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 391 2 0 6 3.5 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ncn(C)n4)cc32)CC1 10.1021/jm100652h
CHEMBL1258988 24616 0 None 3 4 Bovine 10.1 pKi = 10.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 391 2 0 6 3.5 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ncn(C)n4)cc32)CC1 10.1021/jm100652h
4209 9937 75 None -1 33 Rat 10.1 pKi = 10.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
4893 9937 75 None -1 33 Rat 10.1 pKi = 10.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
503 9937 75 None -1 33 Rat 10.1 pKi = 10.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
5385 9937 75 None -1 33 Rat 10.1 pKi = 10.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
CHEMBL2 9937 75 None -1 33 Rat 10.1 pKi = 10.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
DB00457 9937 75 None -1 33 Rat 10.1 pKi = 10.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
49781892 24673 0 None -1 4 Bovine 10.1 pKi = 10.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 381 3 1 4 3.3 CC(=O)NCc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259144 24673 0 None -1 4 Bovine 10.1 pKi = 10.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 381 3 1 4 3.3 CC(=O)NCc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
44289248 175755 0 None 4 7 Human 10.1 pKi = 10.1 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2S1 10.1021/jm011066n
CHEMBL43905 175755 0 None 4 7 Human 10.1 pKi = 10.1 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2S1 10.1021/jm011066n
76315111 91593 0 None - 1 Human 10.1 pKi = 10.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
CHEMBL2234443 91593 0 None - 1 Human 10.1 pKi = 10.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
10716965 174739 0 None 10 3 Rat 10.1 pKi = 10.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 419 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)c(C)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL431720 174739 0 None 10 3 Rat 10.1 pKi = 10.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 419 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)c(C)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
10812130 205960 0 None 2 3 Rat 10.1 pKi = 10.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 421 5 1 6 2.4 COc1ccc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)[nH]c2c1 10.1021/jm000541z
CHEMBL58956 205960 0 None 2 3 Rat 10.1 pKi = 10.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 421 5 1 6 2.4 COc1ccc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)[nH]c2c1 10.1021/jm000541z
10693231 209541 0 None -2 5 Rat 10.1 pKi = 10.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 416 4 1 6 2.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C#N)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL62033 209541 0 None -2 5 Rat 10.1 pKi = 10.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 416 4 1 6 2.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C#N)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
11039289 123618 0 None 12 5 Human 10.0 pKi = 10.0 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 600 13 1 9 4.7 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCCCO[N+](=O)[O-])CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL338029 123618 0 None 12 5 Human 10.0 pKi = 10.0 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 600 13 1 9 4.7 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCCCO[N+](=O)[O-])CC3)cccc2c1=O 10.1021/jm030825u
34580 24663 2 None -1 4 Bovine 10.0 pKi = 10.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 335 1 0 4 3.6 CN1CCN(C2Cc3ccccc3Sc3ccc(C#N)cc32)CC1 10.1021/jm100652h
CHEMBL1259112 24663 2 None -1 4 Bovine 10.0 pKi = 10.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 335 1 0 4 3.6 CN1CCN(C2Cc3ccccc3Sc3ccc(C#N)cc32)CC1 10.1021/jm100652h
19085926 212322 0 None 199 3 Human 10.0 pKi = 10 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O 10.1016/s0960-894x(98)00446-6
CHEMBL81006 212322 0 None 199 3 Human 10.0 pKi = 10 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O 10.1016/s0960-894x(98)00446-6
9959671 39445 0 None 363 3 Human 10.0 pKi = 10 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL141322 39445 0 None 363 3 Human 10.0 pKi = 10 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10721751 41404 0 None 1412 3 Human 10.0 pKi = 10 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 569 10 1 6 4.9 COC(=O)C1=C(C)NC(=O)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL142981 41404 0 None 1412 3 Human 10.0 pKi = 10 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 569 10 1 6 4.9 COC(=O)C1=C(C)NC(=O)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10031709 44085 0 None 2511 3 Human 10.0 pKi = 10 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 613 10 0 5 8.1 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccc(C)cc3)(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145411 44085 0 None 2511 3 Human 10.0 pKi = 10 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 613 10 0 5 8.1 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccc(C)cc3)(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10651219 40512 0 None 1000 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 600 10 3 8 2.1 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
CHEMBL142236 40512 0 None 1000 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 600 10 3 8 2.1 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
10650726 40532 0 None 87 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 571 9 2 7 3.8 CCOc1ccccc1N1CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(=O)OC)C2c2ccc(F)c(F)c2)CC1 10.1021/jm990202+
CHEMBL142251 40532 0 None 87 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 571 9 2 7 3.8 CCOc1ccccc1N1CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(=O)OC)C2c2ccc(F)c(F)c2)CC1 10.1021/jm990202+
10531476 41119 0 None 269 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 590 8 2 10 3.0 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc2nonc2c1 10.1021/jm990200p
CHEMBL142743 41119 0 None 269 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 590 8 2 10 3.0 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc2nonc2c1 10.1021/jm990200p
10747201 43656 0 None 1288 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 618 10 3 8 2.3 COCC1=C(C(=O)OC)C(c2cc(F)c(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
CHEMBL145072 43656 0 None 1288 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 618 10 3 8 2.3 COCC1=C(C(=O)OC)C(c2cc(F)c(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
10699164 43802 0 None 151 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 552 7 2 7 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C#N)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145190 43802 0 None 151 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 552 7 2 7 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C#N)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10745380 45565 0 None 177 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 557 8 2 7 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL146654 45565 0 None 177 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 557 8 2 7 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10438280 108375 0 None 446 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 584 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990200p
CHEMBL298713 108375 0 None 446 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 584 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990200p
11802456 177739 0 None 316 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 584 9 3 7 2.9 CCC1=C(C(=O)OC)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
CHEMBL445577 177739 0 None 316 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 584 9 3 7 2.9 CCC1=C(C(=O)OC)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
10627090 41335 0 None 1288 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 581 9 2 7 3.8 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL142929 41335 0 None 1288 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 581 9 2 7 3.8 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
10721751 41404 0 None 1412 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 569 10 1 6 4.9 COC(=O)C1=C(C)NC(=O)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL142981 41404 0 None 1412 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 569 10 1 6 4.9 COC(=O)C1=C(C)NC(=O)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10438280 108375 0 None 446 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 584 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL298713 108375 0 None 446 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 584 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10578715 109452 0 None 144 3 Human 10.0 pKi = 10.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 10 1 7 4.2 COc1ccc(N2C(=O)c3ccc(C(=O)NCCCN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL304591 109452 0 None 144 3 Human 10.0 pKi = 10.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 10 1 7 4.2 COc1ccc(N2C(=O)c3ccc(C(=O)NCCCN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
10815593 213818 0 None 436 3 Human 9.9 pKi = 9.9 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 2 4 3.7 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
CHEMBL91616 213818 0 None 436 3 Human 9.9 pKi = 9.9 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 2 4 3.7 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
19085866 112194 0 None 117 3 Human 9.9 pKi = 9.9 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 455 6 0 7 2.9 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL311890 112194 0 None 117 3 Human 9.9 pKi = 9.9 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 455 6 0 7 2.9 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
49781893 24674 0 None 1 4 Bovine 9.9 pKi = 9.9 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 409 4 1 4 4.0 CC(C)C(=O)NCc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259145 24674 0 None 1 4 Bovine 9.9 pKi = 9.9 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 409 4 1 4 4.0 CC(C)C(=O)NCc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
10673657 213512 0 None 1071 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 525 7 2 4 4.3 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
CHEMBL89927 213512 0 None 1071 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 525 7 2 4 4.3 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
9985476 44058 0 None 912 3 Human 9.9 pKi = 9.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 570 8 3 7 2.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145394 44058 0 None 912 3 Human 9.9 pKi = 9.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 570 8 3 7 2.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
4209 9937 75 None -1 33 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
4893 9937 75 None -1 33 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
503 9937 75 None -1 33 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
5385 9937 75 None -1 33 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
CHEMBL2 9937 75 None -1 33 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
DB00457 9937 75 None -1 33 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
129211 10521 78 None -7 16 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
2562 10521 78 None -7 16 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
488 10521 78 None -7 16 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
CHEMBL836 10521 78 None -7 16 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
DB00706 10521 78 None -7 16 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
10499343 213304 0 None 79 2 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 369 8 2 6 1.8 COc1ccccc1N1CCN(CCCNc2ncccc2C(N)=O)CC1 10.1021/jm970166j
CHEMBL88512 213304 0 None 79 2 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 369 8 2 6 1.8 COc1ccccc1N1CCN(CCCNc2ncccc2C(N)=O)CC1 10.1021/jm970166j
19085820 212583 0 None 1023 3 Human 9.9 pKi = 9.9 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 500 7 0 9 2.8 O=C1c2cc([N+](=O)[O-])ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL83226 212583 0 None 1023 3 Human 9.9 pKi = 9.9 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 500 7 0 9 2.8 O=C1c2cc([N+](=O)[O-])ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
129211 10521 78 None -1 16 Human 9.9 pKi = 9.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
2562 10521 78 None -1 16 Human 9.9 pKi = 9.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
488 10521 78 None -1 16 Human 9.9 pKi = 9.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
CHEMBL836 10521 78 None -1 16 Human 9.9 pKi = 9.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
DB00706 10521 78 None -1 16 Human 9.9 pKi = 9.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
10576661 213637 0 None 1230 3 Human 9.9 pKi = 9.9 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 479 7 3 4 3.5 N#Cc1ccccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1016/j.ejmech.2017.03.025
CHEMBL90652 213637 0 None 1230 3 Human 9.9 pKi = 9.9 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 479 7 3 4 3.5 N#Cc1ccccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1016/j.ejmech.2017.03.025
129211 10521 78 None -2 16 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2011.04.032
2562 10521 78 None -2 16 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2011.04.032
488 10521 78 None -2 16 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2011.04.032
CHEMBL836 10521 78 None -2 16 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2011.04.032
DB00706 10521 78 None -2 16 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2011.04.032
10576661 213637 0 None 1230 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 479 7 3 4 3.5 N#Cc1ccccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
CHEMBL90652 213637 0 None 1230 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 479 7 3 4 3.5 N#Cc1ccccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
10649481 213597 0 None 123 3 Human 9.9 pKi = 9.9 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 514 7 1 3 4.8 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C(=O)N1C 10.1016/j.ejmech.2017.03.025
CHEMBL90420 213597 0 None 123 3 Human 9.9 pKi = 9.9 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 514 7 1 3 4.8 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C(=O)N1C 10.1016/j.ejmech.2017.03.025
11638677 91364 0 None -5 6 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2011.04.032
CHEMBL2153423 91364 0 None -5 6 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2011.04.032
CHEMBL2220978 91364 0 None -5 6 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2011.04.032
10840194 118605 0 None 245 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 541 9 3 5 3.6 COCC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL328763 118605 0 None 245 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 541 9 3 5 3.6 COCC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
10815240 213631 0 None 33 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 500 7 2 3 4.5 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C(=O)N1 10.1021/jm990612y
CHEMBL90606 213631 0 None 33 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 500 7 2 3 4.5 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C(=O)N1 10.1021/jm990612y
4209 9937 75 None -1 33 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.12.063
4893 9937 75 None -1 33 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.12.063
503 9937 75 None -1 33 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.12.063
5385 9937 75 None -1 33 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.12.063
CHEMBL2 9937 75 None -1 33 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.12.063
DB00457 9937 75 None -1 33 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.12.063
463 8187 22 None 5 13 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
6918097 8187 22 None 5 13 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
837 8187 22 None 5 13 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
CHEMBL2051956 8187 22 None 5 13 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
DB14068 8187 22 None 5 13 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
499 10849 18 None 1 14 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960697s
5685 10849 18 None 1 14 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960697s
CHEMBL25554 10849 18 None 1 14 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960697s
44298624 202486 0 None 63 2 Human 9.8 pKi = 9.8 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 458 8 1 6 2.5 Cc1c[nH]c(=O)n(CCCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL55695 202486 0 None 63 2 Human 9.8 pKi = 9.8 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 458 8 1 6 2.5 Cc1c[nH]c(=O)n(CCCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
487 10406 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
60602 10406 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
CHEMBL405355 10406 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
DB09239 10406 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
19085881 212547 0 None 478 3 Human 9.8 pKi = 9.8 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cells
ChEMBL 500 7 0 9 2.8 O=C1c2ccc([N+](=O)[O-])cc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL82877 212547 0 None 478 3 Human 9.8 pKi = 9.8 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cells
ChEMBL 500 7 0 9 2.8 O=C1c2ccc([N+](=O)[O-])cc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
10530491 109382 0 None 234 2 Human 9.8 pKi = 9.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 540 9 1 6 4.5 Cc1ccc(N2C(=O)c3ccc(C(=O)NCCCN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL304132 109382 0 None 234 2 Human 9.8 pKi = 9.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 540 9 1 6 4.5 Cc1ccc(N2C(=O)c3ccc(C(=O)NCCCN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
487 10406 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Binding affinity towards recombinant human alpha-1A adrenergic receptorBinding affinity towards recombinant human alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm030480f
60602 10406 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Binding affinity towards recombinant human alpha-1A adrenergic receptorBinding affinity towards recombinant human alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm030480f
CHEMBL405355 10406 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Binding affinity towards recombinant human alpha-1A adrenergic receptorBinding affinity towards recombinant human alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm030480f
DB09239 10406 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Binding affinity towards recombinant human alpha-1A adrenergic receptorBinding affinity towards recombinant human alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm030480f
487 10406 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1016/j.bmcl.2004.11.032
60602 10406 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1016/j.bmcl.2004.11.032
CHEMBL405355 10406 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1016/j.bmcl.2004.11.032
DB09239 10406 21 None -1 12 Human 9.8 pKi = 9.8 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1016/j.bmcl.2004.11.032
137659584 166161 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 548 9 3 6 3.2 COCC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(C#N)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1016/j.ejmech.2017.03.025
CHEMBL4100620 166161 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 548 9 3 6 3.2 COCC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(C#N)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1016/j.ejmech.2017.03.025
499 10849 18 None 1 14 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/acs.jmedchem.9b01465
5685 10849 18 None 1 14 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/acs.jmedchem.9b01465
CHEMBL25554 10849 18 None 1 14 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/acs.jmedchem.9b01465
71508712 93843 0 None 40 5 Bovine 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 389 3 0 5 4.4 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ncn(C)n4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2326175 93843 0 None 40 5 Bovine 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 389 3 0 5 4.4 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ncn(C)n4)cc23)CC1 10.1016/j.bmc.2012.10.049
49782998 24689 0 None 1 6 Bovine 9.8 pKi = 9.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 409 4 1 4 4.0 CC(C)C(=O)NCc1ccc2c(c1)[C@@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259190 24689 0 None 1 6 Bovine 9.8 pKi = 9.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 409 4 1 4 4.0 CC(C)C(=O)NCc1ccc2c(c1)[C@@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
10696866 213712 0 None 6165 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 504 7 3 5 3.1 N#Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
CHEMBL91091 213712 0 None 6165 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 504 7 3 5 3.1 N#Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
10974101 123731 0 None 10 5 Human 9.8 pKi = 9.8 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 609 10 1 9 4.2 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C)CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL338608 123731 0 None 10 5 Human 9.8 pKi = 9.8 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 609 10 1 9 4.2 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C)CC3)cccc2c1=O 10.1021/jm030825u
14423371 104230 1 None -1 7 Human 9.8 pKi = 9.8 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 441 11 1 8 3.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL27013 104230 1 None -1 7 Human 9.8 pKi = 9.8 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 441 11 1 8 3.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
4209 9937 75 None -1 33 Bovine 9.8 pKi = 9.8 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
4893 9937 75 None -1 33 Bovine 9.8 pKi = 9.8 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
503 9937 75 None -1 33 Bovine 9.8 pKi = 9.8 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
5385 9937 75 None -1 33 Bovine 9.8 pKi = 9.8 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
CHEMBL2 9937 75 None -1 33 Bovine 9.8 pKi = 9.8 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
DB00457 9937 75 None -1 33 Bovine 9.8 pKi = 9.8 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
9830741 214635 1 None 1 7 Human 9.8 pKi = 9.8 Binding
Binding affinity towards Alpha1A human adrenergic receptors, using [125I]-HEAT as radioligand.Binding affinity towards Alpha1A human adrenergic receptors, using [125I]-HEAT as radioligand.
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm000085e
CHEMBL96467 214635 1 None 1 7 Human 9.8 pKi = 9.8 Binding
Binding affinity towards Alpha1A human adrenergic receptors, using [125I]-HEAT as radioligand.Binding affinity towards Alpha1A human adrenergic receptors, using [125I]-HEAT as radioligand.
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm000085e
9830741 214635 1 None 1 7 Human 9.8 pKi = 9.8 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/j.bmcl.2004.11.032
CHEMBL96467 214635 1 None 1 7 Human 9.8 pKi = 9.8 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/j.bmcl.2004.11.032
9913449 113229 1 None 13 3 Human 9.8 pKi = 9.8 Binding
Compound was evaluated for its affinity for alpha 1a receptor in human prostate tissue preparationsCompound was evaluated for its affinity for alpha 1a receptor in human prostate tissue preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL313990 113229 1 None 13 3 Human 9.8 pKi = 9.8 Binding
Compound was evaluated for its affinity for alpha 1a receptor in human prostate tissue preparationsCompound was evaluated for its affinity for alpha 1a receptor in human prostate tissue preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
137637836 162860 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 509 9 3 6 3.1 COCC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)cc2)NCN1 10.1016/j.ejmech.2017.03.025
CHEMBL4062896 162860 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 509 9 3 6 3.1 COCC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)cc2)NCN1 10.1016/j.ejmech.2017.03.025
10719222 214226 0 None 141 3 Human 9.8 pKi = 9.8 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 472 7 3 3 3.7 O=C1NC=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1016/j.ejmech.2017.03.025
CHEMBL94167 214226 0 None 141 3 Human 9.8 pKi = 9.8 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 472 7 3 3 3.7 O=C1NC=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1016/j.ejmech.2017.03.025
49781232 24696 0 None -1 5 Bovine 9.8 pKi = 9.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 392 2 0 7 2.9 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4nnn(C)n4)cc32)CC1 10.1021/jm100652h
CHEMBL1259216 24696 0 None -1 5 Bovine 9.8 pKi = 9.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 392 2 0 7 2.9 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4nnn(C)n4)cc32)CC1 10.1021/jm100652h
10767607 113906 0 None 831 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 497 7 3 4 3.4 N#CC1(c2ccc(F)cc2)CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
CHEMBL316100 113906 0 None 831 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 497 7 3 4 3.4 N#CC1(c2ccc(F)cc2)CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
10791844 213936 0 None 512 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 3 4 4.0 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL92328 213936 0 None 512 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 3 4 4.0 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
10719222 214226 0 None 141 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 472 7 3 3 3.7 O=C1NC=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
CHEMBL94167 214226 0 None 141 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 472 7 3 3 3.7 O=C1NC=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
9830741 214635 1 None 1 7 Human 9.8 pKi = 9.8 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
CHEMBL96467 214635 1 None 1 7 Human 9.8 pKi = 9.8 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
10649481 213597 0 None 123 3 Human 9.7 pKi = 9.7 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 514 7 1 3 4.8 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C(=O)N1C 10.1021/jm990612y
CHEMBL90420 213597 0 None 123 3 Human 9.7 pKi = 9.7 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 514 7 1 3 4.8 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C(=O)N1C 10.1021/jm990612y
10839105 213598 0 None 660 3 Human 9.7 pKi = 9.7 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 500 7 2 3 4.5 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
CHEMBL90421 213598 0 None 660 3 Human 9.7 pKi = 9.7 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 500 7 2 3 4.5 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
CHEMBL179334 70077 0 None 977 6 Human 9.7 pKi = 9.7 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
10674564 210716 0 None 83 3 Human 9.7 pKi = 9.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 569 10 1 7 4.3 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL69264 210716 0 None 83 3 Human 9.7 pKi = 9.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 569 10 1 7 4.3 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1 10.1021/jm9905918
10074286 212283 0 None 2 4 Human 9.7 pKi = 9.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 489 9 1 8 3.5 COc1ccccc1N1CCN(CCNc2c(C(=O)C(C)C)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL80730 212283 0 None 2 4 Human 9.7 pKi = 9.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 489 9 1 8 3.5 COc1ccccc1N1CCN(CCNc2c(C(=O)C(C)C)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL179334 70077 0 None 977 6 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 608 10 2 7 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1ccc([N+](=O)[O-])cc1 10.1016/j.bmcl.2004.11.032
137646446 164451 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 518 7 2 3 4.6 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)c(F)c3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1016/j.ejmech.2017.03.025
CHEMBL4081581 164451 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 518 7 2 3 4.6 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)c(F)c3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1016/j.ejmech.2017.03.025
9932698 24681 0 None 3 6 Bovine 9.7 pKi = 9.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 435 6 2 4 3.4 NCc1ccc2c(c1)c(C1CCN(CCN3CCNC3=O)CC1)cn2-c1ccc(F)cc1 10.1021/jm100652h
CHEMBL1259172 24681 0 None 3 6 Bovine 9.7 pKi = 9.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 435 6 2 4 3.4 NCc1ccc2c(c1)c(C1CCN(CCN3CCNC3=O)CC1)cn2-c1ccc(F)cc1 10.1021/jm100652h
10697623 113944 0 None 2398 3 Human 9.7 pKi = 9.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 536 7 2 5 3.6 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
CHEMBL316358 113944 0 None 2398 3 Human 9.7 pKi = 9.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 536 7 2 5 3.6 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
13911290 34944 0 None 1 6 Bovine 9.7 pKi = 9.7 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 386 5 1 7 1.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sccc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13735 34944 0 None 1 6 Bovine 9.7 pKi = 9.7 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 386 5 1 7 1.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sccc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
129211 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.008
2562 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.008
488 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.008
CHEMBL836 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.008
DB00706 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.008
129211 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.098
2562 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.098
488 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.098
CHEMBL836 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.098
DB00706 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.098
10005161 212028 0 None 1 4 Human 9.7 pKi = 9.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 475 9 1 8 3.3 CCC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2OC)CC1 10.1021/jm0009336
CHEMBL78874 212028 0 None 1 4 Human 9.7 pKi = 9.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 475 9 1 8 3.3 CCC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2OC)CC1 10.1021/jm0009336
129211 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.11.068
2562 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.11.068
488 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.11.068
CHEMBL836 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.11.068
DB00706 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.11.068
49781450 24629 0 None 1 4 Bovine 9.7 pKi = 9.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 387 2 0 4 4.7 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cccnc4)cc32)CC1 10.1021/jm100652h
CHEMBL1259023 24629 0 None 1 4 Bovine 9.7 pKi = 9.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 387 2 0 4 4.7 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cccnc4)cc32)CC1 10.1021/jm100652h
9916549 128342 0 None 1 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of humanIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of human
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL358595 128342 0 None 1 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of humanIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of human
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
463 8187 22 None 5 13 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
6918097 8187 22 None 5 13 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
837 8187 22 None 5 13 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
CHEMBL2051956 8187 22 None 5 13 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
DB14068 8187 22 None 5 13 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
4209 9937 75 None -1 33 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960697s
4893 9937 75 None -1 33 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960697s
503 9937 75 None -1 33 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960697s
5385 9937 75 None -1 33 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960697s
CHEMBL2 9937 75 None -1 33 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960697s
DB00457 9937 75 None -1 33 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960697s
129211 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
2562 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
488 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
CHEMBL836 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
DB00706 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
9872851 103860 3 None 79 3 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 571 10 1 7 4.6 COc1ccc(CCN2CCC(c3nc(COCC(F)(F)F)c(-c4ccc(F)cc4)o3)CC2)cc1S(N)(=O)=O 10.1021/jm960697s
CHEMBL267336 103860 3 None 79 3 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 571 10 1 7 4.6 COc1ccc(CCN2CCC(c3nc(COCC(F)(F)F)c(-c4ccc(F)cc4)o3)CC2)cc1S(N)(=O)=O 10.1021/jm960697s
9809007 179343 8 None 134 6 Human 9.7 pKi = 9.7 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm9902032
CHEMBL448620 179343 8 None 134 6 Human 9.7 pKi = 9.7 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm9902032
60820 11080 14 None -10 12 Rat 9.7 pKi = 9.7 Binding
Binding affinity towards alpha-1A adrenergic receptors using alpha-1A ligand WB-4101Binding affinity towards alpha-1A adrenergic receptors using alpha-1A ligand WB-4101
ChEMBL 421 6 0 4 4.4 CC(C)Oc1ccccc1N1CCN(Cc2cccc(C(=O)N3CCCCC3)c2)CC1 10.1021/jm00034a003
CHEMBL10085 11080 14 None -10 12 Rat 9.7 pKi = 9.7 Binding
Binding affinity towards alpha-1A adrenergic receptors using alpha-1A ligand WB-4101Binding affinity towards alpha-1A adrenergic receptors using alpha-1A ligand WB-4101
ChEMBL 421 6 0 4 4.4 CC(C)Oc1ccccc1N1CCN(Cc2cccc(C(=O)N3CCCCC3)c2)CC1 10.1021/jm00034a003
10674055 210995 0 None 50 3 Human 9.7 pKi = 9.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 542 9 2 7 3.9 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL70892 210995 0 None 50 3 Human 9.7 pKi = 9.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 542 9 2 7 3.9 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1 10.1021/jm9905918
129211 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2004.11.032
2562 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2004.11.032
488 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2004.11.032
CHEMBL836 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2004.11.032
DB00706 10521 78 None -1 16 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2004.11.032
44390739 71116 1 None - 1 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 361 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1CSc2ccccc2O1 10.1016/j.bmcl.2004.11.032
CHEMBL181215 71116 1 None - 1 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 361 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1CSc2ccccc2O1 10.1016/j.bmcl.2004.11.032
10099811 127801 4 None 676 4 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1016/j.bmcl.2004.11.032
CHEMBL356584 127801 4 None 676 4 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1016/j.bmcl.2004.11.032
18738386 210817 0 None 125 3 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 413 7 0 5 4.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL69848 210817 0 None 125 3 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 413 7 0 5 4.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00347-5
11984570 99579 0 None 2 3 Human 9.7 pKi = 9.7 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 465 5 0 5 4.3 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccc(F)c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243694 99579 0 None 2 3 Human 9.7 pKi = 9.7 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 465 5 0 5 4.3 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccc(F)c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
49781452 24638 0 None -1 4 Bovine 9.7 pKi = 9.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 388 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cncnc4)cc32)CC1 10.1021/jm100652h
CHEMBL1259042 24638 0 None -1 4 Bovine 9.7 pKi = 9.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 388 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cncnc4)cc32)CC1 10.1021/jm100652h
10722045 39589 0 None 436 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 584 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F 10.1021/jm990200p
CHEMBL141444 39589 0 None 436 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 584 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F 10.1021/jm990200p
10626726 40718 0 None 70 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 561 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3Cl)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL142398 40718 0 None 70 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 561 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3Cl)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10371061 43475 0 None 1380 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL144925 43475 0 None 1380 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10627155 43993 0 None 125 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 585 8 2 8 3.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(=O)OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145338 43993 0 None 125 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 585 8 2 8 3.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(=O)OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10554140 125895 0 None 38 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 527 7 2 6 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL342731 125895 0 None 38 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 527 7 2 6 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10099811 127801 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10099811 127801 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990202+
CHEMBL356584 127801 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL356584 127801 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990202+
9916549 128342 0 None 1 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL358595 128342 0 None 1 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10371061 43475 0 None 1380 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL144925 43475 0 None 1380 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
10745870 43492 0 None 3090 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 584 9 2 7 2.8 COC(=O)C1=C(C)NC(=O)N(CC(=O)NCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL144938 43492 0 None 3090 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 584 9 2 7 2.8 COC(=O)C1=C(C)NC(=O)N(CC(=O)NCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10720893 44142 0 None 181 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 526 7 2 5 4.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL145459 44142 0 None 181 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 526 7 2 5 4.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10675068 103225 0 None 758 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 599 9 2 7 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3cccc(F)c3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL262217 103225 0 None 758 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 599 9 2 7 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3cccc(F)c3)CC2)C(=O)N1 10.1021/jm990201h
10508330 125572 0 None 99 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 638 8 2 5 5.9 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)(c3ccc(F)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL342126 125572 0 None 99 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 638 8 2 5 5.9 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)(c3ccc(F)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10099811 127801 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL356584 127801 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
10507500 128472 0 None 1258 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 582 6 2 7 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OC(=O)Cc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL358785 128472 0 None 1258 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 582 6 2 7 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OC(=O)Cc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10555024 128667 0 None 2454 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 568 6 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OCCc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL359012 128667 0 None 2454 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 568 6 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OCCc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10099811 127801 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL356584 127801 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
4013695 108792 20 None 1 5 Rat 9.7 pKi = 9.7 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1021/jm00110a014
CHEMBL301707 108792 20 None 1 5 Rat 9.7 pKi = 9.7 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1021/jm00110a014
10099811 127801 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of humanIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of human
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL356584 127801 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of humanIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of human
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10527469 163044 3 None 1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
CHEMBL40650 163044 3 None 1 16 Human 9.7 pKi = 9.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
10916771 111991 0 None 9 4 Human 9.7 pKi = 9.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 419 7 1 7 2.7 COc1ccccc1N1CCN(CCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL311479 111991 0 None 9 4 Human 9.7 pKi = 9.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 419 7 1 7 2.7 COc1ccccc1N1CCN(CCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
10527469 163044 3 None 1 16 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1016/j.bmcl.2004.11.032
CHEMBL40650 163044 3 None 1 16 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1016/j.bmcl.2004.11.032
9828476 213703 0 None 58 6 Human 9.6 pKi = 9.6 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 532 9 2 7 5.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL91022 213703 0 None 58 6 Human 9.6 pKi = 9.6 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 532 9 2 7 5.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
9828476 92057 0 None - 1 Human 9.6 pKi = 9.6 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 532 9 2 7 4.4 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL2260360 92057 0 None - 1 Human 9.6 pKi = 9.6 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 532 9 2 7 4.4 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
9830741 214635 1 None 1 7 Human 9.6 pKi = 9.6 Binding
Binding affinity towards Alpha1A dog adrenergic receptors, using [125I]HEAT as radioligand.Binding affinity towards Alpha1A dog adrenergic receptors, using [125I]HEAT as radioligand.
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm000085e
CHEMBL96467 214635 1 None 1 7 Human 9.6 pKi = 9.6 Binding
Binding affinity towards Alpha1A dog adrenergic receptors, using [125I]HEAT as radioligand.Binding affinity towards Alpha1A dog adrenergic receptors, using [125I]HEAT as radioligand.
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm000085e
10626910 210563 0 None 537 2 Human 9.6 pKi = 9.6 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NC[C@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL68203 210563 0 None 537 2 Human 9.6 pKi = 9.6 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NC[C@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
9826801 114714 0 None 4 12 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 488 6 1 7 3.2 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL319352 114714 0 None 4 12 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 488 6 1 7 3.2 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
135418497 69813 0 None 1 4 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
CHEMBL1788222 69813 0 None 1 4 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
4209 9937 75 None -1 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2006.05.002
4893 9937 75 None -1 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2006.05.002
503 9937 75 None -1 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2006.05.002
5385 9937 75 None -1 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2006.05.002
CHEMBL2 9937 75 None -1 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2006.05.002
DB00457 9937 75 None -1 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2006.05.002
9826801 114714 0 None 4 12 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 488 6 1 7 3.2 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1016/j.bmc.2012.10.049
CHEMBL319352 114714 0 None 4 12 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 488 6 1 7 3.2 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1016/j.bmc.2012.10.049
9826801 114714 0 None 4 12 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 488 6 1 7 3.2 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm100652h
CHEMBL319352 114714 0 None 4 12 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 488 6 1 7 3.2 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm100652h
9809007 179343 8 None 134 6 Human 9.6 pKi = 9.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
CHEMBL448620 179343 8 None 134 6 Human 9.6 pKi = 9.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
10369288 214037 0 None 169 3 Human 9.6 pKi = 9.6 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 516 9 3 4 3.7 COCC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL92951 214037 0 None 169 3 Human 9.6 pKi = 9.6 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 516 9 3 4 3.7 COCC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
10456471 107309 0 None 1 5 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 451 6 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
CHEMBL291303 107309 0 None 1 5 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 451 6 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
9913449 113229 1 None 13 3 Human 9.6 pKi = 9.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL313990 113229 1 None 13 3 Human 9.6 pKi = 9.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
44300165 108628 0 None 66 3 Human 9.6 pKi = 9.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL300540 108628 0 None 66 3 Human 9.6 pKi = 9.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
10369288 214037 0 None 169 3 Human 9.6 pKi = 9.6 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 516 9 3 4 3.7 COCC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1016/j.ejmech.2017.03.025
CHEMBL92951 214037 0 None 169 3 Human 9.6 pKi = 9.6 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 516 9 3 4 3.7 COCC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1016/j.ejmech.2017.03.025
49781236 24615 0 None -1 4 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 390 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cnn(C)c4)cc32)CC1 10.1021/jm100652h
CHEMBL1258987 24615 0 None -1 4 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 390 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cnn(C)c4)cc32)CC1 10.1021/jm100652h
49781449 24623 0 None 2 4 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 387 2 0 4 4.7 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccccn4)cc32)CC1 10.1021/jm100652h
CHEMBL1259006 24623 0 None 2 4 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 387 2 0 4 4.7 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccccn4)cc32)CC1 10.1021/jm100652h
9847196 36954 0 None 1 5 Bovine 9.6 pKi = 9.6 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(-c4ccccc4)cc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13903 36954 0 None 1 5 Bovine 9.6 pKi = 9.6 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(-c4ccccc4)cc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
10606670 205871 0 None 13 3 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 465 6 0 8 2.4 COc1cc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)n(C)c2cc1OC 10.1021/jm000541z
CHEMBL58862 205871 0 None 13 3 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 465 6 0 8 2.4 COc1cc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)n(C)c2cc1OC 10.1021/jm000541z
3567002 10160 9 None 58 3 Human 9.6 pKi = 9.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10.1016/j.bmcl.2004.11.032
7381 10160 9 None 58 3 Human 9.6 pKi = 9.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10.1016/j.bmcl.2004.11.032
CHEMBL56331 10160 9 None 58 3 Human 9.6 pKi = 9.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10.1016/j.bmcl.2004.11.032
10624993 118464 0 None 630 3 Human 9.6 pKi = 9.6 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 493 7 3 4 3.9 CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL328658 118464 0 None 630 3 Human 9.6 pKi = 9.6 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 493 7 3 4 3.9 CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
11626704 79229 0 None -5 4 Human 9.6 pKi = 9.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(Cl)c1 10.1007/s00044-010-9379-1
CHEMBL198860 79229 0 None -5 4 Human 9.6 pKi = 9.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(Cl)c1 10.1007/s00044-010-9379-1
44289437 176642 0 None -1 7 Human 9.6 pKi = 9.6 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 431 9 1 5 4.7 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2C1=O 10.1021/jm011066n
CHEMBL44403 176642 0 None -1 7 Human 9.6 pKi = 9.6 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 431 9 1 5 4.7 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2C1=O 10.1021/jm011066n
11626704 79229 0 None -5 4 Human 9.6 pKi = 9.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(Cl)c1 10.1007/s00044-010-9379-1
CHEMBL198860 79229 0 None -5 4 Human 9.6 pKi = 9.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(Cl)c1 10.1007/s00044-010-9379-1
11626704 79229 0 None -5 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(Cl)c1 10.1021/jm0580398
CHEMBL198860 79229 0 None -5 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(Cl)c1 10.1021/jm0580398
11583392 79689 1 None -7 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(Cl)cc1 10.1021/jm0580398
CHEMBL200446 79689 1 None -7 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(Cl)cc1 10.1021/jm0580398
3567002 10160 9 None 58 3 Human 9.6 pKi = 9.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10.1016/s0960-894x(03)00305-6
7381 10160 9 None 58 3 Human 9.6 pKi = 9.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10.1016/s0960-894x(03)00305-6
CHEMBL56331 10160 9 None 58 3 Human 9.6 pKi = 9.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10.1016/s0960-894x(03)00305-6
44298650 169934 0 None 100 3 Human 9.6 pKi = 9.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 448 7 1 6 2.0 O=c1[nH]cc(F)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL417954 169934 0 None 100 3 Human 9.6 pKi = 9.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 448 7 1 6 2.0 O=c1[nH]cc(F)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
4431 9506 25 None 1 12 Human 9.6 pKi = 9.6 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 10.1016/j.bmcl.2006.12.111
73 9506 25 None 1 12 Human 9.6 pKi = 9.6 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 10.1016/j.bmcl.2006.12.111
CHEMBL8618 9506 25 None 1 12 Human 9.6 pKi = 9.6 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 10.1016/j.bmcl.2006.12.111
132891 12084 14 None 2 5 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(CC2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
CHEMBL106737 12084 14 None 2 5 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(CC2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
49781235 24702 0 None -1 4 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 390 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccn(C)n4)cc32)CC1 10.1021/jm100652h
CHEMBL1259232 24702 0 None -1 4 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 390 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccn(C)n4)cc32)CC1 10.1021/jm100652h
9985476 44058 0 None 912 3 Human 9.6 pKi = 9.6 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 570 8 3 7 2.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145394 44058 0 None 912 3 Human 9.6 pKi = 9.6 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 570 8 3 7 2.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
52949448 23433 0 None 3 4 Human 9.6 pKi = 9.6 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 430 6 0 5 4.1 COc1ccccc1N1CCN(CC2OCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242352 23433 0 None 3 4 Human 9.6 pKi = 9.6 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 430 6 0 5 4.1 COc1ccccc1N1CCN(CC2OCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
57393527 78333 0 None 3 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 430 6 0 5 4.1 COc1ccccc1N1CCN(CC2COC(c3ccccc3)(c3ccccc3)O2)CC1 10.1021/jm200421e
CHEMBL1946777 78333 0 None 3 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 430 6 0 5 4.1 COc1ccccc1N1CCN(CC2COC(c3ccccc3)(c3ccccc3)O2)CC1 10.1021/jm200421e
CHEMBL1963046 78333 0 None 3 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 430 6 0 5 4.1 COc1ccccc1N1CCN(CC2COC(c3ccccc3)(c3ccccc3)O2)CC1 10.1021/jm200421e
4013695 108792 20 None -1 5 Human 9.6 pKi = 9.6 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL301707 108792 20 None -1 5 Human 9.6 pKi = 9.6 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.ejmech.2011.03.054
4013695 108792 20 None -1 5 Human 9.6 pKi = 9.6 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL301707 108792 20 None -1 5 Human 9.6 pKi = 9.6 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.ejmech.2011.03.054
4209 9937 75 None -1 33 Human 9.6 pKi = 9.6 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
4893 9937 75 None -1 33 Human 9.6 pKi = 9.6 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
503 9937 75 None -1 33 Human 9.6 pKi = 9.6 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
5385 9937 75 None -1 33 Human 9.6 pKi = 9.6 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
CHEMBL2 9937 75 None -1 33 Human 9.6 pKi = 9.6 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
DB00457 9937 75 None -1 33 Human 9.6 pKi = 9.6 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
19085829 212625 0 None 186 3 Human 9.6 pKi = 9.6 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in HEK cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in HEK cells
ChEMBL 473 6 0 7 3.0 O=C1c2cc(F)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL83592 212625 0 None 186 3 Human 9.6 pKi = 9.6 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in HEK cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in HEK cells
ChEMBL 473 6 0 7 3.0 O=C1c2cc(F)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
10647175 138233 0 None 2 3 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 449 5 1 7 2.1 COC(=O)c1ccc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)[nH]c2c1 10.1021/jm000541z
CHEMBL369154 138233 0 None 2 3 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 449 5 1 7 2.1 COC(=O)c1ccc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)[nH]c2c1 10.1021/jm000541z
10478121 177581 0 None 1 5 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 435 6 0 7 3.1 COc1cc2ncn(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
CHEMBL445325 177581 0 None 1 5 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 435 6 0 7 3.1 COc1cc2ncn(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
10527469 163044 3 None -1 16 Rat 9.6 pKi = 9.6 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL40650 163044 3 None -1 16 Rat 9.6 pKi = 9.6 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
490 6979 8 None -2 12 Bovine 9.6 pKi = 9.6 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
9890547 6979 8 None -2 12 Bovine 9.6 pKi = 9.6 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
CHEMBL268758 6979 8 None -2 12 Bovine 9.6 pKi = 9.6 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
18187410 111675 0 None 10 3 Human 9.6 pKi = 9.6 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 418 6 1 6 3.5 O=C1c2ccccc2C(=O)N1CCCCN1CCC(n2c(O)nc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL311247 111675 0 None 10 3 Human 9.6 pKi = 9.6 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 418 6 1 6 3.5 O=C1c2ccccc2C(=O)N1CCCCN1CCC(n2c(O)nc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
11092254 212245 0 None 1 4 Human 9.6 pKi = 9.6 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 495 8 1 8 3.5 COc1ccc(Cl)cc1N1CCN(CCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL80458 212245 0 None 1 4 Human 9.6 pKi = 9.6 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 495 8 1 8 3.5 COc1ccc(Cl)cc1N1CCN(CCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
4209 9937 75 None -1 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
4893 9937 75 None -1 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
503 9937 75 None -1 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
5385 9937 75 None -1 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
CHEMBL2 9937 75 None -1 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
DB00457 9937 75 None -1 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
9843389 93832 0 None 245 2 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 390 3 0 6 3.8 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4nnn(C)n4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325935 93832 0 None 245 2 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 390 3 0 6 3.8 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4nnn(C)n4)cc23)CC1 10.1016/j.bmc.2012.10.049
12765746 109057 4 None -3 9 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm100652h
CHEMBL303313 109057 4 None -3 9 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm100652h
10698013 107216 0 None 2 3 Rat 9.6 pKi = 9.6 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 518 5 1 7 3.3 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C(=O)N(C)C)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL290519 107216 0 None 2 3 Rat 9.6 pKi = 9.6 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 518 5 1 7 3.3 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C(=O)N(C)C)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
4013695 108792 20 None -1 5 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL301707 108792 20 None -1 5 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
11430491 69775 0 None 1 6 Human 9.5 pKi = 9.5 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 435 5 1 9 2.4 COc1cc2nc(N3CCN(C(=O)CC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL178673 69775 0 None 1 6 Human 9.5 pKi = 9.5 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 435 5 1 9 2.4 COc1cc2nc(N3CCN(C(=O)CC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
10792897 174693 0 None 186 2 Human 9.5 pKi = 9.5 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 9 2 7 3.5 Cc1ccc(N2C(=O)c3ccc(C(=O)NC[C@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL431362 174693 0 None 186 2 Human 9.5 pKi = 9.5 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 9 2 7 3.5 Cc1ccc(N2C(=O)c3ccc(C(=O)NC[C@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
10673690 107278 0 None -1 3 Rat 9.5 pKi = 9.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 490 5 2 7 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cc(C(N)=O)ccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL291073 107278 0 None -1 3 Rat 9.5 pKi = 9.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 490 5 2 7 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cc(C(N)=O)ccc54)c3=O)C[C@@H]21 10.1021/jm990567u
10721171 44484 0 None 398 3 Human 9.5 pKi = 9.5 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 539 10 0 6 6.2 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145770 44484 0 None 398 3 Human 9.5 pKi = 9.5 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 539 10 0 6 6.2 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
11134424 111508 0 None -1 4 Human 9.5 pKi = 9.5 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 465 7 1 7 3.5 CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2Cl)CC1 10.1021/jm0009336
CHEMBL310599 111508 0 None -1 4 Human 9.5 pKi = 9.5 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 465 7 1 7 3.5 CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2Cl)CC1 10.1021/jm0009336
4209 9937 75 None -1 33 Rat 9.5 pKi = 9.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
4893 9937 75 None -1 33 Rat 9.5 pKi = 9.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
503 9937 75 None -1 33 Rat 9.5 pKi = 9.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
5385 9937 75 None -1 33 Rat 9.5 pKi = 9.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
CHEMBL2 9937 75 None -1 33 Rat 9.5 pKi = 9.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
DB00457 9937 75 None -1 33 Rat 9.5 pKi = 9.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
10836245 109524 0 None 10 5 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 427 7 0 5 4.4 CC(C)Oc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL305029 109524 0 None 10 5 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 427 7 0 5 4.4 CC(C)Oc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL552830 109524 0 None 10 5 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 427 7 0 5 4.4 CC(C)Oc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
122179430 128219 0 None -3 3 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 599 8 1 13 2.7 CCN(CC)c1ccc2cc(-n3cc(C(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
CHEMBL3582270 128219 0 None -3 3 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 599 8 1 13 2.7 CCN(CC)c1ccc2cc(-n3cc(C(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
44447061 161147 0 None -1 4 Rat 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 474 5 1 5 4.3 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)C(F)(F)F 10.1016/j.bmcl.2007.11.106
CHEMBL398711 161147 0 None -1 4 Rat 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 474 5 1 5 4.3 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)C(F)(F)F 10.1016/j.bmcl.2007.11.106
10626493 214166 0 None 239 3 Human 9.5 pKi = 9.5 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 550 7 1 5 4.0 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C1=O 10.1021/jm990612y
CHEMBL93843 214166 0 None 239 3 Human 9.5 pKi = 9.5 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 550 7 1 5 4.0 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C1=O 10.1021/jm990612y
10770007 41368 0 None 50 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 607 10 2 9 3.8 CCOC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL142957 41368 0 None 50 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 607 10 2 9 3.8 CCOC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
10768829 126162 0 None 32 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 541 7 2 6 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL344525 126162 0 None 32 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 541 7 2 6 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10722099 127872 0 None 190 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 588 8 3 7 2.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1cc(F)c(F)c(F)c1 10.1021/jm990202+
CHEMBL357172 127872 0 None 190 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 588 8 3 7 2.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1cc(F)c(F)c(F)c1 10.1021/jm990202+
10721476 43773 0 None 691 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 554 6 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OCc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL145170 43773 0 None 691 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 554 6 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OCc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10769621 125771 0 None 2290 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 584 8 2 7 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(OC(C)=O)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL342543 125771 0 None 2290 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 584 8 2 7 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(OC(C)=O)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
11712470 78780 0 None -5 4 Human 9.5 pKi = 9.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc([N+](=O)[O-])c1 10.1007/s00044-010-9379-1
CHEMBL197442 78780 0 None -5 4 Human 9.5 pKi = 9.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc([N+](=O)[O-])c1 10.1007/s00044-010-9379-1
11712470 78780 0 None -5 4 Human 9.5 pKi = 9.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc([N+](=O)[O-])c1 10.1007/s00044-010-9379-1
CHEMBL197442 78780 0 None -5 4 Human 9.5 pKi = 9.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc([N+](=O)[O-])c1 10.1007/s00044-010-9379-1
11712470 78780 0 None -5 4 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc([N+](=O)[O-])c1 10.1021/jm0580398
CHEMBL197442 78780 0 None -5 4 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc([N+](=O)[O-])c1 10.1021/jm0580398
44298626 202256 0 None 25 3 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 427 7 1 7 1.4 Cc1n[nH]c(=O)n(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL55290 202256 0 None 25 3 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 427 7 1 7 1.4 Cc1n[nH]c(=O)n(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
9960497 107252 0 None 154 6 Human 9.5 pKi = 9.5 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
CHEMBL290860 107252 0 None 154 6 Human 9.5 pKi = 9.5 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
3416533 201768 6 None 4 2 Rat 9.5 pKi = 9.5 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 447 5 0 8 2.0 COc1ccccc1N1CCN(CCn2c(=O)c3c(c4ccccc4n3C)n(C)c2=O)CC1 10.1021/jm00110a014
CHEMBL54716 201768 6 None 4 2 Rat 9.5 pKi = 9.5 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 447 5 0 8 2.0 COc1ccccc1N1CCN(CCn2c(=O)c3c(c4ccccc4n3C)n(C)c2=O)CC1 10.1021/jm00110a014
10961351 170280 0 None 1 4 Human 9.5 pKi = 9.5 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 449 7 1 7 3.0 CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2F)CC1 10.1021/jm0009336
CHEMBL420205 170280 0 None 1 4 Human 9.5 pKi = 9.5 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 449 7 1 7 3.0 CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2F)CC1 10.1021/jm0009336
71508640 93822 0 None 46 2 Bovine 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 388 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccnn4C)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325926 93822 0 None 46 2 Bovine 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 388 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccnn4C)cc23)CC1 10.1016/j.bmc.2012.10.049
10097792 125367 0 None -1 8 Human 9.5 pKi = 9.5 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN(C)C)c3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL341665 125367 0 None -1 8 Human 9.5 pKi = 9.5 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN(C)C)c3)nc(N)c2cc1OC 10.1021/jm9810654
90645597 119266 0 None -2 3 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 654 12 3 9 4.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCC(=O)NCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298750 119266 0 None -2 3 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 654 12 3 9 4.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCC(=O)NCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
10841070 44453 0 None 2 4 Human 9.5 pKi = 9.5 Binding
Binding affinity against isolated human prostate using [3H]- prazosin.Binding affinity against isolated human prostate using [3H]- prazosin.
ChEMBL 585 10 0 5 7.4 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145746 44453 0 None 2 4 Human 9.5 pKi = 9.5 Binding
Binding affinity against isolated human prostate using [3H]- prazosin.Binding affinity against isolated human prostate using [3H]- prazosin.
ChEMBL 585 10 0 5 7.4 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10504673 209452 0 None -1 3 Rat 9.5 pKi = 9.5 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 473 5 1 6 4.1 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(-c5ccccc5)csc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL61483 209452 0 None -1 3 Rat 9.5 pKi = 9.5 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 473 5 1 6 4.1 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(-c5ccccc5)csc4c3=O)C[C@@H]21 10.1021/jm000541z
9894665 110590 1 None 30 8 Human 9.5 pKi = 9.5 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 585 10 2 8 3.3 CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL309106 110590 1 None 30 8 Human 9.5 pKi = 9.5 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 585 10 2 8 3.3 CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1 10.1021/jm9905918
10474042 177032 0 None -1 6 Human 9.5 pKi = 9.5 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 365 6 0 4 4.1 COc1cccc2c1CCCC2CCCN1CCN(c2ccccn2)CC1 10.1021/jm010866v
CHEMBL444590 177032 0 None -1 6 Human 9.5 pKi = 9.5 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 365 6 0 4 4.1 COc1cccc2c1CCCC2CCCN1CCN(c2ccccn2)CC1 10.1021/jm010866v
9955302 106943 0 None -1 3 Rat 9.5 pKi = 9.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccncc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL287965 106943 0 None -1 3 Rat 9.5 pKi = 9.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccncc54)c3=O)C[C@@H]21 10.1021/jm990567u
50905381 63124 0 None -1 4 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 422 11 2 6 2.7 COc1ccc(C[C@@H](C)NCCOc2ccccc2OC(C)C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630938 63124 0 None -1 4 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 422 11 2 6 2.7 COc1ccc(C[C@@H](C)NCCOc2ccccc2OC(C)C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
49782792 24683 0 None 1 6 Bovine 9.5 pKi = 9.5 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 381 3 1 4 3.3 CC(=O)NCc1ccc2c(c1)[C@@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259174 24683 0 None 1 6 Bovine 9.5 pKi = 9.5 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 381 3 1 4 3.3 CC(=O)NCc1ccc2c(c1)[C@@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
148842 10718 27 None 8 5 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm030825u
496 10718 27 None 8 5 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm030825u
CHEMBL278865 10718 27 None 8 5 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm030825u
13911290 34944 0 None -1 6 Human 9.5 pKi = 9.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 386 5 1 7 1.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sccc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13735 34944 0 None -1 6 Human 9.5 pKi = 9.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 386 5 1 7 1.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sccc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
9809007 179343 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL448620 179343 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
9809007 179343 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL448620 179343 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
50905585 63125 0 None -1 3 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 470 12 2 6 3.5 COc1ccc(C[C@@H](C)NCCOc2ccccc2OCc2ccccc2)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630939 63125 0 None -1 3 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 470 12 2 6 3.5 COc1ccc(C[C@@H](C)NCCOc2ccccc2OCc2ccccc2)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
491 6980 9 None -4 12 Bovine 9.5 pKi = 9.5 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
9891167 6980 9 None -4 12 Bovine 9.5 pKi = 9.5 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
CHEMBL13856 6980 9 None -4 12 Bovine 9.5 pKi = 9.5 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
9809007 179343 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
CHEMBL448620 179343 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
499 10849 18 None -1 14 Bovine 9.5 pKi = 9.5 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
5685 10849 18 None -1 14 Bovine 9.5 pKi = 9.5 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
CHEMBL25554 10849 18 None -1 14 Bovine 9.5 pKi = 9.5 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
9809007 179343 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
CHEMBL448620 179343 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
10599007 211294 0 None -1 8 Bovine 9.5 pKi = 9.5 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccc(C)cc1 10.1021/jm960069a
CHEMBL72657 211294 0 None -1 8 Bovine 9.5 pKi = 9.5 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccc(C)cc1 10.1021/jm960069a
10599007 211294 0 None 1 8 Human 9.5 pKi = 9.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccc(C)cc1 10.1016/j.bmcl.2004.11.032
CHEMBL72657 211294 0 None 1 8 Human 9.5 pKi = 9.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccc(C)cc1 10.1016/j.bmcl.2004.11.032
10917953 214767 0 None 1 10 Bovine 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 489 6 0 8 3.6 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCOC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL97242 214767 0 None 1 10 Bovine 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 489 6 0 8 3.6 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCOC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
10743310 176011 0 None 3 3 Rat 9.5 pKi = 9.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 479 5 1 9 2.4 COc1cnc2sc3c(=O)n(CCN4C[C@@H]5CCc6c(OC)cccc6[C@@H]5C4)c(=O)[nH]c3c2n1 10.1021/jm990567u
CHEMBL441032 176011 0 None 3 3 Rat 9.5 pKi = 9.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 479 5 1 9 2.4 COc1cnc2sc3c(=O)n(CCN4C[C@@H]5CCc6c(OC)cccc6[C@@H]5C4)c(=O)[nH]c3c2n1 10.1021/jm990567u
9830741 214635 1 None -1 7 Rat 9.4 pKi = 9.4 Binding
Binding affinity towards Alpha1A rat adrenergic receptors, using [125I]HEAT as radioligand.Binding affinity towards Alpha1A rat adrenergic receptors, using [125I]HEAT as radioligand.
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm000085e
CHEMBL96467 214635 1 None -1 7 Rat 9.4 pKi = 9.4 Binding
Binding affinity towards Alpha1A rat adrenergic receptors, using [125I]HEAT as radioligand.Binding affinity towards Alpha1A rat adrenergic receptors, using [125I]HEAT as radioligand.
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm000085e
44275505 103576 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity towards recombinant human alpha-1A adrenergic receptorBinding affinity towards recombinant human alpha-1A adrenergic receptor
ChEMBL 556 10 2 7 2.6 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)C(C(=O)NCCCN2CCC(c3ccccn3)CC2)C(=O)N1 10.1021/jm030480f
CHEMBL265001 103576 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity towards recombinant human alpha-1A adrenergic receptorBinding affinity towards recombinant human alpha-1A adrenergic receptor
ChEMBL 556 10 2 7 2.6 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)C(C(=O)NCCCN2CCC(c3ccccn3)CC2)C(=O)N1 10.1021/jm030480f
9874983 72241 18 None - 1 Human 9.4 pKi = 9.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 557 9 2 7 3.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(c3ccccn3)CC2)C(=O)N1 10.1016/j.bmcl.2004.11.032
CHEMBL182998 72241 18 None - 1 Human 9.4 pKi = 9.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 557 9 2 7 3.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(c3ccccn3)CC2)C(=O)N1 10.1016/j.bmcl.2004.11.032
499 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
5685 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
CHEMBL25554 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
9830292 174968 0 None 562 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL433284 174968 0 None 562 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
2435 10362 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm020938y
60149 10362 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm020938y
98 10362 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm020938y
CHEMBL12713 10362 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm020938y
DB06144 10362 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm020938y
2435 10362 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1016/j.bmc.2012.10.049
60149 10362 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1016/j.bmc.2012.10.049
98 10362 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1016/j.bmc.2012.10.049
CHEMBL12713 10362 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1016/j.bmc.2012.10.049
DB06144 10362 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1016/j.bmc.2012.10.049
2435 10362 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm100652h
60149 10362 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm100652h
98 10362 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm100652h
CHEMBL12713 10362 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm100652h
DB06144 10362 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm100652h
9847845 35226 0 None -1 6 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(C)c(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13754 35226 0 None -1 6 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(C)c(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
487 10406 21 None 1 12 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
60602 10406 21 None 1 12 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
CHEMBL405355 10406 21 None 1 12 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
DB09239 10406 21 None 1 12 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
44300129 174207 0 None 912 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL429697 174207 0 None 912 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
10838523 107977 0 None 1 3 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 482 4 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(Cl)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL295741 107977 0 None 1 3 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 482 4 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(Cl)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
134149596 155244 0 None 4 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 368 6 0 5 3.6 CC(C)Oc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3938038 155244 0 None 4 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 368 6 0 5 3.6 CC(C)Oc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
10767264 213773 0 None 102 3 Human 9.4 pKi = 9.4 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 486 7 3 3 4.1 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL91405 213773 0 None 102 3 Human 9.4 pKi = 9.4 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 486 7 3 3 4.1 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
4209 9937 75 None -1 33 Human 9.4 pKi = 9.4 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
4893 9937 75 None -1 33 Human 9.4 pKi = 9.4 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
503 9937 75 None -1 33 Human 9.4 pKi = 9.4 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
5385 9937 75 None -1 33 Human 9.4 pKi = 9.4 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
CHEMBL2 9937 75 None -1 33 Human 9.4 pKi = 9.4 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
DB00457 9937 75 None -1 33 Human 9.4 pKi = 9.4 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
10839825 213520 0 None 2818 3 Human 9.4 pKi = 9.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 525 7 2 4 4.1 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
CHEMBL89965 213520 0 None 2818 3 Human 9.4 pKi = 9.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 525 7 2 4 4.1 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
10552608 107194 0 None 8 3 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 477 4 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nc(C)c(C)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL290243 107194 0 None 8 3 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 477 4 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nc(C)c(C)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
11133288 172812 0 None 7 7 Human 9.4 pKi = 9.4 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 407 12 1 5 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1Cc1ccccc1 10.1021/jm011066n
CHEMBL42558 172812 0 None 7 7 Human 9.4 pKi = 9.4 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 407 12 1 5 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1Cc1ccccc1 10.1021/jm011066n
9865801 101499 10 None 3 3 Human 9.4 pKi = 9.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 401 8 2 5 5.0 COc1c(C)c(C)c(O)c(C)c1CN(C)CCOc1cc(C)c(O)cc1C(C)C 10.1021/jm960697s
CHEMBL25300 101499 10 None 3 3 Human 9.4 pKi = 9.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 401 8 2 5 5.0 COc1c(C)c(C)c(O)c(C)c1CN(C)CCOc1cc(C)c(O)cc1C(C)C 10.1021/jm960697s
11633517 79300 0 None -1 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(C)c1 10.1021/jm0580398
CHEMBL199080 79300 0 None -1 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(C)c1 10.1021/jm0580398
10572854 119343 0 None 2 3 Bovine 9.4 pKi = 9.4 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 396 8 1 5 3.0 COc1ccccc1N1CCN(CCCNc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL330060 119343 0 None 2 3 Bovine 9.4 pKi = 9.4 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 396 8 1 5 3.0 COc1ccccc1N1CCN(CCCNc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10525639 213924 0 None 15 2 Bovine 9.4 pKi = 9.4 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 410 8 1 6 3.9 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)C(C)(C)C)CC1 10.1021/jm970166j
CHEMBL92261 213924 0 None 15 2 Bovine 9.4 pKi = 9.4 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 410 8 1 6 3.9 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)C(C)(C)C)CC1 10.1021/jm970166j
10554957 39767 0 None 1000 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 564 11 0 7 5.5 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(CCCCCN2CCC(C#N)(c3ccccc3)CC2)C(C)=N1 10.1021/jm9902032
CHEMBL141604 39767 0 None 1000 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 564 11 0 7 5.5 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(CCCCCN2CCC(C#N)(c3ccccc3)CC2)C(C)=N1 10.1021/jm9902032
10626772 43010 0 None 776 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 564 11 0 7 5.5 COCC1=NC(C)=C(C(=O)OC)C(c2ccc(F)c(F)c2)N1CCCCCN1CCC(C#N)(c2ccccc2)CC1 10.1021/jm9902032
CHEMBL144534 43010 0 None 776 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 564 11 0 7 5.5 COCC1=NC(C)=C(C(=O)OC)C(c2ccc(F)c(F)c2)N1CCCCCN1CCC(C#N)(c2ccccc2)CC1 10.1021/jm9902032
10650129 44282 0 None 162 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 540 10 0 7 5.2 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145587 44282 0 None 162 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 540 10 0 7 5.2 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10841070 44453 0 None 2 4 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 585 10 0 5 7.4 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145746 44453 0 None 2 4 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 585 10 0 5 7.4 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10815549 128792 0 None 234 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 509 9 0 5 6.2 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL359421 128792 0 None 234 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 509 9 0 5 6.2 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10032383 116887 0 None 194 6 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
136680387 116887 0 None 194 6 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL323579 116887 0 None 194 6 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
44390708 71045 0 None 630 3 Human 9.4 pKi = 9.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)[C@H](c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/j.bmcl.2004.11.032
CHEMBL180932 71045 0 None 630 3 Human 9.4 pKi = 9.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)[C@H](c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/j.bmcl.2004.11.032
9865801 101499 10 None 3 3 Human 9.4 pKi = 9.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 401 8 2 5 5.0 COc1c(C)c(C)c(O)c(C)c1CN(C)CCOc1cc(C)c(O)cc1C(C)C 10.1016/j.bmcl.2004.11.032
CHEMBL25300 101499 10 None 3 3 Human 9.4 pKi = 9.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 401 8 2 5 5.0 COc1c(C)c(C)c(O)c(C)c1CN(C)CCOc1cc(C)c(O)cc1C(C)C 10.1016/j.bmcl.2004.11.032
2389 10104 118 None -6 66 Rat 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
5073 10104 118 None -6 66 Rat 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
96 10104 118 None -6 66 Rat 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
CHEMBL85 10104 118 None -6 66 Rat 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
DB00734 10104 118 None -6 66 Rat 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
44300111 107637 0 None 794 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL293515 107637 0 None 794 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
44431194 99335 0 None 1 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 448 5 0 6 3.6 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccncc4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243229 99335 0 None 1 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 448 5 0 6 3.6 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccncc4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
9959689 108590 0 None 281 3 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 568 7 2 7 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL300222 108590 0 None 281 3 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 568 7 2 7 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
10393665 40696 0 None 47 3 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 593 9 2 9 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL142383 40696 0 None 47 3 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 593 9 2 9 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
10556164 128474 0 None 549 3 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 572 8 3 6 3.1 CC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1cc(F)c(F)c(F)c1 10.1021/jm990202+
CHEMBL358795 128474 0 None 549 3 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 572 8 3 6 3.1 CC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1cc(F)c(F)c(F)c1 10.1021/jm990202+
9809007 179343 8 None 134 6 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL448620 179343 8 None 134 6 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
10816815 126133 0 None 776 3 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 566 6 2 5 4.9 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CCCc4ccccc43)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL344339 126133 0 None 776 3 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 566 6 2 5 4.9 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CCCc4ccccc43)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10839391 164149 0 None 1 3 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cc(C#N)ccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL40780 164149 0 None 1 3 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cc(C#N)ccc54)c3=O)C[C@@H]21 10.1021/jm990567u
101333429 123854 0 None 588 6 Human 9.4 pKi = 9.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1 10.1021/jm00019a001
CHEMBL3392247 123854 0 None 588 6 Human 9.4 pKi = 9.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1 10.1021/jm00019a001
13305910 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
CHEMBL1182155 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
CHEMBL215421 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
CHEMBL3741808 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
13305910 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182155 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL215421 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3741808 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
13305910 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL1182155 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL215421 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL3741808 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
13305910 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL1182155 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL215421 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL3741808 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
13305910 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm301525w
CHEMBL1182155 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm301525w
CHEMBL215421 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm301525w
CHEMBL3741808 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm301525w
13305910 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1039/C4MD00484A
CHEMBL1182155 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1039/C4MD00484A
CHEMBL215421 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1039/C4MD00484A
CHEMBL3741808 18608 1 None -2 9 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1039/C4MD00484A
10624165 107338 0 None 3 3 Rat 9.4 pKi = 9.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 469 6 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C(C)C)c(OC)sc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL291528 107338 0 None 3 3 Rat 9.4 pKi = 9.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 469 6 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C(C)C)c(OC)sc4c3=O)C[C@@H]21 10.1021/jm000541z
10506729 210478 0 None 53 3 Human 9.4 pKi = 9.4 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 544 9 1 6 4.4 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL67552 210478 0 None 53 3 Human 9.4 pKi = 9.4 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 544 9 1 6 4.4 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
49781234 24701 0 None -1 4 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 390 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccnn4C)cc32)CC1 10.1021/jm100652h
CHEMBL1259231 24701 0 None -1 4 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 390 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccnn4C)cc32)CC1 10.1021/jm100652h
10344976 107992 2 None 1 6 Human 9.4 pKi = 9.4 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 477 11 1 10 3.4 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL29591 107992 2 None 1 6 Human 9.4 pKi = 9.4 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 477 11 1 10 3.4 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
49782791 24682 0 None 2 6 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 381 3 1 4 3.3 CC(=O)NCc1ccc2c(c1)[C@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259173 24682 0 None 2 6 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 381 3 1 4 3.3 CC(=O)NCc1ccc2c(c1)[C@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
10506222 118263 0 None 691 3 Human 9.4 pKi = 9.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 523 9 3 5 3.5 COCC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL327716 118263 0 None 691 3 Human 9.4 pKi = 9.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 523 9 3 5 3.5 COCC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
499 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1007/s00044-010-9379-1
5685 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1007/s00044-010-9379-1
CHEMBL25554 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1007/s00044-010-9379-1
499 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm021078o
5685 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm021078o
CHEMBL25554 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm021078o
499 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm030952q
5685 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm030952q
CHEMBL25554 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm030952q
499 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1007/s00044-010-9379-1
5685 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1007/s00044-010-9379-1
CHEMBL25554 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1007/s00044-010-9379-1
499 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.bmc.2010.08.002
5685 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.bmc.2010.08.002
CHEMBL25554 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.bmc.2010.08.002
499 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm991065j
5685 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm991065j
CHEMBL25554 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm991065j
499 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm800461k
5685 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm800461k
CHEMBL25554 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm800461k
499 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm301525w
5685 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm301525w
CHEMBL25554 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm301525w
10527466 209466 0 None -1 3 Rat 9.4 pKi = 9.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 448 5 2 6 2.3 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(NC(C)=O)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL61598 209466 0 None -1 3 Rat 9.4 pKi = 9.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 448 5 2 6 2.3 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(NC(C)=O)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
49782794 24688 0 None -1 6 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 409 4 1 4 4.0 CC(C)C(=O)NCc1ccc2c(c1)[C@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259189 24688 0 None -1 6 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 409 4 1 4 4.0 CC(C)C(=O)NCc1ccc2c(c1)[C@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
9891166 40386 0 None 1 5 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 0 8 3.3 COc1ccccc1N1CCN(CCn2c(=O)c3c(-c4ccccc4)csc3n(C)c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL14213 40386 0 None 1 5 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 0 8 3.3 COc1ccccc1N1CCN(CCn2c(=O)c3c(-c4ccccc4)csc3n(C)c2=O)CC1 10.1016/s0960-894x(01)00159-7
10994812 211875 0 None 3 4 Human 9.4 pKi = 9.4 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 509 9 1 8 3.9 COc1ccc(Cl)cc1N1CCN(CCCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL77618 211875 0 None 3 4 Human 9.4 pKi = 9.4 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 509 9 1 8 3.9 COc1ccc(Cl)cc1N1CCN(CCCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
44299974 108671 0 None 89 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL300821 108671 0 None 89 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
10553935 168599 0 None -1 3 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 481 4 1 6 4.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(Cl)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL41444 168599 0 None -1 3 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 481 4 1 6 4.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(Cl)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
10529370 213718 0 None 524 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 499 9 3 5 3.0 COCC1=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1016/j.ejmech.2017.03.025
CHEMBL91125 213718 0 None 524 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 499 9 3 5 3.0 COCC1=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1016/j.ejmech.2017.03.025
44447063 101359 0 None -1 3 Rat 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 434 6 1 5 4.2 CCC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
CHEMBL252031 101359 0 None -1 3 Rat 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 434 6 1 5 4.2 CCC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
10529370 213718 0 None 524 3 Human 9.4 pKi = 9.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 499 9 3 5 3.0 COCC1=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL91125 213718 0 None 524 3 Human 9.4 pKi = 9.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 499 9 3 5 3.0 COCC1=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
10602912 109515 0 None 301 2 Human 9.3 pKi = 9.3 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 558 9 3 8 2.9 CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL304977 109515 0 None 301 2 Human 9.3 pKi = 9.3 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 558 9 3 8 2.9 CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1 10.1021/jm9905918
44300087 103196 0 None 67 3 Human 9.3 pKi = 9.3 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL262002 103196 0 None 67 3 Human 9.3 pKi = 9.3 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
10364994 174664 0 None -6 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 423 13 1 6 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1021/jm0580398
CHEMBL43116 174664 0 None -6 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 423 13 1 6 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1021/jm0580398
10364994 174664 0 None -6 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 423 13 1 6 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL43116 174664 0 None -6 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 423 13 1 6 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
10095156 85318 0 None 1 3 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL2112073 85318 0 None 1 3 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)C[C@@H]21 10.1021/jm990567u
10678154 177380 0 None 1 3 Rat 9.3 pKi = 9.3 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cscc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL445071 177380 0 None 1 3 Rat 9.3 pKi = 9.3 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cscc4c3=O)C[C@@H]21 10.1021/jm000541z
10414908 209543 0 None 204 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 539 7 0 4 5.9 Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CCCN3CCC(C#N)(c4ccccc4Cl)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL62045 209543 0 None 204 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 539 7 0 4 5.9 Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CCCN3CCC(C#N)(c4ccccc4Cl)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
71817386 109363 0 None 1 7 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419769 109363 0 None 1 7 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL3040851 109363 0 None 1 7 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
11049209 214184 0 None 8 9 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 486 6 1 5 4.4 Cn1ccc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL93923 214184 0 None 8 9 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 486 6 1 5 4.4 Cn1ccc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
44447068 160902 0 None 1 3 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 6 1 5 4.4 CC(C)C(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
CHEMBL398525 160902 0 None 1 3 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 6 1 5 4.4 CC(C)C(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
10647790 108168 0 None 4 3 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 463 4 1 8 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nc(C)cnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL297218 108168 0 None 4 3 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 463 4 1 8 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nc(C)cnc54)c3=O)C[C@@H]21 10.1021/jm990567u
10507220 128054 0 None 316 3 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F 10.1021/jm9902032
CHEMBL357842 128054 0 None 316 3 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F 10.1021/jm9902032
10626843 175444 0 None 67 3 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 568 10 0 8 5.0 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3C(=O)OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL436407 175444 0 None 67 3 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 568 10 0 8 5.0 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3C(=O)OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10032383 116887 0 None 194 6 Human 9.3 pKi = 9.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
136680387 116887 0 None 194 6 Human 9.3 pKi = 9.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL323579 116887 0 None 194 6 Human 9.3 pKi = 9.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
18738385 210503 0 None 181 3 Human 9.3 pKi = 9.3 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 427 7 0 5 4.4 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL67713 210503 0 None 181 3 Human 9.3 pKi = 9.3 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 427 7 0 5 4.4 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00347-5
122065 196328 3 None 2 8 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 380 5 1 6 1.5 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1 10.1021/jm970159v
CHEMBL51433 196328 3 None 2 8 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 380 5 1 6 1.5 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1 10.1021/jm970159v
2865 10915 73 None -4 53 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1016/j.bmcl.2007.11.106
59 10915 73 None -4 53 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1016/j.bmcl.2007.11.106
60854 10915 73 None -4 53 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1016/j.bmcl.2007.11.106
CHEMBL708 10915 73 None -4 53 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1016/j.bmcl.2007.11.106
DB00246 10915 73 None -4 53 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1016/j.bmcl.2007.11.106
49781453 24639 0 None -1 4 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 386 2 0 3 5.3 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccccc4)cc32)CC1 10.1021/jm100652h
CHEMBL1259043 24639 0 None -1 4 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 386 2 0 3 5.3 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccccc4)cc32)CC1 10.1021/jm100652h
10393665 40696 0 None 47 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 593 9 2 9 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL142383 40696 0 None 47 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 593 9 2 9 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
9916549 128342 0 None 1 4 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL358595 128342 0 None 1 4 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
11757736 40521 0 None 870 4 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 570 9 2 6 4.3 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL142243 40521 0 None 870 4 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 570 9 2 6 4.3 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
10840177 44890 0 None 537 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 540 7 2 5 4.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL146109 44890 0 None 537 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 540 7 2 5 4.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
9891213 168281 0 None -12 6 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4128084 168281 0 None -12 6 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
489 6933 28 None -4 12 Bovine 9.3 pKi = 9.3 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm970166j
5640 6933 28 None -4 12 Bovine 9.3 pKi = 9.3 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm970166j
CHEMBL420060 6933 28 None -4 12 Bovine 9.3 pKi = 9.3 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm970166j
44298447 107576 0 None 5 3 Human 9.3 pKi = 9.3 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 430 6 1 6 1.7 Cc1c[nH]c(=O)n(CCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL293149 107576 0 None 5 3 Human 9.3 pKi = 9.3 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 430 6 1 6 1.7 Cc1c[nH]c(=O)n(CCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
4209 9937 75 None -1 33 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
4893 9937 75 None -1 33 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
503 9937 75 None -1 33 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
5385 9937 75 None -1 33 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
CHEMBL2 9937 75 None -1 33 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
DB00457 9937 75 None -1 33 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
10029146 212470 0 None 331 3 Human 9.3 pKi = 9.3 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)[C@@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@@H]1c1ccccc1 10.1016/s0960-894x(98)00451-x
CHEMBL82267 212470 0 None 331 3 Human 9.3 pKi = 9.3 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)[C@@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@@H]1c1ccccc1 10.1016/s0960-894x(98)00451-x
11800077 107288 0 None 2 3 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 481 4 1 6 4.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(Cl)c54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL291154 107288 0 None 2 3 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 481 4 1 6 4.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(Cl)c54)c3=O)C[C@@H]21 10.1021/jm990567u
44289261 171691 0 None 12 7 Human 9.3 pKi = 9.3 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 417 9 1 4 5.1 COc1cccc(OC)c1OCCNCC1Cc2ccccc2C(c2ccccc2)C1 10.1021/jm011066n
CHEMBL42231 171691 0 None 12 7 Human 9.3 pKi = 9.3 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 417 9 1 4 5.1 COc1cccc(OC)c1OCCNCC1Cc2ccccc2C(c2ccccc2)C1 10.1021/jm011066n
52942395 24693 0 None 3 6 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 386 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cncnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL1259203 24693 0 None 3 6 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 386 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cncnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
49781448 24622 0 None 1 4 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 406 2 0 4 5.7 Cc1ccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)s1 10.1021/jm100652h
CHEMBL1259005 24622 0 None 1 4 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 406 2 0 4 5.7 Cc1ccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)s1 10.1021/jm100652h
52942395 24693 0 None 3 6 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 386 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cncnc4)cc23)CC1 10.1021/jm100652h
CHEMBL1259203 24693 0 None 3 6 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 386 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cncnc4)cc23)CC1 10.1021/jm100652h
10744687 107202 0 None -1 3 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 490 5 2 7 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C(N)=O)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL290388 107202 0 None -1 3 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 490 5 2 7 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C(N)=O)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
13911290 34944 0 None -2 6 Rat 9.3 pKi = 9.3 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 386 5 1 7 1.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sccc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13735 34944 0 None -2 6 Rat 9.3 pKi = 9.3 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 386 5 1 7 1.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sccc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
10769331 118310 0 None 79 6 Human 9.3 pKi = 9.3 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 566 9 2 7 5.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1 10.1021/jm980077m
CHEMBL327931 118310 0 None 79 6 Human 9.3 pKi = 9.3 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 566 9 2 7 5.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1 10.1021/jm980077m
10769331 92067 0 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 566 9 2 7 5.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1 10.1007/s00044-004-0120-9
CHEMBL2260370 92067 0 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 566 9 2 7 5.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1 10.1007/s00044-004-0120-9
15054191 204530 0 None 4 2 Rat 9.3 pKi = 9.3 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 423 4 2 5 2.6 O=c1[nH]c2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm00110a014
CHEMBL57163 204530 0 None 4 2 Rat 9.3 pKi = 9.3 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 423 4 2 5 2.6 O=c1[nH]c2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm00110a014
10917316 212266 0 None 10 4 Human 9.3 pKi = 9.3 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 447 8 1 8 2.6 COc1ccc(Cl)cc1N1CCN(CCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL80599 212266 0 None 10 4 Human 9.3 pKi = 9.3 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 447 8 1 8 2.6 COc1ccc(Cl)cc1N1CCN(CCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
10411384 163943 0 None -1 3 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cnccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL40754 163943 0 None -1 3 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cnccc54)c3=O)C[C@@H]21 10.1021/jm990567u
3157 8252 71 None -2 12 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm0580398
7170 8252 71 None -2 12 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm0580398
954 8252 71 None -2 12 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm0580398
CHEMBL707 8252 71 None -2 12 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm0580398
DB00590 8252 71 None -2 12 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm0580398
3157 8252 71 None -2 12 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
7170 8252 71 None -2 12 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
954 8252 71 None -2 12 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
CHEMBL707 8252 71 None -2 12 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
DB00590 8252 71 None -2 12 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
71508713 93844 0 None 295 2 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 388 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccn(C)n4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2326176 93844 0 None 295 2 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 388 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccn(C)n4)cc23)CC1 10.1016/j.bmc.2012.10.049
44358574 126147 0 None -2 5 Human 9.3 pKi = 9.3 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 340 9 1 4 4.0 COc1cccc2c1CCCC2CCCNCCOc1ccccn1 10.1021/jm010866v
CHEMBL344432 126147 0 None -2 5 Human 9.3 pKi = 9.3 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 340 9 1 4 4.0 COc1cccc2c1CCCC2CCCNCCOc1ccccn1 10.1021/jm010866v
44431607 154373 0 None 42 4 Human 9.3 pKi = 9.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(Cl)c3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL393105 154373 0 None 42 4 Human 9.3 pKi = 9.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(Cl)c3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
12765746 109057 4 None -3 9 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm020938y
CHEMBL303313 109057 4 None -3 9 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm020938y
11092112 214407 0 None 3 9 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 485 6 0 6 4.9 O=C1OCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ncccn4)cc23)CC1 10.1021/jm020938y
CHEMBL95175 214407 0 None 3 9 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 485 6 0 6 4.9 O=C1OCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ncccn4)cc23)CC1 10.1021/jm020938y
10844296 208194 0 None -1 3 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 425 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(Cl)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL60471 208194 0 None -1 3 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 425 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(Cl)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
9847196 36954 0 None -2 5 Rat 9.2 pKi = 9.2 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(-c4ccccc4)cc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13903 36954 0 None -2 5 Rat 9.2 pKi = 9.2 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(-c4ccccc4)cc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
4209 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(99)00484-9
4893 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(99)00484-9
503 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(99)00484-9
5385 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(99)00484-9
CHEMBL2 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(99)00484-9
DB00457 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(99)00484-9
4209 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980506g
4893 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980506g
503 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980506g
5385 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980506g
CHEMBL2 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980506g
DB00457 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980506g
9916549 128342 0 None -1 4 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of ratIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of rat
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL358595 128342 0 None -1 4 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of ratIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of rat
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
4209 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm981006q
4893 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm981006q
503 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm981006q
5385 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm981006q
CHEMBL2 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm981006q
DB00457 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm981006q
4209 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
4893 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
503 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
5385 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
CHEMBL2 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
DB00457 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
4209 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
4893 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
503 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
5385 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
CHEMBL2 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
DB00457 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
4209 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm030952q
4893 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm030952q
503 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm030952q
5385 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm030952q
CHEMBL2 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm030952q
DB00457 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm030952q
4209 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
4893 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
503 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
5385 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
CHEMBL2 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
DB00457 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
9824384 125565 1 None -14 8 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL342062 125565 1 None -14 8 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
4209 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.05.003
4893 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.05.003
503 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.05.003
5385 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.05.003
CHEMBL2 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.05.003
DB00457 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.05.003
4209 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
4893 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
503 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
5385 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
CHEMBL2 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
DB00457 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
4209 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
4893 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
503 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
5385 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
CHEMBL2 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
DB00457 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
10718317 107302 0 None 1 3 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL291262 107302 0 None 1 3 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncccc54)c3=O)C[C@@H]21 10.1021/jm990567u
10437624 128049 0 None 398 3 Human 9.2 pKi = 9.2 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 553 10 1 7 4.3 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL357828 128049 0 None 398 3 Human 9.2 pKi = 9.2 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 553 10 1 7 4.3 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
499 10849 18 None -1 14 Bovine 9.2 pKi = 9.2 Binding
Binding affinity of compound towards Alpha-1 adrenergic receptor using [3H]prazosin 0.5 nM ligand in frontal cortex calf was determinedBinding affinity of compound towards Alpha-1 adrenergic receptor using [3H]prazosin 0.5 nM ligand in frontal cortex calf was determined
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm950759z
5685 10849 18 None -1 14 Bovine 9.2 pKi = 9.2 Binding
Binding affinity of compound towards Alpha-1 adrenergic receptor using [3H]prazosin 0.5 nM ligand in frontal cortex calf was determinedBinding affinity of compound towards Alpha-1 adrenergic receptor using [3H]prazosin 0.5 nM ligand in frontal cortex calf was determined
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm950759z
CHEMBL25554 10849 18 None -1 14 Bovine 9.2 pKi = 9.2 Binding
Binding affinity of compound towards Alpha-1 adrenergic receptor using [3H]prazosin 0.5 nM ligand in frontal cortex calf was determinedBinding affinity of compound towards Alpha-1 adrenergic receptor using [3H]prazosin 0.5 nM ligand in frontal cortex calf was determined
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm950759z
3894573 10166 6 None -1 5 Human 9.2 pKi = 9.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1016/j.bmcl.2004.11.032
495 10166 6 None -1 5 Human 9.2 pKi = 9.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1016/j.bmcl.2004.11.032
CHEMBL88272 10166 6 None -1 5 Human 9.2 pKi = 9.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1016/j.bmcl.2004.11.032
44300107 107463 0 None 114 3 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL292365 107463 0 None 114 3 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
44294957 197823 0 None 295 3 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 556 7 2 8 2.7 O=C1OCC2=C1C(c1ccc(F)c(F)c1)N(C(=O)NCCCN1CCN(c3ccccc3[N+](=O)[O-])CC1)C(=O)N2 10.1016/s0960-894x(99)00653-8
CHEMBL51871 197823 0 None 295 3 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 556 7 2 8 2.7 O=C1OCC2=C1C(c1ccc(F)c(F)c1)N(C(=O)NCCCN1CCN(c3ccccc3[N+](=O)[O-])CC1)C(=O)N2 10.1016/s0960-894x(99)00653-8
2142 9870 58 None -2 37 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
4920903 9870 58 None -2 37 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
502 9870 58 None -2 37 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
5775 9870 58 None -2 37 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
CHEMBL597 9870 58 None -2 37 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
DB00692 9870 58 None -2 37 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
10697912 213771 0 None - 1 Human 9.2 pKi = 9.2 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 550 7 2 5 4.0 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
CHEMBL91403 213771 0 None - 1 Human 9.2 pKi = 9.2 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 550 7 2 5 4.0 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
10530552 40019 0 None 26 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 543 7 3 7 3.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL141821 40019 0 None 26 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 543 7 3 7 3.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
4209 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990201h
4893 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990201h
503 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990201h
5385 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990201h
CHEMBL2 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990201h
DB00457 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990201h
24897950 63126 0 None -2 6 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 462 11 2 6 2.9 COc1ccc(C[C@@H](C)NCCOc2ccccc2OCC(F)(F)F)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630940 63126 0 None -2 6 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 462 11 2 6 2.9 COc1ccc(C[C@@H](C)NCCOc2ccccc2OCC(F)(F)F)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
4209 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm0009336
4893 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm0009336
503 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm0009336
5385 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm0009336
CHEMBL2 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm0009336
DB00457 9937 75 None -1 33 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm0009336
499 10849 18 None -1 14 Bovine 9.2 pKi = 9.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960069a
5685 10849 18 None -1 14 Bovine 9.2 pKi = 9.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960069a
CHEMBL25554 10849 18 None -1 14 Bovine 9.2 pKi = 9.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960069a
11016418 112899 0 None 5 9 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 488 6 0 7 4.2 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCN4CCOC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL313424 112899 0 None 5 9 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 488 6 0 7 4.2 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCN4CCOC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
3157 8252 71 None -1 12 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
7170 8252 71 None -1 12 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
954 8252 71 None -1 12 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
CHEMBL707 8252 71 None -1 12 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
DB00590 8252 71 None -1 12 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
10434440 212273 0 None -4 4 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 461 8 1 8 2.9 COc1ccccc1N1CCN(CCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL80641 212273 0 None -4 4 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 461 8 1 8 2.9 COc1ccccc1N1CCN(CCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
489 6933 28 None -3 12 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm960697s
5640 6933 28 None -3 12 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm960697s
CHEMBL420060 6933 28 None -3 12 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm960697s
3894573 10166 6 None -1 5 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm960697s
495 10166 6 None -1 5 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm960697s
CHEMBL88272 10166 6 None -1 5 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm960697s
46934643 23449 0 None 6 4 Human 9.2 pKi = 9.2 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 6 3.5 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3CCCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242632 23449 0 None 6 4 Human 9.2 pKi = 9.2 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 6 3.5 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3CCCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
145956955 168880 0 None -2 3 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 397 5 2 8 2.2 COc1cc2nc(N3CCC[C@H](NC(=O)c4ccco4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4161165 168880 0 None -2 3 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 397 5 2 8 2.2 COc1cc2nc(N3CCC[C@H](NC(=O)c4ccco4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
10742076 107094 0 None -1 3 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL289361 107094 0 None -1 3 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
44390708 71045 0 None 630 3 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)[C@H](c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1021/jm960697s
CHEMBL180932 71045 0 None 630 3 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)[C@H](c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1021/jm960697s
10834793 91354 0 None -1 7 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153557 91354 0 None -1 7 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220925 91354 0 None -1 7 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
56946573 78301 0 None 6 4 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 428 6 0 4 4.9 COc1ccccc1N1CCN(CC2CCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1021/jm200421e
CHEMBL1946780 78301 0 None 6 4 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 428 6 0 4 4.9 COc1ccccc1N1CCN(CC2CCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1021/jm200421e
CHEMBL1962870 78301 0 None 6 4 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 428 6 0 4 4.9 COc1ccccc1N1CCN(CC2CCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1021/jm200421e
9866614 21487 1 None 120 3 Human 9.2 pKi = 9.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 416 9 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)CN2CCCCC2=O)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL12062 21487 1 None 120 3 Human 9.2 pKi = 9.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 416 9 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)CN2CCCCC2=O)CC1 10.1016/j.bmcl.2004.11.032
135559170 108837 0 None 8 7 Rat 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(CC2CN3C(=O)Nc4ccccc4C3=N2)CC1 10.1021/jm970159v
CHEMBL302021 108837 0 None 8 7 Rat 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(CC2CN3C(=O)Nc4ccccc4C3=N2)CC1 10.1021/jm970159v
107715 207724 22 None -1 20 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL1255837 207724 22 None -1 20 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL601773 207724 22 None -1 20 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
9866614 21487 1 None 120 3 Human 9.2 pKi = 9.2 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 416 9 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12062 21487 1 None 120 3 Human 9.2 pKi = 9.2 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 416 9 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
10792898 210724 0 None 93 2 Human 9.2 pKi = 9.2 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 9 2 7 3.5 Cc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL69295 210724 0 None 93 2 Human 9.2 pKi = 9.2 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 9 2 7 3.5 Cc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
9913988 24687 0 None -1 4 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 502 7 1 7 3.1 Cn1nnc(Cc2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm100652h
CHEMBL1259188 24687 0 None -1 4 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 502 7 1 7 3.1 Cn1nnc(Cc2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm100652h
1238 209953 24 None -3 16 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN(C2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm100652h
CHEMBL64249 209953 24 None -3 16 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN(C2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm100652h
10552656 168091 0 None 1 3 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 478 5 1 8 3.0 COc1ccc2sc3c(=O)n(CCN4C[C@@H]5CCc6c(OC)cccc6[C@@H]5C4)c(=O)[nH]c3c2n1 10.1021/jm990567u
CHEMBL41234 168091 0 None 1 3 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 478 5 1 8 3.0 COc1ccc2sc3c(=O)n(CCN4C[C@@H]5CCc6c(OC)cccc6[C@@H]5C4)c(=O)[nH]c3c2n1 10.1021/jm990567u
9895338 101220 0 None 223 3 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)/C(=C(\O)OC)C(C)=N1 10.1021/jm960697s
CHEMBL25121 101220 0 None 223 3 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)/C(=C(\O)OC)C(C)=N1 10.1021/jm960697s
3168 16034 92 None 1 22 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
CHEMBL1108 16034 92 None 1 22 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
DB00450 16034 92 None 1 22 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
10763038 209454 0 None -1 3 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 391 4 1 5 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL61491 209454 0 None -1 3 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 391 4 1 5 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccccc4c3=O)C[C@@H]21 10.1021/jm000541z
52946023 24686 0 None 2 6 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 477 7 2 4 3.6 CC(=O)NCc1ccc2c(c1)c(C1CCN(CCN3CCNC3=O)CC1)cn2-c1ccc(F)cc1 10.1021/jm100652h
CHEMBL1259187 24686 0 None 2 6 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 477 7 2 4 3.6 CC(=O)NCc1ccc2c(c1)c(C1CCN(CCN3CCNC3=O)CC1)cn2-c1ccc(F)cc1 10.1021/jm100652h
10718348 107021 0 None 3 3 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 449 4 1 8 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncncc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL288678 107021 0 None 3 3 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 449 4 1 8 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncncc54)c3=O)C[C@@H]21 10.1021/jm990567u
10415038 11211 0 None 3 4 Human 9.2 pKi = 9.2 Binding
Ability to displace [125I]HEAT from cloned human Alpha-1A adrenergic receptor stably expressed in CHO cellsAbility to displace [125I]HEAT from cloned human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 545 6 1 7 5.3 Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
CHEMBL101610 11211 0 None 3 4 Human 9.2 pKi = 9.2 Binding
Ability to displace [125I]HEAT from cloned human Alpha-1A adrenergic receptor stably expressed in CHO cellsAbility to displace [125I]HEAT from cloned human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 545 6 1 7 5.3 Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
10368033 107201 0 None 5 4 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 483 4 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncc(Cl)nc54)c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL290387 107201 0 None 5 4 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 483 4 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncc(Cl)nc54)c3=O)C[C@@H]21 10.1021/jm000541z
10368033 107201 0 None 5 4 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 483 4 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncc(Cl)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL290387 107201 0 None 5 4 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 483 4 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncc(Cl)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
6603950 210103 9 None -3 8 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm100652h
CHEMBL64875 210103 9 None -3 8 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm100652h
10554913 44120 0 None 11 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 561 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc(Cl)c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145443 44120 0 None 11 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 561 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc(Cl)c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10745766 44258 0 None 141 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 578 9 3 8 2.7 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm990200p
CHEMBL145562 44258 0 None 141 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 578 9 3 8 2.7 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm990200p
10674333 44268 0 None 239 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 554 8 3 6 2.9 CC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145574 44268 0 None 239 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 554 8 3 6 2.9 CC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10415156 127916 0 None 870 4 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 550 8 3 5 3.8 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL357628 127916 0 None 870 4 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 550 8 3 5 3.8 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
489 6933 28 None -2 12 Rat 9.2 pKi = 9.2 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
5640 6933 28 None -2 12 Rat 9.2 pKi = 9.2 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
CHEMBL420060 6933 28 None -2 12 Rat 9.2 pKi = 9.2 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
10741071 175996 0 None -1 3 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 425 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccc(Cl)c4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL440865 175996 0 None -1 3 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 425 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccc(Cl)c4c3=O)C[C@@H]21 10.1021/jm000541z
10478895 107003 0 None 2 3 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 449 4 1 8 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL288530 107003 0 None 2 3 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 449 4 1 8 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
20215436 35288 3 None -1 3 Rat 9.1 pKi = 9.1 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 355 4 1 8 2.1 COc1cc2nc(N3CCN(c4ccco4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL137598 35288 3 None -1 3 Rat 9.1 pKi = 9.1 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 355 4 1 8 2.1 COc1cc2nc(N3CCN(c4ccco4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
4209 9937 75 None -1 33 Bovine 9.1 pKi = 9.1 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
4893 9937 75 None -1 33 Bovine 9.1 pKi = 9.1 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
503 9937 75 None -1 33 Bovine 9.1 pKi = 9.1 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
5385 9937 75 None -1 33 Bovine 9.1 pKi = 9.1 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
CHEMBL2 9937 75 None -1 33 Bovine 9.1 pKi = 9.1 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
DB00457 9937 75 None -1 33 Bovine 9.1 pKi = 9.1 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
44431551 93986 0 None 33 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL232780 93986 0 None 33 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44447067 101390 0 None -1 3 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 446 6 1 5 4.2 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)C1CC1 10.1016/j.bmcl.2007.11.106
CHEMBL252230 101390 0 None -1 3 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 446 6 1 5 4.2 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)C1CC1 10.1016/j.bmcl.2007.11.106
10348924 24717 0 None 3 5 Human 9.1 pKi = 9.1 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 620 10 1 10 3.8 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C#N)CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL125989 24717 0 None 3 5 Human 9.1 pKi = 9.1 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 620 10 1 10 3.8 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C#N)CC3)cccc2c1=O 10.1021/jm030825u
10721564 214129 0 None 33 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 558 7 1 5 4.9 COC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/j.ejmech.2017.03.025
CHEMBL93623 214129 0 None 33 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 558 7 1 5 4.9 COC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/j.ejmech.2017.03.025
10721564 214129 0 None 33 3 Human 9.1 pKi = 9.1 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 558 7 1 5 4.9 COC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm990612y
CHEMBL93623 214129 0 None 33 3 Human 9.1 pKi = 9.1 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 558 7 1 5 4.9 COC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm990612y
10627003 211119 0 None 53 3 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 576 9 2 7 3.8 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(Cl)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL71580 211119 0 None 53 3 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 576 9 2 7 3.8 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(Cl)c2)C3=O)CC1 10.1021/jm9905918
44431546 94917 0 None 3 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 482 7 1 6 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3C#N)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234680 94917 0 None 3 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 482 7 1 6 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3C#N)CC2)CC1 10.1016/j.bmcl.2007.04.008
10626911 108997 0 None 66 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL302940 108997 0 None 66 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
10625617 168475 0 None 1 3 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 477 5 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(OC)c54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL41344 168475 0 None 1 3 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 477 5 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(OC)c54)c3=O)C[C@@H]21 10.1021/jm990567u
3157 8252 71 None -2 12 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.05.003
7170 8252 71 None -2 12 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.05.003
954 8252 71 None -2 12 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.05.003
CHEMBL707 8252 71 None -2 12 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.05.003
DB00590 8252 71 None -2 12 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.05.003
10648335 106938 0 None 1 3 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 478 5 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(OC)ccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL287928 106938 0 None 1 3 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 478 5 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(OC)ccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
10765077 107038 0 None -1 3 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 430 4 2 5 2.8 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c([nH]c5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL288809 107038 0 None -1 3 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 430 4 2 5 2.8 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c([nH]c5ccccc54)c3=O)CC21 10.1021/jm990567u
2142 9870 58 None -1 37 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
4920903 9870 58 None -1 37 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
502 9870 58 None -1 37 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
5775 9870 58 None -1 37 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
CHEMBL597 9870 58 None -1 37 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
DB00692 9870 58 None -1 37 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
3894573 10166 6 None 1 5 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm970166j
495 10166 6 None 1 5 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm970166j
CHEMBL88272 10166 6 None 1 5 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm970166j
10833725 213290 0 None 2 3 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 381 7 1 5 2.7 Cc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL88435 213290 0 None 2 3 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 381 7 1 5 2.7 Cc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10647341 213713 0 None 63 2 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 453 9 1 6 3.8 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC(C)(C)C)CC1 10.1021/jm970166j
CHEMBL91093 213713 0 None 63 2 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 453 9 1 6 3.8 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC(C)(C)C)CC1 10.1021/jm970166j
10550225 213861 0 None 25 2 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 423 8 1 6 3.0 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N2CCCC2)CC1 10.1021/jm970166j
CHEMBL91876 213861 0 None 25 2 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 423 8 1 6 3.0 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N2CCCC2)CC1 10.1021/jm970166j
10524875 214151 0 None 15 3 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ccncc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL93736 214151 0 None 15 3 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ccncc2C(=O)N(C)C)CC1 10.1021/jm970166j
9891937 201527 0 None 31 3 Human 9.1 pKi = 9.1 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 458 8 1 6 2.4 CCc1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL53675 201527 0 None 31 3 Human 9.1 pKi = 9.1 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 458 8 1 6 2.4 CCc1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
44298746 202411 0 None 19 3 Human 9.1 pKi = 9.1 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 452 7 1 6 2.4 Cc1c[nH]c(=O)n(CC2(CN3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL55629 202411 0 None 19 3 Human 9.1 pKi = 9.1 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 452 7 1 6 2.4 Cc1c[nH]c(=O)n(CC2(CN3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)c1=O 10.1016/s0960-894x(03)00305-6
9865577 119086 2 None 1 3 Bovine 9.1 pKi = 9.1 Binding
The compound was screened in vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorThe compound was screened in vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL329160 119086 2 None 1 3 Bovine 9.1 pKi = 9.1 Binding
The compound was screened in vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorThe compound was screened in vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10674840 210495 0 None 50 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 585 10 2 8 3.3 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL67648 210495 0 None 50 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 585 10 2 8 3.3 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1 10.1021/jm9905918
44431192 99334 0 None 1 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 448 5 0 6 3.6 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccnc4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243228 99334 0 None 1 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 448 5 0 6 3.6 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccnc4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
10917920 118223 0 None 7 10 Bovine 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 487 6 1 6 3.8 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL327527 118223 0 None 7 10 Bovine 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 487 6 1 6 3.8 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
56944383 118896 0 None -1 12 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 487 8 1 6 5.1 O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2ccccc2s1 10.1021/jm401895u
CHEMBL3290012 118896 0 None -1 12 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 487 8 1 6 5.1 O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2ccccc2s1 10.1021/jm401895u
10603739 23161 0 None 46 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 607 10 2 9 3.8 CCC1=C(C(=O)OC)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL123012 23161 0 None 46 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 607 10 2 9 3.8 CCC1=C(C(=O)OC)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10698141 40599 0 None 21 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 561 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(Cl)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL142307 40599 0 None 21 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 561 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(Cl)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
11430126 67337 0 None -1 6 Human 9.1 pKi = 9.1 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 421 4 1 9 2.0 COc1cc2nc(N3CCN(C(=O)C4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL175934 67337 0 None -1 6 Human 9.1 pKi = 9.1 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 421 4 1 9 2.0 COc1cc2nc(N3CCN(C(=O)C4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
3584 10549 64 None -2 14 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990567u
5401 10549 64 None -2 14 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990567u
7302 10549 64 None -2 14 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990567u
CHEMBL611 10549 64 None -2 14 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990567u
DB01162 10549 64 None -2 14 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990567u
10793261 127831 0 None 2290 4 Human 9.1 pKi = 9.1 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 575 10 3 8 3.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL356829 127831 0 None 2290 4 Human 9.1 pKi = 9.1 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 575 10 3 8 3.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
57402366 76090 0 None -1 5 Pig 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1033 32 2 17 5.4 COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928139 76090 0 None -1 5 Pig 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1033 32 2 17 5.4 COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
10740866 108872 0 None 1 3 Rat 9.1 pKi = 9.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 421 5 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)cccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL302203 108872 0 None 1 3 Rat 9.1 pKi = 9.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 421 5 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)cccc4c3=O)C[C@@H]21 10.1021/jm000541z
10740369 208642 0 None -1 3 Rat 9.1 pKi = 9.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 411 4 1 6 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)csc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL60721 208642 0 None -1 3 Rat 9.1 pKi = 9.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 411 4 1 6 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)csc4c3=O)C[C@@H]21 10.1021/jm000541z
9847196 36954 0 None -3 5 Human 9.1 pKi = 9.1 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(-c4ccccc4)cc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13903 36954 0 None -3 5 Human 9.1 pKi = 9.1 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(-c4ccccc4)cc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
49781676 24644 0 None 1 4 Bovine 9.1 pKi = 9.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 400 2 0 3 5.7 Cc1ccccc1-c1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259062 24644 0 None 1 4 Bovine 9.1 pKi = 9.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 400 2 0 3 5.7 Cc1ccccc1-c1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
46934639 23442 0 None 6 4 Human 9.1 pKi = 9.1 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 6 3.1 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3CCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242541 23442 0 None 6 4 Human 9.1 pKi = 9.1 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 6 3.1 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3CCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
69782867 168362 0 None -5 6 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 549 8 1 9 4.4 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4C(C)C)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4129291 168362 0 None -5 6 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 549 8 1 9 4.4 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4C(C)C)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
44431547 94918 0 None 34 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234681 94918 0 None 34 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
10721568 210629 0 None 32 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 558 9 3 8 2.9 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL68604 210629 0 None 32 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 558 9 3 8 2.9 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1 10.1021/jm9905918
2389 10104 118 None -6 66 Rat 9.1 pKi = 9.1 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
5073 10104 118 None -6 66 Rat 9.1 pKi = 9.1 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
96 10104 118 None -6 66 Rat 9.1 pKi = 9.1 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
CHEMBL85 10104 118 None -6 66 Rat 9.1 pKi = 9.1 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
DB00734 10104 118 None -6 66 Rat 9.1 pKi = 9.1 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
10949698 212066 0 None 1 4 Human 9.1 pKi = 9.1 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 413 8 1 8 1.9 COc1ccccc1N1CCN(CCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL79161 212066 0 None 1 4 Human 9.1 pKi = 9.1 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 413 8 1 8 1.9 COc1ccccc1N1CCN(CCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
71462043 91343 0 None -1 7 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153555 91343 0 None -1 7 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220895 91343 0 None -1 7 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
44431564 94417 0 None 34 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 501 8 1 6 4.2 COc1ccc(C)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233623 94417 0 None 34 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 501 8 1 6 4.2 COc1ccc(C)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
9872440 109043 0 None 81 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 9 2 7 3.5 Cc1cccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)c1 10.1021/jm9905918
CHEMBL303248 109043 0 None 81 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 9 2 7 3.5 Cc1cccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)c1 10.1021/jm9905918
10506673 210704 0 None 72 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 542 9 2 7 3.2 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccccc2)C3=O)CC1 10.1021/jm9905918
CHEMBL69143 210704 0 None 72 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 542 9 2 7 3.2 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccccc2)C3=O)CC1 10.1021/jm9905918
10047430 111538 0 None 117 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 414 7 0 6 3.4 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL310768 111538 0 None 117 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 414 7 0 6 3.4 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00436-5
44299973 204231 0 None 6 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL56974 204231 0 None 6 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
44295192 108499 0 None 338 3 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 574 7 2 10 2.4 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc3nonc3c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL299539 108499 0 None 338 3 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 574 7 2 10 2.4 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc3nonc3c2)CC1 10.1016/s0960-894x(99)00653-8
9959689 108590 0 None 281 3 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 568 7 2 7 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL300222 108590 0 None 281 3 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 568 7 2 7 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
44447065 101387 0 None -1 3 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 7 1 5 4.6 CCCC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
CHEMBL252228 101387 0 None -1 3 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 7 1 5 4.6 CCCC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
71452768 86346 0 None 53 3 Human 9.1 pKi = 9.1 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
CHEMBL2114249 86346 0 None 53 3 Human 9.1 pKi = 9.1 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
10503057 109398 0 None 1 3 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 436 5 1 7 2.3 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc([N+](=O)[O-])ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL304215 109398 0 None 1 3 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 436 5 1 7 2.3 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc([N+](=O)[O-])ccc4c3=O)C[C@@H]21 10.1021/jm000541z
11519153 92524 0 None 2 4 Human 9.0 pKi = 9.0 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL229085 92524 0 None 2 4 Human 9.0 pKi = 9.0 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11519153 92524 0 None 2 4 Human 9.0 pKi = 9.0 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL229085 92524 0 None 2 4 Human 9.0 pKi = 9.0 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
44289525 172774 0 None 4 9 Bovine 9.0 pKi = 9.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNCC1Oc2ccccc2OC1c1ccc(C)cc1 10.1021/jm960069a
CHEMBL42539 172774 0 None 4 9 Bovine 9.0 pKi = 9.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNCC1Oc2ccccc2OC1c1ccc(C)cc1 10.1021/jm960069a
10601065 119085 0 None 173 3 Human 9.0 pKi = 9.0 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 488 7 4 4 2.8 O=C1NC=C(C(=O)NCCCN2CCC(O)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
CHEMBL329143 119085 0 None 173 3 Human 9.0 pKi = 9.0 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 488 7 4 4 2.8 O=C1NC=C(C(=O)NCCCN2CCC(O)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
90645605 119215 0 None -1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 666 13 2 9 5.2 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCC(=O)NCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298023 119215 0 None -1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 666 13 2 9 5.2 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCC(=O)NCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
10549596 91380 1 None -3 7 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153553 91380 1 None -3 7 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221147 91380 1 None -3 7 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
4209 9937 75 None -1 33 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm020938y
4893 9937 75 None -1 33 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm020938y
503 9937 75 None -1 33 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm020938y
5385 9937 75 None -1 33 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm020938y
CHEMBL2 9937 75 None -1 33 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm020938y
DB00457 9937 75 None -1 33 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm020938y
9931976 67092 1 None 4 4 Rat 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(CC2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
CHEMBL1744044 67092 1 None 4 4 Rat 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(CC2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
4209 9937 75 None -1 33 Rat 9.0 pKi = 9.0 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
4893 9937 75 None -1 33 Rat 9.0 pKi = 9.0 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
503 9937 75 None -1 33 Rat 9.0 pKi = 9.0 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
5385 9937 75 None -1 33 Rat 9.0 pKi = 9.0 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
CHEMBL2 9937 75 None -1 33 Rat 9.0 pKi = 9.0 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
DB00457 9937 75 None -1 33 Rat 9.0 pKi = 9.0 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
13155 10195 0 None -16 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 668 12 2 9 4.5 CN(C(CCCC(=O)NC=1C=CC2=C(C1)C=3NC(N(C(C3S2)=O)CCN4CCN(CC4)C5=C(C=CC=C5)OC)=O)=O)CC6=CC=CC=C6 10.1016/j.ejmech.2014.06.057
90645598 10195 0 None -16 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 668 12 2 9 4.5 CN(C(CCCC(=O)NC=1C=CC2=C(C1)C=3NC(N(C(C3S2)=O)CCN4CCN(CC4)C5=C(C=CC=C5)OC)=O)=O)CC6=CC=CC=C6 10.1016/j.ejmech.2014.06.057
CHEMBL3297829 10195 0 None -16 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 668 12 2 9 4.5 CN(C(CCCC(=O)NC=1C=CC2=C(C1)C=3NC(N(C(C3S2)=O)CCN4CCN(CC4)C5=C(C=CC=C5)OC)=O)=O)CC6=CC=CC=C6 10.1016/j.ejmech.2014.06.057
10650843 210628 0 None 57 3 Human 9.0 pKi = 9.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 576 9 2 7 3.8 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(Cl)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL68601 210628 0 None 57 3 Human 9.0 pKi = 9.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 576 9 2 7 3.8 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(Cl)cc2)C3=O)CC1 10.1021/jm9905918
49781677 24645 0 None -1 4 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 400 2 0 3 5.7 Cc1cccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c1 10.1021/jm100652h
CHEMBL1259063 24645 0 None -1 4 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 400 2 0 3 5.7 Cc1cccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c1 10.1021/jm100652h
10841070 44453 0 None -2 4 Rat 9.0 pKi = 9.0 Binding
Binding affinity against isolated rat prostate using [3H]- prazosin.Binding affinity against isolated rat prostate using [3H]- prazosin.
ChEMBL 585 10 0 5 7.4 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145746 44453 0 None -2 4 Rat 9.0 pKi = 9.0 Binding
Binding affinity against isolated rat prostate using [3H]- prazosin.Binding affinity against isolated rat prostate using [3H]- prazosin.
ChEMBL 585 10 0 5 7.4 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
57390116 76073 0 None -1 5 Pig 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 925 30 2 13 5.9 COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)c3)c2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928122 76073 0 None -1 5 Pig 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 925 30 2 13 5.9 COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)c3)c2)CC1 10.1016/j.bmc.2011.10.063
10793720 210850 0 None 57 2 Human 9.0 pKi = 9.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 602 11 2 9 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1OC 10.1021/jm9905918
CHEMBL70095 210850 0 None 57 2 Human 9.0 pKi = 9.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 602 11 2 9 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1OC 10.1021/jm9905918
9910451 170909 0 None 3 7 Bovine 9.0 pKi = 9 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 428 5 0 6 4.7 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCC#N)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL420997 170909 0 None 3 7 Bovine 9.0 pKi = 9 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 428 5 0 6 4.7 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCC#N)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
10481087 176245 0 None 281 3 Human 9.0 pKi = 9 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 499 8 1 3 6.2 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3Cl)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL44294 176245 0 None 281 3 Human 9.0 pKi = 9 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 499 8 1 3 6.2 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3Cl)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
9959671 39445 0 None 363 3 Human 9.0 pKi = 9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL141322 39445 0 None 363 3 Human 9.0 pKi = 9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10506484 43572 0 None 489 3 Human 9.0 pKi = 9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 534 9 0 6 5.9 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145001 43572 0 None 489 3 Human 9.0 pKi = 9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 534 9 0 6 5.9 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
9894818 105701 0 None 83 7 Human 9.0 pKi = 9 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL279436 105701 0 None 83 7 Human 9.0 pKi = 9 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
9894818 105701 0 None 83 7 Human 9.0 pKi = 9 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL279436 105701 0 None 83 7 Human 9.0 pKi = 9 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
44431548 93826 0 None 26 4 Human 9.0 pKi = 9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 502 8 1 7 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL232593 93826 0 None 26 4 Human 9.0 pKi = 9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 502 8 1 7 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)CC1 10.1016/j.bmcl.2007.04.008
17753379 94578 0 None -1 4 Human 9.0 pKi = 9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233816 94578 0 None -1 4 Human 9.0 pKi = 9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431594 94794 0 None 17 4 Human 9.0 pKi = 9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 532 9 1 8 3.8 COc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234422 94794 0 None 17 4 Human 9.0 pKi = 9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 532 9 1 8 3.8 COc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
10928520 212373 0 None 1 4 Human 9.0 pKi = 9 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 453 7 1 7 3.3 COc1ccc(Cl)cc1N1CCN(CCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL81486 212373 0 None 1 4 Human 9.0 pKi = 9 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 453 7 1 7 3.3 COc1ccc(Cl)cc1N1CCN(CCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
497 10138 8 None 61 3 Human 9.0 pKi = 9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1021/jm960697s
9872515 10138 8 None 61 3 Human 9.0 pKi = 9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1021/jm960697s
CHEMBL24777 10138 8 None 61 3 Human 9.0 pKi = 9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1021/jm960697s
148842 10718 27 None 8 5 Human 9.0 pKi = 9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm960697s
496 10718 27 None 8 5 Human 9.0 pKi = 9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm960697s
CHEMBL278865 10718 27 None 8 5 Human 9.0 pKi = 9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm960697s
148842 10718 27 None 8 5 Human 9.0 pKi = 9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1016/j.bmcl.2004.11.032
496 10718 27 None 8 5 Human 9.0 pKi = 9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1016/j.bmcl.2004.11.032
CHEMBL278865 10718 27 None 8 5 Human 9.0 pKi = 9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1016/j.bmcl.2004.11.032
609483 130440 15 None - 1 Human 9.0 pKi = 9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 407 5 0 5 2.8 COc1ccccc1N1CCN(CCN2C(=O)c3ccccc3C(C)(C)C2=O)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL362051 130440 15 None - 1 Human 9.0 pKi = 9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 407 5 0 5 2.8 COc1ccccc1N1CCN(CCN2C(=O)c3ccccc3C(C)(C)C2=O)CC1 10.1016/j.bmcl.2004.11.032
90645606 119216 0 None 2 3 Human 9.0 pKi = 9 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 652 12 2 9 4.8 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCNC(=O)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298024 119216 0 None 2 3 Human 9.0 pKi = 9 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 652 12 2 9 4.8 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCNC(=O)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
56668277 69954 0 None 616 3 Human 9.0 pKi = 9 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL1789975 69954 0 None 616 3 Human 9.0 pKi = 9 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
11984570 99579 0 None 2 3 Human 9.0 pKi = 9 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 465 5 0 5 4.3 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccc(F)c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243694 99579 0 None 2 3 Human 9.0 pKi = 9 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 465 5 0 5 4.3 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccc(F)c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
49781680 24657 0 None 4 4 Bovine 9.0 pKi = 9 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 414 2 0 3 6.0 Cc1cccc(C)c1-c1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259097 24657 0 None 4 4 Bovine 9.0 pKi = 9 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 414 2 0 3 6.0 Cc1cccc(C)c1-c1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
10626610 43526 0 None 251 3 Human 9.0 pKi = 9 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 556 8 2 6 4.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL144965 43526 0 None 251 3 Human 9.0 pKi = 9 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 556 8 2 6 4.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
44298770 108388 0 None 10 3 Human 9.0 pKi = 9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 464 7 1 6 2.5 O=c1[nH]cc(Cl)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL298838 108388 0 None 10 3 Human 9.0 pKi = 9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 464 7 1 6 2.5 O=c1[nH]cc(Cl)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
15840661 206241 0 None 31 3 Human 9.0 pKi = 9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 432 7 1 5 2.2 O=C1CCNC(=O)N1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL59153 206241 0 None 31 3 Human 9.0 pKi = 9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 432 7 1 5 2.2 O=C1CCNC(=O)N1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
10717073 209404 0 None 1 3 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 421 5 1 6 2.4 COc1ccc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2c1 10.1021/jm000541z
CHEMBL61225 209404 0 None 1 3 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 421 5 1 6 2.4 COc1ccc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2c1 10.1021/jm000541z
10507089 109105 0 None 186 2 Human 9.0 pKi = 9.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL303627 109105 0 None 186 2 Human 9.0 pKi = 9.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
10644505 107541 0 None -1 3 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4sccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL292881 107541 0 None -1 3 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4sccc4c3=O)C[C@@H]21 10.1021/jm000541z
4209 9937 75 None -1 33 Rat 9.0 pKi = 9.0 Binding
Compound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary glandCompound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970740r
4893 9937 75 None -1 33 Rat 9.0 pKi = 9.0 Binding
Compound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary glandCompound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970740r
503 9937 75 None -1 33 Rat 9.0 pKi = 9.0 Binding
Compound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary glandCompound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970740r
5385 9937 75 None -1 33 Rat 9.0 pKi = 9.0 Binding
Compound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary glandCompound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970740r
CHEMBL2 9937 75 None -1 33 Rat 9.0 pKi = 9.0 Binding
Compound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary glandCompound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970740r
DB00457 9937 75 None -1 33 Rat 9.0 pKi = 9.0 Binding
Compound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary glandCompound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970740r
9895326 213806 0 None 177 6 Human 9.0 pKi = 9.0 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 621 12 3 6 5.7 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1 10.1021/jm980077m
CHEMBL91550 213806 0 None 177 6 Human 9.0 pKi = 9.0 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 621 12 3 6 5.7 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1 10.1021/jm980077m
9895326 213806 0 None 177 6 Human 9.0 pKi = 9.0 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 621 12 3 6 5.7 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1 10.1007/s00044-004-0120-9
CHEMBL91550 213806 0 None 177 6 Human 9.0 pKi = 9.0 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 621 12 3 6 5.7 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1 10.1007/s00044-004-0120-9
10742076 107094 0 None -1 3 Rat 9.0 pKi = 9.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL289361 107094 0 None -1 3 Rat 9.0 pKi = 9.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
10606661 107716 0 None 1 3 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 441 5 1 7 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)c(OC)sc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL294027 107716 0 None 1 3 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 441 5 1 7 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)c(OC)sc4c3=O)C[C@@H]21 10.1021/jm000541z
90645592 119261 0 None -1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 555 7 2 8 4.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)c5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298745 119261 0 None -1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 555 7 2 8 4.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)c5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
90645596 119265 0 None -2 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 640 11 3 9 3.8 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCC(=O)NCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298749 119265 0 None -2 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 640 11 3 9 3.8 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCC(=O)NCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
10507411 40956 0 None 457 3 Human 9.0 pKi = 9.0 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 577 9 0 5 7.3 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3C(F)(F)F)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL142606 40956 0 None 457 3 Human 9.0 pKi = 9.0 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 577 9 0 5 7.3 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3C(F)(F)F)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10318686 111060 0 None 60 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 398 7 0 6 2.9 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCC3=O)no2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL309969 111060 0 None 60 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 398 7 0 6 2.9 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCC3=O)no2)CC1 10.1016/s0960-894x(02)00436-5
44295046 108710 0 None 117 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 577 8 2 9 2.8 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL301077 108710 0 None 117 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 577 8 2 9 2.8 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(99)00653-8
57390118 76077 0 None -1 5 Pig 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 953 32 2 13 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928126 76077 0 None -1 5 Pig 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 953 32 2 13 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
57393628 76088 0 None -3 5 Pig 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1005 30 2 17 5.2 COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccc(OCCOCCOCCOCCOc4ccn5ncc(C(=O)NCCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928137 76088 0 None -3 5 Pig 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1005 30 2 17 5.2 COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccc(OCCOCCOCCOCCOc4ccn5ncc(C(=O)NCCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
49781678 24650 0 None -1 4 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 400 2 0 3 5.7 Cc1ccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)cc1 10.1021/jm100652h
CHEMBL1259079 24650 0 None -1 4 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 400 2 0 3 5.7 Cc1ccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)cc1 10.1021/jm100652h
10555288 41514 0 None 45 3 Human 9.0 pKi = 9.0 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 582 8 2 7 4.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(Cl)c1 10.1021/jm990200p
CHEMBL143066 41514 0 None 45 3 Human 9.0 pKi = 9.0 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 582 8 2 7 4.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(Cl)c1 10.1021/jm990200p
10769058 172457 0 None 208 3 Human 9.0 pKi = 9.0 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 552 6 2 5 4.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL424494 172457 0 None 208 3 Human 9.0 pKi = 9.0 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 552 6 2 5 4.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
44289321 168747 0 None 6 3 Human 9.0 pKi = 9.0 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 455 8 1 3 5.1 Cc1ccc(C(C(=O)NCCCN2CCN(c3ccccc3C)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL415887 168747 0 None 6 3 Human 9.0 pKi = 9.0 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 455 8 1 3 5.1 Cc1ccc(C(C(=O)NCCCN2CCN(c3ccccc3C)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
9982050 108711 0 None 2 4 Human 9.0 pKi = 9.0 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 467 6 1 9 2.5 COc1ccccc1N1CCN(CCNc2ccc3c4c(=O)n(C)nc(Cl)c4cn3n2)CC1 10.1021/jm981006q
CHEMBL301078 108711 0 None 2 4 Human 9.0 pKi = 9.0 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 467 6 1 9 2.5 COc1ccccc1N1CCN(CCNc2ccc3c4c(=O)n(C)nc(Cl)c4cn3n2)CC1 10.1021/jm981006q
10531766 213776 0 None 199 6 Human 9.0 pKi = 9.0 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 607 9 2 7 6.3 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
CHEMBL91415 213776 0 None 199 6 Human 9.0 pKi = 9.0 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 607 9 2 7 6.3 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
10531766 92063 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 607 9 2 7 5.4 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1007/s00044-004-0120-9
CHEMBL2260366 92063 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 607 9 2 7 5.4 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1007/s00044-004-0120-9
52942152 23839 0 None -2 4 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 438 13 1 7 4.2 COc1cccc([N+](=O)[O-])c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254743 23839 0 None -2 4 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 438 13 1 7 4.2 COc1cccc([N+](=O)[O-])c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
71659980 152671 0 None 1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 354 6 0 5 3.2 CCOc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3917716 152671 0 None 1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 354 6 0 5 3.2 CCOc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
78815633 154294 2 None 1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 7 0 4 3.5 CCOc1ccccc1N1CCN(CCc2ccc(OC)cc2)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3930616 154294 2 None 1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 7 0 4 3.5 CCOc1ccccc1N1CCN(CCc2ccc(OC)cc2)CC1 10.1016/j.ejmech.2016.06.052
10621309 209554 0 None -1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 405 4 1 5 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccc(C)c4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL62110 209554 0 None -1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 405 4 1 5 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccc(C)c4c3=O)C[C@@H]21 10.1021/jm000541z
9851486 213478 0 None 223 6 Human 8.9 pKi = 8.9 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 592 10 2 6 6.0 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL89685 213478 0 None 223 6 Human 8.9 pKi = 8.9 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 592 10 2 6 6.0 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
9851486 213478 0 None 223 6 Human 8.9 pKi = 8.9 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 592 10 2 6 6.0 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL89685 213478 0 None 223 6 Human 8.9 pKi = 8.9 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 592 10 2 6 6.0 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
10409038 92017 0 None 41 4 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 405 2 2 5 3.6 COc1cc2c(cc1O)C[C@H]1c3c(c(Br)c(O)c(OC)c3-2)CCN1C 10.1021/np990433j
CHEMBL225853 92017 0 None 41 4 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 405 2 2 5 3.6 COc1cc2c(cc1O)C[C@H]1c3c(c(Br)c(O)c(OC)c3-2)CCN1C 10.1021/np990433j
10620533 208643 0 None 1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ncccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL60722 208643 0 None 1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ncccc4c3=O)C[C@@H]21 10.1021/jm000541z
10770057 108849 0 None 42 3 Human 8.9 pKi = 8.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 610 9 2 7 4.5 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(Cl)c(Cl)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL302092 108849 0 None 42 3 Human 8.9 pKi = 8.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 610 9 2 7 4.5 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(Cl)c(Cl)c2)C3=O)CC1 10.1021/jm9905918
19085869 174904 0 None 30 3 Human 8.9 pKi = 8.9 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1ccc2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c2c1 10.1016/s0960-894x(98)00446-6
CHEMBL432947 174904 0 None 30 3 Human 8.9 pKi = 8.9 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1ccc2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c2c1 10.1016/s0960-894x(98)00446-6
10578548 43786 0 None 398 3 Human 8.9 pKi = 8.9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 548 9 0 6 6.2 COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145178 43786 0 None 398 3 Human 8.9 pKi = 8.9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 548 9 0 6 6.2 COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10643502 107726 0 None 1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 380 4 2 5 1.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4[nH]ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL294098 107726 0 None 1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 380 4 2 5 1.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4[nH]ccc4c3=O)C[C@@H]21 10.1021/jm000541z
11505007 175702 0 None -3 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 557 9 1 7 4.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL438673 175702 0 None -3 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 557 9 1 7 4.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
44431616 94851 0 None 3 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 471 8 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234649 94851 0 None 3 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 471 8 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
10342554 111559 0 None 33 3 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 428 7 0 6 3.8 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL310890 111559 0 None 33 3 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 428 7 0 6 3.8 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00436-5
57400556 76085 0 None -1 5 Pig 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 495 13 1 8 3.1 CCOCCOc1ccn2ncc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
CHEMBL1928134 76085 0 None -1 5 Pig 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 495 13 1 8 3.1 CCOCCOc1ccn2ncc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
57400557 76087 0 None -1 5 Pig 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 509 14 1 8 3.2 CCOCCOCc1ccn2ncc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
CHEMBL1928136 76087 0 None -1 5 Pig 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 509 14 1 8 3.2 CCOCCOCc1ccn2ncc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
10650633 44311 0 None 64 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 566 8 2 7 3.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1 10.1021/jm990200p
CHEMBL145610 44311 0 None 64 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 566 8 2 7 3.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1 10.1021/jm990200p
10603727 44464 0 None 114 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 606 10 3 8 3.4 CCC1=C(C(=O)NC)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL145752 44464 0 None 114 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 606 10 3 8 3.4 CCC1=C(C(=O)NC)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
11994665 18606 0 None -1 7 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182151 18606 0 None -1 7 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL215151 18606 0 None -1 7 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
10770317 210670 0 None 123 2 Human 8.9 pKi = 8.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 632 12 2 10 3.2 COc1cc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc(OC)c1OC 10.1021/jm9905918
CHEMBL68913 210670 0 None 123 2 Human 8.9 pKi = 8.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 632 12 2 10 3.2 COc1cc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc(OC)c1OC 10.1021/jm9905918
44268966 40211 0 None 5 6 Bovine 8.9 pKi = 8.9 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 7 1 7 3.6 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL14199 40211 0 None 5 6 Bovine 8.9 pKi = 8.9 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 7 1 7 3.6 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
44275255 105380 0 None 223 3 Human 8.9 pKi = 8.9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 636 12 2 7 7.2 CCC1=NC(CC)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)/C1=C(\O)OC 10.1021/jm960697s
CHEMBL276932 105380 0 None 223 3 Human 8.9 pKi = 8.9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 636 12 2 7 7.2 CCC1=NC(CC)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)/C1=C(\O)OC 10.1021/jm960697s
11554541 78583 0 None -25 4 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc([N+](=O)[O-])cc1 10.1021/jm0580398
CHEMBL196817 78583 0 None -25 4 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc([N+](=O)[O-])cc1 10.1021/jm0580398
11751173 70200 0 None -1 6 Human 8.9 pKi = 8.9 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 445 4 1 9 2.3 COc1cc2nc(N3CCN(C4=CC(=O)c5ccccc5C4=O)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL179743 70200 0 None -1 6 Human 8.9 pKi = 8.9 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 445 4 1 9 2.3 COc1cc2nc(N3CCN(C4=CC(=O)c5ccccc5C4=O)CC3)nc(N)c2cc1OC 10.1021/jm049153d
497 10138 8 None 61 3 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1016/s0960-894x(03)00305-6
9872515 10138 8 None 61 3 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1016/s0960-894x(03)00305-6
CHEMBL24777 10138 8 None 61 3 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1016/s0960-894x(03)00305-6
9804599 108477 0 None 25 3 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 430 7 1 6 1.8 O=c1cc[nH]c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL299452 108477 0 None 25 3 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 430 7 1 6 1.8 O=c1cc[nH]c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
10506361 164484 0 None 1 3 Rat 8.9 pKi = 8.9 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 492 5 1 8 3.5 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc([N+](=O)[O-])cc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL40819 164484 0 None 1 3 Rat 8.9 pKi = 8.9 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 492 5 1 8 3.5 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc([N+](=O)[O-])cc54)c3=O)C[C@@H]21 10.1021/jm990567u
499 10849 18 None -1 14 Rat 8.9 pKi = 8.9 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960069a
5685 10849 18 None -1 14 Rat 8.9 pKi = 8.9 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960069a
CHEMBL25554 10849 18 None -1 14 Rat 8.9 pKi = 8.9 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960069a
10696645 150900 0 None -1 3 Rat 8.9 pKi = 8.9 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 461 4 1 6 3.9 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(C)c54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL39037 150900 0 None -1 3 Rat 8.9 pKi = 8.9 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 461 4 1 6 3.9 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(C)c54)c3=O)C[C@@H]21 10.1021/jm990567u
44431554 173457 0 None 20 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL428197 173457 0 None 20 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857710 149141 0 None 1 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 518 8 1 5 5.4 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1 10.1016/j.bmcl.2007.04.098
CHEMBL388897 149141 0 None 1 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 518 8 1 5 5.4 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1 10.1016/j.bmcl.2007.04.098
497 10138 8 None 61 3 Human 8.9 pKi = 8.9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1016/j.bmcl.2004.11.032
9872515 10138 8 None 61 3 Human 8.9 pKi = 8.9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1016/j.bmcl.2004.11.032
CHEMBL24777 10138 8 None 61 3 Human 8.9 pKi = 8.9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1016/j.bmcl.2004.11.032
56961506 128217 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 544 5 2 13 1.6 COc1cc2nc(N3CCN(C(=O)c4cn(-c5cc6ccc(O)cc6oc5=O)nn4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
CHEMBL3582269 128217 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 544 5 2 13 1.6 COc1cc2nc(N3CCN(C(=O)c4cn(-c5cc6ccc(O)cc6oc5=O)nn4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
10973768 114337 0 None -3 10 Bovine 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 563 6 1 8 4.4 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCn4c(=O)[nH]c5ccccc5c4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL318901 114337 0 None -3 10 Bovine 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 563 6 1 8 4.4 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCn4c(=O)[nH]c5ccccc5c4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
49781894 24678 0 None -3 4 Bovine 8.9 pKi = 8.9 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 423 3 1 4 4.3 CN1CCN(C2Cc3ccccc3Sc3ccc(CNC(=O)C(C)(C)C)cc32)CC1 10.1021/jm100652h
CHEMBL1259158 24678 0 None -3 4 Bovine 8.9 pKi = 8.9 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 423 3 1 4 4.3 CN1CCN(C2Cc3ccccc3Sc3ccc(CNC(=O)C(C)(C)C)cc32)CC1 10.1021/jm100652h
10099811 127801 4 None 676 4 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dogIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dog
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL356584 127801 4 None 676 4 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dogIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dog
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10841851 41089 0 None 562 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 569 9 4 6 2.2 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
CHEMBL142718 41089 0 None 562 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 569 9 4 6 2.2 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
9894818 105701 0 None 83 7 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm00019a001
CHEMBL279436 105701 0 None 83 7 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm00019a001
9809007 179343 8 None 134 6 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
CHEMBL448620 179343 8 None 134 6 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
9982585 108293 0 None 281 3 Human 8.9 pKi = 8.9 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 479 8 1 3 5.8 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL298058 108293 0 None 281 3 Human 8.9 pKi = 8.9 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 479 8 1 3 5.8 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
16721110 90464 0 None -7 3 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 451 5 1 6 3.7 COc1ccc(Cl)cc1N1CCN(CCn2c(C)nc3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL220515 90464 0 None -7 3 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 451 5 1 6 3.7 COc1ccc(Cl)cc1N1CCN(CCn2c(C)nc3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
11384634 101473 0 None -134 4 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 420 5 1 5 3.8 CC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL252818 101473 0 None -134 4 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 420 5 1 5 3.8 CC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
10480509 149109 0 None 89 2 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 483 2 2 5 4.4 COc1cc2c(c(Br)c1O)C[C@H]1c3c(c(Br)c(O)c(OC)c3-2)CCN1C 10.1021/np990433j
CHEMBL388564 149109 0 None 89 2 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 483 2 2 5 4.4 COc1cc2c(c(Br)c1O)C[C@H]1c3c(c(Br)c(O)c(OC)c3-2)CCN1C 10.1021/np990433j
136806217 214478 0 None 12 3 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 576 13 4 8 2.7 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
44328806 214478 0 None 12 3 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 576 13 4 8 2.7 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL95548 214478 0 None 12 3 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 576 13 4 8 2.7 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
10627021 113872 0 None 194 6 Human 8.9 pKi = 8.9 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 577 9 2 5 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1021/jm980077m
CHEMBL315914 113872 0 None 194 6 Human 8.9 pKi = 8.9 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 577 9 2 5 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1021/jm980077m
10627021 92062 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 577 9 2 5 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1007/s00044-004-0120-9
CHEMBL2260365 92062 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 577 9 2 5 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1007/s00044-004-0120-9
10606657 208267 0 None -1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 419 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C)c(C)cc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL60510 208267 0 None -1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 419 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C)c(C)cc4c3=O)C[C@@H]21 10.1021/jm000541z
52942047 23437 0 None 5 4 Human 8.9 pKi = 8.9 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 451 7 0 6 2.7 COc1ccccc1N1CCN(C[C@H]2CO[C@](CN3CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242444 23437 0 None 5 4 Human 8.9 pKi = 8.9 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 451 7 0 6 2.7 COc1ccccc1N1CCN(C[C@H]2CO[C@](CN3CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
44447039 161165 0 None -2 4 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 472 6 1 6 4.7 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccco1 10.1016/j.bmcl.2007.11.106
CHEMBL398744 161165 0 None -2 4 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 472 6 1 6 4.7 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccco1 10.1016/j.bmcl.2007.11.106
71454559 86419 0 None -1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4ccsc4c3=O)CC21 10.1021/jm000541z
CHEMBL2115086 86419 0 None -1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4ccsc4c3=O)CC21 10.1021/jm000541z
10692195 107382 0 None -1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccsc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL291839 107382 0 None -1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccsc4c3=O)C[C@@H]21 10.1021/jm000541z
20215436 35288 3 None -3 3 Human 8.9 pKi = 8.9 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 355 4 1 8 2.1 COc1cc2nc(N3CCN(c4ccco4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL137598 35288 3 None -3 3 Human 8.9 pKi = 8.9 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 355 4 1 8 2.1 COc1cc2nc(N3CCN(c4ccco4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
11857639 92523 1 None 56 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 492 7 1 4 5.2 CC(C)Oc1ccccc1C1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.098
CHEMBL229084 92523 1 None 56 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 492 7 1 4 5.2 CC(C)Oc1ccccc1C1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.098
6603950 210103 9 None -3 8 Bovine 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm020938y
CHEMBL64875 210103 9 None -3 8 Bovine 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm020938y
56837636 76072 0 None 7 5 Pig 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 897 28 2 13 5.1 COc1ccccc1N1CCN(CCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)c3)c2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928121 76072 0 None 7 5 Pig 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 897 28 2 13 5.1 COc1ccccc1N1CCN(CCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)c3)c2)CC1 10.1016/j.bmc.2011.10.063
10095044 109081 0 None 1 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 445 6 0 8 3.2 COc1ccccc1N1CCN(CCn2nc(-c3ccccc3)c3c(C)onc3c2=O)CC1 10.1021/jm0307741
CHEMBL303464 109081 0 None 1 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 445 6 0 8 3.2 COc1ccccc1N1CCN(CCn2nc(-c3ccccc3)c3c(C)onc3c2=O)CC1 10.1021/jm0307741
11189150 138711 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 413 7 1 6 3.2 O=C(NCCCCN1CCN(c2csc3cc(F)ccc23)CC1)c1cnccn1 10.1021/jm0491804
CHEMBL369520 138711 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 413 7 1 6 3.2 O=C(NCCCCN1CCN(c2csc3cc(F)ccc23)CC1)c1cnccn1 10.1021/jm0491804
10691912 174799 0 None 1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cnccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL432147 174799 0 None 1 3 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cnccc4c3=O)C[C@@H]21 10.1021/jm000541z
46224879 208326 3 None -6 7 Human 8.9 pKi = 8.9 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 302 2 0 2 4.6 Cc1ccc2c(c1)c1c(n2/C=C\c2ccccc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
CHEMBL605405 208326 3 None -6 7 Human 8.9 pKi = 8.9 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 302 2 0 2 4.6 Cc1ccc2c(c1)c1c(n2/C=C\c2ccccc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
11712250 79775 0 None -5 4 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1Cl 10.1021/jm0580398
CHEMBL200839 79775 0 None -5 4 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1Cl 10.1021/jm0580398
11454386 69881 0 None -1 6 Human 8.9 pKi = 8.9 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 477 8 1 9 3.6 COc1cc2nc(N3CCN(C(=O)CCCCC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL178923 69881 0 None -1 6 Human 8.9 pKi = 8.9 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 477 8 1 9 3.6 COc1cc2nc(N3CCN(C(=O)CCCCC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
11270912 206371 0 None -2 5 Human 8.8 pKi = 8.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 451 6 0 4 4.6 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL59262 206371 0 None -2 5 Human 8.8 pKi = 8.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 451 6 0 4 4.6 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
11270912 206371 0 None -2 5 Human 8.8 pKi = 8.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 451 6 0 4 4.6 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL59262 206371 0 None -2 5 Human 8.8 pKi = 8.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 451 6 0 4 4.6 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
10578990 210620 0 None 48 3 Human 8.8 pKi = 8.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccccc1N1C(=O)c2ccc(C(=O)NCC(O)CN3CCN(c4ccccc4OC(C)C)CC3)cc2C1=O 10.1021/jm9905918
CHEMBL68565 210620 0 None 48 3 Human 8.8 pKi = 8.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccccc1N1C(=O)c2ccc(C(=O)NCC(O)CN3CCN(c4ccccc4OC(C)C)CC3)cc2C1=O 10.1021/jm9905918
10508332 112768 0 None 109 6 Human 8.8 pKi = 8.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 638 11 2 8 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1 10.1021/jm980077m
CHEMBL313160 112768 0 None 109 6 Human 8.8 pKi = 8.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 638 11 2 8 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1 10.1021/jm980077m
10508332 92065 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 638 11 2 8 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1 10.1007/s00044-004-0120-9
CHEMBL2260368 92065 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 638 11 2 8 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1 10.1007/s00044-004-0120-9
44420428 90269 0 None -3 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 434 5 0 7 3.8 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL220221 90269 0 None -3 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 434 5 0 7 3.8 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
90645593 119262 0 None -1 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 569 8 2 8 3.9 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298746 119262 0 None -1 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 569 8 2 8 3.9 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
44420428 90269 0 None -3 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 434 5 0 7 3.8 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL220221 90269 0 None -3 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 434 5 0 7 3.8 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
10678161 107592 0 None -1 3 Rat 8.8 pKi = 8.8 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 455 5 1 8 2.2 COC(=O)c1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2s1 10.1021/jm000541z
CHEMBL293236 107592 0 None -1 3 Rat 8.8 pKi = 8.8 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 455 5 1 8 2.2 COC(=O)c1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2s1 10.1021/jm000541z
10256583 35605 0 None 1 3 Rat 8.8 pKi = 8.8 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 497 7 1 7 4.1 COc1cc2nc(N3CCN(C(=O)CC(c4ccccc4)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL137903 35605 0 None 1 3 Rat 8.8 pKi = 8.8 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 497 7 1 7 4.1 COc1cc2nc(N3CCN(C(=O)CC(c4ccccc4)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
44431599 94839 0 None 10 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 7 1 5 4.8 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1Cl 10.1016/j.bmcl.2007.04.008
CHEMBL234609 94839 0 None 10 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 7 1 5 4.8 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1Cl 10.1016/j.bmcl.2007.04.008
9915831 108881 0 None 50 2 Human 8.8 pKi = 8.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL302246 108881 0 None 50 2 Human 8.8 pKi = 8.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
9850782 110376 0 None 72 2 Human 8.8 pKi = 8.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(F)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL308671 110376 0 None 72 2 Human 8.8 pKi = 8.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(F)cc2)C3=O)CC1 10.1021/jm9905918
9931977 69814 0 None -1 4 Rat 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
CHEMBL1788223 69814 0 None -1 4 Rat 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
49781451 24630 0 None -2 4 Bovine 8.8 pKi = 8.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 387 2 0 4 4.7 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccncc4)cc32)CC1 10.1021/jm100652h
CHEMBL1259024 24630 0 None -2 4 Bovine 8.8 pKi = 8.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 387 2 0 4 4.7 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccncc4)cc32)CC1 10.1021/jm100652h
49781679 24651 0 None -1 4 Bovine 8.8 pKi = 8.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 414 2 0 3 6.0 Cc1cccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c1C 10.1021/jm100652h
CHEMBL1259080 24651 0 None -1 4 Bovine 8.8 pKi = 8.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 414 2 0 3 6.0 Cc1cccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c1C 10.1021/jm100652h
10531022 127847 0 None 44 3 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 566 8 2 7 3.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(F)c1 10.1021/jm990200p
CHEMBL356978 127847 0 None 44 3 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 566 8 2 7 3.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(F)c1 10.1021/jm990200p
11123606 212214 0 None 2 4 Human 8.8 pKi = 8.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 475 9 1 8 3.3 COc1ccccc1N1CCN(CCCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL80260 212214 0 None 2 4 Human 8.8 pKi = 8.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 475 9 1 8 3.3 COc1ccccc1N1CCN(CCCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
16121006 18613 0 None -75 8 Human 8.8 pKi = 8.8 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
CHEMBL1182182 18613 0 None -75 8 Human 8.8 pKi = 8.8 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
CHEMBL217469 18613 0 None -75 8 Human 8.8 pKi = 8.8 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
11539392 148020 0 None -12 4 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1C 10.1021/jm0580398
CHEMBL382972 148020 0 None -12 4 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1C 10.1021/jm0580398
16121006 18613 0 None -75 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182182 18613 0 None -75 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL217469 18613 0 None -75 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
16121006 18613 0 None -75 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL1182182 18613 0 None -75 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL217469 18613 0 None -75 8 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
10716502 213354 0 None 39 2 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 410 7 1 5 2.5 COc1ccccc1N1CCN(CCC(=O)Nc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL88820 213354 0 None 39 2 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 410 7 1 5 2.5 COc1ccccc1N1CCN(CCC(=O)Nc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10789868 213509 0 None 158 2 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 453 10 1 6 4.0 COc1ccccc1N1CCN(CCCNc2ccncc2C(=O)N(C(C)C)C(C)C)CC1 10.1021/jm970166j
CHEMBL89916 213509 0 None 158 2 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 453 10 1 6 4.0 COc1ccccc1N1CCN(CCCNc2ccncc2C(=O)N(C(C)C)C(C)C)CC1 10.1021/jm970166j
10552164 213679 0 None -1 3 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 466 9 1 6 3.4 CN(C)C(=O)c1cccnc1N1CCC(NCCOc2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL90869 213679 0 None -1 3 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 466 9 1 6 3.4 CN(C)C(=O)c1cccnc1N1CCC(NCCOc2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
10646065 213681 0 None -1 3 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 425 8 2 6 3.2 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)NC(C)(C)C)CC1 10.1021/jm970166j
CHEMBL90874 213681 0 None -1 3 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 425 8 2 6 3.2 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)NC(C)(C)C)CC1 10.1021/jm970166j
44324012 214028 0 None 6 3 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 397 8 2 6 2.4 COc1ccccc1N1CCN(CCCNc2nc(C)cc(C)c2C(N)=O)CC1 10.1021/jm970166j
CHEMBL92901 214028 0 None 6 3 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 397 8 2 6 2.4 COc1ccccc1N1CCN(CCCNc2nc(C)cc(C)c2C(N)=O)CC1 10.1021/jm970166j
44298671 169955 0 None 19 3 Human 8.8 pKi = 8.8 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 460 8 1 7 1.8 COc1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL418112 169955 0 None 19 3 Human 8.8 pKi = 8.8 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 460 8 1 7 1.8 COc1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
44298734 203487 0 None 31 3 Human 8.8 pKi = 8.8 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Cc1cc(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c(=O)[nH]1 10.1016/s0960-894x(03)00305-6
CHEMBL56489 203487 0 None 31 3 Human 8.8 pKi = 8.8 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Cc1cc(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c(=O)[nH]1 10.1016/s0960-894x(03)00305-6
10256583 35605 0 None -1 3 Human 8.8 pKi = 8.8 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 497 7 1 7 4.1 COc1cc2nc(N3CCN(C(=O)CC(c4ccccc4)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL137903 35605 0 None -1 3 Human 8.8 pKi = 8.8 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 497 7 1 7 4.1 COc1cc2nc(N3CCN(C(=O)CC(c4ccccc4)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
10627094 127869 0 None 269 3 Human 8.8 pKi = 8.8 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 581 10 0 7 5.8 COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL357131 127869 0 None 269 3 Human 8.8 pKi = 8.8 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 581 10 0 7 5.8 COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
44431587 94609 0 None -1 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 565 8 1 6 4.7 COc1ccc(Br)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233849 94609 0 None -1 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 565 8 1 6 4.7 COc1ccc(Br)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431560 152356 0 None -2 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
CHEMBL391530 152356 0 None -2 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
44431602 154372 0 None 5 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 5.2 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL393104 154372 0 None 5 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 5.2 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.04.008
44299975 108665 0 None 4 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL300766 108665 0 None 4 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
155552185 180840 0 None -2 16 Human 8.8 pKi = 8.8 Binding
Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)
ChEMBL 491 10 2 5 4.3 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
CHEMBL4544086 180840 0 None -2 16 Human 8.8 pKi = 8.8 Binding
Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)
ChEMBL 491 10 2 5 4.3 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
9959689 108590 0 None 281 3 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 568 7 2 7 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL300222 108590 0 None 281 3 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 568 7 2 7 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
11046644 37477 0 None -4 6 Human 8.8 pKi = 8.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 361 6 0 4 4.0 COc1cccc2c(CCCN3CCN(c4ccccn4)CC3)cccc12 10.1021/jm010866v
CHEMBL139505 37477 0 None -4 6 Human 8.8 pKi = 8.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 361 6 0 4 4.0 COc1cccc2c(CCCN3CCN(c4ccccn4)CC3)cccc12 10.1021/jm010866v
10813408 165132 0 None 2 3 Rat 8.8 pKi = 8.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 449 4 1 8 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cncnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL40896 165132 0 None 2 3 Rat 8.8 pKi = 8.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 449 4 1 8 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cncnc54)c3=O)C[C@@H]21 10.1021/jm990567u
90645599 119209 0 None -1 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 668 13 3 9 4.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCC(=O)NCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298017 119209 0 None -1 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 668 13 3 9 4.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCC(=O)NCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
10767959 167725 0 None -2 3 Rat 8.8 pKi = 8.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C#N)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL41155 167725 0 None -2 3 Rat 8.8 pKi = 8.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C#N)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
132266 8061 12 None -18 9 Rat 8.8 pKi = 8.8 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960510x
486 8061 12 None -18 9 Rat 8.8 pKi = 8.8 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960510x
CHEMBL423294 8061 12 None -18 9 Rat 8.8 pKi = 8.8 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960510x
90645601 119211 0 None -1 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 564 10 2 9 3.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCN(C)C)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298019 119211 0 None -1 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 564 10 2 9 3.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCN(C)C)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
136680383 174781 0 None 21 3 Human 8.8 pKi = 8.8 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(N)=O)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
44328800 174781 0 None 21 3 Human 8.8 pKi = 8.8 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(N)=O)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL432026 174781 0 None 21 3 Human 8.8 pKi = 8.8 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(N)=O)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
16041629 102221 0 None 1 4 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cc(F)ccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL257097 102221 0 None 1 4 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cc(F)ccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
155515982 176789 0 None -6 17 Human 8.8 pKi = 8.8 Binding
Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)
ChEMBL 473 10 2 5 4.1 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
CHEMBL4442460 176789 0 None -6 17 Human 8.8 pKi = 8.8 Binding
Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)
ChEMBL 473 10 2 5 4.1 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
10580182 44247 0 None 1862 3 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 658 7 1 8 4.0 COCC1=C(C(=O)OC)C(c2cc(F)c(F)c(F)c2)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL145553 44247 0 None 1862 3 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 658 7 1 8 4.0 COCC1=C(C(=O)OC)C(c2cc(F)c(F)c(F)c2)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1 10.1021/jm990201h
9984150 108546 0 None 891 3 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 519 7 0 4 5.6 Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CCCN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL299914 108546 0 None 891 3 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 519 7 0 4 5.6 Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CCCN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
10599007 211294 0 None -5 8 Rat 8.8 pKi = 8.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccc(C)cc1 10.1021/jm960069a
CHEMBL72657 211294 0 None -5 8 Rat 8.8 pKi = 8.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccc(C)cc1 10.1021/jm960069a
10793665 113729 0 None 69 6 Human 8.8 pKi = 8.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 597 9 2 5 7.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1021/jm980077m
CHEMBL314960 113729 0 None 69 6 Human 8.8 pKi = 8.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 597 9 2 5 7.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1021/jm980077m
10793665 92056 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 597 9 2 5 6.3 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1007/s00044-004-0120-9
CHEMBL2260359 92056 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 597 9 2 5 6.3 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1007/s00044-004-0120-9
15054187 198445 0 None - 1 Rat 8.7 pKi = 8.7 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 389 4 2 5 2.0 O=c1[nH]c2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccccc2)CC1 10.1021/jm00110a014
CHEMBL51963 198445 0 None - 1 Rat 8.7 pKi = 8.7 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 389 4 2 5 2.0 O=c1[nH]c2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccccc2)CC1 10.1021/jm00110a014
11857709 92403 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL228334 92403 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857638 150588 0 None -1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL390129 150588 0 None -1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857711 92396 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 506 7 1 4 5.5 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
CHEMBL228280 92396 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 506 7 1 4 5.5 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
11857709 92403 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228334 92403 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
9808529 210651 0 None 20 2 Human 8.7 pKi = 8.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 587 10 2 9 3.1 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc([N+](=O)[O-])cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL68746 210651 0 None 20 2 Human 8.7 pKi = 8.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 587 10 2 9 3.1 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc([N+](=O)[O-])cc2)C3=O)CC1 10.1021/jm9905918
18738384 171156 0 None 25 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 441 7 0 5 4.8 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL421297 171156 0 None 25 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 441 7 0 5 4.8 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00347-5
44431180 99624 0 None -9 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 497 5 0 5 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccccc5c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243864 99624 0 None -9 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 497 5 0 5 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccccc5c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
10793023 128300 0 None 60 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 562 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(C)c1 10.1021/jm990200p
CHEMBL358489 128300 0 None 60 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 562 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(C)c1 10.1021/jm990200p
10394346 23735 0 None -1 5 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 638 11 2 10 3.0 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C(N)=O)CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL125365 23735 0 None -1 5 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 638 11 2 10 3.0 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C(N)=O)CC3)cccc2c1=O 10.1021/jm030825u
487 10406 21 None -1 12 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00019a001
60602 10406 21 None -1 12 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00019a001
CHEMBL405355 10406 21 None -1 12 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00019a001
DB09239 10406 21 None -1 12 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00019a001
11270912 206371 0 None -2 5 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 451 6 0 4 4.6 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL59262 206371 0 None -2 5 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 451 6 0 4 4.6 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
10674896 213423 0 None 83 6 Human 8.7 pKi = 8.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 588 9 2 6 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1 10.1021/jm980077m
CHEMBL89243 213423 0 None 83 6 Human 8.7 pKi = 8.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 588 9 2 6 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1 10.1021/jm980077m
10674896 92047 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 588 9 2 6 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1 10.1007/s00044-004-0120-9
CHEMBL2260149 92047 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 588 9 2 6 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1 10.1007/s00044-004-0120-9
53327748 70162 0 None 2 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 435 8 0 5 3.5 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796033 70162 0 None 2 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 435 8 0 5 3.5 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
9894818 105701 0 None 83 7 Human 8.7 pKi = 8.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL279436 105701 0 None 83 7 Human 8.7 pKi = 8.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
10651654 118260 0 None 61 6 Human 8.7 pKi = 8.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 631 9 2 5 7.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1 10.1021/jm980077m
CHEMBL327712 118260 0 None 61 6 Human 8.7 pKi = 8.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 631 9 2 5 7.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1 10.1021/jm980077m
10651654 92064 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 631 9 2 5 7.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1 10.1007/s00044-004-0120-9
CHEMBL2260367 92064 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 631 9 2 5 7.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1 10.1007/s00044-004-0120-9
9894818 105701 0 None 83 7 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL279436 105701 0 None 83 7 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
44390749 70684 0 None 173 6 Human 8.7 pKi = 8.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm960697s
CHEMBL180561 70684 0 None 173 6 Human 8.7 pKi = 8.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm960697s
4209 9937 75 None -1 33 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
4893 9937 75 None -1 33 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
503 9937 75 None -1 33 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
5385 9937 75 None -1 33 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
CHEMBL2 9937 75 None -1 33 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
DB00457 9937 75 None -1 33 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
145962342 168202 0 None -29 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 521 9 0 8 5.1 CCCN(CCC)c1nc(N2CCN(C(=O)c3ccco3)[C@@H]3CCCC[C@@H]32)nc2cc(OC)c(OC)cc12 10.1016/j.bmc.2018.05.023
CHEMBL4126860 168202 0 None -29 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 521 9 0 8 5.1 CCCN(CCC)c1nc(N2CCN(C(=O)c3ccco3)[C@@H]3CCCC[C@@H]32)nc2cc(OC)c(OC)cc12 10.1016/j.bmc.2018.05.023
10767981 203041 0 None -1 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 509 11 1 9 3.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)C3COc4ccccc4O3)nc(N)c2cc1OC 10.1021/jm8016046
CHEMBL561851 203041 0 None -1 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 509 11 1 9 3.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)C3COc4ccccc4O3)nc(N)c2cc1OC 10.1021/jm8016046
44390749 70684 0 None 173 6 Human 8.7 pKi = 8.7 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1016/s0960-894x(99)00484-9
CHEMBL180561 70684 0 None 173 6 Human 8.7 pKi = 8.7 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1016/s0960-894x(99)00484-9
9894818 105701 0 None 83 7 Human 8.7 pKi = 8.7 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL279436 105701 0 None 83 7 Human 8.7 pKi = 8.7 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
44447059 101324 0 None -23 4 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 473 6 1 7 4.1 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccno1 10.1016/j.bmcl.2007.11.106
CHEMBL251834 101324 0 None -23 4 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 473 6 1 7 4.1 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccno1 10.1016/j.bmcl.2007.11.106
10742417 209552 0 None 1 3 Rat 8.7 pKi = 8.7 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 455 5 1 6 3.0 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1Cl 10.1021/jm000541z
CHEMBL62109 209552 0 None 1 3 Rat 8.7 pKi = 8.7 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 455 5 1 6 3.0 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1Cl 10.1021/jm000541z
10793503 126493 0 None 616 3 Human 8.7 pKi = 8.7 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 11 2 8 4.5 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL347499 126493 0 None 616 3 Human 8.7 pKi = 8.7 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 11 2 8 4.5 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
44390749 70684 0 None 173 6 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1016/j.bmcl.2004.11.032
CHEMBL180561 70684 0 None 173 6 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1016/j.bmcl.2004.11.032
57391895 76076 0 None 14 5 Pig 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 925 30 2 13 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928125 76076 0 None 14 5 Pig 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 925 30 2 13 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
9916549 128342 0 None 1 4 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dogIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dog
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL358595 128342 0 None 1 4 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dogIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dog
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
9916549 128342 0 None 1 4 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL358595 128342 0 None 1 4 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10531675 43555 0 None 19 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 602 8 2 5 5.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL144989 43555 0 None 19 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 602 8 2 5 5.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10793503 126493 0 None 616 3 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 588 11 2 8 4.5 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL347499 126493 0 None 616 3 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 588 11 2 8 4.5 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
44446999 101472 0 None 2 3 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 474 5 1 5 4.3 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)C(F)(F)F 10.1016/j.bmcl.2007.11.106
CHEMBL252816 101472 0 None 2 3 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 474 5 1 5 4.3 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)C(F)(F)F 10.1016/j.bmcl.2007.11.106
10048729 195922 0 None 3 4 Human 8.7 pKi = 8.7 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 437 5 1 8 2.5 Cn1nc(Cl)c2cn3nc(NCCN4CCN(c5ccccc5)CC4)ccc3c2c1=O 10.1021/jm981006q
CHEMBL51074 195922 0 None 3 4 Human 8.7 pKi = 8.7 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 437 5 1 8 2.5 Cn1nc(Cl)c2cn3nc(NCCN4CCN(c5ccccc5)CC4)ccc3c2c1=O 10.1021/jm981006q
9847845 35226 0 None -7 6 Rat 8.7 pKi = 8.7 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(C)c(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13754 35226 0 None -7 6 Rat 8.7 pKi = 8.7 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(C)c(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
11604548 79663 0 None -31 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(C)cc1 10.1007/s00044-010-9379-1
CHEMBL200366 79663 0 None -31 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(C)cc1 10.1007/s00044-010-9379-1
11532563 173158 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 14 1 7 4.3 COc1cccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)c1 10.1007/s00044-010-9379-1
CHEMBL427552 173158 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 14 1 7 4.3 COc1cccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)c1 10.1007/s00044-010-9379-1
11604548 79663 0 None -31 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(C)cc1 10.1007/s00044-010-9379-1
CHEMBL200366 79663 0 None -31 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(C)cc1 10.1007/s00044-010-9379-1
11532563 173158 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 14 1 7 4.3 COc1cccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)c1 10.1007/s00044-010-9379-1
CHEMBL427552 173158 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 14 1 7 4.3 COc1cccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)c1 10.1007/s00044-010-9379-1
9809007 179343 8 None 134 6 Human 8.7 pKi = 8.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
CHEMBL448620 179343 8 None 134 6 Human 8.7 pKi = 8.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
11705133 79105 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 453 14 1 7 4.3 COc1ccccc1COc1ccccc1OCCNCCOc1c(OC)cccc1OC 10.1021/jm0580398
CHEMBL198431 79105 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 453 14 1 7 4.3 COc1ccccc1COc1ccccc1OCCNCCOc1c(OC)cccc1OC 10.1021/jm0580398
11604548 79663 0 None -31 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(C)cc1 10.1021/jm0580398
CHEMBL200366 79663 0 None -31 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(C)cc1 10.1021/jm0580398
11669646 79723 0 None -19 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 453 14 1 7 4.3 COc1ccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)cc1 10.1021/jm0580398
CHEMBL200580 79723 0 None -19 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 453 14 1 7 4.3 COc1ccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)cc1 10.1021/jm0580398
11532563 173158 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 453 14 1 7 4.3 COc1cccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)c1 10.1021/jm0580398
CHEMBL427552 173158 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 453 14 1 7 4.3 COc1cccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)c1 10.1021/jm0580398
52941004 23863 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 407 13 1 5 4.7 CCOc1ccccc1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254914 23863 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 407 13 1 5 4.7 CCOc1ccccc1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
71817547 109355 0 None -7 7 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL2419771 109355 0 None -7 7 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL3040800 109355 0 None -7 7 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
134139869 152978 0 None -1 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 384 8 0 5 3.9 COc1ccc(CCN2CCN(c3ccccc3OC(C)C)CC2)cc1OC 10.1016/j.ejmech.2016.06.052
CHEMBL3920110 152978 0 None -1 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 384 8 0 5 3.9 COc1ccc(CCN2CCN(c3ccccc3OC(C)C)CC2)cc1OC 10.1016/j.ejmech.2016.06.052
10642742 213574 0 None 3 3 Bovine 8.7 pKi = 8.7 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 367 7 1 5 2.4 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2)CC1 10.1021/jm970166j
CHEMBL90287 213574 0 None 3 3 Bovine 8.7 pKi = 8.7 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 367 7 1 5 2.4 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2)CC1 10.1021/jm970166j
44298694 107468 0 None 9 3 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 426 7 1 6 2.0 Cc1cn(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c(=O)[nH]c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL292403 107468 0 None 9 3 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 426 7 1 6 2.0 Cc1cn(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c(=O)[nH]c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL5272464 201404 0 None -11 3 Human 8.0 pKi = 8 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 480 10 1 5 4.4 CCCNC(=O)CCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315453 201404 0 None -11 3 Human 8.0 pKi = 8 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 480 10 1 5 4.4 CCCNC(=O)CCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
10415038 11211 0 None 3 4 Human 8.0 pKi = 8 Binding
Binding affinity against Alpha-1A adrenergic receptor in human prostatic tissueBinding affinity against Alpha-1A adrenergic receptor in human prostatic tissue
ChEMBL 545 6 1 7 5.3 Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
CHEMBL101610 11211 0 None 3 4 Human 8.0 pKi = 8 Binding
Binding affinity against Alpha-1A adrenergic receptor in human prostatic tissueBinding affinity against Alpha-1A adrenergic receptor in human prostatic tissue
ChEMBL 545 6 1 7 5.3 Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
10415038 11211 0 None -3 4 Rat 8.0 pKi = 8 Binding
Binding affinity against Alpha-1A adrenergic receptor in rat prostatic tissueBinding affinity against Alpha-1A adrenergic receptor in rat prostatic tissue
ChEMBL 545 6 1 7 5.3 Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
CHEMBL101610 11211 0 None -3 4 Rat 8.0 pKi = 8 Binding
Binding affinity against Alpha-1A adrenergic receptor in rat prostatic tissueBinding affinity against Alpha-1A adrenergic receptor in rat prostatic tissue
ChEMBL 545 6 1 7 5.3 Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
135398737 7745 93 None -5 90 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
38 7745 93 None -5 90 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
722 7745 93 None -5 90 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
CHEMBL42 7745 93 None -5 90 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
DB00363 7745 93 None -5 90 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
2389 10104 118 None -11 66 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
5073 10104 118 None -11 66 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
96 10104 118 None -11 66 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
CHEMBL85 10104 118 None -11 66 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
DB00734 10104 118 None -11 66 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
52937631 68081 0 None -50 3 Human 8.0 pKi = 8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 347 4 0 4 3.4 Cc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1 10.1021/jm1013874
CHEMBL1767141 68081 0 None -50 3 Human 8.0 pKi = 8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 347 4 0 4 3.4 Cc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1 10.1021/jm1013874
44431587 173931 0 None 3 4 Human 8.0 pKi = 8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 565 8 1 6 4.7 COc1ccc(Br)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL429076 173931 0 None 3 4 Human 8.0 pKi = 8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 565 8 1 6 4.7 COc1ccc(Br)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857792 150681 0 None 3 4 Human 8.0 pKi = 8 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 560 8 1 5 5.8 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2007.04.098
CHEMBL390192 150681 0 None 3 4 Human 8.0 pKi = 8 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 560 8 1 5 5.8 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2007.04.098
1524 8962 96 None -7 51 Rat 8.0 pKi = 8 Binding
Binding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 minsBinding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 mins
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1021/acs.jmedchem.2c00633
197 8962 96 None -7 51 Rat 8.0 pKi = 8 Binding
Binding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 minsBinding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 mins
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1021/acs.jmedchem.2c00633
3822 8962 96 None -7 51 Rat 8.0 pKi = 8 Binding
Binding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 minsBinding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 mins
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1021/acs.jmedchem.2c00633
88 8962 96 None -7 51 Rat 8.0 pKi = 8 Binding
Binding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 minsBinding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 mins
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1021/acs.jmedchem.2c00633
CHEMBL51 8962 96 None -7 51 Rat 8.0 pKi = 8 Binding
Binding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 minsBinding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 mins
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1021/acs.jmedchem.2c00633
DB12465 8962 96 None -7 51 Rat 8.0 pKi = 8 Binding
Binding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 minsBinding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 mins
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1021/acs.jmedchem.2c00633
115 7131 71 None -3 7 Human 8.0 pKi = 8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm960697s
2092 7131 71 None -3 7 Human 8.0 pKi = 8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm960697s
7109 7131 71 None -3 7 Human 8.0 pKi = 8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm960697s
CHEMBL709 7131 71 None -3 7 Human 8.0 pKi = 8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm960697s
DB00346 7131 71 None -3 7 Human 8.0 pKi = 8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm960697s
46934793 23401 0 None -7 4 Human 8.0 pKi = 8 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 533 7 0 7 3.8 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CC4(CCCC4)CC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1241557 23401 0 None -7 4 Human 8.0 pKi = 8 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 533 7 0 7 3.8 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CC4(CCCC4)CC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
52941056 23895 0 None -1 4 Human 8.0 pKi = 8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 363 11 1 4 4.3 c1ccc(COc2ccccc2OCCNCCOc2ccccc2)cc1 10.1016/j.bmc.2010.08.002
CHEMBL1255086 23895 0 None -1 4 Human 8.0 pKi = 8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 363 11 1 4 4.3 c1ccc(COc2ccccc2OCCNCCOc2ccccc2)cc1 10.1016/j.bmc.2010.08.002
11668565 22844 0 None -3 3 Human 8.0 pKi = 8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 404 8 1 4 4.9 Fc1ccccc1N1CCN(CCCCNc2ccc(-c3ccccc3)cn2)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL1223799 22844 0 None -3 3 Human 8.0 pKi = 8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 404 8 1 4 4.9 Fc1ccccc1N1CCN(CCCCNc2ccc(-c3ccccc3)cn2)CC1 10.1016/j.bmcl.2010.07.096
71508685 93827 0 None 2 2 Bovine 8.0 pKi = 8 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 385 3 0 3 5.6 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccncc4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325930 93827 0 None 2 2 Bovine 8.0 pKi = 8 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 385 3 0 3 5.6 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccncc4)cc23)CC1 10.1016/j.bmc.2012.10.049
10555223 43899 0 None 158 3 Human 8.0 pKi = 8 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 579 9 3 8 3.3 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(=O)O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm990200p
CHEMBL145267 43899 0 None 158 3 Human 8.0 pKi = 8 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 579 9 3 8 3.3 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(=O)O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm990200p
53328685 70173 0 None 5 3 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 435 7 0 5 3.3 COc1ccccc1N1CCN(CCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796044 70173 0 None 5 3 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 435 7 0 5 3.3 COc1ccccc1N1CCN(CCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
118716707 121779 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 519 5 0 6 3.9 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccc(C(F)(F)F)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342860 121779 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 519 5 0 6 3.9 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccc(C(F)(F)F)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44447013 176182 0 None -4 4 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 500 6 1 5 5.2 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccc(F)cc1 10.1016/j.bmcl.2007.11.106
CHEMBL442290 176182 0 None -4 4 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 500 6 1 5 5.2 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccc(F)cc1 10.1016/j.bmcl.2007.11.106
127028034 144428 0 None 3 3 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 404 9 0 4 5.2 COc1ccccc1N1CCN(CCCCCOc2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3758368 144428 0 None 3 3 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 404 9 0 4 5.2 COc1ccccc1N1CCN(CCCCCOc2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2015.12.068
44447028 101382 0 None -10 4 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 510 8 1 5 5.4 O=C(CCc1ccccc1)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL252201 101382 0 None -10 4 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 510 8 1 5 5.4 O=C(CCc1ccccc1)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
8459 10071 4 None -10 3 Human 8.0 pKi = 8.0 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm9805337
9891980 10071 4 None -10 3 Human 8.0 pKi = 8.0 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm9805337
CHEMBL430717 10071 4 None -10 3 Human 8.0 pKi = 8.0 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm9805337
44428849 150407 0 None -6 3 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 436 4 2 7 2.8 COc1cc2nc(N3CCN(C(=O)c4ccc[nH]4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL389978 150407 0 None -6 3 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 436 4 2 7 2.8 COc1cc2nc(N3CCN(C(=O)c4ccc[nH]4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
118716706 121777 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 451 5 0 6 2.9 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342859 121777 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 451 5 0 6 2.9 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
11474937 203953 0 None -9 4 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 395 5 0 4 3.4 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2C2CC2)CC1 10.1021/jm030944+
CHEMBL56804 203953 0 None -9 4 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 395 5 0 4 3.4 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2C2CC2)CC1 10.1021/jm030944+
44447008 101542 0 None -2 4 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 482 6 1 5 5.1 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccccc1 10.1016/j.bmcl.2007.11.106
CHEMBL253233 101542 0 None -2 4 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 482 6 1 5 5.1 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccccc1 10.1016/j.bmcl.2007.11.106
9867616 175105 0 None -2 3 Rat 8.0 pKi = 8.0 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 435 6 1 8 2.2 COc1cc2nc(N3CCN(C(=O)CC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL434228 175105 0 None -2 3 Rat 8.0 pKi = 8.0 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 435 6 1 8 2.2 COc1cc2nc(N3CCN(C(=O)CC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
44318081 170092 0 None 3 3 Human 7.0 pKi = 7 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)[C@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@@H]1c1ccccc1 10.1016/s0960-894x(98)00451-x
CHEMBL418926 170092 0 None 3 3 Human 7.0 pKi = 7 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)[C@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@@H]1c1ccccc1 10.1016/s0960-894x(98)00451-x
9822477 206231 0 None -34 5 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
CHEMBL59149 206231 0 None -34 5 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
242 7258 124 None -14 51 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
34 7258 124 None -14 51 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
60795 7258 124 None -14 51 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
CHEMBL1112 7258 124 None -14 51 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
DB01238 7258 124 None -14 51 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
2337 10030 77 None -5 62 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1039/C2MD00311B
50 10030 77 None -5 62 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1039/C2MD00311B
5002 10030 77 None -5 62 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1039/C2MD00311B
CHEMBL716 10030 77 None -5 62 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1039/C2MD00311B
DB01224 10030 77 None -5 62 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1039/C2MD00311B
52937119 68094 0 None -15 3 Human 7.0 pKi = 7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.6 CN1CCC(Cn2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)C1 10.1021/jm1013874
CHEMBL1767155 68094 0 None -15 3 Human 7.0 pKi = 7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.6 CN1CCC(Cn2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)C1 10.1021/jm1013874
24803641 68098 0 None -199 4 Human 7.0 pKi = 7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 612 10 0 6 7.5 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(Cc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
CHEMBL1767159 68098 0 None -199 4 Human 7.0 pKi = 7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 612 10 0 6 7.5 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(Cc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
24803639 68105 0 None -251 4 Human 7.0 pKi = 7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 622 14 1 7 6.8 O=c1c2ccccc2c(Cc2ccc(O)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
CHEMBL1767166 68105 0 None -251 4 Human 7.0 pKi = 7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 622 14 1 7 6.8 O=c1c2ccccc2c(Cc2ccc(O)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
44431557 153450 0 None -1 4 Human 7.0 pKi = 7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 541 8 1 6 4.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL392377 153450 0 None -1 4 Human 7.0 pKi = 7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 541 8 1 6 4.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
10362296 101863 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 378 8 1 3 3.6 CC(=O)CC(=O)NCCCN1CCC(c2ccccc2)(c2ccccc2)CC1 10.1021/jm960697s
CHEMBL25537 101863 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 378 8 1 3 3.6 CC(=O)CC(=O)NCCCN1CCC(c2ccccc2)(c2ccccc2)CC1 10.1021/jm960697s
44417715 18610 0 None 2 4 Human 7.0 pKi = 7 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL1182160 18610 0 None 2 4 Human 7.0 pKi = 7 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL215857 18610 0 None 2 4 Human 7.0 pKi = 7 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
11135150 14375 0 None -1 5 Human 7.0 pKi = 7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1087942 14375 0 None -1 5 Human 7.0 pKi = 7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL287686 14375 0 None -1 5 Human 7.0 pKi = 7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
9822477 206231 0 None -34 5 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
CHEMBL59149 206231 0 None -34 5 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
9908478 202415 1 None -7079 7 Human 6.0 pKi = 6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2F)CC1 10.1021/jm0491391
CHEMBL556313 202415 1 None -7079 7 Human 6.0 pKi = 6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2F)CC1 10.1021/jm0491391
135398745 9688 112 None -39 65 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
47 9688 112 None -39 65 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
CHEMBL715 9688 112 None -39 65 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
DB00334 9688 112 None -39 65 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
9923249 12369 0 None - 1 Rat 6.0 pKi = 6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 323 4 2 4 2.8 CCS(=O)(=O)Nc1cccc2c1SCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL107726 12369 0 None - 1 Rat 6.0 pKi = 6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 323 4 2 4 2.8 CCS(=O)(=O)Nc1cccc2c1SCCC2c1c[nH]cn1 10.1021/jm030551a
16041451 104584 0 None -5 4 Human 7.0 pKi = 7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 500 7 2 5 5.4 COc1ccc(Cl)cc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL271913 104584 0 None -5 4 Human 7.0 pKi = 7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 500 7 2 5 5.4 COc1ccc(Cl)cc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
16756753 98903 1 None -37 3 Human 6.0 pKi = 6 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 478 7 1 3 7.0 Cc1ccc(C2CCN(Cc3ccc(Oc4ccc(F)c(F)c4)cc3)CC2)cc1NC(=O)C(C)C 10.1021/jm060383x
CHEMBL242003 98903 1 None -37 3 Human 6.0 pKi = 6 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 478 7 1 3 7.0 Cc1ccc(C2CCN(Cc3ccc(Oc4ccc(F)c(F)c4)cc3)CC2)cc1NC(=O)C(C)C 10.1021/jm060383x
44417709 19192 0 None 2 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
CHEMBL1185857 19192 0 None 2 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
CHEMBL436955 19192 0 None 2 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
127025275 144460 0 None -263 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 474 9 2 5 4.7 CCOC(=O)Nc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1 10.1016/j.bmcl.2015.12.068
CHEMBL3758665 144460 0 None -263 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 474 9 2 5 4.7 CCOC(=O)Nc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1 10.1016/j.bmcl.2015.12.068
19085921 111686 0 None 1 3 Human 6.0 pKi = 6.0 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 513 7 0 9 2.6 COC(=O)c1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL311290 111686 0 None 1 3 Human 6.0 pKi = 6.0 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 513 7 0 9 2.6 COC(=O)c1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00446-6
10939408 54197 0 None -35 5 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 455 7 1 3 5.5 O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL154508 54197 0 None -35 5 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 455 7 1 3 5.5 O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
25022505 195070 0 None 2 3 Rat 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 586 10 1 8 2.9 COC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL500266 195070 0 None 2 3 Rat 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 586 10 1 8 2.9 COC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
3191 109635 97 None -204 25 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
CHEMBL305660 109635 97 None -204 25 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
DB11742 109635 97 None -204 25 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
102 10899 48 None -346 49 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
3659 10899 48 None -346 49 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
8969 10899 48 None -346 49 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
CHEMBL15245 10899 48 None -346 49 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
DB01392 10899 48 None -346 49 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
127046693 146445 0 None -2 2 Human 6.0 pKi = 6.0 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000341aCl ADRA1ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000341aCl ADRA1A
ChEMBL 300 3 2 4 2.2 C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N 10.6019/CHEMBL5212743
CHEMBL3797887 146445 0 None -2 2 Human 6.0 pKi = 6.0 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000341aCl ADRA1ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000341aCl ADRA1A
ChEMBL 300 3 2 4 2.2 C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N 10.6019/CHEMBL5212743
CHEMBL4762646 146445 0 None -2 2 Human 6.0 pKi = 6.0 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000341aCl ADRA1ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000341aCl ADRA1A
ChEMBL 300 3 2 4 2.2 C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N 10.6019/CHEMBL5212743
2812 11551 101 None -2238 34 Rat 5.0 pKi = 5.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
CHEMBL104 11551 101 None -2238 34 Rat 5.0 pKi = 5.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
9844321 107638 0 None -588 5 Rat 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 407 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL293539 107638 0 None -588 5 Rat 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 407 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2Cl)CC1 10.1021/jm030944+
10669270 173068 0 None -28 2 Rat 7.0 pKi = 7.0 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 410 5 0 4 2.6 O=C1C2CCCN2C(=O)N1CCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
CHEMBL42706 173068 0 None -28 2 Rat 7.0 pKi = 7.0 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 410 5 0 4 2.6 O=C1C2CCCN2C(=O)N1CCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
14004040 58409 0 None -6 2 Bovine 7.0 pKi = 7.0 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 227 0 0 2 3.5 c1ccc2c3c(oc2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL158371 58409 0 None -6 2 Bovine 7.0 pKi = 7.0 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 227 0 0 2 3.5 c1ccc2c3c(oc2c1)C1CCCCN1CC3 10.1021/jm00398a025
145951352 169539 0 None -2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 397 5 2 8 2.2 COc1cc2nc(N3CCC[C@@H](NC(=O)c4ccco4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4171710 169539 0 None -2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 397 5 2 8 2.2 COc1cc2nc(N3CCC[C@@H](NC(=O)c4ccco4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
56945164 78289 0 None -338 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 417 9 2 4 4.4 COc1ccccc1OCCNC[C@H]1CCC(c2ccccc2)(c2ccccc2)[C@@H]1O 10.1021/jm200421e
CHEMBL1946786 78289 0 None -338 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 417 9 2 4 4.4 COc1ccccc1OCCNC[C@H]1CCC(c2ccccc2)(c2ccccc2)[C@@H]1O 10.1021/jm200421e
CHEMBL1962756 78289 0 None -338 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 417 9 2 4 4.4 COc1ccccc1OCCNC[C@H]1CCC(c2ccccc2)(c2ccccc2)[C@@H]1O 10.1021/jm200421e
14004039 126339 3 None -5 2 Bovine 6.0 pKi = 6.0 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 193 0 0 2 2.8 c1cc2c(s1)C1CCCCN1CC2 10.1021/jm00398a025
CHEMBL346016 126339 3 None -5 2 Bovine 6.0 pKi = 6.0 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 193 0 0 2 2.8 c1cc2c(s1)C1CCCCN1CC2 10.1021/jm00398a025
10744391 214142 0 None 7 3 Human 8.0 pKi = 8.0 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 514 7 1 3 4.8 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)N(C)C(=O)N1C 10.1021/jm990612y
CHEMBL93693 214142 0 None 7 3 Human 8.0 pKi = 8.0 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 514 7 1 3 4.8 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)N(C)C(=O)N1C 10.1021/jm990612y
1353 8692 93 None -6 85 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
3559 8692 93 None -6 85 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
86 8692 93 None -6 85 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
CHEMBL54 8692 93 None -6 85 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
DB00502 8692 93 None -6 85 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
10092649 199852 56 None 1 9 Human 8.0 pKi = 8.0 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 404 4 1 4 3.9 Cc1ccccc1CN1CCC(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)CC1 10.1021/jm100697g
CHEMBL522460 199852 56 None 1 9 Human 8.0 pKi = 8.0 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 404 4 1 4 3.9 Cc1ccccc1CN1CCC(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)CC1 10.1021/jm100697g
11519153 92394 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL228278 92394 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857861 201559 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL538397 201559 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
44431611 94260 0 None -7 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Cl)cc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233410 94260 0 None -7 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Cl)cc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
17753379 94578 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233816 94578 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431599 94795 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 7 1 5 4.8 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1Cl 10.1016/j.bmcl.2007.04.008
CHEMBL234423 94795 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 7 1 5 4.8 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1Cl 10.1016/j.bmcl.2007.04.008
44431574 153048 0 None 6 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 8 1 6 4.0 COc1ccc(F)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL392066 153048 0 None 6 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 8 1 6 4.0 COc1ccc(F)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
11519153 92394 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228278 92394 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
16041091 101996 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 468 7 2 4 4.5 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)NCc3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256041 101996 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 468 7 2 4 4.5 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)NCc3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
16041263 102222 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL257098 102222 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
145946966 174376 0 None -5 5 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 354 7 0 4 3.9 COc1ccccc1N1CCN(CCCOc2ccc(C)cc2C)CC1 10.1016/j.bmcl.2018.04.059
CHEMBL4209888 174376 0 None -5 5 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 354 7 0 4 3.9 COc1ccccc1N1CCN(CCCOc2ccc(C)cc2C)CC1 10.1016/j.bmcl.2018.04.059
CHEMBL4300899 174376 0 None -5 5 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 354 7 0 4 3.9 COc1ccccc1N1CCN(CCCOc2ccc(C)cc2C)CC1 10.1016/j.bmcl.2018.04.059
6603808 134300 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214986 134300 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL36622 134300 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3740374 134300 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
6603808 134300 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL214986 134300 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL36622 134300 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL3740374 134300 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
6603808 134300 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm301525w
CHEMBL214986 134300 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm301525w
CHEMBL36622 134300 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm301525w
CHEMBL3740374 134300 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm301525w
6603808 134300 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1039/C4MD00484A
CHEMBL214986 134300 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1039/C4MD00484A
CHEMBL36622 134300 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1039/C4MD00484A
CHEMBL3740374 134300 3 None -1 9 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1039/C4MD00484A
46934637 23443 0 None -7 4 Human 7.9 pKi = 7.9 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 6 3.1 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3CCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242542 23443 0 None -7 4 Human 7.9 pKi = 7.9 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 6 3.1 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3CCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
11994551 18612 0 None 1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
CHEMBL1182179 18612 0 None 1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
CHEMBL217143 18612 0 None 1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
50905589 63128 0 None 1 5 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@@H]2Oc3ccccc3O[C@@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630942 63128 0 None 1 5 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@@H]2Oc3ccccc3O[C@@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
44328920 115418 0 None 15 6 Human 7.9 pKi = 7.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 705 14 3 7 5.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCC(F)(F)F)N1 10.1016/s0960-894x(99)00484-9
CHEMBL320736 115418 0 None 15 6 Human 7.9 pKi = 7.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 705 14 3 7 5.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCC(F)(F)F)N1 10.1016/s0960-894x(99)00484-9
118716710 121782 0 None 2 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 444 5 1 7 1.3 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)C4CCCN4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342863 121782 0 None 2 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 444 5 1 7 1.3 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)C4CCCN4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
14004040 58409 0 None -6 2 Bovine 7.0 pKi = 7.0 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 227 0 0 2 3.5 c1ccc2c3c(oc2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL158371 58409 0 None -6 2 Bovine 7.0 pKi = 7.0 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 227 0 0 2 3.5 c1ccc2c3c(oc2c1)C1CCCCN1CC3 10.1021/jm00398a025
10254390 78463 0 None -851 7 Rat 7.0 pKi = 7.0 Binding
Binding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracerBinding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracer
ChEMBL 475 8 1 5 5.1 COc1cccc2cc(C(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)oc12 10.1021/jm050171k
CHEMBL196476 78463 0 None -851 7 Rat 7.0 pKi = 7.0 Binding
Binding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracerBinding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracer
ChEMBL 475 8 1 5 5.1 COc1cccc2cc(C(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)oc12 10.1021/jm050171k
16041090 102168 0 None -1 4 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 496 8 2 6 4.7 COc1ccc(NC(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)c(OC)c1 10.1016/j.bmcl.2007.11.068
CHEMBL256853 102168 0 None -1 4 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 496 8 2 6 4.7 COc1ccc(NC(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)c(OC)c1 10.1016/j.bmcl.2007.11.068
13938361 192142 0 None -141 2 Bovine 7.0 pKi = 7.0 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN([C@@H]1CCN2CCc3c(oc4ccccc34)[C@@H]2C1)S(=O)(=O)CCO 10.1021/jm00150a002
CHEMBL48603 192142 0 None -141 2 Bovine 7.0 pKi = 7.0 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN([C@@H]1CCN2CCc3c(oc4ccccc34)[C@@H]2C1)S(=O)(=O)CCO 10.1021/jm00150a002
14004039 126339 3 None -5 2 Bovine 6.0 pKi = 6.0 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 193 0 0 2 2.8 c1cc2c(s1)C1CCCCN1CC2 10.1021/jm00398a025
CHEMBL346016 126339 3 None -5 2 Bovine 6.0 pKi = 6.0 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 193 0 0 2 2.8 c1cc2c(s1)C1CCCCN1CC2 10.1021/jm00398a025
10242469 38215 0 None - 1 Bovine 6.0 pKi = 6.0 Binding
In Vitro Alpha-1 adrenergic receptor binding affinity on calf frontal cortex membrane preparationIn Vitro Alpha-1 adrenergic receptor binding affinity on calf frontal cortex membrane preparation
ChEMBL 217 1 1 4 0.9 CN1CC(C2=NCCN2)Oc2ccccc21 10.1021/jm021050c
CHEMBL14028 38215 0 None - 1 Bovine 6.0 pKi = 6.0 Binding
In Vitro Alpha-1 adrenergic receptor binding affinity on calf frontal cortex membrane preparationIn Vitro Alpha-1 adrenergic receptor binding affinity on calf frontal cortex membrane preparation
ChEMBL 217 1 1 4 0.9 CN1CC(C2=NCCN2)Oc2ccccc21 10.1021/jm021050c
9887884 126063 51 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of alpha1A adrenergic receptor (unknown origin)Inhibition of alpha1A adrenergic receptor (unknown origin)
ChEMBL 412 4 0 3 5.1 O=C1c2ccccc2C(Cc2ccnc(F)c2)(Cc2ccnc(F)c2)c2ccccc21 10.1016/j.bmcl.2019.126681
CHEMBL343822 126063 51 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of alpha1A adrenergic receptor (unknown origin)Inhibition of alpha1A adrenergic receptor (unknown origin)
ChEMBL 412 4 0 3 5.1 O=C1c2ccccc2C(Cc2ccnc(F)c2)(Cc2ccnc(F)c2)c2ccccc21 10.1016/j.bmcl.2019.126681
10577609 33759 0 None -75 3 Human 6.0 pKi = 6.0 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 509 8 1 9 3.5 COc1cc2nc(N3CCN(C(=O)C(C)Oc4c(OC)cccc4C(C)C)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL136458 33759 0 None -75 3 Human 6.0 pKi = 6.0 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 509 8 1 9 3.5 COc1cc2nc(N3CCN(C(=O)C(C)Oc4c(OC)cccc4C(C)C)CC3)nc(N)c2cc1OC 10.1021/jm9805337
1935 10506 97 None -190 6 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
2551 10506 97 None -190 6 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
6687 10506 97 None -190 6 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
CHEMBL95 10506 97 None -190 6 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
DB00382 10506 97 None -190 6 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
118717460 121920 0 None -2 4 Human 7.0 pKi = 7.0 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 412 10 2 4 6.9 Cc1ccc2c(NCCCCCCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343982 121920 0 None -2 4 Human 7.0 pKi = 7.0 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 412 10 2 4 6.9 Cc1ccc2c(NCCCCCCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
2419 7482 28 None -288 11 Rat 7.0 pKi = 7.0 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
9 7482 28 None -288 11 Rat 7.0 pKi = 7.0 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
CHEMBL13647 7482 28 None -288 11 Rat 7.0 pKi = 7.0 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
118717460 121920 0 None -2 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 412 10 2 4 6.9 Cc1ccc2c(NCCCCCCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343982 121920 0 None -2 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 412 10 2 4 6.9 Cc1ccc2c(NCCCCCCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
481 9667 7 None 4 3 Human 6.0 pKi = 6.0 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1021/jm000542r
9838763 9667 7 None 4 3 Human 6.0 pKi = 6.0 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1021/jm000542r
CHEMBL72958 9667 7 None 4 3 Human 6.0 pKi = 6.0 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1021/jm000542r
131829 211506 15 None -173 6 Human 6.0 pKi = 6.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 295 1 4 5 1.7 Brc1c(NC2=NCCN2)ccc2c1NCCN2 10.1016/0960-894X(95)00391-6
CHEMBL74283 211506 15 None -173 6 Human 6.0 pKi = 6.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 295 1 4 5 1.7 Brc1c(NC2=NCCN2)ccc2c1NCCN2 10.1016/0960-894X(95)00391-6
34458 105119 68 None - 1 Rat 6.0 pKi = 6.0 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 339 2 0 5 3.1 COc1ccc2c(c1OC)CN1CCc3cc4c(cc3C1C2)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL275097 105119 68 None - 1 Rat 6.0 pKi = 6.0 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 339 2 0 5 3.1 COc1ccc2c(c1OC)CN1CCc3cc4c(cc3C1C2)OCO4 10.1021/acs.jmedchem.6b01217
9892644 204125 0 None -30 4 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 511 4 0 4 4.0 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Br)ccc2Br)CC1 10.1021/jm030944+
CHEMBL56899 204125 0 None -30 4 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 511 4 0 4 4.0 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Br)ccc2Br)CC1 10.1021/jm030944+
9906978 49485 2 None -2 12 Human 6.9 pKi = 6.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
CHEMBL150161 49485 2 None -2 12 Human 6.9 pKi = 6.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
10775000 114171 2 None -30 5 Bovine 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 214 1 2 2 2.6 Oc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL317912 114171 2 None -30 5 Bovine 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 214 1 2 2 2.6 Oc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
11301627 16170 0 None 1 2 Rat 5.9 pKi = 5.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 319 4 2 3 3.0 CC(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111537 16170 0 None 1 2 Rat 5.9 pKi = 5.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 319 4 2 3 3.0 CC(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
11301627 16170 0 None 1 2 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 319 4 2 3 3.0 CC(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111537 16170 0 None 1 2 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 319 4 2 3 3.0 CC(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
9922027 122188 0 None 1 3 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 289 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCC=C2c1c[nH]cn1 10.1021/jm030551a
CHEMBL3350265 122188 0 None 1 3 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 289 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCC=C2c1c[nH]cn1 10.1021/jm030551a
10835395 213588 0 None -7 2 Rat 6.9 pKi = 6.9 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 410 6 0 4 3.7 FC(F)(F)c1cccc(N2CCN(CCCCN3CC4CCCCN4C3)CC2)c1 10.1021/jm970216k
CHEMBL90384 213588 0 None -7 2 Rat 6.9 pKi = 6.9 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 410 6 0 4 3.7 FC(F)(F)c1cccc(N2CCN(CCCCN3CC4CCCCN4C3)CC2)c1 10.1021/jm970216k
3151 8244 97 None -147 26 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
945 8244 97 None -147 26 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
965 8244 97 None -147 26 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
CHEMBL219916 8244 97 None -147 26 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
DB01184 8244 97 None -147 26 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
127027974 144539 0 None -9 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 396 8 1 4 3.4 COc1ccccc1N1CCN(CCCCNC(=O)N(C)c2ccccc2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3759312 144539 0 None -9 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 396 8 1 4 3.4 COc1ccccc1N1CCN(CCCCNC(=O)N(C)c2ccccc2)CC1 10.1016/j.bmcl.2015.12.068
46881493 13760 0 None -14 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 389 8 1 4 4.3 Cc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1084658 13760 0 None -14 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 389 8 1 4 4.3 Cc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
9845172 175888 0 None -79 4 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 422 4 0 3 4.9 O=C1CC2(CCCC2)CC(=O)N1CCN1CCC(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL440118 175888 0 None -79 4 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 422 4 0 3 4.9 O=C1CC2(CCCC2)CC(=O)N1CCN1CCC(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
11584530 22871 0 None -158 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 5.8 FC(F)(F)c1cccc(N2CCN(CCCCNc3cc(-c4ccccc4)ccn3)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223857 22871 0 None -158 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 5.8 FC(F)(F)c1cccc(N2CCN(CCCCNc3cc(-c4ccccc4)ccn3)CC2)c1 10.1016/j.bmcl.2010.07.096
9929936 174691 0 None -11 5 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 383 4 0 4 3.1 Cc1ccc(C)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1021/jm030944+
CHEMBL431354 174691 0 None -11 5 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 383 4 0 4 3.1 Cc1ccc(C)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1021/jm030944+
9822812 202651 0 None -45 3 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL55882 202651 0 None -45 3 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
11857862 148832 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL387833 148832 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
44431607 94259 0 None -1 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(Cl)c3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233407 94259 0 None -1 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(Cl)c3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857794 92443 0 None 5 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cccc(OC(F)F)c1 10.1016/j.bmcl.2007.04.098
CHEMBL228553 92443 0 None 5 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cccc(OC(F)F)c1 10.1016/j.bmcl.2007.04.098
11857862 148832 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL387833 148832 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
4038180 6992 14 None 2 8 Rat 7.9 pKi = 7.9 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.009 - 0.015)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.009 - 0.015)
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm025550h
480 6992 14 None 2 8 Rat 7.9 pKi = 7.9 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.009 - 0.015)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.009 - 0.015)
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm025550h
CHEMBL109783 6992 14 None 2 8 Rat 7.9 pKi = 7.9 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.009 - 0.015)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.009 - 0.015)
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm025550h
44308466 210568 0 None 1 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 429 7 0 7 3.2 COC(=O)[C@@H]1CCCN1Cc1ccc(CN2CCN(c3ccccc3OC)CC2)s1 10.1016/s0960-894x(02)00347-5
CHEMBL68241 210568 0 None 1 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 429 7 0 7 3.2 COC(=O)[C@@H]1CCCN1Cc1ccc(CN2CCN(c3ccccc3OC)CC2)s1 10.1016/s0960-894x(02)00347-5
68604 84980 29 None -28 5 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]-WB4101 from rat forebrain homogenate alpha 1 adrenergic receptorDisplacement of [3H]-WB4101 from rat forebrain homogenate alpha 1 adrenergic receptor
ChEMBL 401 5 0 6 2.9 Cc1nc2n(c(=O)c1CCN1CCC(C(=O)c3ccc(F)cc3)CC1)CCS2 10.1021/acs.jmedchem.2c00633
CHEMBL2105437 84980 29 None -28 5 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]-WB4101 from rat forebrain homogenate alpha 1 adrenergic receptorDisplacement of [3H]-WB4101 from rat forebrain homogenate alpha 1 adrenergic receptor
ChEMBL 401 5 0 6 2.9 Cc1nc2n(c(=O)c1CCN1CCC(C(=O)c3ccc(F)cc3)CC1)CCS2 10.1021/acs.jmedchem.2c00633
11590801 22822 0 None -7 3 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.3 FC(F)(F)c1cccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223747 22822 0 None -7 3 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.3 FC(F)(F)c1cccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)c1 10.1016/j.bmcl.2010.07.096
2142 9870 58 None -2 37 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2018.04.059
4920903 9870 58 None -2 37 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2018.04.059
502 9870 58 None -2 37 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2018.04.059
5775 9870 58 None -2 37 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2018.04.059
CHEMBL597 9870 58 None -2 37 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2018.04.059
DB00692 9870 58 None -2 37 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2018.04.059
10745664 128794 0 None 12 3 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 572 8 2 8 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc([N+](=O)[O-])c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL359433 128794 0 None 12 3 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 572 8 2 8 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc([N+](=O)[O-])c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
44289344 175325 0 None 1 3 Human 7.9 pKi = 7.9 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 441 8 1 3 4.8 Cc1ccc(C(C(=O)NCCCN2CCN(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL435576 175325 0 None 1 3 Human 7.9 pKi = 7.9 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 441 8 1 3 4.8 Cc1ccc(C(C(=O)NCCCN2CCN(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
3039881 181036 10 None -19 3 Human 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 337 1 0 1 5.0 CN(C)C1C=CC2(CC1)c1ccccc1CCc1ccc(Cl)cc12 10.1021/jm00109a026
CHEMBL45491 181036 10 None -19 3 Human 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 337 1 0 1 5.0 CN(C)C1C=CC2(CC1)c1ccccc1CCc1ccc(Cl)cc12 10.1021/jm00109a026
1443 8809 34 None -2 11 Bovine 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
33625 8809 34 None -2 11 Bovine 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
501 8809 34 None -2 11 Bovine 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
CHEMBL279516 8809 34 None -2 11 Bovine 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
DB08950 8809 34 None -2 11 Bovine 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
4038180 6992 14 None 2 8 Rat 7.9 pKi = 7.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
480 6992 14 None 2 8 Rat 7.9 pKi = 7.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL109783 6992 14 None 2 8 Rat 7.9 pKi = 7.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
118716721 121793 0 None 1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 466 5 1 6 3.3 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)Nc4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342874 121793 0 None 1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 466 5 1 6 3.3 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)Nc4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
4038180 6992 14 None 2 8 Rat 7.9 pKi = 7.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm030551a
480 6992 14 None 2 8 Rat 7.9 pKi = 7.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm030551a
CHEMBL109783 6992 14 None 2 8 Rat 7.9 pKi = 7.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm030551a
10644955 172966 7 None -1 3 Rat 7.9 pKi = 7.9 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 404 6 0 4 3.1 O=C1C2CCCCN2C(=O)N1CCCCN1CCN(c2cccc(Cl)c2)CC1 10.1021/jm970216k
CHEMBL42644 172966 7 None -1 3 Rat 7.9 pKi = 7.9 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 404 6 0 4 3.1 O=C1C2CCCCN2C(=O)N1CCCCN1CCN(c2cccc(Cl)c2)CC1 10.1021/jm970216k
9824384 125565 1 None -14 8 Human 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm960510x
CHEMBL342062 125565 1 None -14 8 Human 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm960510x
10252540 92132 1 None -58 6 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261604 92132 1 None -58 6 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
132266 8061 12 None -28 9 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2007.01.028
486 8061 12 None -28 9 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2007.01.028
CHEMBL423294 8061 12 None -28 9 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2007.01.028
132266 8061 12 None -28 9 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2018.05.023
486 8061 12 None -28 9 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2018.05.023
CHEMBL423294 8061 12 None -28 9 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2018.05.023
52948119 23438 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 451 7 0 6 2.7 COc1ccccc1N1CCN(C[C@@H]2CO[C@](CN3CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242445 23438 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 451 7 0 6 2.7 COc1ccccc1N1CCN(C[C@@H]2CO[C@](CN3CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
118716723 121795 0 None 2 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 446 4 1 6 2.5 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)NC(C)(C)C)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342876 121795 0 None 2 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 446 4 1 6 2.5 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)NC(C)(C)C)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44288162 175778 0 None -2 3 Rat 7.9 pKi = 7.9 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1ccc2c(c1)C1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC1CC2 10.1021/jm990567u
CHEMBL43921 175778 0 None -2 3 Rat 7.9 pKi = 7.9 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1ccc2c(c1)C1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC1CC2 10.1021/jm990567u
10622830 109203 0 None 5 3 Rat 7.9 pKi = 7.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 437 6 1 6 3.2 COc1cc2c(cc1OC)C(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CN2 10.1021/jm000541z
CHEMBL303988 109203 0 None 5 3 Rat 7.9 pKi = 7.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 437 6 1 6 3.2 COc1cc2c(cc1OC)C(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CN2 10.1021/jm000541z
118717456 121914 0 None -2 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 342 5 2 4 4.9 Cc1ccc2c(NCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343977 121914 0 None -2 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 342 5 2 4 4.9 Cc1ccc2c(NCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
9797396 19653 0 None -39 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 325 5 1 2 4.2 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1188811 19653 0 None -39 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 325 5 1 2 4.2 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL537428 19653 0 None -39 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 325 5 1 2 4.2 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
9797396 19653 0 None -39 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 325 5 1 2 4.2 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
CHEMBL1188811 19653 0 None -39 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 325 5 1 2 4.2 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
CHEMBL537428 19653 0 None -39 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 325 5 1 2 4.2 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
44586430 193809 0 None 3 3 Rat 6.9 pKi = 6.9 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 528 9 1 6 3.4 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL490865 193809 0 None 3 3 Rat 6.9 pKi = 6.9 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 528 9 1 6 3.4 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
155525650 183417 0 None -22 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.2 c1ccc(OCCNC[C@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4457585 183417 0 None -22 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.2 c1ccc(OCCNC[C@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4597956 183417 0 None -22 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.2 c1ccc(OCCNC[C@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
118717456 121914 0 None -2 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 342 5 2 4 4.9 Cc1ccc2c(NCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343977 121914 0 None -2 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 342 5 2 4 4.9 Cc1ccc2c(NCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
145949210 169528 0 None -4 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 459 5 2 9 2.8 COc1cc2nc(N3CCC[C@@H](NC4=CC(=O)c5ccccc5C4=O)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4171491 169528 0 None -4 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 459 5 2 9 2.8 COc1cc2nc(N3CCC[C@@H](NC4=CC(=O)c5ccccc5C4=O)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
145946292 174283 0 None -19 2 Human 5.9 pKi = 5.9 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 CNc1ccc2c(c1)[C@H](NCCOc1cc(F)ccc1F)CCS2(=O)=O 10.1016/j.ejmech.2017.07.071
CHEMBL4210954 174283 0 None -19 2 Human 5.9 pKi = 5.9 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 CNc1ccc2c(c1)[C@H](NCCOc1cc(F)ccc1F)CCS2(=O)=O 10.1016/j.ejmech.2017.07.071
CHEMBL4299802 174283 0 None -19 2 Human 5.9 pKi = 5.9 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 CNc1ccc2c(c1)[C@H](NCCOc1cc(F)ccc1F)CCS2(=O)=O 10.1016/j.ejmech.2017.07.071
12909389 67143 0 None 64 2 Bovine 5.9 pKi = 5.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 320 1 1 3 3.7 CN1CCC(=C2c3cc(C(=O)O)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL174649 67143 0 None 64 2 Bovine 5.9 pKi = 5.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 320 1 1 3 3.7 CN1CCC(=C2c3cc(C(=O)O)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
10221004 211010 0 None -1 5 Human 5.9 pKi = 5.9 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 267 5 2 5 0.9 CCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70973 211010 0 None -1 5 Human 5.9 pKi = 5.9 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 267 5 2 5 0.9 CCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
9953974 84608 0 None 5 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
CHEMBL2092927 84608 0 None 5 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
10694274 205801 0 None 1 3 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 437 6 1 5 3.7 COc1cc2c(cc1OC)NC(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)C2 10.1021/jm000541z
CHEMBL58585 205801 0 None 1 3 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 437 6 1 5 3.7 COc1cc2c(cc1OC)NC(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)C2 10.1021/jm000541z
1971 9641 38 None -24 30 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
2404 9641 38 None -24 30 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
4543 9641 38 None -24 30 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
CHEMBL445 9641 38 None -24 30 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
DB00540 9641 38 None -24 30 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
9950711 115983 0 None 5 4 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL321644 115983 0 None 5 4 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
16655023 114218 2 None -102 7 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human cloned alpha-1A receptorDisplacement of [3H]prazosin from human cloned alpha-1A receptor
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
CHEMBL318235 114218 2 None -102 7 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human cloned alpha-1A receptorDisplacement of [3H]prazosin from human cloned alpha-1A receptor
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
9822477 206231 0 None -43 5 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1021/jm030944+
CHEMBL59149 206231 0 None -43 5 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1021/jm030944+
11183468 116649 2 None -2 6 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL323402 116649 2 None -2 6 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
52937526 68076 0 None -1258 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 363 5 0 5 3.1 COc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1 10.1021/jm1013874
CHEMBL1767137 68076 0 None -1258 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 363 5 0 5 3.1 COc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1 10.1021/jm1013874
24803798 68099 0 None -501 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 640 12 0 6 7.9 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCCc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
CHEMBL1767160 68099 0 None -501 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 640 12 0 6 7.9 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCCc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
218362 211579 5 None -75 4 Human 6.9 pKi = 6.9 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL75030 211579 5 None -75 4 Human 6.9 pKi = 6.9 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
151779 201483 2 None 1 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 384 10 2 4 6.3 c1ccc2c(NCCCCCCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL533979 201483 2 None 1 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 384 10 2 4 6.3 c1ccc2c(NCCCCCCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
127040061 143704 0 None -33 5 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNC[C@H]2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
CHEMBL3739932 143704 0 None -33 5 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNC[C@H]2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
CHEMBL3742489 143704 0 None -33 5 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNC[C@H]2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
127036186 144192 0 None -39 19 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 254 7 1 1 3.7 C=CCN(CC=C)CCc1c[nH]c2ccc(C)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3753318 144192 0 None -39 19 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 254 7 1 1 3.7 C=CCN(CC=C)CCc1c[nH]c2ccc(C)cc12 10.1016/j.bmcl.2015.12.053
127026052 144331 0 None -75 19 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 258 7 1 1 3.5 C=CCN(CC=C)CCc1c[nH]c2ccc(F)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3754496 144331 0 None -75 19 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 258 7 1 1 3.5 C=CCN(CC=C)CCc1c[nH]c2ccc(F)cc12 10.1016/j.bmcl.2015.12.053
183528 175480 6 None -16 2 Human 4.9 pKi = 4.9 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 420 3 4 3 4.7 O=C(c1nc(-c2c[nH]c3cc(Br)ccc23)c[nH]1)c1c[nH]c2cc(O)ccc12 10.1016/0960-894X(96)00376-9
CHEMBL436760 175480 6 None -16 2 Human 4.9 pKi = 4.9 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 420 3 4 3 4.7 O=C(c1nc(-c2c[nH]c3cc(Br)ccc23)c[nH]1)c1c[nH]c2cc(O)ccc12 10.1016/0960-894X(96)00376-9
151779 201483 2 None 1 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 384 10 2 4 6.3 c1ccc2c(NCCCCCCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL533979 201483 2 None 1 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 384 10 2 4 6.3 c1ccc2c(NCCCCCCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
44328739 214430 0 None 1 3 Human 6.9 pKi = 6.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 691 16 3 6 7.5 CCCCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL95263 214430 0 None 1 3 Human 6.9 pKi = 6.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 691 16 3 6 7.5 CCCCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1 10.1016/s0960-894x(99)00484-9
1376848 210535 8 None -1 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 366 4 0 4 3.8 COc1ccccc1N1CCN(Cc2ccc(Br)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL67932 210535 8 None -1 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 366 4 0 4 3.8 COc1ccccc1N1CCN(Cc2ccc(Br)s2)CC1 10.1016/s0960-894x(02)00347-5
9954092 203425 0 None -1000 6 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 423 4 0 4 3.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL56438 203425 0 None -1000 6 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 423 4 0 4 3.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
9903797 16211 5 None 18 4 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 279 5 2 3 2.1 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1C 10.1007/s00044-004-0020-z
CHEMBL111734 16211 5 None 18 4 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 279 5 2 3 2.1 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1C 10.1007/s00044-004-0020-z
25181489 194136 0 None -158 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm301525w
CHEMBL493285 194136 0 None -158 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm301525w
9903797 16211 5 None 18 4 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 279 5 2 3 2.1 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1C 10.1021/jm030551a
CHEMBL111734 16211 5 None 18 4 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 279 5 2 3 2.1 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1C 10.1021/jm030551a
11747739 20007 0 None -1 4 Human 5.9 pKi = 5.9 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1191324 20007 0 None -1 4 Human 5.9 pKi = 5.9 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL542402 20007 0 None -1 4 Human 5.9 pKi = 5.9 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
44267890 23279 0 None 41 3 Human 6.9 pKi = 6.9 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 460 8 1 5 2.0 O=C(CN1CCCCC1=O)NCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12364 23279 0 None 41 3 Human 6.9 pKi = 6.9 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 460 8 1 5 2.0 O=C(CN1CCCCC1=O)NCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(00)00169-4
44460394 212157 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 398 7 0 6 2.9 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL79940 212157 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 398 7 0 6 2.9 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
9959671 39445 0 None 363 3 Human 7.9 pKi = 7.9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL141322 39445 0 None 363 3 Human 7.9 pKi = 7.9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
15054189 202363 0 None 23 3 Rat 7.9 pKi = 7.9 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 433 6 2 6 2.4 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1021/jm00110a014
CHEMBL55528 202363 0 None 23 3 Rat 7.9 pKi = 7.9 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 433 6 2 6 2.4 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1021/jm00110a014
2389 10104 118 None -6 66 Rat 7.9 pKi = 7.9 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
5073 10104 118 None -6 66 Rat 7.9 pKi = 7.9 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
96 10104 118 None -6 66 Rat 7.9 pKi = 7.9 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
CHEMBL85 10104 118 None -6 66 Rat 7.9 pKi = 7.9 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
DB00734 10104 118 None -6 66 Rat 7.9 pKi = 7.9 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
10623356 174908 0 None -8 3 Human 7.9 pKi = 7.9 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 448 7 0 5 4.0 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)c(C)c2)c2ccccn2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL1910243 174908 0 None -8 3 Human 7.9 pKi = 7.9 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 448 7 0 5 4.0 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)c(C)c2)c2ccccn2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL43297 174908 0 None -8 3 Human 7.9 pKi = 7.9 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 448 7 0 5 4.0 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)c(C)c2)c2ccccn2)CC1 10.1021/acs.jmedchem.2c00633
2274 9947 58 None -6 31 Rat 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
4917 9947 58 None -6 31 Rat 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
7279 9947 58 None -6 31 Rat 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
CHEMBL728 9947 58 None -6 31 Rat 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
DB00433 9947 58 None -6 31 Rat 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
44331136 116458 0 None 1 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 540 7 1 5 5.8 O=C1CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccc(NS(=O)(=O)Cc3ccccc3)cc21 10.1016/s0960-894x(98)00732-x
CHEMBL322688 116458 0 None 1 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 540 7 1 5 5.8 O=C1CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccc(NS(=O)(=O)Cc3ccccc3)cc21 10.1016/s0960-894x(98)00732-x
13141184 172669 0 None 17 2 Bovine 7.9 pKi = 7.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 376 1 0 3 5.6 CN1CCC(=C2c3cc(SC(F)(F)F)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL424967 172669 0 None 17 2 Bovine 7.9 pKi = 7.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 376 1 0 3 5.6 CN1CCC(=C2c3cc(SC(F)(F)F)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
57402365 76070 0 None 10 5 Pig 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 441 12 1 6 3.1 CCOCCOc1cccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1 10.1016/j.bmc.2011.10.063
CHEMBL1928119 76070 0 None 10 5 Pig 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 441 12 1 6 3.1 CCOCCOc1cccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1 10.1016/j.bmc.2011.10.063
11393666 199765 0 None -33 19 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 340 2 1 2 4.6 CC1(C)CN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CCN1 10.1016/j.bmcl.2022.128879
CHEMBL5201983 199765 0 None -33 19 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 340 2 1 2 4.6 CC1(C)CN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CCN1 10.1016/j.bmcl.2022.128879
CHEMBL5222597 199765 0 None -33 19 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 340 2 1 2 4.6 CC1(C)CN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CCN1 10.1016/j.bmcl.2022.128879
53779053 85212 0 None 5 3 Human 7.9 pKi = 7.9 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
CHEMBL2111563 85212 0 None 5 3 Human 7.9 pKi = 7.9 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
124 9755 47 None -14 32 Bovine 7.9 pKi = 7.9 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
2032 9755 47 None -14 32 Bovine 7.9 pKi = 7.9 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
4636 9755 47 None -14 32 Bovine 7.9 pKi = 7.9 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
CHEMBL762 9755 47 None -14 32 Bovine 7.9 pKi = 7.9 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
DB00935 9755 47 None -14 32 Bovine 7.9 pKi = 7.9 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
10623356 174908 0 None -8 3 Human 7.9 pKi = 7.9 Binding
Binding affinity to alpha1A receptorBinding affinity to alpha1A receptor
ChEMBL 448 7 0 5 4.0 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)c(C)c2)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL1910243 174908 0 None -8 3 Human 7.9 pKi = 7.9 Binding
Binding affinity to alpha1A receptorBinding affinity to alpha1A receptor
ChEMBL 448 7 0 5 4.0 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)c(C)c2)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL43297 174908 0 None -8 3 Human 7.9 pKi = 7.9 Binding
Binding affinity to alpha1A receptorBinding affinity to alpha1A receptor
ChEMBL 448 7 0 5 4.0 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)c(C)c2)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
44431618 151682 0 None 3 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 488 8 1 7 3.3 COc1ccncc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL391017 151682 0 None 3 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 488 8 1 7 3.3 COc1ccncc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
2470 10425 50 None -316 58 Bovine 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
3300 10425 50 None -316 58 Bovine 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
5265 10425 50 None -316 58 Bovine 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
99 10425 50 None -316 58 Bovine 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
CHEMBL267930 10425 50 None -316 58 Bovine 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
44447010 161019 0 None -4 4 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 496 6 1 5 5.4 Cc1ccc(C(=O)NC2CCc3ccc(CCN4CCN(c5nsc6ccccc56)CC4)cc32)cc1 10.1016/j.bmcl.2007.11.106
CHEMBL398618 161019 0 None -4 4 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 496 6 1 5 5.4 Cc1ccc(C(=O)NC2CCc3ccc(CCN4CCN(c5nsc6ccccc56)CC4)cc32)cc1 10.1016/j.bmcl.2007.11.106
44431545 151798 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 457 7 1 5 3.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL391107 151798 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 457 7 1 5 3.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
2419 7482 28 None -288 11 Human 6.9 pKi = 6.9 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
9 7482 28 None -288 11 Human 6.9 pKi = 6.9 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
CHEMBL13647 7482 28 None -288 11 Human 6.9 pKi = 6.9 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
9954092 203425 0 None -1000 6 Human 6.9 pKi = 6.9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 423 4 0 4 3.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL56438 203425 0 None -1000 6 Human 6.9 pKi = 6.9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 423 4 0 4 3.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1016/j.bmcl.2004.11.032
13156 10220 0 None -416 3 Human 6.9 pKi = 6.9 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 FC1=C(OCCN[C@H]2CCS(C3=CC=C(C=C23)NC)(=O)=O)C=C(C=C1)F 10.1016/j.ejmech.2017.07.071
145946376 10220 0 None -416 3 Human 6.9 pKi = 6.9 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 FC1=C(OCCN[C@H]2CCS(C3=CC=C(C=C23)NC)(=O)=O)C=C(C=C1)F 10.1016/j.ejmech.2017.07.071
CHEMBL4299993 10220 0 None -416 3 Human 6.9 pKi = 6.9 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 FC1=C(OCCN[C@H]2CCS(C3=CC=C(C=C23)NC)(=O)=O)C=C(C=C1)F 10.1016/j.ejmech.2017.07.071
12909383 137481 1 None 5 2 Bovine 6.9 pKi = 6.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 278 0 0 2 3.6 CN1CCC(=C2c3ccccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL368413 137481 1 None 5 2 Bovine 6.9 pKi = 6.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 278 0 0 2 3.6 CN1CCC(=C2c3ccccc3CCn3cccc32)CC1 10.1021/jm00361a008
9929458 129840 0 None -61 2 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 373 5 1 2 4.8 c1ccc2c(c1)CCN(CCCN1CCC(c3c[nH]c4ccccc34)CC1)C2 10.1016/j.bmcl.2015.07.046
CHEMBL3609359 129840 0 None -61 2 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 373 5 1 2 4.8 c1ccc2c(c1)CCN(CCCN1CCC(c3c[nH]c4ccccc34)CC1)C2 10.1016/j.bmcl.2015.07.046
11169638 23966 0 None -1 3 Rat 6.9 pKi = 6.9 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 600 11 1 8 3.3 CCOC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL1256344 23966 0 None -1 3 Rat 6.9 pKi = 6.9 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 600 11 1 8 3.3 CCOC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
9838192 118089 18 None -2 6 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1007/s00044-004-0020-z
CHEMBL326702 118089 18 None -2 6 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1007/s00044-004-0020-z
118717455 121913 0 None -7 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 342 5 2 4 4.9 Cc1ccc2nccc(NCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343976 121913 0 None -7 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 342 5 2 4 4.9 Cc1ccc2nccc(NCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
9838192 118089 18 None -2 6 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm030551a
CHEMBL326702 118089 18 None -2 6 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm030551a
13149 9323 36 None -22 17 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 398 5 1 5 3.8 CC[C@@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC 10.1021/acs.jmedchem.9b01465
3034396 9323 36 None -22 17 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 398 5 1 5 3.8 CC[C@@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC 10.1021/acs.jmedchem.9b01465
CHEMBL299031 9323 36 None -22 17 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 398 5 1 5 3.8 CC[C@@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC 10.1021/acs.jmedchem.9b01465
9815005 116438 0 None 1 3 Rat 5.9 pKi = 5.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 3 2 3 2.6 CS(=O)(=O)Nc1cccc2c1CCCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL322492 116438 0 None 1 3 Rat 5.9 pKi = 5.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 3 2 3 2.6 CS(=O)(=O)Nc1cccc2c1CCCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL4576555 220796 5 None -1 19 Human 5.9 pKi = 5.9 Binding
GPCRScan assay: inhibition of Alpha1AGPCRScan assay: inhibition of Alpha1A
ChEMBL None None None CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1 10.6019/CHEMBL4507307
9815005 116438 0 None 1 3 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 2 3 2.6 CS(=O)(=O)Nc1cccc2c1CCCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL322492 116438 0 None 1 3 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 2 3 2.6 CS(=O)(=O)Nc1cccc2c1CCCCC2c1c[nH]cn1 10.1021/jm030551a
118717455 121913 0 None -7 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 342 5 2 4 4.9 Cc1ccc2nccc(NCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343976 121913 0 None -7 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 342 5 2 4 4.9 Cc1ccc2nccc(NCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
9908478 202415 1 None -954 7 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2F)CC1 10.1021/jm030944+
CHEMBL556313 202415 1 None -954 7 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2F)CC1 10.1021/jm030944+
196129 74573 17 None -1698 15 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
CHEMBL1909065 74573 17 None -1698 15 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
9938248 108983 0 None -1 3 Rat 6.9 pKi = 6.9 Binding
Binding affinity was determined against Alpha-1a adrenergic receptorBinding affinity was determined against Alpha-1a adrenergic receptor
ChEMBL 580 2 4 3 6.0 CN1C[C@H](c2c[nH]c3c(Br)c(Br)cc(O)c23)NC[C@H]1c1c[nH]c2cc(Br)ccc12 10.1016/0960-894X(96)00376-9
CHEMBL302882 108983 0 None -1 3 Rat 6.9 pKi = 6.9 Binding
Binding affinity was determined against Alpha-1a adrenergic receptorBinding affinity was determined against Alpha-1a adrenergic receptor
ChEMBL 580 2 4 3 6.0 CN1C[C@H](c2c[nH]c3c(Br)c(Br)cc(O)c23)NC[C@H]1c1c[nH]c2cc(Br)ccc12 10.1016/0960-894X(96)00376-9
11183468 116649 2 None -2 6 Bovine 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL323402 116649 2 None -2 6 Bovine 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
6918539 150997 2 None - 1 Rat 5.9 pKi = 5.9 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 361 2 2 5 3.4 COc1cc2c(cc1O)[C@@H]1Cc3c(Cl)cc(OC)c(O)c3CN1CC2 10.1021/acs.jmedchem.6b01217
CHEMBL3904484 150997 2 None - 1 Rat 5.9 pKi = 5.9 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 361 2 2 5 3.4 COc1cc2c(cc1O)[C@@H]1Cc3c(Cl)cc(OC)c(O)c3CN1CC2 10.1021/acs.jmedchem.6b01217
11173600 170159 0 None - 1 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 282 5 2 3 2.1 CCS(=O)(=O)Nc1cccc2c1CCCC2CNC 10.1021/jm030551a
CHEMBL419369 170159 0 None - 1 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 282 5 2 3 2.1 CCS(=O)(=O)Nc1cccc2c1CCCC2CNC 10.1021/jm030551a
CHEMBL4752561 220817 0 None 3 2 Human 5.9 pKi = 5.9 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000739a ADRA1ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000739a ADRA1A
ChEMBL None None None COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1 10.6019/CHEMBL5212743
CHEMBL4576555 220796 5 None -1 19 Human 5.9 pKi = 5.9 Binding
GPCRScan assay: inhibition of Alpha1AGPCRScan assay: inhibition of Alpha1A
ChEMBL None None None CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1 10.6019/CHEMBL4507307
10745566 41092 0 None 61 3 Human 7.9 pKi = 7.9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 566 10 1 6 5.1 CNC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F 10.1021/jm9902032
CHEMBL142719 41092 0 None 61 3 Human 7.9 pKi = 7.9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 566 10 1 6 5.1 CNC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F 10.1021/jm9902032
44431553 94359 0 None -10 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 4.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(C(F)(F)F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233592 94359 0 None -10 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 4.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(C(F)(F)F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44426404 92402 0 None 4 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 498 7 1 6 4.4 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccc2c(c1)OCO2 10.1016/j.bmcl.2007.04.098
CHEMBL228333 92402 0 None 4 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 498 7 1 6 4.4 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccc2c(c1)OCO2 10.1016/j.bmcl.2007.04.098
18738387 170277 0 None -1 2 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 399 6 0 5 3.6 COc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL420184 170277 0 None -1 2 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 399 6 0 5 3.6 COc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
16041628 162129 0 None -1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)cc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL403280 162129 0 None -1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)cc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
49865640 22806 0 None 2 3 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 324 7 1 4 3.4 Cc1ccccc1N1CCN(CCCCNc2ccccn2)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL1223681 22806 0 None 2 3 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 324 7 1 4 3.4 Cc1ccccc1N1CCN(CCCCNc2ccccn2)CC1 10.1016/j.bmcl.2010.07.096
57390117 76074 0 None 16 5 Pig 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 455 13 1 6 3.2 CCOCCOCc1ccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1 10.1016/j.bmc.2011.10.063
CHEMBL1928123 76074 0 None 16 5 Pig 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 455 13 1 6 3.2 CCOCCOCc1ccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1 10.1016/j.bmc.2011.10.063
145946714 174337 0 None 2 6 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 398 9 0 5 3.8 COc1ccccc1N1CCN(CCOCCOc2cc(C)cc(C)c2C)CC1 10.1016/j.bmcl.2018.04.059
CHEMBL4213352 174337 0 None 2 6 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 398 9 0 5 3.8 COc1ccccc1N1CCN(CCOCCOc2cc(C)cc(C)c2C)CC1 10.1016/j.bmcl.2018.04.059
CHEMBL4300399 174337 0 None 2 6 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 398 9 0 5 3.8 COc1ccccc1N1CCN(CCOCCOc2cc(C)cc(C)c2C)CC1 10.1016/j.bmcl.2018.04.059
10578735 127898 0 None 28 3 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 557 8 2 7 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(OC)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL357439 127898 0 None 28 3 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 557 8 2 7 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(OC)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
53328508 70171 0 None 4 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 466 8 0 7 3.0 COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccc([N+](=O)[O-])cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796042 70171 0 None 4 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 466 8 0 7 3.0 COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccc([N+](=O)[O-])cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
44431620 93842 0 None -102 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 570 7 1 6 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cnc(Cl)c(Br)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL232609 93842 0 None -102 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 570 7 1 6 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cnc(Cl)c(Br)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
11782656 35856 0 None -75 6 Human 7.8 pKi = 7.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 336 9 1 4 3.8 COc1cccc2c(CCCNCCOc3ccccn3)cccc12 10.1021/jm010866v
CHEMBL138109 35856 0 None -75 6 Human 7.8 pKi = 7.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 336 9 1 4 3.8 COc1cccc2c(CCCNCCOc3ccccn3)cccc12 10.1021/jm010866v
10793963 106448 0 None 9 6 Human 7.8 pKi = 7.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL284470 106448 0 None 9 6 Human 7.8 pKi = 7.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
10793963 92045 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 622 11 2 7 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL2260147 92045 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 622 11 2 7 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
9838192 118089 18 None -2 6 Rat 6.9 pKi = 6.9 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.12 - 0.15)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.12 - 0.15)
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm025550h
CHEMBL326702 118089 18 None -2 6 Rat 6.9 pKi = 6.9 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.12 - 0.15)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.12 - 0.15)
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm025550h
9938248 108983 0 None -1 3 Human 6.9 pKi = 6.9 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 580 2 4 3 6.0 CN1C[C@H](c2c[nH]c3c(Br)c(Br)cc(O)c23)NC[C@H]1c1c[nH]c2cc(Br)ccc12 10.1016/0960-894X(96)00376-9
CHEMBL302882 108983 0 None -1 3 Human 6.9 pKi = 6.9 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 580 2 4 3 6.0 CN1C[C@H](c2c[nH]c3c(Br)c(Br)cc(O)c23)NC[C@H]1c1c[nH]c2cc(Br)ccc12 10.1016/0960-894X(96)00376-9
12909388 67830 0 None 14 2 Bovine 6.9 pKi = 6.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 303 0 0 3 3.4 CN1CCC(=C2c3cc(C#N)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL176365 67830 0 None 14 2 Bovine 6.9 pKi = 6.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 303 0 0 3 3.4 CN1CCC(=C2c3cc(C#N)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
6604117 194626 6 None -1 6 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL2062340 194626 6 None -1 6 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL49623 194626 6 None -1 6 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
122187555 129833 0 None -3 2 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 324 5 1 1 5.7 c1ccc2c(C3CCN(CCCC4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
CHEMBL3609352 129833 0 None -3 2 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 324 5 1 1 5.7 c1ccc2c(C3CCN(CCCC4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
9845181 214940 3 None -1445 13 Human 4.9 pKi = 4.9 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm0491391
CHEMBL98241 214940 3 None -1445 13 Human 4.9 pKi = 4.9 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm0491391
44314198 111189 0 None -95 4 Human 6.9 pKi = 6.9 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL310335 111189 0 None -95 4 Human 6.9 pKi = 6.9 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
155557696 183218 0 None -30 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 377 11 2 4 3.8 OCC(CNCCOc1ccccc1)OC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
CHEMBL4558985 183218 0 None -30 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 377 11 2 4 3.8 OCC(CNCCOc1ccccc1)OC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
CHEMBL4596295 183218 0 None -30 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 377 11 2 4 3.8 OCC(CNCCOc1ccccc1)OC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
2477 7532 59 None -218 29 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
36 7532 59 None -218 29 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
437 7532 59 None -218 29 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
CHEMBL49 7532 59 None -218 29 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
DB00490 7532 59 None -218 29 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
44311789 211514 0 None -1 5 Human 4.9 pKi = 4.9 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 345 1 2 5 3.1 Brc1c(NC2=N[C@@H]3CCCC[C@@H]3N2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL74342 211514 0 None -1 5 Human 4.9 pKi = 4.9 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 345 1 2 5 3.1 Brc1c(NC2=N[C@@H]3CCCC[C@@H]3N2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
92766 113319 35 None 1 6 Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00019a001
CHEMBL31410 113319 35 None 1 6 Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00019a001
191 7191 98 None -107 29 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
201 7191 98 None -107 29 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
2170 7191 98 None -107 29 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
CHEMBL1113 7191 98 None -107 29 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
DB00543 7191 98 None -107 29 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
10804826 30387 2 None -1 4 Bovine 5.8 pKi = 5.8 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL133451 30387 2 None -1 4 Bovine 5.8 pKi = 5.8 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
3823 56995 42 None -3019 11 Rat 4.8 pKi = 4.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
76973198 56995 42 None -3019 11 Rat 4.8 pKi = 4.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL157101 56995 42 None -3019 11 Rat 4.8 pKi = 4.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
44582676 196558 0 None -1 17 Human 6.8 pKi = 6.8 Binding
Inhibition of human cloned alpha1A adrenergic receptor by competitive binding experimentInhibition of human cloned alpha1A adrenergic receptor by competitive binding experiment
ChEMBL 403 9 0 4 4.3 COc1c(OCCF)cccc1C(=O)C1CCN(CCc2ccc(F)cc2)CC1 10.1016/j.bmc.2009.03.021
CHEMBL516088 196558 0 None -1 17 Human 6.8 pKi = 6.8 Binding
Inhibition of human cloned alpha1A adrenergic receptor by competitive binding experimentInhibition of human cloned alpha1A adrenergic receptor by competitive binding experiment
ChEMBL 403 9 0 4 4.3 COc1c(OCCF)cccc1C(=O)C1CCN(CCc2ccc(F)cc2)CC1 10.1016/j.bmc.2009.03.021
19085836 212444 0 None 6 3 Human 6.8 pKi = 6.8 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1cccc2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c12 10.1016/s0960-894x(98)00446-6
CHEMBL82056 212444 0 None 6 3 Human 6.8 pKi = 6.8 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1cccc2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c12 10.1016/s0960-894x(98)00446-6
11140345 210950 0 None 1 6 Human 6.8 pKi = 6.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70692 210950 0 None 1 6 Human 6.8 pKi = 6.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
9900133 15757 0 None -1 4 Bovine 6.8 pKi = 6.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 271 2 2 3 3.1 COC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL109827 15757 0 None -1 4 Bovine 6.8 pKi = 6.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 271 2 2 3 3.1 COC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
185076 193869 5 None -389 7 Human 5.8 pKi = 5.8 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL49137 193869 5 None -389 7 Human 5.8 pKi = 5.8 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
13298529 107996 57 None -134 2 Bovine 5.8 pKi = 5.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 241 1 1 3 1.3 Brc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL295921 107996 57 None -134 2 Bovine 5.8 pKi = 5.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 241 1 1 3 1.3 Brc1cccnc1N1CCNCC1 10.1021/jm00366a007
11464777 108582 0 None -363 5 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 4 0 4 4.2 CC(CN1CCN(c2cc(Cl)ccc2Cl)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1007/s00044-010-9379-1
CHEMBL300152 108582 0 None -363 5 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 4 0 4 4.2 CC(CN1CCN(c2cc(Cl)ccc2Cl)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1007/s00044-010-9379-1
9845181 214940 3 None -1445 13 Human 4.8 pKi = 4.8 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1016/s0960-894x(01)00159-7
CHEMBL98241 214940 3 None -1445 13 Human 4.8 pKi = 4.8 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1016/s0960-894x(01)00159-7
44433348 174128 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 545 10 0 7 4.6 CCN([C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1)S(=O)(=O)c1ccc(OC)c(OC)c1 10.1016/j.bmcl.2007.09.051
CHEMBL429453 174128 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 545 10 0 7 4.6 CCN([C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1)S(=O)(=O)c1ccc(OC)c(OC)c1 10.1016/j.bmcl.2007.09.051
135398737 7745 93 None -5 90 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
38 7745 93 None -5 90 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
722 7745 93 None -5 90 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
CHEMBL42 7745 93 None -5 90 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
DB00363 7745 93 None -5 90 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
44460423 212395 0 None 11 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 446 7 0 6 4.3 O=C1CCCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
CHEMBL81661 212395 0 None 11 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 446 7 0 6 4.3 O=C1CCCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
44431184 99625 0 None -2 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 5 0 5 5.5 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccc(F)cc5c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243866 99625 0 None -2 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 5 0 5 5.5 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccc(F)cc5c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
44295218 195881 0 None 22 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 582 8 2 7 3.5 COC(=O)C1(c2ccccc2)CCN(CCCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL51019 195881 0 None 22 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 582 8 2 7 3.5 COC(=O)C1(c2ccccc2)CCN(CCCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
145947937 174502 0 None -3 6 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 398 9 0 5 3.8 COc1ccccc1N1CCN(CCOCCOc2c(C)cc(C)cc2C)CC1 10.1016/j.bmcl.2018.04.059
CHEMBL4207653 174502 0 None -3 6 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 398 9 0 5 3.8 COc1ccccc1N1CCN(CCOCCOc2c(C)cc(C)cc2C)CC1 10.1016/j.bmcl.2018.04.059
CHEMBL4302655 174502 0 None -3 6 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 398 9 0 5 3.8 COc1ccccc1N1CCN(CCOCCOc2c(C)cc(C)cc2C)CC1 10.1016/j.bmcl.2018.04.059
44447070 101420 0 None -9 4 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 500 6 1 5 5.2 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)c1ccc(F)cc1 10.1016/j.bmcl.2007.11.106
CHEMBL252429 101420 0 None -9 4 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 500 6 1 5 5.2 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)c1ccc(F)cc1 10.1016/j.bmcl.2007.11.106
124 9755 47 None -19 32 Human 7.8 pKi = 7.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
2032 9755 47 None -19 32 Human 7.8 pKi = 7.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
4636 9755 47 None -19 32 Human 7.8 pKi = 7.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
CHEMBL762 9755 47 None -19 32 Human 7.8 pKi = 7.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
DB00935 9755 47 None -19 32 Human 7.8 pKi = 7.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
CHEMBL5270515 201388 0 None -39 3 Human 7.8 pKi = 7.8 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 452 8 1 5 3.6 CCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315265 201388 0 None -39 3 Human 7.8 pKi = 7.8 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 452 8 1 5 3.6 CCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
52937222 68095 0 None -15 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 3 0 4 3.9 CN1CCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1 10.1021/jm1013874
CHEMBL1767156 68095 0 None -15 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 3 0 4 3.9 CN1CCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1 10.1021/jm1013874
10089254 106757 0 None 12 3 Human 7.8 pKi = 7.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 350 7 1 3 3.5 O=C(CCCN1CCC(NC(=O)c2ccccc2)CC1)c1ccccc1 10.1021/jm960697s
CHEMBL286591 106757 0 None 12 3 Human 7.8 pKi = 7.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 350 7 1 3 3.5 O=C(CCCN1CCC(NC(=O)c2ccccc2)CC1)c1ccccc1 10.1021/jm960697s
53328314 70163 0 None 1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 439 7 0 4 4.2 O=C1CC(c2ccccc2)CC(=O)N1CCCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796034 70163 0 None 1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 439 7 0 4 4.2 O=C1CC(c2ccccc2)CC(=O)N1CCCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
144096995 171275 0 None -17 3 Human 6.8 pKi = 6.8 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 371 8 1 4 3.1 CS(=O)(=O)c1ccccc1CCNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
CHEMBL4214499 171275 0 None -17 3 Human 6.8 pKi = 6.8 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 371 8 1 4 3.1 CS(=O)(=O)c1ccccc1CCNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
173712 131099 20 None -8 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 391 6 1 3 4.9 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(Cl)cc1 10.1021/jm060383x
CHEMBL363548 131099 20 None -8 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 391 6 1 3 4.9 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(Cl)cc1 10.1021/jm060383x
1862 6949 18 None -1 7 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00118a019
510 6949 18 None -1 7 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00118a019
CHEMBL281232 6949 18 None -1 7 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00118a019
1960 9632 67 None -57 26 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
439260 9632 67 None -57 26 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
505 9632 67 None -57 26 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
CHEMBL1437 9632 67 None -57 26 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
DB00368 9632 67 None -57 26 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
18738412 212188 0 None 2 3 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 365 6 1 6 3.3 OCc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
CHEMBL80125 212188 0 None 2 3 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 365 6 1 6 3.3 OCc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
6603915 106758 30 None -446 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to alpha1A receptorBinding affinity to alpha1A receptor
ChEMBL 434 7 0 5 3.7 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)cc2)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL1775000 106758 30 None -446 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to alpha1A receptorBinding affinity to alpha1A receptor
ChEMBL 434 7 0 5 3.7 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)cc2)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL286607 106758 30 None -446 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to alpha1A receptorBinding affinity to alpha1A receptor
ChEMBL 434 7 0 5 3.7 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)cc2)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
2803 7742 58 None -3 19 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
516 7742 58 None -3 19 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
704 7742 58 None -3 19 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
CHEMBL134 7742 58 None -3 19 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
DB00575 7742 58 None -3 19 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
11464777 108582 0 None -363 5 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 4 0 4 4.2 CC(CN1CCN(c2cc(Cl)ccc2Cl)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1007/s00044-010-9379-1
CHEMBL300152 108582 0 None -363 5 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 4 0 4 4.2 CC(CN1CCN(c2cc(Cl)ccc2Cl)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1007/s00044-010-9379-1
1220 6975 55 None -407 44 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1016/j.bmcl.2010.01.030
31 6975 55 None -407 44 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1016/j.bmcl.2010.01.030
7 6975 55 None -407 44 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1016/j.bmcl.2010.01.030
CHEMBL56 6975 55 None -407 44 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1016/j.bmcl.2010.01.030
1220 6975 55 None -407 44 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm200421e
31 6975 55 None -407 44 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm200421e
7 6975 55 None -407 44 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm200421e
CHEMBL56 6975 55 None -407 44 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm200421e
11201573 204436 0 None -3 2 Rat 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 442 5 0 6 1.6 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCN(C(C)=O)CC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL57097 204436 0 None -3 2 Rat 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 442 5 0 6 1.6 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCN(C(C)=O)CC3)CC2=O)CC1 10.1021/jm030944+
127027077 144558 0 None -7585 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 403 7 2 4 3.9 O=C(NCCCCN1CCN(c2cccc(O)c2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3759491 144558 0 None -7585 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 403 7 2 4 3.9 O=C(NCCCCN1CCN(c2cccc(O)c2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
10768423 108104 0 None 1 3 Rat 6.8 pKi = 6.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 525 5 1 8 4.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nc(-c6ccccc6)cnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL296711 108104 0 None 1 3 Rat 6.8 pKi = 6.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 525 5 1 8 4.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nc(-c6ccccc6)cnc54)c3=O)C[C@@H]21 10.1021/jm990567u
16040907 104659 0 None -2 4 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 466 7 2 5 4.7 COc1ccccc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL272340 104659 0 None -2 4 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 466 7 2 5 4.7 COc1ccccc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
10577609 33759 0 None -10 3 Rat 6.8 pKi = 6.8 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 509 8 1 9 3.5 COc1cc2nc(N3CCN(C(=O)C(C)Oc4c(OC)cccc4C(C)C)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL136458 33759 0 None -10 3 Rat 6.8 pKi = 6.8 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 509 8 1 9 3.5 COc1cc2nc(N3CCN(C(=O)C(C)Oc4c(OC)cccc4C(C)C)CC3)nc(N)c2cc1OC 10.1021/jm9805337
3952 8669 38 None -26 12 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5353646 8669 38 None -26 12 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5443 8669 38 None -26 12 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5702063 8669 38 None -26 12 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL1331786 8669 38 None -26 12 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL420 8669 38 None -26 12 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
DB00629 8669 38 None -26 12 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
127027080 144631 0 None -45 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 443 7 3 4 3.3 O=C(NCCCCN1CCN(c2cccc3[nH]c(=O)[nH]c23)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3760110 144631 0 None -45 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 443 7 3 4 3.3 O=C(NCCCCN1CCN(c2cccc3[nH]c(=O)[nH]c23)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
11152823 172038 0 None -1 3 Human 6.8 pKi = 6.8 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 367 5 2 6 2.6 COc1cc2nc3c(c(N)c2cc1OC)CC(CNC(=O)c1ccco1)C3 10.1021/jm030952q
CHEMBL423018 172038 0 None -1 3 Human 6.8 pKi = 6.8 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 367 5 2 6 2.6 COc1cc2nc3c(c(N)c2cc1OC)CC(CNC(=O)c1ccco1)C3 10.1021/jm030952q
76333281 91600 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 367 5 2 6 2.6 COc1cc2nc3c(c(N)c2cc1OC)CC(CNC(=O)c1ccoc1)C3 10.1007/s00044-010-9379-1
CHEMBL2234450 91600 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 367 5 2 6 2.6 COc1cc2nc3c(c(N)c2cc1OC)CC(CNC(=O)c1ccoc1)C3 10.1007/s00044-010-9379-1
11273296 177075 0 None 6 3 Rat 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 586 11 1 8 2.9 CCOC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL444648 177075 0 None 6 3 Rat 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 586 11 1 8 2.9 CCOC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
203096 68073 3 None -630 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 341 5 0 4 3.2 CN(C)CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767134 68073 3 None -630 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 341 5 0 4 3.2 CN(C)CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
45358442 68097 0 None -63 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)C1 10.1021/jm1013874
CHEMBL1767158 68097 0 None -63 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)C1 10.1021/jm1013874
24803799 68100 0 None -79 4 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 654 13 0 6 8.3 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCCCc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
CHEMBL1767161 68100 0 None -79 4 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 654 13 0 6 8.3 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCCCc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
25130875 194406 0 None -4 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1CO[C@@H](c2ccccc2)CO1 10.1021/jm800461k
CHEMBL494908 194406 0 None -4 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1CO[C@@H](c2ccccc2)CO1 10.1021/jm800461k
52937730 68086 0 None -794 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 363 5 0 5 3.1 COc1cccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)c1 10.1021/jm1013874
CHEMBL1767147 68086 0 None -794 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 363 5 0 5 3.1 COc1cccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)c1 10.1021/jm1013874
24803480 68102 0 None -199 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 614 15 0 6 7.2 CN(CCCCc1ccc(OCCCN2CCCCCC2)cc1)CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767163 68102 0 None -199 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 614 15 0 6 7.2 CN(CCCCc1ccc(OCCCN2CCCCCC2)cc1)CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
153287574 182026 0 None -21 10 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-Prazosin from human recombinant adrenergic alpha1A receptor expressed in cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Prazosin from human recombinant adrenergic alpha1A receptor expressed in cells after 90 mins by microbeta scintillation counting method
ChEMBL 266 2 1 2 4.0 CC[C@H]1c2ccccc2N(c2ccccc2)C[C@@]1(C)N 10.1021/acsmedchemlett.9b00225
CHEMBL4572167 182026 0 None -21 10 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-Prazosin from human recombinant adrenergic alpha1A receptor expressed in cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Prazosin from human recombinant adrenergic alpha1A receptor expressed in cells after 90 mins by microbeta scintillation counting method
ChEMBL 266 2 1 2 4.0 CC[C@H]1c2ccccc2N(c2ccccc2)C[C@@]1(C)N 10.1021/acsmedchemlett.9b00225
11857863 92453 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccc(F)cc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228608 92453 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccc(F)cc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
44426404 149344 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 498 7 1 6 4.4 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccc2c(c1)OCO2 10.1016/j.bmcl.2007.04.098
CHEMBL389104 149344 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 498 7 1 6 4.4 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccc2c(c1)OCO2 10.1016/j.bmcl.2007.04.098
124 9755 47 None -13 32 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
2032 9755 47 None -13 32 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
4636 9755 47 None -13 32 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
CHEMBL762 9755 47 None -13 32 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
DB00935 9755 47 None -13 32 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
67753767 129832 1 None -1 2 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 318 5 1 1 5.0 c1ccc(CCCN2CCC(c3c[nH]c4ccccc34)CC2)cc1 10.1016/j.bmcl.2015.07.046
CHEMBL3609351 129832 1 None -1 2 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 318 5 1 1 5.0 c1ccc(CCCN2CCC(c3c[nH]c4ccccc34)CC2)cc1 10.1016/j.bmcl.2015.07.046
56649648 74630 0 None -47 8 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 474 8 0 5 3.0 COc1ccccc1N1CCN(CCN(C(=O)C23C4C5C2C2C3C4C52CF)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL1910139 74630 0 None -47 8 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 474 8 0 5 3.0 COc1ccccc1N1CCN(CCN(C(=O)C23C4C5C2C2C3C4C52CF)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
10816903 44467 0 None 32 3 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 571 8 2 7 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(OC)cc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145756 44467 0 None 32 3 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 571 8 2 7 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(OC)cc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
13507646 126392 0 None -3 2 Bovine 7.8 pKi = 7.8 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 243 0 0 2 4.0 c1ccc2c3c(sc2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL346492 126392 0 None -3 2 Bovine 7.8 pKi = 7.8 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 243 0 0 2 4.0 c1ccc2c3c(sc2c1)C1CCCCN1CC3 10.1021/jm00398a025
11801828 213323 0 None 35 6 Human 7.8 pKi = 7.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 606 9 3 6 5.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
CHEMBL88628 213323 0 None 35 6 Human 7.8 pKi = 7.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 606 9 3 6 5.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
11801828 213323 0 None 35 6 Human 7.8 pKi = 7.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 606 9 3 6 5.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1007/s00044-004-0120-9
CHEMBL88628 213323 0 None 35 6 Human 7.8 pKi = 7.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 606 9 3 6 5.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1007/s00044-004-0120-9
13507646 126392 0 None -3 2 Bovine 7.8 pKi = 7.8 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 243 0 0 2 4.0 c1ccc2c3c(sc2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL346492 126392 0 None -3 2 Bovine 7.8 pKi = 7.8 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 243 0 0 2 4.0 c1ccc2c3c(sc2c1)C1CCCCN1CC3 10.1021/jm00398a025
11994669 18602 0 None 3 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1ccc(-c2ccccc2)cc1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182141 18602 0 None 3 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1ccc(-c2ccccc2)cc1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214552 18602 0 None 3 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1ccc(-c2ccccc2)cc1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
52942664 24416 0 None 1 3 Rat 7.8 pKi = 7.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 500 8 2 6 2.7 COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL1258345 24416 0 None 1 3 Rat 7.8 pKi = 7.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 500 8 2 6 2.7 COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
10621590 91381 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153554 91381 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221148 91381 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
25181488 194161 0 None -33 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
CHEMBL493486 194161 0 None -33 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
71151588 125036 0 None -169 10 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 518 9 1 7 3.6 NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1 10.1016/j.ejmech.2014.12.045
CHEMBL3409256 125036 0 None -169 10 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 518 9 1 7 3.6 NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1 10.1016/j.ejmech.2014.12.045
14468881 183062 0 None -14 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 347 10 1 3 4.5 c1ccc(OCCNCCOC(c2ccccc2)c2ccccc2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4462600 183062 0 None -14 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 347 10 1 3 4.5 c1ccc(OCCNCCOC(c2ccccc2)c2ccccc2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4595111 183062 0 None -14 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 347 10 1 3 4.5 c1ccc(OCCNCCOC(c2ccccc2)c2ccccc2)cc1 10.1016/j.ejmech.2019.05.024
71817859 109356 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL2419772 109356 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL3040801 109356 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
145962945 168122 0 None -14 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 511 5 1 7 4.6 COc1cc2nc(N3CCN(C(=O)Cc4ccc5ccccc5c4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4125846 168122 0 None -14 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 511 5 1 7 4.6 COc1cc2nc(N3CCN(C(=O)Cc4ccc5ccccc5c4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
118716699 121609 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 348 4 0 6 1.7 COc1ccccc1N1CCN(CC2COC3(CCOCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3341769 121609 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 348 4 0 6 1.7 COc1ccccc1N1CCN(CC2COC3(CCOCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
12203911 195062 22 None -54 2 Bovine 6.8 pKi = 6.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 255 1 0 3 1.6 CN1CCN(c2ncccc2Br)CC1 10.1021/jm00366a007
CHEMBL50017 195062 22 None -54 2 Bovine 6.8 pKi = 6.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 255 1 0 3 1.6 CN1CCN(c2ncccc2Br)CC1 10.1021/jm00366a007
415628 214971 95 None -13 5 Bovine 6.8 pKi = 6.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 196 1 1 2 1.8 Clc1ccccc1N1CCNCC1 10.1021/jm00366a007
CHEMBL9841 214971 95 None -13 5 Bovine 6.8 pKi = 6.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 196 1 1 2 1.8 Clc1ccccc1N1CCNCC1 10.1021/jm00366a007
127027384 144456 0 None -100 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 480 9 2 5 3.5 CS(=O)(=O)Nc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1 10.1016/j.bmcl.2015.12.068
CHEMBL3758610 144456 0 None -100 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 480 9 2 5 3.5 CS(=O)(=O)Nc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1 10.1016/j.bmcl.2015.12.068
11500225 107978 61 None -38 2 Bovine 5.8 pKi = 5.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 289 1 1 3 1.1 Ic1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL295764 107978 61 None -38 2 Bovine 5.8 pKi = 5.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 289 1 1 3 1.1 Ic1cccnc1N1CCNCC1 10.1021/jm00366a007
44586429 191076 0 None -1 3 Rat 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 514 8 1 6 3.0 COc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL484102 191076 0 None -1 3 Rat 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 514 8 1 6 3.0 COc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
44361064 38389 0 None -6 6 Bovine 6.8 pKi = 6.8 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 338 7 2 4 4.5 N=CCC(O)CC1CCN(c2ccccc2Oc2ccccc2)CC1 10.1021/jm960510x
CHEMBL140450 38389 0 None -6 6 Bovine 6.8 pKi = 6.8 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 338 7 2 4 4.5 N=CCC(O)CC1CCN(c2ccccc2Oc2ccccc2)CC1 10.1021/jm960510x
11732516 211989 0 None 1 2 Human 6.8 pKi = 6.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 418 5 0 7 3.0 COc1ccccc1N1CCN(c2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL78584 211989 0 None 1 2 Human 6.8 pKi = 6.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 418 5 0 7 3.0 COc1ccccc1N1CCN(c2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
9817256 211017 0 None 2 4 Human 5.8 pKi = 5.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL71001 211017 0 None 2 4 Human 5.8 pKi = 5.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
44586483 179246 0 None 1 3 Rat 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 600 11 1 8 3.3 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C(C)C(=O)OC)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL448198 179246 0 None 1 3 Rat 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 600 11 1 8 3.3 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C(C)C(=O)OC)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
24894141 194188 0 None -30 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
CHEMBL493697 194188 0 None -30 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
9944467 16023 0 None 1 4 Rat 6.8 pKi = 6.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 2 2 2 3.4 O=C(Nc1cccc2c1CCCC2c1c[nH]cn1)C(F)(F)F 10.1021/jm030551a
CHEMBL110751 16023 0 None 1 4 Rat 6.8 pKi = 6.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 2 2 2 3.4 O=C(Nc1cccc2c1CCCC2c1c[nH]cn1)C(F)(F)F 10.1021/jm030551a
10420352 175519 10 None -63 4 Human 4.8 pKi = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
CHEMBL43711 175519 10 None -63 4 Human 4.8 pKi = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
24839550 144093 14 None -26 15 Human 5.8 pKi = 5.8 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 240 7 1 1 3.4 C=CCN(CC=C)CCc1c[nH]c2ccccc12 10.1016/j.bmcl.2015.12.053
CHEMBL3752576 144093 14 None -26 15 Human 5.8 pKi = 5.8 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 240 7 1 1 3.4 C=CCN(CC=C)CCc1c[nH]c2ccccc12 10.1016/j.bmcl.2015.12.053
127024960 144494 0 None -15 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 421 7 1 3 4.8 O=C(NCCCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3758920 144494 0 None -15 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 421 7 1 3 4.8 O=C(NCCCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
11742585 170127 0 None 1 2 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 415 5 1 6 2.5 CS(=O)(=O)Nc1ccc2c(c1)OC1(CCN(CCc3ccccn3)CC1)CC2=O 10.1016/s0960-894x(98)00732-x
CHEMBL419164 170127 0 None 1 2 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 415 5 1 6 2.5 CS(=O)(=O)Nc1ccc2c(c1)OC1(CCN(CCc3ccccn3)CC1)CC2=O 10.1016/s0960-894x(98)00732-x
CHEMBL4576555 220796 5 None -1 19 Human 5.8 pKi = 5.8 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000705a ADRA1ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000705a ADRA1A
ChEMBL None None None CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1 10.6019/CHEMBL5212743
76322411 91589 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 7 1 4 4.0 c1ccc(OCCNC2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1007/s00044-010-9379-1
CHEMBL2234439 91589 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 7 1 4 4.0 c1ccc(OCCNC2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1007/s00044-010-9379-1
11176459 108414 0 None -181 5 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 380 4 0 5 2.4 N#Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL299022 108414 0 None -181 5 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 380 4 0 5 2.4 N#Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
155536203 183186 0 None -2 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 403 10 1 4 4.6 c1ccc(OCCNCC[C@@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4473623 183186 0 None -2 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 403 10 1 4 4.6 c1ccc(OCCNCC[C@@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4596045 183186 0 None -2 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 403 10 1 4 4.6 c1ccc(OCCNCC[C@@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
25131198 93035 0 None -288 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNCC2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.02.056
CHEMBL2312537 93035 0 None -288 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNCC2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.02.056
25181489 194136 0 None -158 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm800461k
CHEMBL493285 194136 0 None -158 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm800461k
25131198 93035 0 None -288 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNCC2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm301525w
CHEMBL2312537 93035 0 None -288 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNCC2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm301525w
76307951 91601 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 9 2 8 3.6 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNCOc1c(OC)cccc1OC)C3 10.1007/s00044-010-9379-1
CHEMBL2234451 91601 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 9 2 8 3.6 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNCOc1c(OC)cccc1OC)C3 10.1007/s00044-010-9379-1
11784634 43288 0 None -7 3 Human 5.8 pKi = 5.8 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 468 10 2 8 3.7 COc1cc2nc3c(c(O)c2cc1OC)CCC(CNCCOc1c(OC)cccc1OC)C3 10.1021/jm030952q
CHEMBL144779 43288 0 None -7 3 Human 5.8 pKi = 5.8 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 468 10 2 8 3.7 COc1cc2nc3c(c(O)c2cc1OC)CCC(CNCCOc1c(OC)cccc1OC)C3 10.1021/jm030952q
76307951 91601 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 9 2 8 3.6 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNCOc1c(OC)cccc1OC)C3 10.1007/s00044-010-9379-1
CHEMBL2234451 91601 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 9 2 8 3.6 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNCOc1c(OC)cccc1OC)C3 10.1007/s00044-010-9379-1
9818490 16149 0 None - 1 Rat 5.8 pKi = 5.8 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 319 5 2 3 3.0 CCCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111391 16149 0 None - 1 Rat 5.8 pKi = 5.8 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 319 5 2 3 3.0 CCCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
53328503 70166 0 None -15 3 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 441 6 0 5 3.4 COc1ccccc1N1CCN(CCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796037 70166 0 None -15 3 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 441 6 0 5 3.4 COc1ccccc1N1CCN(CCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
9818490 16149 0 None - 1 Rat 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 319 5 2 3 3.0 CCCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111391 16149 0 None - 1 Rat 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 319 5 2 3 3.0 CCCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
9966903 176192 0 None - 1 Rat 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 321 4 2 4 2.3 COc1ccc(NS(C)(=O)=O)c2c1C(c1c[nH]cn1)CCC2 10.1021/jm030551a
CHEMBL442394 176192 0 None - 1 Rat 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 321 4 2 4 2.3 COc1ccc(NS(C)(=O)=O)c2c1C(c1c[nH]cn1)CCC2 10.1021/jm030551a
44431562 94749 0 None 3 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(OC)c(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)c1 10.1016/j.bmcl.2007.04.008
CHEMBL234194 94749 0 None 3 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(OC)c(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)c1 10.1016/j.bmcl.2007.04.008
44431557 96053 0 None -8 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 541 8 1 6 4.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL236830 96053 0 None -8 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 541 8 1 6 4.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
49865639 22805 0 None -1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 328 7 1 4 3.2 Fc1ccccc1N1CCN(CCCCNc2ccccn2)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL1223680 22805 0 None -1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 328 7 1 4 3.2 Fc1ccccc1N1CCN(CCCCNc2ccccn2)CC1 10.1016/j.bmcl.2010.07.096
44288485 169299 0 None 29 3 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 498 9 1 4 5.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1 10.1016/s0960-894x(01)00320-1
CHEMBL41677 169299 0 None 29 3 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 498 9 1 4 5.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1 10.1016/s0960-894x(01)00320-1
44288359 162525 0 None -2 3 Rat 7.8 pKi = 7.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 461 5 1 6 4.0 COc1cccc2c1CCC1CN(CCCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL40564 162525 0 None -2 3 Rat 7.8 pKi = 7.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 461 5 1 6 4.0 COc1cccc2c1CCC1CN(CCCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
44447072 101421 0 None -25 4 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 483 6 1 6 4.5 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)c1cccnc1 10.1016/j.bmcl.2007.11.106
CHEMBL252430 101421 0 None -25 4 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 483 6 1 6 4.5 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)c1cccnc1 10.1016/j.bmcl.2007.11.106
6604803 123296 2 None -7 4 Bovine 7.8 pKi = 7.8 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL336161 123296 2 None -7 4 Bovine 7.8 pKi = 7.8 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
118716705 121776 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 424 5 0 7 2.6 COc1ccccc1N1CCN(CC2COC3(CCN(c4ccccn4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342858 121776 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 424 5 0 7 2.6 COc1ccccc1N1CCN(CC2COC3(CCN(c4ccccn4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
11176459 108414 0 None -181 5 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 380 4 0 5 2.4 N#Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL299022 108414 0 None -181 5 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 380 4 0 5 2.4 N#Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
9934955 79051 0 None -489 6 Human 5.8 pKi = 5.8 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19826 79051 0 None -489 6 Human 5.8 pKi = 5.8 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
11098175 210949 0 None -1 5 Human 6.8 pKi = 6.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL70691 210949 0 None -1 5 Human 6.8 pKi = 6.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
1220 6975 55 None -407 44 Human 5.8 pKi = 5.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm010866v
31 6975 55 None -407 44 Human 5.8 pKi = 5.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm010866v
7 6975 55 None -407 44 Human 5.8 pKi = 5.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm010866v
CHEMBL56 6975 55 None -407 44 Human 5.8 pKi = 5.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm010866v
1220 6975 55 None -407 44 Human 5.8 pKi = 5.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm0009336
31 6975 55 None -407 44 Human 5.8 pKi = 5.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm0009336
7 6975 55 None -407 44 Human 5.8 pKi = 5.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm0009336
CHEMBL56 6975 55 None -407 44 Human 5.8 pKi = 5.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm0009336
53248365 68860 0 None -186 7 Human 6.8 pKi = 6.8 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 554 6 1 5 2.9 O=C(N(CCN1CCN(c2ccccc2O)CC1)c1ccccn1)C12C3C4C1C1C2C3C41I 10.1021/jm1009956
CHEMBL1774995 68860 0 None -186 7 Human 6.8 pKi = 6.8 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 554 6 1 5 2.9 O=C(N(CCN1CCN(c2ccccc2O)CC1)c1ccccn1)C12C3C4C1C1C2C3C41I 10.1021/jm1009956
71817545 98899 0 None -58 7 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419765 98899 0 None -58 7 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
126720252 171454 0 None -63 12 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by scintillation counting methodDisplacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by scintillation counting method
ChEMBL 697 15 2 6 9.2 NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1 10.1021/acs.jmedchem.8b00168
CHEMBL4216870 171454 0 None -63 12 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by scintillation counting methodDisplacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by scintillation counting method
ChEMBL 697 15 2 6 9.2 NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1 10.1021/acs.jmedchem.8b00168
18738382 22039 0 None 33 3 Human 7.8 pKi = 7.8 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 399 8 0 5 2.7 CC(C)Oc1ccccc1N1CCN(C/C=C/C(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12127 22039 0 None 33 3 Human 7.8 pKi = 7.8 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 399 8 0 5 2.7 CC(C)Oc1ccccc1N1CCN(C/C=C/C(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
9888164 24723 1 None 25 3 Human 7.8 pKi = 7.8 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 416 8 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12603 24723 1 None 25 3 Human 7.8 pKi = 7.8 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 416 8 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
289 7030 12 None -1 14 Human 7.8 pKi = 7.8 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 301 8 0 2 4.9 CCCCC1CCN(CC1)CCCC(=O)c1ccccc1C 10.1021/jm100697g
9948320 7030 12 None -1 14 Human 7.8 pKi = 7.8 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 301 8 0 2 4.9 CCCCC1CCN(CC1)CCCC(=O)c1ccccc1C 10.1021/jm100697g
CHEMBL1242950 7030 12 None -1 14 Human 7.8 pKi = 7.8 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 301 8 0 2 4.9 CCCCC1CCN(CC1)CCCC(=O)c1ccccc1C 10.1021/jm100697g
44431564 155138 0 None -2 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 501 8 1 6 4.2 COc1ccc(C)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL393725 155138 0 None -2 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 501 8 1 6 4.2 COc1ccc(C)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
44308443 210732 0 None -1 2 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 413 6 0 5 4.0 COc1ccccc1N1CCN(Cc2ccc(CN3CCCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL69339 210732 0 None -1 2 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 413 6 0 5 4.0 COc1ccccc1N1CCN(Cc2ccc(CN3CCCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
9864676 134586 0 None -1 5 Bovine 7.8 pKi = 7.8 Binding
Inhibition of [3H]prazosin binding to Alpha-1 adrenergic receptor in bovine frontal cortexInhibition of [3H]prazosin binding to Alpha-1 adrenergic receptor in bovine frontal cortex
ChEMBL 380 6 0 3 4.5 O=C(CCCN1CCN(C2CCCc3ccccc32)CC1)c1ccc(F)cc1 10.1021/jm950759z
CHEMBL366388 134586 0 None -1 5 Bovine 7.8 pKi = 7.8 Binding
Inhibition of [3H]prazosin binding to Alpha-1 adrenergic receptor in bovine frontal cortexInhibition of [3H]prazosin binding to Alpha-1 adrenergic receptor in bovine frontal cortex
ChEMBL 380 6 0 3 4.5 O=C(CCCN1CCN(C2CCCc3ccccc32)CC1)c1ccc(F)cc1 10.1021/jm950759z
145950240 169480 0 None 2 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 465 5 2 9 2.2 COc1cc2nc(N3CCC[C@H](NC(=O)[C@H]4COc5ccccc5O4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4170675 169480 0 None 2 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 465 5 2 9 2.2 COc1cc2nc(N3CCC[C@H](NC(=O)[C@H]4COc5ccccc5O4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
10787126 91345 0 None -2 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153558 91345 0 None -2 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220897 91345 0 None -2 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
10893672 212191 0 None -1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 357 6 1 7 1.3 COc1ccccc1N1CCN(CCNc2cc(C)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL80132 212191 0 None -1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 357 6 1 7 1.3 COc1ccccc1N1CCN(CCNc2cc(C)nn(C)c2=O)CC1 10.1021/jm0009336
11109088 210959 0 None -3 6 Human 7.7 pKi = 7.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70751 210959 0 None -3 6 Human 7.7 pKi = 7.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
9824384 125565 1 None -17 8 Rat 7.7 pKi = 7.7 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm960510x
CHEMBL342062 125565 1 None -17 8 Rat 7.7 pKi = 7.7 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm960510x
10252540 92132 1 None -83 6 Rat 7.7 pKi = 7.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) CEC-treated hippocampusBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) CEC-treated hippocampus
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261604 92132 1 None -83 6 Rat 7.7 pKi = 7.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) CEC-treated hippocampusBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) CEC-treated hippocampus
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
3251 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2010.05.023
5684 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2010.05.023
80 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2010.05.023
CHEMBL31354 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2010.05.023
3251 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.05.024
5684 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.05.024
80 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.05.024
CHEMBL31354 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.05.024
3251 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.02.056
5684 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.02.056
80 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.02.056
CHEMBL31354 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.02.056
3251 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm200421e
5684 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm200421e
80 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm200421e
CHEMBL31354 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm200421e
118716720 121792 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 425 5 0 7 1.0 COc1ccccc1N1CCN(CC2COC3(CCN(S(C)(=O)=O)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342873 121792 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 425 5 0 7 1.0 COc1ccccc1N1CCN(CC2COC3(CCN(S(C)(=O)=O)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
10575664 125986 0 None -2 3 Rat 7.7 pKi = 7.7 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 453 7 1 9 2.0 COc1cc2nc(N3CCN(C(=O)COc4ccccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL343283 125986 0 None -2 3 Rat 7.7 pKi = 7.7 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 453 7 1 9 2.0 COc1cc2nc(N3CCN(C(=O)COc4ccccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
10575664 125986 0 None -2 3 Human 7.7 pKi = 7.7 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 453 7 1 9 2.0 COc1cc2nc(N3CCN(C(=O)COc4ccccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL343283 125986 0 None -2 3 Human 7.7 pKi = 7.7 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 453 7 1 9 2.0 COc1cc2nc(N3CCN(C(=O)COc4ccccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
16756754 98904 27 None -81 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 478 7 1 3 7.0 Cc1ccc(NC(=O)C(C)C)cc1C1CCN(Cc2ccc(Oc3ccc(F)c(F)c3)cc2)CC1 10.1021/jm060383x
CHEMBL242004 98904 27 None -81 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 478 7 1 3 7.0 Cc1ccc(NC(=O)C(C)C)cc1C1CCN(Cc2ccc(Oc3ccc(F)c(F)c3)cc2)CC1 10.1021/jm060383x
11412944 108286 69 None -223 2 Bovine 5.8 pKi = 5.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL298004 108286 69 None -223 2 Bovine 5.8 pKi = 5.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cccnc1N1CCNCC1 10.1021/jm00366a007
70820518 174306 0 None -104 3 Human 5.8 pKi = 5.8 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 391 7 1 4 3.7 CS(=O)(=O)c1ccc(Cl)cc1CNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
CHEMBL4213747 174306 0 None -104 3 Human 5.8 pKi = 5.8 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 391 7 1 4 3.7 CS(=O)(=O)c1ccc(Cl)cc1CNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
CHEMBL4300105 174306 0 None -104 3 Human 5.8 pKi = 5.8 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 391 7 1 4 3.7 CS(=O)(=O)c1ccc(Cl)cc1CNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
57400562 76093 0 None -1 5 Pig 5.8 pKi = 5.8 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 469 14 1 6 3.6 CCOCCOCc1ccc(N2CCN(CCCCNC(=O)c3ccccc3)CC2)c(OC)c1 10.1016/j.bmc.2011.10.063
CHEMBL1928247 76093 0 None -1 5 Pig 5.8 pKi = 5.8 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 469 14 1 6 3.6 CCOCCOCc1ccc(N2CCN(CCCCNC(=O)c3ccccc3)CC2)c(OC)c1 10.1016/j.bmc.2011.10.063
44420419 90206 0 None 2 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 485 4 0 7 3.3 Cn1c(=O)n(CCN2CCN(c3ccc(Cl)c(Cl)c3)CC2)c(=O)c2c1c1ccccc1n2C 10.1016/j.bmcl.2006.09.034
CHEMBL219719 90206 0 None 2 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 485 4 0 7 3.3 Cn1c(=O)n(CCN2CCN(c3ccc(Cl)c(Cl)c3)CC2)c(=O)c2c1c1ccccc1n2C 10.1016/j.bmcl.2006.09.034
10198248 194228 40 None -83 6 Human 4.7 pKi = 4.7 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 213 1 2 5 1.0 c1cnc2cc(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
CHEMBL49395 194228 40 None -83 6 Human 4.7 pKi = 4.7 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 213 1 2 5 1.0 c1cnc2cc(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
134149777 155290 0 None -199 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 353 7 1 5 4.2 COc1ccccc1OCCNCC1CSC2(CCCCC2)S1 10.1016/j.ejmech.2016.09.050
CHEMBL3938383 155290 0 None -199 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 353 7 1 5 4.2 COc1ccccc1OCCNCC1CSC2(CCCCC2)S1 10.1016/j.ejmech.2016.09.050
11464777 108582 0 None -457 5 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 437 4 0 4 4.2 CC(CN1CCN(c2cc(Cl)ccc2Cl)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm030944+
CHEMBL300152 108582 0 None -457 5 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 437 4 0 4 4.2 CC(CN1CCN(c2cc(Cl)ccc2Cl)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm030944+
44431613 94357 0 None -2 4 Human 6.7 pKi = 6.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 529 10 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OCC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
CHEMBL233584 94357 0 None -2 4 Human 6.7 pKi = 6.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 529 10 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OCC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
10792536 213555 0 None 14 3 Human 7.7 pKi = 7.7 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 540 7 3 3 4.7 O=C1NC(C(F)(F)F)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
CHEMBL90184 213555 0 None 14 3 Human 7.7 pKi = 7.7 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 540 7 3 3 4.7 O=C1NC(C(F)(F)F)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
135398737 7745 93 None -5 90 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
38 7745 93 None -5 90 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
722 7745 93 None -5 90 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
CHEMBL42 7745 93 None -5 90 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
DB00363 7745 93 None -5 90 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
44431614 94812 0 None 2 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 533 9 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OCC3CC3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234474 94812 0 None 2 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 533 9 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OCC3CC3)CC2)CC1 10.1016/j.bmcl.2007.04.008
13141182 137671 1 None 10 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 354 0 0 2 4.7 CN1CCC(=C2c3cc(Br)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL368578 137671 1 None 10 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 354 0 0 2 4.7 CN1CCC(=C2c3cc(Br)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
127027078 144605 0 None -14 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 426 7 2 3 4.7 O=C(NCCCCN1CCN(c2cccc3[nH]ccc23)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3759865 144605 0 None -14 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 426 7 2 3 4.7 O=C(NCCCCN1CCN(c2cccc3[nH]ccc23)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
57395341 76086 0 None 2 5 Pig 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 495 13 1 8 2.8 CCOCCOCc1ccn2ncc(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
CHEMBL1928135 76086 0 None 2 5 Pig 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 495 13 1 8 2.8 CCOCCOCc1ccn2ncc(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
71508682 93823 0 None 45 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 371 3 0 5 4.2 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4ccnn4C)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325927 93823 0 None 45 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 371 3 0 5 4.2 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4ccnn4C)cc23)CC1 10.1016/j.bmc.2012.10.049
71508711 93831 0 None 43 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 369 3 0 5 4.3 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cncnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325934 93831 0 None 43 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 369 3 0 5 4.3 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cncnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
10698974 97897 0 None 102 3 Human 7.7 pKi = 7.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 610 5 1 7 4.3 COC(=O)C1=C(C)NC(=O)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL239806 97897 0 None 102 3 Human 7.7 pKi = 7.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 610 5 1 7 4.3 COC(=O)C1=C(C)NC(=O)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
135398737 7745 93 None -5 90 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm401958n
38 7745 93 None -5 90 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm401958n
722 7745 93 None -5 90 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm401958n
CHEMBL42 7745 93 None -5 90 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm401958n
DB00363 7745 93 None -5 90 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm401958n
42631003 206397 13 None -97 8 Human 7.7 pKi = 7.7 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 304 3 0 2 4.2 Cc1ccc2c(c1)c1c(n2CCc2ccccc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
CHEMBL592752 206397 13 None -97 8 Human 7.7 pKi = 7.7 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 304 3 0 2 4.2 Cc1ccc2c(c1)c1c(n2CCc2ccccc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
50905588 63127 0 None -1 6 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@H]2Oc3ccccc3O[C@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630941 63127 0 None -1 6 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@H]2Oc3ccccc3O[C@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
10575494 172526 0 None -4 3 Human 7.7 pKi = 7.7 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 449 7 1 8 2.5 COc1cc2nc(N3CCN(C(=O)CCC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL424658 172526 0 None -4 3 Human 7.7 pKi = 7.7 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 449 7 1 8 2.5 COc1cc2nc(N3CCN(C(=O)CCC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
44329027 10940 0 None 9 6 Human 7.7 pKi = 7.7 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 637 13 3 7 4.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL100045 10940 0 None 9 6 Human 7.7 pKi = 7.7 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 637 13 3 7 4.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COC)N1 10.1016/s0960-894x(99)00484-9
10363912 13310 0 None -36 7 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL1082862 13310 0 None -36 7 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL286003 13310 0 None -36 7 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
10363912 13310 0 None -36 7 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1082862 13310 0 None -36 7 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL286003 13310 0 None -36 7 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
10363912 13310 0 None -36 7 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm200421e
CHEMBL1082862 13310 0 None -36 7 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm200421e
CHEMBL286003 13310 0 None -36 7 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm200421e
11653915 130790 0 None -5 6 Human 7.7 pKi = 7.7 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 296 4 2 5 2.6 COc1cccc(N(NC2=NCCN2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
CHEMBL362954 130790 0 None -5 6 Human 7.7 pKi = 7.7 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 296 4 2 5 2.6 COc1cccc(N(NC2=NCCN2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
52945156 23830 0 None -7 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 455 13 1 6 4.1 COc1cccc(OC)c1[S+]([O-])CCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254660 23830 0 None -7 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 455 13 1 6 4.1 COc1cccc(OC)c1[S+]([O-])CCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
118716722 121794 0 None -1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 446 7 1 6 2.5 CCCCNC(=O)N1CCC2(CC1)OCC(CN1CCN(c3ccccc3OC)CC1)O2 10.1016/j.ejmech.2014.09.070
CHEMBL3342875 121794 0 None -1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 446 7 1 6 2.5 CCCCNC(=O)N1CCC2(CC1)OCC(CN1CCN(c3ccccc3OC)CC1)O2 10.1016/j.ejmech.2014.09.070
44298747 108785 0 None -3 2 Human 7.7 pKi = 7.7 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 480 7 1 6 2.7 O=c1[nH]cc(C(F)(F)F)c(=O)n1CCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL301650 108785 0 None -3 2 Human 7.7 pKi = 7.7 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 480 7 1 6 2.7 O=c1[nH]cc(C(F)(F)F)c(=O)n1CCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
9887458 202452 0 None -512 4 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL55654 202452 0 None -512 4 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
53328313 70161 0 None 1 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 455 7 0 5 3.8 COc1ccc(Cl)cc1N1CCN(CCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796032 70161 0 None 1 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 455 7 0 5 3.8 COc1ccc(Cl)cc1N1CCN(CCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
145958538 169044 0 None -6 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 303 3 2 7 1.2 COc1cc2nc(N3CCC[C@H](N)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4163810 169044 0 None -6 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 303 3 2 7 1.2 COc1cc2nc(N3CCC[C@H](N)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
9905929 19585 0 None -26 2 Rat 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 5 1 2 4.5 Cc1[nH]c2ccccc2c1C1CCN(CCCN2CCCCC2)CC1 10.1016/j.bmcl.2006.05.002
CHEMBL1188265 19585 0 None -26 2 Rat 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 5 1 2 4.5 Cc1[nH]c2ccccc2c1C1CCN(CCCN2CCCCC2)CC1 10.1016/j.bmcl.2006.05.002
CHEMBL535837 19585 0 None -26 2 Rat 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 5 1 2 4.5 Cc1[nH]c2ccccc2c1C1CCN(CCCN2CCCCC2)CC1 10.1016/j.bmcl.2006.05.002
9904117 16174 3 None -1 5 Rat 6.7 pKi = 6.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111554 16174 3 None -1 5 Rat 6.7 pKi = 6.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
44531812 201461 0 None 1 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 374 7 2 6 4.3 COc1cccc2c(NCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL532818 201461 0 None 1 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 374 7 2 6 4.3 COc1cccc2c(NCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
9904117 16174 3 None -1 5 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111554 16174 3 None -1 5 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
44314200 109729 0 None -81 4 Human 5.7 pKi = 5.7 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
CHEMBL306377 109729 0 None -81 4 Human 5.7 pKi = 5.7 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
44531812 201461 0 None 1 4 Human 6.7 pKi = 6.7 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 374 7 2 6 4.3 COc1cccc2c(NCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL532818 201461 0 None 1 4 Human 6.7 pKi = 6.7 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 374 7 2 6 4.3 COc1cccc2c(NCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL5291469 201419 0 None -70 2 Human 6.7 pKi = 6.7 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 508 8 1 6 3.6 O=C(NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O)C1CCOCC1 10.1021/acsmedchemlett.7b00112
CHEMBL5315702 201419 0 None -70 2 Human 6.7 pKi = 6.7 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 508 8 1 6 3.6 O=C(NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O)C1CCOCC1 10.1021/acsmedchemlett.7b00112
44586479 195406 0 None 1 3 Rat 6.7 pKi = 6.7 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 572 10 1 8 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL503007 195406 0 None 1 3 Rat 6.7 pKi = 6.7 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 572 10 1 8 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
52937732 68088 0 None -794 3 Human 6.7 pKi = 6.7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 369 4 0 4 3.4 CN1CCC[C@@H]1Cn1nc(Cc2ccc(F)c(F)c2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767149 68088 0 None -794 3 Human 6.7 pKi = 6.7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 369 4 0 4 3.4 CN1CCC[C@@H]1Cn1nc(Cc2ccc(F)c(F)c2)c2ccccc2c1=O 10.1021/jm1013874
52937828 68091 0 None -6 3 Human 6.7 pKi = 6.7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 347 5 0 4 3.3 CN1CCC[C@@H]1Cn1nc(CCc2ccccc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767152 68091 0 None -6 3 Human 6.7 pKi = 6.7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 347 5 0 4 3.3 CN1CCC[C@@H]1Cn1nc(CCc2ccccc2)c2ccccc2c1=O 10.1021/jm1013874
25130879 180016 0 None -47 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1COC[C@H](c2ccccc2)O1 10.1021/jm800461k
CHEMBL452437 180016 0 None -47 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1COC[C@H](c2ccccc2)O1 10.1021/jm800461k
134138438 154121 0 None -66 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 378 4 0 5 4.3 COc1ccccc1N1CCN(CC2CSC3(CCCCC3)S2)CC1 10.1016/j.ejmech.2016.09.050
CHEMBL3929328 154121 0 None -66 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 378 4 0 5 4.3 COc1ccccc1N1CCN(CC2CSC3(CCCCC3)S2)CC1 10.1016/j.ejmech.2016.09.050
25025581 208775 0 None -3 8 Human 6.7 pKi = 6.7 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 285 4 1 2 3.1 CCOC[C@H]1[C@@H]2CNC[C@@]21c1ccc(Cl)c(Cl)c1 10.1021/jm901818u
CHEMBL608151 208775 0 None -3 8 Human 6.7 pKi = 6.7 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 285 4 1 2 3.1 CCOC[C@H]1[C@@H]2CNC[C@@]21c1ccc(Cl)c(Cl)c1 10.1021/jm901818u
43260 12254 65 None -1 5 Rat 5.7 pKi = 5.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1007/s00044-004-0020-z
CHEMBL1076 12254 65 None -1 5 Rat 5.7 pKi = 5.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1007/s00044-004-0020-z
294234 109670 3 None -512 4 Human 5.7 pKi = 5.7 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
CHEMBL305928 109670 3 None -512 4 Human 5.7 pKi = 5.7 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
25164129 167939 0 None -3715 4 Rat 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 447 12 1 5 4.1 CCCCc1cc(OC2CCN(CCCCNS(=O)(=O)CC)CC2)c2ncccc2c1 10.1016/j.bmcl.2017.09.020
CHEMBL4088036 167939 0 None -3715 4 Rat 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 447 12 1 5 4.1 CCCCc1cc(OC2CCN(CCCCNS(=O)(=O)CC)CC2)c2ncccc2c1 10.1016/j.bmcl.2017.09.020
CHEMBL4117406 167939 0 None -3715 4 Rat 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 447 12 1 5 4.1 CCCCc1cc(OC2CCN(CCCCNS(=O)(=O)CC)CC2)c2ncccc2c1 10.1016/j.bmcl.2017.09.020
43260 12254 65 None -1 5 Rat 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm030551a
CHEMBL1076 12254 65 None -1 5 Rat 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm030551a
3584 10549 64 None -2 14 Human 8.7 pKi = 8.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
5401 10549 64 None -2 14 Human 8.7 pKi = 8.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
7302 10549 64 None -2 14 Human 8.7 pKi = 8.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
CHEMBL611 10549 64 None -2 14 Human 8.7 pKi = 8.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
DB01162 10549 64 None -2 14 Human 8.7 pKi = 8.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
44431560 152356 0 None -2 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL391530 152356 0 None -2 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11081136 212005 0 None 1 3 Human 8.7 pKi = 8.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 467 8 1 7 3.7 COc1ccc(Cl)cc1N1CCN(CCCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL78676 212005 0 None 1 3 Human 8.7 pKi = 8.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 467 8 1 7 3.7 COc1ccc(Cl)cc1N1CCN(CCCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
4431 9506 25 None 1 12 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 10.1016/j.bmcl.2004.11.032
73 9506 25 None 1 12 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 10.1016/j.bmcl.2004.11.032
CHEMBL8618 9506 25 None 1 12 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 10.1016/j.bmcl.2004.11.032
9909211 100983 1 None 1 3 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 404 8 2 7 1.9 COc1ccc(Cl)cc1N1CCN(CCCNc2nccc(C(N)=O)n2)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL24981 100983 1 None 1 3 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 404 8 2 7 1.9 COc1ccc(Cl)cc1N1CCN(CCCNc2nccc(C(N)=O)n2)CC1 10.1016/j.bmcl.2004.11.032
3584 10549 64 None -2 14 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
5401 10549 64 None -2 14 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
7302 10549 64 None -2 14 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
CHEMBL611 10549 64 None -2 14 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
DB01162 10549 64 None -2 14 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
181743 185351 5 None 24 22 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]Prazosin from human adrenergic alpha1A receptorDisplacement of [3H]Prazosin from human adrenergic alpha1A receptor
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4 10.1016/j.bmcl.2009.11.053
CHEMBL467094 185351 5 None 24 22 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]Prazosin from human adrenergic alpha1A receptorDisplacement of [3H]Prazosin from human adrenergic alpha1A receptor
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4 10.1016/j.bmcl.2009.11.053
49781681 24658 0 None -1 4 Bovine 8.7 pKi = 8.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 428 2 0 3 6.3 Cc1cc(C)c(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c(C)c1 10.1021/jm100652h
CHEMBL1259098 24658 0 None -1 4 Bovine 8.7 pKi = 8.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 428 2 0 3 6.3 Cc1cc(C)c(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c(C)c1 10.1021/jm100652h
10097317 206863 0 None 288 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 495 8 2 4 4.9 Cc1ccc(C(O)(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL59590 206863 0 None 288 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 495 8 2 4 4.9 Cc1ccc(C(O)(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(01)00320-1
10026936 170237 0 None 114 3 Human 8.7 pKi = 8.7 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 8 1 3 5.1 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)c(F)c2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL41994 170237 0 None 114 3 Human 8.7 pKi = 8.7 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 8 1 3 5.1 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)c(F)c2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
11200086 203203 0 None -1 4 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 388 4 0 3 4.2 O=C1CC2(CCCC2)CC(=O)N1CCN1CCC(c2ccccc2Cl)CC1 10.1021/jm030944+
CHEMBL56292 203203 0 None -1 4 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 388 4 0 3 4.2 O=C1CC2(CCCC2)CC(=O)N1CCN1CCC(c2ccccc2Cl)CC1 10.1021/jm030944+
44312563 211699 2 None -1 7 Bovine 8.7 pKi = 8.7 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligand
ChEMBL 401 7 1 8 1.0 COc1ccc(C)cc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1021/jm960069a
CHEMBL76168 211699 2 None -1 7 Bovine 8.7 pKi = 8.7 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligand
ChEMBL 401 7 1 8 1.0 COc1ccc(C)cc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1021/jm960069a
10531 8202 21 None -5 24 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
121 8202 21 None -5 24 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
888 8202 21 None -5 24 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL1732 8202 21 None -5 24 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00320 8202 21 None -5 24 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
46934945 23470 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 533 7 0 7 3.8 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CC4(CCCC4)CC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242912 23470 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 533 7 0 7 3.8 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CC4(CCCC4)CC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
100 10577 58 None 1 54 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
2637 10577 58 None 1 54 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
5452 10577 58 None 1 54 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
CHEMBL479 10577 58 None 1 54 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
DB00679 10577 58 None 1 54 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
6761 74574 19 None 1 18 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
CHEMBL1909072 74574 19 None 1 18 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
46882034 12573 0 None -1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 433 10 1 5 4.8 CC(C)Oc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1078773 12573 0 None -1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 433 10 1 5 4.8 CC(C)Oc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
121102 150744 2 None -3 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 370 8 0 5 3.5 CCOc1ccccc1N1CCN(CCc2ccc(OC)c(OC)c2)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3902626 150744 2 None -3 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 370 8 0 5 3.5 CCOc1ccccc1N1CCN(CCc2ccc(OC)c(OC)c2)CC1 10.1016/j.ejmech.2016.06.052
11801214 108998 0 None 25 2 Human 8.7 pKi = 8.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NC[C@@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL302942 108998 0 None 25 2 Human 8.7 pKi = 8.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NC[C@@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
9844511 111373 0 None 85 3 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 411 7 1 5 3.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)n[nH]2)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL310471 111373 0 None 85 3 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 411 7 1 5 3.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)n[nH]2)CC1 10.1016/s0960-894x(00)00472-8
56961460 128216 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 477 4 2 10 2.0 COc1cc2nc(N3CCN(C(=O)c4cc5ccc(O)cc5oc4=O)CC3)nc(N)c2cc1OC 10.1021/ml5004298
CHEMBL3582268 128216 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 477 4 2 10 2.0 COc1cc2nc(N3CCN(C(=O)c4cc5ccc(O)cc5oc4=O)CC3)nc(N)c2cc1OC 10.1021/ml5004298
10393665 40696 0 None 47 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 593 9 2 9 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL142383 40696 0 None 47 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 593 9 2 9 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
10627279 43987 0 None 47 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 9 3 8 3.0 CNC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL145334 43987 0 None 47 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 9 3 8 3.0 CNC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
10767626 162102 0 None -2 3 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 461 4 1 6 3.9 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL40310 162102 0 None -2 3 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 461 4 1 6 3.9 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
10502807 169924 0 None -3 3 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 431 4 1 6 3.1 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c(oc5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL417890 169924 0 None -3 3 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 431 4 1 6 3.1 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c(oc5ccccc54)c3=O)CC21 10.1021/jm990567u
71454865 91378 0 None -2 7 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153551 91378 0 None -2 7 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221145 91378 0 None -2 7 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
10698630 51207 0 None 1230 3 Human 8.7 pKi = 8.7 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 11 3 8 3.4 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL151878 51207 0 None 1230 3 Human 8.7 pKi = 8.7 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 11 3 8 3.4 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
11857791 92415 0 None 10 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 554 7 1 6 4.9 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc2c(c1)OCCO2 10.1016/j.bmcl.2007.04.098
CHEMBL228390 92415 0 None 10 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 554 7 1 6 4.9 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc2c(c1)OCCO2 10.1016/j.bmcl.2007.04.098
11857638 150588 0 None -1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL390129 150588 0 None -1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
10792591 213602 0 None 15 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 542 7 1 4 4.7 CC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/j.ejmech.2017.03.025
CHEMBL90453 213602 0 None 15 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 542 7 1 4 4.7 CC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/j.ejmech.2017.03.025
11071135 214787 0 None 3 8 Bovine 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 500 6 0 6 4.6 CN1CCC(CCN2CCC(c3cn(-c4ccc(F)cc4)c4ccc(-c5ncn(C)n5)cc34)CC2)C1=O 10.1021/jm020938y
CHEMBL97333 214787 0 None 3 8 Bovine 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 500 6 0 6 4.6 CN1CCC(CCN2CCC(c3cn(-c4ccc(F)cc4)c4ccc(-c5ncn(C)n5)cc34)CC2)C1=O 10.1021/jm020938y
56837419 76079 0 None -9 5 Pig 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 997 35 2 14 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928128 76079 0 None -9 5 Pig 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 997 35 2 14 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
10792591 213602 0 None 15 3 Human 8.7 pKi = 8.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 542 7 1 4 4.7 CC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm990612y
CHEMBL90453 213602 0 None 15 3 Human 8.7 pKi = 8.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 542 7 1 4 4.7 CC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm990612y
44447005 101501 0 None -7 4 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 446 6 1 5 4.2 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)C1CC1 10.1016/j.bmcl.2007.11.106
CHEMBL253024 101501 0 None -7 4 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 446 6 1 5 4.2 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)C1CC1 10.1016/j.bmcl.2007.11.106
6604803 123296 2 None 7 4 Rat 8.7 pKi = 8.7 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL336161 123296 2 None 7 4 Rat 8.7 pKi = 8.7 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
10406315 200104 0 None 120 2 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 361 2 2 5 3.5 COc1cc2c(cc1O)C[C@H]1c3c(c(Cl)c(O)c(OC)c3-2)CCN1C 10.1021/np990433j
CHEMBL524439 200104 0 None 120 2 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 361 2 2 5 3.5 COc1cc2c(cc1O)C[C@H]1c3c(c(Cl)c(O)c(OC)c3-2)CCN1C 10.1021/np990433j
134152568 159866 0 None 1 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 354 7 0 4 3.8 COc1ccc(CCN2CCN(c3ccccc3OC(C)C)CC2)cc1 10.1016/j.ejmech.2016.06.052
CHEMBL3976144 159866 0 None 1 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 354 7 0 4 3.8 COc1ccc(CCN2CCN(c3ccccc3OC(C)C)CC2)cc1 10.1016/j.ejmech.2016.06.052
11014848 211903 0 None 1 4 Human 8.6 pKi = 8.6 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 399 7 1 8 1.5 COc1ccccc1N1CCN(CCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL77901 211903 0 None 1 4 Human 8.6 pKi = 8.6 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 399 7 1 8 1.5 COc1ccccc1N1CCN(CCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
10791843 170179 0 None 138 3 Human 8.6 pKi = 8.6 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 2 4 3.7 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
CHEMBL419497 170179 0 None 138 3 Human 8.6 pKi = 8.6 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 2 4 3.7 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
2389 10104 118 None -11 66 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
5073 10104 118 None -11 66 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
96 10104 118 None -11 66 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
CHEMBL85 10104 118 None -11 66 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
DB00734 10104 118 None -11 66 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
44299945 108703 0 None 41 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL301024 108703 0 None 41 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
44294958 195110 0 None 151 3 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 554 7 3 7 1.9 NC(=O)c1ccccc1N1CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL50081 195110 0 None 151 3 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 554 7 3 7 1.9 NC(=O)c1ccccc1N1CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
71508687 93829 0 None 33 2 Bovine 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 385 3 0 3 5.6 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cccnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325932 93829 0 None 33 2 Bovine 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 385 3 0 3 5.6 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cccnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
489 6933 28 None -3 12 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
5640 6933 28 None -3 12 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
CHEMBL420060 6933 28 None -3 12 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
76333280 91592 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
CHEMBL2234442 91592 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
11133868 162121 0 None 4 7 Human 8.6 pKi = 8.6 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNC[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1021/jm011066n
CHEMBL40325 162121 0 None 4 7 Human 8.6 pKi = 8.6 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNC[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1021/jm011066n
76333280 91592 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
CHEMBL2234442 91592 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
132266 8061 12 None -7 9 Bovine 8.6 pKi = 8.6 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960510x
486 8061 12 None -7 9 Bovine 8.6 pKi = 8.6 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960510x
CHEMBL423294 8061 12 None -7 9 Bovine 8.6 pKi = 8.6 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960510x
19085894 212338 0 None 2 3 Human 8.6 pKi = 8.6 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in COS-7 cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in COS-7 cells
ChEMBL 533 7 0 9 2.3 CS(=O)(=O)c1ccc2c(c1)S(=O)(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)C2=O 10.1016/s0960-894x(98)00446-6
CHEMBL81173 212338 0 None 2 3 Human 8.6 pKi = 8.6 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in COS-7 cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in COS-7 cells
ChEMBL 533 7 0 9 2.3 CS(=O)(=O)c1ccc2c(c1)S(=O)(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)C2=O 10.1016/s0960-894x(98)00446-6
3037308 50853 27 None 2 6 Rat 8.6 pKi = 8.6 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 452 7 1 7 4.2 O=c1c(CO)coc2cc(OCCCN3CCC(c4noc5cc(F)ccc45)CC3)ccc12 10.1021/jm9810396
CHEMBL151475 50853 27 None 2 6 Rat 8.6 pKi = 8.6 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 452 7 1 7 4.2 O=c1c(CO)coc2cc(OCCCN3CCC(c4noc5cc(F)ccc45)CC3)ccc12 10.1021/jm9810396
3584 10549 64 None -2 14 Human 8.6 pKi = 8.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
5401 10549 64 None -2 14 Human 8.6 pKi = 8.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
7302 10549 64 None -2 14 Human 8.6 pKi = 8.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
CHEMBL611 10549 64 None -2 14 Human 8.6 pKi = 8.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
DB01162 10549 64 None -2 14 Human 8.6 pKi = 8.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
44300159 108612 0 None 275 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL300355 108612 0 None 275 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
44300170 175039 0 None 4 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL433832 175039 0 None 4 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
10793261 127831 0 None 2290 4 Human 8.6 pKi = 8.6 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 575 10 3 8 3.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm990200p
CHEMBL356829 127831 0 None 2290 4 Human 8.6 pKi = 8.6 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 575 10 3 8 3.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm990200p
10326069 46070 1 None 23 9 Human 8.6 pKi = 8.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL147077 46070 1 None 23 9 Human 8.6 pKi = 8.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
490 6979 8 None -36 12 Rat 8.6 pKi = 8.6 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
9890547 6979 8 None -36 12 Rat 8.6 pKi = 8.6 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
CHEMBL268758 6979 8 None -36 12 Rat 8.6 pKi = 8.6 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
10647424 213560 0 None 741 2 Human 8.6 pKi = 8.6 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 455 7 3 4 3.0 O=C1NC=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
CHEMBL90210 213560 0 None 741 2 Human 8.6 pKi = 8.6 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 455 7 3 4 3.0 O=C1NC=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
9909211 100983 1 None 1 3 Human 8.6 pKi = 8.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 404 8 2 7 1.9 COc1ccc(Cl)cc1N1CCN(CCCNc2nccc(C(N)=O)n2)CC1 10.1021/jm960697s
CHEMBL24981 100983 1 None 1 3 Human 8.6 pKi = 8.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 404 8 2 7 1.9 COc1ccc(Cl)cc1N1CCN(CCCNc2nccc(C(N)=O)n2)CC1 10.1021/jm960697s
52940951 23851 0 None -3 4 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 427 12 1 5 5.0 COc1cccc(Cl)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254828 23851 0 None -3 4 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 427 12 1 5 5.0 COc1cccc(Cl)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
52943356 23852 0 None -2 4 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 407 12 1 5 4.6 COc1cccc(C)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254829 23852 0 None -2 4 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 407 12 1 5 4.6 COc1cccc(C)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
3584 10549 64 None -3 14 Bovine 8.6 pKi = 8.6 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
5401 10549 64 None -3 14 Bovine 8.6 pKi = 8.6 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
7302 10549 64 None -3 14 Bovine 8.6 pKi = 8.6 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
CHEMBL611 10549 64 None -3 14 Bovine 8.6 pKi = 8.6 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
DB01162 10549 64 None -3 14 Bovine 8.6 pKi = 8.6 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
44298735 205239 0 None 39 2 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 472 8 1 6 3.0 CC(C)c1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL57740 205239 0 None 39 2 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 472 8 1 6 3.0 CC(C)c1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
10674647 45750 0 None 457 3 Human 8.6 pKi = 8.6 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 574 10 2 8 4.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL146815 45750 0 None 457 3 Human 8.6 pKi = 8.6 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 574 10 2 8 4.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
10674647 45750 0 None 457 3 Human 8.6 pKi = 8.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 574 10 2 8 4.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL146815 45750 0 None 457 3 Human 8.6 pKi = 8.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 574 10 2 8 4.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
11144555 212017 0 None 2 4 Human 8.6 pKi = 8.6 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 433 8 1 7 3.1 COc1ccccc1N1CCN(CCCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL78785 212017 0 None 2 4 Human 8.6 pKi = 8.6 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 433 8 1 7 3.1 COc1ccccc1N1CCN(CCCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
3157 8252 71 None -2 12 Human 8.6 pKi = 8.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
7170 8252 71 None -2 12 Human 8.6 pKi = 8.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
954 8252 71 None -2 12 Human 8.6 pKi = 8.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
CHEMBL707 8252 71 None -2 12 Human 8.6 pKi = 8.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
DB00590 8252 71 None -2 12 Human 8.6 pKi = 8.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
490 6979 8 None -25 12 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/j.bmcl.2004.11.032
9890547 6979 8 None -25 12 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/j.bmcl.2004.11.032
CHEMBL268758 6979 8 None -25 12 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/j.bmcl.2004.11.032
10576280 118194 0 None - 1 Human 8.6 pKi = 8.6 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 469 7 3 4 3.4 CC1=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL327327 118194 0 None - 1 Human 8.6 pKi = 8.6 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 469 7 3 4 3.4 CC1=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
9891166 40386 0 None -6 5 Rat 8.6 pKi = 8.6 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 0 8 3.3 COc1ccccc1N1CCN(CCn2c(=O)c3c(-c4ccccc4)csc3n(C)c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL14213 40386 0 None -6 5 Rat 8.6 pKi = 8.6 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 0 8 3.3 COc1ccccc1N1CCN(CCn2c(=O)c3c(-c4ccccc4)csc3n(C)c2=O)CC1 10.1016/s0960-894x(01)00159-7
490 6979 8 None -25 12 Human 8.6 pKi = 8.6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
9890547 6979 8 None -25 12 Human 8.6 pKi = 8.6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
CHEMBL268758 6979 8 None -25 12 Human 8.6 pKi = 8.6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
9847845 35226 0 None -10 6 Human 8.6 pKi = 8.6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(C)c(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13754 35226 0 None -10 6 Human 8.6 pKi = 8.6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(C)c(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
155532148 178480 0 None -1 7 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 444 6 0 5 4.2 COc1ccccc1N1CCN(CC2COCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2019.02.056
CHEMBL4466677 178480 0 None -1 7 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 444 6 0 5 4.2 COc1ccccc1N1CCN(CC2COCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2019.02.056
44431545 94856 0 None 12 4 Human 8.6 pKi = 8.6 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 457 7 1 5 3.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234669 94856 0 None 12 4 Human 8.6 pKi = 8.6 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 457 7 1 5 3.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431174 99578 0 None -8 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 5 0 5 5.5 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cc(Cl)c(Cl)cc4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243692 99578 0 None -8 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 5 0 5 5.5 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cc(Cl)c(Cl)cc4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
71508683 93824 0 None 56 2 Bovine 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 388 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cnn(C)c4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325928 93824 0 None 56 2 Bovine 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 388 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cnn(C)c4)cc23)CC1 10.1016/j.bmc.2012.10.049
44447001 162252 0 None -30 4 Rat 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 378 4 1 5 3.6 NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL404000 162252 0 None -30 4 Rat 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 378 4 1 5 3.6 NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
10716964 107368 0 None 1 3 Rat 8.6 pKi = 8.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 419 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)cc(C)cc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL291769 107368 0 None 1 3 Rat 8.6 pKi = 8.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 419 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)cc(C)cc4c3=O)C[C@@H]21 10.1021/jm000541z
11655728 23416 8 None -39 6 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor by filtration binding assayDisplacement of [3H]prazosin from human adrenergic alpha1A receptor by filtration binding assay
ChEMBL 468 5 1 7 3.1 Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C(N)=O)ncn4-5)CC3)cccc2n1 10.1021/jm100482n
CHEMBL1241913 23416 8 None -39 6 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor by filtration binding assayDisplacement of [3H]prazosin from human adrenergic alpha1A receptor by filtration binding assay
ChEMBL 468 5 1 7 3.1 Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C(N)=O)ncn4-5)CC3)cccc2n1 10.1021/jm100482n
134147055 156353 0 None -2 3 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 354 7 0 4 3.8 COc1cccc(CCN2CCN(c3ccccc3OC(C)C)CC2)c1 10.1016/j.ejmech.2016.06.052
CHEMBL3946843 156353 0 None -2 3 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 354 7 0 4 3.8 COc1cccc(CCN2CCN(c3ccccc3OC(C)C)CC2)c1 10.1016/j.ejmech.2016.06.052
2389 10104 118 None -11 66 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2004.11.032
5073 10104 118 None -11 66 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2004.11.032
96 10104 118 None -11 66 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2004.11.032
CHEMBL85 10104 118 None -11 66 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2004.11.032
DB00734 10104 118 None -11 66 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2004.11.032
31101 7516 40 None -4 35 Rat 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
35 7516 40 None -4 35 Rat 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
403 7516 40 None -4 35 Rat 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
CHEMBL493 7516 40 None -4 35 Rat 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
DB01200 7516 40 None -4 35 Rat 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
11154198 208393 0 None -5 5 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 413 6 0 5 3.3 CC(C)Oc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL60583 208393 0 None -5 5 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 413 6 0 5 3.3 CC(C)Oc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
11994797 19086 0 None 1 7 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
CHEMBL1185017 19086 0 None 1 7 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
CHEMBL383938 19086 0 None 1 7 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
45268939 203439 0 None -4 5 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1021/jm8016046
CHEMBL564481 203439 0 None -4 5 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1021/jm8016046
11154198 208393 0 None -5 5 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 413 6 0 5 3.3 CC(C)Oc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL60583 208393 0 None -5 5 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 413 6 0 5 3.3 CC(C)Oc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
11487449 202268 0 None -1 4 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 437 5 0 4 4.2 O=C1CC2(CCCC2)CC(=O)N1CCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL55319 202268 0 None -1 4 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 437 5 0 4 4.2 O=C1CC2(CCCC2)CC(=O)N1CCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
10506674 126502 0 None 354 3 Human 8.5 pKi = 8.5 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 542 9 3 7 3.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL347559 126502 0 None 354 3 Human 8.5 pKi = 8.5 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 542 9 3 7 3.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
46934787 23458 0 None 1 4 Human 8.5 pKi = 8.5 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 7 2.2 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242724 23458 0 None 1 4 Human 8.5 pKi = 8.5 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 7 2.2 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
3584 10549 64 None -2 14 Human 8.5 pKi = 8.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
5401 10549 64 None -2 14 Human 8.5 pKi = 8.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
7302 10549 64 None -2 14 Human 8.5 pKi = 8.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
CHEMBL611 10549 64 None -2 14 Human 8.5 pKi = 8.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
DB01162 10549 64 None -2 14 Human 8.5 pKi = 8.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
134147929 156420 0 None -1 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 7 0 4 3.5 CCOc1ccccc1N1CCN(CCc2cccc(OC)c2)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3947302 156420 0 None -1 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 7 0 4 3.5 CCOc1ccccc1N1CCN(CCc2cccc(OC)c2)CC1 10.1016/j.ejmech.2016.06.052
11145007 170872 0 None -2 4 Human 8.5 pKi = 8.5 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 461 9 1 8 3.0 COc1ccc(Cl)cc1N1CCN(CCCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL420959 170872 0 None -2 4 Human 8.5 pKi = 8.5 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 461 9 1 8 3.0 COc1ccc(Cl)cc1N1CCN(CCCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
19085832 170555 0 None 5 3 Human 7.7 pKi = 7.7 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 483 6 0 7 3.5 Cc1cc(C)c2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c2c1 10.1016/s0960-894x(98)00446-6
CHEMBL420578 170555 0 None 5 3 Human 7.7 pKi = 7.7 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 483 6 0 7 3.5 Cc1cc(C)c2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c2c1 10.1016/s0960-894x(98)00446-6
2337 10030 77 None -5 62 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
50 10030 77 None -5 62 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
5002 10030 77 None -5 62 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
CHEMBL716 10030 77 None -5 62 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
DB01224 10030 77 None -5 62 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
10578926 125744 0 None 75 3 Human 7.7 pKi = 7.7 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 1 7 4.5 COC(=O)C1=C(C)N=C(C)N(CCC[C@@H](C)CN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL342347 125744 0 None 75 3 Human 7.7 pKi = 7.7 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 1 7 4.5 COC(=O)C1=C(C)N=C(C)N(CCC[C@@H](C)CN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
9890459 23703 0 None 13 3 Human 7.7 pKi = 7.7 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 460 10 1 7 1.3 CCOC(=O)C1CCC(=O)N1CC(=O)NCCN1CCN(c2ccccc2OC(C)C)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12529 23703 0 None 13 3 Human 7.7 pKi = 7.7 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 460 10 1 7 1.3 CCOC(=O)C1CCC(=O)N1CC(=O)NCCN1CCN(c2ccccc2OC(C)C)CC1 10.1016/s0960-894x(00)00169-4
45560410 7872 0 None -891 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 340 6 1 5 1.6 COc1ccccc1N1CCN(CC1)CCNC(=O)c1ccccn1 10.1021/acs.jmedchem.2c00633
9825 7872 0 None -891 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 340 6 1 5 1.6 COc1ccccc1N1CCN(CC1)CCNC(=O)c1ccccn1 10.1021/acs.jmedchem.2c00633
CHEMBL4205290 7872 0 None -891 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 340 6 1 5 1.6 COc1ccccc1N1CCN(CC1)CCNC(=O)c1ccccn1 10.1021/acs.jmedchem.2c00633
10640907 11684 1 None -21 5 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 340 6 1 5 1.6 COc1ccccc1N1CCN(CCNC(=O)c2ccncc2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL104593 11684 1 None -21 5 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 340 6 1 5 1.6 COc1ccccc1N1CCN(CCNC(=O)c2ccncc2)CC1 10.1021/acs.jmedchem.2c00633
56971026 76017 0 None -12 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 378 7 1 6 2.1 COc1ccccc1N1CCN(CCCN/C(=N\C#N)c2ccccn2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL1927088 76017 0 None -12 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 378 7 1 6 2.1 COc1ccccc1N1CCN(CCCN/C(=N\C#N)c2ccccn2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL5172506 76017 0 None -12 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 378 7 1 6 2.1 COc1ccccc1N1CCN(CCCN/C(=N\C#N)c2ccccn2)CC1 10.1021/acs.jmedchem.2c00633
44431553 94261 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 4.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(C(F)(F)F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233416 94261 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 4.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(C(F)(F)F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44390704 71327 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 445 7 2 10 -0.2 Cn1c(NCCCN2CCN(c3ccc4c(c3)OCC(CO)O4)CC2)cc(=O)n(C)c1=O 10.1016/j.bmcl.2004.11.032
CHEMBL181475 71327 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 445 7 2 10 -0.2 Cn1c(NCCCN2CCN(c3ccc4c(c3)OCC(CO)O4)CC2)cc(=O)n(C)c1=O 10.1016/j.bmcl.2004.11.032
44331090 215172 0 None 6 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 464 5 1 5 4.3 CS(=O)(=O)Nc1ccc2c(c1)OC1(CCN(CCc3cccc4ccccc34)CC1)CC2=O 10.1016/s0960-894x(98)00732-x
CHEMBL99614 215172 0 None 6 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 464 5 1 5 4.3 CS(=O)(=O)Nc1ccc2c(c1)OC1(CCN(CCc3cccc4ccccc34)CC1)CC2=O 10.1016/s0960-894x(98)00732-x
13141183 168742 1 None 15 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 310 0 0 2 4.6 CN1CCC(=C2c3cc(Cl)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL415761 168742 1 None 15 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 310 0 0 2 4.6 CN1CCC(=C2c3cc(Cl)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
3251 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2011.06.023
5684 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2011.06.023
80 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2011.06.023
CHEMBL31354 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2011.06.023
10839106 118372 0 None 5 3 Human 7.7 pKi = 7.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 500 7 2 3 4.5 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
CHEMBL328268 118372 0 None 5 3 Human 7.7 pKi = 7.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 500 7 2 3 4.5 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
11800744 214110 0 None 10 3 Human 7.7 pKi = 7.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 547 7 3 4 4.4 N#Cc1ccccc1C1CCN(CCCNC(=O)C2=C(C(F)(F)F)NC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
CHEMBL93523 214110 0 None 10 3 Human 7.7 pKi = 7.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 547 7 3 4 4.4 N#Cc1ccccc1C1CCN(CCCNC(=O)C2=C(C(F)(F)F)NC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
24854106 167840 1 None 2 8 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha-1 receptorInhibition of adrenergic alpha-1 receptor
ChEMBL 367 6 1 3 3.9 O=C1Nc2ccc(F)cc2C1CCCCN1CCN(c2ccccc2)CC1 10.1021/jm070279v
CHEMBL411663 167840 1 None 2 8 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha-1 receptorInhibition of adrenergic alpha-1 receptor
ChEMBL 367 6 1 3 3.9 O=C1Nc2ccc(F)cc2C1CCCCN1CCN(c2ccccc2)CC1 10.1021/jm070279v
3251 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm1009956
5684 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm1009956
80 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm1009956
CHEMBL31354 10844 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm1009956
10603951 213295 0 None 11 6 Human 7.7 pKi = 7.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 622 10 1 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL88448 213295 0 None 11 6 Human 7.7 pKi = 7.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 622 10 1 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
10603951 92046 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 622 10 1 7 5.9 COC(=O)C1=C(C)NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL2260148 92046 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 622 10 1 7 5.9 COC(=O)C1=C(C)NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
11097789 109775 1 None -4 6 Human 7.7 pKi = 7.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL306792 109775 1 None -4 6 Human 7.7 pKi = 7.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
10934575 211265 0 None -1 6 Human 7.7 pKi = 7.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72441 211265 0 None -1 6 Human 7.7 pKi = 7.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
9894818 105701 0 None 83 7 Human 7.7 pKi = 7.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL279436 105701 0 None 83 7 Human 7.7 pKi = 7.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
9894818 105701 0 None 83 7 Human 7.7 pKi = 7.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL279436 105701 0 None 83 7 Human 7.7 pKi = 7.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
53328684 70172 0 None 2 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 480 9 0 7 3.4 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccc([N+](=O)[O-])cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796043 70172 0 None 2 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 480 9 0 7 3.4 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccc([N+](=O)[O-])cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
46881494 13380 0 None -20 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 421 9 1 5 4.7 COc1ccccc1OCCNCC1CSC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1083182 13380 0 None -20 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 421 9 1 5 4.7 COc1ccccc1OCCNCC1CSC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
10106205 213916 1 None -12 4 Human 6.7 pKi = 6.7 Binding
Binding affinity towards alpha-1-adrenergic receptorBinding affinity towards alpha-1-adrenergic receptor
ChEMBL 251 2 2 3 3.0 Cc1c(NC2=NCCN2)cccc1-c1ccccc1 10.1021/jm030030n
CHEMBL92221 213916 1 None -12 4 Human 6.7 pKi = 6.7 Binding
Binding affinity towards alpha-1-adrenergic receptorBinding affinity towards alpha-1-adrenergic receptor
ChEMBL 251 2 2 3 3.0 Cc1c(NC2=NCCN2)cccc1-c1ccccc1 10.1021/jm030030n
10183297 100087 0 None -109 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 464 7 1 3 6.7 CC(C)C(=O)Nc1cccc(C2CCN(Cc3ccc(Oc4ccc(F)c(F)c4)cc3)CC2)c1 10.1021/jm060383x
CHEMBL245231 100087 0 None -109 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 464 7 1 3 6.7 CC(C)C(=O)Nc1cccc(C2CCN(Cc3ccc(Oc4ccc(F)c(F)c4)cc3)CC2)c1 10.1021/jm060383x
102 10899 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
3659 10899 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
8969 10899 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
CHEMBL15245 10899 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
DB01392 10899 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
57393634 76094 0 None -1 5 Pig 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 953 32 2 13 6.2 COc1cc(COCCOCCOCCOCCOCc2ccc(N3CCN(CCCCNC(=O)c4ccccc4)CC3)c(OC)c2)ccc1N1CCN(CCCCNC(=O)c2ccccc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928248 76094 0 None -1 5 Pig 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 953 32 2 13 6.2 COc1cc(COCCOCCOCCOCCOCc2ccc(N3CCN(CCCCNC(=O)c4ccccc4)CC3)c(OC)c2)ccc1N1CCN(CCCCNC(=O)c2ccccc2)CC1 10.1016/j.bmc.2011.10.063
2737203 190703 83 None -141 2 Bovine 5.7 pKi = 5.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 188 1 1 4 0.4 N#Cc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL48137 190703 83 None -141 2 Bovine 5.7 pKi = 5.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 188 1 1 4 0.4 N#Cc1cccnc1N1CCNCC1 10.1021/jm00366a007
1028 7079 71 None -48 30 Human 5.7 pKi = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
139148732 7079 71 None -48 30 Human 5.7 pKi = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
479 7079 71 None -48 30 Human 5.7 pKi = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
5816 7079 71 None -48 30 Human 5.7 pKi = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
CHEMBL679 7079 71 None -48 30 Human 5.7 pKi = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
DB00668 7079 71 None -48 30 Human 5.7 pKi = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
43260 12254 65 None -1 5 Rat 5.7 pKi = 5.7 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (1.6 -2.5)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (1.6 -2.5)
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm025550h
CHEMBL1076 12254 65 None -1 5 Rat 5.7 pKi = 5.7 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (1.6 -2.5)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (1.6 -2.5)
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm025550h
10892762 85596 0 None -52 6 Human 6.7 pKi = 6.7 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 326 7 1 4 3.8 COc1cccc(C2CCC(NCCOc3ccccn3)CC2)c1 10.1021/jm010866v
CHEMBL2112774 85596 0 None -52 6 Human 6.7 pKi = 6.7 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 326 7 1 4 3.8 COc1cccc(C2CCC(NCCOc3ccccn3)CC2)c1 10.1021/jm010866v
12134995 108919 0 None -1 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 318 5 1 5 2.6 COc1ccccc1N1CCN(Cc2ccc(CO)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL302495 108919 0 None -1 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 318 5 1 5 2.6 COc1ccccc1N1CCN(Cc2ccc(CO)s2)CC1 10.1016/s0960-894x(02)00347-5
9885114 126382 5 None -47 12 Rat 6.7 pKi = 6.7 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
CHEMBL346389 126382 5 None -47 12 Rat 6.7 pKi = 6.7 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
218362 211579 5 None -75 4 Human 6.7 pKi = 6.7 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL75030 211579 5 None -75 4 Human 6.7 pKi = 6.7 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
9904606 16158 0 None -2 4 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 1 3 2.3 CN(c1cccc2c1CCCC2c1c[nH]cn1)S(C)(=O)=O 10.1021/jm030551a
CHEMBL111463 16158 0 None -2 4 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 1 3 2.3 CN(c1cccc2c1CCCC2c1c[nH]cn1)S(C)(=O)=O 10.1021/jm030551a
11347303 118157 0 None -91 5 Bovine 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1ccc2c(c1)C(c1c[nH]cn1)CCC2 10.1021/jm030551a
CHEMBL327116 118157 0 None -91 5 Bovine 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1ccc2c(c1)C(c1c[nH]cn1)CCC2 10.1021/jm030551a
1220 6975 55 None -1659 44 Rat 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm030944+
31 6975 55 None -1659 44 Rat 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm030944+
7 6975 55 None -1659 44 Rat 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm030944+
CHEMBL56 6975 55 None -1659 44 Rat 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm030944+
11857709 92414 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL228389 92414 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857709 92414 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228389 92414 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
26987 7736 33 None -75 21 Rat 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
6063 7736 33 None -75 21 Rat 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
671 7736 33 None -75 21 Rat 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
CHEMBL1626 7736 33 None -75 21 Rat 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
DB00283 7736 33 None -75 21 Rat 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
9798183 19912 0 None -33 3 Rat 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 343 5 1 2 4.4 Fc1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1190579 19912 0 None -33 3 Rat 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 343 5 1 2 4.4 Fc1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL541129 19912 0 None -33 3 Rat 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 343 5 1 2 4.4 Fc1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
11496213 22846 0 None -35 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 6.1 Clc1cccc(N2CCN(CCCCNc3ccc(-c4ccccc4)cn3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
CHEMBL1223800 22846 0 None -35 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 6.1 Clc1cccc(N2CCN(CCCCNc3ccc(-c4ccccc4)cn3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
46934789 23463 0 None -2 4 Human 7.7 pKi = 7.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 7 2.6 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242819 23463 0 None -2 4 Human 7.7 pKi = 7.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 7 2.6 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
118716708 121780 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 441 5 0 7 2.5 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccco4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342861 121780 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 441 5 0 7 2.5 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccco4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
73346042 98609 5 None -213 17 Human 7.7 pKi = 7.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 9 0 8 0.9 Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O 10.1016/j.bmc.2013.05.050
CHEMBL2413153 98609 5 None -213 17 Human 7.7 pKi = 7.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 9 0 8 0.9 Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O 10.1016/j.bmc.2013.05.050
73346042 98609 5 None -213 17 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 405 9 0 8 0.9 Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O 10.1021/acs.jmedchem.2c00633
CHEMBL2413153 98609 5 None -213 17 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 405 9 0 8 0.9 Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O 10.1021/acs.jmedchem.2c00633
53328316 70165 0 None 1 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 449 9 0 5 3.9 COc1ccccc1N1CCN(CCCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796036 70165 0 None 1 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 449 9 0 5 3.9 COc1ccccc1N1CCN(CCCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
13938356 191857 0 None -154 2 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN(C1CCN2CCc3c(oc4ccccc34)C2C1)S(=O)(=O)CCO 10.1021/jm00150a002
CHEMBL48558 191857 0 None -154 2 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN(C1CCN2CCc3c(oc4ccccc34)C2C1)S(=O)(=O)CCO 10.1021/jm00150a002
127027079 144554 0 None -416 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 442 7 2 4 3.7 O=C1Cc2c(cccc2N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)N1 10.1016/j.bmcl.2015.12.068
CHEMBL3759441 144554 0 None -416 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 442 7 2 4 3.7 O=C1Cc2c(cccc2N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)N1 10.1016/j.bmcl.2015.12.068
145946733 174359 0 None -14 5 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 368 7 0 4 4.2 COc1ccc(N2CCN(CCCOc3c(C)cc(C)cc3C)CC2)cc1 10.1016/j.bmcl.2018.04.059
CHEMBL4205526 174359 0 None -14 5 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 368 7 0 4 4.2 COc1ccc(N2CCN(CCCOc3c(C)cc(C)cc3C)CC2)cc1 10.1016/j.bmcl.2018.04.059
CHEMBL4300710 174359 0 None -14 5 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 368 7 0 4 4.2 COc1ccc(N2CCN(CCCOc3c(C)cc(C)cc3C)CC2)cc1 10.1016/j.bmcl.2018.04.059
11176459 108414 0 None -229 5 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 380 4 0 5 2.4 N#Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL299022 108414 0 None -229 5 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 380 4 0 5 2.4 N#Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
44312037 211398 1 None -2 6 Human 4.7 pKi = 4.7 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 308 1 1 5 2.9 Brc1c(NC2=NCCS2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL73392 211398 1 None -2 6 Human 4.7 pKi = 4.7 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 308 1 1 5 2.9 Brc1c(NC2=NCCS2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
179268 108943 6 None -4 2 Human 5.7 pKi = 5.7 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 454 2 3 1 6.2 Brc1ccc2c(-c3c[nH]c(-c4c[nH]c5cc(Br)ccc45)n3)c[nH]c2c1 10.1016/0960-894X(96)00376-9
CHEMBL302637 108943 6 None -4 2 Human 5.7 pKi = 5.7 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 454 2 3 1 6.2 Brc1ccc2c(-c3c[nH]c(-c4c[nH]c5cc(Br)ccc45)n3)c[nH]c2c1 10.1016/0960-894X(96)00376-9
11959098 186315 56 None -79 2 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 211 1 0 3 1.5 CN1CCN(c2ncccc2Cl)CC1 10.1021/jm00366a007
CHEMBL47415 186315 56 None -79 2 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 211 1 0 3 1.5 CN1CCN(c2ncccc2Cl)CC1 10.1021/jm00366a007
10737133 213440 0 None -15 2 Rat 6.7 pKi = 6.7 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 358 6 0 5 2.3 COc1ccccc1N1CCN(CCCN2CC3CCCCN3C2)CC1 10.1021/jm970216k
CHEMBL89380 213440 0 None -15 2 Rat 6.7 pKi = 6.7 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 358 6 0 5 2.3 COc1ccccc1N1CCN(CCCN2CC3CCCCN3C2)CC1 10.1021/jm970216k
10028436 10305 5 None -109 12 Human 6.7 pKi = 6.7 Binding
Compound was tested for its binding affinity for Alpha 1B adrenergic receptorCompound was tested for its binding affinity for Alpha 1B adrenergic receptor
ChEMBL 487 7 1 4 4.9 Clc1ccc(cc1)OC1CCN(CC1)CC[C@H]1CCCN1S(=O)(=O)c1ccc2c(c1)[nH]cc2 10.1016/s0960-894x(02)00690-x
3237 10305 5 None -109 12 Human 6.7 pKi = 6.7 Binding
Compound was tested for its binding affinity for Alpha 1B adrenergic receptorCompound was tested for its binding affinity for Alpha 1B adrenergic receptor
ChEMBL 487 7 1 4 4.9 Clc1ccc(cc1)OC1CCN(CC1)CC[C@H]1CCCN1S(=O)(=O)c1ccc2c(c1)[nH]cc2 10.1016/s0960-894x(02)00690-x
CHEMBL95104 10305 5 None -109 12 Human 6.7 pKi = 6.7 Binding
Compound was tested for its binding affinity for Alpha 1B adrenergic receptorCompound was tested for its binding affinity for Alpha 1B adrenergic receptor
ChEMBL 487 7 1 4 4.9 Clc1ccc(cc1)OC1CCN(CC1)CC[C@H]1CCCN1S(=O)(=O)c1ccc2c(c1)[nH]cc2 10.1016/s0960-894x(02)00690-x
10903226 20542 0 None -2 4 Human 5.7 pKi = 5.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 281 6 2 5 1.3 CCCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1195368 20542 0 None -2 4 Human 5.7 pKi = 5.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 281 6 2 5 1.3 CCCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL554416 20542 0 None -2 4 Human 5.7 pKi = 5.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 281 6 2 5 1.3 CCCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
44314200 109729 0 None -81 4 Human 5.7 pKi = 5.7 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
CHEMBL306377 109729 0 None -81 4 Human 5.7 pKi = 5.7 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
10626453 128793 0 None 72 3 Human 7.7 pKi = 7.7 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 548 9 0 6 6.2 COC(=O)C1=C(C)N=C(C)N(CCC[C@@H](C)CN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL359430 128793 0 None 72 3 Human 7.7 pKi = 7.7 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 548 9 0 6 6.2 COC(=O)C1=C(C)N=C(C)N(CCC[C@@H](C)CN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
135398737 7745 93 None -5 90 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
38 7745 93 None -5 90 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
722 7745 93 None -5 90 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
CHEMBL42 7745 93 None -5 90 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
DB00363 7745 93 None -5 90 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
10768610 210549 0 None 24 2 Human 7.7 pKi = 7.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 532 8 2 7 2.5 COc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL68045 210549 0 None 24 2 Human 7.7 pKi = 7.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 532 8 2 7 2.5 COc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
9888164 24723 1 None 25 3 Human 7.7 pKi = 7.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 416 8 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCCC2=O)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL12603 24723 1 None 25 3 Human 7.7 pKi = 7.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 416 8 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCCC2=O)CC1 10.1016/j.bmcl.2004.11.032
16041264 102218 0 None -1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cccc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL257077 102218 0 None -1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cccc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
71508710 93830 0 None 50 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 368 3 0 4 4.9 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cccnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325933 93830 0 None 50 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 368 3 0 4 4.9 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cccnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
44289026 173165 0 None 87 3 Human 7.7 pKi = 7.7 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 533 8 1 3 6.5 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C(F)(F)F)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL42763 173165 0 None 87 3 Human 7.7 pKi = 7.7 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 533 8 1 3 6.5 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C(F)(F)F)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
9879119 16218 0 None 4 5 Rat 7.7 pKi = 7.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111771 16218 0 None 4 5 Rat 7.7 pKi = 7.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
53327991 70175 0 None -9 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 449 8 0 5 3.7 COc1ccccc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796046 70175 0 None -9 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 449 8 0 5 3.7 COc1ccccc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
145962368 168236 0 None -74 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 521 9 0 8 5.1 CCCN(CCC)c1nc(N2CCN(C(=O)c3ccco3)[C@H]3CCCC[C@H]32)nc2cc(OC)c(OC)cc12 10.1016/j.bmc.2018.05.023
CHEMBL4127483 168236 0 None -74 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 521 9 0 8 5.1 CCCN(CCC)c1nc(N2CCN(C(=O)c3ccco3)[C@H]3CCCC[C@H]32)nc2cc(OC)c(OC)cc12 10.1016/j.bmc.2018.05.023
9879119 16218 0 None 4 5 Rat 7.7 pKi = 7.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111771 16218 0 None 4 5 Rat 7.7 pKi = 7.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1021/jm030551a
102 10899 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
3659 10899 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
8969 10899 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
CHEMBL15245 10899 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
DB01392 10899 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
145947545 174473 0 None -199 3 Human 6.7 pKi = 6.7 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 341 4 2 4 3.1 CSc1ccc(Cl)cc1Cn1cc(Cl)cc(C(N)=O)c1=N 10.1016/j.ejmech.2017.07.071
CHEMBL4208816 174473 0 None -199 3 Human 6.7 pKi = 6.7 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 341 4 2 4 3.1 CSc1ccc(Cl)cc1Cn1cc(Cl)cc(C(N)=O)c1=N 10.1016/j.ejmech.2017.07.071
CHEMBL4302269 174473 0 None -199 3 Human 6.7 pKi = 6.7 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 341 4 2 4 3.1 CSc1ccc(Cl)cc1Cn1cc(Cl)cc(C(N)=O)c1=N 10.1016/j.ejmech.2017.07.071
102 10899 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
3659 10899 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
8969 10899 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
CHEMBL15245 10899 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
DB01392 10899 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
44301572 208154 0 None - 1 Human 6.7 pKi = 6.7 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 555 7 0 4 6.8 Cc1ccc(C2(c3ccc(C)cc3)CC(=S)N(CCCN3CCC(C#N)(c4ccccc4Cl)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL60452 208154 0 None - 1 Human 6.7 pKi = 6.7 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 555 7 0 4 6.8 Cc1ccc(C2(c3ccc(C)cc3)CC(=S)N(CCCN3CCC(C#N)(c4ccccc4Cl)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
3303 9024 46 None -3235 15 Human 5.7 pKi = 5.7 Binding
Inhibition of alpha1C adrenergic receptor (unknown origin)Inhibition of alpha1C adrenergic receptor (unknown origin)
ChEMBL 326 3 1 3 3.5 Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2 10.1021/acs.jmedchem.7b00151
5311200 9024 46 None -3235 15 Human 5.7 pKi = 5.7 Binding
Inhibition of alpha1C adrenergic receptor (unknown origin)Inhibition of alpha1C adrenergic receptor (unknown origin)
ChEMBL 326 3 1 3 3.5 Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2 10.1021/acs.jmedchem.7b00151
CHEMBL267014 9024 46 None -3235 15 Human 5.7 pKi = 5.7 Binding
Inhibition of alpha1C adrenergic receptor (unknown origin)Inhibition of alpha1C adrenergic receptor (unknown origin)
ChEMBL 326 3 1 3 3.5 Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2 10.1021/acs.jmedchem.7b00151
76307952 91605 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 7 1 4 4.0 c1ccc(OCCNC2COC(c3ccccc3)(c3ccccc3)CO2)cc1 10.1007/s00044-010-9379-1
CHEMBL2234455 91605 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 7 1 4 4.0 c1ccc(OCCNC2COC(c3ccccc3)(c3ccccc3)CO2)cc1 10.1007/s00044-010-9379-1
145962817 168298 0 None -74 6 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4128311 168298 0 None -74 6 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
44568818 194484 0 None -6 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COC(c3ccccc3)(c3ccccc3)CO2)cc1 10.1021/jm800461k
CHEMBL495289 194484 0 None -6 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COC(c3ccccc3)(c3ccccc3)CO2)cc1 10.1021/jm800461k
6917970 10463 61 None -512 33 Rat 5.7 pKi = 5.7 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O 10.1021/acs.jmedchem.6b01217
8370 10463 61 None -512 33 Rat 5.7 pKi = 5.7 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O 10.1021/acs.jmedchem.6b01217
CHEMBL487387 10463 61 None -512 33 Rat 5.7 pKi = 5.7 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O 10.1021/acs.jmedchem.6b01217
44271903 70058 0 None - 1 Bovine 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 208 1 0 2 2.5 CN1CC=C(c2ncccc2Cl)CC1 10.1021/jm00375a017
CHEMBL17926 70058 0 None - 1 Bovine 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 208 1 0 2 2.5 CN1CC=C(c2ncccc2Cl)CC1 10.1021/jm00375a017
11655403 22847 0 None -208 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 5.8 FC(F)(F)c1cccc(N2CCN(CCCCNc3ccc(-c4ccccc4)cn3)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223801 22847 0 None -208 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 5.8 FC(F)(F)c1cccc(N2CCN(CCCCNc3ccc(-c4ccccc4)cn3)CC2)c1 10.1016/j.bmcl.2010.07.096
73347826 99317 0 None -1 7 Human 5.6 pKi = 5.6 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 266 4 1 2 2.4 c1ccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)nc1 10.1016/j.bmc.2013.07.045
CHEMBL2432049 99317 0 None -1 7 Human 5.6 pKi = 5.6 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 266 4 1 2 2.4 c1ccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)nc1 10.1016/j.bmc.2013.07.045
134157330 160483 0 None -75 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 321 7 1 5 2.7 COc1ccccc1OCCNCC1COC2(CCCCC2)O1 10.1016/j.ejmech.2016.09.050
CHEMBL3981480 160483 0 None -75 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 321 7 1 5 2.7 COc1ccccc1OCCNCC1COC2(CCCCC2)O1 10.1016/j.ejmech.2016.09.050
115 7131 71 None -2 7 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
2092 7131 71 None -2 7 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
7109 7131 71 None -2 7 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
CHEMBL709 7131 71 None -2 7 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
DB00346 7131 71 None -2 7 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
44431560 95939 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL236621 95939 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
44433348 97038 0 None -8 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 545 10 0 7 4.6 CCN([C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1)S(=O)(=O)c1ccc(OC)c(OC)c1 10.1016/j.bmcl.2007.09.051
CHEMBL238401 97038 0 None -8 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 545 10 0 7 4.6 CCN([C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1)S(=O)(=O)c1ccc(OC)c(OC)c1 10.1016/j.bmcl.2007.09.051
44431560 95939 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
CHEMBL236621 95939 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
11857863 92458 0 None 2 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccc(F)cc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228658 92458 0 None 2 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccc(F)cc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
1531 9046 69 None -3 16 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
3869 9046 69 None -3 16 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
7207 9046 69 None -3 16 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
CHEMBL429 9046 69 None -3 16 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
DB00598 9046 69 None -3 16 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
49865599 22792 0 None -28 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 340 8 1 5 3.1 COc1ccccc1N1CCN(CCCCNc2ccccn2)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL1223615 22792 0 None -28 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 340 8 1 5 3.1 COc1ccccc1N1CCN(CCCCNc2ccccn2)CC1 10.1016/j.bmcl.2010.07.096
11303180 205005 0 None -7 5 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 369 5 0 4 3.1 COc1ccccc1N1CCN(CCN2C=CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL57540 205005 0 None -7 5 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 369 5 0 4 3.1 COc1ccccc1N1CCN(CCN2C=CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
11303180 205005 0 None -7 5 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 369 5 0 4 3.1 COc1ccccc1N1CCN(CCN2C=CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL57540 205005 0 None -7 5 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 369 5 0 4 3.1 COc1ccccc1N1CCN(CCN2C=CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
76323010 113025 0 None -26 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261606 113025 0 None -26 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL3138929 113025 0 None -26 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
16721032 98963 0 None -26 6 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242507 98963 0 None -26 6 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
10790988 122878 0 None -2 3 Human 7.6 pKi = 7.6 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 483 8 1 10 2.0 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL335731 122878 0 None -2 3 Human 7.6 pKi = 7.6 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 483 8 1 10 2.0 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
10621592 91346 0 None -4 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153559 91346 0 None -4 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220898 91346 0 None -4 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
4011 89183 49 None -125 24 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
CHEMBL21731 89183 49 None -125 24 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
127025258 144472 0 None -173 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 415 7 1 3 4.8 Cc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1C 10.1016/j.bmcl.2015.12.068
CHEMBL3758741 144472 0 None -173 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 415 7 1 3 4.8 Cc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1C 10.1016/j.bmcl.2015.12.068
9844022 129839 0 None -32 2 Rat 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 401 6 1 2 5.6 c1ccc(C2CCN(CCCN3CCC(c4c[nH]c5ccccc45)CC3)CC2)cc1 10.1016/j.bmcl.2015.07.046
CHEMBL3609358 129839 0 None -32 2 Rat 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 401 6 1 2 5.6 c1ccc(C2CCN(CCCN3CCC(c4c[nH]c5ccccc45)CC3)CC2)cc1 10.1016/j.bmcl.2015.07.046
12134991 212492 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL82480 212492 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
11486511 108361 0 None -691 5 Human 6.6 pKi = 6.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCC2)CC(=O)N1CCN1CCCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL298595 108361 0 None -691 5 Human 6.6 pKi = 6.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCC2)CC(=O)N1CCN1CCCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
11994671 18601 0 None 1 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182138 18601 0 None 1 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214506 18601 0 None 1 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
2162 48288 100 None -3 6 Human 5.6 pKi = 5.6 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1016/s0960-894x(99)00484-9
CHEMBL1491 48288 100 None -3 6 Human 5.6 pKi = 5.6 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1016/s0960-894x(99)00484-9
11486511 108361 0 None -691 5 Human 6.6 pKi = 6.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCC2)CC(=O)N1CCN1CCCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL298595 108361 0 None -691 5 Human 6.6 pKi = 6.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCC2)CC(=O)N1CCN1CCCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
21509921 111235 0 None -234 24 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104091 111235 0 None -234 24 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
21509921 111235 0 None -234 24 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104091 111235 0 None -234 24 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
14004033 56006 5 None -2 2 Bovine 4.6 pKi = 4.6 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 177 0 1 2 1.5 c1[nH]nc2c1CCN1CCCCC21 10.1021/jm00398a025
CHEMBL156283 56006 5 None -2 2 Bovine 4.6 pKi = 4.6 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 177 0 1 2 1.5 c1[nH]nc2c1CCN1CCCCC21 10.1021/jm00398a025
13151 7768 0 None -151 4 Rat 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 391 5 1 2 4.9 FC1=CC=C2C(=CNC2=C1)C3CCN(CC3)CCCN4CC5=CC=CC=C5CC4 10.1016/j.bmcl.2015.07.046
9930376 7768 0 None -151 4 Rat 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 391 5 1 2 4.9 FC1=CC=C2C(=CNC2=C1)C3CCN(CC3)CCCN4CC5=CC=CC=C5CC4 10.1016/j.bmcl.2015.07.046
CHEMBL3609360 7768 0 None -151 4 Rat 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 391 5 1 2 4.9 FC1=CC=C2C(=CNC2=C1)C3CCN(CC3)CCCN4CC5=CC=CC=C5CC4 10.1016/j.bmcl.2015.07.046
71508686 93828 0 None 10 2 Bovine 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 368 3 0 4 4.9 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4ccncc4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325931 93828 0 None 10 2 Bovine 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 368 3 0 4 4.9 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4ccncc4)cc23)CC1 10.1016/j.bmc.2012.10.049
44288995 169663 0 None 39 3 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 435 8 1 3 4.9 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)cc2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL417350 169663 0 None 39 3 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 435 8 1 3 4.9 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)cc2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
10962489 17962 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL1178679 17962 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL37212 17962 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
10363912 13310 0 None -36 7 Human 7.6 pKi = 7.6 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL1082862 13310 0 None -36 7 Human 7.6 pKi = 7.6 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL286003 13310 0 None -36 7 Human 7.6 pKi = 7.6 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
155532835 183233 0 None -31 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 9 1 5 4.4 COc1ccccc1OCCNCC1CCOC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4467585 183233 0 None -31 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 9 1 5 4.4 COc1ccccc1OCCNCC1CCOC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4596417 183233 0 None -31 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 9 1 5 4.4 COc1ccccc1OCCNCC1CCOC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
10386062 213551 0 None -19 2 Rat 6.6 pKi = 6.6 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 396 6 0 4 3.3 FC(F)(F)c1cccc(N2CCN(CCCCN3CC4CCCN4C3)CC2)c1 10.1021/jm970216k
CHEMBL90165 213551 0 None -19 2 Rat 6.6 pKi = 6.6 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 396 6 0 4 3.3 FC(F)(F)c1cccc(N2CCN(CCCCN3CC4CCCN4C3)CC2)c1 10.1021/jm970216k
9817327 129834 0 None -50 2 Rat 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 285 5 1 2 3.3 CN(C)CCCN1CCC(c2c[nH]c3ccccc23)CC1 10.1016/j.bmcl.2015.07.046
CHEMBL3609353 129834 0 None -50 2 Rat 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 285 5 1 2 3.3 CN(C)CCCN1CCC(c2c[nH]c3ccccc23)CC1 10.1016/j.bmcl.2015.07.046
44289089 171364 0 None 3 3 Human 6.6 pKi = 6.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 10 1 6 3.2 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)CCc2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL42156 171364 0 None 3 3 Human 6.6 pKi = 6.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 10 1 6 3.2 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)CCc2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
94459 71048 127 None -64 2 Bovine 5.6 pKi = 5.6 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 163 1 1 3 0.5 c1ccc(N2CCNCC2)nc1 10.1021/jm00366a007
CHEMBL18094 71048 127 None -64 2 Bovine 5.6 pKi = 5.6 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 163 1 1 3 0.5 c1ccc(N2CCNCC2)nc1 10.1021/jm00366a007
94459 71048 127 None -64 2 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 163 1 1 3 0.5 c1ccc(N2CCNCC2)nc1 10.1021/jm00375a017
CHEMBL18094 71048 127 None -64 2 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 163 1 1 3 0.5 c1ccc(N2CCNCC2)nc1 10.1021/jm00375a017
14004033 56006 5 None -2 2 Bovine 4.6 pKi = 4.6 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 177 0 1 2 1.5 c1[nH]nc2c1CCN1CCCCC21 10.1021/jm00398a025
CHEMBL156283 56006 5 None -2 2 Bovine 4.6 pKi = 4.6 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 177 0 1 2 1.5 c1[nH]nc2c1CCN1CCCCC21 10.1021/jm00398a025
165413025 197146 2 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human adrenergic alpha1A receptor expressed in human HEK293 cellsDisplacement of [3H]-prazosin from human adrenergic alpha1A receptor expressed in human HEK293 cells
ChEMBL 364 6 2 6 1.3 NC(CCOc1ccc(S(N)(=O)=O)cc1)C1COc2ccccc2O1 10.1021/acs.jmedchem.2c01192
CHEMBL5177166 197146 2 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human adrenergic alpha1A receptor expressed in human HEK293 cellsDisplacement of [3H]-prazosin from human adrenergic alpha1A receptor expressed in human HEK293 cells
ChEMBL 364 6 2 6 1.3 NC(CCOc1ccc(S(N)(=O)=O)cc1)C1COc2ccccc2O1 10.1021/acs.jmedchem.2c01192
2291 9958 58 None -446 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
2561 9958 58 None -446 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
4932 9958 58 None -446 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
CHEMBL631 9958 58 None -446 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
DB01182 9958 58 None -446 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
44431590 94755 0 None -13 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 555 8 1 6 4.9 COc1ccc(C(F)(F)F)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234232 94755 0 None -13 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 555 8 1 6 4.9 COc1ccc(C(F)(F)F)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
44289346 174824 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 466 8 1 4 4.9 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccn3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL432302 174824 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 466 8 1 4 4.9 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccn3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
135398745 9688 112 None -13 65 Rat 7.6 pKi = 7.6 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
47 9688 112 None -13 65 Rat 7.6 pKi = 7.6 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
CHEMBL715 9688 112 None -13 65 Rat 7.6 pKi = 7.6 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
DB00334 9688 112 None -13 65 Rat 7.6 pKi = 7.6 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
11281005 18615 0 None 13 6 Human 7.6 pKi = 7.6 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1016/j.ejmech.2020.112419
CHEMBL1182191 18615 0 None 13 6 Human 7.6 pKi = 7.6 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1016/j.ejmech.2020.112419
CHEMBL218079 18615 0 None 13 6 Human 7.6 pKi = 7.6 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1016/j.ejmech.2020.112419
15254720 68075 0 None -204 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.7 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767136 68075 0 None -204 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.7 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
24803483 68106 0 None -63 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 654 15 0 6 8.2 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
CHEMBL1767167 68106 0 None -63 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 654 15 0 6 8.2 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
132266 8061 12 None -28 9 Human 7.6 pKi = 7.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960697s
486 8061 12 None -28 9 Human 7.6 pKi = 7.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960697s
CHEMBL423294 8061 12 None -28 9 Human 7.6 pKi = 7.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960697s
126225 101751 5 None -13 7 Human 7.6 pKi = 7.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm960697s
CHEMBL25467 101751 5 None -13 7 Human 7.6 pKi = 7.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm960697s
11281005 18615 0 None 13 6 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL1182191 18615 0 None 13 6 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL218079 18615 0 None 13 6 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
76326562 112983 0 None -18 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 479 5 1 9 3.3 COc1cc2nc(N3CCN(C(=O)c4ccc(C(C)=O)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261608 112983 0 None -18 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 479 5 1 9 3.3 COc1cc2nc(N3CCN(C(=O)c4ccc(C(C)=O)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL3138761 112983 0 None -18 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 479 5 1 9 3.3 COc1cc2nc(N3CCN(C(=O)c4ccc(C(C)=O)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
44428847 99068 0 None -18 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 479 5 1 9 3.3 COc1cc2nc(N3CCN(C(=O)c4ccc(C(C)=O)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242723 99068 0 None -18 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 479 5 1 9 3.3 COc1cc2nc(N3CCN(C(=O)c4ccc(C(C)=O)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
12841596 124238 20 None -3 2 Bovine 6.6 pKi = 6.6 Binding
Binding affinity against alpha-1 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]prazosin as radioligandBinding affinity against alpha-1 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]prazosin as radioligand
ChEMBL 237 1 1 5 0.8 Clc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL2448004 124238 20 None -3 2 Bovine 6.6 pKi = 6.6 Binding
Binding affinity against alpha-1 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]prazosin as radioligandBinding affinity against alpha-1 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]prazosin as radioligand
ChEMBL 237 1 1 5 0.8 Clc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL339883 124238 20 None -3 2 Bovine 6.6 pKi = 6.6 Binding
Binding affinity against alpha-1 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]prazosin as radioligandBinding affinity against alpha-1 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]prazosin as radioligand
ChEMBL 237 1 1 5 0.8 Clc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
2419 7482 28 None -288 11 Human 6.6 pKi = 6.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.bmcl.2004.11.032
9 7482 28 None -288 11 Human 6.6 pKi = 6.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.bmcl.2004.11.032
CHEMBL13647 7482 28 None -288 11 Human 6.6 pKi = 6.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.bmcl.2004.11.032
134987 193460 47 None -309 2 Bovine 5.6 pKi = 5.6 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 181 1 1 3 0.6 Fc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL48833 193460 47 None -309 2 Bovine 5.6 pKi = 5.6 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 181 1 1 3 0.6 Fc1cccnc1N1CCNCC1 10.1021/jm00366a007
3386873 71349 4 None - 1 Human 5.6 pKi = 5.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 338 6 2 3 3.9 N=C(CC(O)COc1ccccc1-c1ccccc1)N1CCCCC1 10.1016/j.bmcl.2004.11.032
CHEMBL181583 71349 4 None - 1 Human 5.6 pKi = 5.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 338 6 2 3 3.9 N=C(CC(O)COc1ccccc1-c1ccccc1)N1CCCCC1 10.1016/j.bmcl.2004.11.032
44271616 66450 0 None - 1 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 188 1 0 2 2.1 Cc1cccnc1C1=CCN(C)CC1 10.1021/jm00375a017
CHEMBL17223 66450 0 None - 1 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 188 1 0 2 2.1 Cc1cccnc1C1=CCN(C)CC1 10.1021/jm00375a017
15357024 67453 3 None - 1 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 174 1 0 2 1.8 CN1CC=C(c2ccccn2)CC1 10.1021/jm00375a017
CHEMBL17605 67453 3 None - 1 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 174 1 0 2 1.8 CN1CC=C(c2ccccn2)CC1 10.1021/jm00375a017
3020566 67850 14 None - 1 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 176 1 0 2 1.9 CN1CCC(c2ccccn2)CC1 10.1021/jm00375a017
CHEMBL17648 67850 14 None - 1 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 176 1 0 2 1.9 CN1CCC(c2ccccn2)CC1 10.1021/jm00375a017
2419 7482 28 None -288 11 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm0307741
9 7482 28 None -288 11 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm0307741
CHEMBL13647 7482 28 None -288 11 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm0307741
9950711 115983 0 None 5 4 Rat 6.6 pKi = 6.6 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL321644 115983 0 None 5 4 Rat 6.6 pKi = 6.6 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
52937527 68077 0 None -1584 4 Human 6.6 pKi = 6.6 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 349 4 1 5 2.8 CN1CCC[C@@H]1Cn1nc(Cc2ccc(O)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767138 68077 0 None -1584 4 Human 6.6 pKi = 6.6 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 349 4 1 5 2.8 CN1CCC[C@@H]1Cn1nc(Cc2ccc(O)cc2)c2ccccc2c1=O 10.1021/jm1013874
2419 7482 28 None -288 11 Human 6.6 pKi = 6.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm960697s
9 7482 28 None -288 11 Human 6.6 pKi = 6.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm960697s
CHEMBL13647 7482 28 None -288 11 Human 6.6 pKi = 6.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm960697s
119204 191048 40 None 2 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]-HEAT from human adrenergic alpha1A receptor expressed in rat-1 cellsDisplacement of [125I]-HEAT from human adrenergic alpha1A receptor expressed in rat-1 cells
ChEMBL 279 0 0 3 3.2 CN1CCc2cc3c(c4c2[C@H]1Cc1ccccc1-4)OCO3 10.1039/C7MD00629B
CHEMBL483825 191048 40 None 2 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]-HEAT from human adrenergic alpha1A receptor expressed in rat-1 cellsDisplacement of [125I]-HEAT from human adrenergic alpha1A receptor expressed in rat-1 cells
ChEMBL 279 0 0 3 3.2 CN1CCc2cc3c(c4c2[C@H]1Cc1ccccc1-4)OCO3 10.1039/C7MD00629B
10337773 108362 0 None -63 10 Human 4.6 pKi = 4.6 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 311 3 1 4 1.6 Cn1cc(C(=O)C(=O)N[C@@H]2CN3CCC2CC3)c2ccccc21 10.1016/0960-894X(95)00308-G
CHEMBL298612 108362 0 None -63 10 Human 4.6 pKi = 4.6 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 311 3 1 4 1.6 Cn1cc(C(=O)C(=O)N[C@@H]2CN3CCC2CC3)c2ccccc21 10.1016/0960-894X(95)00308-G
11800278 45965 0 None 15 3 Human 5.6 pKi = 5.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 527 10 3 8 2.4 CCOC(=O)C1CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)NC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL146983 45965 0 None 15 3 Human 5.6 pKi = 5.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 527 10 3 8 2.4 CCOC(=O)C1CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)NC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
1599 9120 50 None -3019 16 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
3955 9120 50 None -3019 16 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
7215 9120 50 None -3019 16 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
CHEMBL841 9120 50 None -3019 16 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
DB00836 9120 50 None -3019 16 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
1028 7079 71 None -47 30 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
139148732 7079 71 None -47 30 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
479 7079 71 None -47 30 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
5816 7079 71 None -47 30 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
CHEMBL679 7079 71 None -47 30 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
DB00668 7079 71 None -47 30 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
2435 7509 100 None -436 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
395 7509 100 None -436 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
520 7509 100 None -436 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
5386 7509 100 None -436 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
CHEMBL844 7509 100 None -436 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
DB00484 7509 100 None -436 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
118717461 121921 0 None -7 4 Human 6.6 pKi = 6.6 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 444 12 2 6 6.3 COc1ccc2c(NCCCCCCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343983 121921 0 None -7 4 Human 6.6 pKi = 6.6 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 444 12 2 6 6.3 COc1ccc2c(NCCCCCCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
118717461 121921 0 None -7 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 444 12 2 6 6.3 COc1ccc2c(NCCCCCCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343983 121921 0 None -7 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 444 12 2 6 6.3 COc1ccc2c(NCCCCCCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
56852956 118820 1 None -66 9 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assayDisplacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assay
ChEMBL 339 5 0 6 2.8 c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1 10.1016/j.bmc.2014.04.026
CHEMBL3289656 118820 1 None -66 9 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assayDisplacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assay
ChEMBL 339 5 0 6 2.8 c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1 10.1016/j.bmc.2014.04.026
137640201 163740 2 None -204 13 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 362 6 0 2 4.3 O=C1CCc2ccccc2N1CCCN1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.8b00265
CHEMBL4072818 163740 2 None -204 13 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 362 6 0 2 4.3 O=C1CCc2ccccc2N1CCCN1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.8b00265
71521479 93034 0 None -831 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
CHEMBL2312536 93034 0 None -831 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
11164948 44517 0 None -8 3 Human 5.6 pKi = 5.6 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 382 5 2 6 3.1 COc1cc2nc3c(c(O)c2cc1OC)CCC(CNC(=O)c1ccco1)C3 10.1021/jm030952q
CHEMBL145793 44517 0 None -8 3 Human 5.6 pKi = 5.6 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 382 5 2 6 3.1 COc1cc2nc3c(c(O)c2cc1OC)CCC(CNC(=O)c1ccco1)C3 10.1021/jm030952q
76318763 91599 0 None - 1 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 381 5 2 6 3.0 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccoc1)C3 10.1007/s00044-010-9379-1
CHEMBL2234449 91599 0 None - 1 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 381 5 2 6 3.0 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccoc1)C3 10.1007/s00044-010-9379-1
56852956 118820 1 None -66 9 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assayDisplacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assay
ChEMBL 339 5 0 6 2.8 c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1 10.1016/j.bmc.2014.04.026
CHEMBL3289656 118820 1 None -66 9 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assayDisplacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assay
ChEMBL 339 5 0 6 2.8 c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1 10.1016/j.bmc.2014.04.026
242 7258 124 None -14 51 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl nan
34 7258 124 None -14 51 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl nan
60795 7258 124 None -14 51 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl nan
CHEMBL1112 7258 124 None -14 51 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl nan
DB01238 7258 124 None -14 51 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl nan
3584 10549 64 None -3 14 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
5401 10549 64 None -3 14 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
7302 10549 64 None -3 14 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
CHEMBL611 10549 64 None -3 14 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
DB01162 10549 64 None -3 14 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
180707 121912 2 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 314 5 2 4 4.3 c1ccc2c(NCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343975 121912 2 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 314 5 2 4 4.3 c1ccc2c(NCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
135398745 9688 112 None -13 65 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
47 9688 112 None -13 65 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
CHEMBL715 9688 112 None -13 65 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
DB00334 9688 112 None -13 65 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
16041629 102221 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cc(F)ccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL257097 102221 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cc(F)ccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
180707 121912 2 None 1 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 314 5 2 4 4.3 c1ccc2c(NCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343975 121912 2 None 1 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 314 5 2 4 4.3 c1ccc2c(NCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
9883506 77339 0 None -2 6 Human 7.6 pKi = 7.6 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 282 3 3 5 2.3 Cc1ccc(N(NC2=NCCN2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
CHEMBL194849 77339 0 None -2 6 Human 7.6 pKi = 7.6 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 282 3 3 5 2.3 Cc1ccc(N(NC2=NCCN2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
46934641 23450 0 None -10 4 Human 7.6 pKi = 7.6 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 6 3.5 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3CCCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242633 23450 0 None -10 4 Human 7.6 pKi = 7.6 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 6 3.5 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3CCCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
56946474 78291 0 None -32 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 403 9 1 4 4.8 COc1ccccc1OCCNCC1CCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm200421e
CHEMBL1946779 78291 0 None -32 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 403 9 1 4 4.8 COc1ccccc1OCCNCC1CCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm200421e
CHEMBL1962769 78291 0 None -32 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 403 9 1 4 4.8 COc1ccccc1OCCNCC1CCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm200421e
44207909 23471 3 None 2 9 Human 6.6 pKi = 6.6 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 407 7 1 4 2.6 O=C(Cc1ccccc1)NC1CCN(CCCN2C(=O)COc3ccccc32)CC1 10.1021/jm100697g
CHEMBL1242923 23471 3 None 2 9 Human 6.6 pKi = 6.6 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 407 7 1 4 2.6 O=C(Cc1ccccc1)NC1CCN(CCCN2C(=O)COc3ccccc32)CC1 10.1021/jm100697g
44538690 116628 0 None -295 7 Human 6.6 pKi = 6.6 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 380 5 0 4 3.9 O=C(CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCO3)c1ccc(F)cc1 10.1021/jm401958n
CHEMBL3233432 116628 0 None -295 7 Human 6.6 pKi = 6.6 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 380 5 0 4 3.9 O=C(CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCO3)c1ccc(F)cc1 10.1021/jm401958n
CHEMBL4795065 220831 25 None 1 2 Human 5.6 pKi = 5.6 Binding
GPCRScan assay: inhibition of Alpha1AGPCRScan assay: inhibition of Alpha1A
ChEMBL None None None C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1 10.6019/CHEMBL4800730
10219 195575 37 None -467 5 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL493439 195575 37 None -467 5 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL50588 195575 37 None -467 5 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL4795065 220831 25 None 1 2 Human 5.6 pKi = 5.6 Binding
GPCRScan assay: inhibition of Alpha1AGPCRScan assay: inhibition of Alpha1A
ChEMBL None None None C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1 10.6019/CHEMBL4800730
12840734 107706 3 None -630 5 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 355 4 0 4 2.5 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1 10.1007/s00044-010-9379-1
CHEMBL293968 107706 3 None -630 5 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 355 4 0 4 2.5 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1 10.1007/s00044-010-9379-1
134133829 150603 0 None -120 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 337 7 1 5 3.5 COc1ccccc1OCCNCC1CSC2(CCCCC2)O1 10.1016/j.ejmech.2016.09.050
CHEMBL3901382 150603 0 None -120 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 337 7 1 5 3.5 COc1ccccc1OCCNCC1CSC2(CCCCC2)O1 10.1016/j.ejmech.2016.09.050
10221830 16193 0 None 1 3 Rat 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 387 5 2 3 4.7 CCS(=O)(=O)Nc1cc(C2CCCCC2)cc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111685 16193 0 None 1 3 Rat 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 387 5 2 3 4.7 CCS(=O)(=O)Nc1cc(C2CCCCC2)cc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
11811395 211480 0 None -2 4 Human 5.6 pKi = 5.6 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 281 5 2 5 1.3 CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74071 211480 0 None -2 4 Human 5.6 pKi = 5.6 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 281 5 2 5 1.3 CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
12840734 107706 3 None -630 5 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 355 4 0 4 2.5 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1 10.1007/s00044-010-9379-1
CHEMBL293968 107706 3 None -630 5 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 355 4 0 4 2.5 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1 10.1007/s00044-010-9379-1
10721586 126499 0 None 141 3 Human 7.6 pKi = 7.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 559 10 3 7 3.4 CC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL347522 126499 0 None 141 3 Human 7.6 pKi = 7.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 559 10 3 7 3.4 CC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
11198145 16587 2 None 1 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL113830 16587 2 None 1 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
44289047 107159 0 None 25 3 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 441 8 1 3 5.2 Cc1ccc(C(C(=O)NCCCN2CCC(c3ccccn3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL289916 107159 0 None 25 3 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 441 8 1 3 5.2 Cc1ccc(C(C(=O)NCCCN2CCC(c3ccccn3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
9822705 107464 0 None -19 4 Rat 7.6 pKi = 7.6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 407 4 0 3 4.4 O=C1CC2(C=CN1CCN1CCN(c3cc(Cl)ccc3Cl)CC1)CCCC2 10.1021/jm030944+
CHEMBL292366 107464 0 None -19 4 Rat 7.6 pKi = 7.6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 407 4 0 3 4.4 O=C1CC2(C=CN1CCN1CCN(c3cc(Cl)ccc3Cl)CC1)CCCC2 10.1021/jm030944+
25131876 92967 0 None -41 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.02.056
CHEMBL2312227 92967 0 None -41 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.02.056
76308474 113011 0 None -31 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@H]3CCCC[C@@H]32)o1 10.1007/s00044-004-0024-8
CHEMBL2261607 113011 0 None -31 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@H]3CCCC[C@@H]32)o1 10.1007/s00044-004-0024-8
CHEMBL3138856 113011 0 None -31 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@H]3CCCC[C@@H]32)o1 10.1007/s00044-004-0024-8
44428846 98964 0 None -31 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@@H]3CCCC[C@@H]32)o1 10.1016/j.bmc.2007.01.028
CHEMBL242508 98964 0 None -31 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@@H]3CCCC[C@@H]32)o1 10.1016/j.bmc.2007.01.028
25181488 194161 0 None -33 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm800461k
CHEMBL493486 194161 0 None -33 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm800461k
25131876 92967 0 None -41 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
CHEMBL2312227 92967 0 None -41 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
10427137 42824 4 None -1 2 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from rat whole brain alpha1 adrenergic receptorDisplacement of [3H]prazosin from rat whole brain alpha1 adrenergic receptor
ChEMBL 336 2 0 2 5.3 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1CCN(C)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL144362 42824 4 None -1 2 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from rat whole brain alpha1 adrenergic receptorDisplacement of [3H]prazosin from rat whole brain alpha1 adrenergic receptor
ChEMBL 336 2 0 2 5.3 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1CCN(C)CC1 10.1021/acs.jmedchem.2c00633
11711943 22872 0 None -28 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 444 8 1 5 5.4 FC(F)(F)c1cccc(N2CCN(CCCCNc3ncc(-c4ccccc4)o3)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223858 22872 0 None -28 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 444 8 1 5 5.4 FC(F)(F)c1cccc(N2CCN(CCCCNc3ncc(-c4ccccc4)o3)CC2)c1 10.1016/j.bmcl.2010.07.096
71062646 156322 0 None -4466 13 Mouse 5.6 pKi = 5.6 Binding
Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.
ChEMBL 338 6 0 4 2.8 c1ccc(OC[C@@H]2CN(CCN3CCc4ccccc43)CCO2)cc1 nan
CHEMBL3946661 156322 0 None -4466 13 Mouse 5.6 pKi = 5.6 Binding
Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.
ChEMBL 338 6 0 4 2.8 c1ccc(OC[C@@H]2CN(CCN3CCc4ccccc43)CCO2)cc1 nan
9796525 16179 0 None 5 3 Rat 6.6 pKi = 6.6 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 3 1 4 2.3 Cn1cnc(C2CCCc3c(NS(C)(=O)=O)cccc32)c1 10.1007/s00044-004-0020-z
CHEMBL111584 16179 0 None 5 3 Rat 6.6 pKi = 6.6 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 3 1 4 2.3 Cn1cnc(C2CCCc3c(NS(C)(=O)=O)cccc32)c1 10.1007/s00044-004-0020-z
9796525 16179 0 None 5 3 Rat 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 1 4 2.3 Cn1cnc(C2CCCc3c(NS(C)(=O)=O)cccc32)c1 10.1021/jm030551a
CHEMBL111584 16179 0 None 5 3 Rat 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 1 4 2.3 Cn1cnc(C2CCCc3c(NS(C)(=O)=O)cccc32)c1 10.1021/jm030551a
10763305 113739 0 None -11 2 Rat 6.6 pKi = 6.6 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 396 5 0 4 3.3 FC(F)(F)c1cccc(N2CCN(CCCN3CC4CCCCN4C3)CC2)c1 10.1021/jm970216k
CHEMBL314997 113739 0 None -11 2 Rat 6.6 pKi = 6.6 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 396 5 0 4 3.3 FC(F)(F)c1cccc(N2CCN(CCCN3CC4CCCCN4C3)CC2)c1 10.1021/jm970216k
18738380 18713 0 None 8 3 Human 7.6 pKi = 7.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 417 9 1 6 1.9 CC(C)Oc1ccccc1N1CCN(CC(O)CC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL11828 18713 0 None 8 3 Human 7.6 pKi = 7.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 417 9 1 6 1.9 CC(C)Oc1ccccc1N1CCN(CC(O)CC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
11857638 148933 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL388361 148933 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857638 148933 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL388361 148933 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
1353 8692 93 None -10 85 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
3559 8692 93 None -10 85 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
86 8692 93 None -10 85 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
CHEMBL54 8692 93 None -10 85 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
DB00502 8692 93 None -10 85 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
44460477 212186 0 None 1 2 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 432 7 0 6 3.9 O=C1CCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
CHEMBL80109 212186 0 None 1 2 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 432 7 0 6 3.9 O=C1CCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
145987771 173868 0 None -8 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 431 6 1 2 5.9 Fc1ccc(N2CCN(CCCc3c[nH]c4ccc(F)cc34)CC2)c(-c2ccccc2)c1 10.1016/j.ejmech.2017.12.063
CHEMBL4289783 173868 0 None -8 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 431 6 1 2 5.9 Fc1ccc(N2CCN(CCCc3c[nH]c4ccc(F)cc34)CC2)c(-c2ccccc2)c1 10.1016/j.ejmech.2017.12.063
44288740 108132 0 None 29 3 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 437 8 1 3 4.9 N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL296965 108132 0 None 29 3 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 437 8 1 3 4.9 N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(00)00307-3
53328505 70168 0 None 2 3 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 455 7 0 5 3.8 COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796039 70168 0 None 2 3 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 455 7 0 5 3.8 COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
76322412 91597 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 354 5 0 5 2.9 COc1ccccc1N1CCN(CC2CO[C@H](c3ccccc3)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL2234447 91597 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 354 5 0 5 2.9 COc1ccccc1N1CCN(CC2CO[C@H](c3ccccc3)O2)CC1 10.1007/s00044-010-9379-1
14004037 60545 2 None -8 2 Bovine 5.6 pKi = 5.6 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 209 0 1 4 1.8 Nc1nc2c(s1)CCN1CCCCC21 10.1021/jm00398a025
CHEMBL160388 60545 2 None -8 2 Bovine 5.6 pKi = 5.6 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 209 0 1 4 1.8 Nc1nc2c(s1)CCN1CCCCC21 10.1021/jm00398a025
1960 9632 67 None -57 26 Rat 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
439260 9632 67 None -57 26 Rat 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
505 9632 67 None -57 26 Rat 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
CHEMBL1437 9632 67 None -57 26 Rat 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
DB00368 9632 67 None -57 26 Rat 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
2435 7509 100 None -21 12 Human 5.6 pKi = 5.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
395 7509 100 None -21 12 Human 5.6 pKi = 5.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
520 7509 100 None -21 12 Human 5.6 pKi = 5.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
5386 7509 100 None -21 12 Human 5.6 pKi = 5.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
CHEMBL844 7509 100 None -21 12 Human 5.6 pKi = 5.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
DB00484 7509 100 None -21 12 Human 5.6 pKi = 5.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
14004037 60545 2 None -8 2 Bovine 5.6 pKi = 5.6 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 209 0 1 4 1.8 Nc1nc2c(s1)CCN1CCCCC21 10.1021/jm00398a025
CHEMBL160388 60545 2 None -8 2 Bovine 5.6 pKi = 5.6 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 209 0 1 4 1.8 Nc1nc2c(s1)CCN1CCCCC21 10.1021/jm00398a025
127027076 144465 0 None -257 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 455 7 1 3 5.2 O=C(NCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3758711 144465 0 None -257 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 455 7 1 3 5.2 O=C(NCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
2777786 181756 82 None -29 2 Bovine 5.5 pKi = 5.5 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 231 1 1 3 1.5 FC(F)(F)c1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL45663 181756 82 None -29 2 Bovine 5.5 pKi = 5.5 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 231 1 1 3 1.5 FC(F)(F)c1cccnc1N1CCNCC1 10.1021/jm00366a007
73213196 111237 4 None -2 13 Human 6.5 pKi = 6.5 Binding
Binding affinity to adrenergic alpha 1A receptor (unknown origin)Binding affinity to adrenergic alpha 1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2014.05.016
CHEMBL3104093 111237 4 None -2 13 Human 6.5 pKi = 6.5 Binding
Binding affinity to adrenergic alpha 1A receptor (unknown origin)Binding affinity to adrenergic alpha 1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2014.05.016
73213196 111237 4 None -2 13 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104093 111237 4 None -2 13 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
11282574 44506 0 None -38 3 Human 6.5 pKi = 6.5 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccccc1C(F)(F)F)C3 10.1021/jm030952q
CHEMBL145785 44506 0 None -38 3 Human 6.5 pKi = 6.5 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccccc1C(F)(F)F)C3 10.1021/jm030952q
76319344 92112 0 None 29 3 Rat 6.5 pKi = 6.5 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 289 2 3 5 2.0 COC(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL2261351 92112 0 None 29 3 Rat 6.5 pKi = 6.5 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 289 2 3 5 2.0 COC(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
73213196 111237 4 None -2 13 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104093 111237 4 None -2 13 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
155552821 183462 0 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 8 1 4 4.2 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)OC2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4544457 183462 0 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 8 1 4 4.2 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)OC2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4598345 183462 0 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 8 1 4 4.2 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)OC2)cc1 10.1016/j.ejmech.2019.05.024
92766 113319 35 None 1 6 Human 7.5 pKi = 7.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1016/j.bmcl.2004.11.032
CHEMBL31410 113319 35 None 1 6 Human 7.5 pKi = 7.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1016/j.bmcl.2004.11.032
12909385 67203 1 None 7 2 Bovine 7.5 pKi = 7.5 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 276 0 0 2 4.0 CN1CCC(=C2c3ccccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL175154 67203 1 None 7 2 Bovine 7.5 pKi = 7.5 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 276 0 0 2 4.0 CN1CCC(=C2c3ccccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
11303180 205005 0 None -9 5 Rat 7.5 pKi = 7.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 369 5 0 4 3.1 COc1ccccc1N1CCN(CCN2C=CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL57540 205005 0 None -9 5 Rat 7.5 pKi = 7.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 369 5 0 4 3.1 COc1ccccc1N1CCN(CCN2C=CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
122179431 128221 0 None -1 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 585 9 1 13 3.1 CCN(CC)c1ccc2cc(-n3cc(CN4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
CHEMBL3582272 128221 0 None -1 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 585 9 1 13 3.1 CCN(CC)c1ccc2cc(-n3cc(CN4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
11384664 89887 0 None -35 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 421 7 1 3 4.8 O=C(NCCCCN1CCN(c2ccccc2Cl)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL218203 89887 0 None -35 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 421 7 1 3 4.8 O=C(NCCCCN1CCN(c2ccccc2Cl)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
127026123 144489 0 None -41 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 401 7 1 3 4.5 Cc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3758881 144489 0 None -41 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 401 7 1 3 4.5 Cc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2015.12.068
2419 7482 28 None -288 11 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm0491391
9 7482 28 None -288 11 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm0491391
CHEMBL13647 7482 28 None -288 11 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm0491391
9845181 214940 3 None -1445 13 Human 6.5 pKi = 6.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1016/j.bmcl.2004.11.032
CHEMBL98241 214940 3 None -1445 13 Human 6.5 pKi = 6.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1016/j.bmcl.2004.11.032
10643994 84031 0 None -2 3 Rat 5.5 pKi = 5.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL2079655 84031 0 None -2 3 Rat 5.5 pKi = 5.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
146025727 178464 0 None -107 27 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 411 3 0 5 6.4 FC(F)(F)c1cc(Oc2nccc3ccsc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4466483 178464 0 None -107 27 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 411 3 0 5 6.4 FC(F)(F)c1cc(Oc2nccc3ccsc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
2419 7482 28 None -288 11 Human 6.5 pKi = 6.5 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor (n >= 2)Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor (n >= 2)
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm980053f
9 7482 28 None -288 11 Human 6.5 pKi = 6.5 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor (n >= 2)Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor (n >= 2)
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm980053f
CHEMBL13647 7482 28 None -288 11 Human 6.5 pKi = 6.5 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor (n >= 2)Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor (n >= 2)
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm980053f
9845181 214940 3 None -1445 13 Human 6.5 pKi = 6.5 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm0307741
CHEMBL98241 214940 3 None -1445 13 Human 6.5 pKi = 6.5 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm0307741
11191047 208596 0 None -8 3 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 490 7 0 6 3.2 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCN(Cc4ccccc4)CC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL60699 208596 0 None -8 3 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 490 7 0 6 3.2 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCN(Cc4ccccc4)CC3)CC2=O)CC1 10.1021/jm030944+
11486511 108361 0 None -870 5 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCC2)CC(=O)N1CCN1CCCN(c2ccccc2Cl)CC1 10.1021/jm030944+
CHEMBL298595 108361 0 None -870 5 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCC2)CC(=O)N1CCN1CCCN(c2ccccc2Cl)CC1 10.1021/jm030944+
11346205 16048 0 None -8 2 Rat 5.5 pKi = 5.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 268 4 3 5 0.8 CCS(=O)(=O)Nc1cccc(NC2=NCCN2)c1 10.1021/jm030551a
CHEMBL110852 16048 0 None -8 2 Rat 5.5 pKi = 5.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 268 4 3 5 0.8 CCS(=O)(=O)Nc1cccc(NC2=NCCN2)c1 10.1021/jm030551a
44460522 212166 0 None 3 2 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 460 7 0 7 3.6 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3C(=O)c4ccccc4C3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL79990 212166 0 None 3 2 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 460 7 0 7 3.6 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3C(=O)c4ccccc4C3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
136680385 214429 0 None 85 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(COCCN)NC(CC)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
44328824 214429 0 None 85 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(COCCN)NC(CC)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
CHEMBL95253 214429 0 None 85 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(COCCN)NC(CC)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
44213782 17312 0 None 309 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)C1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CCC1c1ccccc1 10.1016/s0960-894x(98)00451-x
CHEMBL1169493 17312 0 None 309 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)C1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CCC1c1ccccc1 10.1016/s0960-894x(98)00451-x
44431611 94356 0 None 6 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(Cl)cc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233582 94356 0 None 6 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(Cl)cc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857639 150662 1 None 2 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 492 7 1 4 5.2 CC(C)Oc1ccccc1C1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.098
CHEMBL390184 150662 1 None 2 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 492 7 1 4 5.2 CC(C)Oc1ccccc1C1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.098
9848303 118357 0 None 1 10 Bovine 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 487 6 1 6 3.8 Cn1cc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)nn1 10.1016/j.bmc.2012.10.049
CHEMBL328187 118357 0 None 1 10 Bovine 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 487 6 1 6 3.8 Cn1cc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)nn1 10.1016/j.bmc.2012.10.049
9848303 118357 0 None 1 10 Bovine 8.5 pKi = 8.5 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 487 6 1 6 3.8 Cn1cc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)nn1 10.1021/jm100652h
CHEMBL328187 118357 0 None 1 10 Bovine 8.5 pKi = 8.5 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 487 6 1 6 3.8 Cn1cc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)nn1 10.1021/jm100652h
10971791 215097 0 None -7 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 417 5 1 7 3.4 COc1ccccc1N1CCN(CCn2c(C)nc3c4ccccc4nc-3c2O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL99142 215097 0 None -7 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 417 5 1 7 3.4 COc1ccccc1N1CCN(CCn2c(C)nc3c4ccccc4nc-3c2O)CC1 10.1016/j.bmcl.2006.09.034
118716718 121790 0 None -3 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 532 7 0 9 2.3 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4cccc([N+](=O)[O-])c4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342871 121790 0 None -3 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 532 7 0 9 2.3 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4cccc([N+](=O)[O-])c4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44447002 101500 0 None -301 4 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 434 6 1 5 4.2 CCC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL253022 101500 0 None -301 4 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 434 6 1 5 4.2 CCC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
9960311 210643 0 None 25 2 Human 8.5 pKi = 8.5 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 598 9 2 7 4.5 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(C(C)(C)C)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL68699 210643 0 None 25 2 Human 8.5 pKi = 8.5 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 598 9 2 7 4.5 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(C(C)(C)C)cc2)C3=O)CC1 10.1021/jm9905918
19085839 212561 0 None 97 3 Human 8.5 pKi = 8.5 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL83041 212561 0 None 97 3 Human 8.5 pKi = 8.5 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00446-6
4188516 107154 8 None 1 2 Rat 8.5 pKi = 8.5 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 372 6 0 5 1.6 COc1ccccc1N1CCN(CCCN2C(=O)C3CCCN3C2=O)CC1 10.1021/jm970216k
CHEMBL289873 107154 8 None 1 2 Rat 8.5 pKi = 8.5 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 372 6 0 5 1.6 COc1ccccc1N1CCN(CCCN2C(=O)C3CCCN3C2=O)CC1 10.1021/jm970216k
9891166 40386 0 None -7 5 Human 8.5 pKi = 8.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 0 8 3.3 COc1ccccc1N1CCN(CCn2c(=O)c3c(-c4ccccc4)csc3n(C)c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL14213 40386 0 None -7 5 Human 8.5 pKi = 8.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 0 8 3.3 COc1ccccc1N1CCN(CCn2c(=O)c3c(-c4ccccc4)csc3n(C)c2=O)CC1 10.1016/s0960-894x(01)00159-7
16041628 162129 0 None -1 4 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)cc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL403280 162129 0 None -1 4 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)cc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
10841387 106394 0 None 91 6 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
CHEMBL284103 106394 0 None 91 6 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
10624665 107108 0 None 1 3 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 482 4 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(Cl)ccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL289437 107108 0 None 1 3 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 482 4 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(Cl)ccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
10416624 116427 0 None 263 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 634 14 4 10 2.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(COCCN)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(99)00484-9
136806219 116427 0 None 263 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 634 14 4 10 2.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(COCCN)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(99)00484-9
CHEMBL322405 116427 0 None 263 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 634 14 4 10 2.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(COCCN)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(99)00484-9
2585 7590 103 None -5 22 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
522 7590 103 None -5 22 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
551 7590 103 None -5 22 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
CHEMBL723 7590 103 None -5 22 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
DB01136 7590 103 None -5 22 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
3157 8252 71 None -2 12 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm960697s
7170 8252 71 None -2 12 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm960697s
954 8252 71 None -2 12 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm960697s
CHEMBL707 8252 71 None -2 12 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm960697s
DB00590 8252 71 None -2 12 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm960697s
10841387 106394 0 None 91 6 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
CHEMBL284103 106394 0 None 91 6 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
52947579 23822 0 None -17 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 439 13 1 6 5.0 COc1cccc(OC)c1SCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254582 23822 0 None -17 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 439 13 1 6 5.0 COc1cccc(OC)c1SCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
52945803 23838 0 None -8 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 451 15 1 6 5.1 CCOc1cccc(OCC)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254742 23838 0 None -8 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 451 15 1 6 5.1 CCOc1cccc(OCC)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
52941624 23864 0 None -1 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 393 12 1 5 4.3 COc1ccccc1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254915 23864 0 None -1 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 393 12 1 5 4.3 COc1ccccc1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
10693026 112730 0 None 5 2 Bovine 8.5 pKi = 8.5 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 412 9 1 6 2.8 CCOc1ccccc1OCCNC1CCN(c2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL312935 112730 0 None 5 2 Bovine 8.5 pKi = 8.5 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 412 9 1 6 2.8 CCOc1ccccc1OCCNC1CCN(c2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
25032525 101358 0 None -9 4 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 420 5 1 5 3.8 CC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
CHEMBL252030 101358 0 None -9 4 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 420 5 1 5 3.8 CC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
10769037 43982 0 None 70 3 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 551 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL145332 43982 0 None 70 3 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 551 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
1043 8363 14 None -35 29 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
149 8363 14 None -35 29 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
3251 8363 14 None -35 29 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
8223 8363 14 None -35 29 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL1982133 8363 14 None -35 29 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL442 8363 14 None -35 29 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00696 8363 14 None -35 29 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
15853467 214913 0 None 29 6 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 692 16 3 8 5.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN=[N+]=[N-])N1 10.1016/s0960-894x(99)00484-9
CHEMBL98063 214913 0 None 29 6 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 692 16 3 8 5.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN=[N+]=[N-])N1 10.1016/s0960-894x(99)00484-9
11857864 92459 0 None -2 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4cc(F)ccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228659 92459 0 None -2 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4cc(F)ccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
10553701 107072 0 None 1 3 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(C#N)c54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL289166 107072 0 None 1 3 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(C#N)c54)c3=O)C[C@@H]21 10.1021/jm990567u
9960497 123853 0 None 25 6 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
CHEMBL3392246 123853 0 None 25 6 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
44447015 161020 0 None -3 4 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 483 6 1 6 4.5 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1cccnc1 10.1016/j.bmcl.2007.11.106
CHEMBL398619 161020 0 None -3 4 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 483 6 1 6 4.5 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1cccnc1 10.1016/j.bmcl.2007.11.106
10071710 90907 0 None -2 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 436 5 1 7 2.7 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL220781 90907 0 None -2 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 436 5 1 7 2.7 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
10071710 90907 0 None -2 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 436 5 1 7 2.7 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL220781 90907 0 None -2 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 436 5 1 7 2.7 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
45268939 203439 0 None -4 5 Human 8.5 pKi = 8.5 Binding
Binding affinity to alpha1A adrenergic receptor (unknown origin)Binding affinity to alpha1A adrenergic receptor (unknown origin)
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL564481 203439 0 None -4 5 Human 8.5 pKi = 8.5 Binding
Binding affinity to alpha1A adrenergic receptor (unknown origin)Binding affinity to alpha1A adrenergic receptor (unknown origin)
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
90645603 119213 0 None -1 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 567 8 1 8 4.9 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298021 119213 0 None -1 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 567 8 1 8 4.9 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
24894147 202660 0 None -6 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm8016046
CHEMBL558890 202660 0 None -6 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm8016046
11465618 109175 23 None -12 19 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 354 2 0 2 4.9 CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C 10.1016/j.bmcl.2022.128879
CHEMBL3039528 109175 23 None -12 19 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 354 2 0 2 4.9 CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C 10.1016/j.bmcl.2022.128879
CHEMBL5191141 109175 23 None -12 19 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 354 2 0 2 4.9 CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C 10.1016/j.bmcl.2022.128879
44289034 172732 0 None 199 3 Human 8.5 pKi = 8.5 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 435 8 1 3 4.9 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2cccc(F)c2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL42514 172732 0 None 199 3 Human 8.5 pKi = 8.5 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 435 8 1 3 4.9 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2cccc(F)c2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
2726 7706 68 None -2 72 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
621 7706 68 None -2 72 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
83 7706 68 None -2 72 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
CHEMBL71 7706 68 None -2 72 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
DB00477 7706 68 None -2 72 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
44420431 91512 0 None -4 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 468 5 0 7 4.4 COc1ccc(Cl)cc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL222896 91512 0 None -4 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 468 5 0 7 4.4 COc1ccc(Cl)cc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
76330229 113012 0 None -11 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 515 4 1 8 3.9 COc1cc2nc(N3CCN(C(=O)c4ccc(Br)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261605 113012 0 None -11 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 515 4 1 8 3.9 COc1cc2nc(N3CCN(C(=O)c4ccc(Br)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL3138857 113012 0 None -11 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 515 4 1 8 3.9 COc1cc2nc(N3CCN(C(=O)c4ccc(Br)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
44428845 149140 0 None -11 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 4 1 8 3.9 COc1cc2nc(N3CCN(C(=O)c4ccc(Br)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL388884 149140 0 None -11 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 4 1 8 3.9 COc1cc2nc(N3CCN(C(=O)c4ccc(Br)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
11638677 91364 0 None -138 6 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL2153423 91364 0 None -138 6 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL2220978 91364 0 None -138 6 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
491 6980 9 None -44 12 Rat 8.5 pKi = 8.5 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
9891167 6980 9 None -44 12 Rat 8.5 pKi = 8.5 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
CHEMBL13856 6980 9 None -44 12 Rat 8.5 pKi = 8.5 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
10816832 128282 0 None 234 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 1 7 4.5 COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL358313 128282 0 None 234 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 1 7 4.5 COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
44431551 93985 0 None -1 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL232779 93985 0 None -1 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431620 94573 0 None 4 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 570 7 1 6 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cnc(Cl)c(Br)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233790 94573 0 None 4 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 570 7 1 6 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cnc(Cl)c(Br)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
56837635 76083 0 None -11 5 Pig 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1129 44 2 17 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928132 76083 0 None -11 5 Pig 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1129 44 2 17 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
57398875 76089 0 None 1 5 Pig 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1005 30 2 17 4.7 COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928138 76089 0 None 1 5 Pig 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1005 30 2 17 4.7 COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
11154198 208393 0 None -6 5 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 413 6 0 5 3.3 CC(C)Oc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL60583 208393 0 None -6 5 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 413 6 0 5 3.3 CC(C)Oc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
11801562 92059 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 590 10 2 9 3.7 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL2260362 92059 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 590 10 2 9 3.7 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
90645604 119214 0 None 1 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 652 12 2 9 5.2 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCC(=O)NCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298022 119214 0 None 1 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 652 12 2 9 5.2 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCC(=O)NCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
10582623 108545 0 None -1 3 Rat 8.5 pKi = 8.5 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccnc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL299907 108545 0 None -1 3 Rat 8.5 pKi = 8.5 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccnc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL41844 170011 0 None 194 4 Human 8.5 pKi = 8.5 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 590 10 2 9 4.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)N=C(C)/C(=C(/O)OC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
10745305 43910 0 None 120 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 553 9 0 7 5.2 COC(=O)C1=C(C)N=C(C)N(CCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145278 43910 0 None 120 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 553 9 0 7 5.2 COC(=O)C1=C(C)N=C(C)N(CCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
102 10899 48 None -85 49 Bovine 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
3659 10899 48 None -85 49 Bovine 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
8969 10899 48 None -85 49 Bovine 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
CHEMBL15245 10899 48 None -85 49 Bovine 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
DB01392 10899 48 None -85 49 Bovine 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
16041092 102155 0 None -1 4 Human 8.4 pKi = 8.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256804 102155 0 None -1 4 Human 8.4 pKi = 8.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
136048765 70110 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 502 9 3 8 4.9 COc1ccccc1N1CCN(CCCNc2cc(O)nc(Nc3c(Cl)cccc3Cl)n2)CC1 10.1021/jm0491804
CHEMBL179401 70110 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 502 9 3 8 4.9 COc1ccccc1N1CCN(CCCNc2cc(O)nc(Nc3c(Cl)cccc3Cl)n2)CC1 10.1021/jm0491804
CHEMBL41844 170011 0 None 194 4 Human 8.4 pKi = 8.4 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 590 10 2 9 4.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)N=C(C)/C(=C(/O)OC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
44447007 161576 0 None -4 4 Rat 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 6 1 5 4.4 CC(C)C(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL400236 161576 0 None -4 4 Rat 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 6 1 5 4.4 CC(C)C(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
10817661 92061 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 620 12 3 10 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)OCCO)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL2260364 92061 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 620 12 3 10 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)OCCO)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL347501 126494 0 None 436 3 Human 8.4 pKi = 8.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 620 12 3 10 3.9 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)N=C(C)/C(=C(/O)OCCO)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
4418 40996 85 None -1 7 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL142635 40996 85 None -1 7 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2004.11.032
DB12092 40996 85 None -1 7 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2004.11.032
44316098 175945 0 None 14 3 Human 8.4 pKi = 8.4 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 425 7 0 6 3.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)n(C)n2)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL440499 175945 0 None 14 3 Human 8.4 pKi = 8.4 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 425 7 0 6 3.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)n(C)n2)CC1 10.1016/s0960-894x(00)00472-8
1443 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
33625 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
501 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
CHEMBL279516 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
DB08950 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
10555618 92060 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 604 11 2 9 4.1 CCOC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL2260363 92060 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 604 11 2 9 4.1 CCOC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
4418 40996 85 None -1 7 Human 8.4 pKi = 8.4 Binding
Displacement of [125I-HEAT from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes incubated for 60 minsDisplacement of [125I-HEAT from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes incubated for 60 mins
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.01.068
CHEMBL142635 40996 85 None -1 7 Human 8.4 pKi = 8.4 Binding
Displacement of [125I-HEAT from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes incubated for 60 minsDisplacement of [125I-HEAT from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes incubated for 60 mins
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.01.068
DB12092 40996 85 None -1 7 Human 8.4 pKi = 8.4 Binding
Displacement of [125I-HEAT from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes incubated for 60 minsDisplacement of [125I-HEAT from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes incubated for 60 mins
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.01.068
CHEMBL346649 126407 0 None 104 3 Human 8.4 pKi = 8.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 604 11 2 9 4.9 CCO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
2284 9956 33 None -1 29 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
4926 9956 33 None -1 29 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
7281 9956 33 None -1 29 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
CHEMBL564 9956 33 None -1 29 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
DB00420 9956 33 None -1 29 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
10526419 205827 0 None 7 3 Rat 8.4 pKi = 8.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 425 7 2 6 2.7 COc1cc(N)c(C(=O)NCCN2C[C@@H]3CCc4c(OC)cccc4[C@@H]3C2)cc1OC 10.1021/jm000541z
CHEMBL58612 205827 0 None 7 3 Rat 8.4 pKi = 8.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 425 7 2 6 2.7 COc1cc(N)c(C(=O)NCCN2C[C@@H]3CCc4c(OC)cccc4[C@@H]3C2)cc1OC 10.1021/jm000541z
44328654 113962 0 None 47 6 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 663 14 3 6 6.7 CCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL316495 113962 0 None 47 6 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 663 14 3 6 6.7 CCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1 10.1016/s0960-894x(99)00484-9
136806212 214511 0 None 47 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 636 13 4 7 4.6 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCN)N1 10.1016/s0960-894x(99)00484-9
44328639 214511 0 None 47 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 636 13 4 7 4.6 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL95736 214511 0 None 47 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 636 13 4 7 4.6 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCN)N1 10.1016/s0960-894x(99)00484-9
17753379 94838 0 None 2 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234607 94838 0 None 2 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857711 92401 0 None 8 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 506 7 1 4 5.5 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
CHEMBL228332 92401 0 None 8 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 506 7 1 4 5.5 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
12134986 171173 0 None 70 3 Human 8.4 pKi = 8.4 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)on2)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL421324 171173 0 None 70 3 Human 8.4 pKi = 8.4 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)on2)CC1 10.1016/s0960-894x(00)00472-8
71817549 109357 0 None -4 7 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3040803 109357 0 None -4 7 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3216590 109357 0 None -4 7 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
2894 214850 6 None -8 6 Rat 8.4 pKi = 8.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)C4CCCCC43)nc(N)c2cc1OC 10.1021/jm960510x
CHEMBL97698 214850 6 None -8 6 Rat 8.4 pKi = 8.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)C4CCCCC43)nc(N)c2cc1OC 10.1021/jm960510x
90645602 119212 0 None 1 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 553 7 1 8 5.0 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)c5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298020 119212 0 None 1 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 553 7 1 8 5.0 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)c5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
44431616 94852 0 None 3 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 471 8 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234650 94852 0 None 3 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 471 8 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
3584 10549 64 None -2 14 Rat 8.4 pKi = 8.4 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
5401 10549 64 None -2 14 Rat 8.4 pKi = 8.4 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
7302 10549 64 None -2 14 Rat 8.4 pKi = 8.4 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
CHEMBL611 10549 64 None -2 14 Rat 8.4 pKi = 8.4 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
DB01162 10549 64 None -2 14 Rat 8.4 pKi = 8.4 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
44431184 99625 0 None -2 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 5 0 5 5.5 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccc(F)cc5c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243866 99625 0 None -2 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 5 0 5 5.5 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccc(F)cc5c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
10310103 114089 0 None 1 9 Bovine 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 425 5 0 5 5.3 N#CCCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ncccn4)cc23)CC1 10.1021/jm020938y
CHEMBL317333 114089 0 None 1 9 Bovine 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 425 5 0 5 5.3 N#CCCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ncccn4)cc23)CC1 10.1021/jm020938y
10602180 175760 0 None 5 3 Rat 8.4 pKi = 8.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 525 5 1 8 4.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncc(-c6ccccc6)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL43909 175760 0 None 5 3 Rat 8.4 pKi = 8.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 525 5 1 8 4.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncc(-c6ccccc6)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
10326069 46070 1 None 23 9 Human 8.4 pKi = 8.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL147077 46070 1 None 23 9 Human 8.4 pKi = 8.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
44447003 161575 0 None -8 4 Rat 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 7 1 5 4.6 CCCC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL400235 161575 0 None -8 4 Rat 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 7 1 5 4.6 CCCC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL5275284 201433 0 None -5 3 Human 8.4 pKi = 8.4 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 466 8 1 5 3.9 CC(C)C(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315872 201433 0 None -5 3 Human 8.4 pKi = 8.4 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 466 8 1 5 3.9 CC(C)C(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
10326069 46070 1 None 23 9 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL147077 46070 1 None 23 9 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
1443 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm960697s
33625 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm960697s
501 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm960697s
CHEMBL279516 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm960697s
DB08950 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm960697s
129211 10521 78 None -1 16 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
2562 10521 78 None -1 16 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
488 10521 78 None -1 16 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
CHEMBL836 10521 78 None -1 16 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
DB00706 10521 78 None -1 16 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
9817640 106106 0 None 9 3 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 295 6 1 2 3.6 COc1ccc(CCNCC2CCc3ccccc3C2)cc1 10.1021/jm960697s
CHEMBL282214 106106 0 None 9 3 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 295 6 1 2 3.6 COc1ccc(CCNCC2CCc3ccccc3C2)cc1 10.1021/jm960697s
44298644 169906 0 None 31 3 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 454 7 1 6 2.6 Cc1c[nH]c(=O)n(CC(C)(C)CN2CCN(c3ccccc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL417758 169906 0 None 31 3 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 454 7 1 6 2.6 Cc1c[nH]c(=O)n(CC(C)(C)CN2CCN(c3ccccc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
12909387 69411 0 None 33 2 Bovine 7.5 pKi = 7.5 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 301 0 0 3 3.8 CN1CCC(=C2c3cc(C#N)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL178376 69411 0 None 33 2 Bovine 7.5 pKi = 7.5 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 301 0 0 3 3.8 CN1CCC(=C2c3cc(C#N)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
102012413 85431 0 None 2 2 Human 7.5 pKi = 7.5 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
CHEMBL2112365 85431 0 None 2 2 Human 7.5 pKi = 7.5 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
240 7731 43 None -4 25 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
2769 7731 43 None -4 25 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
44279790 7731 43 None -4 25 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
660 7731 43 None -4 25 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
CHEMBL1729 7731 43 None -4 25 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
CHEMBL560739 7731 43 None -4 25 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
DB00604 7731 43 None -4 25 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
4038180 6992 14 None -2 8 Bovine 7.5 pKi = 7.5 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
480 6992 14 None -2 8 Bovine 7.5 pKi = 7.5 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
CHEMBL109783 6992 14 None -2 8 Bovine 7.5 pKi = 7.5 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
44420423 90780 0 None -4 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 455 4 1 5 4.3 Cc1nc2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL220717 90780 0 None -4 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 455 4 1 5 4.3 Cc1nc2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2006.09.034
127040157 143705 0 None -10 5 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
CHEMBL3739897 143705 0 None -10 5 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
CHEMBL3742490 143705 0 None -10 5 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
155563002 183447 0 None -15 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.2 COc1ccccc1OCCNC[C@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4570387 183447 0 None -15 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.2 COc1ccccc1OCCNC[C@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4598207 183447 0 None -15 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.2 COc1ccccc1OCCNC[C@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
118716709 121781 0 None -1 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 457 5 0 6 3.1 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)C4CCCCC4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342862 121781 0 None -1 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 457 5 0 6 3.1 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)C4CCCCC4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44388493 69879 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 500 8 0 6 4.3 Clc1ccc(C2(Cn3ccnc3)OCC(CN3CCN(CCc4ccccc4)CC3)O2)c(Cl)c1 10.1021/jm0491804
CHEMBL178921 69879 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 500 8 0 6 4.3 Clc1ccc(C2(Cn3ccnc3)OCC(CN3CCN(CCc4ccccc4)CC3)O2)c(Cl)c1 10.1021/jm0491804
46882086 12588 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cc(OC)cc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1 10.1016/j.bmcl.2010.01.030
CHEMBL1078954 12588 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cc(OC)cc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1 10.1016/j.bmcl.2010.01.030
9796667 116243 0 None 9 2 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 3 2 3 2.4 CS(=O)(=O)Nc1ccc(F)c2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL322042 116243 0 None 9 2 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 3 2 3 2.4 CS(=O)(=O)Nc1ccc(F)c2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
11857862 92452 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL228607 92452 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857862 92452 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228607 92452 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
44331174 10941 0 None 1 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 355 3 0 2 4.9 O=C1c2ccccc2CC12CCN(CCc1cccc3ccccc13)CC2 10.1016/s0960-894x(98)00732-x
CHEMBL100052 10941 0 None 1 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 355 3 0 2 4.9 O=C1c2ccccc2CC12CCN(CCc1cccc3ccccc13)CC2 10.1016/s0960-894x(98)00732-x
CHEMBL5269671 201379 0 None -44 3 Human 7.5 pKi = 7.5 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 466 9 1 5 4.0 CCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315170 201379 0 None -44 3 Human 7.5 pKi = 7.5 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 466 9 1 5 4.0 CCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5284242 201394 0 None -56 3 Human 7.5 pKi = 7.5 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 510 11 0 6 4.0 COCCCC(=O)N(C)CCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315342 201394 0 None -56 3 Human 7.5 pKi = 7.5 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 510 11 0 6 4.0 COCCCC(=O)N(C)CCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
9981635 43684 0 None -2 3 Human 7.5 pKi = 7.5 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1cccc(C(F)(F)F)c1)C3 10.1021/jm030952q
CHEMBL145098 43684 0 None -2 3 Human 7.5 pKi = 7.5 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1cccc(C(F)(F)F)c1)C3 10.1021/jm030952q
CHEMBL2112853 43684 0 None -2 3 Human 7.5 pKi = 7.5 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1cccc(C(F)(F)F)c1)C3 10.1021/jm030952q
24803797 67854 0 None -7 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 626 11 0 6 7.6 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
CHEMBL1765111 67854 0 None -7 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 626 11 0 6 7.6 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
24803482 68107 0 None -125 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 640 14 0 6 7.8 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
CHEMBL1767168 68107 0 None -125 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 640 14 0 6 7.8 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
71817861 109183 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3039699 109183 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3217244 109183 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
3826471 104254 13 None -17 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 296 5 0 3 3.1 COc1ccccc1N1CCN(CCc2ccccc2)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL27021 104254 13 None -17 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 296 5 0 3 3.1 COc1ccccc1N1CCN(CCc2ccccc2)CC1 10.1016/j.ejmech.2016.06.052
702235 59986 97 None -7 4 Rat 5.5 pKi = 5.5 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 200 1 2 1 2.6 c1ccc2c(C3CCNCC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
CHEMBL15988 59986 97 None -7 4 Rat 5.5 pKi = 5.5 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 200 1 2 1 2.6 c1ccc2c(C3CCNCC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
CHEMBL2011564 59986 97 None -7 4 Rat 5.5 pKi = 5.5 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 200 1 2 1 2.6 c1ccc2c(C3CCNCC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
10397358 181766 44 None -70 2 Bovine 4.5 pKi = 4.5 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 178 1 2 4 0.1 Nc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL45665 181766 44 None -70 2 Bovine 4.5 pKi = 4.5 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 178 1 2 4 0.1 Nc1cccnc1N1CCNCC1 10.1021/jm00366a007
132060812 168815 0 None -831 10 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting method
ChEMBL 329 4 0 2 4.9 COc1cccc(-c2ccc3c(c2)CCN(Cc2ccccc2)C3)c1 10.1016/j.ejmech.2018.02.024
CHEMBL4160064 168815 0 None -831 10 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting method
ChEMBL 329 4 0 2 4.9 COc1cccc(-c2ccc3c(c2)CCN(Cc2ccccc2)C3)c1 10.1016/j.ejmech.2018.02.024
10287924 116610 0 None -95 5 Human 6.5 pKi = 6.5 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 388 4 0 5 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCc3noc4ccccc34)CC[C@@H]12 10.1021/jm401958n
CHEMBL3233411 116610 0 None -95 5 Human 6.5 pKi = 6.5 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 388 4 0 5 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCc3noc4ccccc34)CC[C@@H]12 10.1021/jm401958n
155770281 184526 0 None -3 9 Human 5.5 pKi = 5.5 Binding
Binding affinity to alpha1a (unknown origin)Binding affinity to alpha1a (unknown origin)
ChEMBL 517 4 1 2 7.6 CC(=O)N1CCC(c2ccc(-c3cc(C(=O)O)cc4cc(-c5ccc(C(F)(F)F)cc5)ccc34)cc2)CC1 10.1021/acs.jmedchem.1c00164
CHEMBL4642592 184526 0 None -3 9 Human 5.5 pKi = 5.5 Binding
Binding affinity to alpha1a (unknown origin)Binding affinity to alpha1a (unknown origin)
ChEMBL 517 4 1 2 7.6 CC(=O)N1CCC(c2ccc(-c3cc(C(=O)O)cc4cc(-c5ccc(C(F)(F)F)cc5)ccc34)cc2)CC1 10.1021/acs.jmedchem.1c00164
118717459 121919 0 None -2 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 444 12 2 6 6.3 COc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(OC)cc34)c2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343981 121919 0 None -2 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 444 12 2 6 6.3 COc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(OC)cc34)c2c1 10.1016/j.bmc.2014.09.017
10579368 112781 0 None -1 6 Human 6.5 pKi = 6.5 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 9 3 6 5.3 CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL313251 112781 0 None -1 6 Human 6.5 pKi = 6.5 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 9 3 6 5.3 CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
10579368 112781 0 None -1 6 Human 6.5 pKi = 6.5 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 9 3 6 5.3 CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL313251 112781 0 None -1 6 Human 6.5 pKi = 6.5 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 9 3 6 5.3 CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
52937018 68074 0 None -31 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 355 6 0 4 3.6 CN(C)CCCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767135 68074 0 None -31 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 355 6 0 4 3.6 CN(C)CCCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
52937223 68096 23 None -5 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 5 0 4 4.1 CN1CCCC1CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767157 68096 23 None -5 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 5 0 4 4.1 CN1CCCC1CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
24803316 68101 0 None -794 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 600 15 1 6 6.9 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1CCNCCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
CHEMBL1767162 68101 0 None -794 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 600 15 1 6 6.9 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1CCNCCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
250 10159 8 None -8912 13 Human 6.5 pKi = 6.5 Binding
Compound was evaluated for binding affinity against Alpha-1C adrenergic receptor using radioligand binding assayCompound was evaluated for binding affinity against Alpha-1C adrenergic receptor using radioligand binding assay
ChEMBL 502 10 1 7 5.0 COc1cc(CCCN2CCC(CC2)CCC(=O)c2cc(Cl)c(c3c2OCCO3)N)ccc1OC 10.1016/0960-894X(95)00358-Z
5311416 10159 8 None -8912 13 Human 6.5 pKi = 6.5 Binding
Compound was evaluated for binding affinity against Alpha-1C adrenergic receptor using radioligand binding assayCompound was evaluated for binding affinity against Alpha-1C adrenergic receptor using radioligand binding assay
ChEMBL 502 10 1 7 5.0 COc1cc(CCCN2CCC(CC2)CCC(=O)c2cc(Cl)c(c3c2OCCO3)N)ccc1OC 10.1016/0960-894X(95)00358-Z
CHEMBL69733 10159 8 None -8912 13 Human 6.5 pKi = 6.5 Binding
Compound was evaluated for binding affinity against Alpha-1C adrenergic receptor using radioligand binding assayCompound was evaluated for binding affinity against Alpha-1C adrenergic receptor using radioligand binding assay
ChEMBL 502 10 1 7 5.0 COc1cc(CCCN2CCC(CC2)CCC(=O)c2cc(Cl)c(c3c2OCCO3)N)ccc1OC 10.1016/0960-894X(95)00358-Z
118717459 121919 0 None -2 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 444 12 2 6 6.3 COc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(OC)cc34)c2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343981 121919 0 None -2 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 444 12 2 6 6.3 COc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(OC)cc34)c2c1 10.1016/j.bmc.2014.09.017
3584 10549 64 None -2 14 Human 7.5 pKi = 7.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
5401 10549 64 None -2 14 Human 7.5 pKi = 7.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
7302 10549 64 None -2 14 Human 7.5 pKi = 7.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
CHEMBL611 10549 64 None -2 14 Human 7.5 pKi = 7.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
DB01162 10549 64 None -2 14 Human 7.5 pKi = 7.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
2286 9957 51 None -10 30 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
4927 9957 51 None -10 30 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
7282 9957 51 None -10 30 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
CHEMBL643 9957 51 None -10 30 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
DB01069 9957 51 None -10 30 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
10043148 213319 0 None -26 2 Rat 6.5 pKi = 6.5 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 344 6 0 5 1.9 COc1ccccc1N1CCN(CCCN2CC3CCCN3C2)CC1 10.1021/jm970216k
CHEMBL88594 213319 0 None -26 2 Rat 6.5 pKi = 6.5 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 344 6 0 5 1.9 COc1ccccc1N1CCN(CCCN2CC3CCCN3C2)CC1 10.1021/jm970216k
11995036 18616 0 None 1 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL1182196 18616 0 None 1 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL218732 18616 0 None 1 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
14004032 126612 2 None -1 2 Bovine 5.5 pKi = 5.5 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 188 0 0 2 2.2 c1cnc2c(c1)CCN1CCCCC21 10.1021/jm00398a025
CHEMBL348538 126612 2 None -1 2 Bovine 5.5 pKi = 5.5 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 188 0 0 2 2.2 c1cnc2c(c1)CCN1CCCCC21 10.1021/jm00398a025
53328116 70158 0 None -5 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 411 5 0 4 3.4 O=C1CC(c2ccccc2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796029 70158 0 None -5 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 411 5 0 4 3.4 O=C1CC(c2ccccc2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
14004032 126612 2 None -1 2 Bovine 5.5 pKi = 5.5 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 188 0 0 2 2.2 c1cnc2c(c1)CCN1CCCCC21 10.1021/jm00398a025
CHEMBL348538 126612 2 None -1 2 Bovine 5.5 pKi = 5.5 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 188 0 0 2 2.2 c1cnc2c(c1)CCN1CCCCC21 10.1021/jm00398a025
11732785 170499 0 None -6 5 Rat 7.5 pKi = 7.5 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 432 7 0 5 3.7 COc1ccccc1N1CCN(CCCCN2CCn3c(cc4ccccc43)C2=O)CC1 10.1021/jm0211220
CHEMBL420510 170499 0 None -6 5 Rat 7.5 pKi = 7.5 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 432 7 0 5 3.7 COc1ccccc1N1CCN(CCCCN2CCn3c(cc4ccccc43)C2=O)CC1 10.1021/jm0211220
10020855 85598 0 None -165 6 Human 7.5 pKi = 7.5 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 351 4 0 4 3.9 COc1cccc(C2CCC(N3CCN(c4ccccn4)CC3)CC2)c1 10.1021/jm010866v
CHEMBL2112778 85598 0 None -165 6 Human 7.5 pKi = 7.5 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 351 4 0 4 3.9 COc1cccc(C2CCC(N3CCN(c4ccccn4)CC3)CC2)c1 10.1021/jm010866v
16041265 102112 0 None -1 4 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 504 6 2 4 6.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256597 102112 0 None -1 4 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 504 6 2 4 6.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
49865600 22793 0 None -83 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 378 7 1 4 4.4 Clc1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
CHEMBL1223616 22793 0 None -83 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 378 7 1 4 4.4 Clc1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
122295 16640 7 None 1 9 Human 7.5 pKi = 7.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00019a001
CHEMBL114166 16640 7 None 1 9 Human 7.5 pKi = 7.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00019a001
11140347 211312 1 None -5 6 Human 7.5 pKi = 7.5 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72768 211312 1 None -5 6 Human 7.5 pKi = 7.5 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
9824384 125565 1 None -177 8 Bovine 7.5 pKi = 7.5 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm960510x
CHEMBL342062 125565 1 None -177 8 Bovine 7.5 pKi = 7.5 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm960510x
145963755 168813 0 None -4 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 465 5 2 9 2.2 COc1cc2nc(N3CCC[C@H](NC(=O)[C@@H]4COc5ccccc5O4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4160032 168813 0 None -4 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 465 5 2 9 2.2 COc1cc2nc(N3CCC[C@H](NC(=O)[C@@H]4COc5ccccc5O4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
10962489 17962 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL1178679 17962 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL37212 17962 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
44417706 18607 0 None 5 7 Human 7.5 pKi = 7.5 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1016/j.ejmech.2020.112419
CHEMBL1182152 18607 0 None 5 7 Human 7.5 pKi = 7.5 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1016/j.ejmech.2020.112419
CHEMBL215188 18607 0 None 5 7 Human 7.5 pKi = 7.5 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1016/j.ejmech.2020.112419
10962489 17962 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL1178679 17962 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL37212 17962 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
11049096 17968 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL1178700 17968 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL37962 17968 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
9822814 108726 0 None -346 5 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL301224 108726 0 None -346 5 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
155567201 183007 0 None -20 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 9 1 5 4.2 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)OC1 10.1016/j.ejmech.2019.05.024
CHEMBL4588223 183007 0 None -20 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 9 1 5 4.2 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)OC1 10.1016/j.ejmech.2019.05.024
CHEMBL4594654 183007 0 None -20 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 9 1 5 4.2 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)OC1 10.1016/j.ejmech.2019.05.024
44417706 18607 0 None 5 7 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
CHEMBL1182152 18607 0 None 5 7 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
CHEMBL215188 18607 0 None 5 7 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
9822814 108726 0 None -346 5 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL301224 108726 0 None -346 5 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
44435219 98567 0 None 6 4 Human 6.5 pKi = 6.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by PDSP assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 367 2 0 2 6.2 O=C(Cc1ccc2ccccc2c1)N1c2ccccc2Sc2ccccc21 10.1016/j.bmcl.2013.04.082
CHEMBL241115 98567 0 None 6 4 Human 6.5 pKi = 6.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by PDSP assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 367 2 0 2 6.2 O=C(Cc1ccc2ccccc2c1)N1c2ccccc2Sc2ccccc21 10.1016/j.bmcl.2013.04.082
9932835 107570 0 None -151 4 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 437 4 0 4 4.2 O=C1CC2(CCCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL293111 107570 0 None -151 4 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 437 4 0 4 4.2 O=C1CC2(CCCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
518 10384 1 None -234 6 Human 5.5 pKi = 5.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1016/j.bmcl.2004.11.032
9839317 10384 1 None -234 6 Human 5.5 pKi = 5.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1016/j.bmcl.2004.11.032
CHEMBL123138 10384 1 None -234 6 Human 5.5 pKi = 5.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1016/j.bmcl.2004.11.032
44271624 71549 3 None - 1 Bovine 5.5 pKi = 5.5 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 192 1 0 2 1.9 CN1CC=C(c2ncccc2F)CC1 10.1021/jm00375a017
CHEMBL18194 71549 3 None - 1 Bovine 5.5 pKi = 5.5 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 192 1 0 2 1.9 CN1CC=C(c2ncccc2F)CC1 10.1021/jm00375a017
518 10384 1 None -234 6 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1021/jm00019a001
9839317 10384 1 None -234 6 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1021/jm00019a001
CHEMBL123138 10384 1 None -234 6 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1021/jm00019a001
20750645 109084 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 346 6 1 5 3.4 CC(C)Oc1ccccc1N1CCN(Cc2cc(CO)cs2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL303485 109084 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 346 6 1 5 3.4 CC(C)Oc1ccccc1N1CCN(Cc2cc(CO)cs2)CC1 10.1016/s0960-894x(02)00347-5
127035062 143229 0 None -11 19 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A receptor after 90 mins by scintillation counting methodDisplacement of [3H]Prazosin from human recombinant alpha 1A receptor after 90 mins by scintillation counting method
ChEMBL 447 12 0 5 5.2 COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC 10.1039/C4MD00418C
CHEMBL3735756 143229 0 None -11 19 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A receptor after 90 mins by scintillation counting methodDisplacement of [3H]Prazosin from human recombinant alpha 1A receptor after 90 mins by scintillation counting method
ChEMBL 447 12 0 5 5.2 COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC 10.1039/C4MD00418C
44582675 196480 0 None -5 15 Human 6.5 pKi = 6.5 Binding
Inhibition of human cloned alpha1A adrenergic receptor by competitive binding experimentInhibition of human cloned alpha1A adrenergic receptor by competitive binding experiment
ChEMBL 405 9 1 4 4.2 COc1c(OCCF)cccc1[C@H](O)C1CCN(CCc2ccc(F)cc2)CC1 10.1016/j.bmc.2009.03.021
CHEMBL515472 196480 0 None -5 15 Human 6.5 pKi = 6.5 Binding
Inhibition of human cloned alpha1A adrenergic receptor by competitive binding experimentInhibition of human cloned alpha1A adrenergic receptor by competitive binding experiment
ChEMBL 405 9 1 4 4.2 COc1c(OCCF)cccc1[C@H](O)C1CCN(CCc2ccc(F)cc2)CC1 10.1016/j.bmc.2009.03.021
12840734 107706 3 None -794 5 Rat 5.5 pKi = 5.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 355 4 0 4 2.5 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1 10.1021/jm030944+
CHEMBL293968 107706 3 None -794 5 Rat 5.5 pKi = 5.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 355 4 0 4 2.5 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1 10.1021/jm030944+
76318762 91590 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 435 9 1 6 4.0 COc1cccc(OC)c1OCCNC1COCC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL2234440 91590 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 435 9 1 6 4.0 COc1cccc(OC)c1OCCNC1COCC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
25131193 92965 0 None -239 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.02.056
CHEMBL2312225 92965 0 None -239 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.02.056
24894141 194188 0 None -30 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm800461k
CHEMBL493697 194188 0 None -30 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm800461k
25131193 92965 0 None -239 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
CHEMBL2312225 92965 0 None -239 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
53328872 70177 0 None -3 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 433 5 0 5 2.9 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796048 70177 0 None -3 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 433 5 0 5 2.9 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
9906978 49485 2 None -2 12 Human 7.5 pKi = 7.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
CHEMBL150161 49485 2 None -2 12 Human 7.5 pKi = 7.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
16041451 104584 0 None -5 4 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 500 7 2 5 5.4 COc1ccc(Cl)cc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL271913 104584 0 None -5 4 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 500 7 2 5 5.4 COc1ccc(Cl)cc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
168270256 196846 0 None -8 2 Rat 7.5 pKi = 7.5 Binding
Displacement of [3H]-prazosin from rat whole cortex membrane homogenate alpha 1 adrenergic receptorDisplacement of [3H]-prazosin from rat whole cortex membrane homogenate alpha 1 adrenergic receptor
ChEMBL 415 3 0 3 3.7 CCN(CC)C(=O)[C@@H]1C=C2c3cccc4c3c(c(Br)n4C)CC2N(C)C1 10.1021/acs.jmedchem.2c00633
CHEMBL5172469 196846 0 None -8 2 Rat 7.5 pKi = 7.5 Binding
Displacement of [3H]-prazosin from rat whole cortex membrane homogenate alpha 1 adrenergic receptorDisplacement of [3H]-prazosin from rat whole cortex membrane homogenate alpha 1 adrenergic receptor
ChEMBL 415 3 0 3 3.7 CCN(CC)C(=O)[C@@H]1C=C2c3cccc4c3c(c(Br)n4C)CC2N(C)C1 10.1021/acs.jmedchem.2c00633
53328686 70174 0 None 2 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 469 7 0 5 4.0 COc1ccc(Cl)cc1N1CCN(CCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796045 70174 0 None 2 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 469 7 0 5 4.0 COc1ccc(Cl)cc1N1CCN(CCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
2337 10030 77 None -3 62 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
50 10030 77 None -3 62 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
5002 10030 77 None -3 62 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
CHEMBL716 10030 77 None -3 62 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
DB01224 10030 77 None -3 62 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
75201901 173204 19 None -251 24 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 356 3 0 6 4.9 Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4277264 173204 19 None -251 24 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 356 3 0 6 4.9 Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12 10.1021/acs.jmedchem.9b00351
16756752 149369 0 None -4168 3 Human 4.5 pKi = 4.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 496 7 1 3 7.8 CC(C)C(=O)Nc1cccc(C2CCN(Cc3ccc(Oc4ccc(Cl)c(Cl)c4)cc3)CC2)c1 10.1021/jm060383x
CHEMBL389129 149369 0 None -4168 3 Human 4.5 pKi = 4.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 496 7 1 3 7.8 CC(C)C(=O)Nc1cccc(C2CCN(Cc3ccc(Oc4ccc(Cl)c(Cl)c4)cc3)CC2)c1 10.1021/jm060383x
44460449 212653 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 426 7 0 6 3.7 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCCC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL83791 212653 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 426 7 0 6 3.7 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCCC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
53328115 70157 0 None -2 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 407 6 0 5 2.8 COc1ccccc1N1CCN(CCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796028 70157 0 None -2 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 407 6 0 5 2.8 COc1ccccc1N1CCN(CCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
132060776 169181 0 None -11 16 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting method
ChEMBL 419 4 0 4 4.4 O=C(OCc1ccccc1)N1CCc2ccc(N3CCN(C4CCCC4)CC3)cc2C1 10.1016/j.ejmech.2018.02.024
CHEMBL4165863 169181 0 None -11 16 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting method
ChEMBL 419 4 0 4 4.4 O=C(OCc1ccccc1)N1CCc2ccc(N3CCN(C4CCCC4)CC3)cc2C1 10.1016/j.ejmech.2018.02.024
44295193 108555 0 None 11 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 576 7 2 9 2.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc3c(c2)OCO3)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL299984 108555 0 None 11 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 576 7 2 9 2.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc3c(c2)OCO3)CC1 10.1016/s0960-894x(99)00653-8
46881382 14096 0 None -275 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 437 9 1 5 5.4 COc1ccccc1OCCNCC1CSC(c2ccccc2)(c2ccccc2)S1 10.1016/j.bmcl.2010.01.030
CHEMBL1086156 14096 0 None -275 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 437 9 1 5 5.4 COc1ccccc1OCCNCC1CSC(c2ccccc2)(c2ccccc2)S1 10.1016/j.bmcl.2010.01.030
49832191 174318 0 None -407 3 Human 6.5 pKi = 6.5 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 CNc1ccc2c(c1)C(NCCOc1cc(F)ccc1F)CCS2(=O)=O 10.1016/j.ejmech.2017.07.071
CHEMBL4218307 174318 0 None -407 3 Human 6.5 pKi = 6.5 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 CNc1ccc2c(c1)C(NCCOc1cc(F)ccc1F)CCS2(=O)=O 10.1016/j.ejmech.2017.07.071
CHEMBL4300210 174318 0 None -407 3 Human 6.5 pKi = 6.5 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 CNc1ccc2c(c1)C(NCCOc1cc(F)ccc1F)CCS2(=O)=O 10.1016/j.ejmech.2017.07.071
1346 6871 117 None -2884 9 Rat 5.5 pKi = 5.5 Binding
Binding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranesBinding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranes
ChEMBL 192 2 1 3 1.1 COc1ccccc1N1CCNCC1 10.1021/jm00110a014
280 6871 117 None -2884 9 Rat 5.5 pKi = 5.5 Binding
Binding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranesBinding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranes
ChEMBL 192 2 1 3 1.1 COc1ccccc1N1CCNCC1 10.1021/jm00110a014
9899402 6871 117 None -2884 9 Rat 5.5 pKi = 5.5 Binding
Binding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranesBinding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranes
ChEMBL 192 2 1 3 1.1 COc1ccccc1N1CCNCC1 10.1021/jm00110a014
CHEMBL9666 6871 117 None -2884 9 Rat 5.5 pKi = 5.5 Binding
Binding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranesBinding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranes
ChEMBL 192 2 1 3 1.1 COc1ccccc1N1CCNCC1 10.1021/jm00110a014
155515301 176746 0 None -29 7 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 444 6 0 5 4.2 COc1ccccc1N1CCN(C[C@H]2OCCOC2(c2ccccc2)c2ccccc2)CC1 10.1016/j.ejmech.2019.02.056
CHEMBL4441888 176746 0 None -29 7 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 444 6 0 5 4.2 COc1ccccc1N1CCN(C[C@H]2OCCOC2(c2ccccc2)c2ccccc2)CC1 10.1016/j.ejmech.2019.02.056
10092819 23545 0 None -34 11 Rat 7.4 pKi = 7.4 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 407 8 1 5 3.8 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1 10.1021/jm0211220
CHEMBL124444 23545 0 None -34 11 Rat 7.4 pKi = 7.4 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 407 8 1 5 3.8 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1 10.1021/jm0211220
44431590 94754 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 555 8 1 6 4.9 COc1ccc(C(F)(F)F)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234231 94754 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 555 8 1 6 4.9 COc1ccc(C(F)(F)F)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431615 94813 0 None 1 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 5 4.7 O=S(=O)(N[C@H]1CC[C@@H](N2CCN(c3ccccc3OCC3CC3)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.008
CHEMBL234476 94813 0 None 1 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 5 4.7 O=S(=O)(N[C@H]1CC[C@@H](N2CCN(c3ccccc3OCC3CC3)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.008
13141187 137494 0 None 9 2 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 378 1 0 3 5.2 CN1CCC(=C2c3cc(SC(F)(F)F)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL368475 137494 0 None 9 2 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 378 1 0 3 5.2 CN1CCC(=C2c3cc(SC(F)(F)F)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
56649650 74633 0 None -41 8 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 466 8 0 5 4.2 COc1ccccc1N1CCN(CCN(C(=O)C23CCC(CF)(CC2)C3)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL1910141 74633 0 None -41 8 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 466 8 0 5 4.2 COc1ccccc1N1CCN(CCN(C(=O)C23CCC(CF)(CC2)C3)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
145946527 174349 0 None 5 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 382 10 0 4 3.6 Cc1cccc(OCCOCCN2CCN(CCc3ccccc3)CC2)c1C 10.1016/j.bmcl.2018.04.059
CHEMBL4217761 174349 0 None 5 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 382 10 0 4 3.6 Cc1cccc(OCCOCCN2CCN(CCc3ccccc3)CC2)c1C 10.1016/j.bmcl.2018.04.059
CHEMBL4300609 174349 0 None 5 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 382 10 0 4 3.6 Cc1cccc(OCCOCCN2CCN(CCc3ccccc3)CC2)c1C 10.1016/j.bmcl.2018.04.059
126225 101751 5 None -13 7 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm0307741
CHEMBL25467 101751 5 None -13 7 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm0307741
126225 101751 5 None -13 7 Human 7.4 pKi = 7.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
CHEMBL25467 101751 5 None -13 7 Human 7.4 pKi = 7.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
3038603 108642 8 None -48 3 Human 7.4 pKi = 7.4 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 335 1 0 1 5.4 CN(C)C1C=CC2(CC1)c1ccccc1C=Cc1ccc(Cl)cc12 10.1021/jm00109a026
CHEMBL300647 108642 8 None -48 3 Human 7.4 pKi = 7.4 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 335 1 0 1 5.4 CN(C)C1C=CC2(CC1)c1ccccc1C=Cc1ccc(Cl)cc12 10.1021/jm00109a026
10790988 122878 0 None -3 3 Rat 7.4 pKi = 7.4 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 483 8 1 10 2.0 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL335731 122878 0 None -3 3 Rat 7.4 pKi = 7.4 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 483 8 1 10 2.0 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
76307950 91595 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL2234445 91595 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
10508016 213935 0 None 3 6 Human 7.4 pKi = 7.4 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 613 9 2 5 7.7 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1 10.1021/jm980077m
CHEMBL92322 213935 0 None 3 6 Human 7.4 pKi = 7.4 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 613 9 2 5 7.7 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1 10.1021/jm980077m
10508016 92066 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 613 9 2 5 6.8 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1 10.1007/s00044-004-0120-9
CHEMBL2260369 92066 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 613 9 2 5 6.8 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1 10.1007/s00044-004-0120-9
76307950 91595 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL2234445 91595 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
9944409 14385 0 None 1 5 Rat 7.4 pKi = 7.4 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL108804 14385 0 None 1 5 Rat 7.4 pKi = 7.4 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
53328315 70164 0 None 1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 469 8 0 5 4.2 COc1ccc(Cl)cc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796035 70164 0 None 1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 469 8 0 5 4.2 COc1ccc(Cl)cc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
10617200 33206 0 None -6 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@@H]1[C@H](NC[C@H]2COc3ccccc3O2)CC[C@H]1Oc1ccccc1 10.1021/jm991065j
CHEMBL135973 33206 0 None -6 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@@H]1[C@H](NC[C@H]2COc3ccccc3O2)CC[C@H]1Oc1ccccc1 10.1021/jm991065j
9944409 14385 0 None 1 5 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL108804 14385 0 None 1 5 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
71719108 92826 1 None -141 4 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 895 16 6 11 3.5 N=C(N)NCCC[C@@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O 10.1016/j.bmcl.2013.11.061
CHEMBL2307889 92826 1 None -141 4 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 895 16 6 11 3.5 N=C(N)NCCC[C@@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O 10.1016/j.bmcl.2013.11.061
10619916 213517 0 None -12 2 Rat 6.4 pKi = 6.4 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 382 5 0 4 3.0 FC(F)(F)c1cccc(N2CCN(CCCN3CC4CCCN4C3)CC2)c1 10.1021/jm970216k
CHEMBL89950 213517 0 None -12 2 Rat 6.4 pKi = 6.4 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 382 5 0 4 3.0 FC(F)(F)c1cccc(N2CCN(CCCN3CC4CCCN4C3)CC2)c1 10.1021/jm970216k
9909389 172090 6 None -524 2 Human 6.4 pKi = 6.4 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 408 6 1 5 3.5 O=C(C1CCCCC1)N(CCN1CCN(c2ccccc2O)CC1)c1ccccn1 10.1021/acs.jmedchem.2c00633
CHEMBL423361 172090 6 None -524 2 Human 6.4 pKi = 6.4 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 408 6 1 5 3.5 O=C(C1CCCCC1)N(CCN1CCN(c2ccccc2O)CC1)c1ccccn1 10.1021/acs.jmedchem.2c00633
9809007 179343 8 None 134 6 Human 7.4 pKi = 7.4 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
CHEMBL448620 179343 8 None 134 6 Human 7.4 pKi = 7.4 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
9976756 13379 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm021078o
CHEMBL1083181 13379 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm021078o
CHEMBL37883 13379 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm021078o
9976756 13379 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL1083181 13379 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL37883 13379 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
9976756 13379 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.bmcl.2010.01.030
CHEMBL1083181 13379 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.bmcl.2010.01.030
CHEMBL37883 13379 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.bmcl.2010.01.030
9976756 13379 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
CHEMBL1083181 13379 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
CHEMBL37883 13379 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
9976756 13379 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm200421e
CHEMBL1083181 13379 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm200421e
CHEMBL37883 13379 0 None -10 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm200421e
44431173 99577 0 None -1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 519 5 0 5 4.8 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4c(F)c(F)c(F)c(F)c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243690 99577 0 None -1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 519 5 0 5 4.8 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4c(F)c(F)c(F)c(F)c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
12613159 194105 11 None -1 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL493054 194105 11 None -1 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
10084076 104692 0 None -20 9 Human 6.4 pKi = 6.4 Binding
Binding affinity towards alpha-1-adrenergic receptorBinding affinity towards alpha-1-adrenergic receptor
ChEMBL 262 0 1 2 2.8 CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@H]3N 10.1021/jm030030n
CHEMBL27251 104692 0 None -20 9 Human 6.4 pKi = 6.4 Binding
Binding affinity towards alpha-1-adrenergic receptorBinding affinity towards alpha-1-adrenergic receptor
ChEMBL 262 0 1 2 2.8 CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@H]3N 10.1021/jm030030n
3024499 182252 73 None -20 2 Bovine 6.4 pKi = 6.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cccc(N2CCNCC2)n1 10.1021/jm00366a007
CHEMBL45773 182252 73 None -20 2 Bovine 6.4 pKi = 6.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cccc(N2CCNCC2)n1 10.1021/jm00366a007
11384983 204081 0 None -295 4 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 433 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2Br)CC1 10.1021/jm030944+
CHEMBL56869 204081 0 None -295 4 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 433 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2Br)CC1 10.1021/jm030944+
10651027 127841 0 None 11 3 Human 5.4 pKi = 5.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 11 3 7 3.7 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(CN(C)C)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL356923 127841 0 None 11 3 Human 5.4 pKi = 5.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 11 3 7 3.7 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(CN(C)C)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
98358 126264 8 None 1 2 Bovine 7.4 pKi = 7.4 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 226 0 1 1 3.3 c1ccc2c3c([nH]c2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL345349 126264 8 None 1 2 Bovine 7.4 pKi = 7.4 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 226 0 1 1 3.3 c1ccc2c3c([nH]c2c1)C1CCCCN1CC3 10.1021/jm00398a025
44267884 22339 0 None 2 3 Human 7.4 pKi = 7.4 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 403 8 0 6 2.2 CC(C)Oc1ccccc1N1CCN(CCOC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12202 22339 0 None 2 3 Human 7.4 pKi = 7.4 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 403 8 0 6 2.2 CC(C)Oc1ccccc1N1CCN(CCOC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
44426405 92444 0 None 2 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc(OC(F)F)cc1 10.1016/j.bmcl.2007.04.098
CHEMBL228554 92444 0 None 2 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc(OC(F)F)cc1 10.1016/j.bmcl.2007.04.098
60785 212672 48 None -309 7 Rat 7.4 pKi = 7.4 Binding
Binding affinity to rat cerebral cortex homogenate alpha 1 adrenergic receptor assessed as inhibition constantBinding affinity to rat cerebral cortex homogenate alpha 1 adrenergic receptor assessed as inhibition constant
ChEMBL 425 5 0 4 3.7 O=S1(=O)c2cccc3cccc(c23)N1CCCN1CCN(c2ccc(F)cc2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL83894 212672 48 None -309 7 Rat 7.4 pKi = 7.4 Binding
Binding affinity to rat cerebral cortex homogenate alpha 1 adrenergic receptor assessed as inhibition constantBinding affinity to rat cerebral cortex homogenate alpha 1 adrenergic receptor assessed as inhibition constant
ChEMBL 425 5 0 4 3.7 O=S1(=O)c2cccc3cccc(c23)N1CCCN1CCN(c2ccc(F)cc2)CC1 10.1021/acs.jmedchem.2c00633
133 9274 52 None -70 43 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
1723 9274 52 None -70 43 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
28693 9274 52 None -70 43 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
CHEMBL19215 9274 52 None -70 43 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
DB13520 9274 52 None -70 43 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
16040907 104659 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 466 7 2 5 4.7 COc1ccccc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL272340 104659 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 466 7 2 5 4.7 COc1ccccc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
71508684 93825 0 None 169 2 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 371 3 0 5 4.2 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cnn(C)c4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325929 93825 0 None 169 2 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 371 3 0 5 4.2 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cnn(C)c4)cc23)CC1 10.1016/j.bmc.2012.10.049
2470 10425 50 None -398 58 Rat 7.4 pKi = 7.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
3300 10425 50 None -398 58 Rat 7.4 pKi = 7.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
5265 10425 50 None -398 58 Rat 7.4 pKi = 7.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
99 10425 50 None -398 58 Rat 7.4 pKi = 7.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
CHEMBL267930 10425 50 None -398 58 Rat 7.4 pKi = 7.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
98358 126264 8 None 1 2 Bovine 7.4 pKi = 7.4 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 226 0 1 1 3.3 c1ccc2c3c([nH]c2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL345349 126264 8 None 1 2 Bovine 7.4 pKi = 7.4 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 226 0 1 1 3.3 c1ccc2c3c([nH]c2c1)C1CCCCN1CC3 10.1021/jm00398a025
44288469 168469 0 None 1 3 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1ccc2c(c1)CCC1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL41332 168469 0 None 1 3 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1ccc2c(c1)CCC1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
127024959 144579 0 None -30 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 405 7 1 3 4.3 O=C(NCCCCN1CCN(c2ccccc2F)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3759607 144579 0 None -30 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 405 7 1 3 4.3 O=C(NCCCCN1CCN(c2ccccc2F)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
155562125 183122 0 None -20 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 8 1 4 4.4 c1ccc(OCCNCC2CCOC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4582160 183122 0 None -20 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 8 1 4 4.4 c1ccc(OCCNCC2CCOC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4595563 183122 0 None -20 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 8 1 4 4.4 c1ccc(OCCNCC2CCOC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
56945165 78293 0 None -69 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 442 6 1 4 4.6 COc1ccccc1N1CCN(C[C@H]2CCC(c3ccccc3)(c3ccccc3)[C@H]2O)CC1 10.1021/jm200421e
CHEMBL1946787 78293 0 None -69 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 442 6 1 4 4.6 COc1ccccc1N1CCN(C[C@H]2CCC(c3ccccc3)(c3ccccc3)[C@H]2O)CC1 10.1021/jm200421e
CHEMBL1962770 78293 0 None -69 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 442 6 1 4 4.6 COc1ccccc1N1CCN(C[C@H]2CCC(c3ccccc3)(c3ccccc3)[C@H]2O)CC1 10.1021/jm200421e
44288492 170193 0 None 3 2 Human 6.4 pKi = 6.4 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 439 9 1 6 2.9 COC(=O)C1(c2ccccc2)CCN(CCNC(=O)CCc2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL41959 170193 0 None 3 2 Human 6.4 pKi = 6.4 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 439 9 1 6 2.9 COC(=O)C1(c2ccccc2)CCN(CCNC(=O)CCc2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
2419 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2010.05.023
9 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2010.05.023
CHEMBL13647 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2010.05.023
2419 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2019.02.056
9 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2019.02.056
CHEMBL13647 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2019.02.056
2419 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.bmcl.2010.01.030
9 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.bmcl.2010.01.030
CHEMBL13647 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.bmcl.2010.01.030
2419 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm991065j
9 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm991065j
CHEMBL13647 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm991065j
2419 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm800461k
9 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm800461k
CHEMBL13647 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm800461k
2419 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm301525w
9 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm301525w
CHEMBL13647 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm301525w
2419 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm200421e
9 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm200421e
CHEMBL13647 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm200421e
3778834 108097 78 None -144 2 Bovine 5.4 pKi = 5.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 208 2 1 5 0.4 O=[N+]([O-])c1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL296653 108097 78 None -144 2 Bovine 5.4 pKi = 5.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 208 2 1 5 0.4 O=[N+]([O-])c1cccnc1N1CCNCC1 10.1021/jm00366a007
11338314 178149 0 None -676 4 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)cc2F)CC1 10.1021/jm0491391
CHEMBL446180 178149 0 None -676 4 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)cc2F)CC1 10.1021/jm0491391
294234 109670 3 None -512 4 Human 5.4 pKi = 5.4 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
CHEMBL305928 109670 3 None -512 4 Human 5.4 pKi = 5.4 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
10640982 33207 0 None -467 5 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@H]1[C@@H](NC[C@H]2COc3ccccc3O2)CC[C@@H]1Oc1ccccc1 10.1021/jm991065j
CHEMBL135974 33207 0 None -467 5 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@H]1[C@@H](NC[C@H]2COc3ccccc3O2)CC[C@@H]1Oc1ccccc1 10.1021/jm991065j
2419 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2016.09.050
9 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2016.09.050
CHEMBL13647 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2016.09.050
9796526 116661 0 None 6 2 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 2 3 2.6 Cc1ccc(NS(C)(=O)=O)c2c1C(c1c[nH]cn1)CCC2 10.1021/jm030551a
CHEMBL323440 116661 0 None 6 2 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 2 3 2.6 Cc1ccc(NS(C)(=O)=O)c2c1C(c1c[nH]cn1)CCC2 10.1021/jm030551a
71455083 88605 0 None -64 7 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand binding assayBinding affinity to adrenergic alpha1A receptor by radioligand binding assay
ChEMBL 389 6 0 3 4.8 O=C(C1CCCCC1)N(CCN1CC=C(c2ccccc2)CC1)c1ccccn1 10.1016/j.bmcl.2012.05.119
CHEMBL2164354 88605 0 None -64 7 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand binding assayBinding affinity to adrenergic alpha1A receptor by radioligand binding assay
ChEMBL 389 6 0 3 4.8 O=C(C1CCCCC1)N(CCN1CC=C(c2ccccc2)CC1)c1ccccn1 10.1016/j.bmcl.2012.05.119
3033538 8101 39 None -7 9 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
7155 8101 39 None -7 9 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
781 8101 39 None -7 9 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
CHEMBL1201216 8101 39 None -7 9 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
DB00298 8101 39 None -7 9 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
13091268 84999 0 None -42 14 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assay
ChEMBL 401 6 1 3 5.0 O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
CHEMBL210578 84999 0 None -42 14 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assay
ChEMBL 401 6 1 3 5.0 O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
52937830 68093 0 None -125 3 Human 7.4 pKi = 7.4 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.7 CN1CCC[C@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767154 68093 0 None -125 3 Human 7.4 pKi = 7.4 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.7 CN1CCC[C@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
17747460 68103 12 None -158 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 640 14 0 6 7.8 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
CHEMBL1767164 68103 12 None -158 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 640 14 0 6 7.8 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
3584 10549 64 None -2 14 Human 7.4 pKi = 7.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm960697s
5401 10549 64 None -2 14 Human 7.4 pKi = 7.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm960697s
7302 10549 64 None -2 14 Human 7.4 pKi = 7.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm960697s
CHEMBL611 10549 64 None -2 14 Human 7.4 pKi = 7.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm960697s
DB01162 10549 64 None -2 14 Human 7.4 pKi = 7.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm960697s
56946579 78288 0 None -11 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 440 6 0 4 4.8 COc1ccccc1N1CCN(CC2CCC(c3ccccc3)(c3ccccc3)C2=O)CC1 10.1021/jm200421e
CHEMBL1946783 78288 0 None -11 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 440 6 0 4 4.8 COc1ccccc1N1CCN(CC2CCC(c3ccccc3)(c3ccccc3)C2=O)CC1 10.1021/jm200421e
CHEMBL1962755 78288 0 None -11 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 440 6 0 4 4.8 COc1ccccc1N1CCN(CC2CCC(c3ccccc3)(c3ccccc3)C2=O)CC1 10.1021/jm200421e
52937729 68085 0 None -251 3 Human 6.4 pKi = 6.4 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.7 CN1CCC[C@@H]1Cn1nc(Cc2cccc(Cl)c2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767146 68085 0 None -251 3 Human 6.4 pKi = 6.4 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.7 CN1CCC[C@@H]1Cn1nc(Cc2cccc(Cl)c2)c2ccccc2c1=O 10.1021/jm1013874
11857791 175776 0 None -1 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 554 7 1 6 4.9 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc2c(c1)OCCO2 10.1016/j.bmcl.2007.04.098
CHEMBL439197 175776 0 None -1 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 554 7 1 6 4.9 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc2c(c1)OCCO2 10.1016/j.bmcl.2007.04.098
3584 10549 64 None -2 14 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
5401 10549 64 None -2 14 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
7302 10549 64 None -2 14 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
CHEMBL611 10549 64 None -2 14 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
DB01162 10549 64 None -2 14 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
44289525 172774 0 None -4 9 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNCC1Oc2ccccc2OC1c1ccc(C)cc1 10.1016/j.bmcl.2004.11.032
CHEMBL42539 172774 0 None -4 9 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNCC1Oc2ccccc2OC1c1ccc(C)cc1 10.1016/j.bmcl.2004.11.032
57402787 75970 0 None -1 5 Pig 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 977 28 2 17 4.4 COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(OCCOCCOCCOCCOc4ccn5ncc(C(=O)NCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1926700 75970 0 None -1 5 Pig 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 977 28 2 17 4.4 COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(OCCOCCOCCOCCOc4ccn5ncc(C(=O)NCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
2142 9870 58 None -2 37 Human 8.4 pKi = 8.4 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
4920903 9870 58 None -2 37 Human 8.4 pKi = 8.4 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
502 9870 58 None -2 37 Human 8.4 pKi = 8.4 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
5775 9870 58 None -2 37 Human 8.4 pKi = 8.4 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
CHEMBL597 9870 58 None -2 37 Human 8.4 pKi = 8.4 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
DB00692 9870 58 None -2 37 Human 8.4 pKi = 8.4 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
10555134 47571 0 None 173 3 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 573 9 2 8 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc3c(c2)OCO3)CC1 10.1007/s00044-004-0120-9
CHEMBL148552 47571 0 None 173 3 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 573 9 2 8 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc3c(c2)OCO3)CC1 10.1007/s00044-004-0120-9
44428851 99093 0 None -8 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 447 4 1 7 3.5 COc1cc2nc(N3CCN(C(=O)c4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242934 99093 0 None -8 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 447 4 1 7 3.5 COc1cc2nc(N3CCN(C(=O)c4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
491 6980 9 None -50 12 Human 8.4 pKi = 8.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
9891167 6980 9 None -50 12 Human 8.4 pKi = 8.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
CHEMBL13856 6980 9 None -50 12 Human 8.4 pKi = 8.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
10555134 47571 0 None 173 3 Human 8.4 pKi = 8.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 573 9 2 8 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc3c(c2)OCO3)CC1 10.1021/jm980506g
CHEMBL148552 47571 0 None 173 3 Human 8.4 pKi = 8.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 573 9 2 8 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc3c(c2)OCO3)CC1 10.1021/jm980506g
3584 10549 64 None -2 14 Human 8.4 pKi = 8.4 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
5401 10549 64 None -2 14 Human 8.4 pKi = 8.4 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
7302 10549 64 None -2 14 Human 8.4 pKi = 8.4 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
CHEMBL611 10549 64 None -2 14 Human 8.4 pKi = 8.4 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
DB01162 10549 64 None -2 14 Human 8.4 pKi = 8.4 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
10554745 44006 0 None 97 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 552 10 1 6 4.9 COC(=O)C1(c2ccccc2)CCN(CCCCCN2C(C)=NC(C)=C(C(N)=O)C2c2ccc(F)cc2F)CC1 10.1021/jm9902032
CHEMBL145353 44006 0 None 97 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 552 10 1 6 4.9 COC(=O)C1(c2ccccc2)CCN(CCCCCN2C(C)=NC(C)=C(C(N)=O)C2c2ccc(F)cc2F)CC1 10.1021/jm9902032
491 6980 9 None -50 12 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/j.bmcl.2004.11.032
9891167 6980 9 None -50 12 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/j.bmcl.2004.11.032
CHEMBL13856 6980 9 None -50 12 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/j.bmcl.2004.11.032
3584 10549 64 None -2 14 Human 8.4 pKi = 8.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
5401 10549 64 None -2 14 Human 8.4 pKi = 8.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
7302 10549 64 None -2 14 Human 8.4 pKi = 8.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
CHEMBL611 10549 64 None -2 14 Human 8.4 pKi = 8.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
DB01162 10549 64 None -2 14 Human 8.4 pKi = 8.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
57390119 76078 0 None 9 5 Pig 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 969 33 2 14 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928127 76078 0 None 9 5 Pig 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 969 33 2 14 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
10603030 214242 0 None 47 3 Human 8.4 pKi = 8.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 565 7 3 4 4.5 N#Cc1cc(F)ccc1C1CCN(CCCNC(=O)C2=C(C(F)(F)F)NC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
CHEMBL94259 214242 0 None 47 3 Human 8.4 pKi = 8.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 565 7 3 4 4.5 N#Cc1cc(F)ccc1C1CCN(CCCNC(=O)C2=C(C(F)(F)F)NC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
44362633 128325 0 None 95 3 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 597 9 3 6 3.9 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCC(C)N2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL358590 128325 0 None 95 3 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 597 9 3 6 3.9 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCC(C)N2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
10674133 170199 0 None 32 2 Human 8.4 pKi = 8.4 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 546 9 2 7 2.9 CCOc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL419624 170199 0 None 32 2 Human 8.4 pKi = 8.4 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 546 9 2 7 2.9 CCOc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
44428848 99069 0 None -17 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 453 4 1 8 3.6 COc1cc2nc(N3CCN(C(=O)c4cccs4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242724 99069 0 None -17 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 453 4 1 8 3.6 COc1cc2nc(N3CCN(C(=O)c4cccs4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
134551 7146 27 None -3 21 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
271 7146 27 None -3 21 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
885 7146 27 None -3 21 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
CHEMBL1403281 7146 27 None -3 21 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
44431594 174189 0 None -1 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 532 9 1 8 3.8 COc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL429623 174189 0 None -1 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 532 9 1 8 3.8 COc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
136806211 214462 0 None 61 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 650 14 4 7 5.0 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCN)N1 10.1016/s0960-894x(99)00484-9
44328738 214462 0 None 61 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 650 14 4 7 5.0 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL95434 214462 0 None 61 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 650 14 4 7 5.0 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCN)N1 10.1016/s0960-894x(99)00484-9
9817640 106106 0 None 9 3 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 295 6 1 2 3.6 COc1ccc(CCNCC2CCc3ccccc3C2)cc1 10.1016/j.bmcl.2004.11.032
CHEMBL282214 106106 0 None 9 3 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 295 6 1 2 3.6 COc1ccc(CCNCC2CCc3ccccc3C2)cc1 10.1016/j.bmcl.2004.11.032
489 6933 28 None -4 12 Bovine 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
5640 6933 28 None -4 12 Bovine 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
CHEMBL420060 6933 28 None -4 12 Bovine 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
10841387 106394 0 None 91 6 Human 8.4 pKi = 8.4 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL284103 106394 0 None 91 6 Human 8.4 pKi = 8.4 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
10841387 106394 0 None 91 6 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL284103 106394 0 None 91 6 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
73453 36389 24 None -6 17 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
CHEMBL1385840 36389 24 None -6 17 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
136680384 214434 0 None 104 6 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
44328799 214434 0 None 104 6 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
CHEMBL95290 214434 0 None 104 6 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
44431602 151719 0 None -6 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 5.2 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL391035 151719 0 None -6 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 5.2 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857710 92395 0 None 10 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 518 8 1 5 5.4 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1 10.1016/j.bmcl.2007.04.098
CHEMBL228279 92395 0 None 10 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 518 8 1 5 5.4 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1 10.1016/j.bmcl.2007.04.098
10674791 44945 0 None 10 3 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 582 8 2 7 4.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1021/jm990200p
CHEMBL146163 44945 0 None 10 3 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 582 8 2 7 4.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1021/jm990200p
10674544 125569 0 None 331 3 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 568 6 2 7 3.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)C(=O)Oc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL342111 125569 0 None 331 3 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 568 6 2 7 3.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)C(=O)Oc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
44417713 19194 0 None 2 8 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1185884 19194 0 None 2 8 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL439346 19194 0 None 2 8 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
118716714 121786 0 None 1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 501 6 0 7 2.7 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(C)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342867 121786 0 None 1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 501 6 0 7 2.7 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(C)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
56837634 76081 0 None -10 5 Pig 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1041 38 2 15 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928130 76081 0 None -10 5 Pig 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1041 38 2 15 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
44362867 44421 0 None 165 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 658 8 2 5 6.9 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3cc(C)cc(C)c3)(c3cc(C)cc(C)c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL145719 44421 0 None 165 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 658 8 2 5 6.9 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3cc(C)cc(C)c3)(c3cc(C)cc(C)c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
2142 9870 58 None -2 37 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
4920903 9870 58 None -2 37 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
502 9870 58 None -2 37 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
5775 9870 58 None -2 37 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
CHEMBL597 9870 58 None -2 37 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
DB00692 9870 58 None -2 37 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
44312563 211699 2 None -3 7 Rat 8.3 pKi = 8.3 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligand
ChEMBL 401 7 1 8 1.0 COc1ccc(C)cc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1021/jm960069a
CHEMBL76168 211699 2 None -3 7 Rat 8.3 pKi = 8.3 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligand
ChEMBL 401 7 1 8 1.0 COc1ccc(C)cc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1021/jm960069a
463 8187 22 None 5 13 Human 8.3 pKi = 8.3 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
6918097 8187 22 None 5 13 Human 8.3 pKi = 8.3 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
837 8187 22 None 5 13 Human 8.3 pKi = 8.3 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
CHEMBL2051956 8187 22 None 5 13 Human 8.3 pKi = 8.3 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
DB14068 8187 22 None 5 13 Human 8.3 pKi = 8.3 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
44299835 205181 0 None 61 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL57691 205181 0 None 61 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
56961507 128220 0 None 1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 678 6 4 11 5.0 COc1cc2nc(N3CCN(C(=S)Nc4ccc(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c(C(=O)O)c4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
CHEMBL3582271 128220 0 None 1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 678 6 4 11 5.0 COc1cc2nc(N3CCN(C(=S)Nc4ccc(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c(C(=O)O)c4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
10554492 175346 0 None -1 3 Rat 8.3 pKi = 8.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 505 5 1 8 3.4 COC(=O)c1ccc2sc3c(=O)n(CCN4C[C@@H]5CCc6c(OC)cccc6[C@@H]5C4)c(=O)[nH]c3c2c1 10.1021/jm990567u
CHEMBL43573 175346 0 None -1 3 Rat 8.3 pKi = 8.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 505 5 1 8 3.4 COC(=O)c1ccc2sc3c(=O)n(CCN4C[C@@H]5CCc6c(OC)cccc6[C@@H]5C4)c(=O)[nH]c3c2c1 10.1021/jm990567u
44294569 108796 0 None -5 4 Human 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 447 7 1 8 2.5 COc1ccccc1N1CCN(CCn2nc(-c3ccccc3)c(C(C)=O)c(N)c2=O)CC1 10.1021/jm981006q
CHEMBL301726 108796 0 None -5 4 Human 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 447 7 1 8 2.5 COc1ccccc1N1CCN(CCn2nc(-c3ccccc3)c(C(C)=O)c(N)c2=O)CC1 10.1021/jm981006q
10532044 92058 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 629 12 2 10 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)OCCC#N)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
136901434 92058 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 629 12 2 10 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)OCCC#N)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL2260361 92058 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 629 12 2 10 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)OCCC#N)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
10603688 127924 0 None 645 3 Human 8.3 pKi = 8.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL357681 127924 0 None 645 3 Human 8.3 pKi = 8.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL151825 51149 0 None 109 3 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 629 12 2 10 4.8 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)N=C(C)/C(=C(/O)OCCC#N)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
136680386 214482 0 None 60 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 680 16 4 8 4.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1 10.1016/s0960-894x(99)00484-9
44328801 214482 0 None 60 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 680 16 4 8 4.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL95578 214482 0 None 60 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 680 16 4 8 4.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1 10.1016/s0960-894x(99)00484-9
44431555 95937 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 535 8 1 7 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL236617 95937 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 535 8 1 7 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857793 92433 0 None 7 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 548 7 1 4 5.9 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
CHEMBL228494 92433 0 None 7 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 548 7 1 4 5.9 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
44273916 105605 0 None 1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL278716 105605 0 None 1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
10603688 127924 0 None 645 3 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL357681 127924 0 None 645 3 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
10154 148907 59 None 58 4 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 327 2 2 5 2.9 COc1cc2c(cc1O)C[C@H]1c3c(cc(O)c(OC)c3-2)CCN1C 10.1021/np990433j
CHEMBL388342 148907 59 None 58 4 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 327 2 2 5 2.9 COc1cc2c(cc1O)C[C@H]1c3c(cc(O)c(OC)c3-2)CCN1C 10.1021/np990433j
44431618 93841 0 None 1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 488 8 1 7 3.3 COc1ccncc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL232607 93841 0 None 1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 488 8 1 7 3.3 COc1ccncc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
10627329 44217 0 None 8 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 595 7 2 6 4.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc(C(F)(F)F)c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145525 44217 0 None 8 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 595 7 2 6 4.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc(C(F)(F)F)c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10091187 85599 1 None -23 6 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 380 5 0 4 4.6 COc1cccc(C2CCC(N3CCN(c4ccccc4OC)CC3)CC2)c1 10.1021/jm010866v
CHEMBL2112779 85599 1 None -23 6 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 380 5 0 4 4.6 COc1cccc(C2CCC(N3CCN(c4ccccc4OC)CC3)CC2)c1 10.1021/jm010866v
10430183 212407 0 None -398 7 Human 7.4 pKi = 7.4 Binding
Binding affinity to human alpha 1A adrenergic receptor expressed in CHO cells assessed as inhibition constantBinding affinity to human alpha 1A adrenergic receptor expressed in CHO cells assessed as inhibition constant
ChEMBL 385 5 1 5 2.1 O=C(NCCN1CCN(c2cccc3c2OCCO3)CC1)c1ccc(F)cc1 10.1021/acs.jmedchem.2c00633
CHEMBL81728 212407 0 None -398 7 Human 7.4 pKi = 7.4 Binding
Binding affinity to human alpha 1A adrenergic receptor expressed in CHO cells assessed as inhibition constantBinding affinity to human alpha 1A adrenergic receptor expressed in CHO cells assessed as inhibition constant
ChEMBL 385 5 1 5 2.1 O=C(NCCN1CCN(c2cccc3c2OCCO3)CC1)c1ccc(F)cc1 10.1021/acs.jmedchem.2c00633
2398 7741 62 None -4 29 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
2801 7741 62 None -4 29 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
701 7741 62 None -4 29 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
CHEMBL415 7741 62 None -4 29 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
DB01242 7741 62 None -4 29 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
12134996 210866 0 None -1 2 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 385 6 0 5 3.2 COc1ccccc1N1CCN(Cc2ccc(CN3CCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL70178 210866 0 None -1 2 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 385 6 0 5 3.2 COc1ccccc1N1CCN(Cc2ccc(CN3CCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
11520239 10404 11 None -144 4 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 613 10 3 7 4.0 COCC1=C(C(=O)OC)[C@@H](N(C(=O)N1)C(=O)NCCCN1CCC(CC1)c1cccc(c1)NC(=O)C)c1ccc(c(c1)F)F 10.1021/jm060383x
1313 10404 11 None -144 4 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 613 10 3 7 4.0 COCC1=C(C(=O)OC)[C@@H](N(C(=O)N1)C(=O)NCCCN1CCC(CC1)c1cccc(c1)NC(=O)C)c1ccc(c(c1)F)F 10.1021/jm060383x
CHEMBL185271 10404 11 None -144 4 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 613 10 3 7 4.0 COCC1=C(C(=O)OC)[C@@H](N(C(=O)N1)C(=O)NCCCN1CCC(CC1)c1cccc(c1)NC(=O)C)c1ccc(c(c1)F)F 10.1021/jm060383x
49865641 22807 0 None -3 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 338 7 1 4 3.7 Cc1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1C 10.1016/j.bmcl.2010.07.096
CHEMBL1223682 22807 0 None -3 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 338 7 1 4 3.7 Cc1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1C 10.1016/j.bmcl.2010.07.096
10320782 106753 0 None -4 7 Rat 7.4 pKi = 7.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@H]1Oc2ccccc2O[C@@H]1c1ccc(C)cc1 10.1021/jm960069a
CHEMBL286565 106753 0 None -4 7 Rat 7.4 pKi = 7.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@H]1Oc2ccccc2O[C@@H]1c1ccc(C)cc1 10.1021/jm960069a
46934645 23459 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 7 2.2 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242725 23459 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 7 2.2 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
15166842 105636 23 None - 1 Bovine 5.4 pKi = 5.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 160 1 1 2 1.5 C1=C(c2ccccn2)CCNC1 10.1021/jm00375a017
CHEMBL278934 105636 23 None - 1 Bovine 5.4 pKi = 5.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 160 1 1 2 1.5 C1=C(c2ccccn2)CCNC1 10.1021/jm00375a017
9823115 205382 0 None -2041 5 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 414 4 0 5 3.0 N#Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL57868 205382 0 None -2041 5 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 414 4 0 5 3.0 N#Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
76311538 91603 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 299 6 1 4 2.8 c1ccc(OCCN[C@H]2COC[C@H](c3ccccc3)O2)cc1 10.1007/s00044-010-9379-1
CHEMBL2234453 91603 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 299 6 1 4 2.8 c1ccc(OCCN[C@H]2COC[C@H](c3ccccc3)O2)cc1 10.1007/s00044-010-9379-1
9823115 205382 0 None -2041 5 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 414 4 0 5 3.0 N#Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL57868 205382 0 None -2041 5 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 414 4 0 5 3.0 N#Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
25132565 194050 0 None -7 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 313 7 1 4 2.8 c1ccc(OCCNC[C@@H]2COC[C@@H](c3ccccc3)O2)cc1 10.1021/jm800461k
CHEMBL492785 194050 0 None -7 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 313 7 1 4 2.8 c1ccc(OCCNC[C@@H]2COC[C@@H](c3ccccc3)O2)cc1 10.1021/jm800461k
22629308 71081 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 425 3 2 5 3.6 N=C(Nc1ccccc1)N1CCN(/C=C2/N=C(c3cccc4ccccc34)OC2=O)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL181071 71081 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 425 3 2 5 3.6 N=C(Nc1ccccc1)N1CCN(/C=C2/N=C(c3cccc4ccccc34)OC2=O)CC1 10.1016/j.bmcl.2004.11.032
9865254 75450 0 None -512 5 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)c(F)c2)CC1 10.1021/jm0491391
CHEMBL192099 75450 0 None -512 5 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)c(F)c2)CC1 10.1021/jm0491391
11948707 172946 0 None -128 13 Human 6.4 pKi = 6.4 Binding
Binding affinity to alpha 1A adrenergic receptor by radioligand binding assayBinding affinity to alpha 1A adrenergic receptor by radioligand binding assay
ChEMBL 373 7 0 8 0.6 COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1 10.1016/j.bmcl.2006.01.052
CHEMBL426317 172946 0 None -128 13 Human 6.4 pKi = 6.4 Binding
Binding affinity to alpha 1A adrenergic receptor by radioligand binding assayBinding affinity to alpha 1A adrenergic receptor by radioligand binding assay
ChEMBL 373 7 0 8 0.6 COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1 10.1016/j.bmcl.2006.01.052
11395842 107467 0 None -21 3 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 412 7 0 4 4.0 CN(CCOc1cc(Cl)ccc1Cl)CCN1C(=O)CC2(CCCC2)CC1=O 10.1021/jm030944+
CHEMBL292399 107467 0 None -21 3 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 412 7 0 4 4.0 CN(CCOc1cc(Cl)ccc1Cl)CCN1C(=O)CC2(CCCC2)CC1=O 10.1021/jm030944+
11058166 211484 0 None -1 5 Human 6.4 pKi = 6.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74114 211484 0 None -1 5 Human 6.4 pKi = 6.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1 10.1021/jm000542r
52942591 24384 0 None 4 3 Rat 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 542 9 1 7 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL1258228 24384 0 None 4 3 Rat 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 542 9 1 7 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
12039032 105038 0 None 14 3 Human 6.4 pKi = 6.4 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 415 9 0 6 2.1 CC(C)Oc1ccccc1N1CCN(CC(=O)CC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL274529 105038 0 None 14 3 Human 6.4 pKi = 6.4 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 415 9 0 6 2.1 CC(C)Oc1ccccc1N1CCN(CC(=O)CC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
127025279 144433 0 None -3 2 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 347 9 1 4 2.8 COc1ccccc1N1CCN(CCCCNC(=O)CC(C)C)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3758403 144433 0 None -3 2 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 347 9 1 4 2.8 COc1ccccc1N1CCN(CCCCNC(=O)CC(C)C)CC1 10.1016/j.bmcl.2015.12.068
44308654 210363 0 None -3 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 401 6 1 6 3.4 COc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL66823 210363 0 None -3 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 401 6 1 6 3.4 COc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3O)s2)CC1 10.1016/s0960-894x(02)00347-5
9822814 108726 0 None -346 5 Human 7.4 pKi = 7.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL301224 108726 0 None -346 5 Human 7.4 pKi = 7.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1016/j.bmcl.2004.11.032
11589069 103022 0 None -25 8 Human 7.4 pKi = 7.4 Binding
Inhibition of adrenergic alpha-1 receptorInhibition of adrenergic alpha-1 receptor
ChEMBL 383 6 1 3 4.4 O=C1Nc2ccccc2C1CCCCN1CCN(c2ccc(Cl)cc2)CC1 10.1021/jm070279v
CHEMBL260994 103022 0 None -25 8 Human 7.4 pKi = 7.4 Binding
Inhibition of adrenergic alpha-1 receptorInhibition of adrenergic alpha-1 receptor
ChEMBL 383 6 1 3 4.4 O=C1Nc2ccccc2C1CCCCN1CCN(c2ccc(Cl)cc2)CC1 10.1021/jm070279v
9822814 108726 0 None -389 5 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL301224 108726 0 None -389 5 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
2419 7482 28 None -288 11 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2011.03.054
9 7482 28 None -288 11 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2011.03.054
CHEMBL13647 7482 28 None -288 11 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2011.03.054
506 9032 39 None -81 6 Human 6.4 pKi = 6.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1016/j.bmcl.2004.11.032
6603904 9032 39 None -81 6 Human 6.4 pKi = 6.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1016/j.bmcl.2004.11.032
CHEMBL19476 9032 39 None -81 6 Human 6.4 pKi = 6.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1016/j.bmcl.2004.11.032
506 9032 39 None -81 6 Human 6.4 pKi = 6.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
6603904 9032 39 None -81 6 Human 6.4 pKi = 6.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
CHEMBL19476 9032 39 None -81 6 Human 6.4 pKi = 6.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
11315660 174767 0 None -144 4 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCCC2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm030944+
CHEMBL431943 174767 0 None -144 4 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCCC2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm030944+
155529118 183343 0 None -37 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.2 c1ccc(OCCNC[C@@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4462768 183343 0 None -37 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.2 c1ccc(OCCNC[C@@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4597358 183343 0 None -37 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.2 c1ccc(OCCNC[C@@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
44420418 90205 0 None -13 3 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 474 4 1 6 4.0 O=c1[nH]c2c(sc3ccccc32)c(=O)n1CCN1CCN(c2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL219718 90205 0 None -13 3 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 474 4 1 6 4.0 O=c1[nH]c2c(sc3ccccc32)c(=O)n1CCN1CCN(c2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2006.09.034
135 9310 43 None -9 56 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
1796 9310 43 None -9 56 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
4184 9310 43 None -9 56 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
CHEMBL6437 9310 43 None -9 56 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
DB06148 9310 43 None -9 56 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
11857864 151027 0 None 1 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4cc(F)ccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL390473 151027 0 None 1 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4cc(F)ccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
2419 7482 28 None -52 11 Bovine 7.4 pKi = 7.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
9 7482 28 None -52 11 Bovine 7.4 pKi = 7.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
CHEMBL13647 7482 28 None -52 11 Bovine 7.4 pKi = 7.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
3158 63041 27 None -295 20 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
CHEMBL1628227 63041 27 None -295 20 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
DB01142 63041 27 None -295 20 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
135 9310 43 None -9 56 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00375a017
1796 9310 43 None -9 56 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00375a017
4184 9310 43 None -9 56 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00375a017
CHEMBL6437 9310 43 None -9 56 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00375a017
DB06148 9310 43 None -9 56 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00375a017
11372228 108444 0 None -51 5 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 373 4 0 3 3.8 O=C1CC2(C=CN1CCN1CCN(c3ccccc3Cl)CC1)CCCC2 10.1007/s00044-010-9379-1
CHEMBL299253 108444 0 None -51 5 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 373 4 0 3 3.8 O=C1CC2(C=CN1CCN1CCN(c3ccccc3Cl)CC1)CCCC2 10.1007/s00044-010-9379-1
11108001 17644 2 None -3 6 Human 7.4 pKi = 7.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL117248 17644 2 None -3 6 Human 7.4 pKi = 7.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540542 17644 2 None -3 6 Human 7.4 pKi = 7.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
11000184 19824 0 None 1 6 Human 7.4 pKi = 7.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1190038 19824 0 None 1 6 Human 7.4 pKi = 7.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540035 19824 0 None 1 6 Human 7.4 pKi = 7.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
11372228 108444 0 None -51 5 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 373 4 0 3 3.8 O=C1CC2(C=CN1CCN1CCN(c3ccccc3Cl)CC1)CCCC2 10.1007/s00044-010-9379-1
CHEMBL299253 108444 0 None -51 5 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 373 4 0 3 3.8 O=C1CC2(C=CN1CCN1CCN(c3ccccc3Cl)CC1)CCCC2 10.1007/s00044-010-9379-1
9802999 202453 0 None -2 3 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 434 5 0 6 3.1 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc([N+](=O)[O-])ccc2Cl)CC1 10.1021/jm030944+
CHEMBL55655 202453 0 None -2 3 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 434 5 0 6 3.1 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc([N+](=O)[O-])ccc2Cl)CC1 10.1021/jm030944+
197001 70121 20 None - 1 Human 6.4 pKi = 6.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1C[C@@H]3N(C)CC2)OCO4 10.1016/j.bmcl.2004.11.032
CHEMBL179440 70121 20 None - 1 Human 6.4 pKi = 6.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1C[C@@H]3N(C)CC2)OCO4 10.1016/j.bmcl.2004.11.032
10840781 43707 0 None 3 3 Human 6.4 pKi = 6.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 569 8 2 7 3.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(C(C)=O)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145122 43707 0 None 3 3 Human 6.4 pKi = 6.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 569 8 2 7 3.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(C(C)=O)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
44292470 108412 5 None -57 2 Bovine 5.4 pKi = 5.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 211 1 1 3 1.5 Cc1ccnc(N2CCNCC2)c1Cl 10.1021/jm00366a007
CHEMBL299007 108412 5 None -57 2 Bovine 5.4 pKi = 5.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 211 1 1 3 1.5 Cc1ccnc(N2CCNCC2)c1Cl 10.1021/jm00366a007
10646816 50155 0 None 7 3 Human 5.4 pKi = 5.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 441 8 3 6 2.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCCCC2)=C(C)N1 10.1021/jm980506g
CHEMBL150743 50155 0 None 7 3 Human 5.4 pKi = 5.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 441 8 3 6 2.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCCCC2)=C(C)N1 10.1021/jm980506g
2419 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm9810654
9 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm9810654
CHEMBL13647 7482 28 None -288 11 Human 6.4 pKi = 6.4 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm9810654
71817857 98900 0 None 3 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419766 98900 0 None 3 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm400867d
25130876 199404 0 None -125 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1CO[C@H](c2ccccc2)CO1 10.1021/jm800461k
CHEMBL521665 199404 0 None -125 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1CO[C@H](c2ccccc2)CO1 10.1021/jm800461k
10236758 122550 5 None -446 13 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 328 7 0 2 4.3 CCCCC1CCN(CCCN2C(=O)CCc3ccccc32)CC1 10.1021/acs.jmedchem.8b00265
CHEMBL3354065 122550 5 None -446 13 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 328 7 0 2 4.3 CCCCC1CCN(CCCN2C(=O)CCc3ccccc32)CC1 10.1021/acs.jmedchem.8b00265
71521480 93036 0 None -1096 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm301525w
CHEMBL2312538 93036 0 None -1096 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm301525w
44462130 212111 0 None 45 3 Human 7.4 pKi = 7.4 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 490 7 0 6 3.5 COC(=O)C1(c2ccccc2)CCN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00451-x
CHEMBL79532 212111 0 None 45 3 Human 7.4 pKi = 7.4 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 490 7 0 6 3.5 COC(=O)C1(c2ccccc2)CCN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00451-x
13141185 67262 0 None 9 2 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 356 0 0 2 4.3 CN1CCC(=C2c3cc(Br)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL175508 67262 0 None 9 2 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 356 0 0 2 4.3 CN1CCC(=C2c3cc(Br)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
155533100 183123 0 None -6 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 377 11 1 4 4.5 COc1ccccc1OCCNCCOC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
CHEMBL4468507 183123 0 None -6 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 377 11 1 4 4.5 COc1ccccc1OCCNCCOC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
CHEMBL4595564 183123 0 None -6 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 377 11 1 4 4.5 COc1ccccc1OCCNCCOC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
56945167 78290 0 None -56 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 442 6 1 4 4.6 COc1ccccc1N1CCN(C[C@H]2CCC(c3ccccc3)(c3ccccc3)[C@@H]2O)CC1 10.1021/jm200421e
CHEMBL1946788 78290 0 None -56 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 442 6 1 4 4.6 COc1ccccc1N1CCN(C[C@H]2CCC(c3ccccc3)(c3ccccc3)[C@@H]2O)CC1 10.1021/jm200421e
CHEMBL1962757 78290 0 None -56 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 442 6 1 4 4.6 COc1ccccc1N1CCN(C[C@H]2CCC(c3ccccc3)(c3ccccc3)[C@@H]2O)CC1 10.1021/jm200421e
12488 8438 56 None -77 23 Rat 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
941361 8438 56 None -77 23 Rat 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
CHEMBL30008 8438 56 None -77 23 Rat 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
DB04841 8438 56 None -77 23 Rat 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
9931327 76585 1 None -2290 5 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 409 4 0 4 2.9 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)c(F)cc2F)CC1 10.1021/jm0491391
CHEMBL193620 76585 1 None -2290 5 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 409 4 0 4 2.9 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)c(F)cc2F)CC1 10.1021/jm0491391
136 10065 32 None -6918 16 Human 5.4 pKi = 5.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
223 10065 32 None -6918 16 Human 5.4 pKi = 5.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
643606 10065 32 None -6918 16 Human 5.4 pKi = 5.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
CHEMBL10347 10065 32 None -6918 16 Human 5.4 pKi = 5.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
1960 9632 67 None -10 26 Bovine 6.4 pKi = 6.4 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
439260 9632 67 None -10 26 Bovine 6.4 pKi = 6.4 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
505 9632 67 None -10 26 Bovine 6.4 pKi = 6.4 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
CHEMBL1437 9632 67 None -10 26 Bovine 6.4 pKi = 6.4 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
DB00368 9632 67 None -10 26 Bovine 6.4 pKi = 6.4 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
9905391 116263 0 None 6 2 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1ccc(Cl)c2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL322082 116263 0 None 6 2 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1ccc(Cl)c2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
123981 23231 22 None -245 8 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 10.1021/jm00019a001
CHEMBL123349 23231 22 None -245 8 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 10.1021/jm00019a001
CHEMBL536803 23231 22 None -245 8 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 10.1021/jm00019a001
11740041 213338 0 None -8 2 Rat 7.4 pKi = 7.4 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 372 7 0 5 2.7 COc1ccccc1N1CCN(CCCCN2CC3CCCCN3C2)CC1 10.1021/jm970216k
CHEMBL88715 213338 0 None -8 2 Rat 7.4 pKi = 7.4 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 372 7 0 5 2.7 COc1ccccc1N1CCN(CCCCN2CC3CCCCN3C2)CC1 10.1021/jm970216k
44431612 155643 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cc(Cl)ccc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL394139 155643 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cc(Cl)ccc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
36811 8236 37 None -2 7 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
535 8236 37 None -2 7 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
937 8236 37 None -2 7 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
CHEMBL926 8236 37 None -2 7 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
DB00841 8236 37 None -2 7 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
44330880 214930 0 None 1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 371 3 0 3 4.6 O=C1OC2(CCN(CCc3cccc4ccccc34)CC2)Cc2ccccc21 10.1016/s0960-894x(98)00732-x
CHEMBL98168 214930 0 None 1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 371 3 0 3 4.6 O=C1OC2(CCN(CCc3cccc4ccccc34)CC2)Cc2ccccc21 10.1016/s0960-894x(98)00732-x
10132012 116522 0 None 7 2 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 339 4 2 3 3.3 CCS(=O)(=O)Nc1cc(Cl)cc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL323004 116522 0 None 7 2 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 339 4 2 3 3.3 CCS(=O)(=O)Nc1cc(Cl)cc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
136806214 214908 0 None 60 3 Human 6.3 pKi = 6.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 633 15 4 9 2.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(CN(C)C)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
44329028 214908 0 None 60 3 Human 6.3 pKi = 6.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 633 15 4 9 2.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(CN(C)C)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL98038 214908 0 None 60 3 Human 6.3 pKi = 6.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 633 15 4 9 2.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(CN(C)C)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
10916464 210932 0 None 1 5 Human 6.3 pKi = 6.3 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70563 210932 0 None 1 5 Human 6.3 pKi = 6.3 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1 10.1021/jm000542r
11312410 15674 0 None 9 3 Rat 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 293 3 2 4 1.5 CS(=O)(=O)Nc1cccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL109755 15674 0 None 9 3 Rat 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 293 3 2 4 1.5 CS(=O)(=O)Nc1cccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
11312410 15674 0 None 9 3 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 293 3 2 4 1.5 CS(=O)(=O)Nc1cccc2c1CCCC2C1=NCCN1 10.1021/jm030551a
CHEMBL109755 15674 0 None 9 3 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 293 3 2 4 1.5 CS(=O)(=O)Nc1cccc2c1CCCC2C1=NCCN1 10.1021/jm030551a
11511026 22808 0 None -75 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.6 Clc1cccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
CHEMBL1223683 22808 0 None -75 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.6 Clc1cccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
127024958 144423 0 None -3 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 403 7 2 4 3.9 O=C(NCCCCN1CCN(c2ccccc2O)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3758330 144423 0 None -3 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 403 7 2 4 3.9 O=C(NCCCCN1CCN(c2ccccc2O)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
76326541 92116 0 None 28 4 Rat 7.3 pKi = 7.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCC[C@H]2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL2261355 92116 0 None 28 4 Rat 7.3 pKi = 7.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCC[C@H]2c1c[nH]cn1 10.1007/s00044-004-0020-z
53328311 70159 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 421 7 0 5 3.1 COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796030 70159 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 421 7 0 5 3.1 COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
9926529 16161 2 None 1 5 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111496 16161 2 None 1 5 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
10698608 50101 0 None 40 3 Human 6.3 pKi = 6.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 10 3 7 2.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)N(C)C)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL150696 50101 0 None 40 3 Human 6.3 pKi = 6.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 10 3 7 2.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)N(C)C)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
76318764 91604 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 359 8 1 6 2.8 COc1cccc(OC)c1OCCN[C@H]1COC[C@H](c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL2234454 91604 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 359 8 1 6 2.8 COc1cccc(OC)c1OCCN[C@H]1COC[C@H](c2ccccc2)O1 10.1007/s00044-010-9379-1
25131192 194104 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 373 9 1 6 2.8 COc1cccc(OC)c1OCCNC[C@@H]1COC[C@H](c2ccccc2)O1 10.1021/jm800461k
CHEMBL493043 194104 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 373 9 1 6 2.8 COc1cccc(OC)c1OCCNC[C@@H]1COC[C@H](c2ccccc2)O1 10.1021/jm800461k
213 10625 55 None -4 43 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
2717 10625 55 None -4 43 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
5533 10625 55 None -4 43 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
CHEMBL621 10625 55 None -4 43 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
DB00656 10625 55 None -4 43 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
44288754 177295 0 None 36 3 Human 7.3 pKi = 7.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 9 1 6 3.4 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(C)c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL44496 177295 0 None 36 3 Human 7.3 pKi = 7.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 9 1 6 3.4 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(C)c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
53328312 70160 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 425 6 0 4 3.8 O=C1CC(c2ccccc2)CC(=O)N1CCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796031 70160 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 425 6 0 4 3.8 O=C1CC(c2ccccc2)CC(=O)N1CCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
118567543 178147 0 None -4 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-prazosin from human alpha1A adrenoreceptor expressed in enriched membranes incubated for 90 mins by liquid scintillation counting methodDisplacement of [3H]-prazosin from human alpha1A adrenoreceptor expressed in enriched membranes incubated for 90 mins by liquid scintillation counting method
ChEMBL 463 4 0 4 4.2 O=C1N(c2cccnc2C(F)(F)F)CC2(CCN(CCc3ccccc3F)CC2)OC12CC2 10.1021/acs.jmedchem.9b01256
CHEMBL4461774 178147 0 None -4 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-prazosin from human alpha1A adrenoreceptor expressed in enriched membranes incubated for 90 mins by liquid scintillation counting methodDisplacement of [3H]-prazosin from human alpha1A adrenoreceptor expressed in enriched membranes incubated for 90 mins by liquid scintillation counting method
ChEMBL 463 4 0 4 4.2 O=C1N(c2cccnc2C(F)(F)F)CC2(CCN(CCc3ccccc3F)CC2)OC12CC2 10.1021/acs.jmedchem.9b01256
71450550 90582 0 None 1 16 Human 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenergicBinding affinity to alpha1A adrenergic
ChEMBL 309 4 1 3 2.0 COc1ccccc1CCN1C2C3C4CC5C6C4C2C6C1(O)C53 10.1016/j.bmcl.2012.08.046
CHEMBL2205836 90582 0 None 1 16 Human 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenergicBinding affinity to alpha1A adrenergic
ChEMBL 309 4 1 3 2.0 COc1ccccc1CCN1C2C3C4CC5C6C4C2C6C1(O)C53 10.1016/j.bmcl.2012.08.046
72457 109051 14 None -4 2 Human 5.3 pKi = 5.3 Binding
Compound was tested for its binding affinity towards Rat-1 cells stably expressing hamster alpha-1b adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards Rat-1 cells stably expressing hamster alpha-1b adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 342 3 4 3 4.0 O=C(c1nc(-c2c[nH]c3ccccc23)c[nH]1)c1c[nH]c2cc(O)ccc12 10.1016/0960-894X(96)00376-9
CHEMBL303282 109051 14 None -4 2 Human 5.3 pKi = 5.3 Binding
Compound was tested for its binding affinity towards Rat-1 cells stably expressing hamster alpha-1b adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards Rat-1 cells stably expressing hamster alpha-1b adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 342 3 4 3 4.0 O=C(c1nc(-c2c[nH]c3ccccc23)c[nH]1)c1c[nH]c2cc(O)ccc12 10.1016/0960-894X(96)00376-9
9814617 16106 0 None 2 2 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 293 3 2 4 1.7 CS(=O)(=O)Nc1cccc2c1OCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111151 16106 0 None 2 2 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 293 3 2 4 1.7 CS(=O)(=O)Nc1cccc2c1OCCC2c1c[nH]cn1 10.1021/jm030551a
9958160 205633 0 None -31 4 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 515 4 0 4 3.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(I)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL58384 205633 0 None -31 4 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 515 4 0 4 3.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(I)ccc2Cl)CC1 10.1021/jm030944+
16041263 102222 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL257098 102222 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
53328506 70169 0 None 1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 459 6 0 4 4.4 O=C1CC(c2ccc(Cl)cc2)CC(=O)N1CCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796040 70169 0 None 1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 459 6 0 4 4.4 O=C1CC(c2ccc(Cl)cc2)CC(=O)N1CCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
44428850 99070 0 None -8 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 448 4 1 8 2.9 COc1cc2nc(N3CCN(C(=O)c4ccccn4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242725 99070 0 None -8 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 448 4 1 8 2.9 COc1cc2nc(N3CCN(C(=O)c4ccccn4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
46881444 14387 0 None -6 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 403 9 1 4 4.5 COc1ccccc1CCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1088072 14387 0 None -6 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 403 9 1 4 4.5 COc1ccccc1CCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
118716703 121774 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 347 4 1 6 1.3 COc1ccccc1N1CCN(CC2COC3(CCNCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342856 121774 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 347 4 1 6 1.3 COc1ccccc1N1CCN(CC2COC3(CCNCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44414173 19661 0 None -7 2 Rat 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 5 0 3 4.2 Cn1cc(C2CCN(CCCN3CCCCC3)CC2)c2ccccc21 10.1016/j.bmcl.2006.05.002
CHEMBL1188901 19661 0 None -7 2 Rat 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 5 0 3 4.2 Cn1cc(C2CCN(CCCN3CCCCC3)CC2)c2ccccc21 10.1016/j.bmcl.2006.05.002
CHEMBL537650 19661 0 None -7 2 Rat 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 5 0 3 4.2 Cn1cc(C2CCN(CCCN3CCCCC3)CC2)c2ccccc21 10.1016/j.bmcl.2006.05.002
21670271 72013 3 None - 1 Bovine 5.3 pKi = 5.3 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 174 1 0 2 1.8 CN1CC=C(c2cccnc2)CC1 10.1021/jm00375a017
CHEMBL18270 72013 3 None - 1 Bovine 5.3 pKi = 5.3 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 174 1 0 2 1.8 CN1CC=C(c2cccnc2)CC1 10.1021/jm00375a017
46846073 12572 0 None -223 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 451 9 1 4 5.6 c1ccc(-c2ccccc2OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.bmcl.2010.01.030
CHEMBL1078772 12572 0 None -223 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 451 9 1 4 5.6 c1ccc(-c2ccccc2OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.bmcl.2010.01.030
240 7731 43 None -4 25 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
2769 7731 43 None -4 25 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
44279790 7731 43 None -4 25 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
660 7731 43 None -4 25 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL1729 7731 43 None -4 25 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL560739 7731 43 None -4 25 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
DB00604 7731 43 None -4 25 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
13298530 105848 20 None -97 2 Bovine 6.3 pKi = 6.3 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 195 1 0 3 1.0 CN1CCN(c2ncccc2F)CC1 10.1021/jm00366a007
CHEMBL280514 105848 20 None -97 2 Bovine 6.3 pKi = 6.3 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 195 1 0 3 1.0 CN1CCN(c2ncccc2F)CC1 10.1021/jm00366a007
6603710 130725 10 None - 1 Human 6.3 pKi = 6.3 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 345 5 2 3 3.9 CCS(=O)(=O)Nc1cccc(C(=C2CCCCC2)c2c[nH]cn2)c1 10.1016/j.bmcl.2004.11.032
CHEMBL362863 130725 10 None - 1 Human 6.3 pKi = 6.3 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 345 5 2 3 3.9 CCS(=O)(=O)Nc1cccc(C(=C2CCCCC2)c2c[nH]cn2)c1 10.1016/j.bmcl.2004.11.032
13298530 105848 20 None -97 2 Bovine 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 195 1 0 3 1.0 CN1CCN(c2ncccc2F)CC1 10.1021/jm00375a017
CHEMBL280514 105848 20 None -97 2 Bovine 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 195 1 0 3 1.0 CN1CCN(c2ncccc2F)CC1 10.1021/jm00375a017
4735 201894 96 None -77 10 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
CHEMBL361506 201894 96 None -77 10 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
CHEMBL55 201894 96 None -77 10 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
2419 7482 28 None -288 11 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm030944+
9 7482 28 None -288 11 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm030944+
CHEMBL13647 7482 28 None -288 11 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm030944+
19085827 111640 0 None 3 3 Human 6.3 pKi = 6.3 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 485 7 0 8 2.9 COc1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL311014 111640 0 None 3 3 Human 6.3 pKi = 6.3 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 485 7 0 8 2.9 COc1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00446-6
44571938 186852 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 300 3 1 3 3.0 Fc1ccn(Cc2c(F)ccc3c2CC[C@H]3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
CHEMBL474796 186852 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 300 3 1 3 3.0 Fc1ccn(Cc2c(F)ccc3c2CC[C@H]3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
44431617 95117 0 None 3 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 458 7 1 6 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234854 95117 0 None 3 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 458 7 1 6 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44390740 129716 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 478 7 3 7 0.9 C[C@@]1(O)C(=O)N(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)C(=O)N[C@@H]1O 10.1016/j.bmcl.2004.11.032
CHEMBL360688 129716 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 478 7 3 7 0.9 C[C@@]1(O)C(=O)N(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)C(=O)N[C@@H]1O 10.1016/j.bmcl.2004.11.032
3033677 209723 40 None -25 9 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]-WB4101 from rat forebrain alpha 1 adrenergic receptorsDisplacement of [3H]-WB4101 from rat forebrain alpha 1 adrenergic receptors
ChEMBL 411 5 1 5 3.8 O=C(c1ccc(F)cc1)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL2355519 209723 40 None -25 9 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]-WB4101 from rat forebrain alpha 1 adrenergic receptorsDisplacement of [3H]-WB4101 from rat forebrain alpha 1 adrenergic receptors
ChEMBL 411 5 1 5 3.8 O=C(c1ccc(F)cc1)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL62919 209723 40 None -25 9 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]-WB4101 from rat forebrain alpha 1 adrenergic receptorsDisplacement of [3H]-WB4101 from rat forebrain alpha 1 adrenergic receptors
ChEMBL 411 5 1 5 3.8 O=C(c1ccc(F)cc1)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1 10.1021/acs.jmedchem.2c00633
127025276 144505 0 None -3 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 416 8 2 4 4.1 COc1ccccc1N1CCN(CCCCNC(=O)Nc2cccc(Cl)c2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3758991 144505 0 None -3 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 416 8 2 4 4.1 COc1ccccc1N1CCN(CCCCNC(=O)Nc2cccc(Cl)c2)CC1 10.1016/j.bmcl.2015.12.068
10579632 42359 0 None 5 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 611 9 2 7 5.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL143940 42359 0 None 5 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 611 9 2 7 5.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
52944674 23894 0 None 2 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 395 11 3 6 3.7 Oc1cccc(O)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1255085 23894 0 None 2 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 395 11 3 6 3.7 Oc1cccc(O)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
134150497 158871 0 None -1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 324 6 0 3 3.8 CC(C)Oc1ccccc1N1CCN(CCc2ccccc2)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3967641 158871 0 None -1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 324 6 0 3 3.8 CC(C)Oc1ccccc1N1CCN(CCc2ccccc2)CC1 10.1016/j.ejmech.2016.06.052
44298780 203327 0 None 25 3 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 478 7 3 7 0.9 C[C@]1(O)C(=O)N(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)C(=O)N[C@H]1O 10.1016/s0960-894x(03)00305-6
CHEMBL56375 203327 0 None 25 3 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 478 7 3 7 0.9 C[C@]1(O)C(=O)N(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)C(=O)N[C@H]1O 10.1016/s0960-894x(03)00305-6
44329026 215204 0 None 19 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 679 16 3 7 6.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCOC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL99864 215204 0 None 19 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 679 16 3 7 6.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCOC)N1 10.1016/s0960-894x(99)00484-9
16041264 102218 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cccc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL257077 102218 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cccc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
2894 214850 6 None -12 6 Bovine 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)C4CCCCC43)nc(N)c2cc1OC 10.1021/jm020938y
CHEMBL97698 214850 6 None -12 6 Bovine 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)C4CCCCC43)nc(N)c2cc1OC 10.1021/jm020938y
44288485 169299 0 None 29 3 Human 8.3 pKi = 8.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 498 9 1 4 5.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL41677 169299 0 None 29 3 Human 8.3 pKi = 8.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 498 9 1 4 5.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1 10.1016/s0960-894x(00)00307-3
10746137 43728 0 None 138 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 599 9 2 7 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3F)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL145134 43728 0 None 138 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 599 9 2 7 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3F)CC2)C(=O)N1 10.1021/jm990201h
90645595 119264 0 None -4 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 611 11 2 8 5.1 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298748 119264 0 None -4 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 611 11 2 8 5.1 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
118716717 121789 0 None 1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 532 7 0 9 2.3 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc([N+](=O)[O-])cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342870 121789 0 None 1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 532 7 0 9 2.3 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc([N+](=O)[O-])cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44404321 77067 0 None -1 2 Human 8.3 pKi = 8.3 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 297 4 1 5 3.0 COc1cccc(N(NC2=NCCO2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
CHEMBL194323 77067 0 None -1 2 Human 8.3 pKi = 8.3 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 297 4 1 5 3.0 COc1cccc(N(NC2=NCCO2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
44404326 140302 0 None -1 2 Human 8.3 pKi = 8.3 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 283 3 2 5 2.7 Cc1ccc(N(NC2=NCCO2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
CHEMBL370818 140302 0 None -1 2 Human 8.3 pKi = 8.3 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 283 3 2 5 2.7 Cc1ccc(N(NC2=NCCO2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
44447018 101639 0 None -131 4 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 496 7 1 5 5.0 O=C(Cc1ccccc1)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL253878 101639 0 None -131 4 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 496 7 1 5 5.0 O=C(Cc1ccccc1)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
44288468 175160 0 None 1 3 Rat 8.3 pKi = 8.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1C1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC1CC2 10.1021/jm990567u
CHEMBL434591 175160 0 None 1 3 Rat 8.3 pKi = 8.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1C1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC1CC2 10.1021/jm990567u
16041630 104323 0 None -2 4 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(F)cccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL270589 104323 0 None -2 4 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(F)cccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
44289525 172774 0 None -5 9 Rat 8.3 pKi = 8.3 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNCC1Oc2ccccc2OC1c1ccc(C)cc1 10.1021/jm960069a
CHEMBL42539 172774 0 None -5 9 Rat 8.3 pKi = 8.3 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNCC1Oc2ccccc2OC1c1ccc(C)cc1 10.1021/jm960069a
44426405 148831 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc(OC(F)F)cc1 10.1016/j.bmcl.2007.04.098
CHEMBL387832 148831 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc(OC(F)F)cc1 10.1016/j.bmcl.2007.04.098
10746433 127861 0 None 295 3 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 619 13 3 9 3.0 COCCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL357061 127861 0 None 295 3 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 619 13 3 9 3.0 COCCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
69781970 168130 0 None -14 5 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4125981 168130 0 None -14 5 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
132266 8061 12 None -28 9 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm8016046
486 8061 12 None -28 9 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm8016046
CHEMBL423294 8061 12 None -28 9 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm8016046
180 7189 56 None -10 40 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
200 7189 56 None -10 40 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
2160 7189 56 None -10 40 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
CHEMBL629 7189 56 None -10 40 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
DB00321 7189 56 None -10 40 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
44431554 95118 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234874 95118 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431547 161383 0 None -2 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL399195 161383 0 None -2 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
11994667 18603 0 None 1 6 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1ccc(-c2ccccc2)cc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182143 18603 0 None 1 6 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1ccc(-c2ccccc2)cc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214694 18603 0 None 1 6 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1ccc(-c2ccccc2)cc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
71458492 91344 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153556 91344 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220896 91344 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
44447012 101574 0 None -56 4 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 516 6 1 5 5.7 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccc(Cl)cc1 10.1016/j.bmcl.2007.11.106
CHEMBL253439 101574 0 None -56 4 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 516 6 1 5 5.7 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccc(Cl)cc1 10.1016/j.bmcl.2007.11.106
10575494 172526 0 None -1 3 Rat 8.3 pKi = 8.3 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 449 7 1 8 2.5 COc1cc2nc(N3CCN(C(=O)CCC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL424658 172526 0 None -1 3 Rat 8.3 pKi = 8.3 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 449 7 1 8 2.5 COc1cc2nc(N3CCN(C(=O)CCC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
44301681 209473 0 None 309 3 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 481 8 2 4 4.6 Cc1ccc(C(O)(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL61643 209473 0 None 309 3 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 481 8 2 4 4.6 Cc1ccc(C(O)(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(01)00320-1
145953314 168208 0 None -6 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 441 7 1 7 3.8 CCCCCC(=O)N1CCN(c2nc(N)c3cc(OC)c(OC)cc3n2)[C@@H]2CCCC[C@@H]21 10.1016/j.bmc.2018.05.023
CHEMBL4127078 168208 0 None -6 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 441 7 1 7 3.8 CCCCCC(=O)N1CCN(c2nc(N)c3cc(OC)c(OC)cc3n2)[C@@H]2CCCC[C@@H]21 10.1016/j.bmc.2018.05.023
10895039 25292 0 None -3 7 Rat 8.2 pKi = 8.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 418 8 1 5 3.6 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3cn2)CC1 10.1021/jm0211220
CHEMBL127400 25292 0 None -3 7 Rat 8.2 pKi = 8.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 418 8 1 5 3.6 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3cn2)CC1 10.1021/jm0211220
CHEMBL129022 25292 0 None -3 7 Rat 8.2 pKi = 8.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 418 8 1 5 3.6 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3cn2)CC1 10.1021/jm0211220
44431617 151679 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 458 7 1 6 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL391016 151679 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 458 7 1 6 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44295044 108357 0 None 169 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 535 6 2 6 3.5 N#CC1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL298579 108357 0 None 169 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 535 6 2 6 3.5 N#CC1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
4418 40996 85 None -1 7 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1007/s00044-010-9379-1
CHEMBL142635 40996 85 None -1 7 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1007/s00044-010-9379-1
DB12092 40996 85 None -1 7 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1007/s00044-010-9379-1
4418 40996 85 None -1 7 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1007/s00044-010-9379-1
CHEMBL142635 40996 85 None -1 7 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1007/s00044-010-9379-1
DB12092 40996 85 None -1 7 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1007/s00044-010-9379-1
10793963 106448 0 None 9 6 Human 8.2 pKi = 8.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
CHEMBL284470 106448 0 None 9 6 Human 8.2 pKi = 8.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
10032383 116887 0 None 194 6 Human 8.2 pKi = 8.2 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
136680387 116887 0 None 194 6 Human 8.2 pKi = 8.2 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL323579 116887 0 None 194 6 Human 8.2 pKi = 8.2 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
11857793 92425 0 None -6 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 548 7 1 4 5.9 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
CHEMBL228445 92425 0 None -6 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 548 7 1 4 5.9 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
10743042 194931 0 None 2 4 Human 8.2 pKi = 8.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 471 5 1 8 3.1 Cn1nc(Cl)c2cn3nc(NCCN4CCN(c5ccccc5Cl)CC4)ccc3c2c1=O 10.1021/jm981006q
CHEMBL49851 194931 0 None 2 4 Human 8.2 pKi = 8.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 471 5 1 8 3.1 Cn1nc(Cl)c2cn3nc(NCCN4CCN(c5ccccc5Cl)CC4)ccc3c2c1=O 10.1021/jm981006q
10651706 128292 0 None 25 3 Human 8.2 pKi = 8.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 637 11 3 8 4.5 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)Oc3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL358406 128292 0 None 25 3 Human 8.2 pKi = 8.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 637 11 3 8 4.5 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)Oc3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
144096985 170873 0 None -5 3 Human 7.3 pKi = 7.3 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 385 9 1 4 3.5 CS(=O)(=O)c1ccccc1CCCNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
CHEMBL4209590 170873 0 None -5 3 Human 7.3 pKi = 7.3 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 385 9 1 4 3.5 CS(=O)(=O)c1ccccc1CCCNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
9841781 129838 0 None -13 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 359 5 1 2 4.8 c1ccc2c(c1)CN(CCCN1CCC(c3c[nH]c4ccccc34)CC1)C2 10.1016/j.bmcl.2015.07.046
CHEMBL3609357 129838 0 None -13 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 359 5 1 2 4.8 c1ccc2c(c1)CN(CCCN1CCC(c3c[nH]c4ccccc34)CC1)C2 10.1016/j.bmcl.2015.07.046
44288794 168855 0 None 39 3 Human 7.3 pKi = 7.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 429 8 1 3 5.0 N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)C2CCCC2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL416073 168855 0 None 39 3 Human 7.3 pKi = 7.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 429 8 1 3 5.0 N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)C2CCCC2)CC1 10.1016/s0960-894x(00)00307-3
10026936 170237 0 None 114 3 Human 7.3 pKi = 7.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 8 1 3 5.1 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)c(F)c2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL41994 170237 0 None 114 3 Human 7.3 pKi = 7.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 8 1 3 5.1 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)c(F)c2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
2267 7347 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/acsmedchemlett.7b00112
271 7347 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/acsmedchemlett.7b00112
7121 7347 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/acsmedchemlett.7b00112
CHEMBL639 7347 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/acsmedchemlett.7b00112
DB00972 7347 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/acsmedchemlett.7b00112
24824726 167888 1 None -64 6 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL4060529 167888 1 None -64 6 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL4117079 167888 1 None -64 6 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5282336 167888 1 None -64 6 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5286389 167888 1 None -64 6 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5273244 201395 0 None -100 3 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 468 9 1 6 2.9 COCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315364 201395 0 None -100 3 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 468 9 1 6 2.9 COCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
2267 7347 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/jm1013874
271 7347 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/jm1013874
7121 7347 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/jm1013874
CHEMBL639 7347 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/jm1013874
DB00972 7347 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/jm1013874
52937728 68084 0 None -100 4 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 351 4 0 4 3.2 CN1CCC[C@@H]1Cn1nc(Cc2cccc(F)c2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767145 68084 0 None -100 4 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 351 4 0 4 3.2 CN1CCC[C@@H]1Cn1nc(Cc2cccc(F)c2)c2ccccc2c1=O 10.1021/jm1013874
155565449 183110 0 None -3 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 433 11 1 5 4.6 COc1ccccc1OCCNCC[C@@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4579802 183110 0 None -3 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 433 11 1 5 4.6 COc1ccccc1OCCNCC[C@@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4595447 183110 0 None -3 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 433 11 1 5 4.6 COc1ccccc1OCCNCC[C@@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
2267 7347 71 None -15 7 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmcl.2017.09.020
271 7347 71 None -15 7 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmcl.2017.09.020
7121 7347 71 None -15 7 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmcl.2017.09.020
CHEMBL639 7347 71 None -15 7 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmcl.2017.09.020
DB00972 7347 71 None -15 7 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmcl.2017.09.020
19608536 144560 0 None -10 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 421 7 1 3 4.8 O=C(NCCCCN1CCN(c2cccc(Cl)c2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3759513 144560 0 None -10 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 421 7 1 3 4.8 O=C(NCCCCN1CCN(c2cccc(Cl)c2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
12575 8769 30 None -331 17 Bovine 6.3 pKi = 6.3 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm00366a007
54459 8769 30 None -331 17 Bovine 6.3 pKi = 6.3 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm00366a007
CHEMBL10316 8769 30 None -331 17 Bovine 6.3 pKi = 6.3 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm00366a007
DB12551 8769 30 None -331 17 Bovine 6.3 pKi = 6.3 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm00366a007
506 9032 39 None -97 6 Rat 6.3 pKi = 6.3 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
6603904 9032 39 None -97 6 Rat 6.3 pKi = 6.3 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
CHEMBL19476 9032 39 None -97 6 Rat 6.3 pKi = 6.3 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
102 10899 48 None -1258 49 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
3659 10899 48 None -1258 49 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
8969 10899 48 None -1258 49 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
CHEMBL15245 10899 48 None -1258 49 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
DB01392 10899 48 None -1258 49 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
10792152 213730 0 None - 1 Human 6.3 pKi = 6.3 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 523 7 3 4 3.9 O=C1NC(C(F)(F)F)=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
CHEMBL91179 213730 0 None - 1 Human 6.3 pKi = 6.3 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 523 7 3 4 3.9 O=C1NC(C(F)(F)F)=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
75306277 116031 0 None -251 23 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 308 0 0 3 4.2 CN1CCC2C(C1)c1cccc3c1N2c1ccccc1CS3 10.1039/C2MD00311B
CHEMBL3217984 116031 0 None -251 23 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 308 0 0 3 4.2 CN1CCC2C(C1)c1cccc3c1N2c1ccccc1CS3 10.1039/C2MD00311B
52937731 68087 0 None -630 4 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 347 4 0 4 3.4 Cc1cccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)c1 10.1021/jm1013874
CHEMBL1767148 68087 0 None -630 4 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 347 4 0 4 3.4 Cc1cccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)c1 10.1021/jm1013874
52937829 68092 0 None -316 3 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 313 6 0 4 3.2 CCCCCc1nn(C[C@H]2CCCN2C)c(=O)c2ccccc12 10.1021/jm1013874
CHEMBL1767153 68092 0 None -316 3 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 313 6 0 4 3.2 CCCCCc1nn(C[C@H]2CCCN2C)c(=O)c2ccccc12 10.1021/jm1013874
11736917 16049 2 None 1 2 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 254 4 2 3 1.5 CCS(=O)(=O)Nc1cccc(C2CCNC2)c1 10.1021/jm030551a
CHEMBL110859 16049 2 None 1 2 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 254 4 2 3 1.5 CCS(=O)(=O)Nc1cccc(C2CCNC2)c1 10.1021/jm030551a
9880162 16074 0 None -1 3 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 321 4 2 4 2.3 COc1ccc2c(c1NS(C)(=O)=O)CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL110976 16074 0 None -1 3 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 321 4 2 4 2.3 COc1ccc2c(c1NS(C)(=O)=O)CCCC2c1c[nH]cn1 10.1021/jm030551a
9823115 205382 0 None -2511 5 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 414 4 0 5 3.0 N#Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL57868 205382 0 None -2511 5 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 414 4 0 5 3.0 N#Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
16041449 101995 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 538 6 2 4 6.7 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256040 101995 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 538 6 2 4 6.7 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
16041092 102155 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256804 102155 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
9820229 129837 0 None -6 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 359 5 1 2 4.8 c1ccc2c(c1)CCN2CCCN1CCC(c2c[nH]c3ccccc23)CC1 10.1016/j.bmcl.2015.07.046
CHEMBL3609356 129837 0 None -6 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 359 5 1 2 4.8 c1ccc2c(c1)CCN2CCCN1CCC(c2c[nH]c3ccccc23)CC1 10.1016/j.bmcl.2015.07.046
10739024 76608 0 None -20 6 Rat 6.3 pKi = 6.3 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19376 76608 0 None -20 6 Rat 6.3 pKi = 6.3 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
10961938 126317 0 None -8511 7 Rat 5.3 pKi = 5.3 Binding
Binding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracerBinding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracer
ChEMBL 485 8 1 4 5.5 COc1c(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc2ccccc12 10.1021/jm050171k
CHEMBL345820 126317 0 None -8511 7 Rat 5.3 pKi = 5.3 Binding
Binding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracerBinding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracer
ChEMBL 485 8 1 4 5.5 COc1c(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc2ccccc12 10.1021/jm050171k
76322413 91602 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 359 8 1 6 2.8 COc1cccc(OC)c1OCCN[C@H]1CO[C@H](c2ccccc2)CO1 10.1007/s00044-010-9379-1
CHEMBL2234452 91602 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 359 8 1 6 2.8 COc1cccc(OC)c1OCCN[C@H]1CO[C@H](c2ccccc2)CO1 10.1007/s00044-010-9379-1
2803 7742 58 None -8 19 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
516 7742 58 None -8 19 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
704 7742 58 None -8 19 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
CHEMBL134 7742 58 None -8 19 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
DB00575 7742 58 None -8 19 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
25132564 194181 0 None -2 2 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 373 9 1 6 2.8 COc1cccc(OC)c1OCCNC[C@@H]1CO[C@@H](c2ccccc2)CO1 10.1021/jm800461k
CHEMBL493661 194181 0 None -2 2 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 373 9 1 6 2.8 COc1cccc(OC)c1OCCNC[C@@H]1CO[C@@H](c2ccccc2)CO1 10.1021/jm800461k
3086326 211310 22 None -138 6 Human 5.3 pKi = 5.3 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 247 1 2 5 1.7 Clc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL72753 211310 22 None -138 6 Human 5.3 pKi = 5.3 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 247 1 2 5 1.7 Clc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
16041630 104323 0 None -2 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(F)cccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL270589 104323 0 None -2 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(F)cccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
49783209 24381 0 None -912 26 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha1A receptorBinding affinity to human adrenergic alpha1A receptor
ChEMBL 396 7 1 6 3.8 CCCCN1CCC(COC(=O)c2cc(Cl)c(NC)c3c2OCCO3)CC1 10.1021/jm100668r
CHEMBL1258223 24381 0 None -912 26 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha1A receptorBinding affinity to human adrenergic alpha1A receptor
ChEMBL 396 7 1 6 3.8 CCCCN1CCC(COC(=O)c2cc(Cl)c(NC)c3c2OCCO3)CC1 10.1021/jm100668r
127036932 144126 0 None -17 22 Human 6.3 pKi = 6.3 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 274 7 1 1 4.0 C=CCN(CC=C)CCc1c[nH]c2ccc(Cl)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3752900 144126 0 None -17 22 Human 6.3 pKi = 6.3 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 274 7 1 1 4.0 C=CCN(CC=C)CCc1c[nH]c2ccc(Cl)cc12 10.1016/j.bmcl.2015.12.053
9813756 15788 0 None 1 3 Rat 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL109848 15788 0 None 1 3 Rat 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
9813756 15788 0 None 1 3 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL109848 15788 0 None 1 3 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
15546405 103933 0 None 12 3 Human 7.3 pKi = 7.3 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 416 8 0 5 2.1 CC(C)Oc1ccccc1N1CCN(CCN(C)C(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL268030 103933 0 None 12 3 Human 7.3 pKi = 7.3 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 416 8 0 5 2.1 CC(C)Oc1ccccc1N1CCN(CCN(C)C(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
44331277 11248 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 371 3 0 3 4.9 O=C1CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccccc21 10.1016/s0960-894x(98)00732-x
CHEMBL101869 11248 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 371 3 0 3 4.9 O=C1CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccccc21 10.1016/s0960-894x(98)00732-x
9800400 129835 1 None -7 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 387 5 1 3 4.0 O=C1c2ccccc2C(=O)N1CCCN1CCC(c2c[nH]c3ccccc23)CC1 10.1016/j.bmcl.2015.07.046
CHEMBL3609354 129835 1 None -7 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 387 5 1 3 4.0 O=C1c2ccccc2C(=O)N1CCCN1CCC(c2c[nH]c3ccccc23)CC1 10.1016/j.bmcl.2015.07.046
10818003 113198 0 None 3 6 Human 7.3 pKi = 7.3 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 649 12 3 6 6.2 CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1 10.1021/jm980077m
CHEMBL313953 113198 0 None 3 6 Human 7.3 pKi = 7.3 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 649 12 3 6 6.2 CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1 10.1021/jm980077m
10818003 113198 0 None 3 6 Human 7.3 pKi = 7.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 649 12 3 6 6.2 CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1 10.1007/s00044-004-0120-9
CHEMBL313953 113198 0 None 3 6 Human 7.3 pKi = 7.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 649 12 3 6 6.2 CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1 10.1007/s00044-004-0120-9
44420412 91571 0 None -3 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 470 5 1 7 3.4 COc1ccc(Cl)cc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL223289 91571 0 None -3 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 470 5 1 7 3.4 COc1ccc(Cl)cc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
14925759 164817 6 None -18 13 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 349 5 0 3 3.2 O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1 10.1021/acs.jmedchem.8b00265
CHEMBL4085780 164817 6 None -18 13 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 349 5 0 3 3.2 O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1 10.1021/acs.jmedchem.8b00265
56946472 78286 0 None -26 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 373 8 1 3 4.8 c1ccc(OCCNCC2CCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm200421e
CHEMBL1946778 78286 0 None -26 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 373 8 1 3 4.8 c1ccc(OCCNCC2CCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm200421e
CHEMBL1962753 78286 0 None -26 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 373 8 1 3 4.8 c1ccc(OCCNCC2CCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm200421e
11372228 108444 0 None -64 5 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 373 4 0 3 3.8 O=C1CC2(C=CN1CCN1CCN(c3ccccc3Cl)CC1)CCCC2 10.1021/jm030944+
CHEMBL299253 108444 0 None -64 5 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 373 4 0 3 3.8 O=C1CC2(C=CN1CCN1CCN(c3ccccc3Cl)CC1)CCCC2 10.1021/jm030944+
11771731 115023 2 None -1 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL319706 115023 2 None -1 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
9947861 210941 0 None 4 4 Human 6.3 pKi = 6.3 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70634 210941 0 None 4 4 Human 6.3 pKi = 6.3 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
76311539 91607 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 299 6 1 4 2.8 c1ccc(OCCN[C@H]2CO[C@H](c3ccccc3)CO2)cc1 10.1007/s00044-010-9379-1
CHEMBL2234457 91607 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 299 6 1 4 2.8 c1ccc(OCCN[C@H]2CO[C@H](c3ccccc3)CO2)cc1 10.1007/s00044-010-9379-1
10267873 117437 0 None 5 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 317 4 2 3 2.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)C1CC1 10.1007/s00044-004-0020-z
CHEMBL325897 117437 0 None 5 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 317 4 2 3 2.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)C1CC1 10.1007/s00044-004-0020-z
14004035 126297 0 None 1 2 Bovine 6.3 pKi = 6.3 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 227 0 1 2 2.6 c1cnc2[nH]c3c(c2c1)CCN1CCCCC31 10.1021/jm00398a025
CHEMBL345621 126297 0 None 1 2 Bovine 6.3 pKi = 6.3 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 227 0 1 2 2.6 c1cnc2[nH]c3c(c2c1)CCN1CCCCC31 10.1021/jm00398a025
25131196 199411 0 None -3 2 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 313 7 1 4 2.8 c1ccc(OCCNC[C@@H]2CO[C@@H](c3ccccc3)CO2)cc1 10.1021/jm800461k
CHEMBL521694 199411 0 None -3 2 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 313 7 1 4 2.8 c1ccc(OCCNC[C@@H]2CO[C@@H](c3ccccc3)CO2)cc1 10.1021/jm800461k
10267873 117437 0 None 5 2 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 317 4 2 3 2.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)C1CC1 10.1021/jm030551a
CHEMBL325897 117437 0 None 5 2 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 317 4 2 3 2.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)C1CC1 10.1021/jm030551a
441383 27105 57 None -257 17 Rat 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL1306 27105 57 None -257 17 Rat 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
11505007 97039 0 None -6 4 Human 7.3 pKi = 7.3 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 557 9 1 7 4.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL238402 97039 0 None -6 4 Human 7.3 pKi = 7.3 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 557 9 1 7 4.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11303253 205376 0 None -147 4 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 371 5 0 4 3.0 COc1ccccc1N1CCN(CCN2CCC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL57859 205376 0 None -147 4 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 371 5 0 4 3.0 COc1ccccc1N1CCN(CCN2CCC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
9909471 203685 0 None -17 4 Human 7.3 pKi = 7.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCCC2)C(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL56620 203685 0 None -17 4 Human 7.3 pKi = 7.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCCC2)C(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
9909471 203685 0 None -17 4 Human 7.3 pKi = 7.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCCC2)C(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL56620 203685 0 None -17 4 Human 7.3 pKi = 7.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCCC2)C(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
14004035 126297 0 None 1 2 Bovine 6.3 pKi = 6.3 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 227 0 1 2 2.6 c1cnc2[nH]c3c(c2c1)CCN1CCCCC31 10.1021/jm00398a025
CHEMBL345621 126297 0 None 1 2 Bovine 6.3 pKi = 6.3 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 227 0 1 2 2.6 c1cnc2[nH]c3c(c2c1)CCN1CCCCC31 10.1021/jm00398a025
1343 8670 62 None -87 9 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
3519 8670 62 None -87 9 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
522 8670 62 None -87 9 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
CHEMBL862 8670 62 None -87 9 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
DB01018 8670 62 None -87 9 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
10411237 124260 0 None -229 3 Rat 6.3 pKi = 6.3 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 444 7 2 3 4.8 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2[nH]1 10.1021/jm0211220
CHEMBL339960 124260 0 None -229 3 Rat 6.3 pKi = 6.3 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 444 7 2 3 4.8 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2[nH]1 10.1021/jm0211220
CHEMBL4287055 124260 0 None -229 3 Rat 6.3 pKi = 6.3 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 444 7 2 3 4.8 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2[nH]1 10.1021/jm0211220
11090351 170170 0 None -2 4 Human 6.3 pKi = 6.3 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL419448 170170 0 None -2 4 Human 6.3 pKi = 6.3 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
76330200 92115 0 None 2 3 Rat 5.3 pKi = 5.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 323 3 2 5 1.2 CN(c1c(O)ccc2c1CCCC2C1=NCCN1)S(C)(=O)=O 10.1007/s00044-004-0020-z
CHEMBL2261354 92115 0 None 2 3 Rat 5.3 pKi = 5.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 323 3 2 5 1.2 CN(c1c(O)ccc2c1CCCC2C1=NCCN1)S(C)(=O)=O 10.1007/s00044-004-0020-z
135423051 84607 0 None 2 3 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
CHEMBL2092926 84607 0 None 2 3 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
456386 209782 6 None -3 2 Human 6.3 pKi = 6.3 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 376 2 3 1 5.5 Brc1ccc2c(-c3c[nH]c(-c4c[nH]c5ccccc45)n3)c[nH]c2c1 10.1016/0960-894X(96)00376-9
CHEMBL63208 209782 6 None -3 2 Human 6.3 pKi = 6.3 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 376 2 3 1 5.5 Brc1ccc2c(-c3c[nH]c(-c4c[nH]c5ccccc45)n3)c[nH]c2c1 10.1016/0960-894X(96)00376-9
44300018 205072 0 None -660 4 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 389 4 0 4 3.2 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm030944+
CHEMBL57593 205072 0 None -660 4 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 389 4 0 4 3.2 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm030944+
44331198 11231 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 357 3 0 2 5.2 c1ccc2c(c1)CCC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
CHEMBL101739 11231 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 357 3 0 2 5.2 c1ccc2c(c1)CCC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
9797995 20719 0 None -51 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 6 1 2 4.6 c1ccc2c(C3CCN(CCCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1196601 20719 0 None -51 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 6 1 2 4.6 c1ccc2c(C3CCN(CCCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL557584 20719 0 None -51 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 6 1 2 4.6 c1ccc2c(C3CCN(CCCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
10626982 118272 0 None 2 6 Human 7.3 pKi = 7.3 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 575 9 2 6 5.9 CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL327775 118272 0 None 2 6 Human 7.3 pKi = 7.3 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 575 9 2 6 5.9 CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
10626982 118272 0 None 2 6 Human 7.3 pKi = 7.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 575 9 2 6 5.9 CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL327775 118272 0 None 2 6 Human 7.3 pKi = 7.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 575 9 2 6 5.9 CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
52941981 24288 0 None -2 3 Rat 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 502 7 1 5 3.1 CN1C(=O)N(CC(O)CN2CCN(c3ccccc3F)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL1257883 24288 0 None -2 3 Rat 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 502 7 1 5 3.1 CN1C(=O)N(CC(O)CN2CCN(c3ccccc3F)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
44314198 111189 0 None -95 4 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL310335 111189 0 None -95 4 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
1201549 7384 24 None -51 20 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
333 7384 24 None -51 20 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
7601 7384 24 None -51 20 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL1201203 7384 24 None -51 20 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL438151 7384 24 None -51 20 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
DB00245 7384 24 None -51 20 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
18001206 19558 0 None -4 2 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 327 5 0 4 3.9 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)noc2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1188049 19558 0 None -4 2 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 327 5 0 4 3.9 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)noc2c1 10.1016/j.bmcl.2006.05.002
CHEMBL534943 19558 0 None -4 2 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 327 5 0 4 3.9 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)noc2c1 10.1016/j.bmcl.2006.05.002
9798656 19662 0 None -38 3 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 353 7 1 2 5.0 c1ccc2c(C3CCN(CCCCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1188902 19662 0 None -38 3 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 353 7 1 2 5.0 c1ccc2c(C3CCN(CCCCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL537651 19662 0 None -38 3 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 353 7 1 2 5.0 c1ccc2c(C3CCN(CCCCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
10859076 20454 0 None 1 6 Human 7.2 pKi = 7.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1194763 20454 0 None 1 6 Human 7.2 pKi = 7.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL553276 20454 0 None 1 6 Human 7.2 pKi = 7.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
134137025 149516 0 None -11 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 362 4 0 5 3.6 COc1ccccc1N1CCN(CC2CSC3(CCCCC3)O2)CC1 10.1016/j.ejmech.2016.09.050
CHEMBL3892434 149516 0 None -11 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 362 4 0 5 3.6 COc1ccccc1N1CCN(CC2CSC3(CCCCC3)O2)CC1 10.1016/j.ejmech.2016.09.050
44288810 176241 0 None 1 3 Human 6.2 pKi = 6.2 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 483 9 2 3 4.5 Cc1ccc(C(C(=O)NCCCN2CCC(C(N)=O)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL44288 176241 0 None 1 3 Human 6.2 pKi = 6.2 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 483 9 2 3 4.5 Cc1ccc(C(C(=O)NCCCN2CCC(C(N)=O)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
12134994 170086 0 None -2 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 316 5 0 5 2.9 COc1ccccc1N1CCN(Cc2ccc(C=O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL418882 170086 0 None -2 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 316 5 0 5 2.9 COc1ccccc1N1CCN(Cc2ccc(C=O)s2)CC1 10.1016/s0960-894x(02)00347-5
6075 156887 42 None -11 16 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
CHEMBL395110 156887 42 None -11 16 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
11568725 22870 0 None -104 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 6.1 Clc1cccc(N2CCN(CCCCNc3cc(-c4ccccc4)ccn3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
CHEMBL1223856 22870 0 None -104 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 6.1 Clc1cccc(N2CCN(CCCCNc3cc(-c4ccccc4)ccn3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
44362633 128325 0 None 95 3 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 597 9 3 6 3.9 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCC(C)N2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL358590 128325 0 None 95 3 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 597 9 3 6 3.9 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCC(C)N2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
10946567 23241 0 None -47 6 Human 7.2 pKi = 7.2 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 265 1 0 2 4.1 CCc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
CHEMBL123448 23241 0 None -47 6 Human 7.2 pKi = 7.2 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 265 1 0 2 4.1 CCc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
10508132 113794 0 None 13 6 Human 7.2 pKi = 7.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 621 10 2 6 5.5 CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1 10.1021/jm980077m
CHEMBL315392 113794 0 None 13 6 Human 7.2 pKi = 7.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 621 10 2 6 5.5 CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1 10.1021/jm980077m
10769499 50990 0 None 489 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 576 10 3 8 3.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL151668 50990 0 None 489 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 576 10 3 8 3.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
10508132 113794 0 None 13 6 Human 7.2 pKi = 7.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 621 10 2 6 5.5 CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL315392 113794 0 None 13 6 Human 7.2 pKi = 7.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 621 10 2 6 5.5 CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1 10.1007/s00044-004-0120-9
155542075 183398 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.4 c1ccc(OCCNCCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4520390 183398 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.4 c1ccc(OCCNCCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4597826 183398 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.4 c1ccc(OCCNCCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
9934955 79051 0 None -165 6 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19826 79051 0 None -165 6 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
23290944 88601 0 None -389 7 Human 6.2 pKi = 6.2 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand binding assayBinding affinity to adrenergic alpha1A receptor by radioligand binding assay
ChEMBL 392 6 0 4 3.8 O=C(C1CCCCC1)N(CCN1CCN(c2ccccc2)CC1)c1ccccn1 10.1016/j.bmcl.2012.05.119
CHEMBL2164350 88601 0 None -389 7 Human 6.2 pKi = 6.2 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand binding assayBinding affinity to adrenergic alpha1A receptor by radioligand binding assay
ChEMBL 392 6 0 4 3.8 O=C(C1CCCCC1)N(CCN1CCN(c2ccccc2)CC1)c1ccccn1 10.1016/j.bmcl.2012.05.119
11474152 107397 0 None -275 4 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 369 4 0 4 2.8 Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL291908 107397 0 None -275 4 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 369 4 0 4 2.8 Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
9816461 17491 7 None 2 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL117094 17491 7 None 2 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL544290 17491 7 None 2 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
11034737 211307 0 None -2 6 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 289 4 2 4 2.8 CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72724 211307 0 None -2 6 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 289 4 2 4 2.8 CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
10769499 50990 0 None 489 3 Human 7.2 pKi = 7.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 576 10 3 8 3.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL151668 50990 0 None 489 3 Human 7.2 pKi = 7.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 576 10 3 8 3.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
44390756 70631 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 445 10 0 7 2.1 CCOC(=O)C1CCC(=O)N1CC(=O)CCN1CCN(c2ccccc2OC(C)C)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL180312 70631 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 445 10 0 7 2.1 CCOC(=O)C1CCC(=O)N1CC(=O)CCN1CCN(c2ccccc2OC(C)C)CC1 10.1016/j.bmcl.2004.11.032
9822942 204716 0 None -48 4 Rat 7.2 pKi = 7.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 411 5 0 4 3.7 CCC1(C)CC(=O)N(CCN2CCN(c3cc(Cl)ccc3Cl)CC2)C(=O)C1 10.1021/jm030944+
CHEMBL57317 204716 0 None -48 4 Rat 7.2 pKi = 7.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 411 5 0 4 3.7 CCC1(C)CC(=O)N(CCN2CCN(c3cc(Cl)ccc3Cl)CC2)C(=O)C1 10.1021/jm030944+
9845181 214940 3 None -4168 13 Bovine 5.2 pKi = 5.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm020938y
CHEMBL98241 214940 3 None -4168 13 Bovine 5.2 pKi = 5.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm020938y
49865601 22794 0 None -34 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 378 7 1 4 4.1 FC(F)(F)c1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223617 22794 0 None -34 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 378 7 1 4 4.1 FC(F)(F)c1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1 10.1016/j.bmcl.2010.07.096
2865 10915 73 None -14 53 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 nan
59 10915 73 None -14 53 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 nan
60854 10915 73 None -14 53 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 nan
CHEMBL708 10915 73 None -14 53 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 nan
DB00246 10915 73 None -14 53 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 nan
44431574 94577 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 8 1 6 4.0 COc1ccc(F)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233814 94577 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 8 1 6 4.0 COc1ccc(F)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
49865668 22823 0 None -6 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 390 8 1 5 4.3 COc1ccccc1N1CCN(CCCCNc2nccc3ccccc23)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL1223748 22823 0 None -6 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 390 8 1 5 4.3 COc1ccccc1N1CCN(CCCCNc2nccc3ccccc23)CC1 10.1016/j.bmcl.2010.07.096
24805674 104594 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 390 8 1 5 4.3 COc1ccccc1N1CCN(CCCCNc2ccc3ccccc3n2)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL271989 104594 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 390 8 1 5 4.3 COc1ccccc1N1CCN(CCCCNc2ccc3ccccc3n2)CC1 10.1016/j.bmcl.2010.07.096
10698880 127646 0 None 630 3 Human 8.2 pKi = 8.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)NC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL355910 127646 0 None 630 3 Human 8.2 pKi = 8.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)NC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
10698880 127646 0 None 630 3 Human 8.2 pKi = 8.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)NC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL355910 127646 0 None 630 3 Human 8.2 pKi = 8.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)NC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
9893246 128270 0 None 34 3 Human 8.2 pKi = 8.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 531 9 3 6 4.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL358253 128270 0 None 34 3 Human 8.2 pKi = 8.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 531 9 3 6 4.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
9893246 128270 0 None 34 3 Human 8.2 pKi = 8.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 531 9 3 6 4.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL358253 128270 0 None 34 3 Human 8.2 pKi = 8.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 531 9 3 6 4.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
11857792 176148 0 None -3 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 560 8 1 5 5.8 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2007.04.098
CHEMBL442059 176148 0 None -3 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 560 8 1 5 5.8 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2007.04.098
16041265 102112 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 504 6 2 4 6.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256597 102112 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 504 6 2 4 6.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
44431548 93821 0 None -2 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 502 8 1 7 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL232592 93821 0 None -2 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 502 8 1 7 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL5272034 201390 0 None -10 3 Human 8.2 pKi = 8.2 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCNC(=O)CCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315277 201390 0 None -10 3 Human 8.2 pKi = 8.2 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCNC(=O)CCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
136806218 119455 0 None 75 3 Human 8.2 pKi = 8.2 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 682 15 4 9 3.9 COc1ccc(C2(c3ccccc3)CCN(CCCNC(=O)C3=C(COCCN)NC(C)=C(C(N)=O)C3c3ccc([N+](=O)[O-])cc3)CC2)cc1 10.1016/s0960-894x(99)00484-9
44328754 119455 0 None 75 3 Human 8.2 pKi = 8.2 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 682 15 4 9 3.9 COc1ccc(C2(c3ccccc3)CCN(CCCNC(=O)C3=C(COCCN)NC(C)=C(C(N)=O)C3c3ccc([N+](=O)[O-])cc3)CC2)cc1 10.1016/s0960-894x(99)00484-9
CHEMBL330401 119455 0 None 75 3 Human 8.2 pKi = 8.2 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 682 15 4 9 3.9 COc1ccc(C2(c3ccccc3)CCN(CCCNC(=O)C3=C(COCCN)NC(C)=C(C(N)=O)C3c3ccc([N+](=O)[O-])cc3)CC2)cc1 10.1016/s0960-894x(99)00484-9
52944615 23881 0 None 1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 431 11 1 4 5.6 Clc1cccc(Cl)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1255002 23881 0 None 1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 431 11 1 4 5.6 Clc1cccc(Cl)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
44298762 107405 0 None 15 3 Human 8.2 pKi = 8.2 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 473 8 1 7 1.9 CN(C)c1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL291951 107405 0 None 15 3 Human 8.2 pKi = 8.2 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 473 8 1 7 1.9 CN(C)c1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
10839389 107130 0 None -3 3 Rat 8.2 pKi = 8.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(C#N)cccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL289627 107130 0 None -3 3 Rat 8.2 pKi = 8.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(C#N)cccc54)c3=O)C[C@@H]21 10.1021/jm990567u
487 10406 21 None -4 12 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
60602 10406 21 None -4 12 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
CHEMBL405355 10406 21 None -4 12 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
DB09239 10406 21 None -4 12 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
44288792 107092 0 None 134 3 Human 8.2 pKi = 8.2 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 451 8 1 3 5.5 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(Cl)cc2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL289339 107092 0 None 134 3 Human 8.2 pKi = 8.2 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 451 8 1 3 5.5 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(Cl)cc2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
124 9755 47 None -13 32 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
2032 9755 47 None -13 32 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
4636 9755 47 None -13 32 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
CHEMBL762 9755 47 None -13 32 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
DB00935 9755 47 None -13 32 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
118716704 121775 0 None 1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 423 5 0 6 3.2 COc1ccccc1N1CCN(CC2COC3(CCN(c4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342857 121775 0 None 1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 423 5 0 6 3.2 COc1ccccc1N1CCN(CC2COC3(CCN(c4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
118716715 121787 0 None 1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 521 6 0 7 3.1 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(Cl)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342868 121787 0 None 1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 521 6 0 7 3.1 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(Cl)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44331169 174726 0 None 14 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 444 6 1 6 3.1 COc1ccccc1CCN1CCC2(CC1)CC(=O)c1ccc(NS(C)(=O)=O)cc1O2 10.1016/s0960-894x(98)00732-x
CHEMBL431631 174726 0 None 14 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 444 6 1 6 3.1 COc1ccccc1CCN1CCC2(CC1)CC(=O)c1ccc(NS(C)(=O)=O)cc1O2 10.1016/s0960-894x(98)00732-x
16041449 101995 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 538 6 2 4 6.7 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256040 101995 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 538 6 2 4 6.7 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
57391896 76080 0 None 1 5 Pig 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1013 36 2 15 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928129 76080 0 None 1 5 Pig 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1013 36 2 15 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
2894 214850 6 None -12 6 Bovine 8.2 pKi = 8.2 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)C4CCCCC43)nc(N)c2cc1OC 10.1021/jm960510x
CHEMBL97698 214850 6 None -12 6 Bovine 8.2 pKi = 8.2 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)C4CCCCC43)nc(N)c2cc1OC 10.1021/jm960510x
46934791 23462 0 None -2 4 Human 8.2 pKi = 8.2 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 7 2.6 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242818 23462 0 None -2 4 Human 8.2 pKi = 8.2 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 7 2.6 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
145960918 168307 0 None -8 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 427 3 1 7 3.2 COc1cc2nc(N3CCN(C(=O)C(C)(C)C)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4128460 168307 0 None -8 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 427 3 1 7 3.2 COc1cc2nc(N3CCN(C(=O)C(C)(C)C)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
46882085 12587 0 None -7 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 419 10 1 5 4.4 CCOc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1078953 12587 0 None -7 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 419 10 1 5 4.4 CCOc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
21830793 98610 10 None -44 46 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 373 7 0 8 0.6 COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1 10.1016/j.bmc.2013.05.050
CHEMBL2413154 98610 10 None -44 46 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 373 7 0 8 0.6 COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1 10.1016/j.bmc.2013.05.050
11948707 172946 0 None -128 13 Human 8.2 pKi = 8.2 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 373 7 0 8 0.6 COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1 10.1021/acs.jmedchem.2c00633
CHEMBL426317 172946 0 None -128 13 Human 8.2 pKi = 8.2 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 373 7 0 8 0.6 COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1 10.1021/acs.jmedchem.2c00633
118716700 121771 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 437 6 0 6 3.2 COc1ccccc1N1CCN(CC2COC3(CCN(Cc4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342853 121771 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 437 6 0 6 3.2 COc1ccccc1N1CCN(CC2COC3(CCN(Cc4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
10841296 43230 0 None 46 3 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 601 8 0 7 6.1 COC(=O)C1=C(C)N=C(C)N(Cc2cccc(CN3CCC(C(=O)OC)(c4ccccc4)CC3)c2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL144731 43230 0 None 46 3 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 601 8 0 7 6.1 COC(=O)C1=C(C)N=C(C)N(Cc2cccc(CN3CCC(C(=O)OC)(c4ccccc4)CC3)c2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10810527 107349 0 None -2 3 Rat 8.2 pKi = 8.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccncc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL291588 107349 0 None -2 3 Rat 8.2 pKi = 8.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccncc4c3=O)C[C@@H]21 10.1021/jm000541z
2142 9870 58 None -1 37 Bovine 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm020938y
4920903 9870 58 None -1 37 Bovine 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm020938y
502 9870 58 None -1 37 Bovine 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm020938y
5775 9870 58 None -1 37 Bovine 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm020938y
CHEMBL597 9870 58 None -1 37 Bovine 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm020938y
DB00692 9870 58 None -1 37 Bovine 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm020938y
3584 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
5401 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
7302 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
CHEMBL611 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
DB01162 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
10507357 210715 0 None 58 2 Human 8.2 pKi = 8.2 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 574 10 1 7 4.0 COC(CNC(=O)c1ccc2c(c1)C(=O)N(c1cccc(F)c1)C2=O)CN1CCN(c2ccccc2OC(C)C)CC1 10.1021/jm9905918
CHEMBL69245 210715 0 None 58 2 Human 8.2 pKi = 8.2 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 574 10 1 7 4.0 COC(CNC(=O)c1ccc2c(c1)C(=O)N(c1cccc(F)c1)C2=O)CN1CCN(c2ccccc2OC(C)C)CC1 10.1021/jm9905918
3584 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
3584 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990202+
5401 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
5401 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990202+
7302 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
7302 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990202+
CHEMBL611 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
CHEMBL611 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990202+
DB01162 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
DB01162 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990202+
3584 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990201h
5401 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990201h
7302 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990201h
CHEMBL611 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990201h
DB01162 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990201h
10747021 127798 0 None 12 3 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 670 8 2 5 7.0 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(Cl)cc3)(c3ccc(Cl)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL356571 127798 0 None 12 3 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 670 8 2 5 7.0 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(Cl)cc3)(c3ccc(Cl)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
3584 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
5401 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
7302 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
CHEMBL611 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
DB01162 10549 64 None -2 14 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
90645600 119210 0 None -1 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 640 12 2 9 4.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCN(C)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298018 119210 0 None -1 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 640 12 2 9 4.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCN(C)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
135398745 9688 112 None -39 65 Human 7.2 pKi = 7.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
47 9688 112 None -39 65 Human 7.2 pKi = 7.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
CHEMBL715 9688 112 None -39 65 Human 7.2 pKi = 7.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
DB00334 9688 112 None -39 65 Human 7.2 pKi = 7.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
3038495 7495 37 None -40 18 Rat 7.2 pKi = 7.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1021/jm0211220
7625 7495 37 None -40 18 Rat 7.2 pKi = 7.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1021/jm0211220
CHEMBL25236 7495 37 None -40 18 Rat 7.2 pKi = 7.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1021/jm0211220
44414264 19560 0 None -7 2 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 326 5 0 3 4.5 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)coc2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1188050 19560 0 None -7 2 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 326 5 0 3 4.5 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)coc2c1 10.1016/j.bmcl.2006.05.002
CHEMBL534944 19560 0 None -7 2 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 326 5 0 3 4.5 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)coc2c1 10.1016/j.bmcl.2006.05.002
11705395 22824 0 None -19 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.6 Clc1cccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
CHEMBL1223749 22824 0 None -19 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.6 Clc1cccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
135398745 9688 112 None -39 65 Human 7.2 pKi = 7.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1021/jm401958n
47 9688 112 None -39 65 Human 7.2 pKi = 7.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1021/jm401958n
CHEMBL715 9688 112 None -39 65 Human 7.2 pKi = 7.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1021/jm401958n
DB00334 9688 112 None -39 65 Human 7.2 pKi = 7.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1021/jm401958n
197033 205931 64 None -7 8 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 319 3 0 3 3.9 Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
CHEMBL589390 205931 64 None -7 8 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 319 3 0 3 3.9 Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
76315668 92110 0 None 36 3 Rat 7.2 pKi = 7.2 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 323 4 3 5 1.6 CCS(=O)(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL2261347 92110 0 None 36 3 Rat 7.2 pKi = 7.2 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 323 4 3 5 1.6 CCS(=O)(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
155555859 183006 0 None -3 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 433 11 1 5 4.6 COc1ccccc1OCCNCC[C@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4551941 183006 0 None -3 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 433 11 1 5 4.6 COc1ccccc1OCCNCC[C@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4594653 183006 0 None -3 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 433 11 1 5 4.6 COc1ccccc1OCCNCC[C@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
118716711 121783 0 None 1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 389 4 0 6 1.6 COc1ccccc1N1CCN(CC2COC3(CCN(C(C)=O)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342864 121783 0 None 1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 389 4 0 6 1.6 COc1ccccc1N1CCN(CC2COC3(CCN(C(C)=O)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
68712 107114 60 None -8 5 Human 5.2 pKi = 5.2 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
CHEMBL289480 107114 60 None -8 5 Human 5.2 pKi = 5.2 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
10326069 46070 1 None 23 9 Human 6.2 pKi = 6.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL147077 46070 1 None 23 9 Human 6.2 pKi = 6.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
73346334 99316 0 None -6 7 Human 5.2 pKi = 5.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 265 4 1 1 3.0 c1ccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)cc1 10.1016/j.bmc.2013.07.045
CHEMBL2432048 99316 0 None -6 7 Human 5.2 pKi = 5.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 265 4 1 1 3.0 c1ccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)cc1 10.1016/j.bmc.2013.07.045
44431560 152356 0 None -2 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
CHEMBL391530 152356 0 None -2 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
44288816 162090 0 None 17 3 Human 7.2 pKi = 7.2 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 443 8 1 3 5.4 N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)C2CCCCC2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL40303 162090 0 None 17 3 Human 7.2 pKi = 7.2 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 443 8 1 3 5.4 N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)C2CCCCC2)CC1 10.1016/s0960-894x(00)00307-3
3038603 108642 8 None -48 3 Human 7.2 pKi = 7.2 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 335 1 0 1 5.4 CN(C)C1C=CC2(CC1)c1ccccc1C=Cc1ccc(Cl)cc12 10.1021/jm00109a026
CHEMBL300647 108642 8 None -48 3 Human 7.2 pKi = 7.2 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 335 1 0 1 5.4 CN(C)C1C=CC2(CC1)c1ccccc1C=Cc1ccc(Cl)cc12 10.1021/jm00109a026
14378574 115364 0 None -24 5 Human 6.2 pKi = 6.2 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 327 2 2 5 2.8 COc1cc2c(cc1O)CCN1Cc3c(ccc(O)c3OC)C[C@@H]21 10.1021/jm0307741
CHEMBL320397 115364 0 None -24 5 Human 6.2 pKi = 6.2 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 327 2 2 5 2.8 COc1cc2c(cc1O)CCN1Cc3c(ccc(O)c3OC)C[C@@H]21 10.1021/jm0307741
10923927 210957 0 None 1 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 279 3 2 5 0.8 O=S1(=O)CCCc2cccc(NCC3=NCCN3)c21 10.1021/jm000542r
CHEMBL70740 210957 0 None 1 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 279 3 2 5 0.8 O=S1(=O)CCCc2cccc(NCC3=NCCN3)c21 10.1021/jm000542r
19968568 92114 0 None 2 3 Rat 6.2 pKi = 6.2 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 323 4 2 5 1.5 COc1ccc2c(c1NS(C)(=O)=O)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL2261353 92114 0 None 2 3 Rat 6.2 pKi = 6.2 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 323 4 2 5 1.5 COc1ccc2c(c1NS(C)(=O)=O)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
118717458 121918 0 None -4 4 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 412 10 2 4 6.9 Cc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343980 121918 0 None -4 4 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 412 10 2 4 6.9 Cc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
118717458 121918 0 None -4 4 Human 6.2 pKi = 6.2 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 412 10 2 4 6.9 Cc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343980 121918 0 None -4 4 Human 6.2 pKi = 6.2 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 412 10 2 4 6.9 Cc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
44295170 108599 0 None 19 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 554 6 2 7 2.8 COC(=O)C1(c2ccccc2)CCN(CCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL300272 108599 0 None 19 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 554 6 2 7 2.8 COC(=O)C1(c2ccccc2)CCN(CCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
10622206 108869 0 None 1 3 Rat 7.2 pKi = 7.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 423 6 1 6 3.6 COc1cc2c(cc1OC)NCN(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)C2 10.1021/jm000541z
CHEMBL302192 108869 0 None 1 3 Rat 7.2 pKi = 7.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 423 6 1 6 3.6 COc1cc2c(cc1OC)NCN(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)C2 10.1021/jm000541z
11211017 205013 0 None -43 6 Human 6.2 pKi = 6.2 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 373 4 0 4 2.7 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)cc2)CC1 10.1021/jm0491391
CHEMBL57546 205013 0 None -43 6 Human 6.2 pKi = 6.2 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 373 4 0 4 2.7 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)cc2)CC1 10.1021/jm0491391
2419 7482 28 None -288 11 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm980053f
9 7482 28 None -288 11 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm980053f
CHEMBL13647 7482 28 None -288 11 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm980053f
16785637 188356 80 None -11 2 Bovine 4.2 pKi = 4.2 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 206 2 2 4 -0.4 NC(=O)c1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL47688 188356 80 None -11 2 Bovine 4.2 pKi = 4.2 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 206 2 2 4 -0.4 NC(=O)c1cccnc1N1CCNCC1 10.1021/jm00366a007
5282322 85019 21 None - 1 Rat 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 785 11 4 15 2.4 CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O nan
CHEMBL2106399 85019 21 None - 1 Rat 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 785 11 4 15 2.4 CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O nan
11091738 124870 0 None -1 5 Rat 6.2 pKi = 6.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 456 7 1 4 4.9 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2cn1 10.1021/jm0211220
CHEMBL340641 124870 0 None -1 5 Rat 6.2 pKi = 6.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 456 7 1 4 4.9 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2cn1 10.1021/jm0211220
10792347 128784 0 None 8 3 Human 7.2 pKi = 7.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 531 9 3 6 3.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL359375 128784 0 None 8 3 Human 7.2 pKi = 7.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 531 9 3 6 3.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
52937630 68080 0 None -199 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 351 4 0 4 3.2 CN1CCC[C@@H]1Cn1nc(Cc2ccc(F)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767140 68080 0 None -199 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 351 4 0 4 3.2 CN1CCC[C@@H]1Cn1nc(Cc2ccc(F)cc2)c2ccccc2c1=O 10.1021/jm1013874
24803638 68104 0 None -199 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 636 15 0 7 7.1 COc1ccc(Cc2nn(C[C@H]3CCCN3CCCCc3ccc(OCCCN4CCCCCC4)cc3)c(=O)c3ccccc23)cc1 10.1021/jm1013874
CHEMBL1767165 68104 0 None -199 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 636 15 0 7 7.1 COc1ccc(Cc2nn(C[C@H]3CCCN3CCCCc3ccc(OCCCN4CCCCCC4)cc3)c(=O)c3ccccc23)cc1 10.1021/jm1013874
53328873 70178 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 447 6 0 5 3.2 COc1ccccc1N1CCN(CCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796049 70178 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 447 6 0 5 3.2 COc1ccccc1N1CCN(CCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
9864325 108515 1 None -758 6 Human 6.2 pKi = 6.2 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 373 4 0 4 2.7 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2F)CC1 10.1021/jm0491391
CHEMBL299691 108515 1 None -758 6 Human 6.2 pKi = 6.2 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 373 4 0 4 2.7 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2F)CC1 10.1021/jm0491391
14378574 115364 0 None -24 5 Human 6.2 pKi = 6.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 327 2 2 5 2.8 COc1cc2c(cc1O)CCN1Cc3c(ccc(O)c3OC)C[C@@H]21 10.1016/j.bmcl.2004.11.032
CHEMBL320397 115364 0 None -24 5 Human 6.2 pKi = 6.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 327 2 2 5 2.8 COc1cc2c(cc1O)CCN1Cc3c(ccc(O)c3OC)C[C@@H]21 10.1016/j.bmcl.2004.11.032
11440979 204439 0 None -8 2 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 400 5 1 6 1.3 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCNCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL57098 204439 0 None -8 2 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 400 5 1 6 1.3 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCNCC3)CC2=O)CC1 10.1021/jm030944+
127036953 144293 0 None -63 22 Human 6.2 pKi = 6.2 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 318 7 1 1 4.1 C=CCN(CC=C)CCc1c[nH]c2ccc(Br)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3754166 144293 0 None -63 22 Human 6.2 pKi = 6.2 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 318 7 1 1 4.1 C=CCN(CC=C)CCc1c[nH]c2ccc(Br)cc12 10.1016/j.bmcl.2015.12.053
10571609 213476 0 None -2 2 Rat 7.2 pKi = 7.2 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 376 6 0 4 3.4 Clc1cccc(N2CCN(CCCCN3CC4CCCCN4C3)CC2)c1 10.1021/jm970216k
CHEMBL89677 213476 0 None -2 2 Rat 7.2 pKi = 7.2 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 376 6 0 4 3.4 Clc1cccc(N2CCN(CCCCN3CC4CCCCN4C3)CC2)c1 10.1021/jm970216k
10594858 172434 0 None -2 2 Rat 7.2 pKi = 7.2 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 362 6 0 4 3.0 Clc1cccc(N2CCN(CCCCN3CC4CCCN4C3)CC2)c1 10.1021/jm970216k
CHEMBL424432 172434 0 None -2 2 Rat 7.2 pKi = 7.2 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 362 6 0 4 3.0 Clc1cccc(N2CCN(CCCCN3CC4CCCN4C3)CC2)c1 10.1021/jm970216k
3565378 185596 8 None -26 2 Rat 7.2 pKi = 7.2 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 424 6 0 4 3.0 O=C1C2CCCN2C(=O)N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
CHEMBL46918 185596 8 None -26 2 Rat 7.2 pKi = 7.2 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 424 6 0 4 3.0 O=C1C2CCCN2C(=O)N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
44361064 38389 0 None -23 6 Rat 6.2 pKi = 6.2 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 338 7 2 4 4.5 N=CCC(O)CC1CCN(c2ccccc2Oc2ccccc2)CC1 10.1021/jm960510x
CHEMBL140450 38389 0 None -23 6 Rat 6.2 pKi = 6.2 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 338 7 2 4 4.5 N=CCC(O)CC1CCN(c2ccccc2Oc2ccccc2)CC1 10.1021/jm960510x
127025278 144492 0 None -33 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 387 9 1 4 3.7 COc1ccccc1N1CCN(CCCCNC(=O)CC2CCCCC2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3758913 144492 0 None -33 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 387 9 1 4 3.7 COc1ccccc1N1CCN(CCCCNC(=O)CC2CCCCC2)CC1 10.1016/j.bmcl.2015.12.068
11994673 19088 0 None -3 6 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL1185036 19088 0 None -3 6 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL385371 19088 0 None -3 6 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
71449516 91379 0 None -3 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153552 91379 0 None -3 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221146 91379 0 None -3 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
11079593 210894 0 None -1 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70326 210894 0 None -1 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
10454026 24679 0 None -2041 8 Rat 6.2 pKi = 6.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 406 8 2 4 3.5 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[nH]2)CC1 10.1021/jm0211220
CHEMBL125916 24679 0 None -2041 8 Rat 6.2 pKi = 6.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 406 8 2 4 3.5 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[nH]2)CC1 10.1021/jm0211220
49800167 24453 0 None -1 3 Rat 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 514 9 2 6 3.1 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL1258457 24453 0 None -1 3 Rat 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 514 9 2 6 3.1 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
53328507 70170 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 469 8 0 5 4.2 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796041 70170 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 469 8 0 5 4.2 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
11554490 22825 0 None -67 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.3 FC(F)(F)c1cccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223750 22825 0 None -67 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.3 FC(F)(F)c1cccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)c1 10.1016/j.bmcl.2010.07.096
9909471 203685 0 None -21 4 Rat 7.2 pKi = 7.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCCC2)C(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL56620 203685 0 None -21 4 Rat 7.2 pKi = 7.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCCC2)C(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
3039881 181036 10 None -19 3 Human 6.2 pKi = 6.2 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 337 1 0 1 5.0 CN(C)C1C=CC2(CC1)c1ccccc1CCc1ccc(Cl)cc12 10.1021/jm00109a026
CHEMBL45491 181036 10 None -19 3 Human 6.2 pKi = 6.2 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 337 1 0 1 5.0 CN(C)C1C=CC2(CC1)c1ccccc1CCc1ccc(Cl)cc12 10.1021/jm00109a026
11651319 188407 27 None -17 2 Bovine 5.2 pKi = 5.2 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cnccc1N1CCNCC1 10.1021/jm00366a007
CHEMBL47740 188407 27 None -17 2 Bovine 5.2 pKi = 5.2 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cnccc1N1CCNCC1 10.1021/jm00366a007
118717457 121915 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 374 7 2 6 4.3 COc1ccc2c(NCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343978 121915 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 374 7 2 6 4.3 COc1ccc2c(NCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
11857861 92451 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL228606 92451 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857861 92451 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228606 92451 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
44275526 105642 0 None 2 3 Human 7.2 pKi = 7.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 621 11 2 6 7.3 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC(C)C)cc1 10.1021/jm960697s
CHEMBL27899 105642 0 None 2 3 Human 7.2 pKi = 7.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 621 11 2 6 7.3 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC(C)C)cc1 10.1021/jm960697s
118717457 121915 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 374 7 2 6 4.3 COc1ccc2c(NCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343978 121915 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 374 7 2 6 4.3 COc1ccc2c(NCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
9884513 19799 0 None -43 2 Rat 6.2 pKi = 6.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 343 5 1 2 4.4 Fc1ccc2[nH]cc(C3CCN(CCCN4CCCCC4)CC3)c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1189871 19799 0 None -43 2 Rat 6.2 pKi = 6.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 343 5 1 2 4.4 Fc1ccc2[nH]cc(C3CCN(CCCN4CCCCC4)CC3)c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL539601 19799 0 None -43 2 Rat 6.2 pKi = 6.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 343 5 1 2 4.4 Fc1ccc2[nH]cc(C3CCN(CCCN4CCCCC4)CC3)c2c1 10.1016/j.bmcl.2006.05.002
11338630 16429 0 None -6 3 Bovine 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 403 4 2 3 4.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)c1ccc2ccccc2c1 10.1021/jm030551a
CHEMBL112814 16429 0 None -6 3 Bovine 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 403 4 2 3 4.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)c1ccc2ccccc2c1 10.1021/jm030551a
53328504 70167 0 None -4 3 Human 5.2 pKi = 5.2 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 445 5 0 4 4.0 O=C1CC(c2ccc(Cl)cc2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796038 70167 0 None -4 3 Human 5.2 pKi = 5.2 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 445 5 0 4 4.0 O=C1CC(c2ccc(Cl)cc2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
101876962 121916 0 None 5 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 342 5 2 4 4.9 Cc1cccc2c(NCCNc3ccnc4c(C)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL3343979 121916 0 None 5 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 342 5 2 4 4.9 Cc1cccc2c(NCCNc3ccnc4c(C)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
11857794 92434 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cccc(OC(F)F)c1 10.1016/j.bmcl.2007.04.098
CHEMBL228496 92434 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cccc(OC(F)F)c1 10.1016/j.bmcl.2007.04.098
57390115 76071 0 None -1 5 Pig 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 455 13 1 6 3.4 CCOCCOc1cccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)c1 10.1016/j.bmc.2011.10.063
CHEMBL1928120 76071 0 None -1 5 Pig 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 455 13 1 6 3.4 CCOCCOc1cccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)c1 10.1016/j.bmc.2011.10.063
10841190 113819 0 None 28 6 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 2 6 6.5 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1 10.1021/jm980077m
CHEMBL315538 113819 0 None 28 6 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 2 6 6.5 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1 10.1021/jm980077m
10841190 92048 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 2 6 5.7 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1 10.1007/s00044-004-0120-9
CHEMBL2260150 92048 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 2 6 5.7 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1 10.1007/s00044-004-0120-9
44126269 208263 5 None -18 6 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 318 3 0 2 4.5 Cc1ccc(CCn2c3c(c4cc(C)ccc42)CN(C)CC3)cc1 10.1016/j.bmcl.2009.11.037
CHEMBL605081 208263 5 None -18 6 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 318 3 0 2 4.5 Cc1ccc(CCn2c3c(c4cc(C)ccc42)CN(C)CC3)cc1 10.1016/j.bmcl.2009.11.037
90645594 119263 0 None -2 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 597 10 2 8 4.7 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298747 119263 0 None -2 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 597 10 2 8 4.7 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
145962478 169028 0 None -13 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 459 5 2 9 2.8 COc1cc2nc(N3CCC[C@H](NC4=CC(=O)c5ccccc5C4=O)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4163587 169028 0 None -13 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 459 5 2 9 2.8 COc1cc2nc(N3CCC[C@H](NC4=CC(=O)c5ccccc5C4=O)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
2470 10425 50 None -398 58 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm00018a001
3300 10425 50 None -398 58 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm00018a001
5265 10425 50 None -398 58 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm00018a001
99 10425 50 None -398 58 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm00018a001
CHEMBL267930 10425 50 None -398 58 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm00018a001
155526629 183177 0 None -14 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.4 COc1ccccc1OCCNCCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4458714 183177 0 None -14 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.4 COc1ccccc1OCCNCCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4595984 183177 0 None -14 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.4 COc1ccccc1OCCNCCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
3584 10549 64 None -2 14 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
5401 10549 64 None -2 14 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
7302 10549 64 None -2 14 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
CHEMBL611 10549 64 None -2 14 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
DB01162 10549 64 None -2 14 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
21712258 176042 0 None 194 2 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 465 8 1 3 5.5 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL44124 176042 0 None 194 2 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 465 8 1 3 5.5 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(01)00320-1
21712258 176042 0 None 194 2 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 465 8 1 3 5.5 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL44124 176042 0 None 194 2 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 465 8 1 3 5.5 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
44288815 108231 0 None 87 3 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 431 8 1 3 5.1 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)C(C)C)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL297667 108231 0 None 87 3 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 431 8 1 3 5.1 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)C(C)C)cc1 10.1016/s0960-894x(00)00307-3
101876962 121916 0 None 5 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 342 5 2 4 4.9 Cc1cccc2c(NCCNc3ccnc4c(C)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL3343979 121916 0 None 5 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 342 5 2 4 4.9 Cc1cccc2c(NCCNc3ccnc4c(C)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
44288392 107145 0 None -1 3 Rat 8.1 pKi = 8.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 475 6 1 6 4.4 COc1cccc2c1CCC1CN(CCCCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL289758 107145 0 None -1 3 Rat 8.1 pKi = 8.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 475 6 1 6 4.4 COc1cccc2c1CCC1CN(CCCCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
44431555 95938 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 535 8 1 7 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL236618 95938 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 535 8 1 7 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
10841819 125532 0 None 346 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 640 7 1 8 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL341838 125532 0 None 346 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 640 7 1 8 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1 10.1021/jm990201h
44289112 171676 0 None 75 3 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 495 9 1 4 5.5 COc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL42220 171676 0 None 75 3 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 495 9 1 4 5.5 COc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1 10.1016/s0960-894x(00)00307-3
8459 10071 4 None -7 3 Rat 8.1 pKi = 8.1 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm9805337
9891980 10071 4 None -7 3 Rat 8.1 pKi = 8.1 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm9805337
CHEMBL430717 10071 4 None -7 3 Rat 8.1 pKi = 8.1 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm9805337
10793504 48514 0 None 436 3 Human 8.1 pKi = 8.1 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 10 3 8 3.2 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc3c(c2)OCO3)CC1 10.1021/jm980506g
CHEMBL149263 48514 0 None 436 3 Human 8.1 pKi = 8.1 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 10 3 8 3.2 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc3c(c2)OCO3)CC1 10.1021/jm980506g
10721049 50496 0 None 245 3 Human 8.1 pKi = 8.1 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 533 9 4 7 2.8 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(O)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL151045 50496 0 None 245 3 Human 8.1 pKi = 8.1 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 533 9 4 7 2.8 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(O)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
10743111 205474 0 None -1 3 Rat 8.1 pKi = 8.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 473 5 1 6 4.1 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(-c5ccccc5)sc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL58105 205474 0 None -1 3 Rat 8.1 pKi = 8.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 473 5 1 6 4.1 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(-c5ccccc5)sc4c3=O)C[C@@H]21 10.1021/jm000541z
10793504 48514 0 None 436 3 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 588 10 3 8 3.2 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc3c(c2)OCO3)CC1 10.1007/s00044-004-0120-9
CHEMBL149263 48514 0 None 436 3 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 588 10 3 8 3.2 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc3c(c2)OCO3)CC1 10.1007/s00044-004-0120-9
10606659 107310 0 None 7 3 Rat 8.1 pKi = 8.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 436 6 0 5 3.4 COc1cc2c(cc1OC)C(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CC2 10.1021/jm000541z
CHEMBL291305 107310 0 None 7 3 Rat 8.1 pKi = 8.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 436 6 0 5 3.4 COc1cc2c(cc1OC)C(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CC2 10.1021/jm000541z
2470 10425 50 None -208 58 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1016/j.bmcl.2004.11.032
3300 10425 50 None -208 58 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1016/j.bmcl.2004.11.032
5265 10425 50 None -208 58 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1016/j.bmcl.2004.11.032
99 10425 50 None -208 58 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1016/j.bmcl.2004.11.032
CHEMBL267930 10425 50 None -208 58 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1016/j.bmcl.2004.11.032
10721730 44267 0 None 245 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 568 6 2 7 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OC(=O)c2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL145571 44267 0 None 245 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 568 6 2 7 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OC(=O)c2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
76326030 91596 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL2234446 91596 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL5286701 201408 0 None -12 3 Human 8.1 pKi = 8.1 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 482 10 1 6 3.3 COCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315483 201408 0 None -12 3 Human 8.1 pKi = 8.1 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 482 10 1 6 3.3 COCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
76326030 91596 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL2234446 91596 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
11619713 79592 0 None -8 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1[N+](=O)[O-] 10.1021/jm0580398
CHEMBL200136 79592 0 None -8 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1[N+](=O)[O-] 10.1021/jm0580398
52947088 23882 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 391 11 1 4 4.9 Cc1cccc(C)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1255003 23882 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 391 11 1 4 4.9 Cc1cccc(C)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
118716713 121785 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 487 6 0 7 2.4 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342866 121785 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 487 6 0 7 2.4 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
118716719 121791 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 493 6 0 8 2.5 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4cccs4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342872 121791 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 493 6 0 8 2.5 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4cccs4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
10572794 213893 0 None - 1 Bovine 8.1 pKi = 8.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 395 7 1 5 3.0 Cc1cccc(C)c1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL92109 213893 0 None - 1 Bovine 8.1 pKi = 8.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 395 7 1 5 3.0 Cc1cccc(C)c1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
44213730 202435 0 None 7 3 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 460 8 2 7 1.3 O=c1[nH]cc(CO)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL55645 202435 0 None 7 3 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 460 8 2 7 1.3 O=c1[nH]cc(CO)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
11234230 108478 0 None -128 5 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 4 0 3 3.6 O=C1CC2(CCCC2)CCN1CCN1CCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL299454 108478 0 None -128 5 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 4 0 3 3.6 O=C1CC2(CCCC2)CCN1CCN1CCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
11234230 108478 0 None -128 5 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 4 0 3 3.6 O=C1CC2(CCCC2)CCN1CCN1CCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL299454 108478 0 None -128 5 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 4 0 3 3.6 O=C1CC2(CCCC2)CCN1CCN1CCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
44292196 186785 2 None -5 2 Bovine 6.2 pKi = 6.2 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 287 3 0 3 3.1 Clc1cccnc1N1CCN(Cc2ccccc2)CC1 10.1021/jm00366a007
CHEMBL47471 186785 2 None -5 2 Bovine 6.2 pKi = 6.2 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 287 3 0 3 3.1 Clc1cccnc1N1CCN(Cc2ccccc2)CC1 10.1021/jm00366a007
541604 172118 10 None 72 4 Human 6.2 pKi = 6.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 201 3 4 4 0.5 CNCC(O)c1cc(O)c(O)cc1F 10.1021/jm00118a019
CHEMBL42359 172118 10 None 72 4 Human 6.2 pKi = 6.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 201 3 4 4 0.5 CNCC(O)c1cc(O)c(O)cc1F 10.1021/jm00118a019
130442572 178687 0 None -147 24 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 395 3 0 5 6.0 FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4469848 178687 0 None -147 24 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 395 3 0 5 6.0 FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
9796594 16145 0 None - 1 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1ccc(O)c2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111372 16145 0 None - 1 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1ccc(O)c2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
11196451 174844 0 None -1 2 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 268 5 2 3 1.7 CCS(=O)(=O)Nc1cccc(CC2CCCN2)c1 10.1021/jm030551a
CHEMBL432451 174844 0 None -1 2 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 268 5 2 3 1.7 CCS(=O)(=O)Nc1cccc(CC2CCCN2)c1 10.1021/jm030551a
76326540 92113 0 None -1 3 Rat 5.2 pKi = 5.2 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 274 2 4 4 1.3 NC(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL2261352 92113 0 None -1 3 Rat 5.2 pKi = 5.2 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 274 2 4 4 1.3 NC(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
44331079 11090 0 None -1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 355 3 0 2 5.3 C1=CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccccc21 10.1016/s0960-894x(98)00732-x
CHEMBL100878 11090 0 None -1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 355 3 0 2 5.3 C1=CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccccc21 10.1016/s0960-894x(98)00732-x
24829343 165800 0 None -89 9 Human 7.2 pKi = 7.2 Binding
Inhibition of adrenergic alpha-1 receptorInhibition of adrenergic alpha-1 receptor
ChEMBL 429 7 1 3 5.1 CCC1(CCCCN2CCN(c3ccc(Cl)cc3)CC2)C(=O)Nc2cc(F)ccc21 10.1021/jm070279v
CHEMBL409662 165800 0 None -89 9 Human 7.2 pKi = 7.2 Binding
Inhibition of adrenergic alpha-1 receptorInhibition of adrenergic alpha-1 receptor
ChEMBL 429 7 1 3 5.1 CCC1(CCCCN2CCN(c3ccc(Cl)cc3)CC2)C(=O)Nc2cc(F)ccc21 10.1021/jm070279v
415628 214971 95 None -60 5 Rat 6.2 pKi = 6.2 Binding
Binding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranesBinding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranes
ChEMBL 196 1 1 2 1.8 Clc1ccccc1N1CCNCC1 10.1021/jm00110a014
CHEMBL9841 214971 95 None -60 5 Rat 6.2 pKi = 6.2 Binding
Binding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranesBinding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranes
ChEMBL 196 1 1 2 1.8 Clc1ccccc1N1CCNCC1 10.1021/jm00110a014
2771 201796 74 None -8 27 Rat 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 nan
CHEMBL1200781 201796 74 None -8 27 Rat 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 nan
CHEMBL549 201796 74 None -8 27 Rat 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 nan
11633992 22873 0 None -5 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 460 8 1 5 5.8 FC(F)(F)c1cccc(N2CCN(CCCCNc3nc(-c4ccccc4)cs3)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223859 22873 0 None -5 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 460 8 1 5 5.8 FC(F)(F)c1cccc(N2CCN(CCCCNc3nc(-c4ccccc4)cs3)CC2)c1 10.1016/j.bmcl.2010.07.096
44289058 172124 0 None 16 3 Human 7.1 pKi = 7.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 403 8 1 3 4.5 CC(C)C(C(=O)NCCCN1CCC(C#N)(c2ccccc2)CC1)c1ccccc1 10.1016/s0960-894x(00)00307-3
CHEMBL42361 172124 0 None 16 3 Human 7.1 pKi = 7.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 403 8 1 3 4.5 CC(C)C(C(=O)NCCCN1CCC(C#N)(c2ccccc2)CC1)c1ccccc1 10.1016/s0960-894x(00)00307-3
4384568 169882 8 None -7 3 Rat 7.1 pKi = 7.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 438 6 0 4 3.4 O=C1C2CCCCN2C(=O)N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
CHEMBL417709 169882 8 None -7 3 Rat 7.1 pKi = 7.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 438 6 0 4 3.4 O=C1C2CCCCN2C(=O)N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
10713438 113808 0 None -4 2 Rat 7.1 pKi = 7.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 358 7 0 5 2.3 COc1ccccc1N1CCN(CCCCN2CC3CCCN3C2)CC1 10.1021/jm970216k
CHEMBL315472 113808 0 None -4 2 Rat 7.1 pKi = 7.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 358 7 0 5 2.3 COc1ccccc1N1CCN(CCCCN2CC3CCCN3C2)CC1 10.1021/jm970216k
21302490 119582 32 None -10 9 Human 7.1 pKi = 7.1 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 393 5 0 4 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12 10.1021/jm401958n
CHEMBL3233142 119582 32 None -10 9 Human 7.1 pKi = 7.1 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 393 5 0 4 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12 10.1021/jm401958n
CHEMBL3306803 119582 32 None -10 9 Human 7.1 pKi = 7.1 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 393 5 0 4 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12 10.1021/jm401958n
DB06077 119582 32 None -10 9 Human 7.1 pKi = 7.1 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 393 5 0 4 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12 10.1021/jm401958n
44309199 210830 0 None - 1 Human 5.1 pKi = 5.1 Binding
In vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligandIn vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligand
ChEMBL 355 6 3 4 2.7 Cc1ccc(CC2(O)CCN(C[C@@H](O)Cc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(01)00392-4
CHEMBL69967 210830 0 None - 1 Human 5.1 pKi = 5.1 Binding
In vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligandIn vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligand
ChEMBL 355 6 3 4 2.7 Cc1ccc(CC2(O)CCN(C[C@@H](O)Cc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(01)00392-4
10473406 210999 0 None - 1 Human 5.1 pKi = 5.1 Binding
In vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligandIn vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligand
ChEMBL 355 6 3 4 2.7 Cc1ccc(CC2(O)CCN(C[C@H](O)Cc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(01)00392-4
CHEMBL70918 210999 0 None - 1 Human 5.1 pKi = 5.1 Binding
In vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligandIn vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligand
ChEMBL 355 6 3 4 2.7 Cc1ccc(CC2(O)CCN(C[C@H](O)Cc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(01)00392-4
118717462 121922 0 None 2 4 Human 7.1 pKi = 7.1 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 444 12 2 6 6.3 COc1cccc2c(NCCCCCCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL3343984 121922 0 None 2 4 Human 7.1 pKi = 7.1 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 444 12 2 6 6.3 COc1cccc2c(NCCCCCCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
9913449 113229 1 None 13 3 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL313990 113229 1 None 13 3 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
16041090 102168 0 None -1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 496 8 2 6 4.7 COc1ccc(NC(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)c(OC)c1 10.1016/j.bmcl.2007.11.068
CHEMBL256853 102168 0 None -1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 496 8 2 6 4.7 COc1ccc(NC(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)c(OC)c1 10.1016/j.bmcl.2007.11.068
56649649 74632 0 None -87 8 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 480 8 0 5 4.6 COc1ccccc1N1CCN(CCN(C(=O)C23CCC(CF)(CC2)CC3)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL1910140 74632 0 None -87 8 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 480 8 0 5 4.6 COc1ccccc1N1CCN(CCN(C(=O)C23CCC(CF)(CC2)CC3)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
44288741 175626 0 None 45 2 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 408 8 1 4 3.3 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc(C)cc2)CC1 10.1016/s0960-894x(01)00320-1
CHEMBL43799 175626 0 None 45 2 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 408 8 1 4 3.3 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc(C)cc2)CC1 10.1016/s0960-894x(01)00320-1
44288741 175626 0 None 45 2 Human 7.1 pKi = 7.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 408 8 1 4 3.3 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc(C)cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL43799 175626 0 None 45 2 Human 7.1 pKi = 7.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 408 8 1 4 3.3 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc(C)cc2)CC1 10.1016/s0960-894x(00)00307-3
76333282 91606 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 8 1 5 4.0 COc1ccccc1OCCNC1COC(c2ccccc2)(c2ccccc2)CO1 10.1007/s00044-010-9379-1
CHEMBL2234456 91606 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 8 1 5 4.0 COc1ccccc1OCCNC1COC(c2ccccc2)(c2ccccc2)CO1 10.1007/s00044-010-9379-1
118717462 121922 0 None 2 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 444 12 2 6 6.3 COc1cccc2c(NCCCCCCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL3343984 121922 0 None 2 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 444 12 2 6 6.3 COc1cccc2c(NCCCCCCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
44568917 194134 0 None -9 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@@H]1COC(c2ccccc2)(c2ccccc2)CO1 10.1021/jm800461k
CHEMBL493283 194134 0 None -9 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@@H]1COC(c2ccccc2)(c2ccccc2)CO1 10.1021/jm800461k
52945071 24415 0 None -1 3 Rat 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 470 7 2 5 2.7 O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1CC(O)CN1CCN(c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL1258344 24415 0 None -1 3 Rat 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 470 7 2 5 2.7 O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1CC(O)CN1CCN(c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
44288857 175562 0 None 43 3 Human 7.1 pKi = 7.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 439 9 1 6 2.9 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL43749 175562 0 None 43 3 Human 7.1 pKi = 7.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 439 9 1 6 2.9 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
49862238 21780 16 None 1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic Alpha-1A receptorBinding affinity to adrenergic Alpha-1A receptor
ChEMBL 367 6 0 5 3.6 COc1cccc(F)c1OC1CN(Cc2cnn(-c3ccccc3)c2C)C1 10.1016/j.bmcl.2010.06.033
CHEMBL1209158 21780 16 None 1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic Alpha-1A receptorBinding affinity to adrenergic Alpha-1A receptor
ChEMBL 367 6 0 5 3.6 COc1cccc(F)c1OC1CN(Cc2cnn(-c3ccccc3)c2C)C1 10.1016/j.bmcl.2010.06.033
44301680 108747 0 None - 1 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 521 7 0 5 5.8 Cc1ccc(C2(c3ccc(C)cc3)OC(=O)N(CCCN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL301416 108747 0 None - 1 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 521 7 0 5 5.8 Cc1ccc(C2(c3ccc(C)cc3)OC(=O)N(CCCN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
10688604 31524 0 None -4 5 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@@H]1[C@H](NC[C@@H]2COc3ccccc3O2)CC[C@H]1Oc1ccccc1 10.1021/jm991065j
CHEMBL134428 31524 0 None -4 5 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@@H]1[C@H](NC[C@@H]2COc3ccccc3O2)CC[C@H]1Oc1ccccc1 10.1021/jm991065j
9929277 107755 0 None -23 4 Rat 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 369 4 0 4 2.7 O=C1CCCC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL294235 107755 0 None -23 4 Rat 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 369 4 0 4 2.7 O=C1CCCC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
456387 107533 5 None -6 2 Human 6.1 pKi = 6.1 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 376 2 3 1 5.5 Brc1ccc2c(-c3nc(-c4c[nH]c5ccccc45)c[nH]3)c[nH]c2c1 10.1016/0960-894X(96)00376-9
CHEMBL292801 107533 5 None -6 2 Human 6.1 pKi = 6.1 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 376 2 3 1 5.5 Brc1ccc2c(-c3nc(-c4c[nH]c5ccccc45)c[nH]3)c[nH]c2c1 10.1016/0960-894X(96)00376-9
44271701 72287 0 None - 1 Bovine 5.1 pKi = 5.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 192 1 0 2 1.9 CN1CC=C(c2ccncc2F)CC1 10.1021/jm00375a017
CHEMBL18306 72287 0 None - 1 Bovine 5.1 pKi = 5.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 192 1 0 2 1.9 CN1CC=C(c2ccncc2F)CC1 10.1021/jm00375a017
145946265 174293 0 None -1 5 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 396 10 0 4 3.9 Cc1cc(C)c(OCCOCCN2CCN(CCc3ccccc3)CC2)c(C)c1 10.1016/j.bmcl.2018.04.059
CHEMBL4203310 174293 0 None -1 5 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 396 10 0 4 3.9 Cc1cc(C)c(OCCOCCN2CCN(CCc3ccccc3)CC2)c(C)c1 10.1016/j.bmcl.2018.04.059
CHEMBL4299892 174293 0 None -1 5 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 396 10 0 4 3.9 Cc1cc(C)c(OCCOCCN2CCN(CCc3ccccc3)CC2)c(C)c1 10.1016/j.bmcl.2018.04.059
10221005 211101 0 None 4 4 Human 6.1 pKi = 6.1 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 267 4 2 5 0.8 Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL71479 211101 0 None 4 4 Human 6.1 pKi = 6.1 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 267 4 2 5 0.8 Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
76330198 92111 0 None 2 3 Rat 6.1 pKi = 6.1 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 337 5 3 5 2.0 CCCS(=O)(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL2261348 92111 0 None 2 3 Rat 6.1 pKi = 6.1 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 337 5 3 5 2.0 CCCS(=O)(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
1547484 7727 74 None -125 20 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
654 7727 74 None -125 20 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
9072 7727 74 None -125 20 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
CHEMBL43064 7727 74 None -125 20 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
DB00568 7727 74 None -125 20 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
10873978 175265 0 None -1 5 Rat 6.1 pKi = 6.1 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 445 7 1 4 5.1 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2o1 10.1021/jm0211220
CHEMBL435218 175265 0 None -1 5 Rat 6.1 pKi = 6.1 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 445 7 1 4 5.1 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2o1 10.1021/jm0211220
11698643 10402 11 None -15 4 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha-1A receptorBinding affinity to human adrenergic alpha-1A receptor
ChEMBL 479 6 0 4 6.0 O=C1C(=Nc2cccc(c2)C(F)(F)F)c2c(N1c1cccc(c1)OCCN1CCCC1)cccc2 10.1016/j.bmcl.2006.05.025
6125 10402 11 None -15 4 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha-1A receptorBinding affinity to human adrenergic alpha-1A receptor
ChEMBL 479 6 0 4 6.0 O=C1C(=Nc2cccc(c2)C(F)(F)F)c2c(N1c1cccc(c1)OCCN1CCCC1)cccc2 10.1016/j.bmcl.2006.05.025
CHEMBL209497 10402 11 None -15 4 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha-1A receptorBinding affinity to human adrenergic alpha-1A receptor
ChEMBL 479 6 0 4 6.0 O=C1C(=Nc2cccc(c2)C(F)(F)F)c2c(N1c1cccc(c1)OCCN1CCCC1)cccc2 10.1016/j.bmcl.2006.05.025
53248361 68856 0 None -50 7 Human 7.1 pKi = 7.1 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 568 7 0 5 3.2 COc1ccccc1N1CCN(CCN(C(=O)C23C4C5C2C2C3C4C52I)c2ccccn2)CC1 10.1021/jm1009956
CHEMBL1774991 68856 0 None -50 7 Human 7.1 pKi = 7.1 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 568 7 0 5 3.2 COc1ccccc1N1CCN(CCN(C(=O)C23C4C5C2C2C3C4C52I)c2ccccn2)CC1 10.1021/jm1009956
2105 9828 37 None -288 32 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
47811 9828 37 None -288 32 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
48 9828 37 None -288 32 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
CHEMBL531 9828 37 None -288 32 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
DB01186 9828 37 None -288 32 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
9867138 202571 0 None -48 4 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 425 7 0 4 4.1 CN(CCN1C(=O)CC2(CCCC2)CC1=O)CCN(C)c1cc(Cl)ccc1Cl 10.1021/jm030944+
CHEMBL55790 202571 0 None -48 4 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 425 7 0 4 4.1 CN(CCN1C(=O)CC2(CCCC2)CC1=O)CCN(C)c1cc(Cl)ccc1Cl 10.1021/jm030944+
448537 167029 89 None -1584 25 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL411 167029 89 None -1584 25 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
12134985 211657 0 None - 1 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 438 7 1 7 2.7 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)nc(N)n2)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL75808 211657 0 None - 1 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 438 7 1 7 2.7 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)nc(N)n2)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL5276489 201422 0 None -70 3 Human 7.1 pKi = 7.1 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 492 8 1 5 4.4 O=C(NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O)C1CCCC1 10.1021/acsmedchemlett.7b00112
CHEMBL5315725 201422 0 None -70 3 Human 7.1 pKi = 7.1 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 492 8 1 5 4.4 O=C(NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O)C1CCCC1 10.1021/acsmedchemlett.7b00112
10314056 214929 1 None 1 3 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 322 3 0 4 3.1 O=C1CC2(CCN(CCc3ccccn3)CC2)Oc2ccccc21 10.1016/s0960-894x(98)00732-x
CHEMBL98167 214929 1 None 1 3 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 322 3 0 4 3.1 O=C1CC2(CCN(CCc3ccccn3)CC2)Oc2ccccc21 10.1016/s0960-894x(98)00732-x
9923051 115446 0 None - 1 Rat 6.1 pKi = 6.1 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 319 4 2 3 2.9 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]c(C)n1 10.1007/s00044-004-0020-z
CHEMBL320765 115446 0 None - 1 Rat 6.1 pKi = 6.1 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 319 4 2 3 2.9 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]c(C)n1 10.1007/s00044-004-0020-z
52937629 68078 0 None -158 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 377 6 0 5 3.5 CCOc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1 10.1021/jm1013874
CHEMBL1767139 68078 0 None -158 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 377 6 0 5 3.5 CCOc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1 10.1021/jm1013874
11288646 15446 0 None - 1 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 268 4 2 3 1.8 CCS(=O)(=O)Nc1cccc2c1CCCC2CN 10.1021/jm030551a
CHEMBL109553 15446 0 None - 1 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 268 4 2 3 1.8 CCS(=O)(=O)Nc1cccc2c1CCCC2CN 10.1021/jm030551a
9923051 115446 0 None - 1 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 319 4 2 3 2.9 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]c(C)n1 10.1021/jm030551a
CHEMBL320765 115446 0 None - 1 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 319 4 2 3 2.9 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]c(C)n1 10.1021/jm030551a
10626686 211098 0 None 7 2 Human 8.1 pKi = 8.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(C[C@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL71473 211098 0 None 7 2 Human 8.1 pKi = 8.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(C[C@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
44331150 11202 0 None 3 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 530 6 1 7 4.4 Cn1cnc(S(=O)(=O)Nc2ccc3c(c2)C(=O)CC2(CCN(CCc4cccc5ccccc45)CC2)O3)c1 10.1016/s0960-894x(98)00732-x
CHEMBL101579 11202 0 None 3 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 530 6 1 7 4.4 Cn1cnc(S(=O)(=O)Nc2ccc3c(c2)C(=O)CC2(CCN(CCc4cccc5ccccc45)CC2)O3)c1 10.1016/s0960-894x(98)00732-x
9847419 214973 0 None 14 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 467 5 2 5 3.9 Cc1[nH]c2ccccc2c1CCN1CCC2(CC1)CC(=O)c1ccc(NS(C)(=O)=O)cc1O2 10.1016/s0960-894x(98)00732-x
CHEMBL98430 214973 0 None 14 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 467 5 2 5 3.9 Cc1[nH]c2ccccc2c1CCN1CCC2(CC1)CC(=O)c1ccc(NS(C)(=O)=O)cc1O2 10.1016/s0960-894x(98)00732-x
10507129 128751 0 None 9 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 562 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1021/jm990200p
CHEMBL359173 128751 0 None 9 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 562 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1021/jm990200p
9867616 175105 0 None -1 3 Human 8.1 pKi = 8.1 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 435 6 1 8 2.2 COc1cc2nc(N3CCN(C(=O)CC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL434228 175105 0 None -1 3 Human 8.1 pKi = 8.1 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 435 6 1 8 2.2 COc1cc2nc(N3CCN(C(=O)CC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
115 7131 71 None -3 7 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
2092 7131 71 None -3 7 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
7109 7131 71 None -3 7 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
CHEMBL709 7131 71 None -3 7 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
DB00346 7131 71 None -3 7 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
4149971 173411 7 None -1 4 Rat 8.1 pKi = 8.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 386 7 0 5 2.0 COc1ccccc1N1CCN(CCCCN2C(=O)C3CCCN3C2=O)CC1 10.1021/jm970216k
CHEMBL42810 173411 7 None -1 4 Rat 8.1 pKi = 8.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 386 7 0 5 2.0 COc1ccccc1N1CCN(CCCCN2C(=O)C3CCCN3C2=O)CC1 10.1021/jm970216k
44300166 203132 0 None 15 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL56248 203132 0 None 15 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
44420408 148536 0 None -5 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 453 5 2 6 2.7 COc1ccc(Cl)cc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL386005 148536 0 None -5 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 453 5 2 6 2.7 COc1ccc(Cl)cc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
10320782 106753 0 None 4 7 Bovine 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@H]1Oc2ccccc2O[C@@H]1c1ccc(C)cc1 10.1021/jm960069a
CHEMBL286565 106753 0 None 4 7 Bovine 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@H]1Oc2ccccc2O[C@@H]1c1ccc(C)cc1 10.1021/jm960069a
10811627 212329 0 None 11 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)no2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL538529 212329 0 None 11 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)no2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL81093 212329 0 None 11 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)no2)CC1 10.1016/s0960-894x(02)00436-5
44268966 40211 0 None -6 6 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 7 1 7 3.6 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL14199 40211 0 None -6 6 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 7 1 7 3.6 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
11857861 201559 0 None -1 4 Human 8.1 pKi = 8.1 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL538397 201559 0 None -1 4 Human 8.1 pKi = 8.1 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
118716698 121770 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 364 4 0 6 2.5 COc1ccccc1N1CCN(CC2COC3(CCSCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342852 121770 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 364 4 0 6 2.5 COc1ccccc1N1CCN(CC2COC3(CCSCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
4165402 185547 8 None 1 2 Rat 8.1 pKi = 8.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 400 7 0 5 2.4 COc1ccccc1N1CCN(CCCCN2C(=O)C3CCCCN3C2=O)CC1 10.1021/jm970216k
CHEMBL46881 185547 8 None 1 2 Rat 8.1 pKi = 8.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 400 7 0 5 2.4 COc1ccccc1N1CCN(CCCCN2C(=O)C3CCCCN3C2=O)CC1 10.1021/jm970216k
9887378 105181 4 None 40 3 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 402 8 1 5 1.7 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL275469 105181 4 None 40 3 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 402 8 1 5 1.7 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
10790430 91594 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 431 9 1 5 4.5 COc1cccc(OC)c1OCCNC[C@@H]1C(=O)c2ccccc2C[C@H]1c1ccccc1 10.1007/s00044-010-9379-1
CHEMBL2234444 91594 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 431 9 1 5 4.5 COc1cccc(OC)c1OCCNC[C@@H]1C(=O)c2ccccc2C[C@H]1c1ccccc1 10.1007/s00044-010-9379-1
44431562 96058 0 None -1 4 Human 8.1 pKi = 8.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(OC)c(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)c1 10.1016/j.bmcl.2007.04.008
CHEMBL236832 96058 0 None -1 4 Human 8.1 pKi = 8.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(OC)c(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)c1 10.1016/j.bmcl.2007.04.008
10651080 112719 0 None 23 6 Human 8.1 pKi = 8.1 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 592 9 3 6 4.7 CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL312871 112719 0 None 23 6 Human 8.1 pKi = 8.1 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 592 9 3 6 4.7 CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
10531532 213873 0 None 8 6 Human 8.1 pKi = 8.1 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 594 9 2 7 6.0 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL91956 213873 0 None 8 6 Human 8.1 pKi = 8.1 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 594 9 2 7 6.0 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
10531532 92068 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 594 9 2 7 5.2 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL2260371 92068 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 594 9 2 7 5.2 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
10651080 112719 0 None 23 6 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 592 9 3 6 4.7 CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL312871 112719 0 None 23 6 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 592 9 3 6 4.7 CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
10790430 91594 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 431 9 1 5 4.5 COc1cccc(OC)c1OCCNC[C@@H]1C(=O)c2ccccc2C[C@H]1c1ccccc1 10.1007/s00044-010-9379-1
CHEMBL2234444 91594 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 431 9 1 5 4.5 COc1cccc(OC)c1OCCNC[C@@H]1C(=O)c2ccccc2C[C@H]1c1ccccc1 10.1007/s00044-010-9379-1
44288841 107916 0 None 3 3 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 440 8 1 2 5.8 Cc1ccc(C(C(=O)NCCCN2CCC(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL295304 107916 0 None 3 3 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 440 8 1 2 5.8 Cc1ccc(C(C(=O)NCCCN2CCC(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
57393627 76082 0 None 11 5 Pig 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1101 42 2 17 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928131 76082 0 None 11 5 Pig 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1101 42 2 17 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
10507651 213286 0 None 42 6 Human 8.1 pKi = 8.1 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 591 9 2 6 5.8 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
CHEMBL88388 213286 0 None 42 6 Human 8.1 pKi = 8.1 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 591 9 2 6 5.8 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
10507651 213286 0 None 42 6 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 591 9 2 6 5.8 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1007/s00044-004-0120-9
CHEMBL88388 213286 0 None 42 6 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 591 9 2 6 5.8 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1007/s00044-004-0120-9
4038180 6992 14 None 2 8 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
480 6992 14 None 2 8 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
CHEMBL109783 6992 14 None 2 8 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
118716716 121788 0 None 2 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 571 7 0 8 3.3 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(OC(F)(F)F)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342869 121788 0 None 2 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 571 7 0 8 3.3 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(OC(F)(F)F)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
73350823 109307 0 None -5 9 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha-1A receptor by competitive binding assayBinding affinity to human adrenergic alpha-1A receptor by competitive binding assay
ChEMBL 509 8 1 5 3.7 O=C(Cc1ccc(OC2CCNCC2)cc1OCCF)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1016/j.bmcl.2013.07.045
CHEMBL2424668 109307 0 None -5 9 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha-1A receptor by competitive binding assayBinding affinity to human adrenergic alpha-1A receptor by competitive binding assay
ChEMBL 509 8 1 5 3.7 O=C(Cc1ccc(OC2CCNCC2)cc1OCCF)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1016/j.bmcl.2013.07.045
CHEMBL3040578 109307 0 None -5 9 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha-1A receptor by competitive binding assayBinding affinity to human adrenergic alpha-1A receptor by competitive binding assay
ChEMBL 509 8 1 5 3.7 O=C(Cc1ccc(OC2CCNCC2)cc1OCCF)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1016/j.bmcl.2013.07.045
13141186 137469 0 None 7 2 Bovine 7.1 pKi = 7.1 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 312 0 0 2 4.2 CN1CCC(=C2c3cc(Cl)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL368357 137469 0 None 7 2 Bovine 7.1 pKi = 7.1 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 312 0 0 2 4.2 CN1CCC(=C2c3cc(Cl)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
10622156 206847 0 None 1 3 Rat 7.1 pKi = 7.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 422 6 0 5 3.7 COc1cc2c(cc1OC)CN(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CC2 10.1021/jm000541z
CHEMBL59575 206847 0 None 1 3 Rat 7.1 pKi = 7.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 422 6 0 5 3.7 COc1cc2c(cc1OC)CN(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CC2 10.1021/jm000541z
2771431 195061 52 None -1 2 Bovine 6.1 pKi = 6.1 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 231 1 1 3 1.8 Clc1cnc(N2CCNCC2)c(Cl)c1 10.1021/jm00366a007
CHEMBL50016 195061 52 None -1 2 Bovine 6.1 pKi = 6.1 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 231 1 1 3 1.8 Clc1cnc(N2CCNCC2)c(Cl)c1 10.1021/jm00366a007
13938357 108507 0 None -79 2 Bovine 5.1 pKi = 5.1 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN([C@H]1CCN2CCc3c(oc4ccccc34)[C@H]2C1)S(=O)(=O)CCO 10.1021/jm00150a002
CHEMBL299595 108507 0 None -79 2 Bovine 5.1 pKi = 5.1 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN([C@H]1CCN2CCc3c(oc4ccccc34)[C@H]2C1)S(=O)(=O)CCO 10.1021/jm00150a002
127025277 144629 0 None -44 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 376 7 1 5 1.6 COc1ccccc1N1CCN(CCCCNC(=O)N2CCOCC2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3760063 144629 0 None -44 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 376 7 1 5 1.6 COc1ccccc1N1CCN(CCCCNC(=O)N2CCOCC2)CC1 10.1016/j.bmcl.2015.12.068
11801861 125566 0 None 181 3 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 609 6 2 6 4.0 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL342064 125566 0 None 181 3 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 609 6 2 6 4.0 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1 10.1021/jm990201h
44222842 201871 0 None -3 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm8016046
CHEMBL549764 201871 0 None -3 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm8016046
10367857 24884 0 None -21379 3 Rat 5.1 pKi = 5.1 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 478 7 2 3 5.5 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2cc(Cl)ccc2[nH]1 10.1021/jm0211220
CHEMBL126889 24884 0 None -21379 3 Rat 5.1 pKi = 5.1 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 478 7 2 3 5.5 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2cc(Cl)ccc2[nH]1 10.1021/jm0211220
10199335 211526 0 None 1 4 Human 6.1 pKi = 6.1 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74467 211526 0 None 1 4 Human 6.1 pKi = 6.1 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
10764133 91347 0 None -6 4 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153560 91347 0 None -6 4 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220899 91347 0 None -6 4 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
44318000 212176 0 None 51 2 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 480 7 0 7 4.0 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3C(=O)CC4(CCCC4)CC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL80036 212176 0 None 51 2 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 480 7 0 7 4.0 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3C(=O)CC4(CCCC4)CC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
16041091 101996 0 None 1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 468 7 2 4 4.5 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)NCc3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256041 101996 0 None 1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 468 7 2 4 4.5 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)NCc3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
44267817 170029 0 None 53 3 Human 7.1 pKi = 7.1 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 420 8 1 5 1.9 CC(C)Oc1cc(F)ccc1N1CCN(CCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL418531 170029 0 None 53 3 Human 7.1 pKi = 7.1 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 420 8 1 5 1.9 CC(C)Oc1cc(F)ccc1N1CCN(CCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
44593557 190697 11 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL481322 190697 11 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
155513941 183057 0 None -53 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 407 12 2 5 3.8 COc1ccccc1OCCNCC(CO)OC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
CHEMBL4439658 183057 0 None -53 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 407 12 2 5 3.8 COc1ccccc1OCCNCC(CO)OC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
CHEMBL4595078 183057 0 None -53 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 407 12 2 5 3.8 COc1ccccc1OCCNCC(CO)OC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
9880254 16073 0 None 43 2 Rat 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 323 4 2 3 2.8 CCS(=O)(=O)Nc1cc(F)cc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL110975 16073 0 None 43 2 Rat 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 323 4 2 3 2.8 CCS(=O)(=O)Nc1cc(F)cc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
10739024 76608 0 None -33 6 Human 6.1 pKi = 6.1 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19376 76608 0 None -33 6 Human 6.1 pKi = 6.1 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
11049096 17968 0 None 1 2 Human 6.1 pKi = 6.1 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL1178700 17968 0 None 1 2 Human 6.1 pKi = 6.1 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL37962 17968 0 None 1 2 Human 6.1 pKi = 6.1 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
11049096 17968 0 None 1 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL1178700 17968 0 None 1 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL37962 17968 0 None 1 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
11334596 16192 1 None -1 2 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 265 4 2 3 1.9 CC(c1cccc(NS(C)(=O)=O)c1)c1c[nH]cn1 10.1021/jm030551a
CHEMBL111682 16192 1 None -1 2 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 265 4 2 3 1.9 CC(c1cccc(NS(C)(=O)=O)c1)c1c[nH]cn1 10.1021/jm030551a
9922027 122188 0 None 1 3 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 289 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCC=C2c1c[nH]cn1 10.1021/jm030551a
CHEMBL3350265 122188 0 None 1 3 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 289 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCC=C2c1c[nH]cn1 10.1021/jm030551a
71062708 161085 0 None -47 12 Mouse 5.1 pKi = 5.1 Binding
Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.
ChEMBL 368 7 0 5 2.8 COc1cccc(OC[C@@H]2CN(CCN3CCc4ccccc43)CCO2)c1 nan
CHEMBL3986651 161085 0 None -47 12 Mouse 5.1 pKi = 5.1 Binding
Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.
ChEMBL 368 7 0 5 2.8 COc1cccc(OC[C@@H]2CN(CCN3CCc4ccccc43)CCO2)c1 nan
2520 210787 70 None -147 12 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
CHEMBL1280 210787 70 None -147 12 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
CHEMBL6966 210787 70 None -147 12 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
10479323 41467 0 None -9 3 Human 7.1 pKi = 7.1 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccc(C(F)(F)F)cc1)C3 10.1021/jm030952q
CHEMBL143026 41467 0 None -9 3 Human 7.1 pKi = 7.1 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccc(C(F)(F)F)cc1)C3 10.1021/jm030952q
10479323 41467 0 None -9 3 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccc(C(F)(F)F)cc1)C3 10.1007/s00044-010-9379-1
CHEMBL143026 41467 0 None -9 3 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccc(C(F)(F)F)cc1)C3 10.1007/s00044-010-9379-1
46882088 12599 0 None -11 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1OC 10.1016/j.bmcl.2010.01.030
CHEMBL1079066 12599 0 None -11 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1OC 10.1016/j.bmcl.2010.01.030
3198 212292 76 None -1698 34 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1201049 212292 76 None -1698 34 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL808 212292 76 None -1698 34 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
44318075 212145 0 None 3 2 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 460 7 0 6 4.7 O=C1CCCCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
CHEMBL79817 212145 0 None 3 2 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 460 7 0 6 4.7 O=C1CCCCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
122187556 129836 0 None -7 2 Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 307 5 1 2 4.2 c1ccc2c(C3CCN(CCCn4cccc4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
CHEMBL3609355 129836 0 None -7 2 Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 307 5 1 2 4.2 c1ccc2c(C3CCN(CCCn4cccc4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
9844321 107638 0 None -478 5 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 407 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL293539 107638 0 None -478 5 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 407 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2Cl)CC1 10.1007/s00044-010-9379-1
42 8844 57 None -15 18 Human 7.1 pKi = 7.1 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1016/s0960-894x(98)00451-x
56971 8844 57 None -15 18 Human 7.1 pKi = 7.1 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1016/s0960-894x(98)00451-x
CHEMBL8412 8844 57 None -15 18 Human 7.1 pKi = 7.1 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1016/s0960-894x(98)00451-x
9844321 107638 0 None -478 5 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 407 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL293539 107638 0 None -478 5 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 407 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2Cl)CC1 10.1007/s00044-010-9379-1
11994915 18604 0 None -1 7 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182145 18604 0 None -1 7 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214762 18604 0 None -1 7 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
25132566 194102 0 None -14 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1COC[C@@H](c2ccccc2)O1 10.1021/jm800461k
CHEMBL493041 194102 0 None -14 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1COC[C@@H](c2ccccc2)O1 10.1021/jm800461k
11234230 108478 0 None -162 5 Rat 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 375 4 0 3 3.6 O=C1CC2(CCCC2)CCN1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm030944+
CHEMBL299454 108478 0 None -162 5 Rat 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 375 4 0 3 3.6 O=C1CC2(CCCC2)CCN1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm030944+
49783419 24521 0 None -263 12 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha1A receptorBinding affinity to human adrenergic alpha1A receptor
ChEMBL 366 6 1 6 2.8 CCCCN1CCC(COC(=O)c2cc(F)c(N)c3c2OCCO3)CC1 10.1021/jm100668r
CHEMBL1258671 24521 0 None -263 12 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha1A receptorBinding affinity to human adrenergic alpha1A receptor
ChEMBL 366 6 1 6 2.8 CCCCN1CCC(COC(=O)c2cc(F)c(N)c3c2OCCO3)CC1 10.1021/jm100668r
130442480 182049 0 None -107 24 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 410 3 0 6 5.7 Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F 10.1021/acs.jmedchem.9b00351
CHEMBL4572614 182049 0 None -107 24 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 410 3 0 6 5.7 Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F 10.1021/acs.jmedchem.9b00351
46915370 61741 0 None -1 6 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 195 0 3 5 -1.6 Cn1c(=O)[nH]c2c([nH]c(=O)n2C)c1=N 10.1021/jm100490m
CHEMBL1241328 61741 0 None -1 6 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 195 0 3 5 -1.6 Cn1c(=O)[nH]c2c([nH]c(=O)n2C)c1=N 10.1021/jm100490m
CHEMBL1615596 61741 0 None -1 6 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 195 0 3 5 -1.6 Cn1c(=O)[nH]c2c([nH]c(=O)n2C)c1=N 10.1021/jm100490m
12134987 211767 0 None 16 2 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 414 7 0 6 2.8 CC(C)Oc1ccccc1N1CCN(CC2=NOC(CN3CCCCC3=O)C2)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL76643 211767 0 None 16 2 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 414 7 0 6 2.8 CC(C)Oc1ccccc1N1CCN(CC2=NOC(CN3CCCCC3=O)C2)CC1 10.1016/s0960-894x(00)00472-8
155565219 183344 0 None -1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 403 10 1 4 4.6 c1ccc(OCCNCC[C@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4580335 183344 0 None -1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 403 10 1 4 4.6 c1ccc(OCCNCC[C@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4597359 183344 0 None -1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 403 10 1 4 4.6 c1ccc(OCCNCC[C@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
44568918 194135 0 None 1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNC[C@@H]1COC(c2ccccc2)(c2ccccc2)CO1 10.1021/jm800461k
CHEMBL493284 194135 0 None 1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNC[C@@H]1COC(c2ccccc2)(c2ccccc2)CO1 10.1021/jm800461k
68712 107114 60 None -8 5 Human 5.1 pKi = 5.1 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
CHEMBL289480 107114 60 None -8 5 Human 5.1 pKi = 5.1 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
2351 10059 64 None -138 21 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
2820 10059 64 None -138 21 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
5035 10059 64 None -138 21 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
CHEMBL81 10059 64 None -138 21 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
DB00481 10059 64 None -138 21 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
1016 10519 78 None -1737 35 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2561 10519 78 None -1737 35 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2733526 10519 78 None -1737 35 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
5384 10519 78 None -1737 35 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
CHEMBL83 10519 78 None -1737 35 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
DB00675 10519 78 None -1737 35 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
44316072 211795 0 None 4 3 Human 8.1 pKi = 8.1 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 425 7 0 6 3.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)nn2C)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL76867 211795 0 None 4 3 Human 8.1 pKi = 8.1 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 425 7 0 6 3.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)nn2C)CC1 10.1016/s0960-894x(00)00472-8
11567620 22848 0 None -5 3 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 404 8 1 4 4.9 Fc1ccccc1N1CCN(CCCCNc2cc(-c3ccccc3)ccn2)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL1223802 22848 0 None -5 3 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 404 8 1 4 4.9 Fc1ccccc1N1CCN(CCCCNc2cc(-c3ccccc3)ccn2)CC1 10.1016/j.bmcl.2010.07.096
57395340 76075 0 None 1 5 Pig 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 469 14 1 6 3.6 CCOCCOCc1ccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)cc1 10.1016/j.bmc.2011.10.063
CHEMBL1928124 76075 0 None 1 5 Pig 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 469 14 1 6 3.6 CCOCCOCc1ccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)cc1 10.1016/j.bmc.2011.10.063
10095156 85318 0 None 1 3 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL2112073 85318 0 None 1 3 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)C[C@@H]21 10.1021/jm990567u
10698907 127809 0 None 602 3 Human 8.0 pKi = 8.0 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 605 12 4 9 2.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)OCCO)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL356623 127809 0 None 602 3 Human 8.0 pKi = 8.0 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 605 12 4 9 2.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)OCCO)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
44295133 195507 0 None 13 3 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 586 7 2 5 5.0 O=C1OCC2=C1C(c1ccc(F)c(F)c1)N(C(=O)NCCCN1CCC(c3ccccc3)(c3ccccc3)CC1)C(=O)N2 10.1016/s0960-894x(99)00653-8
CHEMBL50490 195507 0 None 13 3 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 586 7 2 5 5.0 O=C1OCC2=C1C(c1ccc(F)c(F)c1)N(C(=O)NCCCN1CCC(c3ccccc3)(c3ccccc3)CC1)C(=O)N2 10.1016/s0960-894x(99)00653-8
71817710 109184 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419770 109184 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL3039705 109184 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm400867d
10430193 168377 0 None -60 6 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4129461 168377 0 None -60 6 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
3038495 7495 37 None -6 18 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1016/j.bmcl.2015.12.068
7625 7495 37 None -6 18 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1016/j.bmcl.2015.12.068
CHEMBL25236 7495 37 None -6 18 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1016/j.bmcl.2015.12.068
1588 9105 27 None -26 44 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
28864 9105 27 None -26 44 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
43 9105 27 None -26 44 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
CHEMBL157138 9105 27 None -26 44 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
DB00589 9105 27 None -26 44 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
10582624 209571 0 None -1 3 Rat 8.0 pKi = 8.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 393 4 1 7 1.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4nccnc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL62206 209571 0 None -1 3 Rat 8.0 pKi = 8.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 393 4 1 7 1.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4nccnc4c3=O)C[C@@H]21 10.1021/jm000541z
10530732 174830 0 None -1 3 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 515 4 1 6 4.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cc(C(F)(F)F)ccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL43234 174830 0 None -1 3 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 515 4 1 6 4.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cc(C(F)(F)F)ccc54)c3=O)C[C@@H]21 10.1021/jm990567u
9887378 105181 4 None 40 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 402 8 1 5 1.7 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCC2=O)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL275469 105181 4 None 40 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 402 8 1 5 1.7 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCC2=O)CC1 10.1016/j.bmcl.2004.11.032
11995034 18605 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182148 18605 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214952 18605 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
44388495 70198 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 362 5 3 3 3.4 Nc1ccc(C(=O)NCCN2CCC(c3cccc4[nH]ccc34)CC2)cc1 10.1021/jm0491804
CHEMBL179721 70198 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 362 5 3 3 3.4 Nc1ccc(C(=O)NCCN2CCC(c3cccc4[nH]ccc34)CC2)cc1 10.1021/jm0491804
1212 8443 50 None -19 65 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
204 8443 50 None -19 65 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
3372 8443 50 None -19 65 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
CHEMBL726 8443 50 None -19 65 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
DB00623 8443 50 None -19 65 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
44268966 40211 0 None -7 6 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 7 1 7 3.6 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL14199 40211 0 None -7 6 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 7 1 7 3.6 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
3584 10549 64 None -2 14 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
5401 10549 64 None -2 14 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
7302 10549 64 None -2 14 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
CHEMBL611 10549 64 None -2 14 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
DB01162 10549 64 None -2 14 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
10644152 107171 7 None 1 3 Rat 8.0 pKi = 8.0 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 390 6 0 4 2.7 O=C1C2CCCN2C(=O)N1CCCCN1CCN(c2cccc(Cl)c2)CC1 10.1021/jm970216k
CHEMBL290039 107171 7 None 1 3 Rat 8.0 pKi = 8.0 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 390 6 0 4 2.7 O=C1C2CCCN2C(=O)N1CCCCN1CCN(c2cccc(Cl)c2)CC1 10.1021/jm970216k
44431546 94916 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 482 7 1 6 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3C#N)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234679 94916 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 482 7 1 6 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3C#N)CC2)CC1 10.1016/j.bmcl.2007.04.008
57391897 76084 0 None 1 5 Pig 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 481 12 1 8 2.7 CCOCCOc1ccn2ncc(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
CHEMBL1928133 76084 0 None 1 5 Pig 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 481 12 1 8 2.7 CCOCCOc1ccn2ncc(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
44301573 209576 0 None 154 3 Human 8.0 pKi = 8.0 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 535 7 1 5 4.6 Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CC(O)CN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL62249 209576 0 None 154 3 Human 8.0 pKi = 8.0 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 535 7 1 5 4.6 Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CC(O)CN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
53327992 70179 0 None -1 3 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 461 7 0 5 3.6 COc1ccccc1N1CCN(CCCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796050 70179 0 None -1 3 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 461 7 0 5 3.6 COc1ccccc1N1CCN(CCCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
52948823 23829 0 None -8 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 421 13 1 5 4.9 COc1cccc(OC)c1CCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254659 23829 0 None -8 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 421 13 1 5 4.9 COc1cccc(OC)c1CCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
118716702 121773 0 None 5 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 396 4 0 7 1.1 COc1ccccc1N1CCN(CC2COC3(CCS(=O)(=O)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342855 121773 0 None 5 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 396 4 0 7 1.1 COc1ccccc1N1CCN(CC2COC3(CCS(=O)(=O)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
4110501 175873 8 None -2 2 Rat 8.0 pKi = 8 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 386 6 0 5 2.0 COc1ccccc1N1CCN(CCCN2C(=O)C3CCCCN3C2=O)CC1 10.1021/jm970216k
CHEMBL43992 175873 8 None -2 2 Rat 8.0 pKi = 8 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 386 6 0 5 2.0 COc1ccccc1N1CCN(CCCN2C(=O)C3CCCCN3C2=O)CC1 10.1021/jm970216k
9805944 63001 37 None -16 9 Human 8.0 pKi = 8 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptorDisplacement of [125I]HEAT from adrenergic alpha1A receptor
ChEMBL 462 7 2 3 4.7 CNC(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm800510m
CHEMBL1627 63001 37 None -16 9 Human 8.0 pKi = 8 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptorDisplacement of [125I]HEAT from adrenergic alpha1A receptor
ChEMBL 462 7 2 3 4.7 CNC(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm800510m
2247 7293 81 None -5 42 Rat 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
249 7293 81 None -5 42 Rat 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
2603 7293 81 None -5 42 Rat 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
CHEMBL296419 7293 81 None -5 42 Rat 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
DB00637 7293 81 None -5 42 Rat 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
44461012 111050 0 None 7 3 Human 7.1 pKi = 7.1 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 509 6 0 7 3.7 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3cc4c(cc32)CCCC4)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL309949 111050 0 None 7 3 Human 7.1 pKi = 7.1 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 509 6 0 7 3.7 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3cc4c(cc32)CCCC4)CC1 10.1016/s0960-894x(98)00446-6
9913449 113229 1 None 13 3 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL313990 113229 1 None 13 3 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
5019971 180050 4 None -15 2 Rat 7.0 pKi = 7.0 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 424 5 0 4 3.0 O=C1C2CCCCN2C(=O)N1CCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
CHEMBL45253 180050 4 None -15 2 Rat 7.0 pKi = 7.0 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 424 5 0 4 3.0 O=C1C2CCCCN2C(=O)N1CCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
3805301 108114 83 None 1 2 Bovine 6.1 pKi = 6.1 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1ccc(N2CCNCC2)nc1 10.1021/jm00366a007
CHEMBL296787 108114 83 None 1 2 Bovine 6.1 pKi = 6.1 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1ccc(N2CCNCC2)nc1 10.1021/jm00366a007
44414189 19586 0 None -12 2 Rat 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 342 5 1 5 3.3 Oc1nc2ccccc2n1C1CCN(CCCN2CCCCC2)CC1 10.1016/j.bmcl.2006.05.002
CHEMBL1188266 19586 0 None -12 2 Rat 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 342 5 1 5 3.3 Oc1nc2ccccc2n1C1CCN(CCCN2CCCCC2)CC1 10.1016/j.bmcl.2006.05.002
CHEMBL535838 19586 0 None -12 2 Rat 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 342 5 1 5 3.3 Oc1nc2ccccc2n1C1CCN(CCCN2CCCCC2)CC1 10.1016/j.bmcl.2006.05.002
71061709 156306 0 None -63 12 Mouse 5.0 pKi = 5.0 Binding
Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.
ChEMBL 372 6 0 4 3.5 Clc1cccc(OC[C@@H]2CN(CCN3CCc4ccccc43)CCO2)c1 nan
CHEMBL3946540 156306 0 None -63 12 Mouse 5.0 pKi = 5.0 Binding
Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.
ChEMBL 372 6 0 4 3.5 Clc1cccc(OC[C@@H]2CN(CCN3CCc4ccccc43)CCO2)c1 nan
3658 10879 53 None -9 8 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1016/j.bmcl.2004.06.085
517 10879 53 None -9 8 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1016/j.bmcl.2004.06.085
5709 10879 53 None -9 8 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1016/j.bmcl.2004.06.085
CHEMBL312448 10879 53 None -9 8 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1016/j.bmcl.2004.06.085
DB06694 10879 53 None -9 8 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1016/j.bmcl.2004.06.085
44269078 105373 7 None 1 2 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 202 1 1 2 2.3 CC(C)(C)c1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.06.085
CHEMBL276868 105373 7 None 1 2 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 202 1 1 2 2.3 CC(C)(C)c1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.06.085
135 9310 43 None -46 56 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
1796 9310 43 None -46 56 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
4184 9310 43 None -46 56 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
CHEMBL6437 9310 43 None -46 56 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
DB06148 9310 43 None -46 56 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
44123711 91598 0 None -17 3 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 346 4 0 5 2.9 COc1ccccc1N1CCN(CC2COC3(CCCCC3)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL2234448 91598 0 None -17 3 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 346 4 0 5 2.9 COc1ccccc1N1CCN(CC2COC3(CCCCC3)O2)CC1 10.1007/s00044-010-9379-1
9900133 15757 0 None 1 4 Rat 7.0 pKi = 7.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 271 2 2 3 3.1 COC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL109827 15757 0 None 1 4 Rat 7.0 pKi = 7.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 271 2 2 3 3.1 COC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
46881443 12362 0 None -34 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 405 9 1 5 4.0 COc1cccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1 10.1016/j.bmcl.2010.01.030
CHEMBL1077168 12362 0 None -34 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 405 9 1 5 4.0 COc1cccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1 10.1016/j.bmcl.2010.01.030
44123711 91598 0 None -17 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 346 4 0 5 2.9 COc1ccccc1N1CCN(CC2COC3(CCCCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL2234448 91598 0 None -17 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 346 4 0 5 2.9 COc1ccccc1N1CCN(CC2COC3(CCCCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44123711 91598 0 None -17 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 346 4 0 5 2.9 COc1ccccc1N1CCN(CC2COC3(CCCCC3)O2)CC1 10.1016/j.ejmech.2016.09.050
CHEMBL2234448 91598 0 None -17 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 346 4 0 5 2.9 COc1ccccc1N1CCN(CC2COC3(CCCCC3)O2)CC1 10.1016/j.ejmech.2016.09.050
11449200 85236 0 None 20 3 Rat 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCC[C@H]2c1c[nH]cn1 10.1021/jm030551a
CHEMBL2111710 85236 0 None 20 3 Rat 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCC[C@H]2c1c[nH]cn1 10.1021/jm030551a
9906677 107822 0 None -11 3 Rat 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 355 4 0 4 2.3 O=C1CCC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL294646 107822 0 None -11 3 Rat 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 355 4 0 4 2.3 O=C1CCC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
44312198 211368 0 None -3 4 Human 4.0 pKi = 4.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 292 1 1 5 2.2 Brc1c(NC2=NCCO2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL73164 211368 0 None -3 4 Human 4.0 pKi = 4.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 292 1 1 5 2.2 Brc1c(NC2=NCCO2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
145947560 174487 0 None -4 5 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 344 6 0 3 4.2 Cc1cc(OCCCN2CCN(c3ccccc3)CC2)ccc1Cl 10.1016/j.bmcl.2018.04.059
CHEMBL4212812 174487 0 None -4 5 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 344 6 0 3 4.2 Cc1cc(OCCCN2CCN(c3ccccc3)CC2)ccc1Cl 10.1016/j.bmcl.2018.04.059
CHEMBL4302457 174487 0 None -4 5 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 344 6 0 3 4.2 Cc1cc(OCCCN2CCN(c3ccccc3)CC2)ccc1Cl 10.1016/j.bmcl.2018.04.059
2146 9874 67 None 1 9 Bovine 6.0 pKi = 6.0 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
485 9874 67 None 1 9 Bovine 6.0 pKi = 6.0 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
6041 9874 67 None 1 9 Bovine 6.0 pKi = 6.0 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
CHEMBL1215 9874 67 None 1 9 Bovine 6.0 pKi = 6.0 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
DB00388 9874 67 None 1 9 Bovine 6.0 pKi = 6.0 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
9965896 117151 0 None - 1 Rat 6.0 pKi = 6.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 293 4 2 4 1.8 CCS(=O)(=O)Nc1cccc2c1COC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL324238 117151 0 None - 1 Rat 6.0 pKi = 6.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 293 4 2 4 1.8 CCS(=O)(=O)Nc1cccc2c1COC2c1c[nH]cn1 10.1021/jm030551a
136 10065 32 None -1479 16 Bovine 6.0 pKi = 6.0 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
223 10065 32 None -1479 16 Bovine 6.0 pKi = 6.0 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
643606 10065 32 None -1479 16 Bovine 6.0 pKi = 6.0 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
CHEMBL10347 10065 32 None -1479 16 Bovine 6.0 pKi = 6.0 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
136 10065 32 None -1479 16 Bovine 6.0 pKi = 6.0 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
223 10065 32 None -1479 16 Bovine 6.0 pKi = 6.0 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
643606 10065 32 None -1479 16 Bovine 6.0 pKi = 6.0 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
CHEMBL10347 10065 32 None -1479 16 Bovine 6.0 pKi = 6.0 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
9929936 174691 0 None -9 5 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 0 4 3.1 Cc1ccc(C)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
CHEMBL431354 174691 0 None -9 5 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 0 4 3.1 Cc1ccc(C)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
76318763 91599 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 381 5 2 6 3.0 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccoc1)C3 10.1007/s00044-010-9379-1
CHEMBL2234449 91599 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 381 5 2 6 3.0 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccoc1)C3 10.1007/s00044-010-9379-1
11338016 42750 0 None -7 3 Human 7.0 pKi = 7.0 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 381 5 2 6 3.0 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccco1)C3 10.1021/jm030952q
CHEMBL144286 42750 0 None -7 3 Human 7.0 pKi = 7.0 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 381 5 2 6 3.0 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccco1)C3 10.1021/jm030952q
9929936 174691 0 None -9 5 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 0 4 3.1 Cc1ccc(C)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
CHEMBL431354 174691 0 None -9 5 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 0 4 3.1 Cc1ccc(C)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
9926529 16161 2 None 1 5 Rat 7.0 pKi = 7.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111496 16161 2 None 1 5 Rat 7.0 pKi = 7.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
44361064 38389 0 None -3 6 Human 7.0 pKi = 7.0 Binding
Compound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assay
ChEMBL 338 7 2 4 4.5 N=CCC(O)CC1CCN(c2ccccc2Oc2ccccc2)CC1 10.1021/jm960510x
CHEMBL140450 38389 0 None -3 6 Human 7.0 pKi = 7.0 Binding
Compound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assay
ChEMBL 338 7 2 4 4.5 N=CCC(O)CC1CCN(c2ccccc2Oc2ccccc2)CC1 10.1021/jm960510x
53328687 70176 0 None -1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 483 8 0 5 4.4 COc1ccc(Cl)cc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796047 70176 0 None -1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 483 8 0 5 4.4 COc1ccc(Cl)cc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
10804826 30387 2 None 1 4 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL133451 30387 2 None 1 4 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
10065903 29074 0 None -257 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@H]1[C@@H](NC[C@@H]2COc3ccccc3O2)CC[C@@H]1Oc1ccccc1 10.1021/jm991065j
CHEMBL132378 29074 0 None -257 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@H]1[C@@H](NC[C@@H]2COc3ccccc3O2)CC[C@@H]1Oc1ccccc1 10.1021/jm991065j
44276536 104144 0 None -1584 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 373 8 1 4 3.3 COc1ccccc1N1CCN(CCCCNC(=O)C2CCCCC2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL26962 104144 0 None -1584 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 373 8 1 4 3.3 COc1ccccc1N1CCN(CCCCNC(=O)C2CCCCC2)CC1 10.1016/j.bmcl.2015.12.068
10382537 210945 12 None -144 6 Human 6.0 pKi = 6.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 339 1 2 5 1.6 Ic1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL70676 210945 12 None -144 6 Human 6.0 pKi = 6.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 339 1 2 5 1.6 Ic1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
11488170 42004 0 None -24 3 Human 6.0 pKi = 6.0 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 467 10 2 8 3.6 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNCCOc1c(OC)cccc1OC)C3 10.1021/jm030952q
CHEMBL143558 42004 0 None -24 3 Human 6.0 pKi = 6.0 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 467 10 2 8 3.6 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNCCOc1c(OC)cccc1OC)C3 10.1021/jm030952q
2146 9874 67 None -12 9 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
485 9874 67 None -12 9 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
6041 9874 67 None -12 9 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
CHEMBL1215 9874 67 None -12 9 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
DB00388 9874 67 None -12 9 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
2803 7742 58 None -8 19 Human 6.0 pKi = 6.0 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
516 7742 58 None -8 19 Human 6.0 pKi = 6.0 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
704 7742 58 None -8 19 Human 6.0 pKi = 6.0 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
CHEMBL134 7742 58 None -8 19 Human 6.0 pKi = 6.0 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
DB00575 7742 58 None -8 19 Human 6.0 pKi = 6.0 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
155544514 183134 0 None -309 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.2 COc1ccccc1OCCNC[C@@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4526865 183134 0 None -309 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.2 COc1ccccc1OCCNC[C@@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4595671 183134 0 None -309 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.2 COc1ccccc1OCCNC[C@@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
9944937 118115 0 None 1 2 Bovine 6.0 pKi = 6.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 320 4 2 3 2.1 CN(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL326862 118115 0 None 1 2 Bovine 6.0 pKi = 6.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 320 4 2 3 2.1 CN(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
162265 209053 22 None -5 44 Rat 5.0 pKi = 5.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1007/s00044-004-0020-z
4786 209053 22 None -5 44 Rat 5.0 pKi = 5.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1007/s00044-004-0020-z
CHEMBL61006 209053 22 None -5 44 Rat 5.0 pKi = 5.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1007/s00044-004-0020-z
162265 209053 22 None -5 44 Rat 5.0 pKi = 5.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1021/jm030551a
4786 209053 22 None -5 44 Rat 5.0 pKi = 5.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1021/jm030551a
CHEMBL61006 209053 22 None -5 44 Rat 5.0 pKi = 5.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1021/jm030551a
118718431 122132 0 None 11 2 Human 7.0 pKi = 7.0 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)[C@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@H]1c1ccccc1 10.1016/s0960-894x(98)00451-x
CHEMBL3349545 122132 0 None 11 2 Human 7.0 pKi = 7.0 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)[C@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@H]1c1ccccc1 10.1016/s0960-894x(98)00451-x
44267912 23655 0 None 102 3 Human 7.0 pKi = 7.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 388 8 1 5 1.3 COc1ccccc1N1CCN(CCCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12501 23655 0 None 102 3 Human 7.0 pKi = 7.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 388 8 1 5 1.3 COc1ccccc1N1CCN(CCCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
277 8083 62 None -117 50 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
2913 8083 62 None -117 50 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
765 8083 62 None -117 50 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
CHEMBL516 8083 62 None -117 50 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
DB00434 8083 62 None -117 50 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
10673466 168543 0 None -3 3 Rat 7.0 pKi = 7 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 481 4 1 6 4.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(Cl)cccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL41396 168543 0 None -3 3 Rat 7.0 pKi = 7 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 481 4 1 6 4.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(Cl)cccc54)c3=O)C[C@@H]21 10.1021/jm990567u
10297 33885 30 None -37 43 Rat 5.0 pKi = 5.0 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (6.2 - 15)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (6.2 - 15)
ChEMBL 151 2 2 2 1.1 C[C@H](N)[C@H](O)c1ccccc1 10.1021/jm025550h
CHEMBL136560 33885 30 None -37 43 Rat 5.0 pKi = 5.0 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (6.2 - 15)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (6.2 - 15)
ChEMBL 151 2 2 2 1.1 C[C@H](N)[C@H](O)c1ccccc1 10.1021/jm025550h
25070031 72159 18 None -4897 4 Human 5.0 pKi = 5.0 Binding
Inhibition of adrenergic alpha 1A receptorInhibition of adrenergic alpha 1A receptor
ChEMBL 313 6 1 4 2.7 C[C@@H]1CCCN1CCCOc1ccc(-c2ccc(=O)[nH]n2)cc1 10.1021/jm200401v
CHEMBL1829335 72159 18 None -4897 4 Human 5.0 pKi = 5.0 Binding
Inhibition of adrenergic alpha 1A receptorInhibition of adrenergic alpha 1A receptor
ChEMBL 313 6 1 4 2.7 C[C@@H]1CCCN1CCCOc1ccc(-c2ccc(=O)[nH]n2)cc1 10.1021/jm200401v
2477 7532 59 None - 29 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
36 7532 59 None - 29 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
437 7532 59 None - 29 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
CHEMBL49 7532 59 None - 29 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
DB00490 7532 59 None - 29 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
1816 9318 102 None - 18 Human 8.3 pIC50 = 8.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
4205 9318 102 None - 18 Human 8.3 pIC50 = 8.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
7241 9318 102 None - 18 Human 8.3 pIC50 = 8.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
CHEMBL654 9318 102 None - 18 Human 8.3 pIC50 = 8.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
DB00370 9318 102 None - 18 Human 8.3 pIC50 = 8.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
9952220 105032 6 None - 3 Rat 8.2 pIC50 = 8.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
Drug Central 387 6 2 4 3.8 CNc1cc(OC)c(C(=O)N[C@H]2CCN(Cc3ccccc3)[C@H]2C)cc1Cl None
CHEMBL274491 105032 6 None - 3 Rat 8.2 pIC50 = 8.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
Drug Central 387 6 2 4 3.8 CNc1cc(OC)c(C(=O)N[C@H]2CCN(Cc3ccccc3)[C@H]2C)cc1Cl None
135 9310 43 None -40 56 Human 8.2 pIC50 = 8.2 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 9310 43 None -40 56 Human 8.2 pIC50 = 8.2 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 9310 43 None -40 56 Human 8.2 pIC50 = 8.2 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 9310 43 None -40 56 Human 8.2 pIC50 = 8.2 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 9310 43 None -40 56 Human 8.2 pIC50 = 8.2 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
135398737 7745 93 None - 90 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 7745 93 None - 90 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 7745 93 None - 90 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 7745 93 None - 90 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 7745 93 None - 90 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
5656 209845 87 None - 43 Rat 8.2 pIC50 = 8.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 None
CHEMBL637 209845 87 None - 43 Rat 8.2 pIC50 = 8.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 None
125017 16223 99 None - 0 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 263 4 2 3 2.7 CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1 None
CHEMBL1118 16223 99 None - 0 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 263 4 2 3 2.7 CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1 None
1353 8692 93 None - 85 Bovine 8.1 pIC50 = 8.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 8692 93 None - 85 Bovine 8.1 pIC50 = 8.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 8692 93 None - 85 Bovine 8.1 pIC50 = 8.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 8692 93 None - 85 Bovine 8.1 pIC50 = 8.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 8692 93 None - 85 Bovine 8.1 pIC50 = 8.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
2435 10362 83 None - 48 Rat 8.1 pIC50 = 8.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 10362 83 None - 48 Rat 8.1 pIC50 = 8.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 10362 83 None - 48 Rat 8.1 pIC50 = 8.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 10362 83 None - 48 Rat 8.1 pIC50 = 8.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 10362 83 None - 48 Rat 8.1 pIC50 = 8.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
1427 8794 54 None - 27 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
357 8794 54 None - 27 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
3696 8794 54 None - 27 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
CHEMBL11 8794 54 None - 27 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
DB00458 8794 54 None - 27 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
102 10899 48 None -346 49 Human 8.2 pKd = 8.2 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 10899 48 None -346 49 Human 8.2 pKd = 8.2 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 10899 48 None -346 49 Human 8.2 pKd = 8.2 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 10899 48 None -346 49 Human 8.2 pKd = 8.2 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 10899 48 None -346 49 Human 8.2 pKd = 8.2 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
2803 7742 58 None -3 19 Rat 8.2 pKd = 8.2 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 7742 58 None -3 19 Rat 8.2 pKd = 8.2 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 7742 58 None -3 19 Rat 8.2 pKd = 8.2 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 7742 58 None -3 19 Rat 8.2 pKd = 8.2 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 7742 58 None -3 19 Rat 8.2 pKd = 8.2 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
1353 8692 93 None -10 85 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 8692 93 None -10 85 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 8692 93 None -10 85 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 8692 93 None -10 85 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 8692 93 None -10 85 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
4209 9937 75 None -1 33 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
4893 9937 75 None -1 33 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
503 9937 75 None -1 33 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
5385 9937 75 None -1 33 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
CHEMBL2 9937 75 None -1 33 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
DB00457 9937 75 None -1 33 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
4106 9280 22 3H-PRAZOSIN -1 33 Pig 10.2 pKi = 10.2 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
5358812 9280 22 3H-PRAZOSIN -1 33 Pig 10.2 pKi = 10.2 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
89 9280 22 3H-PRAZOSIN -1 33 Pig 10.2 pKi = 10.2 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
CHEMBL93240 9280 22 3H-PRAZOSIN -1 33 Pig 10.2 pKi = 10.2 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
None 222737 0 3H-PRAZOSIN -5 19 Pig 10.1 pKi = 10.1 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
4209 9937 75 3H-PRAZOSIN -1 33 Pig 9.6 pKi = 9.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 9937 75 3H-PRAZOSIN -1 33 Pig 9.6 pKi = 9.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 9937 75 3H-PRAZOSIN -1 33 Pig 9.6 pKi = 9.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 9937 75 3H-PRAZOSIN -1 33 Pig 9.6 pKi = 9.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 9937 75 3H-PRAZOSIN -1 33 Pig 9.6 pKi = 9.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 9937 75 3H-PRAZOSIN -1 33 Pig 9.6 pKi = 9.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4106 9280 22 3H-PRAZOSIN -1 33 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
5358812 9280 22 3H-PRAZOSIN -1 33 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
89 9280 22 3H-PRAZOSIN -1 33 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
CHEMBL93240 9280 22 3H-PRAZOSIN -1 33 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
2389 10104 118 3H-PRAZOSIN -5 66 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 10104 118 3H-PRAZOSIN -5 66 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 10104 118 3H-PRAZOSIN -5 66 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 10104 118 3H-PRAZOSIN -5 66 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 10104 118 3H-PRAZOSIN -5 66 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
None 222737 0 3H-PRAZOSIN -5 19 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
4209 9937 75 3H-PRAZOSIN -1 33 Pig 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 9937 75 3H-PRAZOSIN -1 33 Pig 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 9937 75 3H-PRAZOSIN -1 33 Pig 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 9937 75 3H-PRAZOSIN -1 33 Pig 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 9937 75 3H-PRAZOSIN -1 33 Pig 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 9937 75 3H-PRAZOSIN -1 33 Pig 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
489 6933 28 3H-PRAZOSIN -8 12 Pig 9.1 pKi = 9.1 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
5640 6933 28 3H-PRAZOSIN -8 12 Pig 9.1 pKi = 9.1 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
CHEMBL420060 6933 28 3H-PRAZOSIN -8 12 Pig 9.1 pKi = 9.1 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
489 6933 28 3H-PRAZOSIN -8 12 Pig 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
5640 6933 28 3H-PRAZOSIN -8 12 Pig 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
CHEMBL420060 6933 28 3H-PRAZOSIN -8 12 Pig 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
2389 10104 118 3H-PRAZOSIN -5 66 Pig 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 10104 118 3H-PRAZOSIN -5 66 Pig 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 10104 118 3H-PRAZOSIN -5 66 Pig 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 10104 118 3H-PRAZOSIN -5 66 Pig 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 10104 118 3H-PRAZOSIN -5 66 Pig 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
463 8187 22 None 5 13 Human 8.0 pKi = 8 Binding
GRAC: human a1A selective antagonistGRAC: human a1A selective antagonist
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
6918097 8187 22 None 5 13 Human 8.0 pKi = 8 Binding
GRAC: human a1A selective antagonistGRAC: human a1A selective antagonist
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
837 8187 22 None 5 13 Human 8.0 pKi = 8 Binding
GRAC: human a1A selective antagonistGRAC: human a1A selective antagonist
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
CHEMBL2051956 8187 22 None 5 13 Human 8.0 pKi = 8 Binding
GRAC: human a1A selective antagonistGRAC: human a1A selective antagonist
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
DB14068 8187 22 None 5 13 Human 8.0 pKi = 8 Binding
GRAC: human a1A selective antagonistGRAC: human a1A selective antagonist
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
4209 9937 75 None -1 33 Rat 8.0 pKi = 8.0 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 9937 75 None -1 33 Rat 8.0 pKi = 8.0 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 9937 75 None -1 33 Rat 8.0 pKi = 8.0 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 9937 75 None -1 33 Rat 8.0 pKi = 8.0 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 9937 75 None -1 33 Rat 8.0 pKi = 8.0 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 9937 75 None -1 33 Rat 8.0 pKi = 8.0 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4209 9937 75 None -1 33 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 9937 75 None -1 33 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 9937 75 None -1 33 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 9937 75 None -1 33 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 9937 75 None -1 33 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 9937 75 None -1 33 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4151 10379 89 None 33 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
493 10379 89 None 33 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
5312125 10379 89 None 33 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
CHEMBL24778 10379 89 None 33 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
DB06207 10379 89 None 33 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
129211 10521 78 None -2 16 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
2562 10521 78 None -2 16 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
488 10521 78 None -2 16 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
CHEMBL836 10521 78 None -2 16 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
DB00706 10521 78 None -2 16 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
129211 10521 78 None -1 16 Human 8.0 pKi = 8.0 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
2562 10521 78 None -1 16 Human 8.0 pKi = 8.0 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
488 10521 78 None -1 16 Human 8.0 pKi = 8.0 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
CHEMBL836 10521 78 None -1 16 Human 8.0 pKi = 8.0 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
DB00706 10521 78 None -1 16 Human 8.0 pKi = 8.0 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
484 9633 51 3H-PRAZOSIN -67 35 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 9633 51 3H-PRAZOSIN -67 35 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 9633 51 3H-PRAZOSIN -67 35 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
2470 10425 50 3H-PRAZOSIN -478 58 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3300 10425 50 3H-PRAZOSIN -478 58 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
5265 10425 50 3H-PRAZOSIN -478 58 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
99 10425 50 3H-PRAZOSIN -478 58 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL267930 10425 50 3H-PRAZOSIN -478 58 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
100 10577 58 3H-PRAZOSIN -20 54 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 10577 58 3H-PRAZOSIN -20 54 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 10577 58 3H-PRAZOSIN -20 54 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 10577 58 3H-PRAZOSIN -20 54 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 10577 58 3H-PRAZOSIN -20 54 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2389 10104 118 3H-PRAZOSIN -5 66 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 10104 118 3H-PRAZOSIN -5 66 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 10104 118 3H-PRAZOSIN -5 66 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 10104 118 3H-PRAZOSIN -5 66 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 10104 118 3H-PRAZOSIN -5 66 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
100 10577 58 3H-PRAZOSIN -20 54 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 10577 58 3H-PRAZOSIN -20 54 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 10577 58 3H-PRAZOSIN -20 54 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 10577 58 3H-PRAZOSIN -20 54 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 10577 58 3H-PRAZOSIN -20 54 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
None 222737 0 3H-PRAZOSIN -5 19 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
2726 7706 68 3H-PRAZOSIN -20 72 Pig 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 7706 68 3H-PRAZOSIN -20 72 Pig 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 7706 68 3H-PRAZOSIN -20 72 Pig 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 7706 68 3H-PRAZOSIN -20 72 Pig 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 7706 68 3H-PRAZOSIN -20 72 Pig 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
124 9755 47 3H-PRAZOSIN -36 32 Pig 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 9755 47 3H-PRAZOSIN -36 32 Pig 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 9755 47 3H-PRAZOSIN -36 32 Pig 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 9755 47 3H-PRAZOSIN -36 32 Pig 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 9755 47 3H-PRAZOSIN -36 32 Pig 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
None 223020 0 3H-PRAZOSIN -2 3 Pig 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 609 10 1 8 6.0 CC1=C(C(C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC None
126225 101751 5 3H-PRAZOSIN -41 7 Pig 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 None
CHEMBL25467 101751 5 3H-PRAZOSIN -41 7 Pig 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 None
None 223020 0 3H-PRAZOSIN -2 3 Pig 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 609 10 1 8 6.0 CC1=C(C(C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC None
135398737 7745 93 3H-PRAZOSIN -9 90 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 7745 93 3H-PRAZOSIN -9 90 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 7745 93 3H-PRAZOSIN -9 90 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 7745 93 3H-PRAZOSIN -9 90 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 7745 93 3H-PRAZOSIN -9 90 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
489 6933 28 3H-PRAZOSIN -8 12 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
5640 6933 28 3H-PRAZOSIN -8 12 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
CHEMBL420060 6933 28 3H-PRAZOSIN -8 12 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
124 9755 47 3H-PRAZOSIN -36 32 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 9755 47 3H-PRAZOSIN -36 32 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 9755 47 3H-PRAZOSIN -36 32 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 9755 47 3H-PRAZOSIN -36 32 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 9755 47 3H-PRAZOSIN -36 32 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
None 223020 0 3H-PRAZOSIN -2 3 Pig 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 609 10 1 8 6.0 CC1=C(C(C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC None
100 10577 58 3H-PRAZOSIN -20 54 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 10577 58 3H-PRAZOSIN -20 54 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 10577 58 3H-PRAZOSIN -20 54 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 10577 58 3H-PRAZOSIN -20 54 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 10577 58 3H-PRAZOSIN -20 54 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
1028 7079 71 3H-PRAZOSIN -741 30 Pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 7079 71 3H-PRAZOSIN -741 30 Pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 7079 71 3H-PRAZOSIN -741 30 Pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 7079 71 3H-PRAZOSIN -741 30 Pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 7079 71 3H-PRAZOSIN -741 30 Pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 7079 71 3H-PRAZOSIN -741 30 Pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
3016 8194 48 None 46 5 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 284 1 0 2 3.2 Clc1ccc2c(c1)C(=NCC(=O)N2C)c1ccccc1 None
3364 8194 48 None 46 5 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 284 1 0 2 3.2 Clc1ccc2c(c1)C(=NCC(=O)N2C)c1ccccc1 None
852 8194 48 None 46 5 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 284 1 0 2 3.2 Clc1ccc2c(c1)C(=NCC(=O)N2C)c1ccccc1 None
CHEMBL12 8194 48 None 46 5 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 284 1 0 2 3.2 Clc1ccc2c(c1)C(=NCC(=O)N2C)c1ccccc1 None
DB00829 8194 48 None 46 5 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 284 1 0 2 3.2 Clc1ccc2c(c1)C(=NCC(=O)N2C)c1ccccc1 None
4508 9913 98 None 1 13 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O None
4866774 9913 98 None 1 13 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O None
509 9913 98 None 1 13 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O None
838 9913 98 None 1 13 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O None
CHEMBL1740 9913 98 None 1 13 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O None
DB11124 9913 98 None 1 13 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O None
162265 209053 22 None -5 44 Rat 8.3 pKi = 8.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
4786 209053 22 None -5 44 Rat 8.3 pKi = 8.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
CHEMBL61006 209053 22 None -5 44 Rat 8.3 pKi = 8.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
2470 10425 50 3H-PRAZOSIN -478 58 Pig 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3300 10425 50 3H-PRAZOSIN -478 58 Pig 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
5265 10425 50 3H-PRAZOSIN -478 58 Pig 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
99 10425 50 3H-PRAZOSIN -478 58 Pig 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL267930 10425 50 3H-PRAZOSIN -478 58 Pig 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
68712 107114 60 None -8 5 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
CHEMBL289480 107114 60 None -8 5 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
2146 9874 67 None -2 9 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
485 9874 67 None -2 9 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
6041 9874 67 None -2 9 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
CHEMBL1215 9874 67 None -2 9 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
DB00388 9874 67 None -2 9 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
2695 10613 81 None 9 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
5504 10613 81 None 9 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
7310 10613 81 None 9 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
CHEMBL770 10613 81 None 9 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
DB00797 10613 81 None 9 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
2435 7509 100 None -21 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
395 7509 100 None -21 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
520 7509 100 None -21 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
5386 7509 100 None -21 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
CHEMBL844 7509 100 None -21 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
DB00484 7509 100 None -21 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
1830 9368 44 None 1 28 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
207 9368 44 None 1 28 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
23897 9368 44 None 1 28 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
CHEMBL460 9368 44 None 1 28 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
DB01618 9368 44 None 1 28 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
2162 48288 100 None -3 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
Drug Central 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl None
CHEMBL1491 48288 100 None -3 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
Drug Central 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl None
446220 140299 14 None 19 45 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 303 3 0 5 1.9 COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C None
CHEMBL370805 140299 14 None 19 45 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 303 3 0 5 1.9 COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C None
1028 7079 71 None -48 30 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 7079 71 None -48 30 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 7079 71 None -48 30 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 7079 71 None -48 30 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 7079 71 None -48 30 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 7079 71 None -48 30 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
1960 9632 67 None -57 26 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
439260 9632 67 None -57 26 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
505 9632 67 None -57 26 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL1437 9632 67 None -57 26 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
DB00368 9632 67 None -57 26 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
126225 101751 5 3H-PRAZOSIN -41 7 Pig 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 None
CHEMBL25467 101751 5 3H-PRAZOSIN -41 7 Pig 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 None
484 9633 51 3H-PRAZOSIN -67 35 Pig 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 9633 51 3H-PRAZOSIN -67 35 Pig 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 9633 51 3H-PRAZOSIN -67 35 Pig 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
2146 9874 67 None 1 9 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
485 9874 67 None 1 9 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
6041 9874 67 None 1 9 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
CHEMBL1215 9874 67 None 1 9 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
DB00388 9874 67 None 1 9 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
2202 9906 96 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
4850 9906 96 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
49 9906 96 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
CHEMBL1371770 9906 96 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
DB12478 9906 96 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
135398737 7745 93 3H-PRAZOSIN -9 90 Pig 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 7745 93 3H-PRAZOSIN -9 90 Pig 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 7745 93 3H-PRAZOSIN -9 90 Pig 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 7745 93 3H-PRAZOSIN -9 90 Pig 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 7745 93 3H-PRAZOSIN -9 90 Pig 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
1960 9632 67 None -10 26 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
439260 9632 67 None -10 26 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
505 9632 67 None -10 26 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL1437 9632 67 None -10 26 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
DB00368 9632 67 None -10 26 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
5284550 48495 15 None 1 9 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 None
CHEMBL1492500 48495 15 None 1 9 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 None
2477 7532 59 None 1 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
36 7532 59 None 1 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
437 7532 59 None 1 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
CHEMBL49 7532 59 None 1 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
DB00490 7532 59 None 1 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
37 7565 60 None -18 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
460 7565 60 None -18 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
54746 7565 60 None -18 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
CHEMBL1201087 7565 60 None -18 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
DB00248 7565 60 None -18 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
66265 100788 15 None -1 19 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1 None
CHEMBL248702 100788 15 None -1 19 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1 None
3151 8244 97 None -8 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
945 8244 97 None -8 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
965 8244 97 None -8 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
CHEMBL219916 8244 97 None -8 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
DB01184 8244 97 None -8 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
16362 9899 71 None -35 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
2172 9899 71 None -35 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
90 9899 71 None -35 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
CHEMBL1423 9899 71 None -35 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
DB01100 9899 71 None -35 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
15387 52596 55 None 1 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 263 5 0 2 3.5 CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1 None
CHEMBL1531134 52596 55 None 1 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 263 5 0 2 3.5 CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1 None
68617 212306 62 None 3 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 None
CHEMBL1709 212306 62 None 3 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 None
CHEMBL809 212306 62 None 3 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 None
2470 10425 50 3H-PRAZOSIN -478 58 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3300 10425 50 3H-PRAZOSIN -478 58 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
5265 10425 50 3H-PRAZOSIN -478 58 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
99 10425 50 3H-PRAZOSIN -478 58 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL267930 10425 50 3H-PRAZOSIN -478 58 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
126225 101751 5 3H-PRAZOSIN -41 7 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 None
CHEMBL25467 101751 5 3H-PRAZOSIN -41 7 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 None
135398737 7745 93 3H-PRAZOSIN -9 90 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 7745 93 3H-PRAZOSIN -9 90 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 7745 93 3H-PRAZOSIN -9 90 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 7745 93 3H-PRAZOSIN -9 90 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 7745 93 3H-PRAZOSIN -9 90 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
484 9633 51 3H-PRAZOSIN -67 35 Pig 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 9633 51 3H-PRAZOSIN -67 35 Pig 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 9633 51 3H-PRAZOSIN -67 35 Pig 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
2995 211184 53 None 3 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
CHEMBL1696 211184 53 None 3 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
CHEMBL72 211184 53 None 3 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
DB01151 211184 53 None 3 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
3947 213174 53 None -1 16 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 418 7 0 3 5.8 CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1 None
CHEMBL87708 213174 53 None -1 16 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 418 7 0 3 5.8 CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1 None
3658 10879 53 None -9 8 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
517 10879 53 None -9 8 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
5709 10879 53 None -9 8 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
CHEMBL312448 10879 53 None -9 8 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
DB06694 10879 53 None -9 8 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
2448 106099 70 None -5 18 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 419 6 1 3 4.5 O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1 None
CHEMBL28218 106099 70 None -5 18 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 419 6 1 3 4.5 O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1 None
DB12401 106099 70 None -5 18 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 419 6 1 3 4.5 O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1 None
21302490 119582 32 None -10 9 Human 8.2 pKi = 8.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
Drug Central 393 5 0 4 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12 None
CHEMBL3233142 119582 32 None -10 9 Human 8.2 pKi = 8.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
Drug Central 393 5 0 4 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12 None
CHEMBL3306803 119582 32 None -10 9 Human 8.2 pKi = 8.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
Drug Central 393 5 0 4 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12 None
DB06077 119582 32 None -10 9 Human 8.2 pKi = 8.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
Drug Central 393 5 0 4 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12 None
242 7258 124 None -14 51 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
34 7258 124 None -14 51 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
60795 7258 124 None -14 51 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
CHEMBL1112 7258 124 None -14 51 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
DB01238 7258 124 None -14 51 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
125564 7453 97 None -12 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 367 3 0 3 4.7 CCN1CCN(CC1)c1nc2CCCCCCc2c(c1)c1ccc(cc1)F None
388 7453 97 None -12 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 367 3 0 3 4.7 CCN1CCN(CC1)c1nc2CCCCCCc2c(c1)c1ccc(cc1)F None
7670 7453 97 None -12 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 367 3 0 3 4.7 CCN1CCN(CC1)c1nc2CCCCCCc2c(c1)c1ccc(cc1)F None
CHEMBL178803 7453 97 None -12 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 367 3 0 3 4.7 CCN1CCN(CC1)c1nc2CCCCCCc2c(c1)c1ccc(cc1)F None
DB09223 7453 97 None -12 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 367 3 0 3 4.7 CCN1CCN(CC1)c1nc2CCCCCCc2c(c1)c1ccc(cc1)F None
1971 9641 38 None -1 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
2404 9641 38 None -1 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
4543 9641 38 None -1 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
CHEMBL445 9641 38 None -1 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
DB00540 9641 38 None -1 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
2267 7347 71 None -15 7 Human 8.1 pKi = 8.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
271 7347 71 None -15 7 Human 8.1 pKi = 8.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
7121 7347 71 None -15 7 Human 8.1 pKi = 8.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
CHEMBL639 7347 71 None -15 7 Human 8.1 pKi = 8.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
DB00972 7347 71 None -15 7 Human 8.1 pKi = 8.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
2267 7347 71 None -15 7 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
271 7347 71 None -15 7 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
7121 7347 71 None -15 7 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
CHEMBL639 7347 71 None -15 7 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
DB00972 7347 71 None -15 7 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
135 9310 43 None -9 56 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 9310 43 None -9 56 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 9310 43 None -9 56 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 9310 43 None -9 56 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 9310 43 None -9 56 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
277 8083 62 None -20 50 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
2913 8083 62 None -20 50 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
765 8083 62 None -20 50 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
CHEMBL516 8083 62 None -20 50 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
DB00434 8083 62 None -20 50 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
3294 8787 111 None -10 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
71360 8787 111 None -10 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
87 8787 111 None -10 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
CHEMBL14376 8787 111 None -10 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
DB04946 8787 111 None -10 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
1613 9127 53 None -2 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
205 9127 53 None -2 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
3964 9127 53 None -2 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
CHEMBL831 9127 53 None -2 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
DB00408 9127 53 None -2 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
240 7731 43 None -4 25 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
2769 7731 43 None -4 25 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
44279790 7731 43 None -4 25 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
660 7731 43 None -4 25 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
CHEMBL1729 7731 43 None -4 25 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
CHEMBL560739 7731 43 None -4 25 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
DB00604 7731 43 None -4 25 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
3584 10549 64 None -3 14 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
5401 10549 64 None -3 14 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
7302 10549 64 None -3 14 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
CHEMBL611 10549 64 None -3 14 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
DB01162 10549 64 None -3 14 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
2274 9947 58 None -3 31 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
4917 9947 58 None -3 31 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
7279 9947 58 None -3 31 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
CHEMBL728 9947 58 None -3 31 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
DB00433 9947 58 None -3 31 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
214 10632 58 None -9 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
2740 10632 58 None -9 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
5566 10632 58 None -9 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
66064 10632 58 None -9 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL422 10632 58 None -9 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00831 10632 58 None -9 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
1225 8253 26 None -26 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
3958 8253 26 None -26 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
667468 8253 26 None -26 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
667477 8253 26 None -26 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
CHEMBL101740 8253 26 None -26 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
CHEMBL860 8253 26 None -26 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
DB01142 8253 26 None -26 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
115 7131 71 None -2 7 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
2092 7131 71 None -2 7 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
7109 7131 71 None -2 7 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
CHEMBL709 7131 71 None -2 7 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
DB00346 7131 71 None -2 7 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
135398737 7745 93 None -5 90 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 7745 93 None -5 90 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 7745 93 None -5 90 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 7745 93 None -5 90 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 7745 93 None -5 90 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
135398745 9688 112 None -39 65 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 9688 112 None -39 65 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 9688 112 None -39 65 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 9688 112 None -39 65 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
1890 9535 49 None -1 16 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl None
4449 9535 49 None -1 16 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl None
7247 9535 49 None -1 16 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl None
CHEMBL623 9535 49 None -1 16 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl None
DB01149 9535 49 None -1 16 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl None
2470 10425 50 None -316 58 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3300 10425 50 None -316 58 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
5265 10425 50 None -316 58 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
99 10425 50 None -316 58 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL267930 10425 50 None -316 58 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
124 9755 47 None -14 32 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 9755 47 None -14 32 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 9755 47 None -14 32 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 9755 47 None -14 32 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 9755 47 None -14 32 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2389 10104 118 None -6 66 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 10104 118 None -6 66 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 10104 118 None -6 66 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 10104 118 None -6 66 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 10104 118 None -6 66 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
1353 8692 93 None -6 85 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 8692 93 None -6 85 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 8692 93 None -6 85 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 8692 93 None -6 85 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 8692 93 None -6 85 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
1443 8809 34 None -2 11 Bovine 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
33625 8809 34 None -2 11 Bovine 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
501 8809 34 None -2 11 Bovine 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
CHEMBL279516 8809 34 None -2 11 Bovine 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
DB08950 8809 34 None -2 11 Bovine 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
212 10578 47 None -7 25 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
2639 10578 47 None -7 25 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
941651 10578 47 None -7 25 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
CHEMBL1201 10578 47 None -7 25 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
DB01623 10578 47 None -7 25 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
2726 7706 68 3H-PRAZOSIN -20 72 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 7706 68 3H-PRAZOSIN -20 72 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 7706 68 3H-PRAZOSIN -20 72 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 7706 68 3H-PRAZOSIN -20 72 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 7706 68 3H-PRAZOSIN -20 72 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
4106 9280 22 3H-PRAZOSIN -1 33 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
5358812 9280 22 3H-PRAZOSIN -1 33 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
89 9280 22 3H-PRAZOSIN -1 33 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
CHEMBL93240 9280 22 3H-PRAZOSIN -1 33 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
209 9831 97 None -11 23 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
2113 9831 97 None -11 23 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
4748 9831 97 None -11 23 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
CHEMBL567 9831 97 None -11 23 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
DB00850 9831 97 None -11 23 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
2865 10915 73 None -14 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 10915 73 None -14 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 10915 73 None -14 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 10915 73 None -14 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 10915 73 None -14 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
115 7131 71 None -3 7 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
2092 7131 71 None -3 7 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
7109 7131 71 None -3 7 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
CHEMBL709 7131 71 None -3 7 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
DB00346 7131 71 None -3 7 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
2470 10425 50 None -208 58 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3300 10425 50 None -208 58 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
5265 10425 50 None -208 58 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
99 10425 50 None -208 58 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL267930 10425 50 None -208 58 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
135398737 7745 93 None -5 90 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 7745 93 None -5 90 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 7745 93 None -5 90 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 7745 93 None -5 90 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 7745 93 None -5 90 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
2470 10425 50 None -398 58 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3300 10425 50 None -398 58 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
5265 10425 50 None -398 58 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
99 10425 50 None -398 58 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL267930 10425 50 None -398 58 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
103 10925 61 None -6 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2875 10925 61 None -6 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
5736 10925 61 None -6 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL285802 10925 61 None -6 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
DB09225 10925 61 None -6 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2142 9870 58 None -1 37 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 9870 58 None -1 37 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 9870 58 None -1 37 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 9870 58 None -1 37 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 9870 58 None -1 37 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 9870 58 None -1 37 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
1212 8443 50 None -16 65 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
204 8443 50 None -16 65 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3372 8443 50 None -16 65 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL726 8443 50 None -16 65 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00623 8443 50 None -16 65 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
124 9755 47 None -13 32 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 9755 47 None -13 32 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 9755 47 None -13 32 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 9755 47 None -13 32 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 9755 47 None -13 32 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
3389 224490 0 None -1 26 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 549 12 0 6 6.8 CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1 None
463 8187 22 None -7 13 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
6918097 8187 22 None -7 13 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
837 8187 22 None -7 13 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
CHEMBL2051956 8187 22 None -7 13 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
DB14068 8187 22 None -7 13 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
1524 8962 96 None -5 51 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
197 8962 96 None -5 51 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
3822 8962 96 None -5 51 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
88 8962 96 None -5 51 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
CHEMBL51 8962 96 None -5 51 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
DB12465 8962 96 None -5 51 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
124 9755 47 None -19 32 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 9755 47 None -19 32 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 9755 47 None -19 32 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 9755 47 None -19 32 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 9755 47 None -19 32 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2284 9956 33 None -3 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
4926 9956 33 None -3 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
7281 9956 33 None -3 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
CHEMBL564 9956 33 None -3 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
DB00420 9956 33 None -3 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
1588 9105 27 None -23 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
28864 9105 27 None -23 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
43 9105 27 None -23 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL157138 9105 27 None -23 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
DB00589 9105 27 None -23 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
31101 7516 40 None -12 35 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
35 7516 40 None -12 35 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
403 7516 40 None -12 35 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
CHEMBL493 7516 40 None -12 35 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
DB01200 7516 40 None -12 35 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
2142 9870 58 None -2 37 Human 8.1 pKi = 8.1 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 9870 58 None -2 37 Human 8.1 pKi = 8.1 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 9870 58 None -2 37 Human 8.1 pKi = 8.1 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 9870 58 None -2 37 Human 8.1 pKi = 8.1 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 9870 58 None -2 37 Human 8.1 pKi = 8.1 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 9870 58 None -2 37 Human 8.1 pKi = 8.1 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
11978813 7508 79 None -10 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
5014 7508 79 None -10 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
7672 7508 79 None -10 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
CHEMBL2105760 7508 79 None -10 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
DB09128 7508 79 None -10 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
4418 40996 85 None -1 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 None
CHEMBL142635 40996 85 None -1 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 None
DB12092 40996 85 None -1 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 None
1443 8809 34 None 1 11 Human 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
33625 8809 34 None 1 11 Human 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
501 8809 34 None 1 11 Human 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
CHEMBL279516 8809 34 None 1 11 Human 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
DB08950 8809 34 None 1 11 Human 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
102 10899 48 None -85 49 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 10899 48 None -85 49 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 10899 48 None -85 49 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 10899 48 None -85 49 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 10899 48 None -85 49 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
2398 7741 62 None 1 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
2801 7741 62 None 1 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
701 7741 62 None 1 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
CHEMBL415 7741 62 None 1 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
DB01242 7741 62 None 1 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
2601 10552 33 None -5 21 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
443951 10552 33 None -5 21 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
56 10552 33 None -5 21 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL73151 10552 33 None -5 21 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
DB13399 10552 33 None -5 21 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
2389 10104 118 None -11 66 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 10104 118 None -11 66 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 10104 118 None -11 66 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 10104 118 None -11 66 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 10104 118 None -11 66 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
115237 62359 119 None -36 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
CHEMBL1621 62359 119 None -36 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
DB01267 62359 119 None -36 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
2585 7590 103 None -9 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
522 7590 103 None -9 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
551 7590 103 None -9 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
CHEMBL723 7590 103 None -9 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
DB01136 7590 103 None -9 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
5440 35497 37 None -1 9 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 None
CHEMBL1378 35497 37 None -1 9 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 None
DB00372 35497 37 None -1 9 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 None
2435 10362 83 None -16 48 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 10362 83 None -16 48 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 10362 83 None -16 48 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 10362 83 None -16 48 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 10362 83 None -16 48 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
3157 8252 71 None -2 12 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
7170 8252 71 None -2 12 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
954 8252 71 None -2 12 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
CHEMBL707 8252 71 None -2 12 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
DB00590 8252 71 None -2 12 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
5639 105671 75 None -1 5 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 None
CHEMBL279229 105671 75 None -1 5 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 None
3036780 114308 20 None -52 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
46780481 114308 20 None -52 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
9903970 114308 20 None -52 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3187365 114308 20 None -52 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3544974 114308 20 None -52 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL504548 114308 20 None -52 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
DB06216 114308 20 None -52 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
3584 10549 64 None -2 14 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
5401 10549 64 None -2 14 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
7302 10549 64 None -2 14 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
CHEMBL611 10549 64 None -2 14 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
DB01162 10549 64 None -2 14 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
3584 10549 64 None -2 14 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
5401 10549 64 None -2 14 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
7302 10549 64 None -2 14 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
CHEMBL611 10549 64 None -2 14 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
DB01162 10549 64 None -2 14 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
1238 209953 24 None -3 16 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
Drug Central 344 1 0 3 4.3 CN1CCN(C2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 None
CHEMBL64249 209953 24 None -3 16 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
Drug Central 344 1 0 3 4.3 CN1CCN(C2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 None
2865 10915 73 None -4 53 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 10915 73 None -4 53 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 10915 73 None -4 53 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 10915 73 None -4 53 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 10915 73 None -4 53 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
463 8187 22 None -8 13 Bovine 8.0 pKi = 8.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
6918097 8187 22 None -8 13 Bovine 8.0 pKi = 8.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
837 8187 22 None -8 13 Bovine 8.0 pKi = 8.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
CHEMBL2051956 8187 22 None -8 13 Bovine 8.0 pKi = 8.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
DB14068 8187 22 None -8 13 Bovine 8.0 pKi = 8.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
2435 10362 83 None -3 48 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 10362 83 None -3 48 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 10362 83 None -3 48 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 10362 83 None -3 48 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 10362 83 None -3 48 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
4209 9937 75 None -1 33 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 9937 75 None -1 33 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 9937 75 None -1 33 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 9937 75 None -1 33 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 9937 75 None -1 33 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 9937 75 None -1 33 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
129211 10521 78 None -7 16 Bovine 8.0 pKi = 8 Binding
NoneNone
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
2562 10521 78 None -7 16 Bovine 8.0 pKi = 8 Binding
NoneNone
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
488 10521 78 None -7 16 Bovine 8.0 pKi = 8 Binding
NoneNone
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
CHEMBL836 10521 78 None -7 16 Bovine 8.0 pKi = 8 Binding
NoneNone
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
DB00706 10521 78 None -7 16 Bovine 8.0 pKi = 8 Binding
NoneNone
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
4151 10379 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 31285236
4151 10379 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 32608144
4151 10379 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 7651358
493 10379 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 31285236
493 10379 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 32608144
493 10379 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 7651358
5312125 10379 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 31285236
5312125 10379 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 32608144
5312125 10379 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 7651358
CHEMBL24778 10379 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 31285236
CHEMBL24778 10379 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 32608144
CHEMBL24778 10379 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 7651358
DB06207 10379 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 31285236
DB06207 10379 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 32608144
DB06207 10379 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 7651358
129211 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10334511
129211 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10369480
129211 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 31285236
129211 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 32608144
129211 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7651358
129211 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7815325
129211 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9249248
129211 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9490024
2562 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10334511
2562 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10369480
2562 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 31285236
2562 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 32608144
2562 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7651358
2562 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7815325
2562 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9249248
2562 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9490024
488 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10334511
488 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10369480
488 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 31285236
488 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 32608144
488 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7651358
488 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7815325
488 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9249248
488 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9490024
CHEMBL836 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10334511
CHEMBL836 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10369480
CHEMBL836 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 31285236
CHEMBL836 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 32608144
CHEMBL836 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7651358
CHEMBL836 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7815325
CHEMBL836 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9249248
CHEMBL836 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9490024
DB00706 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10334511
DB00706 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10369480
DB00706 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 31285236
DB00706 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 32608144
DB00706 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7651358
DB00706 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7815325
DB00706 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9249248
DB00706 10521 78 None -1 16 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9490024
4431 9506 25 None 1 12 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 11459121
73 9506 25 None 1 12 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 11459121
CHEMBL8618 9506 25 None 1 12 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 11459121
1753 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10433504
1753 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
1753 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
1753 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
1753 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7651358
1753 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7815325
483 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10433504
483 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
483 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
483 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
483 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7651358
483 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7815325
6082 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10433504
6082 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
6082 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
6082 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
6082 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7651358
6082 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7815325
CHEMBL524 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10433504
CHEMBL524 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
CHEMBL524 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
CHEMBL524 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
CHEMBL524 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7651358
CHEMBL524 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7815325
DB00723 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10433504
DB00723 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
DB00723 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
DB00723 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
DB00723 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7651358
DB00723 9282 28 None -11 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7815325
247704 7078 31 None -10 5 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@H](c1ccc(c(c1)O)O)O 7815325
4450 7078 31 None -10 5 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@H](c1ccc(c(c1)O)O)O 7815325
CHEMBL42280 7078 31 None -10 5 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@H](c1ccc(c(c1)O)O)O 7815325
507 10101 0 None -2511 2 Rat 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12824165
2146 9874 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10433504
2146 9874 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
2146 9874 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
2146 9874 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
485 9874 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10433504
485 9874 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
485 9874 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
485 9874 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
6041 9874 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10433504
6041 9874 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
6041 9874 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
6041 9874 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
CHEMBL1215 9874 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10433504
CHEMBL1215 9874 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
CHEMBL1215 9874 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
CHEMBL1215 9874 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
DB00388 9874 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10433504
DB00388 9874 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
DB00388 9874 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
DB00388 9874 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
1960 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10433504
1960 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
1960 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
1960 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
1960 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7651358
1960 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7815325
1960 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 8564227
439260 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10433504
439260 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
439260 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
439260 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
439260 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7651358
439260 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7815325
439260 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 8564227
505 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10433504
505 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
505 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
505 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
505 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7651358
505 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7815325
505 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 8564227
CHEMBL1437 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10433504
CHEMBL1437 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
CHEMBL1437 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
CHEMBL1437 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
CHEMBL1437 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7651358
CHEMBL1437 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7815325
CHEMBL1437 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 8564227
DB00368 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10433504
DB00368 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
DB00368 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
DB00368 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
DB00368 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7651358
DB00368 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7815325
DB00368 9632 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 8564227
1028 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
1028 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7651358
1028 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7815325
1028 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 8564227
139148732 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
139148732 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7651358
139148732 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7815325
139148732 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 8564227
479 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
479 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7651358
479 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7815325
479 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 8564227
5816 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
5816 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7651358
5816 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7815325
5816 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 8564227
CHEMBL679 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
CHEMBL679 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7651358
CHEMBL679 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7815325
CHEMBL679 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 8564227
DB00668 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
DB00668 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7651358
DB00668 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7815325
DB00668 7079 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 8564227
481 9667 7 None 4 3 Human 6.2 pKi = 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 8719417
9838763 9667 7 None 4 3 Human 6.2 pKi = 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 8719417
CHEMBL72958 9667 7 None 4 3 Human 6.2 pKi = 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 8719417
2765 7730 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
2765 7730 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
515 7730 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
515 7730 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
CHEMBL13852 7730 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
CHEMBL13852 7730 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
DB09202 7730 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
DB09202 7730 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
11079 9510 63 None -22 5 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
3369 9510 63 None -22 5 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
4436 9510 63 None -22 5 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
5509 9510 63 None -22 5 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
CHEMBL761 9510 63 None -22 5 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
DB06711 9510 63 None -22 5 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
2419 7482 28 None -288 11 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11354357
2419 7482 28 None -288 11 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11459121
2419 7482 28 None -288 11 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 32608144
9 7482 28 None -288 11 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11354357
9 7482 28 None -288 11 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11459121
9 7482 28 None -288 11 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 32608144
CHEMBL13647 7482 28 None -288 11 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11354357
CHEMBL13647 7482 28 None -288 11 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11459121
CHEMBL13647 7482 28 None -288 11 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 32608144
2419 7482 28 None -288 11 Rat 7.0 pKi = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11354357
9 7482 28 None -288 11 Rat 7.0 pKi = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11354357
CHEMBL13647 7482 28 None -288 11 Rat 7.0 pKi = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11354357
5268 10428 40 None -251 18 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 11459121
5268 10428 40 None -251 18 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 32608144
53 10428 40 None -251 18 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 11459121
53 10428 40 None -251 18 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 32608144
CHEMBL300555 10428 40 None -251 18 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 11459121
CHEMBL300555 10428 40 None -251 18 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 32608144
4038180 6992 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 20978120
4038180 6992 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 28444738
4038180 6992 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 34355529
4038180 6992 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 7616455
4038180 6992 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 9249248
480 6992 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 20978120
480 6992 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 28444738
480 6992 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 34355529
480 6992 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 7616455
480 6992 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 9249248
CHEMBL109783 6992 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 20978120
CHEMBL109783 6992 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 28444738
CHEMBL109783 6992 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 34355529
CHEMBL109783 6992 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 7616455
CHEMBL109783 6992 14 None -6 8 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 9249248
1531 9046 69 None -7 16 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
3869 9046 69 None -7 16 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
7207 9046 69 None -7 16 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
CHEMBL429 9046 69 None -7 16 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
DB00598 9046 69 None -7 16 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
216249 8087 51 None - 1 Human 7.4 pKi = 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 5 2 5 1.4 Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1 14678390
3469 8087 51 None - 1 Human 7.4 pKi = 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 5 2 5 1.4 Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1 14678390
CHEMBL257978 8087 51 None - 1 Human 7.4 pKi = 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 5 2 5 1.4 Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1 14678390
10453764 8979 0 None -1 3 Rat 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 402 4 0 8 0.9 Clc1ccccc1N1CCN(CC1)CCn1cnc2c1c(=O)n(C)c(=O)n2C 17639498
8896 8979 0 None -1 3 Rat 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 402 4 0 8 0.9 Clc1ccccc1N1CCN(CC1)CCn1cnc2c1c(=O)n(C)c(=O)n2C 17639498
124 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10433504
124 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
124 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
124 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
124 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7651358
124 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7815325
124 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8564227
124 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8719417
2032 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10433504
2032 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
2032 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
2032 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
2032 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7651358
2032 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7815325
2032 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8564227
2032 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8719417
4636 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10433504
4636 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
4636 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
4636 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
4636 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7651358
4636 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7815325
4636 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8564227
4636 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8719417
CHEMBL762 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10433504
CHEMBL762 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
CHEMBL762 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
CHEMBL762 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
CHEMBL762 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7651358
CHEMBL762 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7815325
CHEMBL762 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8564227
CHEMBL762 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8719417
DB00935 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10433504
DB00935 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
DB00935 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
DB00935 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
DB00935 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7651358
DB00935 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7815325
DB00935 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8564227
DB00935 9755 47 None -19 32 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8719417
115 7131 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10812954
115 7131 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 31285236
115 7131 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 32608144
2092 7131 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10812954
2092 7131 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 31285236
2092 7131 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 32608144
7109 7131 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10812954
7109 7131 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 31285236
7109 7131 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 32608144
CHEMBL709 7131 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10812954
CHEMBL709 7131 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 31285236
CHEMBL709 7131 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 32608144
DB00346 7131 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10812954
DB00346 7131 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 31285236
DB00346 7131 71 None -3 7 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 32608144
1588 9105 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
1588 9105 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 32608144
28864 9105 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
28864 9105 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 32608144
43 9105 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
43 9105 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 32608144
CHEMBL157138 9105 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
CHEMBL157138 9105 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 32608144
DB00589 9105 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
DB00589 9105 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 32608144
2398 7741 62 None 1 29 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 32608144
2801 7741 62 None 1 29 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 32608144
701 7741 62 None 1 29 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 32608144
CHEMBL415 7741 62 None 1 29 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 32608144
DB01242 7741 62 None 1 29 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 32608144
2142 9870 58 None -2 37 Rat 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 11331292
4920903 9870 58 None -2 37 Rat 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 11331292
502 9870 58 None -2 37 Rat 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 11331292
5775 9870 58 None -2 37 Rat 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 11331292
CHEMBL597 9870 58 None -2 37 Rat 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 11331292
DB00692 9870 58 None -2 37 Rat 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 11331292
135398737 7745 93 None -5 90 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 11459121
135398737 7745 93 None -5 90 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 32608144
38 7745 93 None -5 90 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 11459121
38 7745 93 None -5 90 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 32608144
722 7745 93 None -5 90 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 11459121
722 7745 93 None -5 90 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 32608144
CHEMBL42 7745 93 None -5 90 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 11459121
CHEMBL42 7745 93 None -5 90 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 32608144
DB00363 7745 93 None -5 90 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 11459121
DB00363 7745 93 None -5 90 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 32608144
180 7189 56 None -12 40 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 32608144
200 7189 56 None -12 40 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 32608144
2160 7189 56 None -12 40 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 32608144
CHEMBL629 7189 56 None -12 40 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 32608144
DB00321 7189 56 None -12 40 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 32608144
1971 9641 38 None -1 30 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 32608144
2404 9641 38 None -1 30 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 32608144
4543 9641 38 None -1 30 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 32608144
CHEMBL445 9641 38 None -1 30 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 32608144
DB00540 9641 38 None -1 30 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 32608144
3584 10549 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 31285236
3584 10549 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 32608144
3584 10549 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 9379432
5401 10549 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 31285236
5401 10549 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 32608144
5401 10549 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 9379432
7302 10549 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 31285236
7302 10549 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 32608144
7302 10549 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 9379432
CHEMBL611 10549 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 31285236
CHEMBL611 10549 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 32608144
CHEMBL611 10549 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 9379432
DB01162 10549 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 31285236
DB01162 10549 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 32608144
DB01162 10549 64 None -2 14 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 9379432
132266 8061 12 None -28 9 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 32608144
132266 8061 12 None -28 9 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 8917649
486 8061 12 None -28 9 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 32608144
486 8061 12 None -28 9 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 8917649
CHEMBL423294 8061 12 None -28 9 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 32608144
CHEMBL423294 8061 12 None -28 9 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 8917649
2142 9870 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 32608144
2142 9870 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7651358
4920903 9870 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 32608144
4920903 9870 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7651358
502 9870 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 32608144
502 9870 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7651358
5775 9870 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 32608144
5775 9870 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7651358
CHEMBL597 9870 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 32608144
CHEMBL597 9870 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7651358
DB00692 9870 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 32608144
DB00692 9870 58 None -2 37 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7651358
2585 7590 103 None -9 22 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 32608144
522 7590 103 None -9 22 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 32608144
551 7590 103 None -9 22 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 32608144
CHEMBL723 7590 103 None -9 22 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 32608144
DB01136 7590 103 None -9 22 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 32608144
1443 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10334511
1443 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 32608144
1443 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 9249248
33625 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10334511
33625 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 32608144
33625 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 9249248
501 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10334511
501 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 32608144
501 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 9249248
CHEMBL279516 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10334511
CHEMBL279516 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 32608144
CHEMBL279516 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 9249248
DB08950 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10334511
DB08950 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 32608144
DB08950 8809 34 None 1 11 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 9249248
2389 10104 118 None -11 66 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 11459121
2389 10104 118 None -11 66 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 32608144
5073 10104 118 None -11 66 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 11459121
5073 10104 118 None -11 66 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 32608144
96 10104 118 None -11 66 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 11459121
96 10104 118 None -11 66 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 32608144
CHEMBL85 10104 118 None -11 66 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 11459121
CHEMBL85 10104 118 None -11 66 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 32608144
DB00734 10104 118 None -11 66 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 11459121
DB00734 10104 118 None -11 66 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 32608144
490 6979 8 None -25 12 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 11354357
9890547 6979 8 None -25 12 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 11354357
CHEMBL268758 6979 8 None -25 12 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 11354357
219050 10146 25 None -15 21 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 12388666
52 10146 25 None -15 21 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 12388666
CHEMBL431367 10146 25 None -15 21 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 12388666
13134 7488 0 None - 1 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None O=C(CCC1=CC=C2C=C3C(C)=CC(C)=[N]3[B+3]([F-])([N-]21)[F-])N4CCN(CC4)C5=NC6=C(C=C(C(OC)=C6)OC)C(N)=N5 19572943
3894573 10166 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10334511
3894573 10166 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 32608144
3894573 10166 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 8632751
3894573 10166 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 9249248
3894573 10166 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 9490024
495 10166 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10334511
495 10166 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 32608144
495 10166 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 8632751
495 10166 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 9249248
495 10166 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 9490024
CHEMBL88272 10166 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10334511
CHEMBL88272 10166 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 32608144
CHEMBL88272 10166 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 8632751
CHEMBL88272 10166 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 9249248
CHEMBL88272 10166 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 9490024
3157 8252 71 None -2 12 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 31285236
3157 8252 71 None -2 12 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 32608144
7170 8252 71 None -2 12 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 31285236
7170 8252 71 None -2 12 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 32608144
954 8252 71 None -2 12 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 31285236
954 8252 71 None -2 12 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 32608144
CHEMBL707 8252 71 None -2 12 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 31285236
CHEMBL707 8252 71 None -2 12 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 32608144
DB00590 8252 71 None -2 12 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 31285236
DB00590 8252 71 None -2 12 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 32608144
497 10138 8 None 61 3 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10369480
9872515 10138 8 None 61 3 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10369480
CHEMBL24777 10138 8 None 61 3 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10369480
489 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 11459121
489 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 32608144
489 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 7651358
489 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 8764344
489 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9190863
489 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9249248
489 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9490024
5640 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 11459121
5640 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 32608144
5640 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 7651358
5640 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 8764344
5640 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9190863
5640 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9249248
5640 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9490024
CHEMBL420060 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 11459121
CHEMBL420060 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 32608144
CHEMBL420060 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 7651358
CHEMBL420060 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 8764344
CHEMBL420060 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9190863
CHEMBL420060 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9249248
CHEMBL420060 6933 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9490024
498 10403 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10812954
498 10403 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 32608144
498 10403 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 7752182
498 10403 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 9190863
5311437 10403 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10812954
5311437 10403 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 32608144
5311437 10403 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 7752182
5311437 10403 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 9190863
178103275 10099 0 None - 1 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 20015090
178103275 10099 0 None - 1 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 23935897
6663 10099 0 None - 1 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 20015090
6663 10099 0 None - 1 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 23935897
499 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10334511
499 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 32608144
499 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7651358
499 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9249248
499 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9490024
5685 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10334511
5685 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 32608144
5685 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7651358
5685 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9249248
5685 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9490024
CHEMBL25554 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10334511
CHEMBL25554 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 32608144
CHEMBL25554 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7651358
CHEMBL25554 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9249248
CHEMBL25554 10849 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9490024
4209 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10334511
4209 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10369480
4209 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
4209 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7651358
4209 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9249248
4209 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9490024
4893 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10334511
4893 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10369480
4893 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
4893 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7651358
4893 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9249248
4893 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9490024
503 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10334511
503 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10369480
503 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
503 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7651358
503 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9249248
503 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9490024
5385 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10334511
5385 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10369480
5385 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
5385 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7651358
5385 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9249248
5385 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9490024
CHEMBL2 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10334511
CHEMBL2 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10369480
CHEMBL2 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
CHEMBL2 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7651358
CHEMBL2 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9249248
CHEMBL2 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9490024
DB00457 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10334511
DB00457 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10369480
DB00457 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
DB00457 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7651358
DB00457 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9249248
DB00457 9937 75 None -1 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9490024
487 10406 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 32608144
487 10406 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 7651358
487 10406 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 9249248
60602 10406 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 32608144
60602 10406 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 7651358
60602 10406 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 9249248
CHEMBL405355 10406 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 32608144
CHEMBL405355 10406 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 7651358
CHEMBL405355 10406 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 9249248
DB09239 10406 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 32608144
DB09239 10406 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 7651358
DB09239 10406 21 None -1 12 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 9249248
3567002 10160 9 None 58 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10369480
3567002 10160 9 None 58 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 32608144
7381 10160 9 None 58 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10369480
7381 10160 9 None 58 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 32608144
CHEMBL56331 10160 9 None 58 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10369480
CHEMBL56331 10160 9 None 58 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 32608144
148842 10718 27 None 8 5 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 9249248
496 10718 27 None 8 5 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 9249248
CHEMBL278865 10718 27 None 8 5 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 9249248
499 10849 18 None -1 14 Rat 9.9 pKi = 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 11331292
499 10849 18 None -1 14 Rat 9.9 pKi = 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9384500
5685 10849 18 None -1 14 Rat 9.9 pKi = 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 11331292
5685 10849 18 None -1 14 Rat 9.9 pKi = 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9384500
CHEMBL25554 10849 18 None -1 14 Rat 9.9 pKi = 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 11331292
CHEMBL25554 10849 18 None -1 14 Rat 9.9 pKi = 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9384500
444 213445 53 None 6 18 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 239 3 1 2 3.3 CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1 None
CHEMBL894 213445 53 None 6 18 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 239 3 1 2 3.3 CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1 None
146570 50228 67 None 1 4 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 324 5 0 3 3.8 CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
CHEMBL1508 50228 67 None 1 4 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 324 5 0 3 3.8 CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
228 7233 28 None -1 23 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
33 7233 28 None -1 23 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
6005 7233 28 None -1 23 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
CHEMBL53 7233 28 None -1 23 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
DB00714 7233 28 None -1 23 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
1209 8439 75 None -1 32 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
203 8439 75 None -1 32 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
3386 8439 75 None -1 32 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
CHEMBL41 8439 75 None -1 32 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
DB00472 8439 75 None -1 32 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
2105 9828 37 None -2 32 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
47811 9828 37 None -2 32 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
48 9828 37 None -2 32 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
CHEMBL531 9828 37 None -2 32 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
DB01186 9828 37 None -2 32 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
2803 7742 58 None -8 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 7742 58 None -8 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 7742 58 None -8 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 7742 58 None -8 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 7742 58 None -8 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
3337 213146 27 None 13 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
65801 213146 27 None 13 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
66264 213146 27 None 13 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
91452 213146 27 None 13 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
CHEMBL87493 213146 27 None 13 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
DB00574 213146 27 None 13 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
521 8186 69 None -16 7 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
5311068 8186 69 None -16 7 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
835 8186 69 None -16 7 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
CHEMBL778 8186 69 None -16 7 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
DB00633 8186 69 None -16 7 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
2726 7706 68 None -5 72 Human 8.0 pKi None 8.0 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 7706 68 None -5 72 Human 8.0 pKi None 8.0 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 7706 68 None -5 72 Human 8.0 pKi None 8.0 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 7706 68 None -5 72 Human 8.0 pKi None 8.0 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 7706 68 None -5 72 Human 8.0 pKi None 8.0 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
2202 9906 96 None -2 21 Human 6.1 pKi None 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
4850 9906 96 None -2 21 Human 6.1 pKi None 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
49 9906 96 None -2 21 Human 6.1 pKi None 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
CHEMBL1371770 9906 96 None -2 21 Human 6.1 pKi None 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
DB12478 9906 96 None -2 21 Human 6.1 pKi None 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
37 7565 60 None -18 17 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
460 7565 60 None -18 17 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
54746 7565 60 None -18 17 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
CHEMBL1201087 7565 60 None -18 17 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
DB00248 7565 60 None -18 17 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
277 8083 62 None -20 50 Human 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 11459121
2913 8083 62 None -20 50 Human 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 11459121
765 8083 62 None -20 50 Human 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 11459121
CHEMBL516 8083 62 None -20 50 Human 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 11459121
DB00434 8083 62 None -20 50 Human 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 11459121
135 9310 43 None -40 56 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 11459121
1796 9310 43 None -40 56 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 11459121
4184 9310 43 None -40 56 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 11459121
CHEMBL6437 9310 43 None -40 56 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 11459121
DB06148 9310 43 None -40 56 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 11459121
1524 8962 96 None -5 51 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 11459121
197 8962 96 None -5 51 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 11459121
3822 8962 96 None -5 51 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 11459121
88 8962 96 None -5 51 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 11459121
CHEMBL51 8962 96 None -5 51 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 11459121
DB12465 8962 96 None -5 51 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 11459121
2470 10425 50 None -208 58 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 11459121
3300 10425 50 None -208 58 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 11459121
5265 10425 50 None -208 58 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 11459121
99 10425 50 None -208 58 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 11459121
CHEMBL267930 10425 50 None -208 58 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 11459121
491 6980 9 None -50 12 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 11354357
9891167 6980 9 None -50 12 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 11354357
CHEMBL13856 6980 9 None -50 12 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 11354357
5074 10105 80 None -6 30 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 11459121
97 10105 80 None -6 30 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 11459121
CHEMBL267777 10105 80 None -6 30 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 11459121
DB12693 10105 80 None -6 30 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 11459121
491 6980 9 None -44 12 Rat 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 11354357
9891167 6980 9 None -44 12 Rat 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 11354357
CHEMBL13856 6980 9 None -44 12 Rat 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 11354357
2601 10552 33 None -5 21 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
443951 10552 33 None -5 21 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
56 10552 33 None -5 21 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
CHEMBL73151 10552 33 None -5 21 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
DB13399 10552 33 None -5 21 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
490 6979 8 None -36 12 Rat 8.6 pKi None 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 11354357
9890547 6979 8 None -36 12 Rat 8.6 pKi None 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 11354357
CHEMBL268758 6979 8 None -36 12 Rat 8.6 pKi None 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 11354357
489 6933 28 None -2 12 Rat 9.0 pKi None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 11331292
5640 6933 28 None -2 12 Rat 9.0 pKi None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 11331292
CHEMBL420060 6933 28 None -2 12 Rat 9.0 pKi None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 11331292
487 10406 21 None -4 12 Rat 9.3 pKi None 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 11331292
60602 10406 21 None -4 12 Rat 9.3 pKi None 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 11331292
CHEMBL405355 10406 21 None -4 12 Rat 9.3 pKi None 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 11331292
DB09239 10406 21 None -4 12 Rat 9.3 pKi None 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 11331292
4209 9937 75 None -1 33 Rat 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 11331292
4893 9937 75 None -1 33 Rat 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 11331292
503 9937 75 None -1 33 Rat 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 11331292
5385 9937 75 None -1 33 Rat 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 11331292
CHEMBL2 9937 75 None -1 33 Rat 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 11331292
DB00457 9937 75 None -1 33 Rat 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 11331292